nvq
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-Q
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811-04347
GMO Trust
(Exact name of registrant as specified in charter)
|
|
|
40 Rowes Wharf, Boston, MA
|
|
02110 |
|
|
|
(Address of principal executive offices)
|
|
(Zip code) |
J.B. Kittredge, Chief Executive Officer, 40 Rowes Wharf, Boston, MA 02110
(Name and address of agent for service)
Registrants telephone number, including area code: 617-346-7646
Date of fiscal year end: 02/29/12
Date of reporting period: 11/30/11
Item 1. Schedule of Investments.
|
|
The Schedules of Investments for each series of the registrant for the periods ended November
30, 2011 are filed herewith. |
GMO Alpha Only Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 88.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 88.8% |
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
17,261,193 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
369,389,527 |
|
|
28,378,805 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
553,386,700 |
|
|
27,582,893 |
|
|
GMO Quality Fund, Class VI |
|
|
602,410,392 |
|
|
25,722,604 |
|
|
GMO U.S. Core Equity Fund, Class VI |
|
|
312,272,417 |
|
|
1,199,545 |
|
|
GMO U.S. Treasury Fund |
|
|
30,000,626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL UNITED STATES |
|
|
1,867,459,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $1,855,551,315) |
|
|
1,867,459,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 2.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 2.2% |
|
|
|
|
|
1,107,841 |
|
|
Vanguard Emerging Markets ETF (a) |
|
|
45,199,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $48,528,455) |
|
|
45,199,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 2.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 2.2% |
|
|
|
|
USD 15,000,000 |
|
|
Bank of Tokyo-Mitsubishi (Tokyo) Time Deposit, 0.03%, due 12/01/11 |
|
|
15,000,000 |
|
USD 1,968,707 |
|
|
Lloyds Bank (London) Time Deposit, 0.03%, due 12/01/11 |
|
|
1,968,707 |
|
USD 15,000,000 |
|
|
Royal Bank of Scotland (London) Time Deposit, 0.03%, due 12/01/11 |
|
|
15,000,000 |
|
USD 15,000,000 |
|
|
Skandinaviska Enskilda Banken, AB (Stockholm) Time Deposit, 0.03%, due 12/01/11 |
|
|
15,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
46,968,707 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $46,968,707) |
|
|
46,968,707 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 93.2%
(Cost $1,951,048,477) |
|
|
1,959,628,282 |
|
|
|
|
|
Other Assets and Liabilities (net) 6.8% |
|
|
143,336,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
2,102,964,570 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
AUD |
|
|
4,912,247 |
|
|
$ |
5,043,023 |
|
|
$ |
(59,067 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
5,488,718 |
|
|
|
5,634,841 |
|
|
|
(87,366 |
) |
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
AUD |
|
|
4,586,569 |
|
|
|
4,708,674 |
|
|
|
(207,645 |
) |
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
AUD |
|
|
3,303,403 |
|
|
|
3,391,347 |
|
|
|
(67,097 |
) |
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
AUD |
|
|
5,209,374 |
|
|
|
5,348,060 |
|
|
|
(77,997 |
) |
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
CHF |
|
|
5,980,971 |
|
|
|
6,548,841 |
|
|
|
91,149 |
|
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
CHF |
|
|
6,597,275 |
|
|
|
7,223,660 |
|
|
|
84,963 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
CHF |
|
|
4,507,208 |
|
|
|
4,935,150 |
|
|
|
59,263 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
CHF |
|
|
3,128,070 |
|
|
|
3,425,068 |
|
|
|
(4,113 |
) |
|
12/16/11 |
|
|
Bank of America N.A. |
|
DKK |
|
|
6,607,373 |
|
|
|
1,194,146 |
|
|
|
13,076 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
DKK |
|
|
4,173,855 |
|
|
|
754,338 |
|
|
|
11,915 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
DKK |
|
|
4,521,490 |
|
|
|
817,166 |
|
|
|
14,000 |
|
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
EUR |
|
|
6,305,930 |
|
|
|
8,474,152 |
|
|
|
135,032 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
EUR |
|
|
11,709,295 |
|
|
|
15,735,402 |
|
|
|
274,483 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
7,605,198 |
|
|
|
10,220,158 |
|
|
|
53,270 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
EUR |
|
|
9,855,026 |
|
|
|
13,243,564 |
|
|
|
234,436 |
|
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
EUR |
|
|
9,367,977 |
|
|
|
12,589,049 |
|
|
|
208,432 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
EUR |
|
|
8,425,608 |
|
|
|
11,322,657 |
|
|
|
208,462 |
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
GBP |
|
|
3,968,901 |
|
|
|
6,225,942 |
|
|
|
(13,901 |
) |
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
GBP |
|
|
5,360,946 |
|
|
|
8,409,617 |
|
|
|
(17,485 |
) |
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
GBP |
|
|
5,595,736 |
|
|
|
8,777,928 |
|
|
|
(12,319 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
3,591,294 |
|
|
|
5,633,597 |
|
|
|
9,044 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
GBP |
|
|
4,124,354 |
|
|
|
6,469,798 |
|
|
|
7,912 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
GBP |
|
|
6,857,488 |
|
|
|
10,757,215 |
|
|
|
(19,130 |
) |
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
GBP |
|
|
8,261,631 |
|
|
|
12,959,868 |
|
|
|
(48,285 |
) |
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
HKD |
|
|
26,486,794 |
|
|
|
3,409,612 |
|
|
|
(6,277 |
) |
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
HKD |
|
|
16,069,259 |
|
|
|
2,068,576 |
|
|
|
(912 |
) |
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
HKD |
|
|
14,772,798 |
|
|
|
1,901,684 |
|
|
|
(1,395 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
JPY |
|
|
1,149,714,290 |
|
|
|
14,828,510 |
|
|
|
129,120 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
JPY |
|
|
775,784,777 |
|
|
|
10,005,731 |
|
|
|
112,497 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
JPY |
|
|
909,118,951 |
|
|
|
11,725,417 |
|
|
|
127,194 |
|
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
JPY |
|
|
538,195,012 |
|
|
|
6,941,403 |
|
|
|
76,744 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
JPY |
|
|
1,035,083,157 |
|
|
|
13,350,048 |
|
|
|
142,882 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
NOK |
|
|
5,296,702 |
|
|
|
916,417 |
|
|
|
17,186 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
NOK |
|
|
8,950,217 |
|
|
|
1,548,535 |
|
|
|
18,803 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
NZD |
|
|
378,476 |
|
|
|
295,239 |
|
|
|
3,541 |
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
SEK |
|
|
12,430,758 |
|
|
|
1,835,577 |
|
|
|
(3,844 |
) |
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
SEK |
|
|
6,878,269 |
|
|
|
1,015,674 |
|
|
|
9,841 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
SEK |
|
|
9,883,287 |
|
|
|
1,459,407 |
|
|
|
11,141 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
SEK |
|
|
10,411,349 |
|
|
|
1,537,383 |
|
|
|
16,926 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
SEK |
|
|
11,613,817 |
|
|
|
1,714,945 |
|
|
|
20,067 |
|
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
SGD |
|
|
2,199,618 |
|
|
|
1,716,266 |
|
|
|
8,467 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
SGD |
|
|
3,659,591 |
|
|
|
2,855,419 |
|
|
|
(389 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
258,969,104 |
|
|
$ |
1,472,624 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
Contracts |
|
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
54 |
|
|
Amesterdam IDX
|
|
December 2011
|
|
$ |
4,373,724 |
|
|
$ |
(120,269 |
) |
|
386 |
|
|
CAC 40
|
|
December 2011
|
|
|
16,398,769 |
|
|
|
(581,983 |
) |
|
73 |
|
|
DAX
|
|
December 2011
|
|
|
14,995,837 |
|
|
|
(2,121,298 |
) |
|
484 |
|
|
FTSE 100
|
|
December 2011
|
|
|
41,888,502 |
|
|
|
(2,406,163 |
) |
|
41 |
|
|
FTSE/MIB
|
|
December 2011
|
|
|
4,220,950 |
|
|
|
(521,542 |
) |
|
39 |
|
|
Hang Seng
|
|
December 2011
|
|
|
4,691,594 |
|
|
|
(132,598 |
) |
|
52 |
|
|
IBEX 35
|
|
December 2011
|
|
|
5,910,565 |
|
|
|
(98,485 |
) |
|
62 |
|
|
MSCI Singapore
|
|
December 2011
|
|
|
3,037,050 |
|
|
|
(88,101 |
) |
|
387 |
|
|
OMXS 30
|
|
December 2011
|
|
|
5,658,010 |
|
|
|
(176,456 |
) |
|
4,280 |
|
|
Russell 2000 Mini
|
|
December 2011
|
|
|
315,307,600 |
|
|
|
(22,433,779 |
) |
|
394 |
|
|
S&P 400 E-Mini Index
|
|
December 2011
|
|
|
34,794,140 |
|
|
|
(1,818,408 |
) |
|
10,228 |
|
|
S&P 500 E-Mini Index
|
|
December 2011
|
|
|
637,204,400 |
|
|
|
(30,119,961 |
) |
|
150 |
|
|
SPI 200
|
|
December 2011
|
|
|
16,384,340 |
|
|
|
(628,262 |
) |
|
414 |
|
|
TOPIX
|
|
December 2011
|
|
|
39,768,874 |
|
|
|
(149,116 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,144,634,355 |
|
|
$ |
(61,396,421 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
Fund Pays |
|
Fund Receives |
|
(Depreciation) |
|
|
48,194,814 |
|
|
|
1/27/2012 |
|
|
BNP Paribas |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.54% |
|
$ |
6,294,299 |
|
|
40,768,636 |
|
|
|
2/7/2012 |
|
|
Citibank N.A. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.50% |
|
|
5,756,481 |
|
|
71,790,697 |
|
|
|
3/12/2012 |
|
|
JP Morgan Chase Bank, N.A. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.59% |
|
|
10,527,493 |
|
|
34,844,229 |
|
|
|
3/15/2012 |
|
|
Morgan Stanley Capital Services Inc. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.55% |
|
|
3,779,440 |
|
|
67,674,918 |
|
|
|
3/21/2012 |
|
|
BNP Paribas |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.60% |
|
|
5,680,516 |
|
|
41,682,173 |
|
|
|
4/3/2012 |
|
|
Deutsche Bank AG |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.65% |
|
|
5,569,041 |
|
|
199,997,901 |
|
|
|
5/9/2012 |
|
|
JP Morgan Chase Bank, N.A. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.60% |
|
|
33,007,220 |
|
|
124,881,524 |
|
|
|
5/11/2012 |
|
|
BNP Paribas |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.61% |
|
|
20,335,993 |
|
|
58,999,209 |
|
|
|
6/12/2012 |
|
|
Citibank N.A. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.56% |
|
|
7,257,536 |
|
|
55,599,968 |
|
|
|
7/19/2012 |
|
|
Citibank N.A. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.52% |
|
|
6,635,588 |
|
|
42,003,150 |
|
|
|
8/7/2012 |
|
|
CitiBank N.A. |
|
MSCI Daily Total Return EAFE |
|
12 month USD LIBOR BBA minus 0.54% |
|
|
2,498,868 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
107,342,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient
cash and/or securities to cover any commitments or collateral requirements of the relevant broker
or exchange.
Notes to Schedule of Investments:
BBA British Banks Association
ETF Exchange-Traded Fund
MSCI Morgan Stanley Capital International
USD LIBOR London Interbank Offered Rate denominated in United States Dollars
(a) |
|
Represents an investment to obtain exposure in emerging markets. The Vanguard Emerging Markets ETF
is a separate investment portfolio of Vanguard, Inc., a registered investment company. The Vanguard
Emerging Markets ETF prospectus states that the fund invests substantially all (normally about 95%)
of its assets in the common stocks included in the MSCI Emerging Market Index, while employing a
form of sampling to reduce risk. |
Currency Abbreviations:
AUD Australian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes
and gross and net unrealized appreciation (depreciation) in value of investments were
as follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$2,115,549,146
|
|
$
|
|
$(155,920,864)
|
|
$(155,920,864) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO International Growth
Equity Fund, Class IV |
|
$ |
442,255,674 |
|
|
$ |
266,853,504 |
|
|
$ |
274,344,115 |
|
|
$ |
3,824,404 |
|
|
$ |
|
|
|
$ |
369,389,527 |
|
GMO International
Intrinsic Value Fund,
Class IV |
|
|
442,388,249 |
|
|
|
388,351,490 |
|
|
|
182,323,378 |
|
|
|
10,650,746 |
|
|
|
|
|
|
|
553,386,700 |
|
GMO Quality Fund, Class VI |
|
|
580,359,319 |
|
|
|
349,740,323 |
|
|
|
346,412,842 |
|
|
|
10,856,623 |
|
|
|
|
|
|
|
602,410,392 |
|
GMO U.S. Core Equity
Fund, Class VI |
|
|
300,019,377 |
|
|
|
175,514,348 |
|
|
|
160,978,985 |
|
|
|
5,280,748 |
|
|
|
|
|
|
|
312,272,417 |
|
GMO U.S. Treasury Fund |
|
|
95,036,569 |
|
|
|
1,256,123,669 |
|
|
|
1,321,213,634 |
|
|
|
38,052 |
|
|
|
5,618 |
|
|
|
30,000,626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
1,860,059,188 |
|
|
$ |
2,436,583,334 |
|
|
$ |
2,285,272,954 |
|
|
$ |
30,650,573 |
|
|
$ |
5,618 |
|
|
$ |
1,867,459,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the funds in which the Fund invests (underlying funds) and other investment
funds are generally valued at their net asset value. Investments held by the underlying funds
are valued as follows: Securities listed on a securities exchange (other than exchange-traded
options) for which market quotations are readily available are valued at (i) the last sale price
or (ii) official closing price as of the close of regular trading on the New York Stock Exchange
(NYSE) or, (iii) if there is no such reported sale or official closing price (or in the event
the Manager deems the over-the-counter (OTC) market to be a better indicator of market value),
at the most recent quoted price. Unlisted securities for which market quotations are readily
available are generally valued at the most recent quoted price. Non-emerging market debt
instruments with a remaining maturity of sixty days or less may be valued at amortized cost
(unless circumstances dictate otherwise; for example, if the issuers creditworthiness has
become impaired), which approximates market value. Derivatives and other securities for which
quotations are not readily available or whose values the Manager has determined to be unreliable
are valued at fair value as determined in good faith by the Trustees or persons acting at their
direction pursuant to procedures approved by the Trustees. Although the goal of fair valuation
is to determine the amount the owner of the securities might reasonably expect to receive upon
their current sale, because of the uncertainty inherent in fair value pricing, the value
determined for a particular security may be materially different from the value realized upon
its sale. As of November 30, 2011, the total value of securities held directly and indirectly
that were fair valued using methods determined in good faith by or at the direction of the
Trustees of the Trust represented less than 0.1% of net assets. The Fund and the underlying
funds classify such securities (levels defined below) as Level 3. For the period ended November
30, 2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the
creditworthiness of its counterparties. See Derivative financial instruments below for a
further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the underlying funds.
|
|
|
Security
Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
44.2% |
Futures Contracts |
|
(0.2)% |
Swap Agreements |
|
5.1% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
1,867,459,662 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,867,459,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
1,867,459,662 |
|
|
|
|
|
|
|
|
|
|
|
1,867,459,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
45,199,913 |
|
|
|
|
|
|
|
|
|
|
|
45,199,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS |
|
|
45,199,913 |
|
|
|
|
|
|
|
|
|
|
|
45,199,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
46,968,707 |
|
|
|
|
|
|
|
|
|
|
|
46,968,707 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
1,959,628,282 |
|
|
|
|
|
|
|
|
|
|
|
1,959,628,282 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
2,099,846 |
|
|
|
|
|
|
|
2,099,846 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
107,342,475 |
|
|
|
|
|
|
|
107,342,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
109,442,321 |
|
|
|
|
|
|
|
109,442,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,959,628,282 |
|
|
$ |
109,442,321 |
|
|
$ |
|
|
|
$ |
2,069,070,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
$ |
|
|
|
$ |
(627,222 |
) |
|
$ |
|
|
|
$ |
(627,222 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
(54,372,148 |
) |
|
|
(7,024,273 |
) |
|
|
|
|
|
|
(61,396,421 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
(54,372,148 |
) |
|
|
(7,651,495 |
) |
|
|
|
|
|
|
(62,023,643 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(54,372,148 |
) |
|
$ |
(7,651,495 |
) |
|
$ |
|
|
|
$ |
(62,023,643 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds indirect
investments in securities using Level 3 inputs were less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. The Fund and some of the underlying funds are
non-diversified investment companies under the Investment Company Act of 1940 (the 1940 Act)
and therefore a decline in the market value of a particular security held by the Fund or an
underlying fund may affect the Funds or the underlying funds performance more than if the Fund
or the underlying fund were diversified. Selected risks of investing in the Fund are summarized
below, including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund or an underlying fund purchases equity investments at a
discount from their value as determined by the Manager, the Fund runs the risk that the
market prices of these investments will not increase to that value for a variety of
reasons, one of which may be the Managers overestimation of the
value of those investments. The Fund or an underlying fund also may purchase equity
investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. In addition, the value of the
Funds shares will be adversely affected if the equity investments that are the subject of
the Funds short positions appreciate in value.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent a Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests will not perform as expected or that the Fund will invest in underlying funds
with higher fees or expenses.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Leveraging Risk The use of reverse repurchase agreements and other derivatives may
cause the Funds portfolio to be leveraged. The Fund and some underlying funds are not
limited in the extent to which they may use derivatives or in the absolute face value of
their derivative positions. Leverage increases the Funds portfolio losses when the value
of its investments decline.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies, or that the
U.S. dollar will decline in value relative to the foreign currency being hedged.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Short Sales Risk The Fund runs the risk that the Funds loss on a short sale of
securities that the Fund does not own is unlimited.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Fund is not limited in the extent to which it
uses derivatives or in the absolute face value of its derivative positions. As a result, the
Fund may be leveraged in terms of aggregate exposure of its assets, and its net long exposure
may exceed 100% of its net assets. The Funds foreign currency exposure may differ significantly
from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to hedge some or all of the currency exposure of
the underlying Funds and assets in which the Fund invests, adjust against anticipated currency
exchange rate changes and adjust exposure to foreign currencies. Forward currency
contracts outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until
the contracts expire or are closed. Futures contracts involve, to varying degrees, risk of loss
in excess of the variation margin. Under some circumstances, futures exchanges may establish
daily limits on the amount that the price of a futures contract can vary from the previous days
settlement price, thereby effectively preventing liquidation of unfavorable positions. Futures
contracts expose the Fund to the risk that it may not be able to enter into a closing
transaction due to an illiquid market. Because regular trading on many foreign
exchanges closes prior to the close of the NYSE, closing prices for these foreign futures
contracts (including foreign index futures) do not reflect the events that occur after that
close but before the close of the NYSE. As a result, the Fund and the underlying funds generally
value foreign futures contracts using fair value prices, which are based on local closing prices
adjusted by a factor, supplied by a third party vendor using that vendors proprietary
models. During the period ended November 30, 2011, the Fund used futures contracts
to hedge some or all of the broad market exposure of the underlying Funds and assets in
which the Fund invests. Futures contracts outstanding at the end of the period are
listed in the Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on
notional amounts. To the extent the return of the reference asset exceeds or falls short of the
interest payments, one party is entitled to receive a payment from or obligated to make a
payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to hedge some or all of the broad market exposure of the underlying Funds and assets in which
the Fund invests. Swap agreements outstanding at the end of the period are listed in
the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward
currency contracts |
|
$ |
|
|
|
$ |
2,099,846 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,099,846 |
|
Unrealized appreciation on swap
agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
107,342,475 |
|
|
|
|
|
|
|
107,342,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
2,099,846 |
|
|
$ |
|
|
|
$ |
107,342,475 |
|
|
$ |
|
|
|
$ |
109,442,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward
currency contracts |
|
$ |
|
|
|
$ |
(627,222 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(627,222 |
) |
Unrealized depreciation on futures
contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(61,396,421 |
) |
|
|
|
|
|
|
(61,396,421 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(627,222 |
) |
|
$ |
|
|
|
$ |
(61,396,421 |
) |
|
$ |
|
|
|
$ |
(62,023,643 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table above is based
on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to
have a greater impact on the Fund (with correspondingly greater risk) the greater
the notional amount. For further information on notional amounts, see
the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures
contracts) or notional amounts (swap agreements) outstanding at each month-end, was as follows for
the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
Average amount outstanding |
|
$ |
366,342,801 |
|
|
$ |
1,277,077,198 |
|
|
$ |
745,131,487 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Alternative Asset Opportunity Fund
(A Series of GMO Trust)
Consolidated Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) / |
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 18.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 18.8% |
|
|
|
|
|
8,050,032 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b)(c) |
|
|
8,077,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $8,145,406) |
|
|
8,077,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 45.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 45.5% |
|
|
|
|
|
791,020 |
|
|
GMO Short-Duration Collateral Fund |
|
|
5,228,644 |
|
|
573,668 |
|
|
GMO U.S. Treasury Fund |
|
|
14,347,435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Affiliated Issuers |
|
|
19,576,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $20,778,576) |
|
|
19,576,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 36.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 1.2% |
|
|
|
|
|
331,329 |
|
|
SSgA USD
Liquidity Fund-Class S2 Shares, 0.00%(a)(d)(e) |
|
|
331,329 |
|
|
185,678 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(e) |
|
|
185,678 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Money Market Funds |
|
|
517,007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 34.8% |
|
|
|
|
|
1,900,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (c)(f) |
|
|
1,898,301 |
|
|
13,100,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(f) |
|
|
13,088,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government |
|
|
14,986,590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $15,503,060) |
|
|
15,503,597 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.3%
(Cost $44,427,042) |
|
|
43,156,748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.3%) |
|
|
(141,386 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
43,015,362 |
|
|
|
|
|
|
|
|
|
A summary
of outstanding financial instruments at November 30, 2011 is as
follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
1,500,000 |
|
|
$ |
1,541,882 |
|
|
$ |
1,317 |
|
|
12/13/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
700,000 |
|
|
|
686,105 |
|
|
|
(35 |
) |
|
1/10/12 |
|
|
Credit Suisse International |
|
GBP |
|
|
1,500,000 |
|
|
|
2,352,521 |
|
|
|
(13,799 |
) |
|
2/14/12 |
|
|
Deutsche Bank AG |
|
JPY |
|
|
211,600,000 |
|
|
|
2,732,525 |
|
|
|
(21,249 |
) |
|
1/24/12 |
|
|
Credit Suisse International |
|
NZD |
|
|
200,000 |
|
|
|
155,589 |
|
|
|
(1,351 |
) |
|
1/24/12 |
|
|
Deutsche Bank AG |
|
NZD |
|
|
1,500,000 |
|
|
|
1,166,913 |
|
|
|
(15,667 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
8,635,535 |
|
|
$ |
(50,784 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
1,200,000 |
|
|
$ |
1,233,506 |
|
|
$ |
(32,675 |
) |
|
12/13/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
6,000,000 |
|
|
|
5,880,901 |
|
|
|
(10,830 |
) |
|
1/10/12 |
|
|
Credit Suisse International |
|
GBP |
|
|
1,700,000 |
|
|
|
2,666,190 |
|
|
|
17,884 |
|
|
1/24/12 |
|
|
Deutsche Bank AG |
|
NZD |
|
|
800,000 |
|
|
|
622,354 |
|
|
|
(13,314 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
10,402,951 |
|
|
$ |
(38,935 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys
|
|
|
|
|
|
|
|
|
|
|
|
|
|
52 |
|
|
FTSE 100
|
|
December 2011
|
|
$ |
4,500,419 |
|
|
$ |
75,767 |
|
|
133 |
|
|
FTSE JSE 40
|
|
December 2011
|
|
|
4,859,644 |
|
|
|
161,081 |
|
|
16 |
|
|
Gasoline RBOB(a)
|
|
December 2011
|
|
|
1,719,245 |
|
|
|
(53,347 |
) |
|
18 |
|
|
Live Cattle(a)
|
|
February 2012
|
|
|
889,920 |
|
|
|
(15,914 |
) |
|
9 |
|
|
S&P 500 Index
|
|
December 2011
|
|
|
2,803,500 |
|
|
|
72,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
14,772,728 |
|
|
$ |
240,271 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
Hang Seng
|
|
December 2011
|
|
$ |
721,784 |
|
|
$ |
(24,548 |
) |
|
2 |
|
|
Light Sweet Crude Oil(a)
|
|
December 2011
|
|
|
200,720 |
|
|
|
(2,827 |
) |
|
7 |
|
|
MSCI Taiwan
|
|
December 2011
|
|
|
177,597 |
|
|
|
(6,257 |
) |
|
48 |
|
|
Natural Gas(a)
|
|
December 2011
|
|
|
1,704,000 |
|
|
|
175,911 |
|
|
56 |
|
|
Nikkei 225
|
|
December 2011
|
|
|
6,239,303 |
|
|
|
5,020 |
|
|
43 |
|
|
S&P TSE 60 Index
|
|
December 2011
|
|
|
5,855,875 |
|
|
|
(63,410 |
) |
|
5 |
|
|
Silver(a)
|
|
March 2012
|
|
|
820,100 |
|
|
|
27,739 |
|
|
14 |
|
|
Soybean(a)
|
|
January 2012
|
|
|
791,875 |
|
|
|
64,862 |
|
|
15 |
|
|
SPI 200
|
|
December 2011
|
|
|
1,638,435 |
|
|
|
(12,408 |
) |
|
5 |
|
|
UK Gilt Long Bond
|
|
March 2012
|
|
|
890,351 |
|
|
|
(1,267 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
19,040,040 |
|
|
$ |
162,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient
cash and/or securities to cover any
commitments or collateral requirements of the relevant broker or exchange.
|
|
|
Notes to Consolidated Schedule of Investments: |
|
RBOB Reformulated Blendstock
for Oxygenate Blending. |
|
(a) |
|
All or a portion of this security is owned by GMO Alternative Asset SPC Ltd., which is a 100% owned
subsidiary of GMO Alternative Asset Opportunity Fund. |
|
(b) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument or
financial statistic. |
|
(c) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options, if
any. |
|
(d) |
|
Fund is domiciled in Ireland. |
|
(e) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(f) |
|
Rate shown represents yield-to-maturity. |
Currency Abbreviations:
AUD
Australian Dollar
CAD Canadian Dollar
GBP British Pound
JPY Japanese Yen
NZD New Zealand Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
52,627,615 |
|
|
$ |
95,344 |
|
|
$ |
(9,566,211 |
) |
|
$ |
(9,470,867 |
) |
Investments in Affiliated Issuers
In addition to its consolidated subsidiary, the Fund makes investments in other GMO Trust funds
(underlying funds). The Schedule of Investments of the underlying funds should be read in
conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Short-Duration Collateral Fund |
|
$ |
8,210,791 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
62,197 |
|
|
$ |
|
|
|
$ |
2,739,474 |
|
|
$ |
5,228,644 |
|
GMO U.S. Treasury Fund |
|
|
5,481,937 |
|
|
|
11,958,378 |
|
|
|
3,095,000 |
|
|
|
2,096 |
|
|
|
280 |
|
|
|
|
|
|
|
14,347,435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
13,692,728 |
|
|
$ |
11,958,378 |
|
|
$ |
3,095,000 |
|
|
$ |
64,293 |
|
|
$ |
280 |
|
|
$ |
2,739,474 |
|
|
$ |
19,576,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined at the end of the
fiscal year ending February 29, 2012. |
Basis of presentation and principles of consolidation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
The accompanying consolidated Schedule of Investments include the accounts of the GMO
Alternative Asset Opportunity Fund and its wholly owned investment in GMO Alternative Asset SPC
Ltd. The consolidated Schedule of Investments include 100% of the assets and liabilities of GMO
Alternative Asset SPC Ltd.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 0.4% of net assets. The underlying funds classify such securities (levels
defined below) as Level 3. For the period ended November 30, 2011, the Fund did not
reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its
counterparties. See Derivative financial instruments below for a further discussion
on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Futures Contracts |
|
0.5% |
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 1.3% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the
valuation of the Funds investments. The inputs or methodology used for valuing securities are
not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. They may also include fair value adjustments provided by an
independent pricing service applied to equity securities (including the value of equity
securities that underlie futures (to the extent the market for such futures closes prior to the
close of the NYSE) and other derivatives) due to market events that have occurred since the
local market close but prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
$ |
|
|
|
$ |
8,077,072 |
|
|
$ |
|
|
|
$ |
8,077,072 |
|
Mutual Funds |
|
|
19,576,079 |
|
|
|
|
|
|
|
|
|
|
|
19,576,079 |
|
Short-Term Investments |
|
|
15,503,597 |
|
|
|
|
|
|
|
|
|
|
|
15,503,597 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
35,079,676 |
|
|
|
8,077,072 |
|
|
|
|
|
|
|
43,156,748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
|
|
|
|
|
19,201 |
|
|
|
|
|
|
|
19,201 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Physical commodity contract risk |
|
|
268,512 |
|
|
|
|
|
|
|
|
|
|
|
268,512 |
|
Equity risk |
|
|
72,684 |
|
|
|
241,868 |
|
|
|
|
|
|
|
314,552 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
35,420,872 |
|
|
$ |
8,338,141 |
|
|
$ |
|
|
|
$ |
43,759,013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
$ |
|
|
|
$ |
(108,920 |
) |
|
$ |
|
|
|
$ |
(108,920 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Physical commodity contract risk |
|
|
(72,088 |
) |
|
|
|
|
|
|
|
|
|
|
(72,088 |
) |
Equity risk |
|
|
(63,410 |
) |
|
|
(43,213 |
) |
|
|
|
|
|
|
(106,623 |
) |
Interest rate risk |
|
|
(1,267 |
) |
|
|
|
|
|
|
|
|
|
|
(1,267 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(136,765 |
) |
|
$ |
(152,133 |
) |
|
$ |
|
|
|
$ |
(288,898 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds indirect
investments in securities and derivative financial instruments using Level 3 inputs were 8.7%
and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Loan agreements
The Fund may invest in loans to corporate, governmental, or other borrowers. The Funds
investments in loans may be in the form of participations in loans or assignments of all or a
portion of loans. A loan is often administered by a bank or other financial institution that
acts as agent for all holders. The agent administers the terms of the loan, as specified in the
loan agreement. When investing in a loan participation, (i) the Fund has the right to receive
payments of principal, interest and any fees to which it is entitled only from the party from
whom the Fund has purchased the participation and only upon receipt by that party of payments
from the borrower and (ii) the Fund generally has no right to enforce compliance by the borrower
with the terms of the loan agreement or to vote on matters arising under the loan agreement.
Thus, the Fund may be subject to credit risk both of the party from whom it purchased the loan
participation and the borrower and the Fund may have minimal control over the terms of any loan
modification. When the Fund purchases assignments of loans, it acquires direct rights against
the borrower. The Fund had no loan agreements outstanding at the end of the period.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Because the Fund invests in its wholly-owned subsidiary, other GMO Funds, including GMO
Short-Duration Collateral Fund and GMO U.S. Treasury Fund, and unaffiliated money market funds,
it is exposed to the risks to which its wholly-owned subsidiary and the other underlying funds
in which it invests are exposed, as well as the risk that investments made through its
wholly-owned subsidiary will not perform as expected. Therefore, unless otherwise noted herein,
the selected risks summarized below include both direct and indirect risks of the Fund, and as
indicated above, references in this section to investments made by the Fund include those made
both directly by the Fund and indirectly by the Fund through its wholly-owned subsidiary,
another GMO Fund or an unaffiliated money market fund.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies.
Market Risk Equity Securities The market value of equity investments may
decline due to factors affecting the issuing companies, their industries, or the economy
and equity markets generally. If the Fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. The Fund also may
purchase equity investments that typically trade at higher multiples of current earnings
than other securities, and the market values of these investments often are more sensitive
to changes in future earnings expectations than those other securities. Declines in stock
market prices generally are likely to reduce the net asset value of the Funds shares.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Commodities Risk Because of the Funds exposure to commodity markets, the value
of its shares is affected by factors particular to the commodity markets and may fluctuate
more than the value of shares of a fund with a broader range of investments.
Foreign Investment Risk The market prices of many foreign securities fluctuate
more than those of U.S. securities. Many foreign markets are less stable, smaller, less
liquid and less regulated than U.S. markets, and the cost of trading in those markets often
is higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other
income payable on foreign securities, on transactions in those securities and on the
repatriation of proceeds generated from those securities. Also, many foreign markets require
a license for the Fund to invest directly in those markets, and the Fund is subject to the
risk that it could not invest if its license were terminated or suspended. In some foreign
markets, prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of foreign
issuers) tend to be greater for investments in companies tied economically to emerging
countries, the economies of which tend to be more volatile than the economies of developed
countries.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Short Sales Risk The Fund runs the risk that the Funds loss on a short sale of
securities that the Fund does not own is unlimited.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. Below investment grade securities have speculative characteristics, and changes in
economic conditions or other circumstances are more likely to impair the capacity of
issuers to make principal and interest payments than is the case with issuers of investment
grade securities.
Liquidity Risk Low trading volume, lack of a market maker, a large size position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests will not perform as expected or that the Fund will invest in underlying funds
with higher fees or expenses.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the
decline in the net assets of the Fund below a certain level over a specified period of time and
entitle a counterparty to elect to terminate early with respect to some or all the transactions
under the ISDA Agreement with that counterparty. Such an election by one or more of the
counterparties could have a material adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives
with specialized terms because the value of those derivatives in some cases is determined only
by reference to similar derivatives with more standardized terms. As a result, incorrect
valuations may result in increased cash payments to counterparties, undercollateralization
and/or errors in the calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to adjust
exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward
currency contracts outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain markets and enhance the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust exposure to certain markets. The Fund had no swap agreements outstanding at the end
of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by
risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Physical commodity |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
Unrealized appreciation on forward currency contracts |
|
$ |
|
|
|
$ |
19,201 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
19,201 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
314,552 |
|
|
|
268,512 |
|
|
|
583,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
19,201 |
|
|
$ |
|
|
|
$ |
314,552 |
|
|
$ |
268,512 |
|
|
$ |
602,265 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(108,920 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(108,920 |
) |
Unrealized depreciation on futures contracts* |
|
|
(1,267 |
) |
|
|
|
|
|
|
|
|
|
|
(106,623 |
) |
|
|
(72,088 |
) |
|
|
(179,978 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(1,267 |
) |
|
$ |
(108,920 |
) |
|
$ |
|
|
|
$ |
(106,623 |
) |
|
$ |
(72,088 |
) |
|
$ |
(288,898 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures
contracts), or notional amounts (swap agreements), outstanding at each month-end, was as follows
for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
Currency |
|
Futures |
|
Swap |
|
|
Contracts |
|
Contracts |
|
Agreements |
Average amount outstanding |
|
$ |
3,451,156 |
|
$ |
9,428,733 |
|
$ |
9,648,555 |
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Asset Allocation Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($)/ |
|
|
|
|
|
|
Shares/ Number of
Contracts/ Principal
Amount |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 104.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 104.0% |
|
|
|
|
|
116,000,000 |
|
|
U.S. Treasury Note, 1.00%, due 07/15/13 |
|
|
117,431,904 |
|
|
78,000,000 |
|
|
U.S. Treasury Note, 1.13%, due 06/15/13(a)(b) |
|
|
79,066,416 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government |
|
|
196,498,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $195,701,646) |
|
|
196,498,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 1.9% |
|
|
|
|
|
142,787 |
|
|
GMO U.S. Treasury Fund |
|
|
3,571,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $3,571,109) |
|
|
3,571,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPTIONS PURCHASED 2.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options on Futures 0.3% |
|
|
|
|
|
600 |
|
|
10 Year U.S. Treasury Note Future Options Call, Expires 12/23/11, Strike 129.50 |
|
|
553,125 |
|
|
600 |
|
|
10 Year U.S. Treasury Note Future Options Call, Expires 12/23/11, Strike 132.50 |
|
|
75,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Options on Futures |
|
|
628,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options on Interest Rate Swaps 1.7% |
|
|
|
|
|
300,000,000 |
|
|
Swaption Call, Expires 12/01/11, Strike 1.00%,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 300,000,000 USD in which it will
pay 3 month USD LIBOR and will receive 1.00%, maturing on December 5, 2013,
(OTC) (CP Merrill Lynch Capital Services Inc.) |
|
|
2,016,300 |
|
|
250,000,000 |
|
|
Swaption Call, Expires 05/21/12, Strike 0.77%,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 250,000,000 USD in which it will
pay 3 month USD LIBOR and will receive 0.77%, maturing on May 23, 2013,
(OTC) (CP Merrill Lynch Capital Services Inc.) |
|
|
586,250 |
|
|
250,000,000 |
|
|
Swaption Call, Expires 05/20/13, Strike 0.77%,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 250,000,000 USD in which it will
pay a 3 month USD LIBOR and will receive 0.77%, maturing on May 22, 2014,
(OTC) (CP Merrill Lynch Capital Services Inc.) |
|
|
643,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Options on Interest Rate Swaps |
|
|
3,245,550 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL OPTIONS PURCHASED (COST $2,686,366) |
|
|
3,873,675 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.7% |
|
|
|
|
|
1,347,409 |
|
|
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(c) |
|
|
1,347,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $1,347,409) |
|
|
1,347,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 108.6%
(Cost $203,306,530) |
|
|
205,290,513 |
|
|
|
|
|
Other Assets and Liabilities (net) (8.6%) |
|
|
(16,341,704 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
188,948,809 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
|
Appreciation |
|
Contracts |
|
|
Type |
|
Date |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,275 |
|
|
Euro Dollar 90 Day |
|
March 2012 |
|
$ |
316,837,500 |
|
|
$ |
192,763 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,275 |
|
|
Euro Dollar 90 Day |
|
March 2013 |
|
$ |
316,582,500 |
|
|
$ |
(346,848 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reverse Repurchase Agreements
|
|
|
|
|
|
|
|
|
Face Value |
|
Description |
|
Market Value |
|
USD |
|
12,983,750 |
|
Deutsche Bank AG,
0.15%, dated
11/03/11, to be
repurchased on
demand at face
value plus accrued
interest with a
stated maturity
date of 12/5/11. |
|
$ |
(12,985,211 |
) |
USD |
|
4,993,750 |
|
Deutsche Bank AG,
0.16%, dated
11/23/11, to be
repurchased on
demand at face
value plus accrued
interest with a
stated maturity
date of 12/23/11. |
|
|
(4,993,928 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(17,979,139 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Average balance outstanding |
|
$ |
(30,166,766 |
) |
Average interest rate |
|
|
0.16 |
% |
Maximum balance outstanding |
|
$ |
(51,381,250 |
) |
Average balance outstanding was calculated based on daily face
value balances outstanding during the period that the Fund has
entered into reverse
repurchase agreements.
Written Options
A summary of open written option contracts for the fund at November 30, 2011 is as follows:
Options on Futures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract |
|
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
|
Market |
|
|
|
|
|
Number |
|
|
Date |
|
|
|
|
|
|
Description |
|
Premiums |
|
|
Value |
|
Call |
|
|
1,200 |
|
|
|
12/23/2011 |
|
|
USD |
|
10 Year U.S.
Treasury Note Option Call, Strike 131.00 |
|
$ |
(972,384 |
) |
|
$ |
(450,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options on Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of underlying swap |
|
|
|
|
|
|
|
|
|
Notional |
|
|
Expiration |
|
|
|
|
|
Receive |
|
|
Fixed |
|
|
Variable
|
|
|
|
|
|
|
|
Description |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
|
(Pay) # |
|
|
Rate |
|
|
Rate |
|
|
Premiums |
|
|
Market Value |
|
Call- OTC 2 Year
Interest Rate Swap |
|
|
600,000,000 |
|
|
USD |
|
|
12/01/11 |
|
|
Merrill Lynch Capital Services Inc. |
|
(Pay) |
|
|
0.60% |
|
|
3 Month LIBOR |
|
$ |
(360,000 |
) |
|
$ |
(1,200 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Call OTC 2 Year
Interest Rate Swap |
|
|
250,000,000 |
|
|
USD |
|
|
05/21/12 |
|
|
Merrill Lynch Capital Services Inc. |
|
(Pay) |
|
|
0.77% |
|
|
3 Month LIBOR |
|
|
(193,750 |
) |
|
|
(832,250 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(553,750 |
) |
|
$ |
(833,450 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,526,134 |
) |
|
$ |
(1,283,450 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
|
|
Receive |
|
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
|
(Pay)# |
|
|
Fixed Rate |
|
|
Variable Rate |
|
|
(Depreciation) |
|
190,000,000 |
|
USD |
|
|
1/15/2014 |
|
|
Barclays Bank PLC |
|
(Pay) |
|
|
0.92 |
% |
|
3 Month LIBOR |
|
$ |
(878,905 |
) |
75,000,000 |
|
USD |
|
|
1/15/2017 |
|
|
Barclays Bank PLC |
|
Receive |
|
|
2.19 |
% |
|
3 Month LIBOR |
|
|
3,007,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,128,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate. |
|
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient
cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
CP
Counterparty
LIBOR London Interbank Offered Rate
OTC Over-the-Counter
(a) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options. |
|
(b) |
|
All or a portion of this security has been pledged to cover collateral requirements on reverse
repurchase agreements. |
|
(c) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
Currency Abbreviations:
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 203,273,976 |
|
$ |
2,534,778 |
|
|
$ |
(518,241 |
) |
|
$ |
2,016,537 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
9,857,886 |
|
|
$ |
209,531,678 |
|
|
$ |
215,813,100 |
|
|
$ |
6,488 |
|
|
$ |
190 |
|
|
$ |
3,571,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds.
Quotation or quoted price typically means the bid price for securities held long and
the ask price for securities sold short. If the pricing convention for a security does not
involve a bid or an ask, quotation or quoted price may be a market quotation provided by a
market participant or other third party pricing source in accordance with the convention for
that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government |
|
$ |
196,498,320 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
196,498,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
196,498,320 |
|
|
|
|
|
|
|
|
|
|
|
196,498,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
3,571,109 |
|
|
|
|
|
|
|
|
|
|
|
3,571,109 |
|
Options Purchased |
|
|
628,125 |
|
|
|
3,245,550 |
|
|
|
|
|
|
|
3,873,675 |
|
Short-Term Investments |
|
|
1,347,409 |
|
|
|
|
|
|
|
|
|
|
|
1,347,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
202,044,963 |
|
|
|
3,245,550 |
|
|
|
|
|
|
|
205,290,513 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
192,763 |
|
|
|
|
|
|
|
|
|
|
|
192,763 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
|
|
|
|
3,007,749 |
|
|
|
|
|
|
|
3,007,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
202,237,726 |
|
|
$ |
6,253,299 |
|
|
$ |
|
|
|
$ |
208,491,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Written Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
$ |
(450,000 |
) |
|
$ |
(833,450 |
) |
|
|
|
|
|
$ |
(1,283,450 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
(346,848 |
) |
|
|
|
|
|
|
|
|
|
|
(346,848 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
|
|
|
|
(878,905 |
) |
|
|
|
|
|
|
(878,905 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(796,848 |
) |
|
$ |
(1,712,355 |
) |
|
|
|
|
|
$ |
(2,509,203 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with
the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. As of November 30,
2011, the Fund had received $17,977,500 from reverse repurchase agreements relating to
securities with a market value, plus accrued interest, of $18,339,600. Reverse repurchase
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the
value of inflation indexed bonds will be directly correlated to changes in nominal interest
rates, and short term increases in inflation may lead to a decline in their value. Coupon
payments received by the Fund from inflation indexed bonds are included in the Funds gross
income for the period in which they accrue. In addition, any increase or decrease in the
principal amount of an inflation indexed bond will increase or decrease taxable ordinary income
to the Fund, even though principal is not paid until maturity. The Fund had no
inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of rising interest rates and widening
of credit spreads. |
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities. |
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions. |
|
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk. |
|
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline. |
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
|
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse |
changes in investment regulations, capital requirements or exchange controls could adversely
affect the value of the Funds investments. These and other risks (e.g., nationalization,
expropriation or other confiscation of assets of foreign issuers) tend to be greater for
investments in companies tied economically to emerging countries, the economies of which
tend to be more volatile than the economies of developed countries. |
|
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies. |
|
Liquidity Risk Low trading volume, lack of a market maker, large size of
position or legal restrictions may limit or prevent the Fund from selling particular
securities or unwinding derivative positions at desirable prices. The more less-liquid
securities the Fund holds, the more likely it is to honor a redemption request in-kind. |
|
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another creates additional risk. |
|
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected. |
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency
exposure in its portfolio. For these purposes, the Fund may use an instrument denominated in a
different currency that the Manager believes is highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting their investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest rate exposure and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust interest rate exposure. Option contracts purchased by the Fund and
outstanding at the end of the period are listed in the Funds Schedule of Investments.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions),
securities or currencies it owns or in which it may invest. Writing options alters the Funds
exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell
the underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund
does not own), it bears an unlimited risk of loss if the price of the underlying asset increases
during the term of the option. OTC options expose the Fund to the risk the Fund may not be able
to enter into a closing transaction because of an illiquid market. During the period ended
November 30, 2011, the Fund used written option contracts to adjust interest rate exposure.
Written options outstanding at the end of the period are listed in the Funds Schedule of
Investments.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
Amount of |
|
|
of |
|
|
|
|
|
|
Amount of |
|
|
Number of |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
(600,000,000 |
) |
|
|
(500 |
) |
|
$ |
(396,500 |
) |
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(250,000,000 |
) |
|
|
(2,400 |
) |
|
|
(1,913,518 |
) |
Options bought back |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,700 |
|
|
|
783,884 |
|
Options expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
(850,000,000 |
) |
|
|
(1,200 |
) |
|
$ |
(1,526,134 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other
agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an
agreement by the holders of an asset-backed security to a maturity extension, or a write-down on
the collateral underlying the security. For credit default swap agreements on corporate or
sovereign issuers, a credit event may be triggered by such occurrences as the issuers
bankruptcy, failure to pay interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure. Swap agreements outstanding at the end of the period are
listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
Fair Values of Derivative Instruments as of November 30, 2011: |
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (purchased options) |
|
|
|
|
|
$ |
3,873,675 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,873,675 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
192,763 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
192,763 |
|
Unrealized appreciation on swap agreements |
|
|
|
|
|
|
3,007,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,007,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
7,074,187 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
7,074,187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Written options outstanding |
|
|
|
|
|
$ |
(1,283,450 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(1,283,450 |
) |
Unrealized depreciation on futures contracts* |
|
|
|
|
|
|
(346,848 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(346,848 |
) |
Unrealized depreciation on swap agreements |
|
|
|
|
|
|
(878,905 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(878,905 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(2,509,203 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,509,203 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts), notional amounts
(swap agreements), or principal amounts (options), outstanding at each month-end, was as follows
for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
2,735,211,417 |
|
|
$ |
1,322,666,667 |
|
|
$ |
1,623,311,111 |
|
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Benchmark-Free Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares / Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 99.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 99.9% |
|
|
|
|
|
1,295,649 |
|
|
GMO Alpha Only Fund, Class IV |
|
|
32,248,698 |
|
|
70,767 |
|
|
GMO Alternative Asset Opportunity Fund |
|
|
2,098,944 |
|
|
1,167,908 |
|
|
GMO Currency Hedged International Equity Fund, Class III |
|
|
24,526,066 |
|
|
50,094 |
|
|
GMO Debt Opportunities Fund, Class VI |
|
|
1,246,330 |
|
|
349,911 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
3,313,658 |
|
|
1,434,027 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
16,763,776 |
|
|
643,686 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
11,032,771 |
|
|
2,039,394 |
|
|
GMO Quality Fund, Class VI |
|
|
44,540,361 |
|
|
271,150 |
|
|
GMO Special Situations Fund, Class VI |
|
|
7,169,211 |
|
|
1,093,863 |
|
|
GMO Strategic Fixed Income Fund, Class VI |
|
|
18,617,554 |
|
|
52,430 |
|
|
GMO World Opportunity Overlay Fund |
|
|
1,237,343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $173,029,865) |
|
|
162,794,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS Collateralized Debt Obligations 0.0% |
|
|
|
|
|
1,599,399 |
|
|
American
Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52 |
|
|
15,994 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Other 0.1% |
|
|
|
|
|
2,500,000 |
|
|
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37 |
|
|
156,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
172,469 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 0.1% |
|
|
|
|
|
16,900 |
|
|
Agency for
International Development Floater (Support of C.A.B.E.I.), 6 mo. U.S. Treasury Bill + .40%, 0.47%, due 10/01/12(a) |
|
|
16,703 |
|
|
33,334 |
|
|
Agency for
International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a) |
|
|
33,283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
49,986 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $638,559) |
|
|
222,455 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
12,686 |
|
|
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(b) |
|
|
12,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $12,686) |
|
|
12,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.1%
(Cost $173,681,110) |
|
|
163,029,853 |
|
|
|
|
|
Other Assets and Liabilities (net) (0.1%) |
|
|
(121,018 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
162,908,835 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933.
These securities may be resold in transactions exempt from registration, normally to qualified
institutional investors.
C.A.B.E.I. Central American Bank for Economic Integration
CDO Collateralized Debt Obligation
CMBS Commercial Mortgage Backed Security
LIBOR London Interbank Offered Rate
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which
are subject to
change based on the terms of the security.
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of
the Trustees of GMO Trust. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$199,875,402
|
|
$ |
1,849,627 |
|
|
$ |
(38,695,176 |
) |
|
$ |
(36,845,549 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Alpha Only
Fund, Class IV |
|
$ |
599,996,684 |
|
|
$ |
197,074,875 |
|
|
$ |
792,155,653 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
32,248,698 |
|
GMO Alternative
Asset Opportunity
Fund |
|
|
24,921,958 |
|
|
|
875,402 |
|
|
|
22,888,196 |
|
|
|
|
|
|
|
|
|
|
|
2,098,944 |
|
GMO Asset
Allocation Bond
Fund, Class VI |
|
|
244,450,911 |
|
|
|
70,337,131 |
|
|
|
309,024,681 |
|
|
|
1,006,285 |
|
|
|
11,911,428 |
|
|
|
|
|
GMO Currency Hedged
International
Equity Fund, Class
III |
|
|
363,301,368 |
|
|
|
54,090,981 |
|
|
|
372,947,091 |
|
|
|
|
|
|
|
1,635,149 |
|
|
|
24,526,066 |
|
GMO Debt
Opportunities Fund,
Class VI |
|
|
|
|
|
|
1,250,622 |
|
|
|
1,790 |
|
|
|
|
|
|
|
|
|
|
|
1,246,330 |
|
GMO Emerging
Country Debt Fund,
Class IV |
|
|
54,942,811 |
|
|
|
4,117,286 |
|
|
|
58,755,133 |
|
|
|
565,954 |
|
|
|
|
|
|
|
3,313,658 |
|
GMO Emerging
Markets Fund, Class
VI |
|
|
340,226,922 |
|
|
|
57,009,354 |
|
|
|
355,580,075 |
|
|
|
6,934 |
|
|
|
23,871,370 |
|
|
|
16,763,776 |
|
GMO Flexible
Equities Fund,
Class VI |
|
|
72,002,968 |
|
|
|
89,749,325 |
|
|
|
148,362,232 |
|
|
|
|
|
|
|
|
|
|
|
11,032,771 |
|
GMO Quality Fund,
Class VI |
|
|
851,695,924 |
|
|
|
79,507,946 |
|
|
|
896,986,741 |
|
|
|
8,441,682 |
|
|
|
|
|
|
|
44,540,361 |
|
GMO Special
Situations Fund,
Class VI |
|
|
148,674,177 |
|
|
|
9,445,979 |
|
|
|
146,946,136 |
|
|
|
|
|
|
|
|
|
|
|
7,169,211 |
|
GMO Strategic Fixed
Income Fund, Class
VI |
|
|
417,114,334 |
|
|
|
30,522,730 |
|
|
|
450,772,882 |
|
|
|
|
|
|
|
|
|
|
|
18,617,554 |
|
GMO World
Opportunity Overlay
Fund |
|
|
22,044,262 |
|
|
|
|
|
|
|
20,920,476 |
|
|
|
|
|
|
|
|
|
|
|
1,237,343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
3,139,372,319 |
|
|
$ |
593,981,631 |
|
|
$ |
3,575,341,086 |
|
|
$ |
10,020,855 |
|
|
$ |
37,417,947 |
|
|
$ |
162,794,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of
the underlying funds and other investment
funds are generally valued at their net asset value. Investments held by the Fund and the
underlying funds are valued as follows: Securities listed on a securities exchange (other than
exchange-traded options) for which market quotations are readily available are valued at (i) the
last sale price or (ii) official closing price as of the close of regular trading on the New
York Stock Exchange (NYSE) or, (iii) if there is no such reported sale or official closing
price (or in the event the Manager deems the over-the-counter (OTC) market to be a better
indicator of market value), at the most recent quoted price. Unlisted securities for which
market quotations are readily available are generally valued at the most recent quoted price.
Non-emerging market debt instruments with a remaining maturity of sixty days or less may be
valued at amortized cost (unless circumstances dictate otherwise; for example, if the issuers
creditworthiness has become impaired), which approximates market value. Derivatives and other
securities for which quotations are not readily available or whose values the Manager has
determined to be unreliable are valued at fair value as determined in good faith by the Trustees
or persons acting at their direction pursuant to procedures approved by the Trustees. Although
the goal of fair valuation is to determine the amount the owner of the securities might
reasonably expect to receive upon their current sale, because of the uncertainty inherent in
fair value pricing, the value determined for a particular security may be materially different
from the value realized upon its sale. As of November 30, 2011, the total value of securities
held directly and indirectly that were fair valued using methods determined in good faith by or
at the direction of the Trustees of the Trust represented 0.8% of net assets. The Fund and the
underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
|
|
|
|
|
Security
Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
|
39.5 |
% |
Futures Contracts |
|
|
0.1 |
% |
Swap Agreements |
|
|
1.0 |
% |
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 1.2% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales,
issuances and settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward.
The effective date of the guidance was for interim and annual periods beginning after December
15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. The Fund valued certain other debt
securities by using a specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
162,794,712 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
162,794,712 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
|
|
|
|
|
156,475 |
|
|
|
15,994 |
|
|
|
172,469 |
|
U.S. Government Agency |
|
|
|
|
|
|
|
|
|
|
49,986 |
|
|
|
49,986 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
156,475 |
|
|
|
65,980 |
|
|
|
222,455 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
12,686 |
|
|
|
|
|
|
|
|
|
|
|
12,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
162,807,398 |
|
|
|
156,475 |
|
|
|
65,980 |
|
|
|
163,029,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
162,807,398 |
|
|
$ |
156,475 |
|
|
$ |
65,980 |
|
|
$ |
163,029,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds investments
(both direct and indirect) in securities and derivative financial instruments using Level 3
inputs were 5.4% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
Balances |
|
|
Investments |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
Transfers |
|
|
Transfers |
|
|
as of |
|
|
Held as of |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
into |
|
|
out of |
|
|
November |
|
|
November |
|
|
|
28, 2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
Level 3* |
|
|
Level 3* |
|
|
30, 2011 |
|
|
30,2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed
Securities |
|
$ |
21,992,549 |
|
|
$ |
|
|
|
$ |
(21,265,322 |
) |
|
$ |
101,703 |
|
|
$ |
1,082,690 |
|
|
$ |
(1,895,626 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
15,994 |
|
|
$ |
(1,077 |
) |
U.S. Government
Agency |
|
|
167,552 |
|
|
|
|
|
|
|
(118,269 |
) |
|
|
(133 |
) |
|
|
446 |
|
|
|
390 |
|
|
|
|
|
|
|
|
|
|
$ |
49,986 |
|
|
|
657 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Obligations |
|
|
22,160,101 |
|
|
|
|
|
|
|
(21,383,591 |
) |
|
|
101,570 |
|
|
|
1,083,136 |
|
|
|
(1,895,236 |
) |
|
|
|
|
|
|
|
|
|
|
65,980 |
|
|
|
(420 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
22,160,101 |
|
|
$ |
|
|
|
$ |
(21,383,591 |
) |
|
$ |
101,570 |
|
|
$ |
1,083,136 |
|
|
$ |
(1,895,236 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
65,980 |
|
|
$ |
(420 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The fund accounts for investments transferred into Level 3 at the value at the beginning of the
period and transfers out of Level 3 at the value
at the end of the period. |
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those Funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Declines
in stock market prices generally are likely to reduce the net asset
value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of companies with
smaller market capitalizations often are less widely held and trade less frequently and in
lesser quantities, and their market prices often fluctuate more, than the securities of
companies with larger market capitalization.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the
underlying funds in which the Fund is currently invested will increase the Funds total
expenses. The fees and expenses associated with an investment in the Fund are less
predictable and may be higher than fees and expenses associated with an investment in funds
that charge a fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. Below investment grade securities have speculative characteristics, and changes in
economic conditions or other circumstances are more likely to impair the capacity of
issuers to make principal and interest payments than is the case with issuers of investment
grade securities.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-
backed securities involve risk of loss of principal if obligors of the underlying obligations
default and the value of the defaulted obligations exceeds whatever credit support the
securities may have. The obligations of issuers (and obligors of underlying assets) also are
subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of
creditors. Many asset-backed securities in which the Fund has invested are now rated below
investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
Subsequent events
On January 1, 2012, the Fund instituted a fee arrangement pursuant to which Class III shares of the Fund
pay the Manager a 0.65% management fee and a 0.15% shareholder service fee.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Benchmark-Free Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares / Par Value ($) |
|
|
Description |
|
Value ($) |
|
| | |
|
|
|
|
MUTUAL FUNDS 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 100.0% |
|
|
|
|
|
25,570,956 |
|
|
GMO Alpha Only Fund, Class IV |
|
|
636,461,095 |
|
|
1,360,461 |
|
|
GMO Alternative Asset Opportunity Fund |
|
|
40,351,269 |
|
|
23,159,675 |
|
|
GMO Currency Hedged International Equity Fund, Class III |
|
|
486,353,174 |
|
|
952,678 |
|
|
GMO Debt Opportunities Fund, Class VI |
|
|
23,702,634 |
|
|
6,176,520 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
58,491,649 |
|
|
28,523,466 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
333,439,316 |
|
|
12,304,236 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
210,894,599 |
|
|
40,521,686 |
|
|
GMO Quality Fund, Class VI |
|
|
884,993,618 |
|
|
5,324,963 |
|
|
GMO Special Situations Fund, Class VI |
|
|
140,792,009 |
|
|
22,400,886 |
|
|
GMO Strategic Fixed Income Fund, Class VI |
|
|
381,263,081 |
|
|
919,464 |
|
|
GMO World Opportunity Overlay Fund |
|
|
21,699,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $3,216,263,706) |
|
|
3,218,441,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.0% |
|
|
|
|
|
56,610 |
|
|
State Street Eurodollar Time Deposit, 0.01%, due 12/1/11 |
|
|
56,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $56,610) |
|
|
56,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL
INVESTMENTS 100.0%
(Cost $3,216,320,316) |
|
|
3,218,498,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(82,423 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
3,218,415,986 |
|
|
|
|
|
|
|
|
|
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
|
$3,216,320,316
|
|
$ |
62,921,132 |
|
|
$ |
(60,743,039 |
) |
|
$ |
2,178,093 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Alpha Only Fund, Class IV |
|
$ |
|
|
|
$ |
875,909,533 |
|
|
$ |
256,088,549 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
636,461,095 |
|
GMO Alternative Asset Opportunity Fund |
|
|
|
|
|
|
41,667,279 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,351,269 |
|
GMO Asset Allocation Bond Fund, Class VI |
|
|
|
|
|
|
251,967,993 |
|
|
|
249,306,832 |
|
|
|
2,449,871 |
|
|
|
|
|
|
|
|
|
GMO Currency Hedged International Equity Fund, Class III |
|
|
|
|
|
|
491,405,563 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
486,353,174 |
|
GMO Debt Opportunities Fund, Class VI |
|
|
|
|
|
|
23,750,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,702,634 |
|
GMO Emerging Country Debt Fund, Class IV |
|
|
|
|
|
|
59,154,781 |
|
|
|
|
|
|
|
217,065 |
|
|
|
|
|
|
|
58,491,649 |
|
GMO Emerging Markets Fund, Class VI |
|
|
|
|
|
|
374,498,695 |
|
|
|
1,429,284 |
|
|
|
134,530 |
|
|
|
65,834 |
|
|
|
333,439,316 |
|
GMO Flexible Equities Fund, Class VI |
|
|
|
|
|
|
222,074,091 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
210,894,599 |
|
GMO Quality Fund, Class VI |
|
|
|
|
|
|
848,133,970 |
|
|
|
672,591 |
|
|
|
5,354,206 |
|
|
|
|
|
|
|
884,993,618 |
|
GMO Special Situations Fund, Class VI |
|
|
|
|
|
|
143,718,849 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140,792,009 |
|
GMO Strategic Fixed Income Fund, Class VI |
|
|
|
|
|
|
441,971,273 |
|
|
|
84,511,567 |
|
|
|
|
|
|
|
|
|
|
|
381,263,081 |
|
GMO World Opportunity Overlay Fund |
|
|
|
|
|
|
20,918,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21,699,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
|
|
|
$ |
3,795,170,752 |
|
|
$ |
592,008,823 |
|
|
$ |
8,155,672 |
|
|
$ |
65,834 |
|
|
$ |
3,218,441,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods
determined in good faith by or at the direction of the Trustees of the Trust represented 0.8% of
net assets. The Fund and the underlying funds classify such securities (levels defined below) as
Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described
in the disclosures of the
underlying funds.
|
|
|
|
|
Security
Type |
|
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
|
39.4 |
% |
Futures Contracts |
|
|
0.1 |
% |
Swap Agreements |
|
|
1.0 |
% |
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 1.1% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
3,218,441,799 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,218,441,799 |
|
Short-Term Investments |
|
|
56,610 |
|
|
|
|
|
|
|
|
|
|
|
56,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
3,218,498,409 |
|
|
|
|
|
|
|
|
|
|
|
3,218,498,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,218,498,409 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,218,498,409 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the
summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds, please
refer to the underlying funds portfolio valuation notes. The aggregate net values of the Funds
investments (both direct and indirect) in securities and derivative financial instruments using
Level 3 inputs were 5.3% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at November 30, 2011,
whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those Funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline due to
factors affecting the issuing companies, their industries, or the economy and equity markets
generally. If an underlying fund purchases equity investments at a discount from their value as
determined by the Manager, the Fund runs the risk that the market prices of these investments
will not increase to that value for a variety of reasons, one of which may be the Managers
overestimation of the value of those investments. An underlying fund also may purchase equity
investments that typically trade at higher multiples of current earnings than other securities,
and the market values of these investments often are more sensitive to changes in future
earnings expectations than those other securities. Declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and
less regulated than U.S. markets, and the cost of trading in those markets often is higher than
in U.S. markets. Foreign portfolio transactions generally involve higher commission rates,
transfer taxes and custodial costs than similar transactions in the U.S. In addition, the Fund
may be subject to foreign taxes on capital gains or other income payable on foreign securities,
on transactions in those securities and on the repatriation of proceeds generated from those
securities. Also, many foreign markets require a license for the Fund to invest directly in
those markets, and the Fund is subject to the risk that it could not invest if its license were
terminated or suspended. In some foreign markets, prevailing custody and trade settlement
practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to
credit and other risks with respect to participating brokers, custodians, clearing banks or
other clearing agents, escrow agents and issuers. Further, adverse changes in investment
regulations, capital requirements or exchange controls could adversely affect the value of the
Funds investments. These and other risks (e.g., nationalization, expropriation or other
confiscation of assets of foreign issuers) tend to be greater for investments in companies tied
economically to emerging countries, the economies of which tend to be more volatile than the
economies of developed countries.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to
severe credit downgrades, illiquidity, defaults and declines in market value.
Smaller Company Risk Smaller companies may have limited product lines, markets
or financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of companies with
smaller market capitalizations often are less widely held and trade less frequently and in
lesser quantities, and their market prices often fluctuate more, than the securities of
companies with larger market capitalization.
Liquidity Risk Low trading volume, lack of a market maker, large size
of position or legal restrictions may limit or prevent the Fund or an underlying fund from
selling particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not move as
expected relative to the value of the relevant underlying assets, rates or indices. Derivatives
also present other Fund risks, including market risk, liquidity risk, currency risk and
counterparty risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of
foreign currency holdings and investments denominated in foreign currencies.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an investment
in the underlying funds, including the risk that the underlying funds in which it invests do not
perform as expected. Because the Fund bears the fees and expenses of the underlying funds in
which it invests, new investments in underlying funds with higher fees or expenses than those of
the underlying funds in which the Fund is currently invested will increase the Funds total
expenses. The fees and expenses associated with an investment in the Fund are less predictable
and may be higher than fees and expenses associated with an investment in funds that charge a
fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the risk
that GMOs proprietary investment techniques will fail to produce the desired results. The
Funds portfolio managers may use quantitative analyses and/or models and any imperfections or
limitations in such analyses and/or models could affect the ability of the portfolio managers to
implement strategies. By necessity, these analyses and models make simplifying assumptions that
limit their efficacy. Models that appear to explain prior market data can fail to predict future
market events. Further, the data used in models may be inaccurate and/or it may not include the
most recent information about a company or a security. The Fund is also subject to the risk that
deficiencies in the Managers or another service providers internal systems or controls will
cause losses for the Fund or impair Fund operations.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable or
unwilling to satisfy its obligations to pay principal or interest payments or to otherwise honor
its obligations. The market value of a fixed income security normally will decline as a result
of the issuers failure to meet its payment obligations or the markets expectation of a
default, which may result from the downgrading of the issuers credit rating. Below investment
grade securities have speculative characteristics, and changes in economic conditions or other
circumstances are more likely to impair the capacity of issuers to make principal and interest
payments than is the case with issuers of investment grade securities.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets and
may fluctuate more than the value of shares of a fund with a broader range of investments.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the Funds
portfolio losses when the value of its investments decline.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the real
estate industry and may fluctuate more than the value of a portfolio that consists of securities
of companies in a broader range of industries.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short sale
of securities that the underlying fund does not own is unlimited.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates additional
risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well as
other changes in foreign and domestic economic and political conditions could adversely affect
the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in large
amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Core Plus Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value |
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 46.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
|
|
|
USD |
|
170,411 |
|
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38 |
|
|
163,751 |
|
USD |
|
241,147 |
|
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36 |
|
|
232,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
396,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
|
|
|
USD |
|
493,644 |
|
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39 |
|
|
437,359 |
|
USD |
|
28,821 |
|
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .04%, 0.33%, due 12/20/54 |
|
|
27,610 |
|
USD |
|
150,000 |
|
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33 |
|
|
149,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
614,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 45.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 2.7% |
|
|
|
|
USD |
|
293,914 |
|
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37 |
|
|
14,696 |
|
USD |
|
104,140 |
|
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%,
0.29%, due 10/06/13 |
|
|
103,880 |
|
USD |
|
1,020,265 |
|
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
264,950 |
|
USD |
|
102,563 |
|
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36 |
|
|
30,000 |
|
USD |
|
858,523 |
|
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
225,899 |
|
USD |
|
132,754 |
|
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36 |
|
|
83,635 |
|
USD |
|
500,000 |
|
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17 |
|
|
500,825 |
|
USD |
|
300,000 |
|
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24 |
|
|
292,500 |
|
USD |
|
428,691 |
|
Crest Exeter Street Solar, Series 04-1A, Class A1, 144A, 3 mo. LIBOR + .35%, 0.71%, due 06/28/19 |
|
|
394,395 |
|
USD |
|
132,689 |
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14 |
|
|
133,020 |
|
USD |
|
633,335 |
|
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo.
LIBOR + .16%, 0.42%, due 04/25/36 |
|
|
376,043 |
|
USD |
|
383,994 |
|
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36 |
|
|
205,737 |
|
USD |
|
95,080 |
|
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36 |
|
|
26,622 |
|
USD |
|
776,581 |
|
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33 |
|
|
636,796 |
|
USD |
|
800,000 |
|
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20 |
|
|
792,000 |
|
USD |
|
155,556 |
|
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36 |
|
|
54,445 |
|
USD |
|
700,000 |
|
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
210,000 |
|
USD |
|
500,000 |
|
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37 |
|
|
105,000 |
|
USD |
|
36,862 |
|
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23 |
|
|
35,756 |
|
USD |
|
14,299 |
|
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37 |
|
|
14,196 |
|
USD |
|
55,326 |
|
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + .29%,
0.55%, due 12/25/32 |
|
|
16,044 |
|
USD |
|
100,421 |
|
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35 |
|
|
90,971 |
|
USD |
|
261,468 |
|
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18 |
|
|
258,774 |
|
USD |
|
136,777 |
|
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22 |
|
|
136,436 |
|
|
|
|
|
|
|
|
|
|
USD |
|
39,152 |
|
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35 |
|
|
30,245 |
|
USD |
|
296,211 |
|
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14 |
|
|
297,653 |
|
USD |
|
517,441 |
|
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14 |
|
|
519,195 |
|
USD |
|
400,000 |
|
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + .13%,
0.38%, due 02/15/17 |
|
|
396,876 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,246,589 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.5% |
|
|
|
|
USD |
|
210,000 |
|
CIT Group, Inc., 144A, 7.00%, due 05/04/15 |
|
|
209,475 |
|
USD |
|
350,000 |
|
CIT Group, Inc., 144A, 7.00%, due 05/02/16 |
|
|
343,700 |
|
USD |
|
490,000 |
|
CIT Group, Inc., 144A, 7.00%, due 05/02/17 |
|
|
481,425 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,034,600 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 33.7% |
|
|
|
|
USD |
|
14,281,227 |
|
Republic of Albania Par Bond, Zero Coupon, due 08/31/25(a) |
|
|
6,997,801 |
|
USD |
|
18,895,214 |
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(b)(c) |
|
|
18,958,683 |
|
USD |
|
30,000,000 |
|
U.S. Treasury Note, 2.50%, due 03/31/15(b) |
|
|
31,989,840 |
|
USD |
|
10,100,000 |
|
U.S. Treasury Receipts, 0.00%, due 02/15/12(d) |
|
|
10,078,659 |
|
USD |
|
10,100,000 |
|
U.S. Treasury Receipts, 0.00%, due 08/15/12(d) |
|
|
10,020,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
78,045,930 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 9.0% |
|
|
|
|
USD |
|
20,000,000 |
|
Federal National Mortage Assoc.,TBA, 4.00%, due 02/01/40 |
|
|
20,825,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
106,152,119 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $104,703,068) |
|
|
107,162,583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 62.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 62.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
854,029 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
8,087,653 |
|
|
7,417,054 |
|
|
GMO Short-Duration Collateral Fund |
|
|
49,026,728 |
|
|
93,858 |
|
|
GMO Special Purpose Holding Fund(e) |
|
|
36,604 |
|
|
1,533,857 |
|
|
GMO U.S. Treasury Fund |
|
|
38,361,760 |
|
|
2,030,456 |
|
|
GMO World Opportunity Overlay Fund |
|
|
47,918,767 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
143,431,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $148,632,765) |
|
|
143,431,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.1% |
|
|
|
|
|
264,081 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(f) |
|
|
264,081 |
|
|
|
|
|
U.S. Government 0.6% |
|
|
|
|
|
1,300,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (b)(g) |
|
|
1,298,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $1,562,825) |
|
|
1,562,919 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 109.0%
(Cost $254,898,658) |
|
|
252,157,014 |
|
|
|
|
|
Other Assets and Liabilities (net) (9.0%) |
|
|
(20,772,312 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
231,384,702 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Barclays Bank PLC |
|
AUD |
|
|
1,700,000 |
|
|
$ |
1,747,466 |
|
|
$ |
(7,040 |
) |
|
12/06/11 |
|
|
Citibank N.A. |
|
AUD |
|
|
300,000 |
|
|
|
308,376 |
|
|
|
(4,512 |
) |
|
12/06/11 |
|
|
Credit Suisse International |
|
AUD |
|
|
1,900,000 |
|
|
|
1,953,050 |
|
|
|
91,088 |
|
|
12/06/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
12,100,000 |
|
|
|
12,437,847 |
|
|
|
637,787 |
|
|
12/06/11 |
|
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
700,000 |
|
|
|
719,545 |
|
|
|
6,528 |
|
|
12/13/11 |
|
|
Barclays Bank PLC |
|
CAD |
|
|
900,000 |
|
|
|
882,135 |
|
|
|
(22,028 |
) |
|
12/13/11 |
|
|
Citibank N.A. |
|
CAD |
|
|
800,000 |
|
|
|
784,120 |
|
|
|
(19,957 |
) |
|
12/13/11 |
|
|
Credit Suisse International |
|
CAD |
|
|
5,100,000 |
|
|
|
4,998,766 |
|
|
|
(23,682 |
) |
|
12/13/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
5,800,000 |
|
|
|
5,684,871 |
|
|
|
36,380 |
|
|
12/13/11 |
|
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
3,800,000 |
|
|
|
3,724,571 |
|
|
|
(61,193 |
) |
|
1/31/12 |
|
|
Deutsche Bank AG |
|
CHF |
|
|
600,000 |
|
|
|
657,851 |
|
|
|
2,178 |
|
|
2/07/12 |
|
|
Citibank N.A. |
|
EUR |
|
|
300,000 |
|
|
|
403,371 |
|
|
|
(2,073 |
) |
|
2/07/12 |
|
|
Credit Suisse International |
|
EUR |
|
|
1,700,000 |
|
|
|
2,285,769 |
|
|
|
16,915 |
|
|
1/10/12 |
|
|
Citibank N.A. |
|
GBP |
|
|
1,200,000 |
|
|
|
1,882,017 |
|
|
|
(40,153 |
) |
|
1/10/12 |
|
|
Credit Suisse International |
|
GBP |
|
|
3,800,000 |
|
|
|
5,959,720 |
|
|
|
(89,982 |
) |
|
1/10/12 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
700,000 |
|
|
|
1,097,843 |
|
|
|
(24,257 |
) |
|
1/10/12 |
|
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
1,200,000 |
|
|
|
1,882,017 |
|
|
|
(13,137 |
) |
|
2/14/12 |
|
|
Credit Suisse International |
|
JPY |
|
|
210,000,000 |
|
|
|
2,711,864 |
|
|
|
2,291 |
|
|
2/21/12 |
|
|
Deutsche Bank AG |
|
NOK |
|
|
29,000,000 |
|
|
|
5,003,329 |
|
|
|
59,586 |
|
|
2/21/12 |
|
|
Royal Bank of Scotland PLC |
|
NOK |
|
|
5,100,000 |
|
|
|
879,896 |
|
|
|
13,689 |
|
|
1/24/12 |
|
|
Credit Suisse International |
|
NZD |
|
|
1,500,000 |
|
|
|
1,166,913 |
|
|
|
(10,137 |
) |
|
12/20/11 |
|
|
Barclays Bank PLC |
|
SEK |
|
|
14,700,000 |
|
|
|
2,170,368 |
|
|
|
(44,155 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/20/11 |
|
|
Citibank N.A. |
|
SEK |
|
|
10,600,000 |
|
|
|
1,565,027 |
|
|
|
(9,463 |
) |
|
12/20/11 |
|
|
Credit Suisse International |
|
SEK |
|
|
18,400,000 |
|
|
|
2,716,651 |
|
|
|
54,014 |
|
|
12/20/11 |
|
|
Deutsche Bank AG |
|
SEK |
|
|
12,400,000 |
|
|
|
1,830,786 |
|
|
|
(106,909 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
65,454,169 |
|
|
$ |
441,778 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
# |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Citibank N.A. |
|
AUD |
|
|
1,500,000 |
|
|
$ |
1,541,882 |
|
|
$ |
10,645 |
|
|
12/06/11 |
|
|
Credit Suisse International |
|
AUD |
|
|
3,800,000 |
|
|
|
3,906,101 |
|
|
|
(30,735 |
) |
|
12/06/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
1,600,000 |
|
|
|
1,644,674 |
|
|
|
(14,274 |
) |
|
12/06/11 |
|
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
1,900,000 |
|
|
|
1,953,051 |
|
|
|
(95,550 |
) |
|
12/13/11 |
|
|
Citibank N.A. |
|
CAD |
|
|
1,200,000 |
|
|
|
1,176,180 |
|
|
|
5,108 |
|
|
12/13/11 |
|
|
Credit Suisse International |
|
CAD |
|
|
1,400,000 |
|
|
|
1,372,210 |
|
|
|
(52,452 |
) |
|
12/13/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
16,900,000 |
|
|
|
16,564,538 |
|
|
|
(256,915 |
) |
|
1/31/12 |
|
|
Barclays Bank PLC |
|
CHF |
|
|
1,100,000 |
|
|
|
1,206,061 |
|
|
|
17,916 |
|
|
1/31/12 |
|
|
Credit Suisse International |
|
CHF |
|
|
5,300,000 |
|
|
|
5,811,021 |
|
|
|
153,080 |
|
|
1/31/12 |
|
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
2,200,000 |
|
|
|
2,412,122 |
|
|
|
41,182 |
|
|
2/07/12 |
|
|
Citibank N.A. |
|
EUR |
|
|
900,000 |
|
|
|
1,210,113 |
|
|
|
1,602 |
|
|
2/07/12 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
10,800,000 |
|
|
|
14,521,358 |
|
|
|
182,842 |
|
|
1/10/12 |
|
|
Citibank N.A. |
|
GBP |
|
|
1,500,000 |
|
|
|
2,352,521 |
|
|
|
(17,621 |
) |
|
1/10/12 |
|
|
Credit Suisse International |
|
GBP |
|
|
3,200,000 |
|
|
|
5,018,711 |
|
|
|
(24,037 |
) |
|
1/10/12 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
500,000 |
|
|
|
784,174 |
|
|
|
6,026 |
|
|
1/10/12 |
|
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
700,000 |
|
|
|
1,097,843 |
|
|
|
5,031 |
|
|
2/14/12 |
|
|
Barclays Bank PLC |
|
JPY |
|
|
70,000,000 |
|
|
|
903,955 |
|
|
|
7,884 |
|
|
2/14/12 |
|
|
Citibank N.A. |
|
JPY |
|
|
110,000,000 |
|
|
|
1,420,500 |
|
|
|
982 |
|
|
2/14/12 |
|
|
Credit Suisse International |
|
JPY |
|
|
130,000,000 |
|
|
|
1,678,773 |
|
|
|
15,546 |
|
|
2/14/12 |
|
|
Deutsche Bank AG |
|
JPY |
|
|
500,000,000 |
|
|
|
6,456,818 |
|
|
|
50,210 |
|
|
2/14/12 |
|
|
Royal Bank of Scotland PLC |
|
JPY |
|
|
120,000,000 |
|
|
|
1,549,636 |
|
|
|
12,335 |
|
|
1/24/12 |
|
|
Citibank N.A. |
|
NZD |
|
|
600,000 |
|
|
|
466,765 |
|
|
|
(13,705 |
) |
|
1/24/12 |
|
|
Deutsche Bank AG |
|
NZD |
|
|
1,000,000 |
|
|
|
777,942 |
|
|
|
10,108 |
|
|
1/24/12 |
|
|
Royal Bank of Scotland PLC |
|
NZD |
|
|
1,000,000 |
|
|
|
777,942 |
|
|
|
(19,732 |
) |
|
12/20/11 |
|
|
Barclays Bank PLC |
|
SEK |
|
|
9,000,000 |
|
|
|
1,328,797 |
|
|
|
500 |
|
|
12/20/11 |
|
|
Credit Suisse International |
|
SEK |
|
|
42,000,000 |
|
|
|
6,201,050 |
|
|
|
300,175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
84,134,738 |
|
|
$ |
296,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
|
Appreciation |
|
Contracts |
|
|
Type |
|
Date |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
95 |
|
|
Euro Bund |
|
December 2011 |
|
$ |
17,082,318 |
|
|
$ |
(365,359 |
) |
|
4 |
|
|
Japanese Government Bond 10 Yr. (TSE) |
|
December 2011 |
|
|
7,311,501 |
|
|
|
(55,355 |
) |
|
75 |
|
|
U.S. Treasury Note 10 Yr. (CBT) |
|
March 2012 |
|
|
9,700,781 |
|
|
|
(91,629 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
34,094,600 |
|
|
$ |
(512,343 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69 |
|
|
Australian Government Bond 10 Yr. |
|
December 2011 |
|
$ |
8,278,555 |
|
|
$ |
(181,976 |
) |
|
40 |
|
|
Canadian Government Bond 10 Yr. |
|
March 2012 |
|
|
5,177,509 |
|
|
|
(27,456 |
) |
|
2 |
|
|
Euro BOBL |
|
December 2011 |
|
|
329,556 |
|
|
|
(180 |
) |
|
2 |
|
|
Euro SCHATZ |
|
December 2011 |
|
|
296,178 |
|
|
|
(631 |
) |
|
12 |
|
|
U.S. Treasury Bond 30 Yr. (CBT) |
|
March 2012 |
|
|
1,696,500 |
|
|
|
15,339 |
|
|
83 |
|
|
U.S. Treasury Note 2 Yr. (CBT) |
|
March 2012 |
|
|
18,301,500 |
|
|
|
(5,436 |
) |
|
31 |
|
|
U.S. Treasury Note 5 Yr. (CBT) |
|
March 2012 |
|
|
3,801,860 |
|
|
|
4,751 |
|
|
65 |
|
|
UK Gilt Long Bond |
|
March 2012 |
|
|
11,574,564 |
|
|
|
129,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
49,456,222 |
|
|
$ |
(66,484 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
|
|
|
Amount of Future |
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
Receive |
|
Annual |
|
|
Credit |
|
|
Reference |
|
|
Payments by the Fund |
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)^ |
|
Premium |
|
|
Spread (1) |
|
|
Entity |
|
|
Under the Contract (2) |
|
(Depreciation) |
|
2,000,000 USD |
|
12/20/2013 |
|
Barclays Bank PLC |
|
Receive |
|
|
0.25 |
% |
|
|
5.45 |
% |
|
SLM Corp. |
|
2,000,000 USD |
|
$ |
(196,502 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a credit event occurs, as defined
under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of
protection an amount equal to the notional amount of the swap and take delivery of the referenced
obligation or underlying securities comprising the referenced index or (ii) pay a net settlement
amount in the form of cash or securities equal to the notional amount of the swap less the recovery
value of the referenced obligation or underlying securities comprising the referenced index. |
|
|
|
(Pay) Fund pays premium and buys credit protection. If a credit event occurs, as defined under
the terms of that particular swap agreement, the Fund will either (i) receive from the seller of
protection an amount equal to the notional amount of the swap and deliver the referenced obligation
or underlying securities comprising the referenced index or (ii) receive a net settlement amount in
the form of cash or securities equal to the notional amount of the swap less the recovery value of
the referenced obligation or underlying securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in determining the market value
of credit default swap agreements on the reference security, as of November 30, 2011, serve as an
indicator of the current status of the payment/performance risk and reflect the likelihood or risk
of default for the reference entity. The implied credit spread of a particular referenced entity
reflects the cost of buying/selling protection. Wider (i.e. higher) credit spreads represent a
deterioration of the referenced entitys credit soundness and a greater likelihood or risk of
default or other credit event occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a seller of credit protection
if a credit event occurs as defined under the terms of that particular swap agreement. |
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
Receive |
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
|
Variable Rate |
|
(Depreciation) |
|
3,700,000 CHF |
|
3/21/2022 |
|
Citibank N.A. |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
$ |
132,453 |
|
4,600,000 CHF |
|
3/21/2022 |
|
Deutsche Bank AG |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
164,671 |
|
3,900,000 CHF |
|
3/21/2022 |
|
Barclays Bank PLC |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
139,612 |
|
40,400,000 SEK |
|
3/21/2022 |
|
JPMorgan Chase Bank, N.A. |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(271,431 |
) |
57,100,000 SEK |
|
3/21/2022 |
|
Barclays Bank PLC |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(383,631 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(218,326 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
93,846 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate. |
|
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
Fund Pays |
|
Fund Receives |
|
(Depreciation) |
|
175,000,000 USD |
|
2/17/2012 |
|
Merrill Lynch Capital Services, Inc. |
|
1 month LIBOR minus 0.15% |
|
Lehman Aggregate Total Return Index |
|
$ |
(410,153 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011 for the above contracts and/or agreements, the Fund had sufficient cash
and/or securities to cover any commitments or collateral requirements of the relevant broker or
exchange.
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933.
These securities may be resold in transactions exempt from registration, normally to qualified
institutional investors.
CHF LIBOR London Interbank Offered Rate denominated in Swiss Franc.
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance
Corporation.
FSA Insured as to the payment of principal and interest by Financial Security Assurance.
LIBOR London Interbank Offered Rate
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp.
SEK STIBOR Stockholm Interbank Offered Rate denominated in Swedish Krona.
TBA To Be Announced Delayed Delivery Security
XL Insured as to the payment of principal and interest by XL Capital Assurance.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which
are subject to change based on the terms of the security.
(a) |
|
Security is backed by the U.S. Government. |
|
(b) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options, if
any. (Note 4). |
|
(c) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument or
financial statistic. |
(d) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the
Trustees of GMO Trust. |
|
(e) |
|
Underlying investment represents interests in defaulted claims. See Other matters for additional
information. |
|
(f) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(g) |
|
Rate shown represents yield-to-maturity. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
EUR Euro
GBP British Pound
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$280,404,549 |
|
$4,952,485 |
|
$(33,200,020) |
|
$(28,247,535) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Returm of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of
period |
|
GMO Emerging Country
Debt Fund, Class IV |
|
$ |
7,081,912 |
|
|
$ |
1,124,659 |
|
|
$ |
400,000 |
|
|
$ |
94,659 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
8,087,653 |
|
GMO Short-Duration
Collateral Fund |
|
|
76,989,022 |
|
|
|
|
|
|
|
|
|
|
|
583,195 |
|
|
|
|
|
|
|
25,686,857 |
|
|
|
49,026,728 |
|
GMO Special Purpose
Holding Fund |
|
|
46,929 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,604 |
|
GMO U.S. Treasury Fund |
|
|
7,570,707 |
|
|
|
58,587,844 |
|
|
|
27,800,000 |
|
|
|
6,608 |
|
|
|
1,236 |
|
|
|
|
|
|
|
38,361,760 |
|
GMO World Opportunity
Overlay Fund |
|
|
47,034,438 |
|
|
|
2,150,000 |
|
|
|
3,175,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,918,767 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
138,723,008 |
|
|
$ |
61,862,503 |
|
|
$ |
31,375,000 |
|
|
$ |
684,462 |
|
|
$ |
1,236 |
|
|
$ |
25,686,857 |
|
|
$ |
143,431,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined through the
fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are
generally valued at their net asset value. Derivatives and other securities for which quotations
are not readily available or whose values the Manager has determined to be unreliable are valued
at fair value as determined in good faith by the Trustees or persons acting at their direction
pursuant to procedures approved by the Trustees. Although the goal of fair valuation is to
determine the amount the owner of the securities might reasonably expect to receive upon their
current sale, because of the uncertainty inherent in fair value pricing, the value determined
for a particular security may be materially different from the value realized upon its
sale. As of November 30, 2011, the total value of securities held directly and
indirectly that were fair valued using methods determined in good faith by or at the direction
of the Trustees of the Trust represented 9.8% of net assets. The Fund and the underlying funds
classify such securities (levels defined below) as Level 3. For the period ended November 30,
2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the
creditworthiness of its counterparties. See Derivative financial instruments below
for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 7.8% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. The Fund also valued certain other debt
securities by using an estimated specified spread above the LIBOR rate or U.S. Treasury yield.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
557,010 |
|
|
$ |
6,700,043 |
|
|
$ |
7,257,053 |
|
Corporate Debt |
|
|
|
|
|
|
1,034,600 |
|
|
|
|
|
|
|
1,034,600 |
|
U.S. Government |
|
|
31,989,840 |
|
|
|
25,956,484 |
|
|
|
20,099,606 |
|
|
|
78,045,930 |
|
U.S. Government Agency |
|
|
|
|
|
|
20,825,000 |
|
|
|
|
|
|
|
20,825,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
31,989,840 |
|
|
|
48,373,094 |
|
|
|
26,799,649 |
|
|
|
107,162,583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
143,394,908 |
|
|
|
36,604 |
|
|
|
|
|
|
|
143,431,512 |
|
Short-Term Investments |
|
|
1,562,919 |
|
|
|
|
|
|
|
|
|
|
|
1,562,919 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
176,947,667 |
|
|
|
48,409,698 |
|
|
|
26,799,649 |
|
|
|
252,157,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
1,741,628 |
|
|
|
|
|
|
|
1,741,628 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
149,195 |
|
|
|
|
|
|
|
|
|
|
|
149,195 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
|
|
|
|
436,736 |
|
|
|
|
|
|
|
436,736 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
177,096,862 |
|
|
$ |
50,588,062 |
|
|
$ |
26,799,649 |
|
|
$ |
254,484,573 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
$ |
|
|
|
$ |
(1,003,699 |
) |
|
$ |
|
|
|
$ |
(1,003,699 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
(728,022 |
) |
|
|
|
|
|
|
|
|
|
|
(728,022 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk |
|
|
|
|
|
|
(196,502 |
) |
|
|
|
|
|
|
(196,502 |
) |
Interest Rate risk |
|
|
|
|
|
|
(1,065,215 |
) |
|
|
|
|
|
|
(1,065,215 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(728,022 |
) |
|
$ |
(2,265,416 |
) |
|
$ |
|
|
|
$ |
(2,993,438 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds investments (both direct and indirect) in securities and derivative financial instruments
using Level 3 inputs were 33.5% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments Still |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as of |
|
|
Held as of |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Total Realized |
|
|
Appreciation |
|
|
Transfers into |
|
|
Transfers out of |
|
|
November 30, |
|
|
November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
level 3 * |
|
|
2011 |
|
|
2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Backed Securities |
|
$ |
9,187,027 |
|
|
$ |
|
|
|
$ |
(1,897,778 |
) |
|
$ |
107,138 |
|
|
$ |
253,386 |
|
|
$ |
(949,730 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
6,700,043 |
|
|
$ |
(919,037 |
) |
U.S Government |
|
|
19,856,848 |
|
|
|
|
|
|
|
|
|
|
|
961,293 |
|
|
|
|
|
|
|
(718,535 |
) |
|
|
|
|
|
|
|
|
|
|
20,099,606 |
|
|
|
(718,535 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
29,043,875 |
|
|
$ |
|
|
|
$ |
(1,897,778 |
) |
|
$ |
1,068,431 |
|
|
$ |
253,386 |
|
|
$ |
(1,668,265 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
26,799,649 |
|
|
$ |
(1,637,572 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the
Funds Schedule of Investments.
The Fund may purchase or sell securities on a when-issued or forward commitment basis. Payment
and delivery may take place a month or more after the date of the transaction. The price of the
underlying securities and the date when the securities will be delivered and paid for are fixed
at the time the transaction is negotiated. Collateral consisting of liquid securities or cash
and cash equivalents is maintained with the custodian in an amount at least equal to these
commitments. Delayed delivery commitments outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in the
Fund are summarized below. The risks of investing in the Fund depend on the types of investments
in its portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of rising interest rates and widening
of credit spreads. |
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities. |
|
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind. |
|
Derivatives Risk The use of derivatives involves the risk that their value may or
may not move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk. |
|
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline. |
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions. |
|
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk. |
|
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
|
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected. |
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries. |
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also
are subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of
creditors. Many asset-backed securities in which the Fund has invested are now rated below
investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an
attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains
unclear. New regulations could, among other things, restrict the Funds ability to engage in
derivatives transactions (for example, by making certain types of derivatives transactions no
longer available to the Fund) and/or increase the costs of such derivatives transactions (for
example, by increasing margin or capital requirements), and the Fund may be unable to execute
its investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to
adjust exposure to foreign currencies and otherwise adjust currency
exchange rate risk. Forward currency contracts outstanding at the end of the period are
listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees,
risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain markets and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust exposure to foreign currencies and otherwise manage currency exchange rate
risk. The Fund had no purchased options contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market.
During the period ended November 30, 2011, the Fund used written option contracts to adjust
exposure to foreign currencies and otherwise manage currency exchange rate risk. The Fund had no
written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
Amount of |
|
|
Number of |
|
|
|
|
|
Amount of |
|
|
Number of |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
|
(18,200,000 |
) |
|
|
|
|
|
$ |
(358,868 |
) |
|
|
|
|
|
|
|
|
|
$ |
|
|
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised |
|
|
18,200,000 |
|
|
|
|
|
|
|
358,868 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure and adjust exposure to certain markets, achieve exposure to a
reference entitys credit, and/or provide a measure of protection against default loss.
Swap agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by
risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency contracts |
|
$ |
|
|
|
$ |
1,741,628 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,741,628 |
|
Unrealized appreciation on futures contracts* |
|
|
149,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
149,195 |
|
Unrealized appreciation on swap agreements |
|
|
436,736 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
436,736 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
585,931 |
|
|
$ |
1,741,628 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,327,559 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(1,003,699 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,003,699 |
) |
Unrealized depreciation on futures contracts* |
|
|
(728,022 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(728,022 |
) |
Unrealized depreciation on swap agreements |
|
|
(1,065,215 |
) |
|
|
|
|
|
|
(196,502 |
) |
|
|
|
|
|
|
|
|
|
|
(1,261,717 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(1,793,237 |
) |
|
$ |
(1,003,699 |
) |
|
$ |
(196,502 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,993,438 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative
appreciation/depreciation of futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance,
the table above is based on market values or unrealized
appreciation / (depreciation) rather than the notional amounts of derivatives. Changes to
market values of reference asset(s) will tend to have a greater
impact on the Fund (with correspondingly greater risk) the greater the notional
amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and
futures contracts), notional amounts (swap agreements), or principal amounts (options) outstanding
at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
115,604,669 |
|
|
$ |
141,462,660 |
|
|
$ |
264,476,201 |
|
|
$ |
8,616,483 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Currency Hedged International Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value/Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 35.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 3.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 3.2% |
|
|
|
|
CAD |
2,000,000 |
|
|
Government of Canada, 3.50%, due 06/01/20 |
|
|
2,182,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 6.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 6.5% |
|
|
|
|
EUR |
3,300,000 |
|
|
Government of France, 4.00%, due 10/25/38 |
|
|
4,452,699 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 6.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 6.3% |
|
|
|
|
EUR |
2,500,000 |
|
|
Republic of Deutschland, 4.75%, due 07/04/34(a) |
|
|
4,274,980 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 4.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 4.6% |
|
|
|
|
EUR |
3,100,000 |
|
|
Italy Buoni Poliennali Del Tesoro, 5.00%, due 08/01/34 |
|
|
3,135,348 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 1.1% |
|
|
|
|
EUR |
500,000 |
|
|
Netherlands Government Bond, 3.75%, due 01/15/42 |
|
|
770,236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 2.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 2.9% |
|
|
|
|
EUR |
1,900,000 |
|
|
Government of Spain, 4.70%, due 07/30/41 |
|
|
1,970,836 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 5.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 5.2% |
|
|
|
|
GBP |
2,000,000 |
|
|
United Kingdom Gilt, 3.75%, due 09/07/19 |
|
|
3,540,695 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 5.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 5.7% |
|
|
|
|
USD |
3,913,210 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b) |
|
|
3,926,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $23,156,613) |
|
|
24,253,550 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 63.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 63.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 63.0% |
|
|
|
|
|
253,387 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
2,399,577 |
|
|
2,683,050 |
|
|
GMO Short-Duration Collateral Fund |
|
|
17,734,963 |
|
|
5,496 |
|
|
GMO Special Purpose Holding Fund(c) |
|
|
2,143 |
|
|
352,464 |
|
|
GMO U.S. Treasury Fund |
|
|
8,815,122 |
|
|
599,715 |
|
|
GMO World Opportunity Overlay Fund |
|
|
14,153,284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
43,105,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $44,317,664) |
|
|
43,105,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares/Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.5% |
|
|
|
|
|
356,735 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(d) |
|
|
356,735 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 0.9% |
|
|
|
|
USD |
625,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(e) |
|
|
624,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $981,131) |
|
|
981,176 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.9% |
|
|
|
|
|
|
|
|
(Cost $68,455,408) |
|
|
68,339,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.1% |
|
|
54,159 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
68,393,974 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized
Appreciation |
|
Date |
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11
|
|
Barclays Bank PLC
|
|
AUD
|
|
|
400,000 |
|
|
$ |
411,169 |
|
|
$ |
(1,472 |
) |
12/06/11
|
|
Citibank N.A.
|
|
AUD
|
|
|
200,000 |
|
|
|
205,584 |
|
|
|
(3,008 |
) |
12/06/11
|
|
Credit Suisse
International
|
|
AUD
|
|
|
200,000 |
|
|
|
205,584 |
|
|
|
9,588 |
|
12/06/11
|
|
Deutsche Bank AG
|
|
AUD
|
|
|
3,900,000 |
|
|
|
4,008,893 |
|
|
|
206,202 |
|
12/06/11
|
|
Royal Bank of
Scotland PLC
|
|
AUD
|
|
|
200,000 |
|
|
|
205,584 |
|
|
|
1,865 |
|
12/13/11
|
|
Barclays Bank PLC
|
|
CAD
|
|
|
200,000 |
|
|
|
196,030 |
|
|
|
(4,895 |
) |
12/13/11
|
|
Citibank N.A.
|
|
CAD
|
|
|
300,000 |
|
|
|
294,045 |
|
|
|
(7,484 |
) |
12/13/11
|
|
Credit Suisse
International
|
|
CAD
|
|
|
1,400,000 |
|
|
|
1,372,210 |
|
|
|
(5,597 |
) |
12/13/11
|
|
Deutsche Bank AG
|
|
CAD
|
|
|
1,700,000 |
|
|
|
1,666,255 |
|
|
|
11,153 |
|
12/13/11
|
|
Royal Bank of
Scotland PLC
|
|
CAD
|
|
|
1,300,000 |
|
|
|
1,274,195 |
|
|
|
(17,826 |
) |
1/31/12
|
|
Deutsche Bank AG
|
|
CHF
|
|
|
200,000 |
|
|
|
219,284 |
|
|
|
726 |
|
2/07/12
|
|
Citibank N.A.
|
|
EUR
|
|
|
200,000 |
|
|
|
268,914 |
|
|
|
(1,382 |
) |
2/07/12
|
|
Credit Suisse
International
|
|
EUR
|
|
|
500,000 |
|
|
|
672,285 |
|
|
|
4,975 |
|
1/10/12
|
|
Citibank N.A.
|
|
GBP
|
|
|
300,000 |
|
|
|
470,504 |
|
|
|
(10,323 |
) |
1/10/12
|
|
Credit Suisse
International
|
|
GBP
|
|
|
900,000 |
|
|
|
1,411,513 |
|
|
|
(30,599 |
) |
1/10/12
|
|
Deutsche Bank AG
|
|
GBP
|
|
|
200,000 |
|
|
|
313,669 |
|
|
|
(6,931 |
) |
1/10/12
|
|
Royal Bank of
Scotland PLC
|
|
GBP
|
|
|
300,000 |
|
|
|
470,504 |
|
|
|
(6,974 |
) |
2/14/12
|
|
Credit Suisse
International
|
|
JPY
|
|
|
60,000,000 |
|
|
|
774,818 |
|
|
|
655 |
|
2/21/12
|
|
Deutsche Bank AG
|
|
NOK
|
|
|
8,600,000 |
|
|
|
1,483,746 |
|
|
|
17,670 |
|
2/21/12
|
|
Royal Bank of
Scotland PLC
|
|
NOK
|
|
|
1,400,000 |
|
|
|
241,540 |
|
|
|
3,758 |
|
1/24/12
|
|
Credit Suisse
International
|
|
NZD
|
|
|
400,000 |
|
|
|
311,177 |
|
|
|
(2,703 |
) |
12/20/11
|
|
Barclays Bank PLC
|
|
SEK
|
|
|
4,300,000 |
|
|
|
634,869 |
|
|
|
(12,765 |
) |
12/20/11
|
|
Citibank N.A.
|
|
SEK
|
|
|
3,100,000 |
|
|
|
457,697 |
|
|
|
(2,749 |
) |
12/20/11
|
|
Credit Suisse
International
|
|
SEK
|
|
|
6,300,000 |
|
|
|
930,158 |
|
|
|
18,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/20/11
|
|
Deutsche Bank AG
|
|
SEK
|
|
|
3,600,000 |
|
|
|
531,519 |
|
|
|
(31,165 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
19,031,746 |
|
|
$ |
128,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11
|
|
Citibank N.A.
|
|
AUD
|
|
|
400,000 |
|
|
$ |
411,168 |
|
|
$ |
4,961 |
|
12/06/11
|
|
Credit Suisse
International
|
|
AUD
|
|
|
1,200,000 |
|
|
|
1,233,505 |
|
|
|
(11,071 |
) |
12/06/11
|
|
Deutsche Bank AG
|
|
AUD
|
|
|
500,000 |
|
|
|
513,961 |
|
|
|
(4,461 |
) |
12/06/11
|
|
Royal Bank of
Scotland PLC
|
|
AUD
|
|
|
500,000 |
|
|
|
513,961 |
|
|
|
(24,041 |
) |
12/13/11
|
|
Citibank N.A.
|
|
CAD
|
|
|
400,000 |
|
|
|
392,060 |
|
|
|
1,703 |
|
12/13/11
|
|
Credit Suisse
International
|
|
CAD
|
|
|
100,000 |
|
|
|
98,015 |
|
|
|
(3,747 |
) |
12/13/11
|
|
Deutsche Bank AG
|
|
CAD
|
|
|
7,600,000 |
|
|
|
7,449,141 |
|
|
|
(123,044 |
) |
1/31/12
|
|
Barclays Bank PLC
|
|
CHF
|
|
|
300,000 |
|
|
|
328,926 |
|
|
|
4,886 |
|
1/31/12
|
|
Credit Suisse
International
|
|
CHF
|
|
|
1,600,000 |
|
|
|
1,754,271 |
|
|
|
42,973 |
|
1/31/12
|
|
Royal Bank of
Scotland PLC
|
|
CHF
|
|
|
700,000 |
|
|
|
767,493 |
|
|
|
13,103 |
|
2/07/12
|
|
Citibank N.A.
|
|
EUR
|
|
|
100,000 |
|
|
|
134,457 |
|
|
|
178 |
|
2/07/12
|
|
Deutsche Bank AG
|
|
EUR
|
|
|
14,300,000 |
|
|
|
19,227,354 |
|
|
|
242,096 |
|
1/10/12
|
|
Citibank N.A.
|
|
GBP
|
|
|
400,000 |
|
|
|
627,339 |
|
|
|
(4,699 |
) |
1/10/12
|
|
Credit Suisse
International
|
|
GBP
|
|
|
3,000,000 |
|
|
|
4,705,042 |
|
|
|
(56,610 |
) |
1/10/12
|
|
Deutsche Bank AG
|
|
GBP
|
|
|
100,000 |
|
|
|
156,835 |
|
|
|
1,205 |
|
1/10/12
|
|
Royal Bank of
Scotland PLC
|
|
GBP
|
|
|
200,000 |
|
|
|
313,669 |
|
|
|
1,438 |
|
2/14/12
|
|
Barclays Bank PLC
|
|
JPY
|
|
|
20,000,000 |
|
|
|
258,273 |
|
|
|
2,253 |
|
2/14/12
|
|
Citibank N.A.
|
|
JPY
|
|
|
30,000,000 |
|
|
|
387,409 |
|
|
|
268 |
|
2/14/12
|
|
Credit Suisse
International
|
|
JPY
|
|
|
40,000,000 |
|
|
|
516,545 |
|
|
|
4,783 |
|
2/14/12
|
|
Deutsche Bank AG
|
|
JPY
|
|
|
150,000,000 |
|
|
|
1,937,045 |
|
|
|
15,063 |
|
2/14/12
|
|
Royal Bank of
Scotland PLC
|
|
JPY
|
|
|
30,000,000 |
|
|
|
387,409 |
|
|
|
3,084 |
|
1/24/12
|
|
Citibank N.A.
|
|
NZD
|
|
|
200,000 |
|
|
|
155,588 |
|
|
|
(4,568 |
) |
1/24/12
|
|
Deutsche Bank AG
|
|
NZD
|
|
|
300,000 |
|
|
|
233,383 |
|
|
|
3,032 |
|
1/24/12
|
|
Royal Bank of
Scotland PLC
|
|
NZD
|
|
|
200,000 |
|
|
|
155,588 |
|
|
|
(3,946 |
) |
12/20/11
|
|
Barclays Bank PLC
|
|
SEK
|
|
|
2,600,000 |
|
|
|
383,875 |
|
|
|
144 |
|
12/20/11
|
|
Credit Suisse
International
|
|
SEK
|
|
|
13,200,000 |
|
|
|
1,948,902 |
|
|
|
96,124 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
44,991,214 |
|
|
$ |
201,107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
|
Australian Government Bond 3 Yr. |
|
December 2011 |
|
$ |
1,222,846 |
|
|
$ |
12,678 |
|
|
82 |
|
|
Euro BOBL |
|
December 2011 |
|
|
13,511,786 |
|
|
|
4,457 |
|
|
25 |
|
|
Euro Bund |
|
December 2011 |
|
|
4,495,347 |
|
|
|
(119,052 |
) |
|
44 |
|
|
Euro SCHATZ |
|
December 2011 |
|
|
6,515,921 |
|
|
|
19,098 |
|
|
1 |
|
|
Japanese Government Bond 10 Yr. (TSE) |
|
December 2011 |
|
|
1,827,875 |
|
|
|
(15,223 |
) |
|
2 |
|
|
U.S. Treasury Note 2 Yr. (CBT) |
|
March 2012 |
|
|
441,000 |
|
|
|
25 |
|
|
2 |
|
|
U.S. Treasury Note 10 Yr. (CBT) |
|
March 2012 |
|
|
258,688 |
|
|
|
(2,443 |
) |
|
47 |
|
|
UK Gilt Long Bond |
|
March 2012 |
|
|
8,369,300 |
|
|
|
(74,575 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
36,642,763 |
|
|
$ |
(175,035 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15 |
|
|
Australian Government Bond 10 Yr. |
|
December 2011 |
|
$ |
1,799,686 |
|
|
$ |
(39,626 |
) |
|
5 |
|
|
Canadian Government Bond 10 Yr. |
|
March 2012 |
|
|
647,189 |
|
|
|
(3,908 |
) |
|
3 |
|
|
U.S. Treasury Bond 30 Yr. (CBT) |
|
March 2012 |
|
|
424,125 |
|
|
|
11,382 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,871,000 |
|
|
$ |
(32,152 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
|
Amount of Future |
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
Receive |
|
Annual |
|
|
Credit |
|
|
Reference |
|
Payments by the Fund |
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)^ |
|
Premium |
|
|
Spread (1) |
|
|
Entity |
|
Under the Contract (2) |
|
(Depreciation) |
|
14,000,000 |
|
USD |
|
3/20/2014 |
|
Deutsche Bank AG |
|
(Pay) |
|
|
1.70 |
% |
|
|
5.01 |
% |
|
Republic of Italy |
|
NA |
|
$ |
930,266 |
|
10,000,000 |
|
USD |
|
3/20/2019 |
|
Deutsche Bank AG |
|
Receive |
|
|
1.66 |
% |
|
|
4.75 |
% |
|
Republic of Italy |
|
10,000,000 USD |
|
|
(1,629,036 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(698,770 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a
credit event occurs, as defined under the terms of that particular
swap agreement, the Fund will either (i) pay to the buyer of
protection an amount equal to the notional amount of the swap and take
delivery of the referenced obligation or underlying securities
comprising the referenced index or (ii) pay a net settlement amount in
the form of cash or securities equal to the notional amount of the
swap less the recovery value of the referenced obligation or
underlying securities comprising the referenced
index.
(Pay) Fund pays premium and buys credit protection. If a credit
event occurs, as defined under the terms of that particular swap
agreement, the Fund will either (i) receive from the seller of
protection an amount equal to the notional amount of the swap and
deliver the referenced obligation or underlying securities comprising
the referenced index or (ii) receive a net settlement amount in the
form of cash or securities equal to the notional amount of the swap
less the recovery value of the referenced obligation or underlying
securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in
determining the market value of credit default swap agreements on the
reference security, as of November 30, 2011, serve as an indicator of
the current status of the payment/performance risk and reflect the
likelihood or risk of default for the reference entity. The implied
credit spread of a particular referenced entity reflects the cost of
buying/selling protection. Wider (i.e.higher) credit spreads
represent a deterioration of the referenced entitys credit soundness
and a greater likelihood or risk of default or other credit event
occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a
seller of credit protection if a credit event occurs as defined under
the terms of that particular swap agreement. |
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
Receive |
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
|
Variable Rate |
|
(Depreciation) |
|
1,300,000 CHF |
|
3/21/2022 |
|
Citibank N.A. |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
$ |
46,537 |
|
1,500,000 CHF |
|
3/21/2022 |
|
Deutsche Bank AG |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
53,697 |
|
1,200,000 CHF |
|
3/21/2022 |
|
Barclays Bank PLC |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
42,958 |
|
15,000,000 EUR |
|
6/29/2013 |
|
Merrill Lynch Capital Services |
|
Receive |
|
|
2.02 |
% |
|
3 Month EUR LIBOR |
|
|
185,933 |
|
13,000,000 SEK |
|
3/21/2022 |
|
JPMorgan Chase Bank, N.A. |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(87,341 |
) |
12,000,000 SEK |
|
3/21/2022 |
|
Barclays Bank PLC |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(80,623 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
161,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
26,426 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate. |
|
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash
and/or securities to cover any commitments or collateral requirements of the relevant broker or
exchange.
|
|
|
Notes to Schedule of Investments: |
|
CHF LIBOR London Interbank Offered Rate denominated in Swiss Franc. |
|
EUR LIBOR London Interbank Offered Rate denominated in Euros. |
|
SEK STIBOR Stockholm Interbank Offered Rate denominated in Swedish Krona. |
|
(a) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options, if
any. |
|
(b) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument
or financial statistic. |
|
(c) |
|
Underlying investment represents interests in defaulted claims. See Other Matters for
additional information. |
|
(d) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
|
|
(e) |
|
Rate shown represents yield-to-maturity. |
Currency Abbreviations:
AUD
Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
EUR Euro
GBP British Pound
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
75,697,825 |
|
$ |
2,224,998 |
|
|
$ |
(9,583,008 |
) |
|
$ |
(7,358,010 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
Sales |
|
Dividend |
|
of Realized |
|
Return of |
|
Value, end |
Affiliate |
|
period |
|
Purchases |
|
Proceeds |
|
Income* |
|
Gains* |
|
Capital* |
|
of period |
GMO Emerging
Country Debt Fund,
Class IV |
|
$ |
2,089,035 |
|
$ |
632,923 |
|
$ |
390,000 |
|
$ |
27,923 |
|
$ |
|
|
$ |
|
|
$ |
2,399,577 |
GMO Short-Duration
Collateral Fund |
|
|
27,850,062 |
|
|
|
|
|
|
|
|
210,965 |
|
|
|
|
|
9,291,982 |
|
|
17,734,963 |
GMO Special Purpose
Holding Fund |
|
|
2,748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,143 |
GMO U.S. Treasury
Fund |
|
|
5,008,836 |
|
|
22,153,742 |
|
|
18,350,000 |
|
|
3,293 |
|
|
449 |
|
|
|
|
|
8,815,122 |
GMO World
Opportunity Overlay
Fund |
|
|
14,255,462 |
|
|
1,600,000 |
|
|
2,300,000 |
|
|
|
|
|
|
|
|
|
|
|
14,153,284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
49,206,143 |
|
$ |
24,386,665 |
|
$ |
21,040,000 |
|
$ |
242,181 |
|
$ |
449 |
|
$ |
9,291,982 |
|
$ |
43,105,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined at the end of the
fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 1.3% of net assets. The underlying funds classify such securities (levels
defined below) as Level 3. For the period ended November 30, 2011, the Fund did not
reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its
counterparties. See Derivative financial instruments below for a further discussion
on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 8.9% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government |
|
$ |
|
|
|
$ |
3,926,355 |
|
|
$ |
|
|
|
$ |
3,926,355 |
|
Foreign Government Obligations |
|
|
|
|
|
|
20,327,195 |
|
|
|
|
|
|
|
20,327,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
24,253,550 |
|
|
|
|
|
|
|
24,253,550 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
43,102,946 |
|
|
|
2,143 |
|
|
|
|
|
|
|
43,105,089 |
|
Short-Term Investments |
|
|
981,176 |
|
|
|
|
|
|
|
|
|
|
|
981,176 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
44,084,122 |
|
|
|
24,255,693 |
|
|
|
|
|
|
|
68,339,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
|
|
|
|
|
712,146 |
|
|
|
|
|
|
|
712,146 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
47,640 |
|
|
|
|
|
|
|
|
|
|
|
47,640 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
930,266 |
|
|
|
|
|
|
|
930,266 |
|
Interest Rate Risk |
|
|
|
|
|
|
329,125 |
|
|
|
|
|
|
|
329,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
44,131,762 |
|
|
$ |
26,227,230 |
|
|
$ |
|
|
|
$ |
70,358,992 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
$ |
|
|
|
$ |
(382,060 |
) |
|
$ |
|
|
|
$ |
(382,060 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
(254,827 |
) |
|
|
|
|
|
|
|
|
|
|
(254,827 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
(1,629,036 |
) |
|
|
|
|
|
|
(1,629,036 |
) |
Interest Rate Risk |
|
|
|
|
|
|
(167,964 |
) |
|
|
|
|
|
|
(167,964 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(254,827 |
) |
|
$ |
(2,179,060 |
) |
|
$ |
|
|
|
$ |
(2,433,887 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a
further discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than
the uncertainties surrounding inputs for a non-derivative security with the same market value. |
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of
the Funds investments (both direct and indirect) in securities and derivative financial
instruments using Level 3 inputs were 25.3% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November
30, 2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day
the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings
and other assets and liabilities resulting from changes in exchange rates are recorded as
unrealized foreign currency gains or losses. Realized gains or losses and unrealized
appreciation or depreciation on investment securities and income and expenses are translated on
the respective dates of such transactions. The effects of changes in foreign currency exchange
rates on investments in securities are not separated from the effects of changes in market
prices of those securities, but are included with the net realized and unrealized gain or loss
on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to
repurchase the security at an agreed upon price and date. The Fund, through its custodian,
takes possession of securities it acquired under the repurchase agreement. The value of the
securities acquired is required by contract to be marked to market daily and additional
collateral is required to be transferred so that the market value is at least equal to the
amount owed to the Fund by the seller. If the seller of a repurchase agreement defaults or
enters into insolvency proceedings and/or the value of the securities subject to the repurchase
agreement is insufficient, the Funds recovery of cash from the seller may be delayed and the
Fund may incur a loss equal to the difference between the cash it paid and the value of the
securities. The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any
inflation related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation,
real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation
pending against various entities related to the 2002 fraud and related default of securities
previously held by SPHF. The outcome of the lawsuits against the remaining defendants is not
known and any potential recoveries are not reflected in the net asset value of SPHF. For the
period ended November 30, 2011, the Fund received no distributions from SPHF in connection with
the defaulted securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act)
and therefore a decline in the market value of a particular security held by the Fund may
affect the Funds performance more than if the Fund were diversified. Selected risks of
investing in the Fund are summarized below. The risks of investing in the Fund depend on the
types of investments in its portfolio and the investment strategies the Manager employs on its
behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to
severe credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset backed security will be
unable or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the
markets expectation of a default, which may result from the downgrading of the issuers
credit rating. The Funds investments in below investment grade securities have
speculative characteristics, and changes in economic conditions or other circumstances are
more likely to impair the capacity of issuers to make principal and interest payments than
is the case with issuers of investment grade securities.
Liquidity Risk Low trading volume, lack of a market maker, large size of position
or legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may or
may not move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC
derivatives contract or a borrower of the Funds securities will be unable or unwilling to
make timely settlement payments or otherwise honor its obligations. The risk of
counterparty default is particularly acute in economic environments in which financial
services firms are exposed to systemic risks of the type evidenced by the insolvency of
Lehman Brothers in 2008 and subsequent market disruptions.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments
in asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs
the risk that GMOs proprietary investment techniques will fail to produce the desired
results. The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of
the portfolio managers to implement strategies. By necessity, these analyses and models
make simplifying assumptions that limit their efficacy. Models that appear to explain
prior market data can fail to predict future market events. Further, the data used in
models may be inaccurate and/or it may not include the most recent information about a
company or a security. The Fund is also subject to the risk that deficiencies in the
Managers or another service providers internal systems or controls will cause losses for
the Fund or impair Fund operations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Foreign Investment Risk The market prices of many foreign securities fluctuate
more than those of U.S. securities. Many foreign markets are less stable, smaller, less
liquid and less regulated than U.S. markets, and the cost of trading in those markets
often is higher than in U.S. markets. Foreign portfolio transactions generally involve
higher commission rates, transfer taxes and custodial costs than similar transactions in
the U.S. In addition, the Fund may be subject to foreign taxes on capital gains or other
income payable on foreign securities, on transactions in those securities and on the
repatriation of proceeds generated from those securities. Also, many foreign markets
require a license for the Fund to invest directly in those markets, and the Fund is
subject to the risk that it could not invest if its license were terminated or suspended.
In some foreign markets, prevailing custody and trade settlement practices (e.g., the
requirement to pay for securities prior to receipt) expose the Fund to credit and other
risks with respect to participating brokers, custodians, clearing banks or other clearing
agents, escrow agents and issuers. Further, adverse changes in investment regulations,
capital requirements or exchange controls could adversely affect the value of the Funds
investments. These and other risks (e.g., nationalization, expropriation or other
confiscation of assets of foreign issuers) tend to be greater for investments in companies
tied economically to emerging countries, the economies of which tend to be more volatile
than the economies of developed countries.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal
structure (e.g., determination as to the amount of underlying assets or other support needed to
produce the cash flows necessary to service interest and make principal payments), the quality
of the underlying assets and, if any, the level of credit support and the credit quality of the
credit-support provider. Asset-backed securities involve risk of loss of principal if obligors
of the underlying obligations default and the value of the defaulted obligations exceeds
whatever credit support the securities may have. The obligations of issuers (and obligors of
underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the
rights and remedies of creditors. Many asset-backed securities in which the Fund has invested
are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand
for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have,
adverse valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at
as high a yield as is provided by the asset-backed security. The risk of investing in
asset-backed securities has increased because performance of the various sectors in which the
assets underlying asset-backed securities are concentrated (e.g., auto loans, student loans,
sub-prime mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund
below a certain level over a specified period of time and entitle a counterparty to elect to
terminate early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value
of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of
the investment exposures of the Funds portfolio. Derivatives may relate to securities,
interest rates, currencies, currency exchange rates, inflation rates, commodities and related
indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements,
and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the
Fund may use an instrument denominated in a different currency that the Manager believes is
highly correlated with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face
value of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than,
the risks associated with investing directly in securities and other more traditional assets.
In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to
a derivatives contract will be unable or unwilling to make timely settlement payments or
otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with
the other party to the contract. If the counterparty defaults, the Fund will have contractual
remedies, but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after
the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral
to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the
collateral is called for and the day the Fund receives it. When a counterpartys obligations
are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse
if the counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The
pricing models used by the Fund or their pricing agents may not produce valuations that are
consistent with the values realized when OTC derivatives are actually closed out or sold. This
valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized
terms because the value of those derivatives in some cases is determined only by reference to
similar derivatives with more standardized terms. As a result, incorrect valuations may result
in increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic
costs of taking some derivative positions may be prohibitive, and if a counterparty or its
affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade
with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or
otherwise reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of
derivatives also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the
risk that it will be required to pay the full notional value of the swap contract in the event
of a default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation
service and changes in value are recorded by the Fund as unrealized gains or losses. Realized
gains or losses on the contracts are equal to the difference between the value of the contract
at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and
the risk that the counterparty will be unable or unwilling to meet the terms of the
contracts. During the period ended November 30, 2011, the Fund used forward currency
contracts to adjust exposure to foreign
currencies and otherwise adjust currency exchange rate
risk. Forward currency contracts outstanding at the end of the period are listed in the Funds
Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the
settlement price established at the close of business each day by the board of trade or
exchange on which they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded
by the Fund. The payable or receivable is settled on the following business day. Gains or
losses are recognized but not accounted for as realized until the contracts expire or are
closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation
margin. Under some circumstances, futures exchanges may establish daily limits on the amount
that the price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest rate exposure and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust interest rate exposure, to adjust exposure to foreign currencies and
otherwise manage currency exchange rate risk. The Fund had no purchased option
contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions),
securities or currencies it owns or in which it may invest. Writing options alters the Funds
exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell
the underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When
the Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written option contracts to adjust exposure to foreign currencies and otherwise
manage currency exchange rate risk. The Fund had no written option contracts outstanding at the
end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the
time it was closed. Realized gains and losses on purchased options are included in realized
gains and losses on investment securities. If a written call option is exercised, the premium
originally received is recorded as an addition to sales proceeds. If a written put option is
exercised, the premium originally received is recorded as a reduction in the cost of
investments purchased. Gains and losses from the expiration or closing of written option
contracts are separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
Amount of |
|
|
Number of |
|
|
|
|
|
|
Amount of |
|
|
Number of |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
|
(8,000,000 |
) |
|
|
|
|
|
$ |
(157,744 |
) |
|
|
|
|
|
|
|
|
|
$ |
|
|
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
8,000,000 |
|
|
|
|
|
|
|
157,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options bought back |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty
may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective
commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest
payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence
of a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers,
a credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on
the measured variance (or square of volatility) of a specified underlying asset. One party
agrees to exchange a fixed rate or strike price payment for the floating rate or realized
price variance on the underlying asset with respect to the notional amount. At inception, the
strike price chosen is generally fixed at a level such that the fair value of the swap is zero.
As a result, no money changes hands at the initiation of the contract. At the expiration date,
the amount payable by one party to the other is the difference between the realized price
variance of the underlying asset and the strike price multiplied by the notional amount. A
receiver of the realized price variance would be entitled to receive a payment when the
realized price variance of the underlying asset is greater than the strike price and would be
obligated to make a payment when that variance is less than the strike price. A payer of the
realized price variance would be obligated to make a payment when the realized price variance
of the underlying asset is greater than the strike price and would be entitled to receive a
payment when that variance is less than the strike price. This type of agreement is essentially
a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure, achieve exposure to a reference entitys credit, and/or
provide a measure of protection against default loss. Swap agreements outstanding at
the end of the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency
contracts |
|
$ |
|
|
|
$ |
712,146 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
712,146 |
|
Unrealized appreciation on futures contracts* |
|
|
47,640 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
47,640 |
|
Unrealized appreciation on swap agreements |
|
|
329,125 |
|
|
|
|
|
|
|
930,266 |
|
|
|
|
|
|
|
|
|
|
|
1,259,391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
376,765 |
|
|
$ |
712,146 |
|
|
$ |
930,266 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,019,177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency
contracts |
|
$ |
|
|
|
$ |
(382,060 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(382,060 |
) |
Unrealized depreciation on futures contracts* |
|
|
(254,827 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(254,827 |
) |
Unrealized depreciation on swap agreements |
|
|
(167,964 |
) |
|
|
|
|
|
|
(1,629,036 |
) |
|
|
|
|
|
|
|
|
|
|
(1,797,000 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(422,791 |
) |
|
$ |
(382,060 |
) |
|
$ |
(1,629,036 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,433,887 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures
contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
54,522,151 |
|
|
$ |
49,600,340 |
|
|
$ |
66,652,943 |
|
|
$ |
3,787,465 |
|
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Currency Hedged International Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares/Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 98.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 98.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
11,292,804 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
241,666,004 |
|
|
18,564,730 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
362,012,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $603,538,697) |
|
|
603,678,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 1.0% |
|
|
|
|
|
USD |
2,000,000 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
2,000,000 |
|
EUR |
7,033 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11 |
|
|
9,430 |
|
USD |
2,000,000 |
|
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
2,000,000 |
|
USD |
154,731 |
|
|
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
154,731 |
|
USD |
2,000,000 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
2,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
6,164,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $6,164,161) |
|
|
6,164,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.6%
(Cost $609,702,858) |
|
|
609,842,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.4% |
|
|
2,708,508 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
612,550,898 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
EUR |
|
|
2,308,000 |
|
|
$ |
3,101,579 |
|
|
$ |
(73,234 |
) |
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
EUR |
|
|
12,536,000 |
|
|
|
16,846,360 |
|
|
|
(317,156 |
) |
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
GBP |
|
|
2,065,000 |
|
|
|
3,239,328 |
|
|
|
(59,580 |
) |
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
JPY |
|
|
214,446,000 |
|
|
|
2,765,830 |
|
|
|
(12,814 |
) |
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
SGD |
|
|
2,519,429 |
|
|
|
1,965,801 |
|
|
|
(15,303 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
27,918,898 |
|
|
$ |
(478,087 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
# |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
AUD |
|
|
8,156,794 |
|
|
$ |
8,373,947 |
|
|
$ |
(98,080 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
AUD |
|
|
15,106,904 |
|
|
|
15,509,086 |
|
|
|
(277,323 |
) |
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
AUD |
|
|
10,646,477 |
|
|
|
10,929,911 |
|
|
|
(581,426 |
) |
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
AUD |
|
|
4,585,677 |
|
|
|
4,707,759 |
|
|
|
(69,805 |
) |
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
AUD |
|
|
6,715,716 |
|
|
|
6,894,504 |
|
|
|
(136,405 |
) |
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
AUD |
|
|
4,607,576 |
|
|
|
4,730,241 |
|
|
|
(68,986 |
) |
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
CAD |
|
|
1,736,750 |
|
|
|
1,702,140 |
|
|
|
3,360 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
CAD |
|
|
3,216,000 |
|
|
|
3,151,912 |
|
|
|
2,292 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
2,161,000 |
|
|
|
2,117,936 |
|
|
|
(4,489 |
) |
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
CAD |
|
|
1,719,249 |
|
|
|
1,684,988 |
|
|
|
(6,885 |
) |
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
CAD |
|
|
3,283,000 |
|
|
|
3,217,577 |
|
|
|
(54,597 |
) |
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
CHF |
|
|
3,799,379 |
|
|
|
4,160,115 |
|
|
|
48,930 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
CHF |
|
|
5,196,967 |
|
|
|
5,690,399 |
|
|
|
68,333 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
CHF |
|
|
11,722,497 |
|
|
|
12,835,502 |
|
|
|
(35,041 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
CHF |
|
|
9,754,433 |
|
|
|
10,680,578 |
|
|
|
148,897 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
CHF |
|
|
7,313,575 |
|
|
|
8,007,970 |
|
|
|
106,819 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
CHF |
|
|
6,690,116 |
|
|
|
7,325,316 |
|
|
|
80,916 |
|
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
CHF |
|
|
2,619,000 |
|
|
|
2,867,664 |
|
|
|
17,438 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
CHF |
|
|
3,784,000 |
|
|
|
4,143,276 |
|
|
|
52,079 |
|
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
DKK |
|
|
23,630,000 |
|
|
|
4,270,632 |
|
|
|
65,929 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
DKK |
|
|
20,808,155 |
|
|
|
3,760,642 |
|
|
|
61,576 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
DKK |
|
|
18,116,000 |
|
|
|
3,274,091 |
|
|
|
57,174 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
DKK |
|
|
21,090,000 |
|
|
|
3,811,580 |
|
|
|
65,301 |
|
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
DKK |
|
|
26,622,000 |
|
|
|
4,811,374 |
|
|
|
(16,732 |
) |
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
DKK |
|
|
16,476,000 |
|
|
|
2,977,695 |
|
|
|
49,058 |
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
EUR |
|
|
11,812,312 |
|
|
|
15,873,840 |
|
|
|
323,296 |
|
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
EUR |
|
|
7,817,983 |
|
|
|
10,506,107 |
|
|
|
194,988 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
EUR |
|
|
16,229,535 |
|
|
|
21,809,875 |
|
|
|
142,044 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
EUR |
|
|
8,731,571 |
|
|
|
11,733,822 |
|
|
|
204,680 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
EUR |
|
|
15,708,607 |
|
|
|
21,109,832 |
|
|
|
399,367 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
EUR |
|
|
12,466,375 |
|
|
|
16,752,795 |
|
|
|
296,555 |
|
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
EUR |
|
|
26,283,068 |
|
|
|
35,320,200 |
|
|
|
527,561 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
EUR |
|
|
11,679,244 |
|
|
|
15,695,018 |
|
|
|
504,440 |
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
GBP |
|
|
8,040,133 |
|
|
|
12,612,409 |
|
|
|
(28,161 |
) |
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
GBP |
|
|
5,052,133 |
|
|
|
7,925,188 |
|
|
|
(16,478 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
GBP |
|
|
5,497,670 |
|
|
|
8,624,094 |
|
|
|
(17,601 |
) |
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
GBP |
|
|
13,060,000 |
|
|
|
20,486,981 |
|
|
|
(279,815 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
9,701,416 |
|
|
|
15,218,433 |
|
|
|
(44,175 |
) |
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
GBP |
|
|
7,391,732 |
|
|
|
11,595,274 |
|
|
|
133,349 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
GBP |
|
|
12,812,586 |
|
|
|
20,098,868 |
|
|
|
(35,742 |
) |
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
GBP |
|
|
5,640,000 |
|
|
|
8,847,364 |
|
|
|
(23,612 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
GBP |
|
|
9,077,000 |
|
|
|
14,238,923 |
|
|
|
(55,112 |
) |
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
HKD |
|
|
74,228,380 |
|
|
|
9,555,327 |
|
|
|
(8,080 |
) |
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
HKD |
|
|
10,690,000 |
|
|
|
1,376,110 |
|
|
|
(812 |
) |
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
JPY |
|
|
1,407,000,929 |
|
|
|
18,146,880 |
|
|
|
197,474 |
|
|
12/16/11 |
|
|
Bank of New York
Mellon |
|
JPY |
|
|
968,666,160 |
|
|
|
12,493,431 |
|
|
|
139,162 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
JPY |
|
|
1,193,276,769 |
|
|
|
15,390,360 |
|
|
|
178,786 |
|
|
12/16/11 |
|
|
Deutsche Bank, AG |
|
JPY |
|
|
2,045,064,280 |
|
|
|
26,376,341 |
|
|
|
286,470 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
JPY |
|
|
954,196,868 |
|
|
|
12,306,812 |
|
|
|
137,800 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
JPY |
|
|
2,370,126,057 |
|
|
|
30,568,845 |
|
|
|
327,171 |
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
NOK |
|
|
21,030,774 |
|
|
|
3,638,671 |
|
|
|
85,405 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
NOK |
|
|
38,428,750 |
|
|
|
6,648,808 |
|
|
|
124,687 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
NOK |
|
|
35,940,000 |
|
|
|
6,218,214 |
|
|
|
117,376 |
|
|
12/16/11 |
|
|
Royal Bank of
Scotland PLC |
|
NOK |
|
|
21,671,000 |
|
|
|
3,749,441 |
|
|
|
(63,291 |
) |
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
NZD |
|
|
3,111,000 |
|
|
|
2,426,811 |
|
|
|
(43,500 |
) |
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
NZD |
|
|
2,244,000 |
|
|
|
1,750,487 |
|
|
|
19,221 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
NZD |
|
|
2,635,000 |
|
|
|
2,055,496 |
|
|
|
23,582 |
|
|
12/16/11 |
|
|
Bank of America,
N.A. |
|
SEK |
|
|
15,789,000 |
|
|
|
2,331,469 |
|
|
|
33,969 |
|
|
12/16/11 |
|
|
Brown Brothers
Harriman & Co. |
|
SEK |
|
|
12,090,886 |
|
|
|
1,785,391 |
|
|
|
19,731 |
|
|
12/16/11 |
|
|
JPMorgan Chase
Bank, N.A. |
|
SEK |
|
|
24,891,000 |
|
|
|
3,675,509 |
|
|
|
28,058 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
SEK |
|
|
17,442,000 |
|
|
|
2,575,558 |
|
|
|
42,311 |
|
|
12/16/11 |
|
|
State Street Bank
and Trust Company |
|
SEK |
|
|
3,724,121 |
|
|
|
549,919 |
|
|
|
6,435 |
|
|
12/16/11 |
|
|
Morgan Stanley
Capital Services
Inc. |
|
SGD |
|
|
2,774,000 |
|
|
|
2,164,431 |
|
|
|
(2,855 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
575,870,169 |
|
|
$ |
3,353,017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$615,556,547 |
|
$ |
|
|
|
$ |
(5,714,157 |
) |
|
$ |
(5,714,157 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO
International
Growth Equity Fund,
Class IV |
|
$ |
243,215,675 |
|
|
$ |
105,609,127 |
|
|
$ |
91,325,791 |
|
|
$ |
1,180,645 |
|
|
$ |
|
|
|
$ |
241,666,004 |
|
GMO International
Intrinsic Value
Fund, Class IV |
|
|
243,669,947 |
|
|
|
226,504,506 |
|
|
|
84,404,601 |
|
|
|
3,280,660 |
|
|
|
|
|
|
|
362,012,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
486,885,622 |
|
|
$ |
332,113,633 |
|
|
$ |
175,730,392 |
|
|
$ |
4,461,305 |
|
|
$ |
|
|
|
$ |
603,678,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods
determined in good faith by or at the direction of the Trustees of the Trust represented less
than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3.
For the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC
derivatives contracts based on the creditworthiness of its counterparties. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
|
|
|
Security
Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
89.4% |
Futures Contracts |
|
0.4% |
Swap Agreements |
|
(0.0)^ |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
603,678,229 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
603,678,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
603,678,229 |
|
|
|
|
|
|
|
|
|
|
|
603,678,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
6,164,161 |
|
|
|
|
|
|
|
|
|
|
|
6,164,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
609,842,390 |
|
|
|
|
|
|
|
|
|
|
|
609,842,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
|
|
|
|
|
5,322,020 |
|
|
|
|
|
|
|
5,322,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
609,842,390 |
|
|
$ |
5,322,020 |
|
|
$ |
|
|
|
$ |
615,164,410
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
|
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds indirect
investments in securities using Level 3 inputs were less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. The Fund and some of the underlying funds are
non-diversified investment companies under the Investment Company Act of 1940 (the 1940 Act)
and therefore a decline in the market value of a particular security held by the Fund or an
underlying fund may affect the Funds or the underlying funds performance more than if the Fund
or underlying fund were diversified. Selected risks of investing in the Fund are summarized
below, including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund or an underlying fund purchases equity investments at a
discount from their value as determined by the Manager, the Fund runs the risk that the
market prices of these investments will not increase to that value for a variety of
reasons, one of which may be the Managers overestimation of the value of those
investments. The Fund or an underlying fund also may purchase equity investments that
typically trade at higher multiples of current earnings than other securities, and the
market values of these investments often are more sensitive to changes in future earnings
expectations than those other securities. Because the Fund and the underlying funds
normally do not take temporary defensive positions, declines in stock market prices
generally are likely to reduce the net asset value of the Funds shares. |
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and |
custodial costs than similar transactions in the U.S. In addition, the Fund may be subject
to foreign taxes on capital gains or other income payable on foreign securities, on
transactions in those securities and on the repatriation of proceeds generated from those
securities. Also, many foreign markets require a license for the Fund to invest directly in
those markets, and the Fund is subject to the risk that it could not invest if its license
were terminated or suspended. In some foreign markets, prevailing custody and trade
settlement practices (e.g., the requirement to pay for securities prior to receipt) expose
the Fund to credit and other risks with respect to participating brokers, custodians,
clearing banks or other clearing agents, escrow agents and issuers. Further, adverse changes
in investment regulations, capital requirements or exchange controls could adversely affect
the value of the Funds investments. |
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk. |
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests will not perform as expected. Because the Fund bears the fees and expenses of
the underlying funds in which it invests, new investments in underlying funds with higher
fees or expenses than those of the underlying funds in which the Fund is currently invested
will increase the Funds total expenses. The fees and expenses associated with an
investment in the Fund are less predictable and may be higher than fees and expenses
associated with an investment in funds that charge a fixed management fee. |
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind. |
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations. |
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies,
or that the U.S. dollar will decline in value relative to the foreign currency being hedged
by the Fund or an underlying fund. |
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. |
Leveraging Risk The use of derivatives and securities lending may cause the Funds
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
investments decline. |
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk. |
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to hedge foreign currency exposure in the
underlying Funds investments relative to the U.S. dollar. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the
expiration date, the amount payable by one party to the other is the difference between the
realized price variance of the underlying asset and the strike price multiplied by the notional
amount. A receiver of the realized price variance would be entitled to receive a payment when
the realized price variance of the underlying asset is greater than the strike price and would
be obligated to make a payment when that variance is less than the strike price. A payer of the
realized price variance would be obligated to make a payment when the realized price variance of
the underlying asset is greater than the strike price and would be entitled to receive a payment
when that variance is less than the strike price. This type of agreement is essentially a
forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by
risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency contracts |
|
$ |
|
|
|
$ |
5,322,020 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,322,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
5,322,020 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,322,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,447,090 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
provided by authoritative accounting guidance, the table above is
based on market values or unrealized appreciation / (depreciation)
rather than the notional amounts of derivatives. Changes to
market values of reference asset(s) will tend to have a greater
impact on the Fund (with correspondingly greater risk) the greater
the notional amount. For further information on notional amounts, see
the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts)
outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
Forward |
|
|
|
Currency |
|
|
|
Contracts |
|
Average amount outstanding |
|
$ |
471,453,787 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Debt Opportunities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 98.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 94.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Airlines 0.5% |
|
|
|
|
|
1,721,076 |
|
|
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24 |
|
|
826,117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto
Financing 10.1% |
|
|
|
|
|
467,809 |
|
|
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14 |
|
|
469,273 |
|
|
2,910,301 |
|
|
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13 |
|
|
2,928,025 |
|
|
928,820 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14 |
|
|
931,142 |
|
|
3,375,000 |
|
|
Ford Credit Floorplan Master Owner Trust, Series 10-3, Class C, 144A, 4.99%, due 02/15/17 |
|
|
3,595,050 |
|
|
61,199 |
|
|
Franklin Auto Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.95%, 2.20%, due 05/20/16 |
|
|
61,260 |
|
|
244,602 |
|
|
Merrill Auto Trust Securitization, Series 08-1, Class A4B, 1 mo. LIBOR + 2.20%, 2.45%, due 04/15/15 |
|
|
245,556 |
|
|
77,819 |
|
|
Merrill Auto Trust Securitization, Series 07-1, Class A4, 1 mo. LIBOR + .06%, 0.31%, due 12/15/13 |
|
|
77,795 |
|
|
3,000,000 |
|
|
Santander Consumer Acquired Receivables Trust, Series 11-WO, Class C, 144A, 3.19%, due 10/15/15 |
|
|
2,985,000 |
|
|
5,000,000 |
|
|
Santander Drive Auto Receivables Trust, Series 10-2, Class C, 3.89%, due 07/17/17 |
|
|
5,075,000 |
|
|
840,841 |
|
|
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14 |
|
|
843,691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Auto Financing |
|
|
17,211,792 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business
Loans 9.0% |
|
|
|
|
|
466,726 |
|
|
ACAS Business Loan Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .14%, 0.60%, due 08/16/19 |
|
|
455,058 |
|
|
261,610 |
|
|
Bayview Commercial Asset Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .36%, 0.62%, due 04/25/34 |
|
|
198,824 |
|
|
377,489 |
|
|
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35 |
|
|
283,117 |
|
|
1,239,041 |
|
|
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36 |
|
|
780,595 |
|
|
848,649 |
|
|
Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, 1 mo. LIBOR + .24%, 0.50%, due 07/25/37 |
|
|
534,649 |
|
|
1,000,000 |
|
|
CNH
Wholesale Master Note Trust, Series 2011-1A, Class B, 144A, 1
mo. LIBOR + 1.65%, 1.90%, due 12/15/15 |
|
|
998,750 |
|
|
327,052 |
|
|
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32 |
|
|
289,441 |
|
|
716,844 |
|
|
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33 |
|
|
587,812 |
|
|
4,500,000 |
|
|
Great
America Leasing Receivables, Series 09-1, Class C, 144A, 6.48%, due
12/15/16 |
|
|
4,736,250 |
|
|
1,604,560 |
|
|
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37 |
|
|
1,283,038 |
|
|
884,322 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30 |
|
|
680,539 |
|
|
668,975 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30 |
|
|
527,755 |
|
|
2,000,000 |
|
|
Navistar Financial Dealer Note Master Trust, Series 09-1, Class B, 144A, 1 mo. LIBOR + 4.25%, 4.51%, due 10/26/15 |
|
|
2,049,400 |
|
|
2,000,000 |
|
|
Navistar Financial Dealer Note Master Trust, Series 11-1, Class C, 144A, 1 mo. LIBOR + 2.50%, 2.76%, due 10/25/16 |
|
|
2,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Business Loans |
|
|
15,405,228 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS 5.6% |
|
|
|
|
|
1,367,744 |
|
|
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44 |
|
|
1,350,647 |
|
|
5,100,000 |
|
|
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20 |
|
|
4,615,500 |
|
|
|
|
|
|
|
|
|
|
|
696,036 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A1, 144A, 1 mo. LIBOR + .39%, 1.14%, due 03/06/20 |
|
|
689,076 |
|
|
800,000 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20 |
|
|
792,000 |
|
|
2,222,875 |
|
|
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21 |
|
|
2,111,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS |
|
|
9,558,955 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS Collateralized Debt Obligations 3.7% |
|
|
|
|
|
1,499,437 |
|
|
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due
11/23/52 |
|
|
14,994 |
|
|
896,353 |
|
|
Crest Exeter Street Solar, Series 04-1A, Class A1, 144A, 3 mo. LIBOR + .35%, 0.71%, due 06/28/19 |
|
|
824,645 |
|
|
1,489,226 |
|
|
G-Force LLC, Series 05-RR2, Class A2, 144A, 5.16%, due 12/25/39 |
|
|
1,399,872 |
|
|
835,999 |
|
|
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30 |
|
|
771,209 |
|
|
4,500,988 |
|
|
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46 |
|
|
3,285,721 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS Collateralized Debt Obligations |
|
|
6,296,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Collateralized Debt Obligations 2.7% |
|
|
|
|
|
5,200,000 |
|
|
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13 |
|
|
4,580,680 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Cards 7.8% |
|
|
|
|
|
4,000,000 |
|
|
Capital One Multi-Asset Execution Trust, Series 03-C3, Class C3, 1 mo. LIBOR + 2.25%, 2.50%, due 07/15/16 |
|
|
4,028,800 |
|
|
5,400,000 |
|
|
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17 |
|
|
5,408,910 |
|
|
4,000,000 |
|
|
World Financial Network Credit Card Master Trust, Series 06-A, Class B, 144A, 1 mo. LIBOR + .35%, 0.60%, due 02/15/17 |
|
|
3,918,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Credit Cards |
|
|
13,356,147 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Auto Financing 7.5% |
|
|
|
|
|
885,191 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13 |
|
|
882,978 |
|
|
654,310 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-BF, Class A4, FSA, 1 mo. LIBOR + .05%, 0.30%, due 12/06/13 |
|
|
654,297 |
|
|
869,064 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14 |
|
|
868,616 |
|
|
2,014,016 |
|
|
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + .50%, 0.75%, due 03/08/16 |
|
|
2,006,363 |
|
|
3,040,000 |
|
|
Avis Budget
Rental Car Funding AESOP LLC Series, 07-02A, Class A, 144A, AMBAC, 1
mo. LIBOR + 14%, 0.39%, due 08/20/13 |
|
|
3,006,156 |
|
|
5,331,795 |
|
|
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14 |
|
|
5,357,760 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Auto Financing |
|
|
12,776,170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Business Loans 0.1% |
|
|
|
|
|
246,368 |
|
|
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30 |
|
|
178,617 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured High Yield Collateralized Debt Obligations ♣ 1.0% |
|
|
|
|
|
1,901,923 |
|
|
Augusta Funding Ltd., Series 10A, Class F1, 144A, CapMAC, 3mo. LIBOR +.25%, 0.62%, due 06/30/17(a) |
|
|
1,671,714 |
|
|
34,396 |
|
|
GSC Partners CDO Fund Ltd., Series 03-4A, Class A3, 144A, AMBAC, 3 mo. LIBOR + .46%, 0.87%, due 12/16/15 |
|
|
33,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured High Yield Collateralized Debt Obligations |
|
|
1,705,594 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Other 5.8% |
|
|
|
|
|
5,900,000 |
|
|
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37 |
|
|
5,922,715 |
|
|
1,255,927 |
|
|
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41 |
|
|
1,112,820 |
|
|
1,778,421 |
|
|
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41 |
|
|
1,582,169 |
|
|
1,239,551 |
|
|
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14 |
|
|
991,641 |
|
|
300,000 |
|
|
Toll Road
Investment Part II, Series 1999B, 144A, MBIA, Zero Coupon, due 02/15/30 |
|
|
40,599 |
|
|
4,200,000 |
|
|
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37 |
|
|
262,878 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Other |
|
|
9,912,822 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Asset-Backed Securities (United States) ♦ 1.0% |
|
|
|
|
|
782,825 |
|
|
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34 |
|
|
618,432 |
|
|
240,999 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 03-HE3, Class A, AMBAC, 1 mo. LIBOR + .38%, 0.64%, due 12/25/33 |
|
|
194,004 |
|
|
70,722 |
|
|
Quest Trust, Series 04-X1, Class A, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 03/25/34 |
|
|
53,041 |
|
|
1,186,080 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + .22%, 0.48%, due 11/25/35 |
|
|
830,256 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Residential Asset-Backed Securities (United States) |
|
|
1,695,733 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Mortgage-Backed Securities (United States) 0.9% |
|
|
|
|
|
47,178 |
|
|
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34 |
|
|
30,147 |
|
|
125,438 |
|
|
Chevy Chase Mortgage Funding Corp., Series 04-1A, Class A2, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 01/25/35 |
|
|
78,398 |
|
|
1,053,463 |
|
|
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37 |
|
|
621,543 |
|
|
529,229 |
|
|
GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, 1 mo. LIBOR + .23%, 0.49%, due 10/25/34 |
|
|
371,307 |
|
|
26,500 |
|
|
GreenPoint Home Equity Loan Trust, Series 04-1, Class A, AMBAC, 1 mo. LIBOR + .23%, 0.72%, due 07/25/29 |
|
|
17,840 |
|
|
34,612 |
|
|
GreenPoint Home Equity Loan Trust, Series 04-4, Class A, AMBAC, 1 mo. LIBOR + .28%, 0.81%, due 08/15/30 |
|
|
21,380 |
|
|
63,772 |
|
|
Lehman ABS Corp., Series 04-2, Class A, AMBAC, 1 mo. LIBOR + .22%, 0.70%, due 06/25/34 |
|
|
42,089 |
|
|
15,089 |
|
|
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + .29%, 0.55%, due 12/25/32 |
|
|
4,376 |
|
|
476,998 |
|
|
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35 |
|
|
432,113 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Residential Mortgage-Backed Securities (United States) |
|
|
1,619,193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Time Share 1.0% |
|
|
|
|
|
283,257 |
|
|
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18 |
|
|
280,338 |
|
|
242,773 |
|
|
Sierra Receivables Funding Co., Series 07-1A, Class A2, 144A, FGIC, 1 mo. LIBOR + .15%, 0.40%, due 03/20/19 |
|
|
233,821 |
|
|
1,193,971 |
|
|
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19 |
|
|
1,159,097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Time Share |
|
|
1,673,256 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Transportation 0.4% |
|
|
|
|
|
431,108 |
|
|
CLI Funding LLC, Series 06-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .18%, 0.43%, due 08/18/21 |
|
|
396,620 |
|
|
314,167 |
|
|
GE Seaco Finance SRL, Series 04-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .30%, 0.55%, due 04/17/19 |
|
|
305,527 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Transportation |
|
|
702,147 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Asset-Backed Securities (United States) ♦ 21.5% |
|
|
|
|
|
104,471 |
|
|
Accredited Mortgage Loan Trust, Series 04-4, Class A1B, 1 mo. LIBOR + .39%, 0.65%, due 01/25/35 |
|
|
81,879 |
|
|
813,469 |
|
|
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36 |
|
|
760,594 |
|
|
252,094 |
|
|
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36 |
|
|
229,406 |
|
|
263,483 |
|
|
ACE Securities Corp., Series 06-ASP4, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36 |
|
|
243,392 |
|
|
91,202 |
|
|
ACE Securities Corp., Series 06-SL4, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 09/25/36 |
|
|
18,696 |
|
|
481,157 |
|
|
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35 |
|
|
84,203 |
|
|
567,865 |
|
|
ACE Securities Corp., Series 06-ASP2, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 03/25/36 |
|
|
469,908 |
|
|
1,462,478 |
|
|
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36 |
|
|
716,614 |
|
|
2,800,000 |
|
|
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36 |
|
|
784,000 |
|
|
1,061,437 |
|
|
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36 |
|
|
172,484 |
|
|
1,234,921 |
|
|
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36 |
|
|
151,278 |
|
|
557,627 |
|
|
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36 |
|
|
186,805 |
|
|
273,161 |
|
|
ACE Securities Corp., Series 06-ASL1, Class A, 1 mo. LIBOR + .14%, 0.40%, due 02/25/36 |
|
|
56,681 |
|
|
1,070,976 |
|
|
ACE Securities Corp., Series 06-OP1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 04/25/36 |
|
|
626,521 |
|
|
727,749 |
|
|
ACE Securities Corp., Series 07-HE1, Class A2A, 1 mo. LIBOR + .09%, 0.35%, due 01/25/37 |
|
|
214,686 |
|
|
436,796 |
|
|
ACE Securities Corp., Series 07-ASL1, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 12/25/36 |
|
|
41,496 |
|
|
1,322,611 |
|
|
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37 |
|
|
66,130 |
|
|
391,426 |
|
|
Argent Securities, Inc., Series 04-W8, Class A5, 1 mo. LIBOR + .52%, 1.30%, due 05/25/34 |
|
|
338,400 |
|
|
1,317,607 |
|
|
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36 |
|
|
382,106 |
|
|
8,247,144 |
|
|
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
2,141,680 |
|
|
1,373,637 |
|
|
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
361,438 |
|
|
1,384,594 |
|
|
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36 |
|
|
404,994 |
|
|
1,701,426 |
|
|
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36 |
|
|
986,827 |
|
|
2,407,936 |
|
|
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37 |
|
|
1,896,250 |
|
|
668,697 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 05/28/39 |
|
|
217,327 |
|
|
742,997 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39 |
|
|
209,897 |
|
|
1,573,823 |
|
|
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40 |
|
|
945,867 |
|
|
654,442 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36 |
|
|
397,181 |
|
|
1,500,000 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36 |
|
|
200,250 |
|
|
337,160 |
|
|
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37 |
|
|
53,305 |
|
|
4,700,000 |
|
|
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37 |
|
|
2,896,610 |
|
|
1,306,618 |
|
|
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36 |
|
|
993,030 |
|
|
20,921 |
|
|
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33 |
|
|
17,574 |
|
|
800,000 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 06-WFH4, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 |
|
|
552,000 |
|
|
1,600,000 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36 |
|
|
480,000 |
|
|
8,530 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 04-OPT1, Class A1B, 1 mo. LIBOR + .41%, 0.67%, due 10/25/34 |
|
|
7,933 |
|
|
5,200,000 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37 |
|
|
3,783,000 |
|
|
57,388 |
|
|
Equity One ABS, Inc., Series 04-1, Class AV2, 1 mo. LIBOR + .30%, 0.56%, due 04/25/34 |
|
|
41,229 |
|
|
|
|
|
|
|
|
|
|
|
1,187,503 |
|
|
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36 |
|
|
705,080 |
|
|
146,687 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A2, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36 |
|
|
48,865 |
|
|
2,662,239 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36 |
|
|
745,427 |
|
|
426,660 |
|
|
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36 |
|
|
228,596 |
|
|
407,525 |
|
|
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35 |
|
|
350,089 |
|
|
391,725 |
|
|
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35 |
|
|
344,596 |
|
|
876,133 |
|
|
Household Home Equity Loan Trust, Series 06-1, Class A1, 1 mo. LIBOR + .16%, 0.41%, due 01/20/36 |
|
|
770,997 |
|
|
3,902,775 |
|
|
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36 |
|
|
1,232,886 |
|
|
1,978,025 |
|
|
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36 |
|
|
593,407 |
|
|
2,255,555 |
|
|
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36 |
|
|
789,444 |
|
|
228,804 |
|
|
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35 |
|
|
215,075 |
|
|
1,600,000 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
480,000 |
|
|
226,639 |
|
|
Master Asset-Backed Securities Trust, Series 06-AM3, Class A2, 1 mo. LIBOR + .13%, 0.39%, due 10/25/36 |
|
|
219,840 |
|
|
3,069,552 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36 |
|
|
813,431 |
|
|
876,736 |
|
|
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36 |
|
|
105,208 |
|
|
599,864 |
|
|
Merrill Lynch Mortgage Investors, Series 07-HE2, Class A2A, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37 |
|
|
272,938 |
|
|
261,049 |
|
|
Merrill Lynch Mortgage Trust, Series 06-SD1, Class A, 1 mo. LIBOR + .28%, 0.54%, due 01/25/47 |
|
|
161,198 |
|
|
235,014 |
|
|
Morgan Stanley Capital, Inc., Series 04-SD1, Class A, 1 mo. LIBOR + .40%, 0.66%, due 08/25/34 |
|
|
168,623 |
|
|
3,600,000 |
|
|
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37 |
|
|
756,000 |
|
|
458,109 |
|
|
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37 |
|
|
374,504 |
|
|
1,065,573 |
|
|
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 |
|
|
261,065 |
|
|
1,000,000 |
|
|
Nationstar Home Equity Loan Trust, Series 06-B, Class AV3, 1 mo. LIBOR + .17%, 0.43%, due 09/25/36 |
|
|
777,969 |
|
|
900,000 |
|
|
Nomura Home Equity Loan, Inc., Series 06-HE3, Class 2A3, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
353,672 |
|
|
740,750 |
|
|
Peoples Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35 |
|
|
426,524 |
|
|
611,622 |
|
|
RAAC Series Trust, Series 06-SP1, Class A2, 1 mo. LIBOR + .19%, 0.45%, due 09/25/45 |
|
|
507,035 |
|
|
137,226 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS8, Class A2, 1 mo. LIBOR + .29%, 0.55%, due 10/25/33 |
|
|
125,740 |
|
|
41,108 |
|
|
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37 |
|
|
40,812 |
|
|
26,092 |
|
|
Saxon Asset Securities Trust, Series 04-1, Class A, 1 mo. LIBOR + .27%, 0.80%, due 03/25/35 |
|
|
16,259 |
|
|
378,402 |
|
|
Saxon Asset Securities Trust, Series 06-3, Class A2, 1 mo. LIBOR + .11%, 0.37%, due 10/25/46 |
|
|
346,238 |
|
|
48,948 |
|
|
Securitized Asset Backed Receivables LLC, Series 06-NC1, Class A2, 1 mo. LIBOR + .16%, 0.42%, due 03/25/36 |
|
|
45,032 |
|
|
800,000 |
|
|
Securitized Asset-Backed Receivables LLC Trust, Series 06-HE1, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 07/25/36 |
|
|
256,000 |
|
|
51,139 |
|
|
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36 |
|
|
50,756 |
|
|
2,200,000 |
|
|
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37 |
|
|
924,000 |
|
|
774,775 |
|
|
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36 |
|
|
557,838 |
|
|
|
|
|
|
|
|
|
|
|
342,580 |
|
|
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35 |
|
|
264,643 |
|
|
1,546,934 |
|
|
Yale Mortgage Loan Trust, Series 07-1, Class A, 144A, 1 mo. LIBOR + .40%, 0.66%, due 06/25/37 |
|
|
123,755 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Asset-Backed Securities (United States) |
|
|
36,665,213 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (Australian) 4.3% |
|
|
|
|
|
766,706 |
|
|
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38 |
|
|
746,818 |
|
|
954,302 |
|
|
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38 |
|
|
917,004 |
|
|
199,939 |
|
|
Interstar Millennium Trust, Series 03-3G, Class A2, 3 mo. LIBOR + .25%, 0.86%, due 09/27/35 |
|
|
183,512 |
|
|
1,983,998 |
|
|
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36 |
|
|
1,824,604 |
|
|
371,209 |
|
|
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36 |
|
|
330,376 |
|
|
168,026 |
|
|
Interstar Millennium Trust, Series 06-2GA, Class A2, 144A, 3 mo. LIBOR + .08%, 0.81%, due 05/27/38 |
|
|
153,663 |
|
|
411,396 |
|
|
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36 |
|
|
396,661 |
|
|
691,446 |
|
|
Medallion Trust, Series 06-1G, Class A1, 3 mo. LIBOR + .05%, 0.39%, due 06/14/37 |
|
|
672,765 |
|
|
1,154,340 |
|
|
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38 |
|
|
1,056,337 |
|
|
93,463 |
|
|
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36 |
|
|
90,639 |
|
|
100,522 |
|
|
Superannuation Members Home Loans Global Fund, Series 8, Class A1, 3 mo. LIBOR + .07%, 0.53%, due 01/12/37 |
|
|
98,486 |
|
|
955,002 |
|
|
Superannuation Members Home Loans Global Fund, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.40%, due 06/12/40 |
|
|
899,786 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (Australian) |
|
|
7,370,651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (European) 7.6% |
|
|
|
|
|
1,862,343 |
|
|
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66 |
|
|
1,527,121 |
|
|
3,032,383 |
|
|
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39 |
|
|
2,686,631 |
|
|
403,491 |
|
|
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .04%, 0.33%, due 12/20/54 |
|
|
386,544 |
|
|
254,838 |
|
|
Granite Master Issuer Plc, Series 06-3, Class A3, 1 mo. LIBOR + .04%, 0.29%, due 12/20/54 |
|
|
243,371 |
|
|
210,079 |
|
|
Granite Mortgages Plc, Series 04-3, Class 2A1, 3 mo. LIBOR + .14%, 0.63%, due 09/20/44 |
|
|
201,886 |
|
|
1,461,789 |
|
|
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43 |
|
|
1,300,993 |
|
|
369,666 |
|
|
Leek Finance Plc, Series 17A, Class A2B, 144A, 3 mo. LIBOR + .28%, 0.63%, due 12/21/37 |
|
|
330,851 |
|
|
737,343 |
|
|
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34 |
|
|
592,381 |
|
|
1,472,010 |
|
|
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .11%, 0.68%, due 11/15/38 |
|
|
1,090,244 |
|
|
1,004,304 |
|
|
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39 |
|
|
750,516 |
|
|
3,300,000 |
|
|
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33 |
|
|
3,267,990 |
|
|
600,000 |
|
|
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33 |
|
|
596,940 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (European) |
|
|
12,975,468 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (United States) 0.1% |
|
|
|
|
|
61,847 |
|
|
Chevy Chase Mortgage Funding Corp., Series 04-3A, Class A2, 144A, 1 mo. LIBOR + .30%, 0.56%, due 08/25/35 |
|
|
38,654 |
|
|
273,048 |
|
|
Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/26/34 |
|
|
221,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (United States) |
|
|
259,823 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Loans 2.4% |
|
|
|
|
|
2,600,000 |
|
|
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24 |
|
|
2,535,000 |
|
|
44,672 |
|
|
Goal Capital Funding Trust, Series 07-1, Class A1, 3 mo. LIBOR + .02%, 0.38%, due 06/25/21 |
|
|
44,587 |
|
|
122,873 |
|
|
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23 |
|
|
119,187 |
|
|
1,100,000 |
|
|
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19 |
|
|
1,085,744 |
|
|
351,713 |
|
|
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22 |
|
|
350,834 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Student Loans |
|
|
4,135,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time
Share 1.5% |
|
|
|
|
|
1,768,966 |
|
|
Marriott
Vacation Club Owner Trust, Series 09-2A, Class A, 144A, 4.81%, due
07/20/31 |
|
|
1,804,345 |
|
|
209,166 |
|
|
Sierra
Receivables Funding Co., Series 08-1A, Class A2, 144A, 1 mo. LIBOR +
4.00%, 4.25%, due 02/20/20 |
|
|
214,951 |
|
|
457,744 |
|
|
Sierra
Receivables Funding Co. LLC, Series 11-1A, Class B, 144A, 4.23%, due
04/20/26 |
|
|
455,590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time
Share |
|
|
2,474,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
161,380,285 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.8% |
|
|
|
|
|
1,290,000 |
|
|
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13 |
|
|
1,330,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 3.3% |
|
|
|
|
|
250,000 |
|
|
Agency for International Development Floater (Support of Belize), 6 mo. U.S. Treasury Bill + .50%, 0.57%, due 01/01/14(a) |
|
|
246,711 |
|
|
1,355,035 |
|
|
Agency for International Development Floater (Support of Jamaica), 3 mo. LIBOR + .30%, 0.82%, due 10/01/18(a) |
|
|
1,310,407 |
|
|
3,773,204 |
|
|
Agency for International Development Floater (Support of Jamaica), 6 mo. U.S. Treasury Bill + 0.75%, 0.82%, due 03/30/19(a) |
|
|
3,636,723 |
|
|
36,240 |
|
|
Agency for International Development Floater (Support of Morocco), 6 mo. U.S. Treasury Bill + .45%, 0.52%, due 11/15/14(a) |
|
|
35,462 |
|
|
47,506 |
|
|
Agency for
International Development Floater (Support of Peru), Series A, 6 mo. U.S. Treasury Bill + .35%, 0.42%, due 05/01/14(a) |
|
|
46,592 |
|
|
74,879 |
|
|
Agency for
International Development Floater (Support of Peru), Series B, 6 mo. U.S. Treasury Bill +.35%, 0.42%, due 05/01/14(a) |
|
|
73,438 |
|
|
50,001 |
|
|
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a) |
|
|
49,924 |
|
|
200,000 |
|
|
U.S. Department of Transportation, 144A, 6.00%, due 12/07/21 |
|
|
219,406 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
5,618,663 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $170,327,872) |
|
|
168,329,523 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money
Market Funds |
|
|
|
|
|
2,202,247 |
|
|
State Street Institutional Liquid Reserve Fund-Institutional Class, 0.17%(b) |
|
|
2,202,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $2,202,247) |
|
|
2,202,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.9%
(Cost $172,530,119) |
|
|
170,531,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.1% |
|
|
113,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
170,645,745 |
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments: |
|
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933.
These securities may be resold in transactions exempt from registration, normally to qualified
institutional investors. |
|
AMBAC Insured as to the payment of principal and interest by AMBAC Assurance Corporation. |
|
CapMAC Insured as to the payment of principal and interest by Capital Markets Assurance
Corporation. |
|
CDO Collateralized Debt Obligation |
|
CMBS Commercial Mortgage Backed Security |
|
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance
Corporation. |
|
FSA Insured as to the payment of principal and interest by Financial Security Assurance. |
|
LIBOR London Interbank Offered Rate |
|
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp. |
|
MTN Medium Term Note |
|
XL Insured as to the payment of principal and interest by XL Capital Assurance. |
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which
are subject to change based on the terms of the security.
|
|
|
♣ |
|
These securities were categorized as high yield as a result of being rated below investment grade at issuance. |
|
♦ |
|
These securities are primarily backed by subprime mortgages. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of
the Trustees of GMO Trust. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 173,407,257 |
|
$ |
12,967,812 |
|
|
$ |
(15,843,299 |
) |
|
$ |
(2,875,487 |
) |
Debt Opportunities Fund (the Fund) commenced operations on October 3, 2011.
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
4.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Typically the Fund values debt instruments based on the most recent quoted price supplied by a
single pricing source chosen by the Manager. Although the Manager normally does not evaluate
pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and
may change a pricing source at any time. The Manager monitors erratic or unusual movements
(including unusual inactivity) in the prices supplied for a security and has discretion to
override a price supplied by a source (e.g., by taking a price supplied by another) when it
believes that the price supplied is not reliable. Although alternative prices may be available
for securities held by the Fund, those alternative sources are not typically part of the
valuation process and do not necessarily provide greater certainty about the prices used by the
Fund. As of November 30, 2011, the total value of securities held directly for which no
alternative pricing source was available represented 12.4% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The Fund utilized a number of fair value techniques on Level 3 investments, including the
following: The Fund valued certain debt securities using quoted prices. The Fund valued certain
other debt securities by using an estimated specified spread above the LIBOR Rate.
The following is a summary of the respective levels assigned to the Funds investments
and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
16,276,366 |
|
|
$ |
145,103,919 |
|
|
$ |
161,380,285 |
|
Corporate Debt |
|
|
|
|
|
|
1,330,575 |
|
|
|
|
|
|
|
1,330,575 |
|
U.S. Government Agency |
|
|
|
|
|
|
219,406 |
|
|
|
5,399,257 |
|
|
|
5,618,663 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
17,826,347 |
|
|
|
150,503,176 |
|
|
|
168,329,523 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
2,202,247 |
|
|
|
|
|
|
|
|
|
|
|
2,202,247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
2,202,247 |
|
|
|
17,826,347 |
|
|
|
150,503,176 |
|
|
|
170,531,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
2,202,247 |
|
|
$ |
17,826,347 |
|
|
$ |
150,503,176 |
|
|
$ |
170,531,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The aggregate net values of the Funds direct investments in securities using Level 3
inputs were 88.2% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments Still |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
Transfer |
|
|
Transfer |
|
|
Balances as of |
|
|
Held as of |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
into |
|
|
out of |
|
|
November 30, |
|
|
November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
level 3 * |
|
|
2011 |
|
|
2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
152,648,992 |
|
|
$ |
(6,683,665 |
) |
|
$ |
265,951 |
|
|
$ |
678,865 |
|
|
$ |
(1,806,224 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
145,103,919 |
|
|
$ |
(1,806,224 |
) |
U.S. Government Agency |
|
|
|
|
|
|
5,441,111 |
|
|
|
(30,517 |
) |
|
|
3,982 |
|
|
|
492 |
|
|
|
(15,811 |
) |
|
|
|
|
|
|
|
|
|
|
5,399,257 |
|
|
|
(15,811 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
158,090,103 |
|
|
$ |
(6,714,182 |
) |
|
$ |
269,933 |
|
|
$ |
679,357 |
|
|
$ |
(1,822,035 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
150,503,176 |
|
|
$ |
(1,822,035 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at
the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) as
amended, and therefore a decline in the market value of a particular security held by the Fund
may affect the Funds performance more than if the Fund were
diversified. Selected risks of
investing in the Fund are summarized below. The risks of investing in the Fund depend on the
types of investments in its portfolio and the investment strategies the Manager employs on its
behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening credit
spreads. |
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities. |
|
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind. |
|
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk. |
|
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline. |
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default
is particularly acute in economic environments in which financial services firms are
exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in
2008 and subsequent market disruptions. |
|
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
|
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected. |
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
|
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to |
the risk that it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries. |
|
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies. |
The Fund invests in asset-backed securities, which may be backed by many types of assets,
including pools of residential and commercial mortgages, automobile loans, educational loans,
home equity loans, or credit card receivables, which expose the Fund to additional types of
market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made
to corporations, or a combination of these bonds and loans (commonly referred to as
collateralized debt obligations or collateralized loan obligations) and by the fees earned
by service providers. Payment of interest on asset backed securities and repayment of principal
largely depend on the cash flows generated by the assets backing the securities. The market risk
of a particular asset-backed security depends on many factors, including the deal structure
(e.g., determination as to the amount of underlying assets or other support needed to produce
the cash flows necessary to service interest and make principal payments), the quality of the
underlying assets and, if any, the level of credit support and the credit quality of the
credit-support provider. Asset-backed securities involve risk of loss of principal if obligors
of the underlying obligations default and the value of the defaulted obligations exceeds
whatever credit support the securities may have. The obligations of issuers (and obligors of
underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the
rights and remedies of creditors. Many asset-backed securities in which the Fund has invested
are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There can
be no assurance these conditions will not occur again. Also, government actions and proposals
affecting the terms of underlying home and consumer loans, changes in demand for products (e.g.,
automobiles) financed by those loans, and the inability of borrowers to refinance existing loans
(e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity
effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund
is exposed to the risk of having limited recourse if the counterparty defaults. The Fund may
invest in derivatives with a limited number of counterparties, and events affecting the
creditworthiness of any of those counterparties may have a pronounced effect on the Fund.
Derivatives risk is particularly acute in environments (like those experienced recently) in
which financial services firms are exposed to systemic risks of the type evidenced by the
insolvency of Lehman Brothers and subsequent market disruptions. During these periods of market
disruptions, the Fund may have a greater need for cash to provide collateral for large swings in
its mark-to-market obligations under the derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself.
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees,
risk of loss in excess of the variation margin. Under some circumstances, futures exchanges may
establish daily limits on the amount that the price of a futures contract can vary from the
previous days settlement price, thereby effectively preventing liquidation of unfavorable
positions. Futures contracts expose the Fund to the risk that it may not be able to enter into a
closing transaction due to an illiquid market. The Fund had no futures contracts outstanding at
the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC
options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of
credit default protection receives periodic payments in return for its obligation to pay the
principal amount of a debt security (or other agreed-upon value) to the other party upon the
occurrence of a credit event. If no credit event occurs, the seller has no payment obligations
so long as there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Developed World Stock Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 93.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.5% |
|
|
|
|
|
12,203 |
|
|
BHP Billiton Ltd |
|
|
457,206 |
|
|
327,592 |
|
|
Telstra Corp Ltd |
|
|
1,076,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
1,533,567 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.3% |
|
|
|
|
|
20,578 |
|
|
OMV AG |
|
|
683,361 |
|
|
9,268 |
|
|
Voestalpine AG |
|
|
269,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
952,879 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.0% |
|
|
|
|
|
143,879 |
|
|
Dexia SA * |
|
|
72,968 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 0.9% |
|
|
|
|
|
10,800 |
|
|
Canadian Pacific Railway Ltd |
|
|
650,785 |
|
|
40,800 |
|
|
EnCana Corp |
|
|
822,040 |
|
|
49,600 |
|
|
Husky Energy, Inc. |
|
|
1,235,198 |
|
|
14,200 |
|
|
Research In Motion Ltd * |
|
|
255,891 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
2,963,914 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 0.1% |
|
|
|
|
|
59,699 |
|
|
Nokia Oyj |
|
|
345,036 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 5.1% |
|
|
|
|
|
55,504 |
|
|
AXA |
|
|
803,678 |
|
|
31,946 |
|
|
BNP Paribas |
|
|
1,271,708 |
|
|
19,689 |
|
|
Bouygues SA |
|
|
641,739 |
|
|
7,768 |
|
|
Casino Guichard-Perrachon SA |
|
|
691,291 |
|
|
31,309 |
|
|
CNP Assurances |
|
|
421,394 |
|
|
7,895 |
|
|
Compagnie de Saint-Gobain |
|
|
334,771 |
|
|
11,268 |
|
|
EADS NV |
|
|
338,061 |
|
|
5,283 |
|
|
Lafarge SA |
|
|
193,105 |
|
|
4,319 |
|
|
LVMH Moet Hennessy Louis Vuitton SA |
|
|
680,036 |
|
|
22,018 |
|
|
Peugeot SA |
|
|
412,249 |
|
|
21,858 |
|
|
Renault SA |
|
|
819,029 |
|
|
57,866 |
|
|
Sanofi |
|
|
4,047,495 |
|
|
10,071 |
|
|
Schneider Electric SA |
|
|
572,677 |
|
|
61,855 |
|
|
Total SA |
|
|
3,191,258 |
|
|
1,988 |
|
|
Unibail-Rodamco SE REIT |
|
|
370,588 |
|
|
7,706 |
|
|
Vinci SA |
|
|
344,504 |
|
|
52,457 |
|
|
Vivendi SA |
|
|
1,209,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
16,343,559 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 3.6% |
|
|
|
|
|
16,059 |
|
|
Allianz SE (Registered) |
|
|
1,668,917 |
|
|
21,533 |
|
|
BASF AG |
|
|
1,573,059 |
|
|
11,421 |
|
|
Bayerische Motoren Werke AG |
|
|
865,793 |
|
|
98,877 |
|
|
E.ON AG |
|
|
2,447,570 |
|
|
8,417 |
|
|
Hannover Rueckversicherung AG (Registered) |
|
|
439,413 |
|
|
4,463 |
|
|
K+S AG |
|
|
243,025 |
|
|
3,188 |
|
|
Linde AG |
|
|
491,306 |
|
|
7,969 |
|
|
Muenchener Rueckversicherungs-Gesellschaft AG (Registered) |
|
|
1,007,115 |
|
|
17,760 |
|
|
RWE AG |
|
|
736,228 |
|
|
3,797 |
|
|
Siemens AG (Registered) |
|
|
384,253 |
|
|
22,486 |
|
|
Suedzucker AG |
|
|
716,345 |
|
|
|
|
|
|
|
|
|
|
|
6,297 |
|
|
Volkswagen AG |
|
|
959,068 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
11,532,092 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 0.1% |
|
|
|
|
|
32,500 |
|
|
CLP Holdings Ltd |
|
|
289,429 |
|
|
37 |
|
|
Esprit Holdings Ltd |
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
289,483 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 0.5% |
|
|
|
|
|
79,376 |
|
|
CRH Plc |
|
|
1,515,341 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 3.5% |
|
|
|
|
|
649,254 |
|
|
Enel SPA |
|
|
2,766,407 |
|
|
228,155 |
|
|
ENI SPA |
|
|
4,831,931 |
|
|
71,236 |
|
|
Finmeccanica SPA |
|
|
309,055 |
|
|
57,445 |
|
|
Mediaset SPA |
|
|
169,815 |
|
|
19,976 |
|
|
Mediobanca SPA |
|
|
129,078 |
|
|
128,256 |
|
|
Parmalat SPA |
|
|
260,601 |
|
|
16,884 |
|
|
Saipem SPA |
|
|
755,464 |
|
|
844,992 |
|
|
Telecom Italia SPA |
|
|
956,637 |
|
|
668,670 |
|
|
Telecom Italia SPA-Di RISP |
|
|
653,364 |
|
|
487,518 |
|
|
UniCredit SPA |
|
|
509,159 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
11,341,511 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 9.4% |
|
|
|
|
|
36,500 |
|
|
Aeon Co Ltd |
|
|
498,756 |
|
|
13,200 |
|
|
Astellas Pharma Inc |
|
|
508,813 |
|
|
23,200 |
|
|
Bridgestone Corp |
|
|
537,591 |
|
|
126,000 |
|
|
Cosmo Oil Co Ltd |
|
|
348,446 |
|
|
10,300 |
|
|
Credit Saison Co Ltd |
|
|
188,608 |
|
|
10,000 |
|
|
Daito Trust Construction Co Ltd |
|
|
891,891 |
|
|
1,700 |
|
|
Fast Retailing Co Ltd |
|
|
275,870 |
|
|
29,000 |
|
|
Fuji Heavy Industries Ltd |
|
|
167,614 |
|
|
11,300 |
|
|
Gree Inc |
|
|
379,375 |
|
|
151,000 |
|
|
Hitachi Ltd |
|
|
837,885 |
|
|
14,400 |
|
|
Honda Motor Co Ltd |
|
|
456,975 |
|
|
89 |
|
|
INPEX Corp |
|
|
600,828 |
|
|
129,000 |
|
|
Itochu Corp |
|
|
1,310,948 |
|
|
137,820 |
|
|
JX Holdings, Inc. |
|
|
876,483 |
|
|
157,000 |
|
|
Kawasaki Kisen Kaisha Ltd |
|
|
272,980 |
|
|
209 |
|
|
KDDI Corp |
|
|
1,384,792 |
|
|
20,700 |
|
|
Komatsu Ltd |
|
|
529,751 |
|
|
144,000 |
|
|
Marubeni Corp |
|
|
889,593 |
|
|
198,000 |
|
|
Mazda Motor Corp * |
|
|
361,100 |
|
|
74,000 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
429,898 |
|
|
25,400 |
|
|
Mitsubishi Corp |
|
|
525,105 |
|
|
29,000 |
|
|
Mitsubishi Electric Corp |
|
|
274,527 |
|
|
40,600 |
|
|
Mitsui & Co Ltd |
|
|
640,582 |
|
|
80,000 |
|
|
Mitsui OSK Lines Ltd |
|
|
254,309 |
|
|
195,000 |
|
|
Mizuho Financial Group, Inc. |
|
|
256,704 |
|
|
5,200 |
|
|
Murata Manufacturing Co Ltd |
|
|
308,147 |
|
|
1,300 |
|
|
Nintendo Co Ltd |
|
|
197,909 |
|
|
51,000 |
|
|
Nippon Telegraph & Telephone Corp |
|
|
2,515,242 |
|
|
170,000 |
|
|
Nippon Yusen Kabushiki Kaisha |
|
|
378,699 |
|
|
94,200 |
|
|
Nissan Motor Co Ltd |
|
|
865,068 |
|
|
7,000 |
|
|
Nitto Denko Corp |
|
|
290,968 |
|
|
98 |
|
|
NTT Data Corp |
|
|
304,659 |
|
|
325 |
|
|
NTT Docomo Inc |
|
|
574,452 |
|
|
7,710 |
|
|
ORIX Corp |
|
|
650,530 |
|
|
|
|
|
|
|
|
|
|
|
231,100 |
|
|
Resona Holdings Inc |
|
|
1,035,084 |
|
|
20,000 |
|
|
Ricoh Company Ltd |
|
|
180,234 |
|
|
12,600 |
|
|
Sankyo Co Ltd |
|
|
629,823 |
|
|
14,100 |
|
|
Seven & I Holdings Co Ltd |
|
|
393,679 |
|
|
15,000 |
|
|
Shizuoka Bank Ltd (The) |
|
|
155,503 |
|
|
64,500 |
|
|
Showa Shell Sekiyu KK |
|
|
431,812 |
|
|
321,000 |
|
|
Sojitz Corp |
|
|
503,707 |
|
|
139,800 |
|
|
Sumitomo Corp |
|
|
1,866,058 |
|
|
180,000 |
|
|
Taisei Corp |
|
|
466,512 |
|
|
40,700 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
1,671,711 |
|
|
52,000 |
|
|
TonenGeneral Sekiyu KK |
|
|
593,048 |
|
|
68,000 |
|
|
Toray Industries Inc |
|
|
509,790 |
|
|
22,100 |
|
|
Toyota Motor Corp |
|
|
727,765 |
|
|
48,100 |
|
|
Toyota Tsusho Corp |
|
|
809,357 |
|
|
8,650 |
|
|
Yamada Denki Co Ltd |
|
|
625,681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
30,384,862 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 1.6% |
|
|
|
|
|
39,000 |
|
|
DBS Group Holdings Ltd |
|
|
387,834 |
|
|
2,786,000 |
|
|
Golden Agri-Resources Ltd |
|
|
1,573,653 |
|
|
115,100 |
|
|
Keppel Corp Ltd |
|
|
855,004 |
|
|
133,050 |
|
|
Oversea-Chinese Banking Corp Ltd |
|
|
847,548 |
|
|
106,000 |
|
|
Sembcorp Industries Ltd |
|
|
356,554 |
|
|
476,600 |
|
|
Singapore Telecommunications |
|
|
1,161,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
5,182,294 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 2.7% |
|
|
|
|
|
168,371 |
|
|
Banco Bilbao Vizcaya Argentaria SA |
|
|
1,418,311 |
|
|
161,229 |
|
|
Banco Popular Espanol SA |
|
|
688,487 |
|
|
262,848 |
|
|
Banco Santander SA |
|
|
1,972,997 |
|
|
19,281 |
|
|
Ferrovial SA |
|
|
239,099 |
|
|
52,753 |
|
|
Gas Natural SDG SA |
|
|
918,366 |
|
|
5,274 |
|
|
Inditex SA |
|
|
448,465 |
|
|
12,957 |
|
|
Indra Sistemas SA |
|
|
182,674 |
|
|
146,793 |
|
|
Mapfre SA |
|
|
491,382 |
|
|
36,316 |
|
|
Repsol YPF SA |
|
|
1,096,415 |
|
|
69,703 |
|
|
Telefonica SA |
|
|
1,308,907 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
8,765,103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 0.2% |
|
|
|
|
|
40,274 |
|
|
Svenska Cellulosa AB Class B |
|
|
599,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 0.7% |
|
|
|
|
|
6,922 |
|
|
Nestle SA (Registered) |
|
|
388,482 |
|
|
26,477 |
|
|
Novartis AG (Registered) |
|
|
1,429,871 |
|
|
2,678 |
|
|
Zurich Financial Services AG * |
|
|
589,798 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
2,408,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 9.9% |
|
|
|
|
|
24,945 |
|
|
Antofagasta Plc |
|
|
465,830 |
|
|
68,373 |
|
|
ARM Holdings Plc |
|
|
642,486 |
|
|
80,154 |
|
|
AstraZeneca Plc |
|
|
3,691,713 |
|
|
216,006 |
|
|
Aviva Plc |
|
|
1,060,232 |
|
|
221,666 |
|
|
BAE Systems Plc |
|
|
956,998 |
|
|
281,683 |
|
|
Barclays Plc |
|
|
811,451 |
|
|
21,969 |
|
|
BHP Billiton Plc |
|
|
675,598 |
|
|
264,414 |
|
|
BP Plc |
|
|
1,914,982 |
|
|
28,992 |
|
|
British American Tobacco Plc |
|
|
1,345,434 |
|
|
557,553 |
|
|
BT Group Plc |
|
|
1,668,432 |
|
|
|
|
|
|
|
|
|
|
|
13,768 |
|
|
Burberry Group Plc |
|
|
275,822 |
|
|
25,174 |
|
|
Diageo Plc |
|
|
539,177 |
|
|
144,250 |
|
|
GlaxoSmithKline Plc |
|
|
3,196,873 |
|
|
13,357 |
|
|
Imperial Tobacco Group Plc |
|
|
480,545 |
|
|
573,329 |
|
|
Legal & General Group Plc |
|
|
957,727 |
|
|
73,747 |
|
|
Marks & Spencer Group Plc |
|
|
383,719 |
|
|
9,361 |
|
|
Next Plc |
|
|
395,663 |
|
|
570,002 |
|
|
Old Mutual Plc |
|
|
1,018,571 |
|
|
13,524 |
|
|
Pearson Plc |
|
|
245,674 |
|
|
2,417 |
|
|
Randgold Resources Ltd |
|
|
257,142 |
|
|
22,797 |
|
|
Rio Tinto Plc |
|
|
1,200,163 |
|
|
622,747 |
|
|
Royal Bank of Scotland Group Plc * |
|
|
207,288 |
|
|
81,181 |
|
|
Royal Dutch Shell Plc A Shares (London) |
|
|
2,839,272 |
|
|
66,116 |
|
|
Royal Dutch Shell Plc B Shares (London) |
|
|
2,382,461 |
|
|
40,095 |
|
|
SSE Plc |
|
|
830,237 |
|
|
31,409 |
|
|
Tate & Lyle Plc |
|
|
332,657 |
|
|
985,189 |
|
|
Vodafone Group Plc |
|
|
2,667,014 |
|
|
11,599 |
|
|
Weir Group Plc (The) |
|
|
377,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
31,820,180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 54.5% |
|
|
|
|
|
34,800 |
|
|
3M Co. |
|
|
2,820,192 |
|
|
65,600 |
|
|
Abbott Laboratories |
|
|
3,578,480 |
|
|
5,200 |
|
|
Abercrombie & Fitch Co.-Class A |
|
|
249,132 |
|
|
44,200 |
|
|
Accenture Plc.-Class A |
|
|
2,560,506 |
|
|
12,200 |
|
|
ACE Ltd. |
|
|
848,266 |
|
|
3,200 |
|
|
Affiliated Managers Group, Inc. * |
|
|
302,624 |
|
|
9,200 |
|
|
Altera Corp. |
|
|
346,564 |
|
|
10,800 |
|
|
Altria Group, Inc. |
|
|
309,852 |
|
|
2,100 |
|
|
Amazon.com, Inc. * |
|
|
403,809 |
|
|
11,200 |
|
|
Amdocs Ltd. * |
|
|
316,288 |
|
|
15,700 |
|
|
Ameren Corp. |
|
|
530,817 |
|
|
13,400 |
|
|
American Capital Agency Corp. REIT |
|
|
384,446 |
|
|
24,000 |
|
|
American Express Co. |
|
|
1,152,960 |
|
|
12,400 |
|
|
Ameriprise Financial, Inc. |
|
|
569,284 |
|
|
7,300 |
|
|
Anadarko Petroleum Corp. |
|
|
593,271 |
|
|
76,000 |
|
|
Annaly Capital Management, Inc. REIT |
|
|
1,221,320 |
|
|
9,400 |
|
|
Apple, Inc. * |
|
|
3,592,680 |
|
|
10,600 |
|
|
Assurant, Inc. |
|
|
415,944 |
|
|
39,500 |
|
|
Automatic Data Processing, Inc. |
|
|
2,018,055 |
|
|
1,500 |
|
|
AutoZone, Inc. * |
|
|
492,570 |
|
|
5,700 |
|
|
AvalonBay Communities, Inc. REIT |
|
|
711,645 |
|
|
16,400 |
|
|
Baker Hughes, Inc. |
|
|
895,604 |
|
|
21,500 |
|
|
Baxter International, Inc. |
|
|
1,110,690 |
|
|
13,200 |
|
|
Becton, Dickinson and Co. |
|
|
973,896 |
|
|
5,900 |
|
|
Bed Bath & Beyond, Inc. * |
|
|
357,009 |
|
|
10,200 |
|
|
Best Buy Co., Inc. |
|
|
276,318 |
|
|
5,100 |
|
|
Borg Warner, Inc. * |
|
|
336,192 |
|
|
4,700 |
|
|
Boston Properties, Inc. REIT |
|
|
448,286 |
|
|
19,500 |
|
|
BristolMyers Squibb Co. |
|
|
638,040 |
|
|
4,100 |
|
|
Camden Property Trust REIT |
|
|
236,693 |
|
|
18,000 |
|
|
Capital One Financial Corp. |
|
|
803,880 |
|
|
17,500 |
|
|
Caterpillar, Inc. |
|
|
1,712,900 |
|
|
18,000 |
|
|
CBRE Group, Inc. * |
|
|
302,580 |
|
|
31,500 |
|
|
CBS Corp.-Class B (Non Voting) |
|
|
820,260 |
|
|
9,100 |
|
|
Celanese Corp.-Class A |
|
|
423,059 |
|
|
17,600 |
|
|
CenterPoint Energy, Inc. |
|
|
350,240 |
|
|
3,500 |
|
|
CF Industries Holdings, Inc. |
|
|
489,300 |
|
|
29,400 |
|
|
Chevron Corp. |
|
|
3,022,908 |
|
|
|
|
|
|
|
|
|
|
|
1,700 |
|
|
Chipotle Mexican Grill, Inc. * |
|
|
546,652 |
|
|
15,600 |
|
|
CH Robinson Worldwide, Inc. |
|
|
1,068,756 |
|
|
38,500 |
|
|
Cisco Systems, Inc. |
|
|
717,640 |
|
|
5,400 |
|
|
Cliffs Natural Resources, Inc. |
|
|
366,174 |
|
|
22,000 |
|
|
Coach, Inc. |
|
|
1,376,980 |
|
|
114,800 |
|
|
Coca-Cola Co. (The) |
|
|
7,718,004 |
|
|
13,800 |
|
|
Cognizant Technology Solutions Corp.-Class A * |
|
|
929,430 |
|
|
12,600 |
|
|
Comcast Corp.-Class A (Non-Voting) |
|
|
281,736 |
|
|
17,400 |
|
|
Computer Sciences Corp. |
|
|
425,082 |
|
|
51,053 |
|
|
ConocoPhillips |
|
|
3,641,100 |
|
|
11,200 |
|
|
Covidien Plc |
|
|
510,160 |
|
|
6,100 |
|
|
CR Bard, Inc. |
|
|
531,859 |
|
|
26,300 |
|
|
CSX Corp. |
|
|
570,973 |
|
|
9,700 |
|
|
Danaher Corp. |
|
|
469,286 |
|
|
9,900 |
|
|
Deere & Co. |
|
|
784,575 |
|
|
4,200 |
|
|
Digital Realty Trust, Inc. REIT |
|
|
266,700 |
|
|
9,400 |
|
|
DirectTV Class A * |
|
|
443,868 |
|
|
28,900 |
|
|
Discover Financial Services |
|
|
688,398 |
|
|
4,500 |
|
|
Dollar Tree, Inc. * |
|
|
366,705 |
|
|
6,800 |
|
|
Dominion Resources, Inc./Virginia |
|
|
351,016 |
|
|
13,800 |
|
|
Dow Chemical Co. (The) |
|
|
382,398 |
|
|
14,100 |
|
|
Du Pont (E.I.) de Nemours & Co. |
|
|
672,852 |
|
|
16,800 |
|
|
Duke Energy Corp. |
|
|
350,280 |
|
|
7,900 |
|
|
Eastman Chemical Co. |
|
|
312,998 |
|
|
22,100 |
|
|
Ecolab, Inc. |
|
|
1,260,142 |
|
|
53,900 |
|
|
Eli Lilly & Co. |
|
|
2,040,115 |
|
|
18,500 |
|
|
EMC Corp. * |
|
|
425,685 |
|
|
6,600 |
|
|
Equity Residential REIT |
|
|
364,254 |
|
|
1,700 |
|
|
Essex Property Trust, Inc. REIT |
|
|
225,845 |
|
|
18,900 |
|
|
Expeditors International of Washington, Inc. |
|
|
822,339 |
|
|
64,200 |
|
|
Exxon Mobil Corp. |
|
|
5,164,248 |
|
|
11,100 |
|
|
FirstEnergy Corp. |
|
|
493,617 |
|
|
8,800 |
|
|
FLIR Systems, Inc. |
|
|
236,368 |
|
|
10,100 |
|
|
FMC Technologies, Inc. * |
|
|
528,836 |
|
|
14,300 |
|
|
Forest Laboratories, Inc. * |
|
|
428,428 |
|
|
4,200 |
|
|
Fossil, Inc. * |
|
|
376,278 |
|
|
24,000 |
|
|
General Dynamics Corp. |
|
|
1,585,440 |
|
|
9,500 |
|
|
Genuine Parts Co. |
|
|
555,750 |
|
|
12,400 |
|
|
Google, Inc.-Class A * |
|
|
7,432,436 |
|
|
3,700 |
|
|
Green Mountain Coffee Roasters, Inc. * |
|
|
193,991 |
|
|
31,200 |
|
|
Halliburton Co. |
|
|
1,148,160 |
|
|
4,900 |
|
|
Hansen Natural Corp. * |
|
|
451,780 |
|
|
30,700 |
|
|
Hartford Financial Services Group, Inc. (The) |
|
|
545,232 |
|
|
17,400 |
|
|
Hewlett-Packard Co. |
|
|
486,330 |
|
|
6,800 |
|
|
Honeywell International, Inc. |
|
|
368,220 |
|
|
17,100 |
|
|
Hormel Foods Corp. |
|
|
514,881 |
|
|
8,700 |
|
|
Hospitality Properties Trust REIT |
|
|
191,661 |
|
|
12,300 |
|
|
International Business Machines Corp. |
|
|
2,312,400 |
|
|
13,300 |
|
|
Intuit, Inc. |
|
|
708,092 |
|
|
195,600 |
|
|
Johnson & Johnson |
|
|
12,659,232 |
|
|
4,000 |
|
|
Joy Global, Inc. |
|
|
365,120 |
|
|
32,900 |
|
|
KimberlyClark Corp. |
|
|
2,351,363 |
|
|
12,200 |
|
|
Kraft Foods, Inc.-Class A |
|
|
441,030 |
|
|
18,700 |
|
|
Las Vegas Sands Corp. * |
|
|
873,477 |
|
|
12,200 |
|
|
Leucadia National Corp. |
|
|
285,724 |
|
|
3,300 |
|
|
Liberty Media Corp. Capital-Class A * |
|
|
251,724 |
|
|
9,700 |
|
|
Limited Brands, Inc. |
|
|
410,601 |
|
|
4,900 |
|
|
Lululemon Athletica, Inc. * |
|
|
243,530 |
|
|
21,400 |
|
|
Macys, Inc. |
|
|
691,862 |
|
|
31,500 |
|
|
Marathon Oil Corp. |
|
|
880,740 |
|
|
|
|
|
|
|
|
|
|
|
1,300 |
|
|
MasterCard, Inc.-Class A |
|
|
486,915 |
|
|
5,800 |
|
|
McDonalds Corp. |
|
|
554,016 |
|
|
23,100 |
|
|
Medtronic, Inc. |
|
|
841,533 |
|
|
162,800 |
|
|
Merck & Co., Inc. |
|
|
5,820,100 |
|
|
218,700 |
|
|
Microsoft Corp. |
|
|
5,594,346 |
|
|
7,800 |
|
|
Motorola Solutions, Inc. |
|
|
364,026 |
|
|
10,300 |
|
|
NASDAQ OMX Group, Inc. (The) * |
|
|
270,375 |
|
|
10,400 |
|
|
National Oilwell Varco, Inc. |
|
|
745,680 |
|
|
23,500 |
|
|
Nike, Inc.-Class B |
|
|
2,260,230 |
|
|
19,500 |
|
|
NiSource, Inc. |
|
|
446,745 |
|
|
9,300 |
|
|
Norfolk Southern Corp. |
|
|
702,522 |
|
|
5,100 |
|
|
Occidental Petroleum Corp. |
|
|
504,390 |
|
|
73,500 |
|
|
Oracle Corp. |
|
|
2,304,225 |
|
|
38,100 |
|
|
Paychex, Inc. |
|
|
1,109,091 |
|
|
18,800 |
|
|
Pepco Holdings, Inc. |
|
|
371,864 |
|
|
67,300 |
|
|
PepsiCo, Inc. |
|
|
4,307,200 |
|
|
185,673 |
|
|
Pfizer, Inc. |
|
|
3,726,457 |
|
|
15,700 |
|
|
Philip Morris International, Inc. |
|
|
1,196,968 |
|
|
5,200 |
|
|
PPG Industries, Inc. |
|
|
456,300 |
|
|
2,100 |
|
|
Precision Castparts Corp. |
|
|
345,975 |
|
|
1,900 |
|
|
Priceline.com, Inc. * |
|
|
923,191 |
|
|
13,800 |
|
|
ProLogis, Inc. REIT |
|
|
383,916 |
|
|
8,200 |
|
|
Prudential Financial, Inc. |
|
|
415,248 |
|
|
3,300 |
|
|
Public Storage REIT |
|
|
435,270 |
|
|
88,200 |
|
|
Qualcomm, Inc. |
|
|
4,833,360 |
|
|
20,100 |
|
|
Reynolds American, Inc. |
|
|
841,386 |
|
|
5,000 |
|
|
Rockwell Automation, Inc. |
|
|
375,150 |
|
|
10,000 |
|
|
Rockwell Collins, Inc. |
|
|
549,000 |
|
|
20,600 |
|
|
RR Donnelley & Sons Co. |
|
|
309,412 |
|
|
4,800 |
|
|
Schlumberger Ltd. |
|
|
361,584 |
|
|
8,700 |
|
|
SigmaAldrich Corp. |
|
|
563,847 |
|
|
4,200 |
|
|
Simon Property Group, Inc. REIT |
|
|
522,228 |
|
|
32,700 |
|
|
SLM Corp. |
|
|
421,176 |
|
|
9,200 |
|
|
Southern Co. |
|
|
403,972 |
|
|
20,600 |
|
|
Starbucks Corp. |
|
|
895,688 |
|
|
22,800 |
|
|
Stryker Corp. |
|
|
1,113,324 |
|
|
7,800 |
|
|
St Jude Medical, Inc. |
|
|
299,832 |
|
|
30,542 |
|
|
Supervalu, Inc. |
|
|
224,484 |
|
|
40,900 |
|
|
Sysco Corp. |
|
|
1,167,286 |
|
|
8,400 |
|
|
T. Rowe Price Group, Inc. |
|
|
476,784 |
|
|
22,200 |
|
|
TD Ameritrade Holding Corp. |
|
|
361,638 |
|
|
13,300 |
|
|
Teradata Corp. * |
|
|
721,259 |
|
|
6,100 |
|
|
Tiffany & Co. |
|
|
408,944 |
|
|
4,000 |
|
|
Time Warner Cable, Inc. |
|
|
241,920 |
|
|
10,600 |
|
|
TJX Cos., Inc. (The) |
|
|
654,020 |
|
|
16,800 |
|
|
Travelers Cos., Inc. (The) |
|
|
945,000 |
|
|
20,215 |
|
|
UnitedHealth Group, Inc. |
|
|
985,885 |
|
|
19,700 |
|
|
United Technologies Corp. |
|
|
1,509,020 |
|
|
44,800 |
|
|
Valero Energy Corp. |
|
|
997,696 |
|
|
7,700 |
|
|
Varian Medical Systems, Inc. * |
|
|
479,171 |
|
|
3,300 |
|
|
VF Corp. |
|
|
457,677 |
|
|
19,300 |
|
|
Viacom, Inc.-Class B |
|
|
863,868 |
|
|
13,900 |
|
|
Virgin Media, Inc. |
|
|
308,024 |
|
|
6,000 |
|
|
Visa, Inc.-Class A |
|
|
581,820 |
|
|
105,600 |
|
|
WalMart Stores, Inc. |
|
|
6,219,840 |
|
|
12,000 |
|
|
WellPoint, Inc. |
|
|
846,600 |
|
|
9,100 |
|
|
Western Digital Corp. * |
|
|
264,537 |
|
|
4,600 |
|
|
Whole Foods Market, Inc. |
|
|
313,260 |
|
|
19,200 |
|
|
Williams Cos., Inc. |
|
|
619,776 |
|
|
4,800 |
|
|
WW Grainger, Inc. |
|
|
897,120 |
|
|
|
|
|
|
|
|
|
|
|
5,200 |
|
|
Wynn Resorts Ltd. |
|
|
626,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
175,934,196 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $299,737,804) |
|
|
301,984,414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 0.3% |
|
|
|
|
|
12,089 |
|
|
Porsche Automobil Holding SE 1.24% |
|
|
740,798 |
|
|
1,702 |
|
|
Volkswagen AG 1.95% |
|
|
294,100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
1,034,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $975,526) |
|
|
1,034,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 0.0% |
|
|
|
|
|
6,727 |
|
|
American International Group, Inc., Warrants, Strike 45.00, Expires 01/19/21* |
|
|
41,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $125,109) |
|
|
41,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 4.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 4.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
549,062 |
|
|
GMO U.S. Treasury Fund |
|
|
13,732,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $13,732,028) |
|
|
13,732,028 |
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.8% |
|
|
|
|
USD |
2,103,373 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
2,103,373 |
|
AUD |
9,892 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11 |
|
|
10,173 |
|
CAD |
13,154 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11 |
|
|
12,897 |
|
CHF |
9,068 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
9,925 |
|
DKK |
52,423 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11 |
|
|
9,473 |
|
HKD |
77,826 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
10,018 |
|
NOK |
59,276 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
10,263 |
|
SEK |
66,813 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11 |
|
|
9,873 |
|
SGD |
12,698 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
9,908 |
|
JPY |
9,323,720 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
120,213 |
|
EUR |
108,276 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
145,490 |
|
GBP |
24,182 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
37,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
2,489,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $2,489,545) |
|
|
2,489,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.0%
(Cost $317,060,012) |
|
|
319,282,054 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 1.0% |
|
|
3,347,202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
322,629,256 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
Units of |
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
CAD |
|
|
3,146,071 |
|
|
$ |
3,083,377 |
|
|
$ |
4,367 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
1,625,728 |
|
|
|
2,184,716 |
|
|
|
(39,198 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
GBP |
|
|
1,287,643 |
|
|
|
2,019,902 |
|
|
|
2,835 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
GBP |
|
|
1,327,209 |
|
|
|
2,081,968 |
|
|
|
(6,658 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
GBP |
|
|
2,031,850 |
|
|
|
3,187,326 |
|
|
|
5,668 |
|
|
12/16/11 |
|
|
Bank of America N.A. |
|
HKD |
|
|
7,800,772 |
|
|
|
1,004,184 |
|
|
|
740 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
HKD |
|
|
37,993,622 |
|
|
|
4,890,872 |
|
|
|
3,604 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
HKD |
|
|
20,189,866 |
|
|
|
2,599,016 |
|
|
|
1,985 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
HKD |
|
|
7,703,303 |
|
|
|
991,637 |
|
|
|
195 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
JPY |
|
|
47,721,000 |
|
|
|
615,484 |
|
|
|
(4,629 |
) |
|
12/16/11 |
|
|
Bank of America N.A. |
|
SEK |
|
|
12,141,987 |
|
|
|
1,792,936 |
|
|
|
(26,123 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SEK |
|
|
5,162,681 |
|
|
|
762,343 |
|
|
|
(7,387 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
SEK |
|
|
4,003,522 |
|
|
|
591,177 |
|
|
|
(6,533 |
) |
|
12/16/11 |
|
|
Bank of America, N.A. |
|
SGD |
|
|
1,544,058 |
|
|
|
1,204,761 |
|
|
|
(11,579 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SGD |
|
|
3,066,619 |
|
|
|
2,392,749 |
|
|
|
(11,805 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank N.A. |
|
SGD |
|
|
3,392,840 |
|
|
|
2,647,285 |
|
|
|
(14,413 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
SGD |
|
|
1,646,540 |
|
|
|
1,284,723 |
|
|
|
(3,902 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
SGD |
|
|
1,943,689 |
|
|
|
1,516,576 |
|
|
|
(11,359 |
) |
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
SGD |
|
|
4,005,840 |
|
|
|
3,125,582 |
|
|
|
(24,183 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
37,976,614 |
|
|
$ |
(148,375 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
CAD |
|
|
1,169,601 |
|
|
$ |
1,146,294 |
|
|
$ |
3,870 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
CHF |
|
|
1,297,087 |
|
|
|
1,420,240 |
|
|
|
18,945 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
214,708 |
|
|
|
235,094 |
|
|
|
2,857 |
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
EUR |
|
|
2,827,242 |
|
|
|
3,799,357 |
|
|
|
77,380 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
EUR |
|
|
1,803,658 |
|
|
|
2,423,825 |
|
|
|
42,280 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
624,763 |
|
|
|
839,581 |
|
|
|
16,657 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
3,356,248 |
|
|
|
4,510,255 |
|
|
|
79,840 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
JPY |
|
|
56,992,510 |
|
|
|
735,064 |
|
|
|
8,077 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
JPY |
|
|
164,686,939 |
|
|
|
2,124,060 |
|
|
|
23,041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
17,233,770 |
|
|
$ |
272,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Amsterdam Exchanges Index |
|
December 2011 |
|
$ |
80,995 |
|
|
$ |
3,544 |
|
9 |
|
CAC 40 |
|
December 2011 |
|
|
382,355 |
|
|
|
21,128 |
|
2 |
|
DAX |
|
December 2011 |
|
|
410,845 |
|
|
|
21,122 |
|
7 |
|
FTSE 100 |
|
December 2011 |
|
|
605,825 |
|
|
|
17,064 |
|
56 |
|
FTSE/MIB |
|
December 2011 |
|
|
5,765,200 |
|
|
|
707,874 |
|
1 |
|
IBEX 35 |
|
December 2011 |
|
|
113,665 |
|
|
|
3,105 |
|
2 |
|
MSCI Singapore |
|
December 2011 |
|
|
97,969 |
|
|
|
3,466 |
|
33 |
|
S&P 500 E-Mini Index |
|
December 2011 |
|
|
2,055,900 |
|
|
|
49,088 |
|
81 |
|
TOPIX |
|
December 2011 |
|
|
7,780,866 |
|
|
|
1,825 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
17,293,620 |
|
|
$ |
828,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
2 |
|
Hang Seng |
|
December 2011 |
|
$ |
240,595 |
|
|
$ |
(14,355 |
) |
30 |
|
OMXS 30 |
|
December 2011 |
|
|
438,605 |
|
|
|
(15,319 |
) |
5 |
|
S&P Toronto 60 |
|
December 2011 |
|
|
680,916 |
|
|
|
14,664 |
|
12 |
|
SPI 200 |
|
December 2011 |
|
|
1,310,747 |
|
|
|
(45,507 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,670,863 |
|
|
$ |
(60,517 |
) |
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
REIT Real Estate Investment Trust
* |
|
Non-income producing security. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NOK Norwegian Krone
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
323,542,525 |
|
|
$ |
21,215,745 |
|
|
$ |
(25,476,216 |
) |
|
$ |
(4,260,471 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury
Fund |
|
$ |
11,923,000 |
|
|
$ |
32,535,000 |
|
|
$ |
30,731,304 |
|
|
$ |
4,115 |
|
|
$ |
543 |
|
|
$ |
13,732,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
38.5% |
Futures Contracts |
|
0.2% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the fair value of equity securities that
underlie
futures (to the extent the market for such futures closes prior to the close of the NYSE) and
other derivatives) due to market events that have occurred since the local market close but
prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
1,533,567 |
|
|
$ |
|
|
|
$ |
1,533,567 |
|
Austria |
|
|
|
|
|
|
952,879 |
|
|
|
|
|
|
|
952,879 |
|
Belgium |
|
|
|
|
|
|
72,968 |
|
|
|
|
|
|
|
72,968 |
|
Canada |
|
|
2,963,914 |
|
|
|
|
|
|
|
|
|
|
|
2,963,914 |
|
Finland |
|
|
|
|
|
|
345,036 |
|
|
|
|
|
|
|
345,036 |
|
France |
|
|
|
|
|
|
16,343,559 |
|
|
|
|
|
|
|
16,343,559 |
|
Germany |
|
|
|
|
|
|
11,532,092 |
|
|
|
|
|
|
|
11,532,092 |
|
Hong Kong |
|
|
|
|
|
|
289,483 |
|
|
|
|
|
|
|
289,483 |
|
Ireland |
|
|
|
|
|
|
1,515,341 |
|
|
|
|
|
|
|
1,515,341 |
|
Italy |
|
|
|
|
|
|
11,341,511 |
|
|
|
|
|
|
|
11,341,511 |
|
Japan |
|
|
|
|
|
|
30,384,862 |
|
|
|
|
|
|
|
30,384,862 |
|
Singapore |
|
|
|
|
|
|
5,182,294 |
|
|
|
|
|
|
|
5,182,294 |
|
Spain |
|
|
|
|
|
|
8,765,103 |
|
|
|
|
|
|
|
8,765,103 |
|
Sweden |
|
|
|
|
|
|
599,278 |
|
|
|
|
|
|
|
599,278 |
|
Switzerland |
|
|
|
|
|
|
2,408,151 |
|
|
|
|
|
|
|
2,408,151 |
|
United Kingdom |
|
|
|
|
|
|
31,820,180 |
|
|
|
|
|
|
|
31,820,180 |
|
United States |
|
|
175,934,196 |
|
|
|
|
|
|
|
|
|
|
|
175,934,196 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
178,898,110 |
|
|
|
123,086,304 |
|
|
|
|
|
|
|
301,984,414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany |
|
|
|
|
|
|
1,034,898 |
|
|
|
|
|
|
|
1,034,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
|
|
|
|
1,034,898 |
|
|
|
|
|
|
|
1,034,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
|
|
|
|
41,169 |
|
|
|
|
|
|
|
41,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS |
|
|
|
|
|
|
41,169 |
|
|
|
|
|
|
|
41,169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
13,732,028 |
|
|
|
|
|
|
|
|
|
|
|
13,732,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
13,732,028 |
|
|
|
|
|
|
|
|
|
|
|
13,732,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
2,489,545 |
|
|
|
|
|
|
|
|
|
|
|
2,489,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
195,119,683 |
|
|
|
124,162,371 |
|
|
|
|
|
|
|
319,282,054 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
|
|
|
|
|
292,341 |
|
|
|
|
|
|
|
292,341 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
|
63,752 |
|
|
|
779,128 |
|
|
|
|
|
|
|
842,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
63,752 |
|
|
|
1,071,469 |
|
|
|
|
|
|
|
1,135,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
195,183,435 |
|
|
$ |
125,233,840 |
|
|
$ |
|
|
|
$ |
320,417,275 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS |
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
$ |
|
|
|
$ |
(167,769 |
) |
|
$ |
|
|
|
$ |
(167,769 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
|
|
|
|
|
(75,181 |
) |
|
|
|
|
|
|
(75,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
(242,950 |
) |
|
|
|
|
|
|
(242,950 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(242,950 |
) |
|
$ |
|
|
|
$ |
(242,950 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see
the Investment and other risks and Derivative financial instruments sections below for a
further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline due to
factors affecting the issuing companies, their industries, or the economy and equity markets
generally. If the Fund purchases equity investments at a discount from their value as determined
by the Manager, the Fund runs the risk that the market prices of these investments will not
increase to that value for a variety of reasons, one of which may be the Managers
overestimation of the value of those investments. The Fund also may purchase equity investments
that typically trade at higher multiples of current earnings than other securities, and the
market values of these investments often are more sensitive to changes in future earnings
expectations than those other securities. Because the Fund normally does not take temporary
defensive positions, declines in stock market prices generally are likely to reduce the net
asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its investment
objective by effectively implementing its investment approach. The Fund runs the risk that GMOs
proprietary investment techniques will fail to produce the desired results. The Funds portfolio
managers may use quantitative analyses and/or models and any imperfections or limitations in
such analyses and/or models could affect the ability of the portfolio managers to implement
strategies. By necessity, these analyses and models make simplifying assumptions that limit
their efficacy. Models that appear to explain prior market data can fail to predict future
market events. Further, the data used in models may be inaccurate and/or it may not include the
most recent information about a company or a security. The Fund is also subject to the risk that
deficiencies in the Managers or another service providers internal systems or controls will
cause losses for the Fund or impair Fund operations.
Foreign Investment Risk The market prices of many foreign securities fluctuate more than
those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less
regulated than U.S. markets, and the cost of trading in those markets often is higher than in
U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer
taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be
subject to foreign taxes on capital gains or other income payable on foreign securities, on
transactions in those securities and on the repatriation of proceeds generated from those
securities. Also, many foreign markets require a license for the Fund to invest directly in
those markets, and the Fund is subject to the risk that it could not invest if its license were
terminated or suspended. In some foreign markets, prevailing custody and trade settlement
practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to
credit and other risks with respect to participating
brokers, custodians, clearing banks or
other clearing agents, escrow agents and issuers. Further, adverse changes in investment
regulations, capital requirements or exchange controls could adversely affect the value of the
Funds investments. These and other risks (e.g., nationalization, expropriation or other
confiscation of assets of foreign issuers) tend to be greater for investments in companies tied
economically to emerging countries, the economies of which tend to be more volatile than the
economies of developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of the
Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk The use of derivatives involves the risk that their value may not move as
expected relative to the value of the relevant underlying assets, rates or indices. Derivatives
also present other Fund risks, including market risk, liquidity risk, currency risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its portfolio
to be leveraged. Leverage increases the Funds portfolio losses when the value of its
investments decline.
Focused Investment Risk Focusing investments in countries, regions, sectors or companies or
in industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt securities
markets and adversely affect global economies and markets. Those events as well as other changes
in foreign and domestic economic and political conditions could adversely affect the value of
the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the
Fund is subject to the risk that these shareholders will disrupt the Funds operations by
purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that
index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes and adjust exposure to foreign currencies. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain securities markets and maintain the diversity and liquidity of
the portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used total return swap
agreements to achieve returns comparable to holding and lending a direct equity position. The
Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or warrants held
by the Fund at the end of the period are listed in the Funds Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized
by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
41,169 |
|
|
$ |
|
|
|
$ |
41,169 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
292,341 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
292,341 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
842,880 |
|
|
|
|
|
|
|
842,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
292,341 |
|
|
$ |
|
|
|
$ |
884,049 |
|
|
$ |
|
|
|
$ |
1,176,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(167,769 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(167,769 |
) |
Unrealized depreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(75,181 |
) |
|
|
|
|
|
|
(75,181 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(167,769 |
) |
|
$ |
|
|
|
$ |
(75,181 |
) |
|
$ |
|
|
|
$ |
(242,950 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation
of futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures
contracts and rights and/or warrants), or notional amounts (swap agreements) outstanding at each
month-end, was as follows for the period ended November 30, 2011: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Rights and/or |
|
|
Swap |
|
|
|
Contracts |
|
|
Contracts |
|
|
Warrants |
|
|
Agreements |
|
Average amount outstanding |
|
$ |
61,961,392 |
|
|
$ |
16,643,284 |
|
|
$ |
72,825 |
|
|
$ |
92,570 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Domestic Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) / |
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 11.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 2.8% |
|
|
|
|
|
9,312,000 |
|
|
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13 |
|
|
9,604,900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 8.0% |
|
|
|
|
|
27,168,858 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a) |
|
|
27,260,118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 0.2% |
|
|
|
|
|
471,650 |
|
|
Agency for
International Development Floater (Support of Jamaica), 6 mo. U.S. Treasury Bill + 0.75%, 0.82%, due 03/30/19(b) |
|
|
454,590 |
|
|
233,336 |
|
|
Agency for
International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(b) |
|
|
232,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
687,569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $37,498,148) |
|
|
37,552,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 88.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 88.9% |
|
|
|
|
|
45,578,624 |
|
|
GMO Short-Duration Collateral Fund |
|
|
301,274,708 |
|
|
1,483 |
|
|
GMO Special Purpose Holding Fund(c) |
|
|
578 |
|
|
28,812 |
|
|
GMO U.S. Treasury Fund |
|
|
720,599 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
301,995,885 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $327,957,777) |
|
|
301,995,885 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
30,184 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(d) |
|
|
30,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $30,184) |
|
|
30,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.9% |
|
|
|
|
|
|
|
|
(Cost $365,486,109) |
|
|
339,578,656 |
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.1% |
|
|
173,479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
339,752,135 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
|
Amount of Future |
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
Receive |
|
|
Annual |
|
|
Credit |
|
|
Reference |
|
Payments by the Fund |
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)^ |
|
|
Premium |
|
|
Spread (1) |
|
|
Entity |
|
Under the Contract (2) |
|
|
(Depreciation) |
|
11,500,000 USD |
|
3/20/2013 |
|
Barclays Bank PLC |
|
(Pay) |
|
|
0.61 |
% |
|
|
1.20 |
% |
|
Health Care Properties |
|
NA |
|
$ |
74,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a credit event occurs, as
defined under the terms of that particular swap agreement, the Fund will either (i) pay to the
buyer of protection an amount equal to the notional amount of the swap and take delivery of the
referenced obligation or underlying securities comprising the referenced index or (ii) pay a net
settlement amount in the form of cash or securities equal to the notional amount of the swap less
the recovery value of the referenced obligation or underlying securities comprising the referenced
index. |
|
|
|
(Pay) Fund pays premium and buys credit protection. If a credit event occurs, as defined under
the terms of that particular swap agreement, the Fund will either (i) receive from the seller of
protection an amount equal to the notional amount of the swap and deliver the referenced obligation
or underlying securities comprising the referenced index or (ii) receive a net settlement amount in
the form of cash or securities equal to the notional amount of the swap less the recovery value of
the referenced obligation or underlying securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in determining the market value
of credit default swap agreements on the reference security, as of November 30, 2011, serve as an
indicator of the current status of the payment/performance risk and reflect the likelihood or risk
of default for the reference entity. The implied credit spread of a particular referenced entity
reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a
deterioration of the referenced entitys credit soundness and a greater likelihood or risk of
default or other credit event occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a seller of credit protection
if a credit event occurs as defined under the terms of that particular swap agreement. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient
cash and/or securities to cover any commitments or collateral requirements of the relevant broker
or exchange.
Notes to Schedule of Investments:
MTN
Medium Term Note
The rates shown on variable rate notes are the current interest rates
at November 30, 2011, which are subject to change based on the terms of the security.
(a) Indexed security in which price and/or coupon is linked to the prices of a specific instrument
or financial statistic.
(b) Security valued at fair value using methods determined in good faith by or at the direction of
the Trustees of GMO Trust.
(c) Underlying investment represents interests in defaulted claims. See Other Matters for
additional information.
(d) Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
Currency Abbreviations:
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
381,961,238 |
|
|
$ |
305,861 |
|
|
$ |
(42,688,443 |
) |
|
$ |
(42,382,582 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Short-Duration
Collateral Fund |
|
$ |
473,106,122 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,583,799 |
|
|
$ |
|
|
|
$ |
157,848,603 |
|
|
$ |
301,274,708 |
|
GMO Special Purpose
Holding Fund |
|
|
741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
578 |
|
GMO U.S. Treasury
Fund |
|
|
14,663,527 |
|
|
|
13,710,000 |
|
|
|
27,653,000 |
|
|
|
492 |
|
|
|
30 |
|
|
|
|
|
|
|
720,599 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
487,770,390 |
|
|
$ |
13,710,000 |
|
|
$ |
27,653,000 |
|
|
$ |
3,584,291 |
|
|
$ |
30 |
|
|
$ |
157,848,603 |
|
|
$ |
301,995,885 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined at the end of the
fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 3.2% of net assets. The Fund and the underlying funds classify such securities
(levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not
reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its
counterparties. See Derivative financial instruments below for a further discussion
on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held indirectly for which no alternative
pricing source was available represented 9.8% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the
ask price for securities sold short. If the pricing convention for a security does not involve a
bid or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and market data from pricing vendors) to value credit default swaps.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value technique on Level 3 investments: The Fund valued certain debt
securities by using a specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt |
|
$ |
|
|
|
$ |
9,604,900 |
|
|
$ |
|
|
|
$ |
9,604,900 |
|
U.S. Government |
|
|
|
|
|
|
27,260,118 |
|
|
|
|
|
|
|
27,260,118 |
|
U.S. Government Agency |
|
|
|
|
|
|
|
|
|
|
687,569 |
|
|
|
687,569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
36,865,018 |
|
|
|
687,569 |
|
|
|
37,552,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
301,995,307 |
|
|
|
578 |
|
|
|
|
|
|
|
301,995,885 |
|
Short-Term Investments |
|
|
30,184 |
|
|
|
|
|
|
|
|
|
|
|
30,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
302,025,491 |
|
|
|
36,865,596 |
|
|
|
687,569 |
|
|
|
339,578,656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
74,725 |
|
|
|
|
|
|
|
74,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
302,025,491 |
|
|
$ |
36,940,321 |
|
|
$ |
687,569 |
|
|
$ |
339,653,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds investments (both direct and indirect) in securities and derivative financial instruments
using Level 3 inputs were 63.9% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as |
|
|
|
from Investments |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
Transfers |
|
|
Transfers out |
|
|
of November |
|
|
|
Still Held as of |
|
|
|
28, 2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
into level 3 * |
|
|
of level 3 * |
|
|
30, 2011 |
|
|
|
November 30, 2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency |
|
$ |
983,567 |
|
|
$ |
|
|
|
$ |
(296,234 |
) |
|
$ |
16 |
|
|
$ |
(34 |
) |
|
$ |
254 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
687,569 |
|
|
|
$ |
254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
983,567 |
|
|
$ |
|
|
|
$ |
(296,234 |
) |
|
$ |
16 |
|
|
$ |
(34 |
) |
|
$ |
254 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
687,569 |
|
|
|
$ |
254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the
beginning of the period and transferred out of Level 3
at the value at the end of the period. |
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or
to otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the
issuers credit rating. The Funds investments in below investment grade securities have
speculative characteristics, and changes in economic conditions or other circumstances are
more likely to impair the capacity of issuers to make principal and interest payments than
is the case with issuers of investment grade securities.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk.
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of widening of credit spreads.
Derivatives Risk The use of derivatives involves the risk that their value may or
may not move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted
obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an
attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by
making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other
relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used credit default
swap agreements to provide a measure of protection against default loss. Swap
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure.
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized
appreciation on
swap agreements |
|
$ |
|
|
|
$ |
|
|
|
$ |
74,725 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
74,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
74,725 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
74,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The derivative financial instruments outstanding as of period end (as
disclosed in the Schedule of Investments) serve as indicators of the volume of
derivative activity for the Fund during the period.
Subsequent Events
On November 17, 2011, the
Funds Board of Trustees approved a reverse stock split for Class
III and Class VI of the Fund of one new share for every nine
current shares. The reverse splits were effective for
shareholders of record after the close of the NYSE on January 13, 2012. Transactions in shares were effected at the relevant classs post-split price starting January 17, 2012. The ticker symbols
and cusips for the share classes did not change.
The
reverse splits reduced the number of shares outstanding for the share classes, and
resulted in a proportionate increase in the price per share of each share class. The reverse
splits did not change the value of a shareholders investment.
Every nine pre-split shares held by a shareholder resulted in the receipt of one
post-split share, which is priced nine times higher than the pre-split shares.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Emerging Countries Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 85.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 11.7% |
|
|
|
|
|
6,300 |
|
|
Banco Bradesco ADR |
|
|
103,950 |
|
|
172,000 |
|
|
Banco do Brasil SA |
|
|
2,301,767 |
|
|
29,600 |
|
|
Banco Santander Brasil SA ADR |
|
|
228,512 |
|
|
19,000 |
|
|
BM&F BOVESPA SA |
|
|
103,807 |
|
|
39,600 |
|
|
BR Malls Participacoes SA |
|
|
400,960 |
|
|
18,000 |
|
|
Brasil Brokers Participacoes SA |
|
|
60,619 |
|
|
17,660 |
|
|
Brasil Telecom SA ADR |
|
|
314,701 |
|
|
11,700 |
|
|
BRF Brasil Foods SA |
|
|
235,755 |
|
|
7,070 |
|
|
Centrais Eletricas Brasileiras SA Sponsored ADR |
|
|
65,680 |
|
|
21,200 |
|
|
CETIP SA |
|
|
308,325 |
|
|
14,709 |
|
|
Cia de Saneamento Basico do Estado de Sao Paulo |
|
|
406,615 |
|
|
18,100 |
|
|
Cielo SA |
|
|
481,939 |
|
|
4,200 |
|
|
Companhia de Bebidas das Americas |
|
|
115,199 |
|
|
2,700 |
|
|
Companhia de Bebidas das Americas ADR |
|
|
92,826 |
|
|
3,600 |
|
|
Companhia de Concessoes Rodoviarias |
|
|
22,993 |
|
|
20,300 |
|
|
Companhia de Saneamento de Minas Gerais-Copasa MG * |
|
|
362,253 |
|
|
10,100 |
|
|
Cosan SA Industria e Comercio |
|
|
150,242 |
|
|
25,200 |
|
|
Cyrela Brazil Realty SA |
|
|
209,448 |
|
|
27,300 |
|
|
Electrobras (Centro) |
|
|
250,151 |
|
|
2,100 |
|
|
Embraer SA ADR |
|
|
53,592 |
|
|
5,700 |
|
|
Fleury SA * |
|
|
64,932 |
|
|
9,600 |
|
|
Gafisa SA ADR |
|
|
57,792 |
|
|
64,500 |
|
|
Gerdau SA |
|
|
413,391 |
|
|
44,900 |
|
|
Gerdau SA Sponsored ADR |
|
|
344,832 |
|
|
500 |
|
|
HRT Participacoes em Petroleo SA * |
|
|
183,869 |
|
|
110,690 |
|
|
Itau Unibanco Holding SA ADR |
|
|
1,970,282 |
|
|
74,100 |
|
|
JBS SA * |
|
|
243,811 |
|
|
35,800 |
|
|
Light SA |
|
|
542,637 |
|
|
5,200 |
|
|
LPS Brasil Consultoria de Imoveis SA |
|
|
77,669 |
|
|
2,500 |
|
|
MPX Mineracao e Energia SA * |
|
|
59,723 |
|
|
2,000 |
|
|
Multiplan Empreendimentos Imobiliarios SA |
|
|
40,037 |
|
|
22,100 |
|
|
Multiplus SA |
|
|
387,408 |
|
|
3,200 |
|
|
OdontoPrev SA |
|
|
44,416 |
|
|
18,800 |
|
|
PDG Realty SA Empreendimentos e Participacoes |
|
|
69,863 |
|
|
96,530 |
|
|
Petroleo Brasileiro SA (Petrobras) ADR |
|
|
2,605,345 |
|
|
65,200 |
|
|
Redecard SA |
|
|
1,099,677 |
|
|
4,600 |
|
|
Souza Cruz SA |
|
|
58,354 |
|
|
2,600 |
|
|
Sul America SA |
|
|
18,979 |
|
|
25,060 |
|
|
Telefonica Brasil SA ADR |
|
|
675,868 |
|
|
2,838 |
|
|
Tim Participacoes SA ADR |
|
|
67,573 |
|
|
12,200 |
|
|
Ultrapar Participacoes SA |
|
|
214,673 |
|
|
10,800 |
|
|
Ultrapar Participacoes SA Sponsored ADR |
|
|
191,916 |
|
|
7,700 |
|
|
Usinas Siderurgicas de Minas Gerais SA |
|
|
75,793 |
|
|
5,500 |
|
|
Usinas Siderurgicas de Minas Gerais SA Sponsored ADR |
|
|
32,835 |
|
|
15,900 |
|
|
Vale SA |
|
|
366,210 |
|
|
109,400 |
|
|
Vale SA Sponsored ADR |
|
|
2,543,550 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
18,720,769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chile 0.2% |
|
|
|
|
|
500 |
|
|
Compania Cervecerias Unidas ADR |
|
|
28,615 |
|
|
560 |
|
|
Embotelladora Andina SA ADR Class B |
|
|
15,232 |
|
|
14,272 |
|
|
Empresa National de Telecomunicaciones SA |
|
|
289,232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Chile |
|
|
333,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China 12.2% |
|
|
|
|
|
94,000 |
|
|
Air China Ltd Class H |
|
|
72,170 |
|
|
300 |
|
|
Baidu Inc Sponsored ADR * |
|
|
39,297 |
|
|
2,344,000 |
|
|
Bank of China Ltd Class H |
|
|
764,253 |
|
|
693,100 |
|
|
Bank of Communications Co Ltd Class H |
|
|
452,549 |
|
|
93,000 |
|
|
Belle International Holdings Ltd |
|
|
178,935 |
|
|
563,000 |
|
|
China CITIC Bank Corp Class H |
|
|
303,279 |
|
|
92,900 |
|
|
China Coal Energy Co Class H |
|
|
110,972 |
|
|
333,200 |
|
|
China Communication Services Corp Ltd Class H |
|
|
160,873 |
|
|
879,000 |
|
|
China Communications Construction Co Ltd Class H |
|
|
677,797 |
|
|
303,000 |
|
|
China Construction Bank Class H |
|
|
215,481 |
|
|
81,000 |
|
|
China Life Insurance Co Ltd Class H |
|
|
217,831 |
|
|
106,000 |
|
|
China Mengniu Dairy Co Ltd |
|
|
381,920 |
|
|
489,464 |
|
|
China Mobile Ltd |
|
|
4,833,160 |
|
|
4,082 |
|
|
China Mobile Ltd Sponsored ADR |
|
|
202,753 |
|
|
84,000 |
|
|
China National Building Material Co Ltd Class H |
|
|
102,249 |
|
|
162,000 |
|
|
China Overseas Land & Investment Ltd |
|
|
285,960 |
|
|
82,600 |
|
|
China Pacific Insurance Group Co Ltd |
|
|
237,703 |
|
|
1,977,083 |
|
|
China Petroleum & Chemical Corp Class H |
|
|
2,093,409 |
|
|
24,000 |
|
|
China Resources Cement Holdings Ltd |
|
|
17,929 |
|
|
149,000 |
|
|
China Shenhua Energy Co Ltd Class H |
|
|
657,687 |
|
|
2,221,900 |
|
|
China Telecom Corp Ltd Class H |
|
|
1,357,050 |
|
|
308,000 |
|
|
China Unicom Hong Kong Ltd |
|
|
668,686 |
|
|
10,300 |
|
|
China Unicom Hong Kong Ltd ADR |
|
|
222,171 |
|
|
31,000 |
|
|
China Yurun Food Group Ltd |
|
|
44,807 |
|
|
141,200 |
|
|
Citic Pacific Ltd |
|
|
268,243 |
|
|
37,000 |
|
|
CNOOC Ltd |
|
|
71,774 |
|
|
780 |
|
|
CNOOC Ltd ADR |
|
|
150,790 |
|
|
32,000 |
|
|
Cosco Pacific Ltd |
|
|
37,745 |
|
|
499,000 |
|
|
Country Garden Holdings Co |
|
|
178,621 |
|
|
244,000 |
|
|
Dongfeng Motor Group Co Ltd Class H |
|
|
366,471 |
|
|
79,000 |
|
|
Evergrande Real Estate Group Ltd |
|
|
33,041 |
|
|
67,000 |
|
|
Foxconn International Holdings Ltd * |
|
|
42,802 |
|
|
749,000 |
|
|
GOME Electrical Appliances Holdings Ltd |
|
|
192,388 |
|
|
82,500 |
|
|
Great Wall Motor Co Ltd Class H |
|
|
118,818 |
|
|
46,000 |
|
|
Guangzhou R&F Properties Co Ltd Class H |
|
|
38,231 |
|
|
45,000 |
|
|
Haitian International Holdings Ltd |
|
|
39,020 |
|
|
38,500 |
|
|
Hengan International Group Co Ltd |
|
|
362,718 |
|
|
1,000 |
|
|
Home Inns & Hotels Management Inc ADR * |
|
|
31,060 |
|
|
318,000 |
|
|
Hopson Development Holdings Ltd |
|
|
191,179 |
|
|
1,144,000 |
|
|
Industrial and Commercial Bank of China Ltd Class H |
|
|
667,022 |
|
|
3,400 |
|
|
Inner Mongolia Yitai Coal Co Class B |
|
|
18,089 |
|
|
67,000 |
|
|
Intime Department Store Group Co Ltd |
|
|
78,672 |
|
|
12,000 |
|
|
Jiangxi Copper Co Ltd Class H |
|
|
28,508 |
|
|
244,000 |
|
|
Kingdee International Software Group Co Ltd |
|
|
83,003 |
|
|
112,000 |
|
|
Kunlun Energy Company Ltd |
|
|
151,590 |
|
|
32,000 |
|
|
Lenovo Group Ltd |
|
|
22,811 |
|
|
18,500 |
|
|
Longfor Properties |
|
|
21,931 |
|
|
1,200 |
|
|
Netease.Com Inc ADR * |
|
|
54,108 |
|
|
6,000 |
|
|
New Oriental Education & Technology Group Inc Sponsored ADR * |
|
|
151,440 |
|
|
1,000 |
|
|
PetroChina Co Ltd ADR |
|
|
130,750 |
|
|
463,553 |
|
|
PetroChina Co Ltd Class H |
|
|
601,952 |
|
|
406,000 |
|
|
PICC Property & Casualty Co Ltd Class H |
|
|
550,214 |
|
|
25,000 |
|
|
Shanghai Industrial Holdings Ltd |
|
|
67,917 |
|
|
102,251 |
|
|
Sino-Ocean Land Holdings Ltd |
|
|
40,824 |
|
|
90,000 |
|
|
Tingyi (Cayman Islands) Holding Corp |
|
|
292,805 |
|
|
240,000 |
|
|
Yangzijiang Shipbuilding Holdings Ltd |
|
|
172,871 |
|
|
64,000 |
|
|
Zijin Mining Group Co Ltd Class H |
|
|
28,607 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total China |
|
|
19,584,936 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Czech Republic 1.6% |
|
|
|
|
|
40,558 |
|
|
CEZ AS |
|
|
1,601,264 |
|
|
3,116 |
|
|
Komercni Banka AS |
|
|
515,102 |
|
|
3,575 |
|
|
Pegas Nonwovens SA |
|
|
85,292 |
|
|
356 |
|
|
Philip Morris CR AS |
|
|
231,286 |
|
|
8,365 |
|
|
Telefonica 02 Czech Republic AS |
|
|
175,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Czech Republic |
|
|
2,607,992 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt 1.4% |
|
|
|
|
|
14,835 |
|
|
Alexandria Mineral Oils Co |
|
|
159,529 |
|
|
59,003 |
|
|
Commercial International Bank |
|
|
235,782 |
|
|
2,693 |
|
|
EFG-Hermes Holding GDR * |
|
|
9,702 |
|
|
10,010 |
|
|
EFG-Hermes Holding SAE * |
|
|
18,365 |
|
|
8,394 |
|
|
Egyptian Co for Mobile Services |
|
|
136,507 |
|
|
60,139 |
|
|
Egyptian Kuwaiti Holding Co SAE |
|
|
62,380 |
|
|
36,806 |
|
|
ElSwedy Electric Co |
|
|
134,228 |
|
|
10,381 |
|
|
Orascom Construction Industries |
|
|
382,182 |
|
|
136,655 |
|
|
Orascom Telecom Holding SAE * |
|
|
67,744 |
|
|
104,741 |
|
|
Orascom Telecom Holding SAE GDR (Registered Shares) * |
|
|
273,307 |
|
|
19,791 |
|
|
Oriental Weavers Co |
|
|
99,700 |
|
|
40,877 |
|
|
Sidi Kerir Petrochemicals Co |
|
|
84,941 |
|
|
131,908 |
|
|
South Valley Cement |
|
|
76,402 |
|
|
188,467 |
|
|
Talaat Moustafa Group * |
|
|
117,517 |
|
|
181,129 |
|
|
Telecom Egypt |
|
|
423,721 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Egypt |
|
|
2,282,007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hungary 1.2% |
|
|
|
|
|
1,327 |
|
|
Egis Gyogyszergyar Nyrt |
|
|
108,774 |
|
|
123,215 |
|
|
Magyar Telekom Nyrt |
|
|
282,078 |
|
|
2,489 |
|
|
MOL Hungarian Oil and Gas Nyrt * |
|
|
207,180 |
|
|
79,889 |
|
|
OTP Bank Nyrt |
|
|
1,186,633 |
|
|
441 |
|
|
Richter Gedeon Nyrt |
|
|
66,481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hungary |
|
|
1,851,146 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 5.0% |
|
|
|
|
|
3,256 |
|
|
ACC Ltd |
|
|
72,280 |
|
|
24,159 |
|
|
Ambuja Cements Ltd |
|
|
70,200 |
|
|
1,493 |
|
|
Asian Paints Ltd |
|
|
83,043 |
|
|
30,368 |
|
|
Aurobindo Pharma Ltd |
|
|
54,479 |
|
|
2,417 |
|
|
Bajaj Auto Ltd |
|
|
78,902 |
|
|
4,253 |
|
|
Bank of Baroda (a) |
|
|
58,171 |
|
|
7,966 |
|
|
Bank of India |
|
|
50,691 |
|
|
2,359 |
|
|
Bharat Petroleum Corp Ltd |
|
|
24,339 |
|
|
29,275 |
|
|
Bharti Airtel Ltd |
|
|
215,810 |
|
|
9,683 |
|
|
Cairn India Ltd * |
|
|
57,154 |
|
|
11,777 |
|
|
Canara Bank Ltd |
|
|
98,602 |
|
|
20,228 |
|
|
Coal India Ltd |
|
|
128,869 |
|
|
10,740 |
|
|
Coromandel International Ltd |
|
|
59,556 |
|
|
39,899 |
|
|
Dish TV India Ltd * |
|
|
49,896 |
|
|
24,902 |
|
|
Essar Oil Ltd * |
|
|
33,567 |
|
|
17,981 |
|
|
GAIL India Ltd |
|
|
138,384 |
|
|
7,560 |
|
|
Grasim Industries Ltd (a) |
|
|
354,366 |
|
|
4,278 |
|
|
HCL Technologies Ltd |
|
|
32,677 |
|
|
13,917 |
|
|
HDFC Bank Ltd |
|
|
120,880 |
|
|
3,100 |
|
|
HDFC Bank Ltd ADR |
|
|
85,746 |
|
|
5,575 |
|
|
Hero Honda Motors Ltd |
|
|
218,089 |
|
|
13,048 |
|
|
Hindalco Industries Ltd |
|
|
31,781 |
|
|
9,596 |
|
|
Hindustan Petroleum Corp Ltd |
|
|
51,155 |
|
|
2,397 |
|
|
Hindustan Unilever Ltd |
|
|
18,280 |
|
|
38,197 |
|
|
Hindustan Zinc Ltd |
|
|
89,638 |
|
|
|
|
|
|
|
|
|
|
|
110,349 |
|
|
Idea Cellular Ltd * |
|
|
203,650 |
|
|
11,609 |
|
|
Indian Oil Corp Ltd |
|
|
58,095 |
|
|
13,773 |
|
|
Indraprastha Gas Ltd |
|
|
106,809 |
|
|
14,642 |
|
|
IndusInd Bank Ltd (a) |
|
|
70,865 |
|
|
9,423 |
|
|
Infosys Technologies Ltd |
|
|
482,827 |
|
|
7,960 |
|
|
Infosys Technologies Ltd Sponsored ADR |
|
|
410,895 |
|
|
2,737 |
|
|
JSW Steel Ltd |
|
|
31,508 |
|
|
3,955 |
|
|
Jubilant Foodworks Ltd * |
|
|
59,456 |
|
|
2,540 |
|
|
Kotak Mahindra Bank Ltd |
|
|
23,152 |
|
|
2,204 |
|
|
Lupin Ltd |
|
|
20,260 |
|
|
12,017 |
|
|
Mahindra & Mahindra Ltd |
|
|
171,293 |
|
|
2,415 |
|
|
Maruti Suzuki India Ltd |
|
|
45,874 |
|
|
24,090 |
|
|
Mphasis Ltd |
|
|
151,013 |
|
|
1,021 |
|
|
Nestle India Ltd |
|
|
82,979 |
|
|
67,909 |
|
|
NHPC Ltd |
|
|
29,561 |
|
|
38,117 |
|
|
NTPC Ltd |
|
|
121,076 |
|
|
102,832 |
|
|
Oil & Natural Gas Corp Ltd |
|
|
534,714 |
|
|
29,699 |
|
|
Petronet LNG Ltd |
|
|
94,154 |
|
|
66,557 |
|
|
Power Grid Corp of India Ltd |
|
|
127,955 |
|
|
4,152 |
|
|
Punjab National Bank Ltd (a) |
|
|
72,006 |
|
|
16,249 |
|
|
Rallis India Ltd |
|
|
47,597 |
|
|
13,124 |
|
|
Reliance Industries Ltd |
|
|
201,181 |
|
|
1,402 |
|
|
Reliance Industries Ltd Sponsored GDR, 144A |
|
|
42,233 |
|
|
26,977 |
|
|
Rural Electrification Corp Ltd |
|
|
97,143 |
|
|
106,932 |
|
|
Sesa Goa Ltd |
|
|
387,309 |
|
|
74,708 |
|
|
Shree Renuka Sugars Ltd |
|
|
44,244 |
|
|
2,732 |
|
|
State Bank of India |
|
|
92,878 |
|
|
48,007 |
|
|
Steel Authority of India Ltd |
|
|
75,637 |
|
|
100,275 |
|
|
Sterlite Industries India Ltd |
|
|
197,666 |
|
|
2,200 |
|
|
Sterlite Industries India Ltd ADR |
|
|
17,732 |
|
|
8,768 |
|
|
Sun TV Network Ltd |
|
|
44,677 |
|
|
26,707 |
|
|
Tata Consultancy Services Ltd |
|
|
582,353 |
|
|
69,520 |
|
|
Tata Motors Ltd |
|
|
238,317 |
|
|
4,800 |
|
|
Tata Motors Ltd Sponsored ADR |
|
|
82,560 |
|
|
73,428 |
|
|
Tata Power Co Ltd |
|
|
131,979 |
|
|
28,073 |
|
|
Tata Steel Ltd |
|
|
210,389 |
|
|
2,051 |
|
|
Ultratech Cement Ltd |
|
|
45,423 |
|
|
12,498 |
|
|
Union Bank of India |
|
|
51,114 |
|
|
16,547 |
|
|
Wipro Ltd |
|
|
123,290 |
|
|
7,900 |
|
|
Wipro Ltd ADR |
|
|
75,840 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total India |
|
|
7,964,259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 6.4% |
|
|
|
|
|
498,500 |
|
|
Astra International Tbk PT |
|
|
4,004,063 |
|
|
285,000 |
|
|
Bank Central Asia Tbk PT |
|
|
254,057 |
|
|
664,621 |
|
|
Bank Danamon Indonesia Tbk PT |
|
|
328,689 |
|
|
1,556,672 |
|
|
Bank Mandiri Tbk PT |
|
|
1,133,817 |
|
|
465,000 |
|
|
Bank Negara Indonesia (Persero) Tbk PT |
|
|
200,123 |
|
|
1,321,500 |
|
|
Bank Rakyat Tbk PT |
|
|
978,644 |
|
|
83,500 |
|
|
Bumi Resources Tbk PT |
|
|
19,292 |
|
|
3,000 |
|
|
Gudang Garam Tbk PT |
|
|
21,947 |
|
|
392,500 |
|
|
Indofood Sukses Makmur Tbk PT |
|
|
209,663 |
|
|
90,500 |
|
|
Indosat Tbk PT |
|
|
54,632 |
|
|
116,000 |
|
|
Jasa Marga PT |
|
|
50,517 |
|
|
661,000 |
|
|
Kalbe Farma Tbk PT |
|
|
261,554 |
|
|
948,000 |
|
|
Perusahaan Gas Negara PT |
|
|
329,270 |
|
|
139,500 |
|
|
Tambang Batubara Bukit Asam Tbk PT |
|
|
268,585 |
|
|
935,000 |
|
|
Telekomunikasi Indonesia Tbk PT |
|
|
766,223 |
|
|
9,800 |
|
|
Telekomunikasi Indonesia Tbk PT Sponsored ADR |
|
|
320,950 |
|
|
399,575 |
|
|
United Tractors Tbk PT |
|
|
1,053,842 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
10,255,868 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 0.5% |
|
|
|
|
|
25,000 |
|
|
AirAsia Berhad |
|
|
29,915 |
|
|
156,680 |
|
|
AMMB Holdings Berhad |
|
|
298,014 |
|
|
40,160 |
|
|
Genting Berhad |
|
|
141,536 |
|
|
39,800 |
|
|
Genting Malaysia Berhad |
|
|
50,138 |
|
|
56,083 |
|
|
Hong Leong Bank Berhad |
|
|
186,379 |
|
|
64,900 |
|
|
Landmarks Berhad * |
|
|
22,984 |
|
|
33,200 |
|
|
Petronas Chemicals Group Bhd |
|
|
63,971 |
|
|
16,500 |
|
|
Sime Darby Berhad |
|
|
47,359 |
|
|
19 |
|
|
UMW Holdings Berhad |
|
|
40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Malaysia |
|
|
840,336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexico 1.3% |
|
|
|
|
|
202,100 |
|
|
America Movil SAB de CV Class L |
|
|
240,550 |
|
|
61,140 |
|
|
America Movil SAB de CV Class L ADR |
|
|
1,456,355 |
|
|
220 |
|
|
Grupo Elektra SA de CV |
|
|
21,458 |
|
|
15,900 |
|
|
Grupo Financiero Banorte SAB de CV Class O |
|
|
53,814 |
|
|
10,300 |
|
|
Grupo Financiero Inbursa, SAB de CV |
|
|
19,254 |
|
|
1,400 |
|
|
Grupo Televisa SA Sponsored ADR |
|
|
29,064 |
|
|
59,000 |
|
|
Grupo Televisa SA-Series CPO |
|
|
245,766 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Mexico |
|
|
2,066,261 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Morocco 0.3% |
|
|
|
|
|
537 |
|
|
Attijariwafa Bank |
|
|
23,198 |
|
|
27,286 |
|
|
Maroc Telecom |
|
|
463,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Morocco |
|
|
486,258 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 1.2% |
|
|
|
|
|
281,000 |
|
|
Alliance Global Group Inc |
|
|
67,084 |
|
|
76,380 |
|
|
BDO Unibank Inc |
|
|
98,157 |
|
|
2,118,500 |
|
|
Lopez Holding Corp |
|
|
225,283 |
|
|
107,617 |
|
|
Metropolitan Bank & Trust Co |
|
|
166,420 |
|
|
15,345 |
|
|
Philippine Long Distance Telephone Co |
|
|
852,577 |
|
|
7,390 |
|
|
Philippine Long Distance Telephone Co Sponsored ADR |
|
|
407,928 |
|
|
60,000 |
|
|
Universal Robina Corp |
|
|
69,385 |
|
|
315,000 |
|
|
Vista Land & Lifescapes Inc |
|
|
21,206 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Philippines |
|
|
1,908,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland 1.8% |
|
|
|
|
|
4,932 |
|
|
Asseco Poland SA |
|
|
73,215 |
|
|
14,125 |
|
|
Grupa Lotos SA * |
|
|
106,314 |
|
|
39,011 |
|
|
KGHM Polska Miedz SA |
|
|
1,550,366 |
|
|
29,648 |
|
|
PGE SA |
|
|
189,854 |
|
|
8,632 |
|
|
Polski Koncern Naftowy Orlen SA * |
|
|
104,016 |
|
|
91,363 |
|
|
Polskie Gornictwo Naftowe i Gazownictwo SA |
|
|
112,425 |
|
|
187,714 |
|
|
Tauron Polska Energia SA |
|
|
304,713 |
|
|
83,774 |
|
|
Telekomunikacja Polska SA |
|
|
462,956 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Poland |
|
|
2,903,859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 11.2% |
|
|
|
|
|
1,625 |
|
|
Eurasia Drilling Co Ltd GDR |
|
|
42,546 |
|
|
66,025 |
|
|
Gazprom Neft Class S |
|
|
308,517 |
|
|
6,614 |
|
|
Gazprom Neft JSC Sponsored ADR |
|
|
151,521 |
|
|
417,668 |
|
|
Gazprom OAO Sponsored ADR |
|
|
4,829,635 |
|
|
46,022 |
|
|
KamAZ * |
|
|
60,685 |
|
|
63,111 |
|
|
Lukoil OAO ADR |
|
|
3,553,646 |
|
|
26,176 |
|
|
Magnit OJSC Sponsored GDR |
|
|
582,088 |
|
|
21,347 |
|
|
Magnitogorsk Iron & Steel Works Sponsored GDR (Registered Shares) |
|
|
133,659 |
|
|
12,347 |
|
|
Mail.ru Group Ltd GDR (Registered Shares) * |
|
|
382,219 |
|
|
24,490 |
|
|
Mechel Sponsored ADR |
|
|
266,696 |
|
|
|
|
|
|
|
|
|
|
|
22,901 |
|
|
MMC Norilsk Nickel JSC ADR |
|
|
404,368 |
|
|
22,400 |
|
|
Mobile Telesystems Sponsored ADR |
|
|
387,072 |
|
|
4,392 |
|
|
NovaTek OAO Sponsored GDR (Registered Shares) |
|
|
672,885 |
|
|
36,018 |
|
|
OAO Tatneft Sponsored GDR (Registered Shares) |
|
|
1,166,372 |
|
|
241,202 |
|
|
Rosneft OJSC GDR (Registered Shares) |
|
|
1,765,249 |
|
|
37,343 |
|
|
Rostelecom * |
|
|
196,573 |
|
|
58,663 |
|
|
Sberbank
Sponsored ADR *(a) |
|
|
713,672 |
|
|
7,823 |
|
|
Sistema JSFC Sponsored GDR (Registered Shares) |
|
|
156,869 |
|
|
184,231 |
|
|
Surgutneftegas Sponsored ADR |
|
|
1,770,849 |
|
|
10,005 |
|
|
Uralkali Sponsored GDR (Registered Shares) |
|
|
406,492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
17,951,613 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Africa 3.6% |
|
|
|
|
|
23,064 |
|
|
Absa Group Ltd |
|
|
409,282 |
|
|
4,200 |
|
|
African Rainbow Minerals Ltd |
|
|
93,661 |
|
|
3,747 |
|
|
AngloGold Ashanti Ltd |
|
|
177,519 |
|
|
70,253 |
|
|
Aveng Ltd |
|
|
308,747 |
|
|
6,399 |
|
|
Bidvest Group Ltd |
|
|
124,769 |
|
|
12,743 |
|
|
Exxaro Resources Ltd |
|
|
284,400 |
|
|
173,951 |
|
|
FirstRand Ltd |
|
|
432,233 |
|
|
916 |
|
|
Gold Fields Ltd |
|
|
15,435 |
|
|
3,200 |
|
|
Gold Fields Ltd Sponsored ADR |
|
|
54,208 |
|
|
68,039 |
|
|
Growthpoint Properties Ltd |
|
|
154,478 |
|
|
4,362 |
|
|
Kumba Iron Ore Ltd |
|
|
274,772 |
|
|
19,606 |
|
|
MTN Group Ltd |
|
|
353,186 |
|
|
14,408 |
|
|
Murray & Roberts Holdings Ltd * |
|
|
44,738 |
|
|
13,324 |
|
|
Nedbank Group Ltd |
|
|
236,399 |
|
|
18,793 |
|
|
Remgro Ltd |
|
|
283,569 |
|
|
46,523 |
|
|
RMB Holdings Ltd |
|
|
151,042 |
|
|
30,981 |
|
|
Sanlam Ltd |
|
|
114,867 |
|
|
11,833 |
|
|
Sasol Ltd |
|
|
567,673 |
|
|
800 |
|
|
Sasol Ltd Sponsored ADR |
|
|
38,328 |
|
|
20,736 |
|
|
Shoprite Holdings Ltd |
|
|
350,019 |
|
|
2,840 |
|
|
Standard Bank Group Ltd |
|
|
34,636 |
|
|
19,457 |
|
|
Steinhoff International Holdings Ltd * |
|
|
56,999 |
|
|
97,361 |
|
|
Telkom South Africa Ltd |
|
|
348,906 |
|
|
5,617 |
|
|
Tiger Brands Ltd |
|
|
170,130 |
|
|
35,585 |
|
|
Vodacom Group Ltd |
|
|
402,392 |
|
|
9,670 |
|
|
Wilson Bayly Holmes-Ovcon Ltd |
|
|
125,807 |
|
|
42,121 |
|
|
Woolworths Holdings Ltd |
|
|
210,606 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Africa |
|
|
5,818,801 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 12.7% |
|
|
|
|
|
9 |
|
|
BS Financial Group Inc * |
|
|
94 |
|
|
14,187 |
|
|
Celltrion Inc |
|
|
470,480 |
|
|
609 |
|
|
CJ CheilJedang Corp |
|
|
156,120 |
|
|
1,200 |
|
|
Daewoo International Corp |
|
|
29,876 |
|
|
1,920 |
|
|
Daewoo Shipbuilding & Marine Engineering Co Ltd |
|
|
51,517 |
|
|
21,162 |
|
|
DGB Financial Group Inc * |
|
|
249,256 |
|
|
5,318 |
|
|
Dongbu Insurance Co Ltd |
|
|
245,084 |
|
|
548 |
|
|
Doosan Heavy Industries and Construction Co |
|
|
32,597 |
|
|
312 |
|
|
E-Mart Co Ltd * |
|
|
80,954 |
|
|
259 |
|
|
GLOVIS Co Ltd |
|
|
51,501 |
|
|
895 |
|
|
GS Home Shopping Inc |
|
|
85,636 |
|
|
17,932 |
|
|
Hana Financial Group Inc |
|
|
648,722 |
|
|
12,547 |
|
|
Hanwha Corp |
|
|
410,551 |
|
|
3,149 |
|
|
Hyosung Corp |
|
|
177,282 |
|
|
1,841 |
|
|
Hyundai Heavy Industries Co Ltd |
|
|
459,316 |
|
|
7,167 |
|
|
Hyundai Hysco |
|
|
271,054 |
|
|
2,306 |
|
|
Hyundai Mobis |
|
|
639,479 |
|
|
4,362 |
|
|
Hyundai Motor Co |
|
|
848,479 |
|
|
|
|
|
|
|
|
|
|
|
3,491 |
|
|
Hyundai Steel Co |
|
|
309,903 |
|
|
42,525 |
|
|
Industrial Bank of Korea |
|
|
565,329 |
|
|
9,737 |
|
|
INTOPS Co Ltd |
|
|
179,412 |
|
|
10,558 |
|
|
Kangwon Land Inc |
|
|
260,240 |
|
|
3,324 |
|
|
Kia Motors Corp |
|
|
211,463 |
|
|
86,960 |
|
|
Korea Exchange Bank |
|
|
635,508 |
|
|
1,216 |
|
|
Korea Investment Holdings Co Ltd |
|
|
40,861 |
|
|
642 |
|
|
Korea Zinc Co Ltd |
|
|
197,887 |
|
|
6,000 |
|
|
KT Corp |
|
|
192,152 |
|
|
21,100 |
|
|
KT Corp Sponsored ADR |
|
|
338,655 |
|
|
18,627 |
|
|
KT&G Corp |
|
|
1,260,614 |
|
|
59,208 |
|
|
LG Uplus Corp |
|
|
353,980 |
|
|
133 |
|
|
Lotte Shopping Co Ltd |
|
|
41,932 |
|
|
1,128 |
|
|
NCSoft Corp |
|
|
306,939 |
|
|
1,000 |
|
|
NHN Corp * |
|
|
221,854 |
|
|
444 |
|
|
OCI Company Ltd |
|
|
93,664 |
|
|
150 |
|
|
ORION Corp |
|
|
81,060 |
|
|
5,474 |
|
|
POSCO |
|
|
1,844,885 |
|
|
577 |
|
|
POSCO ADR |
|
|
49,420 |
|
|
47,580 |
|
|
Samho International Co Ltd * |
|
|
78,719 |
|
|
718 |
|
|
Samsung C&T Corp |
|
|
43,354 |
|
|
4,442 |
|
|
Samsung Electronics Co Ltd |
|
|
4,042,752 |
|
|
3,041 |
|
|
Samsung Fire & Marine Insurance Co Ltd |
|
|
599,911 |
|
|
2,078 |
|
|
Samsung Life Insurance Co Ltd |
|
|
154,776 |
|
|
17,657 |
|
|
Shinhan Financial Group Co Ltd |
|
|
658,306 |
|
|
595 |
|
|
Shinsegae Co Ltd |
|
|
127,992 |
|
|
3,763 |
|
|
SK C&C Co Ltd |
|
|
462,463 |
|
|
3,018 |
|
|
SK Telecom Co Ltd |
|
|
404,406 |
|
|
72,839 |
|
|
SK Telecom Co Ltd ADR |
|
|
1,077,289 |
|
|
226 |
|
|
SK Holdings Co Ltd |
|
|
29,438 |
|
|
68,986 |
|
|
Woori Finance Holdings Co Ltd |
|
|
618,063 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
20,391,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sri Lanka 0.1% |
|
|
|
|
|
131,522 |
|
|
Hatton National Bank Plc |
|
|
177,701 |
|
|
10,386 |
|
|
Hatton National Bank Plc (Non Voting) |
|
|
7,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sri Lanka |
|
|
185,452 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 6.6% |
|
|
|
|
|
130,660 |
|
|
Asia Cement Corp |
|
|
144,455 |
|
|
131,871 |
|
|
Asustek Computer Inc |
|
|
921,398 |
|
|
78,400 |
|
|
Catcher Technology Co Ltd |
|
|
383,103 |
|
|
371,594 |
|
|
Chunghwa Telecom Co Ltd |
|
|
1,231,791 |
|
|
4,289 |
|
|
Chunghwa Telecom Co Ltd ADR |
|
|
143,381 |
|
|
1,308,577 |
|
|
Compal Electronics Inc |
|
|
1,193,644 |
|
|
325,314 |
|
|
Far Eastone Telecommunications Co Ltd |
|
|
619,760 |
|
|
46,000 |
|
|
Formosa Chemicals & Fibre Co |
|
|
120,968 |
|
|
17,092 |
|
|
Fubon Financial Holding Co Ltd |
|
|
17,815 |
|
|
28,091 |
|
|
Hon Hai Precision Industry Co Ltd |
|
|
76,393 |
|
|
4,772 |
|
|
HTC Corp |
|
|
78,564 |
|
|
263,000 |
|
|
Innolux Display Corp * |
|
|
113,396 |
|
|
287,353 |
|
|
Lite-On Technology Corp |
|
|
314,907 |
|
|
52,000 |
|
|
MediaTek Inc |
|
|
496,248 |
|
|
117,289 |
|
|
Nan Ya Plastics Corp |
|
|
218,433 |
|
|
50,793 |
|
|
Novatek Microelectronics Corp Ltd |
|
|
127,930 |
|
|
147,100 |
|
|
Powertech Technology Inc |
|
|
335,283 |
|
|
830,200 |
|
|
ProMOS Technologies Inc * |
|
|
9,306 |
|
|
542,715 |
|
|
Quanta Computer Inc |
|
|
1,092,341 |
|
|
134,880 |
|
|
Taishin Financial Holding Co Ltd |
|
|
50,289 |
|
|
12,000 |
|
|
Taiwan Cement Corp |
|
|
13,349 |
|
|
186,928 |
|
|
Taiwan Mobile Co Ltd |
|
|
601,534 |
|
|
|
|
|
|
|
|
|
|
|
295,660 |
|
|
Taiwan Semiconductor Manufacturing Co Ltd |
|
|
741,223 |
|
|
13,289 |
|
|
TPK Holding Co Ltd * |
|
|
182,028 |
|
|
1,202,000 |
|
|
United Microelectronics Corp |
|
|
533,361 |
|
|
20,400 |
|
|
United Microelectronics Corp Sponsored ADR |
|
|
46,716 |
|
|
581,395 |
|
|
Wistron Corp |
|
|
732,054 |
|
|
13,000 |
|
|
Yungtay Engineering Co Ltd |
|
|
19,726 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Taiwan |
|
|
10,559,396 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 3.7% |
|
|
|
|
|
199,890 |
|
|
Advanced Info Service Pcl (Foreign Registered) (a) |
|
|
912,071 |
|
|
500,488 |
|
|
Asian Property Development Pcl (Foreign Registered) (a) |
|
|
79,796 |
|
|
13,000 |
|
|
Bangkok Bank Pcl (Foreign Registered) (a) |
|
|
67,515 |
|
|
34,950 |
|
|
Bangkok Bank Pcl NVDR |
|
|
166,578 |
|
|
211,200 |
|
|
Bangkok Dusit Medical Service Pcl (Foreign Registered) (a) |
|
|
515,402 |
|
|
6,950 |
|
|
Banpu Pcl (Foreign Registered) (a) |
|
|
124,561 |
|
|
91,200 |
|
|
BEC World Pcl (Foreign Registered) (a) |
|
|
116,675 |
|
|
248,500 |
|
|
Charoen Pokphand Foods Pcl (Foreign Registered) (a) |
|
|
268,634 |
|
|
102,700 |
|
|
CP ALL Pcl (Foreign Registered) (a) |
|
|
168,115 |
|
|
121,900 |
|
|
Electricity Generating Pcl (Foreign Registered) (a) |
|
|
348,575 |
|
|
1,463,400 |
|
|
Hemaraj Land and Development Pcl (Foreign Registered) (a) |
|
|
107,273 |
|
|
716,200 |
|
|
Home Product Center Pcl (Foreign Registered) (a) |
|
|
238,682 |
|
|
620,300 |
|
|
IRPC Pcl (Foreign Registered) (a) |
|
|
79,742 |
|
|
57,910 |
|
|
Kasikornbank Pcl (Foreign Registered) (a) |
|
|
225,343 |
|
|
69,900 |
|
|
Kasikornbank Pcl NVDR |
|
|
269,694 |
|
|
222,000 |
|
|
Land & Houses Pcl NVDR |
|
|
43,597 |
|
|
25,297 |
|
|
PTT Global Chemical Pcl NVDR * (a) |
|
|
53,159 |
|
|
98,922 |
|
|
PTT Pcl (Foreign Registered) (a) |
|
|
995,790 |
|
|
32,500 |
|
|
Robinson Department Store Pcl (Foreign Registered) (a) |
|
|
38,665 |
|
|
46,939 |
|
|
Siam Cement Pcl (Foreign Registered) (a) |
|
|
549,412 |
|
|
2,800 |
|
|
Siam Cement Pcl NVDR |
|
|
28,999 |
|
|
64,450 |
|
|
Siam Commercial Bank Pcl (Foreign Registered) (a) |
|
|
230,334 |
|
|
8,000 |
|
|
Siam Makro Pcl (Foreign Registered) (a) |
|
|
59,316 |
|
|
202,200 |
|
|
Thai Tap Water Supply Pcl (Foreign Registered) (a) |
|
|
34,460 |
|
|
65,300 |
|
|
Thanachart Capital Pcl (Foreign Registered) (a) |
|
|
53,702 |
|
|
23,100 |
|
|
Tisco Financial Group Pcl (Foreign Registered) (a) |
|
|
29,375 |
|
|
50,050 |
|
|
Total Access Communication Pcl (Foreign Registered) (a) |
|
|
129,884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Thailand |
|
|
5,935,349 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turkey 2.6% |
|
|
|
|
|
13,109 |
|
|
Akbank TAS |
|
|
46,390 |
|
|
102,737 |
|
|
Arcelik AS |
|
|
348,028 |
|
|
32,902 |
|
|
Enka Insaat ve Sanayi AS |
|
|
81,633 |
|
|
267,558 |
|
|
Eregli Demir ve Celik Fabrikalari TAS |
|
|
500,593 |
|
|
49,107 |
|
|
Haci Omer Sabanci Holding AS |
|
|
154,980 |
|
|
118,803 |
|
|
Koc Holding AS |
|
|
411,387 |
|
|
18,689 |
|
|
Tupras-Turkiye Petrol Rafineriler AS |
|
|
427,864 |
|
|
136,620 |
|
|
Turk Telekomunikasyon AS |
|
|
562,279 |
|
|
81,324 |
|
|
Turkcell Iletisim Hizmet AS * |
|
|
406,554 |
|
|
141,044 |
|
|
Turkiye Garanti Bankasi |
|
|
483,173 |
|
|
44,808 |
|
|
Turkiye IS Bankasi Class C |
|
|
92,802 |
|
|
63,636 |
|
|
Turkiye Sise ve Cam Fabrikalari AS |
|
|
107,638 |
|
|
76,671 |
|
|
Turkiye Vakiflar Bankasi TAO Class D |
|
|
113,835 |
|
|
54,724 |
|
|
Turkiye Halk Bankasi AS |
|
|
331,042 |
|
|
36,579 |
|
|
Yapi ve Kredi Bankasi AS * |
|
|
61,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Turkey |
|
|
4,129,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $149,184,453) |
|
|
136,776,380 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 11.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 8.5% |
|
|
|
|
|
12,900 |
|
|
AES Tiete SA 11.00% |
|
|
175,843 |
|
|
93,949 |
|
|
Banco Bradesco SA 0.62% |
|
|
1,539,364 |
|
|
37,500 |
|
|
Banco do Estado do Rio Grande do Sul SA Class B 0.59% |
|
|
400,019 |
|
|
23,700 |
|
|
Bradespar SA 0.03% |
|
|
434,460 |
|
|
10,200 |
|
|
Brasil Telecom SA 2.70% |
|
|
60,917 |
|
|
42,100 |
|
|
Centrais Eletricas Brasileiras SA Class B 6.98% |
|
|
548,032 |
|
|
3,700 |
|
|
Companhia Paranaense de Energia Class B 0.85% |
|
|
74,661 |
|
|
23,900 |
|
|
Eletropaulo Metropolitana SA 10.99% |
|
|
432,839 |
|
|
116,952 |
|
|
Itausa-Investimentos Itau SA 0.51% |
|
|
682,304 |
|
|
46,800 |
|
|
Klabin SA 2.65% |
|
|
186,853 |
|
|
2,000 |
|
|
Lojas Americanas SA 0.43% |
|
|
16,700 |
|
|
49,600 |
|
|
Metalurgica Gerdau SA 4.34% |
|
|
469,573 |
|
|
10,524 |
|
|
Petroleo Brasileiro SA (Petrobras) 0.56% |
|
|
128,324 |
|
|
124,690 |
|
|
Petroleo Brasileiro SA Sponsored ADR 0.60% |
|
|
3,125,978 |
|
|
45,500 |
|
|
Tele Norte Leste Participacoes ADR 5.35% |
|
|
430,430 |
|
|
54,900 |
|
|
Usinas Siderrurgicas de Minas Gerais SA Class A 3.15% |
|
|
314,521 |
|
|
11,100 |
|
|
Vale Fertilizantes SA 0.44% |
|
|
151,859 |
|
|
10,756 |
|
|
Vale SA Class A 0.98% |
|
|
232,149 |
|
|
194,130 |
|
|
Vale SA Sponsored ADR 2.10% |
|
|
4,245,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
13,650,449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chile 0.0% |
|
|
|
|
|
3,380 |
|
|
Embotelladora Andina SA B Shares 1.86% |
|
|
15,076 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 1.9% |
|
|
|
|
|
2,932,141 |
|
|
Surgutneftegaz Class S 7.78% |
|
|
1,604,051 |
|
|
845 |
|
|
Transneft 0.70% |
|
|
1,393,464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
2,997,515 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 1.3% |
|
|
|
|
|
6,794 |
|
|
Hyundai Motor Co 2.29% |
|
|
423,550 |
|
|
3,032 |
|
|
Samsung Electronics Co Ltd (Non Voting) 0.86% |
|
|
1,690,682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
2,114,232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $19,763,586) |
|
|
18,777,272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.6% |
|
|
|
|
|
61,234 |
|
|
Vanguard Emerging Markets ETF (b) |
|
|
2,498,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $2,391,343) |
|
|
2,498,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
78,090 |
|
|
GMO U.S. Treasury Fund |
|
|
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $1,953,021) |
|
|
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.6% |
|
|
|
|
USD 200,000 |
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
200,000 |
|
|
|
|
|
|
|
|
|
|
|
EUR |
7 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%,
due 12/01/11 |
|
|
9 |
|
|
HKD |
18,087 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%,
due 12/01/11 |
|
|
2,328 |
|
|
USD |
5,605 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.03%, due 12/01/11 |
|
|
5,605 |
|
|
ZAR |
1,373,305 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 4.85%, due 12/01/11 |
|
|
169,257 |
|
|
USD |
200,000 |
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
200,000 |
|
|
USD |
200,000 |
|
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
200,000 |
|
|
USD |
200,000 |
|
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
200,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
977,199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $977,199) |
|
|
977,199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.4%
(Cost $174,269,602) |
|
|
160,982,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.4%) |
|
|
(671,561 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
160,310,659 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments: |
|
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities
may be resold in transactions exempt from registration, normally to qualified institutional investors. |
|
ADR American Depositary Receipt |
|
CPO Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a bundle of
shares of the multiple series of one issuer that trade together as a unit. |
|
ETF Exchange-Traded Fund |
|
Foreign Registered Shares issued to foreign investors in markets that have foreign ownership limits. |
|
GDR Global Depository Receipt |
|
NVDR Non-Voting Depository Receipt |
|
* |
|
Non-income producing security. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
|
(b) |
|
Represents an investment to obtain exposure in Emerging Markets. The Vanguard Emerging Markets ETF is a separate investment portfolio of
Vanguard, Inc., a registered investment company. The Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all
(normally about 95%) of its assets in the common stocks included in the MSCI Emerging Market Index, while employing a form of sampling to reduce
risk. |
|
Currency Abbreviations: |
|
EUR Euro |
|
HKD Hong Kong Dollar |
|
USD United States Dollar |
|
ZAR South African Rand |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
|
$179,081,907
|
|
$ |
7,683,373
|
|
$ |
(25,783,060
|
) |
$ |
(18,099,687 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds).
The Schedule of Investments of the underlying funds should be read in
conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust
during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of
period |
|
GMO U.S. Treasury Fund |
|
$ |
14 |
|
|
$ |
24,100,653 |
|
|
$ |
22,148,591 |
|
|
$ |
539 |
|
|
$ |
82 |
|
|
$ |
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
4.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
65.5% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on
inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments: Certain of the Funds securities
in Thailand and India were valued at the local price as adjusted by applying a premium or
discount when the holdings exceed foreign ownership limitations. The
Fund values certain securities using a price from a comparable
security related to the same issuer that trades on a different
exchange.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
$ |
18,720,769 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
18,720,769 |
|
Chile |
|
|
333,079 |
|
|
|
|
|
|
|
|
|
|
|
333,079 |
|
China |
|
|
982,369 |
|
|
|
18,602,567 |
|
|
|
|
|
|
|
19,584,936 |
|
Czech Republic |
|
|
|
|
|
|
2,607,992 |
|
|
|
|
|
|
|
2,607,992 |
|
Egypt |
|
|
99,700 |
|
|
|
2,182,307 |
|
|
|
|
|
|
|
2,282,007 |
|
Hungary |
|
|
|
|
|
|
1,851,146 |
|
|
|
|
|
|
|
1,851,146 |
|
India |
|
|
782,023 |
|
|
|
6,626,828 |
|
|
|
555,408 |
|
|
|
7,964,259 |
|
Indonesia |
|
|
320,950 |
|
|
|
9,934,918 |
|
|
|
|
|
|
|
10,255,868 |
|
Malaysia |
|
|
|
|
|
|
840,336 |
|
|
|
|
|
|
|
840,336 |
|
Mexico |
|
|
2,066,261 |
|
|
|
|
|
|
|
|
|
|
|
2,066,261 |
|
Morocco |
|
|
|
|
|
|
486,258 |
|
|
|
|
|
|
|
486,258 |
|
Philippines |
|
|
407,928 |
|
|
|
1,500,112 |
|
|
|
|
|
|
|
1,908,040 |
|
Poland |
|
|
|
|
|
|
2,903,859 |
|
|
|
|
|
|
|
2,903,859 |
|
Russia |
|
|
2,990,392 |
|
|
|
14,247,549 |
|
|
|
713,672 |
|
|
|
17,951,613 |
|
South Africa |
|
|
270,055 |
|
|
|
5,548,746 |
|
|
|
|
|
|
|
5,818,801 |
|
South Korea |
|
|
1,465,364 |
|
|
|
18,925,861 |
|
|
|
|
|
|
|
20,391,225 |
|
Sri Lanka |
|
|
7,751 |
|
|
|
177,701 |
|
|
|
|
|
|
|
185,452 |
|
Taiwan |
|
|
190,097 |
|
|
|
10,369,299 |
|
|
|
|
|
|
|
10,559,396 |
|
Thailand |
|
|
|
|
|
|
562,027 |
|
|
|
5,373,322 |
|
|
|
5,935,349 |
|
Turkey |
|
|
|
|
|
|
4,129,734 |
|
|
|
|
|
|
|
4,129,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
28,636,738 |
|
|
|
101,497,240 |
|
|
|
6,642,402 |
|
|
|
136,776,380 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
|
13,650,449 |
|
|
|
|
|
|
|
|
|
|
|
13,650,449 |
|
Chile |
|
|
15,076 |
|
|
|
|
|
|
|
|
|
|
|
15,076 |
|
Russia |
|
|
1,604,051 |
|
|
|
1,393,464 |
|
|
|
|
|
|
|
2,997,515 |
|
South Korea |
|
|
|
|
|
|
2,114,232 |
|
|
|
|
|
|
|
2,114,232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
15,269,576 |
|
|
|
3,507,696 |
|
|
|
|
|
|
|
18,777,272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
2,498,347 |
|
|
|
|
|
|
|
|
|
|
|
2,498,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS |
|
|
2,498,347 |
|
|
|
|
|
|
|
|
|
|
|
2,498,347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
1,953,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
977,199 |
|
|
|
|
|
|
|
|
|
|
|
977,199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
49,334,882 |
|
|
|
105,004,936 |
|
|
|
6,642,402 |
|
|
|
160,982,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
49,334,882 |
|
|
$ |
105,004,936 |
|
|
$ |
6,642,402 |
|
|
$ |
160,982,220 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net value of the Funds direct
investments in securities using Level 3 inputs was 4.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as |
|
|
Investments |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Total Realized |
|
|
Appreciation |
|
|
Transfers |
|
|
Transfers out |
|
|
of November |
|
|
Still Held as of |
|
|
|
28, 2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
into Level 3 * |
|
|
of
Level 3 * |
|
|
30, 2011 |
|
|
November 30, 2011 |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt |
|
$ |
2,848,899 |
|
|
$ |
794,300 |
|
|
$ |
(1,366,801 |
) |
|
$ |
|
|
|
$ |
(528,905 |
) |
|
$ |
189,125 |
|
|
$ |
|
|
|
$ |
(1,936,618) |
** |
|
$ |
|
|
|
$ |
|
|
India |
|
|
526,696 |
|
|
|
901,030 |
|
|
|
(657,336 |
) |
|
|
|
|
|
|
(34,188 |
) |
|
|
(83,651 |
) |
|
|
|
|
|
|
(97,143) |
** |
|
|
555,408 |
|
|
|
(63,299 |
) |
Russia |
|
|
2,973,126 |
|
|
|
4,120,423 |
|
|
|
(5,132,550 |
) |
|
|
|
|
|
|
240,948 |
|
|
|
(714,705 |
) |
|
|
|
|
|
|
(773,570) |
** |
|
|
713,672 |
|
|
|
29,381 |
|
Thailand |
|
|
8,703,006 |
|
|
|
4,575,899 |
|
|
|
(8,200,063 |
) |
|
|
|
|
|
|
1,534,035 |
|
|
|
(1,239,555 |
) |
|
|
|
|
|
|
|
|
|
|
5,373,322 |
|
|
|
523,638 |
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia |
|
|
2,878,315 |
|
|
|
440,923 |
|
|
|
(441,968 |
) |
|
|
|
|
|
|
608 |
|
|
|
119,637 |
|
|
|
|
|
|
|
(2,997,515) |
** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
17,930,042 |
|
|
$ |
10,832,575 |
|
|
$ |
(15,798,718 |
) |
|
$ |
|
|
|
$ |
1,212,498 |
|
|
$ |
(1,729,149 |
) |
|
$ |
|
|
|
$ |
(5,804,846 |
) |
|
$ |
6,642,402 |
|
|
$ |
489,720 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value
at the beginning of the period and transferred out of Level 3 at the value at the end of the
period. |
|
** |
|
Financial assets transferred between Level 2 and Level 3 were due to a change in observable
and/or unobservable inputs. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline due to
factors affecting the issuing companies, their industries, or the economy and equity markets
generally. If the Fund purchases equity investments at a discount from their value as determined
by the Manager, the Fund runs the risk that the market prices of these investments will not
increase to that value for a variety of reasons, one of which may be the Managers
overestimation of value of those investments. Because the Fund normally does not take temporary
defensive positions, declines in stock market prices generally are likely to reduce the net
asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more than
those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less
regulated than U.S. markets, and the cost of trading in those markets often is higher than in
U.S. markets. Foreign portfolio transactions generally involve higher commission rates, transfer
taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be
subject to foreign taxes on capital gains or other income payable on foreign securities, on
transactions in those securities and on the repatriation of proceeds generated from those
securities. Also, many foreign markets require a license for the Fund to invest directly in
those markets, and the Fund is subject to the risk that it could not invest if its license were
terminated or suspended. In some foreign markets, prevailing custody and trade settlement
practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to
credit and other risks with respect to participating brokers, custodians, clearing banks or
other clearing agents, escrow agents and issuers. Further, adverse changes in investment
regulations, capital requirements or exchange controls could adversely affect the value of the
Funds investments. These and other risks (e.g., nationalization, expropriation or other
confiscation of assets of foreign issuers) tend to be greater for investments in companies tied
economically to emerging countries, the economies of which tend to be more volatile than the
economies of developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of the
Funds foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or legal
restrictions may limit or prevent the Fund from selling particular securities or unwinding
derivative positions at desirable prices. The more less-liquid securities the Fund holds, the
more likely it is to honor a redemption request in-kind. In addition, the Fund may buy
securities that are less liquid than those in its benchmark.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well as
other changes in foreign and domestic economic and political conditions could adversely affect
the value of the Funds investments.
Smaller Company Risk Smaller companies may have limited product lines, markets or financial
resources, may lack the competitive strength of larger companies, or may lack managers with
experience or depend on a few key employees. The securities of small- and midcap companies often
are less widely held and trade less frequently and in lesser quantities, and their market prices
often fluctuate more, than the securities of companies with larger market capitalizations. The
Fund may buy securities that have smaller market capitalizations than those in its benchmark.
Management and Operational Risk The Fund relies on GMOs ability to achieve its investment
objective by effectively implementing its investment approach. The Fund runs the risk that GMOs
proprietary investment techniques will fail to produce the
desired results. The Funds portfolio
managers may use quantitative analyses and/or models and any imperfections or limitations in
such analyses and/or models could affect the ability of the portfolio managers to implement
strategies. By necessity, these analyses and models make simplifying assumptions that limit
their efficacy. Models that appear to explain prior market data can fail to predict future
market events. Further, the data used in models may be inaccurate and/or it may not include the
most recent information about a company or a security. The Fund is also subject to the risk that
deficiencies in the Managers or another service providers internal systems or controls will
cause losses for the Fund or impair Fund operations.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Focused Investment Risk Focusing investments in a limited number of countries and
geographic regions creates additional risk.
Derivatives Risk The use of derivatives involves the risk that their value may not move as
expected relative to the value of the relevant underlying assets, rates or indices. Derivatives
also present other Fund risks, including market risk, liquidity risk, currency risk and
counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an investment in
underlying funds, including the risk that the underlying funds (including ETFs) in which it
invests will not perform as expected.
Leveraging Risk The Funds use of reverse repurchase agreements and other derivatives and
securities lending may cause its portfolio to be leveraged. Leverage increases the Funds
portfolio losses when the value of its investments decline.
Large Shareholder Risk To the extent that shares of the Fund are held by large shareholders
(e.g., institutional investors, asset allocation funds or other GMO Funds), the Fund is subject
to the risk that these shareholders will disrupt the Funds operations by purchasing or
redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC
derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated,
the counterparty may interpret contractual terms (e.g., the definition of default) differently
than the Fund and if that occurs, the Fund may decide not to pursue its claims against the
counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The
Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC
derivatives contracts or those payments may be delayed or made only after the Fund has incurred
the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of
the contracts. Most
forward currency contracts are not collateralized. The Fund had no forward currency contracts
outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market. The Fund
had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other
relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. The Fund held no rights or warrants
at the end of the period.
The volume of derivative activity, based on absolute values (rights and/or warrants),
outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
Right and/or |
|
|
|
Warrants |
|
Average amount outstanding |
|
$ |
3,908 |
|
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Emerging Country Debt Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 99.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Albania 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
|
|
1,613,000 |
|
|
Albania Government International Bond, 7.50%, due 11/04/15 |
|
|
1,863,953 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Argentina 11.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 10.1% |
|
|
|
|
USD |
|
|
9,000,000 |
|
|
Province of Buenos Aires, Reg S, Step Up, 4.00%, due 05/15/35 |
|
|
3,262,500 |
|
EUR |
|
|
19,000,000 |
|
|
Republic of Argentina, Step Up, 2.26%, due 12/31/38 |
|
|
6,637,876 |
|
DEM |
|
|
3,830,000 |
|
|
Republic of Argentina Discount Bond, Series DM, 6 mo. DEM LIBOR + .81%, 1.00%, due 03/31/23(b) |
|
|
1,578,778 |
|
USD |
|
|
10,240,448 |
|
|
Republic of Argentina Discount Bond, 5.77%, due 12/31/33 |
|
|
7,065,909 |
|
EUR |
|
|
35,562,828 |
|
|
Republic of Argentina Discount Bond, 5.45%, due 12/31/33 |
|
|
28,193,595 |
|
EUR |
|
|
351,220,524 |
|
|
Republic of Argentina GDP Linked, due 12/15/35(c) |
|
|
44,833,811 |
|
ARS |
|
|
28,000,000 |
|
|
Republic of Argentina GDP Linked, due 12/15/35(c)(d) |
|
|
487,907 |
|
USD |
|
|
24,331,990 |
|
|
Republic of Argentina GDP Linked, due 12/15/35(c) |
|
|
2,596,223 |
|
ARS |
|
|
28,000,000 |
|
|
Republic of Argentina Global Par Bond, Step Up, due 12/31/38 |
|
|
2,317,079 |
|
USD |
|
|
7,500,000 |
|
|
Republic of Argentina Par Bond, Step Up, 2.50%, due 12/31/38 |
|
|
2,388,750 |
|
EUR |
|
|
181,000,000 |
|
|
Republic of Argentina Par Bond, Step Up, 2.26%, due 12/31/38 |
|
|
65,666,596 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,029,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Judgments 1.5% |
|
|
|
|
USD |
|
|
32,000,000 |
|
|
Republic of Argentina Discount Bond, Series L-GL, 6 mo. LIBOR + .81%, 6.17%, due 03/31/23(b)(d)(e) |
|
|
16,320,000 |
|
USD |
|
|
15,000,000 |
|
|
Republic of Argentina Global Par Bond, Series L-GP, Step Up, due 03/31/23(b)(d)(e) |
|
|
8,542,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24,862,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Argentina |
|
|
189,891,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bahamas 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
2,500,000 |
|
|
Commonwealth of Bahamas, Reg S, 6.95%, due 11/20/29 |
|
|
2,775,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barbados 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
4,800,000 |
|
|
Government of Barbados, Reg S, 7.00%, due 08/04/22 |
|
|
4,800,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belize 0.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
12,925,000 |
|
|
Government of Belize, Reg S, Step Up, 6.00%, due 02/20/29 |
|
|
7,755,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bosnia & Herzegovina 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
DEM |
|
|
18,428,120 |
|
|
Bosnia & Herzegovina, Series A, Reg S, 6 mo. DEM LIBOR + .81%, 2.51%, due 12/11/17 |
|
|
9,622,007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 5.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.6% |
|
|
|
|
USD |
|
|
9,000,000 |
|
|
Petrobras International Finance Co., 6.88%, due 01/20/40 |
|
|
9,881,100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 0.6% |
|
|
|
|
USD |
|
|
9,000,000 |
|
|
Banco Nacional de Desenvolvimento Economico e Social, Reg S, 5.50%, due 07/12/20 |
|
|
9,585,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 4.0% |
|
|
|
|
USD |
|
|
3,366,904 |
|
|
Brazilian Government International Exit Bonds, 6.00%, due 09/15/13 |
|
|
3,484,745 |
|
USD |
|
|
131,825 |
|
|
Brazilian Government International Exit Bonds, Odd Lot, 6.00%, due 09/15/13 |
|
|
128,529 |
|
USD |
|
|
42,000,000 |
|
|
Republic of
Brazil, 8.25%, due 01/20/34(g) |
|
|
61,425,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,038,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
84,504,374 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chile 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
USD |
|
|
1,700,000 |
|
|
Empresa Nacional del Petroleo, Reg. S, 5.25%, due 08/10/20 |
|
|
1,785,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Colombia 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 0.6% |
|
|
|
|
USD |
|
|
8,000,000 |
|
|
Ecopetrol SA, 7.63%, due 07/23/19 |
|
|
9,600,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 1.0% |
|
|
|
|
USD |
|
|
8,000,000 |
|
|
Republic of Colombia, 8.70%, due 02/15/16 |
|
|
9,440,000 |
|
USD |
|
|
3,800,000 |
|
|
Republic of Colombia, 11.85%, due 03/09/28 |
|
|
6,400,302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,840,302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Colombia |
|
|
25,440,302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Congo Republic (Brazzaville) 4.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
108,440,600 |
|
|
Republic of Congo, Reg S, Series INTL, Step Up, 3.00%, due 06/30/29 |
|
|
75,908,420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Croatia 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
8,000,000 |
|
|
Croatia Government International Bond, Reg. S, 6.38%, due 03/24/21 |
|
|
7,100,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dominican Republic 3.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 1.4% |
|
|
|
|
USD |
|
|
27,052,008 |
|
|
Autopistas Del Nordeste Ltd., Reg S, 9.39%, due 04/15/24 |
|
|
23,129,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 2.5% |
|
|
|
|
USD |
|
|
8,000,000 |
|
|
Dominican Republic, Reg S, 8.63%, due 04/20/27 |
|
|
8,480,000 |
|
USD |
|
|
42,557,000 |
|
|
Dominican Republic Discount Bond, 6 mo. LIBOR + .81%, 1.55%, due 08/30/24 |
|
|
32,343,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,823,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Dominican Republic |
|
|
63,952,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ecuador 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
11,587,000 |
|
|
Republic of Ecuador, Step Up, Reg S, due 08/15/30(b) |
|
|
2,896,750 |
|
USD |
|
|
1,375,909 |
|
|
Republic of Ecuador PDI (Global Bearer Capitalization Bond), PIK, 6 mo. LIBOR + .81%, 1.31%, due 02/27/15 |
|
|
983,775 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ecuador |
|
|
3,880,525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
USD |
|
|
3,000,000 |
|
|
African Export-Import Bank, 8.75%, due 11/13/14 |
|
|
3,236,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
El Salvador 1.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
19,000,000 |
|
|
El Salvador Government International Bond, Reg S, 7.63%, due 02/01/41 |
|
|
19,627,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gabon 0.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
7,000,000 |
|
|
Gabonese Republic, Reg S, 8.20%, due 12/12/17 |
|
|
8,050,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Grenada 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
9,000,000 |
|
|
Republic of Grenada, Reg S, Step Up, 4.50%, due 09/15/25 |
|
|
5,130,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Iceland 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
6,000,000 |
|
|
Iceland Government International Bond, Reg S, 4.88%, due 06/16/16 |
|
|
5,880,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 2.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
USD |
|
|
10,600,000 |
|
|
Majapahit Holding BV, Reg. S, 7.75%, due 01/20/20 |
|
|
12,208,550 |
|
USD |
|
|
31,000,000 |
|
|
Majapahit Holding BV, Reg S, 7.88%, due 06/29/37 |
|
|
35,650,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
47,858,550 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Iraq 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
15,000,000 |
|
|
Republic of Iraq, Reg S, 5.80%, due 01/15/28(g) |
|
|
12,150,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Israel 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
USD |
|
|
3,000,000 |
|
|
Israel Electric Corp Ltd, Reg. S, 7.88%, due 12/15/26 |
|
|
3,146,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ivory Coast 2.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
65,439,000 |
|
|
Ivory Coast Government International Bond, Reg S, Step Up, 2.50%, due 12/31/32(b) |
|
|
32,392,305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jamaica 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt |
|
|
|
|
USD |
|
|
4,000,000 |
|
|
National Road Operating & Constructing Co. Ltd., 144A, 9.38%, due 11/10/24 |
|
|
4,030,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Latvia 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
4,000,000 |
|
|
Republic of Latvia, Reg. S, 5.25%, due 06/16/21 |
|
|
3,680,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lithuania 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
1,000,000 |
|
|
Republic of Lithuania, Reg S, 5.13%, due 09/14/17 |
|
|
960,880 |
|
USD |
|
|
4,000,000 |
|
|
Republic of Lithuania, Reg S, 7.38%, due 02/11/20 |
|
|
4,240,000 |
|
USD |
|
|
6,000,000 |
|
|
Republic of
Lithuania, Reg S, 6.13%, due
03/09/21(g) |
|
|
5,790,000 |
|
USD |
|
|
7,000,000 |
|
|
Republic of Lithuania, 144A, 6.13%, due 03/09/21 |
|
|
6,755,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Lithuania |
|
|
17,745,880 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 0.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
|
|
|
MYR |
|
|
50,000,000 |
|
|
Transshipment Megahub Berhad, Series F, 6.70%, due 11/02/12 |
|
|
14,472,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexico 9.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 2.9% |
|
|
|
|
EUR |
|
|
37,500,000 |
|
|
Pemex Project Funding Master Trust, Reg S, 5.50%, due 02/24/25 |
|
|
46,893,266 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 6.5% |
|
|
|
|
GBP |
|
|
29,994,000 |
|
|
United Mexican States, GMTN, 6.75%, due 02/06/24 |
|
|
50,116,350 |
|
USD |
|
|
55,000,000 |
|
|
United Mexican States, 5.75%, due 10/12/2110 |
|
|
56,375,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106,491,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Mexico |
|
|
153,384,616 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nigeria 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
6,100,000 |
|
|
Nigeria Government International Bond, Reg S, 6.75%, due 01/28/21 |
|
|
6,344,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pakistan 0.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
20,000,000 |
|
|
Islamic Republic of Pakistan, Reg S, 7.88%, due 03/31/36 |
|
|
12,600,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peru 1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
12,452,000 |
|
|
Peru Enhanced Pass-Through Finance Ltd., Reg S, Zero Coupon, due 06/02/25 |
|
|
6,786,340 |
|
USD |
|
|
8,600,000 |
|
|
Peru Par Bond, Series 30 Yr., Step Up, 3.00%, due 03/07/27 |
|
|
7,310,000 |
|
USD |
|
|
3,784,333 |
|
|
Peru Trust, Series 97-I-P, Class A3, Zero Coupon, due 12/31/15(d)(f) |
|
|
567,650 |
|
USD |
|
|
1,253,404 |
|
|
Peru Trust, Series 98-I-P, Zero Coupon, due 03/10/16(d)(f) |
|
|
188,010 |
|
USD |
|
|
1,356,611 |
|
|
Peru Trust II, Series 98-A LB, Zero Coupon, due 02/28/16(d)(f) |
|
|
203,492 |
|
USD |
|
|
8,000,000 |
|
|
Republic of
Peru, Series 30 Yr., 5.63%, due
11/18/50(g) |
|
|
8,480,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Peru |
|
|
23,535,492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 9.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 8.4% |
|
|
|
|
USD |
|
|
35,651,000 |
|
|
Central Bank of Philippines, Series A, 8.60%, due 06/15/27 |
|
|
45,276,770 |
|
USD |
|
|
55,450,000 |
|
|
National Power Corp., Global Bond, 9.63%, due 05/15/28 |
|
|
73,194,000 |
|
USD |
|
|
8,500,000 |
|
|
National Power Corp., Global Bond, 8.40%, due 12/15/16 |
|
|
10,370,000 |
|
USD |
|
|
6,296,000 |
|
|
Power Sector Assets & Liabilities Management Corp, Reg. S, 7.39%, due 12/02/24 |
|
|
7,696,860 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
136,537,630 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 0.7% |
|
|
|
|
USD |
|
|
3,000,000 |
|
|
Republic of Philippines, 6.50%, due 01/20/20 |
|
|
3,577,500 |
|
USD |
|
|
8,000,000 |
|
|
Republic of Philippines, 5.50%, due 03/30/26 |
|
|
8,880,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,457,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Philippines |
|
|
148,995,130 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qatar 2.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 0.2% |
|
|
|
|
USD |
|
|
3,500,000 |
|
|
Qtel International Finance Ltd., Reg S, 5.00%, due 10/19/25 |
|
|
3,325,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 1.9% |
|
|
|
|
USD |
|
|
30,000,000 |
|
|
Qatar Goverment International Bond, 144A, 5.75%, due 01/20/42 |
|
|
30,525,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Qatar |
|
|
33,850,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 5.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 4.9% |
|
|
|
|
USD |
|
|
36,200,000 |
|
|
Gaz Capital
SA, Reg S, 9.25%, due 04/23/19(g) |
|
|
44,073,500 |
|
USD |
|
|
3,000,000 |
|
|
Sberbank of Russia Via SB Capital SA, Reg S, 5.72%, due 06/16/21 |
|
|
2,857,500 |
|
USD |
|
|
14,900,000 |
|
|
Transcapital Ltd. (Transneft), Reg S, 8.70%, due 08/07/18 |
|
|
17,954,500 |
|
USD |
|
|
7,600,000 |
|
|
VTB Bank OJSC Via VTB Capital SA, Reg S, 6.55%, due 10/13/20 |
|
|
7,220,000 |
|
USD |
|
|
9,000,000 |
|
|
VTB Capital SA, Reg S, 6.25%, due 06/30/35 |
|
|
8,932,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
81,038,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 1.0% |
|
|
|
|
USD |
|
|
15,000,000 |
|
|
RSHB Capital SA, Reg S, 6.30%, due 05/15/17 |
|
|
15,225,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
96,263,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senegal 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
5,900,000 |
|
|
Republic of Senegal, Reg S, 8.75%, due 05/13/21 |
|
|
5,767,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serbia 1.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
12,000,000 |
|
|
Republic of Serbia, 144A, 7.25%, due 09/28/21 |
|
|
11,490,000 |
|
USD |
|
|
12,970,558 |
|
|
Republic of Serbia, Reg S, Step Up, 6.75%, due 11/01/24 |
|
|
12,419,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Serbia |
|
|
23,909,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Africa 0.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 0.3% |
|
|
|
|
ZAR |
|
|
163,000,000 |
|
|
Eskom Holdings Ltd., Zero Coupon, due 12/31/32 |
|
|
2,034,047 |
|
ZAR |
|
|
20,000,000 |
|
|
Transnet Ltd., 13.50%, due 04/18/28 |
|
|
2,908,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,942,936 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 0.5% |
|
|
|
|
USD |
|
|
7,500,000 |
|
|
South Africa Government International Bond, 6.25%, due 03/08/41 |
|
|
8,456,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Africa |
|
|
13,399,186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 1.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
USD |
|
|
8,000,000 |
|
|
Export-Import Bank of Korea, 5.13%, due 06/29/20 |
|
|
8,332,800 |
|
USD |
|
|
4,000,000 |
|
|
Korea Gas Corp., Reg S, 6.00%, due 07/15/14 |
|
|
4,298,800 |
|
USD |
|
|
8,000,000 |
|
|
Korea Hydro & Nuclear Power Co Ltd., Reg S, 4.75%, due 07/13/21 |
|
|
8,079,760 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
20,711,360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sri Lanka 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
1,500,000 |
|
|
Republic of Sri Lanka, Reg S, 8.25%, due 10/24/12 |
|
|
1,520,445 |
|
USD |
|
|
1,000,000 |
|
|
Republic of Sri Lanka, Reg S, 7.40%, due 01/22/15 |
|
|
1,056,200 |
|
USD |
|
|
6,500,000 |
|
|
Republic of Sri Lanka, Reg S, 6.25%, due 10/04/20 |
|
|
6,532,500 |
|
USD |
|
|
2,000,000 |
|
|
Republic of Sri Lanka, Reg S, 6.25%, due 07/27/21 |
|
|
1,990,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sri Lanka |
|
|
11,099,145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
USD |
|
|
4,000,000 |
|
|
PTTEP Canada International Finance Ltd., Reg S, 5.69%, due 04/05/21 |
|
|
4,146,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trinidad And Tobago 1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.5% |
|
|
|
|
USD |
|
|
8,000,000 |
|
|
First Citizens St Lucia Ltd, Reg S, 4.90%, due 02/09/16 |
|
|
8,080,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 0.9% |
|
|
|
|
USD |
|
|
11,500,000 |
|
|
Petroleum Company of Trinidad and Tobago Ltd., Reg S, 9.75%, due 08/14/19 |
|
|
13,455,000 |
|
USD |
|
|
1,312,500 |
|
|
Petroleum Company of Trinidad and Tobago Ltd., Reg. S, 6.00%, due 05/08/22 |
|
|
1,286,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,741,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Trinidad And Tobago |
|
|
22,821,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tunisia 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency |
|
|
|
|
JPY |
|
|
360,000,000 |
|
|
Banque Centrale De Tunisie, Series 6BR, 4.35%, due 08/15/17 |
|
|
4,838,835 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turkey 4.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.1% |
|
|
|
|
USD |
|
|
2,000,000 |
|
|
Export Credit Bank of Turkey, 144A, 5.38%, due 11/04/16 |
|
|
1,992,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 4.4% |
|
|
|
|
USD |
|
|
41,000,000 |
|
|
Republic of
Turkey, 6.75%, due
05/30/40(g) |
|
|
43,357,500 |
|
USD |
|
|
30,000,000 |
|
|
Republic of
Turkey, 6.00%, due
01/14/41(g) |
|
|
28,837,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72,195,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Turkey |
|
|
74,187,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ukraine 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
4,000,000 |
|
|
City of Kyiv Via Kyiv Finance PLC, Reg. S, 9.38%, due 07/11/16 |
|
|
3,040,000 |
|
USD |
|
|
8,000,000 |
|
|
Ukraine
Government International Bond, Reg. S, 7.95%, due
02/23/21(g) |
|
|
7,040,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ukraine |
|
|
10,080,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 6.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 2.8% |
|
|
|
|
USD |
|
|
3,278,241 |
|
|
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24 |
|
|
1,573,556 |
|
USD |
|
|
150,112 |
|
|
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34 |
|
|
95,921 |
|
USD |
|
|
1,119,855 |
|
|
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30 |
|
|
811,895 |
|
USD |
|
|
17,399,785 |
|
|
Countrywide Home Equity Loan Trust, Series 05-F, Class 2A, AMBAC, 1 mo. LIBOR + .24%, 0.49%, due 12/15/35 |
|
|
8,177,899 |
|
USD |
|
|
12,778,105 |
|
|
Countrywide Home Equity Loan Trust, Series 05-H, Class 2A, FGIC, 1 mo. LIBOR + .24%, 0.49%, due 12/15/35 |
|
|
5,782,092 |
|
USD |
|
|
7,614,489 |
|
|
Countrywide Home Equity Loan Trust, Series 06-D, Class 2A, XL, 1 mo. LIBOR + .20%, 0.45%, due 05/15/36 |
|
|
2,855,433 |
|
USD |
|
|
3,789,097 |
|
|
First Franklin Mortgage Loan Asset Backed Certificates, Series 05-FF10, Class A6M, 1 mo. LIBOR + .35%, 0.61%, due 11/25/35 |
|
|
947,274 |
|
USD |
|
|
1,261,840 |
|
|
GSAMP Trust, Series 05-HE6, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35 |
|
|
1,165,688 |
|
USD |
|
|
9,250,000 |
|
|
Home Equity Asset Trust, Series 07-1, Class 2A4, 1 mo. LIBOR + .23%, 0.49%, due 05/25/37 |
|
|
416,250 |
|
USD |
|
|
8,608,688 |
|
|
IXIS Real Estate Capital Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36 |
|
|
1,850,868 |
|
USD |
|
|
12,857,159 |
|
|
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36 ¨ |
|
|
3,857,148 |
|
USD |
|
|
6,280,768 |
|
|
Morgan Stanley ABS Capital I, Series 06-NC3, Class A2C, 1 mo. LIBOR + .17%, 0.43%, due 03/25/36 |
|
|
3,391,615 |
|
|
|
|
|
|
|
|
|
|
|
|
USD |
|
|
14,530,541 |
|
|
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 ¨ |
|
|
3,559,983 |
|
USD |
|
|
14,724,282 |
|
|
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A4, 1 mo. LIBOR + .22%, 0.48%, due 11/25/36 ¨ |
|
|
3,754,692 |
|
USD |
|
|
12,868,000 |
|
|
Option One Mortgage Loan Trust, Series 06-3, Class 2A4, 1 mo. LIBOR + .22%, 0.48%, due 02/25/37 |
|
|
3,860,400 |
|
USD |
|
|
8,000,000 |
|
|
Wamu Asset-Backed Certificates, Series 07-HE2, Class 2A4, 1 mo. LIBOR + .36%, 0.62%, due 04/25/37 |
|
|
2,740,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
44,840,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 4.0% |
|
|
|
|
USD |
|
|
9,639,573 |
|
|
Republic of Albania Par Bond, Zero Coupon, due 08/31/25(a) |
|
|
4,723,391 |
|
USD |
|
|
60,470,275 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(c)(g)(h) |
|
|
60,673,395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,396,786 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
110,237,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Uruguay 2.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
29,851,571 |
|
|
Republic of Uruguay, 7.63%, due 03/21/36 |
|
|
39,702,590 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Venezuela 8.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.7% |
|
|
|
|
USD |
|
|
20,000,000 |
|
|
Electricidad de Caracas Finance BV, 8.50%, due 04/10/18 |
|
|
12,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Agency 1.3% |
|
|
|
|
USD |
|
|
29,000,000 |
|
|
Petroleos de Venezuela SA, Reg S, 8.50%, due 11/02/17 |
|
|
21,677,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 6.3% |
|
|
|
|
USD |
|
|
23,100,000 |
|
|
Republic of Venezuela, Reg S, 8.25%, due 10/13/24 |
|
|
14,610,750 |
|
USD |
|
|
30,000,000 |
|
|
Republic of Venezuela, Reg S, 9.00%, due 05/07/23 |
|
|
20,250,000 |
|
USD |
|
|
18,500,000 |
|
|
Republic of Venezuela, Reg S, 12.75%, due 08/23/22 |
|
|
16,233,750 |
|
USD |
|
|
64,500,000 |
|
|
Republic of Venezuela, Reg. S, 11.95%, due 08/05/31 |
|
|
51,277,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
102,372,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Venezuela |
|
|
136,049,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vietnam 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
USD |
|
|
4,000,000 |
|
|
Socialist Republic of Vietnam, Series 30 Yr., 6 mo. LIBOR + .81%, 1.38%, due 03/13/28 |
|
|
3,160,000 |
|
USD |
|
|
19,750,000 |
|
|
Socialist Republic of Vietnam, Series 30 Yr., Step Up, 4.00%, due 03/12/28 |
|
|
15,010,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Vietnam |
|
|
18,170,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $1,677,998,133) |
|
|
1,626,769,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOAN ASSIGNMENTS 1.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Angola 0.3% |
|
|
|
|
USD |
|
|
2,300,000 |
|
|
Angolan Ministry of Finance Loan Agreement, 6 mo. LIBOR + 5.50%, 5.94%, due 03/07/13 |
|
|
2,139,000 |
|
USD |
|
|
2,300,000 |
|
|
Angolan Ministry of Finance Loan Agreement, 6 mo. LIBOR + 5.50%, 5.94%, due 07/08/13 |
|
|
2,116,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Angola |
|
|
4,255,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dominican Republic 0.1% |
|
|
|
|
USD |
|
|
3,200,135 |
|
|
Dominican Republic, 6 mo. LIBOR + 1.75%, 2.20%, due 08/15/15 |
|
|
2,598,190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 1.0% |
|
|
|
|
EUR |
|
|
1,828,570 |
|
|
Republic of Indonesia, Indonesia Paris Club Debt, 4.00%, due 06/01/21(i) |
|
|
1,824,359 |
|
|
|
|
|
|
|
|
|
|
|
|
USD |
|
|
3,213,600 |
|
|
Republic of Indonesia Loan Agreement, dated June 14, 1995, 6 mo. LIBOR + .88%, 1.25%, due 12/14/19 |
|
|
2,892,240 |
|
USD |
|
|
3,213,600 |
|
|
Republic of Indonesia Loan Agreement, dated June 14, 1995, 6 mo. LIBOR + .88%, 1.25%, due 12/14/19 |
|
|
2,892,240 |
|
USD |
|
|
4,284,800 |
|
|
Republic of Indonesia Loan Agreement, dated June 14, 1995, 6 mo. LIBOR + .88%, 1.25%, due 12/14/19 |
|
|
3,856,320 |
|
USD |
|
|
717,901 |
|
|
Republic of Indonesia Loan Agreement, dated September 29, 1994, 7.24%, due 12/01/11 |
|
|
656,879 |
|
USD |
|
|
2,335,068 |
|
|
Republic of Indonesia Loan Agreement, dated September 29, 1994, 6 mo. LIBOR + .88%, 1.31%, due 12/01/19 |
|
|
2,136,587 |
|
JPY |
|
|
48,600,000 |
|
|
Republic of Indonesia Loan Agreement, 6 mo. JPY TIBOR + .88%, 1.20%, due 03/28/13 |
|
|
589,015 |
|
USD |
|
|
989,999 |
|
|
Republic of Indonesia Loan Agreement, 6 mo. LIBOR +.88%, 1.31%, due 03/29/13 |
|
|
930,599 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
15,778,239 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vietnam 0.5% |
|
|
|
|
USD |
|
|
18,000,000 |
|
|
Vietnam Shipbuilding Industry Group Loan Agreement, 6 mo. LIBOR + 1.50%, 4.63%, due 06/26/15(b) |
|
|
8,280,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LOAN ASSIGNMENTS (COST $36,775,632) |
|
|
30,911,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LOAN PARTICIPATIONS 6.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt 0.2% |
|
|
|
|
CHF |
|
|
3,708,432 |
|
|
Paris Club Loan Agreement (Participation with Standard Chartered Bank), due 01/03/24 |
|
|
3,186,949 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 1.7% |
|
|
|
|
USD |
|
|
395,520 |
|
|
Republic of Indonesia Loan Agreement (Participation with Citibank), 6 mo. LIBOR +.88%, 1.25%, due 12/14/19 |
|
|
355,968 |
|
USD |
|
|
527,360 |
|
|
Republic of Indonesia Loan Agreement (Participation with Citibank), 6 mo. LIBOR +.88%, 1.25%, due 12/14/19 |
|
|
474,624 |
|
USD |
|
|
395,520 |
|
|
Republic of Indonesia Loan Agreement (Participation with Citibank), 6 mo. LIBOR +.88%, 1.25%, due 12/14/19 |
|
|
355,968 |
|
JPY |
|
|
287,323,957 |
|
|
Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 6 mo. JPY TIBOR +.88%, 1.20%, due 03/28/13 |
|
|
3,482,266 |
|
USD |
|
|
9,513,696 |
|
|
Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 3 mo. LIBOR + 1.25%, 1.70%, due 02/12/13 |
|
|
8,942,874 |
|
USD |
|
|
8,604,627 |
|
|
Republic of Indonesia Loan Agreement (Participation with Deutsche Bank), 6 mo. LIBOR +.88%, 1.42%, due 09/29/19 |
|
|
7,873,234 |
|
USD |
|
|
6,477,988 |
|
|
Republic of Indonesia Loan Agreement (Participation with Morgan Stanley), 6 mo. LIBOR + .88%, 1.25%, due 12/14/19 |
|
|
5,830,189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
27,315,123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Iraq 2.7% |
|
|
|
|
JPY |
|
|
4,781,786,145 |
|
|
Republic of Iraq Paris Club Loan Agreement (Participation with Deutsche Bank), due 01/01/28 |
|
|
38,187,267 |
|
JPY |
|
|
624,805,614 |
|
|
Republic of Iraq Paris Club Loan, T Chatani (Participation with Deutsche Bank), due 01/01/28 |
|
|
4,900,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Iraq |
|
|
43,088,018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 0.4% |
|
|
|
|
EUR |
|
|
57,042,402 |
|
|
Russian Foreign Trade Obligations (Participation with GML International Ltd) (b)(d) |
|
|
6,835,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vietnam 1.3% |
|
|
|
|
JPY |
|
|
1,972,198,951 |
|
|
Socialist Republic of Vietnam Loan Agreement (Participation with Deutsche Bank), 6 mo. JPY LIBOR + .60%, 0.93%, due 09/01/17 |
|
|
21,868,117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL LOAN PARTICIPATIONS (COST $90,818,731) |
|
|
102,293,647 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PROMISSORY NOTES 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ghana 0.0% |
|
|
|
|
USD |
|
|
3,312,500 |
|
|
Republic of Ghana Promissory Notes, 0.00%, due (b)(d)(j) |
|
|
331,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PROMISSORY NOTES (COST $3,312,500) |
|
|
331,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
OPTIONS PURCHASED 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options on Interest Rate Swaps 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ILS |
|
|
200,000,000 |
|
|
ILS Swaption Put, Expires 02/16/12, Strike 4.38%
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
200,000,000 ILS in which it will receive 3 month ILS TELBOR and will pay 4.38%, maturing on February 20, 2013. (OTC) (CP JP Morgan Chase Bank, N.A.) |
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
ILS |
|
|
300,000,000 |
|
|
ILS Swaption Put, Expires 03/01/12 ,Strike 4.44%
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
300,000,000 ILS in which it will receive 3 month ILS TELBOR and will pay 4.44%, maturing on March 5, 2013. (OTC) (CP JP Morgan Chase Bank, N.A.) |
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
ZAR |
|
|
800,000,000 |
|
|
ZAR Swaption Put, Expires 02/14/12, Strike 7.24%
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
800,000,000 ZAR in which it will receive 3 month ZAR JIBAR and will pay 7.24%, maturing on February 14, 2013. (OTC) (CP JP Morgan Chase Bank, N.A.) |
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Options on Interest Rate Swaps |
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL OPTIONS PURCHASED (COST $1,188,216) |
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
MUTUAL FUNDS 3.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 3.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 3.8% |
|
|
|
|
|
|
|
3,976,082 |
|
|
GMO Short-Duration Collateral Fund |
|
|
26,281,902 |
|
|
|
|
21,409 |
|
|
GMO Special Purpose Holding Fund(k) |
|
|
8,349 |
|
|
|
|
1 |
|
|
GMO U.S. Treasury Fund |
|
|
31 |
|
|
|
|
1,515,449 |
|
|
GMO World Opportunity Overlay Fund |
|
|
35,764,589 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
62,054,871 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $64,643,226) |
|
|
62,054,871 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nigeria 0.3% |
|
|
|
|
|
|
|
25,000 |
|
|
Central Bank of Nigeria Oil Warrants, Expires 11/15/20* |
|
|
4,500,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Uruguay 0.0% |
|
|
|
|
|
|
|
4,000,000 |
|
|
Banco Central Del Uruguay Value Recovery Rights, VRRB, Expires 01/02/21*(d) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Venezuela 0.3% |
|
|
|
|
|
|
|
205,145 |
|
|
Republic of Venezuela Oil Warrants, Expires 04/15/20* |
|
|
5,590,201 |
|
|
|
|
6,660 |
|
|
Republic of Venezuela Oil Warrants, Expires 04/15/20* |
|
|
181,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Venezuela |
|
|
5,771,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total RIGHTS/WARRANTS (COST $0) |
|
|
10,271,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.2% |
|
|
|
|
|
|
|
3,125,102 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(l) |
|
|
3,125,102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $3,125,102) |
|
|
3,125,102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 112.5% (Cost $1,877,861,540) |
|
|
1,835,757,050 |
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (12.5%) |
|
|
(203,457,503 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,632,299,547 |
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
Counterparty |
|
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/07/12 |
|
Deutsche Bank AG |
|
EUR |
|
|
10,000,000 |
|
|
$ |
13,445,702 |
|
|
$ |
(57,298 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/07/12 |
|
Deutsche Bank AG |
|
EUR |
|
|
280,000,000 |
|
|
$ |
376,479,656 |
|
|
|
4,740,344 |
|
1/10/12 |
|
Credit Suisse International |
|
GBP |
|
|
30,000,000 |
|
|
|
47,050,418 |
|
|
$ |
(721,118 |
) |
2/14/12 |
|
Deutsche Bank AG |
|
JPY |
|
|
4,600,000,000 |
|
|
|
59,402,725 |
|
|
|
461,928 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
482,932,799 |
|
|
$ |
4,481,154 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Reverse Repurchase Agreements
|
|
|
|
|
|
|
|
|
|
|
Face Value |
|
Description |
|
Market Value |
USD
|
|
|
27,875,000 |
|
|
Barclays Bank PLC, 0.19%,
dated 11/14/11, to be
repurchased on demand at face
value plus accrued interest
with a stated maturity date of
12/14/11.
|
|
$ |
(27,877,501 |
) |
USD
|
|
|
16,706,250 |
|
|
Barclays Bank PLC, 0.19%,
dated 11/18/11, to be
repurchased on demand at face
value plus accrued interest
with a stated maturity date of
12/19/11.
|
|
|
(16,707,396 |
) |
USD
|
|
|
1,640,606 |
|
|
Barclays Bank PLC, 0.25%,
dated 11/09/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(1,640,845 |
) |
|
|
|
|
|
|
|
|
|
|
|
USD
|
|
|
1,102,969 |
|
|
Barclays Bank PLC, 0.35%,
dated 11/18/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(1,103,076 |
) |
USD
|
|
|
7,554,267 |
|
|
JPMorgan Chase Bank, N.A.,
0.00%, dated 11/07/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(7,554,267 |
) |
USD
|
|
|
13,060,583 |
|
|
JPMorgan Chase Bank, N.A.,
0.55%, dated 11/04/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(13,065,173 |
) |
USD
|
|
|
19,965,000 |
|
|
JPMorgan Chase Bank, N.A.,
0.70%, dated 03/04/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(20,069,040 |
) |
USD
|
|
|
36,015,188 |
|
|
JPMorgan Chase Bank, N.A.,
0.75%, dated 02/04/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(36,238,031 |
) |
USD
|
|
|
33,223,125 |
|
|
JPMorgan Chase Bank, N.A.,
0.75%, dated 11/02/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(33,242,505 |
) |
USD
|
|
|
29,922,500 |
|
|
JPMorgan Chase Bank, N.A.,
0.90%, dated 11/16/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(29,929,981 |
) |
USD
|
|
|
30,617,361 |
|
|
JPMorgan Chase Bank, N.A.,
0.95%, dated 11/16/11, to be
repurchased on demand at face
value plus accrued interest.
(m)
|
|
|
(30,625,441 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(218,053,256 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average balance outstanding |
|
$ |
(279,217,889 |
) |
Average interest rate |
|
|
0.51 |
% |
Maximum balance outstanding |
|
$ |
(351,205,903 |
) |
Average balance outstanding was calculated based on daily face value balances outstanding during
the period that the Fund has entered into reverse repurchase agreements.
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
Net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
Amount of Future |
|
Unrealized |
Notional |
|
Expiration |
|
|
|
Receive |
|
Annual |
|
Credit |
|
Reference |
|
Payments by the Fund |
|
Appreciation/ |
Amount |
|
Date |
|
Counterparty |
|
(Pay)^ |
|
Premium |
|
Spread (1) |
|
Entity |
|
Under the Contract (2) |
|
(Depreciation) |
1,000,100
|
|
USD
|
|
12/20/2011
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.60 |
% |
|
|
2.4 |
% |
|
Stemcor UK Ltd.
|
|
|
1,000,100 |
|
|
USD
|
|
$ |
2,711 |
|
8,500,000
|
|
EUR
|
|
1/20/2012
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
0.42 |
% |
|
|
1.41 |
% |
|
Republic of Kazakhstan
|
|
|
N/A |
|
|
|
|
|
(1,685 |
) |
4,100,000,000
|
|
KZT
|
|
1/20/2012
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
0.32 |
% |
|
|
1.06 |
% |
|
Republic of Kazakhstan
|
|
|
4,100,000,000 |
|
|
KZT
|
|
|
3,006 |
|
20,000,000
|
|
USD
|
|
6/20/2012
|
|
Goldman Sachs
International
|
|
(Pay)
|
|
|
5.00 |
% |
|
|
N/A |
|
|
Republic of Argentina
|
|
|
N/A |
|
|
|
|
|
(362,684 |
) |
5,000,000
|
|
USD
|
|
7/30/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
3.05 |
% |
|
|
0.57 |
% |
|
Republic of Chile
|
|
|
5,000,000 |
|
|
USD
|
|
|
135,851 |
|
5,000,000
|
|
USD
|
|
8/20/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
3.50 |
% |
|
|
4.65 |
% |
|
Republic of Jamaica
|
|
|
5,000,000 |
|
|
USD
|
|
|
7,300 |
|
15,000,000
|
|
USD
|
|
9/20/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
(Pay)
|
|
|
1.15 |
% |
|
|
0.66 |
% |
|
Republic of Peru
|
|
|
N/A |
|
|
|
|
|
(93,828 |
) |
10,000,000
|
|
USD
|
|
9/20/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
(Pay)
|
|
|
1.25 |
% |
|
|
1.72 |
% |
|
Gazprom OAO
|
|
|
N/A |
|
|
|
|
|
13,589 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85,000,000
|
|
PEN
|
|
9/20/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
0.92 |
% |
|
|
0.62 |
% |
|
Republic of Peru
|
|
|
85,000,000 |
|
|
PEN
|
|
|
133,264 |
|
2,000,000
|
|
USD
|
|
9/20/2012
|
|
Goldman Sachs
International
|
|
(Pay)
|
|
|
9.20 |
% |
|
|
4.24 |
% |
|
Republic of Argentina
|
|
|
N/A |
|
|
|
|
|
(115,869 |
) |
10,000,000
|
|
USD
|
|
10/4/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
2.95 |
% |
|
|
0.57 |
% |
|
Republic of Chile
|
|
|
10,000,000 |
|
|
USD
|
|
|
249,802 |
|
4,000,000
|
|
USD
|
|
10/20/2012
|
|
UBS AG
|
|
(Pay)
|
|
|
3.90 |
% |
|
|
6.79 |
% |
|
Petroleos de Venezuela
|
|
|
N/A |
|
|
|
|
|
81,079 |
|
4,000,000
|
|
USD
|
|
10/20/2012
|
|
UBS AG
|
|
(Pay)
|
|
|
4.13 |
% |
|
|
6.79 |
% |
|
Petroleos de Venezuela
|
|
|
N/A |
|
|
|
|
|
72,161 |
|
42,000,000
|
|
USD
|
|
12/20/2012
|
|
Morgan Stanley
Capital Services
Inc.
|
|
(Pay)
|
|
|
1.20 |
% |
|
|
0.05 |
% |
|
Reference security within
CDX IG Index
|
|
|
N/A |
|
|
|
|
|
(614,198 |
) |
125,384,851
|
|
USD
|
|
12/20/2012
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
0.71 |
% |
|
|
0.01 |
% |
|
Reference security within
CDX IG Index
|
|
|
125,384,851 |
|
|
USD
|
|
|
1,113,029 |
|
20,000,000
|
|
USD
|
|
12/20/2012
|
|
JP Morgan Chase
Bank, N.A.
|
|
(Pay)
|
|
|
5.00 |
% |
|
|
5.02 |
% |
|
Republic of Argentina
|
|
|
N/A |
|
|
|
|
|
(192,532 |
) |
10,000,000
|
|
USD
|
|
12/20/2012
|
|
Goldman Sachs
International
|
|
(Pay)
|
|
|
5.00 |
% |
|
|
5.02 |
% |
|
Republic of Argentina
|
|
|
N/A |
|
|
|
|
|
(96,266 |
) |
22,000,000
|
|
USD
|
|
6/20/2013
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
5.79 |
% |
|
|
7.07 |
% |
|
Republic of Argentina
|
|
|
N/A |
|
|
|
|
|
(158,061 |
) |
82,046,951
|
|
RUB
|
|
6/21/2013
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
2.35 |
% |
|
|
10.34 |
% |
|
VTB Leasing
|
|
|
82,046,951 |
|
|
RUB
|
|
|
(42,878 |
) |
16,938,484
|
|
USD
|
|
6/24/2013
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
1.37 |
% |
|
|
4.32 |
% |
|
VTB Leasing
|
|
|
16,938,484 |
|
|
USD
|
|
|
(381,538 |
) |
277,250,000
|
|
PEN
|
|
8/20/2013
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
0.96 |
% |
|
|
0.89 |
% |
|
Republic of Peru
|
|
|
277,250,000 |
|
|
PEN
|
|
|
393,636 |
|
50,000,000
|
|
USD
|
|
8/20/2013
|
|
JP Morgan Chase
Bank, N.A.
|
|
(Pay)
|
|
|
1.20 |
% |
|
|
1.07 |
% |
|
Republic of Peru
|
|
|
N/A |
|
|
|
|
|
(280,864 |
) |
130,000,000
|
|
USD
|
|
10/20/2013
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
3.30 |
% |
|
|
1.14 |
% |
|
Republic of Brazil
|
|
|
130,000,000 |
|
|
USD
|
|
|
5,772,647 |
|
80,000,000
|
|
USD
|
|
10/20/2013
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
4.05 |
% |
|
|
1.14 |
% |
|
Republic of Brazil
|
|
|
80,000,000 |
|
|
USD
|
|
|
4,748,564 |
|
11,850,000,000
|
|
JPY
|
|
10/20/2013
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
3.20 |
% |
|
|
0.98 |
% |
|
Republic of Brazil
|
|
|
N/A |
|
|
|
|
|
(6,914,746 |
) |
7,110,000,000
|
|
JPY
|
|
10/20/2013
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
3.95 |
% |
|
|
0.98 |
% |
|
Republic of Brazil
|
|
|
N/A |
|
|
|
|
|
(5,506,221 |
) |
10,000,000
|
|
USD
|
|
12/24/2013
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
3.80 |
% |
|
|
2.04 |
% |
|
Republic of Turkey
|
|
|
10,000,000 |
|
|
USD
|
|
|
525,067 |
|
14,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.68 |
% |
|
|
5.01 |
% |
|
Italy Government
International Bond
|
|
|
N/A |
|
|
|
|
|
936,715 |
|
39,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.49 |
% |
|
|
1.48 |
% |
|
Republic of Austria
|
|
|
N/A |
|
|
|
|
|
(126,988 |
) |
28,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.70 |
% |
|
|
5.01 |
% |
|
Republic of Italy
|
|
|
N/A |
|
|
|
|
|
1,860,532 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.45 |
% |
|
|
0.50 |
% |
|
United Kingdom Government
|
|
|
N/A |
|
|
|
|
|
(344,005 |
) |
10,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.85 |
% |
|
|
5.01 |
% |
|
Italy Government
International Bond
|
|
|
N/A |
|
|
|
|
|
629,926 |
|
39,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
2.39 |
% |
|
|
89.29 |
% |
|
Hellenic Republic of
Greece
|
|
|
N/A |
|
|
|
|
|
21,734,124 |
|
39,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.28 |
% |
|
|
0.50 |
% |
|
United Kingdom Government
|
|
|
N/A |
|
|
|
|
|
(793,077 |
) |
14,000,000
|
|
USD
|
|
3/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
2.80 |
% |
|
|
89.29 |
% |
|
Hellenic Republic of
Greece
|
|
|
N/A |
|
|
|
|
|
7,753,554 |
|
2,000,000
|
|
USD
|
|
8/24/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
4.25 |
% |
|
|
3.73 |
% |
|
Lebanese Republic
|
|
|
N/A |
|
|
|
|
|
(49,271 |
) |
15,000,000
|
|
USD
|
|
9/20/2014
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
3.77 |
% |
|
|
1.99 |
% |
|
Russian Federation
|
|
|
15,000,000 |
|
|
USD
|
|
|
841,809 |
|
15,000,000
|
|
USD
|
|
9/20/2014
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
4.03 |
% |
|
|
2.62 |
% |
|
Sberbank
|
|
|
N/A |
|
|
|
|
|
(680,984 |
) |
5,000,000
|
|
USD
|
|
3/20/2015
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
5.00 |
% |
|
|
8.64 |
% |
|
Government of Ukraine
|
|
|
5,000,000 |
|
|
USD
|
|
|
(457,383 |
) |
25,000,000
|
|
USD
|
|
3/20/2015
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
5.00 |
% |
|
|
8.64 |
% |
|
Government of Ukraine
|
|
|
25,000,000 |
|
|
USD
|
|
|
(2,286,915 |
) |
8,000,000
|
|
USD
|
|
3/20/2015
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
5.00 |
% |
|
|
8.64 |
% |
|
Government of Ukraine
|
|
|
8,000,000 |
|
|
USD
|
|
|
(731,813 |
) |
575,500,000
|
|
EUR
|
|
3/20/2015
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
3.72 |
% |
|
|
8.82 |
% |
|
Venezuela Eurobond
|
|
|
N/A |
|
|
|
|
|
103,265,374 |
|
765,000,000
|
|
USD
|
|
3/20/2015
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
3.80 |
% |
|
|
8.90 |
% |
|
Bolivarian Republic of
Venezuela
|
|
|
765,000,000 |
|
|
USD
|
|
|
(103,351,103 |
) |
412,500,000
|
|
USD
|
|
4/20/2015
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
4.40 |
% |
|
|
8.92 |
% |
|
Bolivarian Republic of
Venezuela
|
|
|
412,500,000 |
|
|
USD
|
|
|
(51,190,774 |
) |
300,000,000
|
|
EUR
|
|
4/20/2015
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
4.32 |
% |
|
|
8.85 |
% |
|
Bolivarian Republic of
Venezuela
|
|
|
N/A |
|
|
|
|
|
49,429,850 |
|
30,000,000
|
|
USD
|
|
6/20/2015
|
|
Barclays Bank PLC
|
|
(Pay)
|
|
|
5.00 |
% |
|
|
N/A |
|
|
CDX 13 Emerging Sovereign
|
|
|
N/A |
|
|
|
|
|
(2,599,833 |
) |
40,000,000
|
|
USD
|
|
6/20/2015
|
|
Barclays Bank PLC
|
|
(Pay)
|
|
|
5.00 |
% |
|
|
N/A |
|
|
CDX 13 Emerging Sovereign
|
|
|
N/A |
|
|
|
|
|
(3,466,444 |
) |
11,000,000
|
|
USD
|
|
6/20/2015
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
5.00 |
% |
|
|
N/A |
|
|
CDX 13 Emerging Sovereign
|
|
|
N/A |
|
|
|
|
|
(953,272 |
) |
15,000,000
|
|
USD
|
|
9/20/2015
|
|
Barclays Bank PLC
|
|
(Pay)
|
|
|
1.00 |
% |
|
|
1.43 |
% |
|
Republic of Colombia
|
|
|
N/A |
|
|
|
|
|
208,572 |
|
56,950,000,000
|
|
COP
|
|
11/20/2015
|
|
Citibank N.A.
|
|
Receive
|
|
|
1.81 |
% |
|
|
1.16 |
% |
|
Republic of Colombia
|
|
|
56,950,000,000 |
|
|
COP
|
|
|
699,513 |
|
15,000,000
|
|
USD
|
|
2/20/2016
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
2.16 |
% |
|
|
1.50 |
% |
|
Republic of Colombia
|
|
|
N/A |
|
|
|
|
|
(490,077 |
) |
56,700,000,000
|
|
COP
|
|
2/20/2016
|
|
Citibank N.A.
|
|
Receive
|
|
|
1.46 |
% |
|
|
1.19 |
% |
|
Republic of Colombia
|
|
|
56,700,000,000 |
|
|
COP
|
|
|
413,669 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
114,800,000,000
|
|
COP
|
|
4/20/2016
|
|
Citibank N.A.
|
|
Receive
|
|
|
1.33 |
% |
|
|
1.21 |
% |
|
Republic of Colombia
|
|
114,800,000,000COP
|
|
|
|
|
359,565 |
|
25,000,000
|
|
USD
|
|
4/20/2016
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
1.90 |
% |
|
|
1.53 |
% |
|
Republic of Colombia
|
|
|
N/A |
|
|
|
|
|
(442,052 |
) |
18,333,333
|
|
EUR
|
|
6/17/2016
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
5.60 |
% |
|
|
11.49 |
% |
|
Republic of Angola
|
|
|
18,333,333 |
|
|
EUR
|
|
|
343,183 |
|
20,000,000
|
|
USD
|
|
8/20/2016
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
2.15 |
% |
|
|
1.58 |
% |
|
Republic of Colombia
|
|
|
N/A |
|
|
|
|
|
(628,944 |
) |
97,680,000,000
|
|
COP
|
|
8/20/2016
|
|
Citibank N.A.
|
|
Receive
|
|
|
1.51 |
% |
|
|
1.26 |
% |
|
Republic of Colombia
|
|
|
97,680,000,000 |
|
|
COP
|
|
|
726,397 |
|
32,500,000
|
|
USD
|
|
2/20/2017
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
2.43 |
% |
|
|
9.51 |
% |
|
Bolivarian Republic of
Venezuela
|
|
|
32,500,000 |
|
|
USD
|
|
|
(8,702,498 |
) |
32,000,000
|
|
PEN
|
|
5/20/2017
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
0.79 |
% |
|
|
1.37 |
% |
|
Republic of Peru
|
|
|
32,000,000 |
|
|
PEN
|
|
|
(327,684 |
) |
2,500,000
|
|
USD
|
|
5/20/2017
|
|
Deutsche Bank AG
|
|
(Pay)
|
|
|
1.05 |
% |
|
|
1.70 |
% |
|
Republic of Peru
|
|
|
N/A |
|
|
|
|
|
81,174 |
|
35,000,000
|
|
USD
|
|
7/20/2017
|
|
UBS AG
|
|
Receive
|
|
|
2.26 |
% |
|
|
2.84 |
% |
|
Republic of Turkey
|
|
|
35,000,000 |
|
|
USD
|
|
|
(739,479 |
) |
4,500,000
|
|
USD
|
|
7/20/2017
|
|
JP Morgan Chase
Bank, N.A.
|
|
Receive
|
|
|
3.30 |
% |
|
|
5.58 |
% |
|
Republic of Jamaica
|
|
|
4,500,000 |
|
|
USD
|
|
|
(411,989 |
) |
10,000,000
|
|
USD
|
|
12/20/2018
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
0.44 |
% |
|
|
1.02 |
% |
|
United Kingdom Government
|
|
|
10,000,000 |
|
|
USD
|
|
|
(365,000 |
) |
10,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.62 |
% |
|
|
4.75 |
% |
|
Italy Government
International Bond
|
|
|
10,000,000 |
|
|
USD
|
|
|
(1,651,339 |
) |
30,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.46 |
% |
|
|
2.00 |
% |
|
Republic of Austria
|
|
|
30,000,000 |
|
|
USD
|
|
|
(936,286 |
) |
20,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.66 |
% |
|
|
4.75 |
% |
|
Republic of Italy
|
|
|
20,000,000 |
|
|
USD
|
|
|
(3,258,071 |
) |
10,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.70 |
% |
|
|
4.75 |
% |
|
Italy Government
International Bond
|
|
|
10,000,000 |
|
|
USD
|
|
|
(1,606,732 |
) |
30,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
2.25 |
% |
|
|
55.21 |
% |
|
Hellenic Republic of
Greece
|
|
|
30,000,000 |
|
|
USD
|
|
|
(17,010,710 |
) |
30,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.25 |
% |
|
|
1.03 |
% |
|
United Kingdom Government
|
|
|
30,000,000 |
|
|
USD
|
|
|
512,410 |
|
10,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
2.61 |
% |
|
|
55.21 |
% |
|
Hellenic Republic of
Greece
|
|
|
10,000,000 |
|
|
USD
|
|
|
(5,624,296 |
) |
10,000,000
|
|
USD
|
|
3/20/2019
|
|
Deutsche Bank AG
|
|
Receive
|
|
|
1.35 |
% |
|
|
1.03 |
% |
|
United Kingdom Government
|
|
|
10,000,000 |
|
|
USD
|
|
|
239,130 |
|
6,000,000
|
|
USD
|
|
3/20/2020
|
|
Barclays Bank PLC
|
|
Receive
|
|
|
1.00 |
% |
|
|
5.79 |
% |
|
Republic of Croatia
|
|
|
6,000,000 |
|
|
USD
|
|
|
(1,564,774 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000,000
|
|
USD
|
|
8/15/2031
|
|
Goldman Sachs
International
|
|
(Pay)
|
|
|
1.84 |
% |
|
|
1.98 |
% |
|
United Mexican States
|
|
|
N/A |
|
|
|
|
|
240,168 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(22,025,792 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to
(Pay) Receive
|
|
$ |
19,845,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a credit event occurs, as defined
under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of
protection an amount equal to the notional amount of the swap and take delivery of the referenced
obligation or underlying securities comprising the referenced index or (ii) pay a net settlement
amount in the form of cash or securities equal to the notional amount of the swap less the recovery
value of the referenced obligation or underlying securities comprising the referenced index.
(Pay) Fund pays premium and buys credit protection. If a credit event occurs, as defined under
the terms of that particular swap agreement, the Fund will either (i) receive from the seller of
protection an amount equal to the notional amount of the swap and deliver the referenced obligation
or underlying securities comprising the referenced index or (ii) receive a net settlement amount in
the form of cash or securities equal to the notional amount of the swap less the recovery value of
the referenced obligation or underlying securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in determining the market value of
credit default swap agreements on the reference security, as of November 30, 2011, serve as an
indicator of the current status of the payment/performance risk and reflect the likelihood or risk
of default for the reference entity. The implied credit spread of a particular referenced entity
reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a
deterioration of the referenced entitys credit soundness and a greater likelihood or risk of
default or other credit event occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a seller of credit protection if
a credit event occurs as defined under the terms of that particular swap agreement. |
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
|
|
Receive |
|
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
|
(Pay)# |
|
|
Fixed Rate |
|
|
Variable Rate |
|
|
(Depreciation) |
|
46,800,000 |
|
PEN |
|
|
4/21/2014 |
|
|
JP Morgan Chase Bank, N.A. |
|
Receive |
|
|
5.03 |
% |
|
6 month LIBOR |
|
$ |
1,018,993 |
|
51,000,000 |
|
BRL |
|
|
1/2/2013 |
|
|
JP Morgan Chase Bank, N.A. |
|
Receive |
|
|
13.80 |
% |
|
Floating Rate CDI |
|
|
947,317 |
|
43,000,000 |
|
PEN |
|
|
2/16/2012 |
|
|
JP Morgan Chase Bank, N.A. |
|
(Pay) |
|
|
1.41 |
% |
|
6 month LIBOR |
|
|
(335,425 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,630,885 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate.
|
|
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
|
Fund Pays |
|
|
Fund Receives |
|
|
(Depreciation) |
|
5,000,000 |
|
USD |
|
|
12/12/2011 |
|
|
Barclays Bank PLC |
|
0.85% of notional amount |
|
Total Return on Venezuela 11.75% Bond |
|
$ |
324,689 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash
and/or securities to cover any commitments or collateral requirements of the relevant broker or
exchange.
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
AMBAC Insured as to the payment of principal and interest by AMBAC Assurance Corporation.
CDI Certificado de Deposito Interbancario
CP Counterparty
DEM LIBOR London Interbank Offered Rate denominated in Deutsche Marks
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
GDP Gross Domestic Product
GMTN Global Medium Term Note
ILS TELBOR Tel Aviv Interbank Offered Rate denominated in Israeli Shekel
JPY LIBOR London Interbank Offered Rate denominated in Japanese Yen
JPY TIBOR Tokyo Interbank Offered Rate
LIBOR London Interbank Offered Rate
MTN Medium Term Note
OTC Over-the-Counter
PDI Past Due Interest
PIK Payment In Kind
Reg S Security exempt from registration under Regulation S of the Securities Act of 1933, which exempts from registration securities offered and
sold outside the United States. Security may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act of 1933.
VRRB Variable Rate Reduction Bond
XL Insured as to the payment of principal and interest by XL Capital Assurance.
ZAR Jibar Johannesburg Interbank Offered Rate denominated in South African Rand
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the
security.
|
|
¨ |
These securities are primarily backed by subprime mortgages. |
|
* |
Non-income producing security. |
|
(a) |
Security is backed by the U.S. Government. |
|
(b) |
Security is in default. |
|
(c) |
Indexed security in which price and/or coupon is linked to the prices of a specific instrument or
financial statistic. |
|
(d) |
Security valued at fair value using methods determined in good faith by or at the direction of the
Trustees of GMO Trust. |
|
(e) |
Security represents a judgment against the Government of Argentina (Argentina) relating to
Argentinas failure to make payments on sovereign debt held by the Fund. See Other matters for
additional information. |
|
(f) |
These Peru Trust securities are currently in default. See Other matters for additional
information. |
|
(g) |
All or a portion of this security has been pledged to cover collateral requirements on reverse
repurchase agreements. |
|
(h) |
All or a portion of this security has been pledged to cover
margin requirements on futures contracts, collateral on open swap
contracts, forward currency contracts, and/or written options, if any. |
|
(i) |
Non-performing. Borrower not currently paying interest. |
|
(j) |
Republic of Ghana promissory notes are currently in default. See Other matters for additional
information. |
|
(k) |
Underlying investment represents interests in defaulted claims. See Other matters for additional
information. |
|
(l) |
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(m) |
These Reverse Repurchase Agreements have an open maturity date and can be closed on demand. |
Currency Abbreviations:
ARS Argentine Peso
BRL Brazilian Real
CHF Swiss Franc
COP Colombian Peso
DEM Deutsche Mark
EUR Euro
GBP British Pound
ILS Israeli Shekel
JPY Japanese Yen
KZT Kazakhstan Tenge
MYR Malaysian Ringgit
PEN Peruvian Sol
RUB Russian Ruble
USD United States Dollar
ZAR South African Rand
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$ 1,885,658,404 |
|
$ |
177,271,527 |
|
|
$ |
(227,172,881 |
) |
|
$ |
(49,901,354) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Returm of |
|
|
Value, end of |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
period |
|
GMO Short-Duration
Collateral Fund |
|
$ |
41,271,731 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
312,635 |
|
|
$ |
|
|
|
$ |
13,770,029 |
|
|
$ |
26,281,902 |
|
GMO Special Purpose
Holding Fund |
|
|
10,705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,349 |
|
GMO U.S. Treasury
Fund |
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31 |
|
GMO World
Opportunity Overlay
Fund |
|
|
34,370,376 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,764,589 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
75,652,843 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
312,635 |
|
|
$ |
|
|
|
$ |
13,770,029 |
|
|
$ |
62,054,871 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 31, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined through fiscal
year ending February 29, 2012. |
|
|
Basis of presentation |
|
|
|
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities. |
|
|
|
Portfolio valuation |
|
|
|
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 2.3% of net assets. The Fund and the underlying funds classify such securities
(levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not
reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its
counterparties. See Derivative financial instruments below for a further discussion
on valuation of derivatives. |
|
|
|
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 21.7% of the net assets of the Fund. |
|
|
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security. |
|
|
|
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities. |
|
|
|
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010. |
|
|
|
The three levels are defined as follows: |
|
|
|
Level 1 Valuations based on quoted prices for identical securities in active markets. |
|
|
|
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and market data from pricing vendors) to value certain credit default swaps. |
|
|
|
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. In some |
|
|
cases, quoted prices or prices calculated by using industry models are adjusted by a specified
discount for liquidity or other considerations (including the Argentine judgment described in
Other Matters below). In addition, the Fund valued certain sovereign debt securities using
comparable securities issued by the sovereign adjusted by a specified spread. The Fund valued
certain other debt securities by using a specified spread above the LIBOR rate. The Fund deemed
certain defaulted securities to be worthless. The Fund also used third party valuation services
to value certain credit default swaps using unobservable inputs. |
|
|
|
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011: |
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
1,573,556 |
|
|
$ |
80,868,860 |
|
|
$ |
82,442,416 |
|
Corporate Debt |
|
|
|
|
|
|
112,991,600 |
|
|
|
4,030,000 |
|
|
|
117,021,600 |
|
Foreign Government Agency |
|
|
|
|
|
|
308,151,672 |
|
|
|
40,098,195 |
|
|
|
348,249,867 |
|
Foreign Government Obligations |
|
|
|
|
|
|
622,725,934 |
|
|
|
366,069,962 |
|
|
|
988,795,896 |
|
Judgments |
|
|
|
|
|
|
|
|
|
|
24,862,500 |
|
|
|
24,862,500 |
|
U.S. Government |
|
|
|
|
|
|
65,396,786 |
|
|
|
|
|
|
|
65,396,786 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
1,110,839,548 |
|
|
|
515,929,517 |
|
|
|
1,626,769,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan Assignments |
|
|
|
|
|
|
|
|
|
|
30,911,429 |
|
|
|
30,911,429 |
|
Loan Participations |
|
|
|
|
|
|
|
|
|
|
102,293,647 |
|
|
|
102,293,647 |
|
Promissory Notes |
|
|
|
|
|
|
|
|
|
|
331,250 |
|
|
|
331,250 |
|
Options Purchased |
|
|
|
|
|
|
0 |
* |
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
62,046,522 |
|
|
|
8,349 |
|
|
|
|
|
|
|
62,054,871 |
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
10,271,686 |
|
|
|
10,271,686 |
|
Short-Term Investments |
|
|
3,125,102 |
|
|
|
|
|
|
|
|
|
|
|
3,125,102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
65,171,624 |
|
|
|
1,110,847,897 |
|
|
|
659,737,529 |
|
|
|
1,835,757,050 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
|
|
|
|
|
5,202,272 |
|
|
|
|
|
|
|
5,202,272 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
50,829,141 |
|
|
|
152,698,230 |
|
|
|
203,527,371 |
|
Interest Rate Risk |
|
|
|
|
|
|
1,966,310 |
|
|
|
|
|
|
|
1,966,310 |
|
Equity Risk |
|
|
|
|
|
|
324,689 |
|
|
|
|
|
|
|
324,689 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
65,171,624 |
|
|
$ |
1,169,170,309 |
|
|
$ |
812,435,759 |
|
|
$ |
2,046,777,692 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
$ |
|
|
|
$ |
(778,416 |
) |
|
$ |
|
|
|
$ |
(778,416 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
(62,308,788 |
) |
|
|
(163,244,375 |
) |
|
|
(225,553,163 |
) |
Interest Rate Risk |
|
|
|
|
|
|
(335,425 |
) |
|
|
|
|
|
|
(335,425 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(63,422,629 |
) |
|
$ |
(163,244,375 |
) |
|
$ |
(226,667,004 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Represents the investment in securities that were determined to have a fair value of zero
at November 30, 2011. |
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks. |
|
|
|
** |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
|
|
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds investments (both direct and indirect) in securities and derivative financial instruments
using Level 3 inputs were 42.1% and (0.6)% of total net assets, respectively. |
|
|
|
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2. |
|
|
|
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as of |
|
|
|
from Investments |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Total Realized |
|
|
Appreciation |
|
|
Transfers into |
|
|
Transfers out of |
|
|
November 30, |
|
|
|
Still Held as of |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
level 3 * |
|
|
2011 |
|
|
|
November 30, 2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
96,820,133 |
|
|
$ |
503,783 |
|
|
$ |
(9,378,111 |
) |
|
$ |
10,308 |
|
|
$ |
268,242 |
|
|
$ |
(7,355,495 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
80,868,860 |
|
|
|
$ |
(7,355,494 |
) |
Corporate Debt |
|
|
8,020,000 |
|
|
|
4,000,000 |
|
|
|
(8,000,000 |
) |
|
|
|
|
|
|
|
|
|
|
10,000 |
|
|
|
|
|
|
|
|
|
|
|
4,030,000 |
|
|
|
|
4,030,000 |
|
Foreign Government Agency |
|
|
137,425,667 |
|
|
|
27,840,937 |
|
|
|
(17,550,306 |
) |
|
|
698,575 |
|
|
|
444,476 |
|
|
|
1,423,282 |
|
|
|
|
|
|
|
(110,184,436 |
) |
|
|
40,098,195 |
|
|
|
|
163,980 |
|
Foreign Government Obligations |
|
|
523,408,255 |
|
|
|
54,268,789 |
|
|
|
(68,374,293 |
) |
|
|
8,742,561 |
|
|
|
8,054,743 |
|
|
|
(53,608,549 |
) |
|
|
|
|
|
|
(106,421,544 |
) |
|
|
366,069,962 |
|
|
|
|
(48,769,800 |
) |
Judgments |
|
|
28,170,000 |
|
|
|
|
|
|
|
|
|
|
|
481,588 |
|
|
|
|
|
|
|
(3,789,088 |
) |
|
|
|
|
|
|
|
|
|
|
24,862,500 |
|
|
|
|
(3,789,088 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Obligations |
|
|
793,844,055 |
|
|
|
86,613,509 |
|
|
|
(103,302,710 |
) |
|
|
9,933,032 |
|
|
|
8,767,461 |
|
|
|
(63,319,850 |
) |
|
|
|
|
|
|
(216,605,980 |
) |
|
|
515,929,517 |
|
|
|
|
(55,720,402 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan Assignments |
|
|
33,280,252 |
|
|
|
970,000 |
|
|
|
(2,659,041 |
) |
|
|
721,968 |
|
|
|
614,511 |
|
|
|
(2,016,261 |
) |
|
|
|
|
|
|
|
|
|
|
30,911,429 |
|
|
|
|
(2,016,261 |
) |
Loan Participations |
|
|
117,371,965 |
|
|
|
|
|
|
|
(11,617,259 |
) |
|
|
1,533,602 |
|
|
|
3,326,096 |
|
|
|
(8,320,757 |
) |
|
|
|
|
|
|
|
|
|
|
102,293,647 |
|
|
|
|
(8,320,757 |
) |
Promissory Notes |
|
|
1,071,677 |
|
|
|
|
|
|
|
(817,249 |
) |
|
|
42,241 |
|
|
|
|
|
|
|
34,581 |
|
|
|
|
|
|
|
|
|
|
|
331,250 |
|
|
|
|
|
|
Rights and Warrants |
|
|
10,377,589 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(105,903 |
) |
|
|
|
|
|
|
|
|
|
|
10,271,686 |
|
|
|
|
(105,903 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
955,945,538 |
|
|
|
87,583,509 |
|
|
|
(118,396,259 |
) |
|
|
12,230,843 |
|
|
|
12,708,068 |
|
|
|
(73,728,190 |
) |
|
|
|
|
|
|
(216,605,980 |
) |
|
|
659,737,529 |
|
|
|
|
(66,163,323 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements |
|
|
(10,713,914 |
) |
|
|
|
|
|
|
1,124,209 |
|
|
|
|
|
|
|
(1,124,209 |
) |
|
|
167,769 |
|
|
|
|
|
|
|
|
|
|
|
(10,546,145 |
) |
|
|
|
(10,546,145 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
945,231,624 |
|
|
$ |
87,583,509 |
|
|
$ |
(117,272,050 |
) |
|
$ |
12,230,843 |
|
|
$ |
11,583,859 |
|
|
$ |
(73,560,421 |
) |
|
$ |
|
|
|
$ |
(216,605,980 |
) |
|
$ |
649,191,384 |
|
|
|
$ |
(76,709,468 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at
the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
|
|
Foreign currency translation |
|
|
|
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities. |
|
|
|
Loan agreements |
|
|
|
The Fund may invest in loans to corporate, governmental, or other borrowers. The Funds
investments in loans may be in the form of participations in loans or assignments of all or a
portion of loans. A loan is often administered by a bank or other financial institution that
acts as agent for all holders. The agent administers the terms of the loan, as specified in the
loan agreement. When investing in a loan participation, (i) the Fund has the right to receive
payments of principal, interest and any fees to which it is entitled only from the party from
whom the Fund has purchased the participation and only upon receipt by that party of payments
from the borrower and (ii) the Fund generally has no right to enforce compliance by the borrower
with the terms of the loan agreement or to vote on matters arising under the loan agreement.
Thus, the Fund may be subject to credit risk both of the party from whom it purchased the loan
participation and the borrower and the Fund may have minimal control over the terms of any loan
modification. When the Fund purchases assignments of loans, it acquires direct rights against
the borrower. Loan agreements outstanding at the end of the period are listed in the Funds
Schedule of Investments. |
|
|
|
Repurchase agreements |
|
|
|
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period. |
|
|
|
Reverse repurchase agreements |
|
|
|
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. As of November 30,
2011, the Fund had received $217,682,849 from reverse repurchase agreements relating to
securities with a market value, plus accrued interest, of $221,928,239. Reverse repurchase
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments. |
|
|
|
Inflation-indexed bonds |
|
|
|
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon. |
|
|
|
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds |
|
|
gross income for the period in which they accrue. In addition, any increase or decrease in the
principal amount of an inflation indexed bond will increase or decrease taxable ordinary income
to the Fund, even though principal is not paid until maturity. Inflation-indexed bonds
outstanding at the end of the period are listed in the Funds Schedule of Investments. |
|
|
|
Other matters |
|
|
|
In December 2005, the Fund entered into litigation against the Government of Argentina
(Argentina) relating to Argentinas failure to make payments on sovereign debt held by the
Fund. A judgment was awarded in the Funds favor on September 24, 2007; however, the Funds
ability to collect on this judgment remains uncertain, and the Fund is not able to transfer or
sell the judgment without court consent. In late May 2010, Argentina commenced a public debt
exchange in which certain defaulted debts, including legal judgments on those debts, were
eligible to be exchanged for currently performing Argentina Bonds. The eligible portion of the
Funds judgment was tendered in the debt exchange and the Fund received new bonds in June 2010.
The remaining portion of the Funds judgment, which continues to be valued according to the
Funds valuation policy, represented 1.5% of the net assets of the Fund as of November 30, 2011. |
|
|
|
Peru Trust, Series 1998 I-P; Peru Trust, Series 97-I-P; and Peru Trust II, Series 98-A LB (the
Peru Trusts) held by the Fund are currently in default. The Peru Trusts hold obligations of
Istituto per i Servizi Assicurativi e il Credito allEspotazione (SACE), the Italian Agency
for Insurance of Export Credits. The obligations are payable only to the extent SACE recovers
amounts from the Government of Peru (Peru) in relation to certain export insurance policies.
Peru fully paid all of its obligations to SACE on August 24, 2009; however, payments to the Peru
Trusts by SACE remain outstanding. Litigation between the Peru Trusts and SACE is pending in
Italy with respect to the outstanding payments. The Peru Trusts ability to recover such
payments, and the Funds corresponding ability to receive payment with respect to its investment
in the Peru Trusts, remains uncertain. The Peru Trusts, which continue to be valued according to
the Funds valuation policy, represented 0.1% of the net assets of the Fund as of November 30,
2011. Costs associated with this action are borne by the Fund. |
|
|
|
In July 2008, the Fund entered into litigation against GNPA Limited (GNPA) (an entity wholly
owned by the government of Ghana) seeking payment on an unconditional promissory note issued by
GNPA. A judgment was awarded in the Funds favor in February 2010; however, the Funds ability
to collect on this judgment remains uncertain. The defaulted promissory note, which continues to
be valued according to the Funds valuation policy, represented less than 0.1% of the net assets
of the Fund as of November 30, 2011. Costs associated with this action are borne by the Fund. |
|
|
|
In connection with the Funds purchase of Venezuelan bonds between 2000 and 2002, the Fund
acquired warrants which (along with related payments on those warrants) have not been received
in custody. The Funds trading counterparties have acknowledged their delivery obligations but
have not necessarily accepted legal liability for payment. Because there can be no assurance
that the Fund will receive the warrants (or related payments), the Fund values the warrants at
fair value using methods determined in good faith by or at the discretion of the Trustees of GMO
Trust. The value of any possible recovery is carried at $1,015,199 representing 0.1% of the net
assets of the Fund as of November 30, 2011. |
|
|
|
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation. |
|
|
|
Investment and other risks |
|
|
|
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time. |
|
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of rising interest rates and widening
of credit spreads. |
|
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers |
|
|
|
failure to meet its payment obligations or the markets expectation of a default, which may
result from the downgrading of the issuers credit rating. The Funds investments in below
investment grade securities have speculative characteristics, and changes in economic
conditions or other circumstances are more likely to impair the capacity of issuers to make
principal and interest payments than is the case with issuers of investment grade
securities. Because the Fund typically invests in securities that are of lesser quality than
those in its benchmark, in rapidly declining markets, the percentage decline in the value of
the Fund is likely to exceed that of its benchmark. |
|
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind. Sovereign debt of
emerging countries is not widely traded and may be subject to purchase and sale
restrictions. In addition, because the Fund typically invests in securities that are less
liquid than those in its benchmark, in rapidly declining markets the percentage decline in
the Funds investments is likely to exceed that of its benchmark. |
|
|
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries. |
|
|
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline. |
|
|
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk. |
|
|
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies. |
|
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
|
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions. |
|
|
Focused Investment Risk Focusing investments in a limited number of countries,
regions, sectors or companies creates additional risk. |
|
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
|
|
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade. |
|
|
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations. |
|
|
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities. |
|
|
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions. |
|
|
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations. |
|
|
Derivative financial instruments |
|
|
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts. |
|
|
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency. |
|
|
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency. |
|
|
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments. |
|
|
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending. |
|
|
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets. |
|
|
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation. |
|
|
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund. |
|
|
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value. |
|
|
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund. |
|
|
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders. |
|
|
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk that it will be required to pay the full
notional value of the swap contract in the event of a default. |
|
|
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above). |
|
|
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk. |
|
|
Forward currency contracts |
|
|
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed. |
|
|
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to
adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward
currency contracts outstanding at the end of the period are listed in the Funds Schedule of
Investments. |
|
|
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period. |
|
|
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust interest rate exposure. Option contracts purchased by the Fund and
outstanding at the end of the period are listed in the Funds Schedule of Investments. |
|
|
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions),
securities or currencies it owns or in which it may invest. Writing options alters the Funds
exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell
the underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When |
|
|
the Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer of an option, the Fund has no control over
whether it will be required to sell (call) or purchase (put) the underlying asset and as a
result bears the risk of an unfavorable change in the price of the asset underlying the option.
In the event that the Fund writes call options without an offsetting exposure (e.g., call
options on an asset that the Fund does not own), it bears an unlimited risk of loss if the price
of the underlying asset increases during the term of the option. OTC options expose the Fund to
the risk the Fund may not be able to enter into a closing transaction because of an illiquid
market. The Fund had no written option contracts outstanding at the end of the period. |
|
|
|
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed. |
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models. |
|
|
|
Swap agreements |
|
|
|
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral. |
|
|
|
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses. |
|
|
|
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal). |
|
|
|
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party. |
|
|
|
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination. |
|
|
|
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring. |
|
|
|
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment |
|
|
when that variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset. |
|
|
|
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate. |
|
|
|
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure, adjust exposure to certain markets, achieve exposure to a
reference entitys credit, and/or provide a measure of protection against default loss. Swap
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments. |
|
|
|
Rights and warrants |
|
|
|
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. Additionally, the Fund
owns warrants linked to the price of oil. During the period ended November 30, 2011, the Fund held rights
and/or warrants received to adjust exposure to certain markets. Rights and/or warrants held by the Fund at the end of
the period are listed in the Funds Schedule of Investments. |
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (purchased options, rights
and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
10,271,686 |
|
|
$ |
10,271,686 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
5,202,272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,202,272 |
|
Unrealized appreciation on swap agreements |
|
|
1,966,310 |
|
|
|
|
|
|
|
203,527,371 |
|
|
|
324,689 |
|
|
|
|
|
|
|
205,818,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,966,310 |
|
|
$ |
5,202,272 |
|
|
$ |
203,527,371 |
|
|
$ |
324,689 |
|
|
$ |
10,271,686 |
|
|
$ |
221,292,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(778,416 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(778,416 |
) |
Unrealized depreciation on swap agreements |
|
|
(335,425 |
) |
|
|
|
|
|
|
(225,553,163 |
) |
|
|
|
|
|
|
|
|
|
|
(225,888,588 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(335,425 |
) |
|
$ |
(778,416 |
) |
|
$ |
(225,553,163 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(226,667,004 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance,
the table above is based on market values or unrealized appreciation / (depreciation) rather than the notional
amounts of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the
Fund (with correspondingly greater risk) the greater the notional amount. For further information on notional amounts,
see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, and rights
and/or warrants), notional amounts (swap agreements), or principal amounts (options) outstanding at
each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
Currency |
|
Swap |
|
|
|
|
|
Rights and/or |
|
|
Contracts |
|
Agreements |
|
Options |
|
Warrants |
Average amount outstanding |
|
$ |
539,499,784 |
|
|
$ |
4,565,788,786 |
|
|
$ |
401,027,019 |
|
|
$ |
10,306,987 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Emerging Domestic Opportunities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 83.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 10.3% |
|
|
|
|
|
138,500 |
|
|
Arcos Dorados Holdings Inc Class A |
|
|
3,035,920 |
|
|
533,400 |
|
|
Brasil Brokers Participacoes SA |
|
|
1,796,337 |
|
|
95,912 |
|
|
Companhia de Bebidas das Americas |
|
|
2,630,705 |
|
|
146,600 |
|
|
Fleury SA |
|
|
1,670,008 |
|
|
231,400 |
|
|
Gafisa SA ADR |
|
|
1,393,028 |
|
|
331,200 |
|
|
Itau Unibanco Holding SA ADR |
|
|
5,895,360 |
|
|
409,100 |
|
|
Light SA |
|
|
6,200,918 |
|
|
155,300 |
|
|
LPS Brasil Consultoria de Imoveis SA |
|
|
2,319,602 |
|
|
305,400 |
|
|
Multiplus SA |
|
|
5,353,599 |
|
|
285,100 |
|
|
PDG Realty SA Empreendimentos e Participacoes |
|
|
1,059,459 |
|
|
290,400 |
|
|
Redecard SA |
|
|
4,897,946 |
|
|
202,800 |
|
|
Telefonica Brasil SA ADR |
|
|
5,469,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
41,722,398 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China 11.8% |
|
|
|
|
|
9,531 |
|
|
Baidu Inc Sponsored ADR * |
|
|
1,248,466 |
|
|
1,678,000 |
|
|
China Mengniu Dairy Co Ltd |
|
|
6,045,864 |
|
|
207,500 |
|
|
China Mobile Ltd |
|
|
2,048,937 |
|
|
2,144,000 |
|
|
Dah Chong Hong Holdings Ltd |
|
|
2,971,178 |
|
|
1,912,000 |
|
|
Dongfeng Motor Group Co Ltd Class H |
|
|
2,871,691 |
|
|
710,000 |
|
|
Galaxy Entertainment Group Ltd * |
|
|
1,417,254 |
|
|
1,669,000 |
|
|
Haitian International Holdings Ltd |
|
|
1,447,221 |
|
|
532,500 |
|
|
Hengan International Group Co Ltd |
|
|
5,016,811 |
|
|
36,000 |
|
|
Home Inns & Hotels Management Inc ADR * |
|
|
1,118,160 |
|
|
2,257,500 |
|
|
Intime Department Store Group Co Ltd |
|
|
2,650,763 |
|
|
6,974,450 |
|
|
Kingdee International Software Group Co Ltd |
|
|
2,372,535 |
|
|
1,920,000 |
|
|
Kunlun Energy Company Ltd |
|
|
2,598,688 |
|
|
170,700 |
|
|
New Oriental Education & Technology Group Inc Sponsored ADR * |
|
|
4,308,468 |
|
|
4,245,500 |
|
|
Sun Art Retail Group Ltd * |
|
|
5,803,663 |
|
|
1,430,000 |
|
|
Tingyi (Cayman Islands) Holding Corp |
|
|
4,652,341 |
|
|
1,974,000 |
|
|
Trinity Ltd |
|
|
1,444,343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total China |
|
|
48,016,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 0.5% |
|
|
|
|
|
707,000 |
|
|
Chow Sang Sang Holdings International Ltd |
|
|
1,961,573 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 6.0% |
|
|
|
|
|
18,378 |
|
|
Asian Paints Ltd |
|
|
1,022,213 |
|
|
375,442 |
|
|
Coromandel International Ltd |
|
|
2,081,917 |
|
|
1,485,240 |
|
|
Dish TV India Ltd * |
|
|
1,857,364 |
|
|
31,191 |
|
|
Glaxo SmithKline Consumer Healthcare Ltd |
|
|
1,502,147 |
|
|
33,985 |
|
|
Hero Honda Motors Ltd |
|
|
1,329,464 |
|
|
914,220 |
|
|
Idea Cellular Ltd * |
|
|
1,687,204 |
|
|
394,039 |
|
|
Indraprastha Gas Ltd |
|
|
3,055,754 |
|
|
299,602 |
|
|
IndusInd Bank Ltd (a) |
|
|
1,450,022 |
|
|
66,894 |
|
|
Jubilant Foodworks Ltd * |
|
|
1,005,625 |
|
|
81,990 |
|
|
Kotak Mahindra Bank Ltd |
|
|
747,325 |
|
|
139,725 |
|
|
Mahindra & Mahindra Ltd |
|
|
1,991,673 |
|
|
36,062 |
|
|
Nestle India Ltd |
|
|
2,930,854 |
|
|
398,058 |
|
|
Petronet LNG Ltd |
|
|
1,261,953 |
|
|
473,846 |
|
|
Rallis India Ltd |
|
|
1,388,002 |
|
|
187,993 |
|
|
Sun TV Network Ltd |
|
|
957,922 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total India |
|
|
24,269,439 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 9.2% |
|
|
|
|
|
10,158,500 |
|
|
ACE Hardware Indonesia Tbk PT |
|
|
4,306,727 |
|
|
1,350,500 |
|
|
Astra International Tbk PT |
|
|
10,847,518 |
|
|
2,967,500 |
|
|
Bank Central Asia Tbk PT |
|
|
2,645,313 |
|
|
4,750,855 |
|
|
Bank Danamon Indonesia Tbk PT |
|
|
2,349,542 |
|
|
13,194,500 |
|
|
Bank Mandiri Tbk PT |
|
|
9,610,337 |
|
|
1,564,500 |
|
|
Indomobil Sukses Internasional Tbk PT * |
|
|
2,298,063 |
|
|
4,412,500 |
|
|
Kalbe Farma Tbk PT |
|
|
1,745,999 |
|
|
11,000 |
|
|
Sumber Alfaria Trijaya Tbk PT |
|
|
5,117 |
|
|
1,310,287 |
|
|
United Tractors Tbk PT |
|
|
3,455,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
37,264,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Macau 0.3% |
|
|
|
|
|
354,400 |
|
|
Wynn Macau Ltd * |
|
|
1,038,780 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 1.8% |
|
|
|
|
|
1,294,700 |
|
|
AMMB Holdings Berhad |
|
|
2,462,590 |
|
|
1,522,400 |
|
|
Hong Leong Bank Berhad |
|
|
5,059,359 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Malaysia |
|
|
7,521,949 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexico 1.9% |
|
|
|
|
|
139,770 |
|
|
First Cash Financial Services, Inc. * |
|
|
5,073,651 |
|
|
105,400 |
|
|
Grupo Televisa SA Sponsored ADR |
|
|
2,188,104 |
|
|
142,700 |
|
|
Grupo Televisa SA-Series CPO |
|
|
594,420 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Mexico |
|
|
7,856,175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nigeria 0.6% |
|
|
|
|
|
963,551 |
|
|
Nestle Nigeria Plc |
|
|
2,290,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 0.9% |
|
|
|
|
|
10,070,645 |
|
|
Puregold Price Club Inc * |
|
|
3,532,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 3.3% |
|
|
|
|
|
276,647 |
|
|
Magnit OJSC Sponsored GDR (Registered Shares) |
|
|
6,151,930 |
|
|
606,727 |
|
|
Sberbank
Sponsored ADR *(a) |
|
|
7,381,208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
13,533,138 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Africa 5.0% |
|
|
|
|
|
1,282,280 |
|
|
Growthpoint Properties Ltd |
|
|
2,911,323 |
|
|
304,198 |
|
|
Shoprite Holdings Ltd |
|
|
5,134,797 |
|
|
92,715 |
|
|
Tiger Brands Ltd |
|
|
2,808,183 |
|
|
450,500 |
|
|
Vodacom Group Ltd |
|
|
5,094,220 |
|
|
111,703 |
|
|
Wilson Bayly Holmes-Ovcon Ltd |
|
|
1,453,257 |
|
|
614,307 |
|
|
Woolworths Holdings Ltd |
|
|
3,071,549 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Africa |
|
|
20,473,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 5.2% |
|
|
|
|
|
8,135 |
|
|
E-Mart Co Ltd * |
|
|
2,110,769 |
|
|
28,330 |
|
|
GS Home Shopping Inc |
|
|
2,710,698 |
|
|
23,046 |
|
|
Hyundai Mobis |
|
|
6,390,912 |
|
|
31,557 |
|
|
Hyundai Motor Co |
|
|
6,138,345 |
|
|
113,155 |
|
|
Kangwon Land Inc |
|
|
2,789,112 |
|
|
2,097 |
|
|
ORION Corp |
|
|
1,133,213 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
21,273,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 1.4% |
|
|
|
|
|
1,461,000 |
|
|
Chunghwa Telecom Co Ltd |
|
|
4,843,046 |
|
|
|
|
|
|
|
|
|
|
|
6,900 |
|
|
Chunghwa Telecom Co Ltd ADR |
|
|
230,667 |
|
|
100 |
|
|
Taiwan Mobile Co Ltd |
|
|
322 |
|
|
400,000 |
|
|
Yungtay Engineering Co Ltd |
|
|
606,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Taiwan |
|
|
5,680,978 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 10.8% |
|
|
|
|
|
997,800 |
|
|
Advanced Info Service Pcl (Foreign Registered) (a) |
|
|
4,552,825 |
|
|
1,940,100 |
|
|
Bangkok Dusit Medical Service Pcl (Foreign Registered) (a) |
|
|
4,734,522 |
|
|
2,003,300 |
|
|
BEC World Pcl (Foreign Registered) (a) |
|
|
2,562,875 |
|
|
1,955,100 |
|
|
Charoen Pokphand Foods Pcl (Foreign Registered) (a) |
|
|
2,113,506 |
|
|
3,192,900 |
|
|
CP ALL Pcl (Foreign Registered) (a) |
|
|
5,226,630 |
|
|
48,180,600 |
|
|
Hemaraj Land and Development Pcl (Foreign Registered) (a) |
|
|
3,531,837 |
|
|
668,100 |
|
|
Hemaraj Land and Development Pcl NVDR |
|
|
48,975 |
|
|
21,746,886 |
|
|
Home Product Center Pcl (Foreign Registered) (a) |
|
|
7,247,397 |
|
|
14,110,800 |
|
|
Land & Houses Pcl NVDR |
|
|
2,771,117 |
|
|
1,264,100 |
|
|
Robinson Department Store Pcl (Foreign Registered) (a) |
|
|
1,503,897 |
|
|
291,100 |
|
|
Siam Makro Pcl (Foreign Registered) (a) |
|
|
2,158,381 |
|
|
9,802,700 |
|
|
Thai Tap Water Supply Pcl (Foreign Registered) (a) |
|
|
1,670,636 |
|
|
2,375,900 |
|
|
Thanachart Capital Pcl (Foreign Registered) (a) |
|
|
1,953,915 |
|
|
123,300 |
|
|
Tisco Financial Group Pcl (Foreign Registered) (a) |
|
|
156,794 |
|
|
744,500 |
|
|
Tisco Financial Group Pcl NVDR |
|
|
946,742 |
|
|
1,068,600 |
|
|
Total Access Communication Pcl NVDR |
|
|
2,799,261 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Thailand |
|
|
43,979,310 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turkey 1.4% |
|
|
|
|
|
2,164,603 |
|
|
Dogus Otomotiv Servis ve Ticaret AS * |
|
|
3,894,476 |
|
|
549,702 |
|
|
Turkiye Garanti Bankasi |
|
|
1,883,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Turkey |
|
|
5,777,585 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 12.6% |
|
|
|
|
|
190,200 |
|
|
ColgatePalmolive Co. |
|
|
17,403,300 |
|
|
233,700 |
|
|
Dominos Pizza, Inc. * |
|
|
7,698,078 |
|
|
463,800 |
|
|
Yum! Brands, Inc. |
|
|
25,991,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
51,092,730 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $322,855,513) |
|
|
337,283,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 1.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 1.3% |
|
|
|
|
|
393,100 |
|
|
AES Tiete SA 11.00% |
|
|
5,358,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $5,094,419) |
|
|
5,358,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 8.8% |
|
|
|
|
|
|
|
|
|
United States 8.8% |
|
|
|
|
|
|
826,119 |
|
|
Vanguard Emerging Markets ETF (b) |
|
|
33,705,655 |
|
|
47,784 |
|
|
iShares MSCI Emerging Markets Index Fund (c) |
|
|
1,913,272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
35,618,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $34,467,517) |
|
|
35,618,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 3.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 3.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
509,802 |
|
|
GMO U.S. Treasury Fund |
|
|
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $12,750,143) |
|
|
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 1.0% |
|
|
|
|
USD |
1,750,000 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
1,750,000 |
|
ZAR |
16,132 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 4.85%, due 12/01/11 |
|
|
1,988 |
|
USD |
1,750,000 |
|
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
1,750,000 |
|
USD |
641,740 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
641,740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
4,143,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $4,143,728) |
|
|
4,143,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 97.3%
(Cost $379,311,320) |
|
|
395,154,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 2.7% |
|
|
11,125,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
406,280,278 |
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments: |
|
ADR American Depositary Receipt |
|
CP Counterparty |
|
CPO Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a bundle of shares of the multiple series of one issuer that trade together as a unit. |
|
ETF Exchange-Traded Fund |
|
Foreign Registered Shares issued to foreign investors in markets that have foreign ownership limits. |
|
GDR Global Depository Receipt |
|
MSCI Morgan Stanley Capital International |
|
NVDR Non-Voting Depository Receipt |
|
* |
|
Non-income producing security. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
|
(b) |
|
Represents an investment to equitize cash in the Vanguard Emerging Markets ETF, which is a separate investment portfolio of Vanguard, Inc., a registered
investment company. The Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all (normally about 95%) of its assets in the common stocks
included in the MSCI Emerging Market Index, while employing a form of sampling to reduce risk. |
|
(c) |
|
Represents an investment to equitize cash in the iShares® MSCI Emerging Markets Index Fund, which is a separate investment portfolio of iShares, Inc., a registered investment
company. The iShares® MSCI Emerging Markets Index Funds prospectus states that it invests in global emerging markets and seeks investment results that correspond generally
to the price and yield performance, before fees and expenses, of the MSCI Emerging Markets Index. iShares® is a registered trademark of BlackRock. Neither BlackRock nor the
iShares® Funds make any representations regarding the advisability of investing in the iShares® MSCI Emerging Markets Index Fund. |
|
Currency Abbreviations: |
|
HKD Hong Kong Dollar |
|
SGD Singapore Dollar |
|
USD United States Dollar |
|
ZAR South African Rand
|
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$381,264,390
|
|
$22,041,542
|
|
$ |
(8,151,095
|
) |
$13,890,447 |
Investments In Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should
be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period March 1, 2011 (commencement of operations)
through November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S Treasury
Fund |
|
$ |
|
|
|
$ |
143,790,376 |
|
|
$ |
131,040,493 |
|
|
$ |
632 |
|
|
$ |
12 |
|
|
$ |
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
11.4% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and
securities markets that are closed prior to the close of the NYSE due to time zone differences
(including the value of equity securities that underlie futures (to the extent the market for
such futures closes prior to the close of the NYSE) and other derivatives) will be adjusted, to
the extent practicable and available, based on inputs from an independent pricing service
approved by the Trustees. The table below shows the percentage of the net assets of the Fund
that were valued using fair value prices obtained from an independent pricing service as of
November 30, 2011. These securities listed on foreign exchanges (including the value of equity
securities that underlie futures (to the extent the market for such futures closes prior to the
close of the NYSE) and other derivatives) are classified as being valued using Level 2 inputs in
the table below.
|
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
|
|
Equity Securities
|
|
42.9% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value techniques on Level 3 investments: Certain of the Funds
securities in Thailand and India were valued at the local price as adjusted by applying a
premium or discount when the holdings exceed foreign ownership
limitations. The Fund also valued certain securities using a price
from a comparable security related to the same issuer that trades on a
different exchange.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
$ |
41,722,398 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
41,722,398 |
|
China |
|
|
12,478,757 |
|
|
|
35,537,626 |
|
|
|
|
|
|
|
48,016,383 |
|
Hong Kong |
|
|
|
|
|
|
1,961,573 |
|
|
|
|
|
|
|
1,961,573 |
|
India |
|
|
|
|
|
|
22,819,417 |
|
|
|
1,450,022 |
|
|
|
24,269,439 |
|
Indonesia |
|
|
|
|
|
|
37,264,378 |
|
|
|
|
|
|
|
37,264,378 |
|
Macau |
|
|
|
|
|
|
1,038,780 |
|
|
|
|
|
|
|
1,038,780 |
|
Malaysia |
|
|
|
|
|
|
7,521,949 |
|
|
|
|
|
|
|
7,521,949 |
|
Mexico |
|
|
7,856,175 |
|
|
|
|
|
|
|
|
|
|
|
7,856,175 |
|
Nigeria |
|
|
|
|
|
|
2,290,071 |
|
|
|
|
|
|
|
2,290,071 |
|
Philippines |
|
|
3,532,345 |
|
|
|
|
|
|
|
|
|
|
|
3,532,345 |
|
Russia |
|
|
|
|
|
|
6,151,930 |
|
|
|
7,381,208 |
|
|
|
13,533,138 |
|
South Africa |
|
|
|
|
|
|
20,473,329 |
|
|
|
|
|
|
|
20,473,329 |
|
South Korea |
|
|
|
|
|
|
21,273,049 |
|
|
|
|
|
|
|
21,273,049 |
|
Taiwan |
|
|
230,667 |
|
|
|
5,450,311 |
|
|
|
|
|
|
|
5,680,978 |
|
Thailand |
|
|
|
|
|
|
6,566,095 |
|
|
|
37,413,215 |
|
|
|
43,979,310 |
|
Turkey |
|
|
|
|
|
|
5,777,585 |
|
|
|
|
|
|
|
5,777,585 |
|
United States |
|
|
51,092,730 |
|
|
|
|
|
|
|
|
|
|
|
51,092,730 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
116,913,072 |
|
|
|
174,126,093 |
|
|
|
46,244,445 |
|
|
|
337,283,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
|
5,358,429 |
|
|
|
|
|
|
|
|
|
|
|
5,358,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
5,358,429 |
|
|
|
|
|
|
|
|
|
|
|
5,358,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
35,618,927 |
|
|
|
|
|
|
|
|
|
|
|
35,618,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS |
|
|
35,618,927 |
|
|
|
|
|
|
|
|
|
|
|
35,618,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
12,750,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
4,143,728 |
|
|
|
|
|
|
|
|
|
|
|
4,143,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
174,784,299 |
|
|
|
174,126,093 |
|
|
|
46,244,445 |
|
|
|
395,154,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
174,784,299 |
|
|
$ |
174,126,093 |
|
|
$ |
46,244,445 |
|
|
$ |
395,154,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to
the underlying funds portfolio valuation notes. The aggregate net values of the Funds direct
investments in securities using Level 3 inputs were 11.4% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from Investments |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as |
|
|
Still Held as |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Total Realized |
|
|
Appreciation |
|
|
Transfers |
|
|
Transfers out |
|
|
of November |
|
|
November 30, |
|
|
|
28, 2011 ** |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
into level 3 * |
|
|
of level 3 * |
|
|
30, 2011 |
|
|
2011 |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India |
|
$ |
|
|
|
$ |
3,084,067 |
|
|
$ |
(1,253,166 |
) |
|
$ |
|
|
|
$ |
(158,913 |
) |
|
$ |
(221,966 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,450,022 |
|
|
$ |
(221,966 |
) |
Russia |
|
|
|
|
|
|
5,951,644 |
|
|
|
(514,229 |
) |
|
|
|
|
|
|
(102,138 |
) |
|
|
2,045,931 |
|
|
|
|
|
|
|
|
|
|
|
7,381,208 |
|
|
|
2,045,931 |
|
Thailand |
|
|
|
|
|
|
35,377,315 |
|
|
|
(1,735,771 |
) |
|
|
|
|
|
|
(36,759 |
) |
|
|
3,808,430 |
|
|
|
|
|
|
|
|
|
|
|
37,413,215 |
|
|
|
3,808,430 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
44,413,026 |
|
|
$ |
(3,503,166 |
) |
|
$ |
|
|
|
$ |
(297,810 |
) |
|
$ |
5,632,395 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
46,244,445 |
|
|
$ |
5,632,395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
|
** |
|
Note: Fund commenced operation on March 1, 2011. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of value of those investments. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments related to emerging markets, the
economies of which tend to be more volatile than the economies of developed markets.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Focused Investment Risk The Funds investments in companies whose prospects are
linked to the internal development and growth of emerging markets create additional risk
because the performance of those companies is likely to be highly correlated.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. The Fund is also subject to risk because the Fund does not seek to
control risk relative to a particular securities market index or benchmark.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds (including
ETFs) in which it invests will not perform as expected.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. The Fund had no forward currency
contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market. The Fund
had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated
terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange
rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A
liquidation payment received or made at the termination of the swap agreements is recorded as
realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Emerging Markets Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 85.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 11.9% |
|
|
|
|
|
231,100 |
|
|
Arcos Dorados Holdings Inc Class A |
|
|
5,065,712 |
|
|
2,742,010 |
|
|
Banco Bradesco ADR |
|
|
45,243,165 |
|
|
10,920,200 |
|
|
Banco do Brasil SA |
|
|
146,138,104 |
|
|
1,851,200 |
|
|
Banco Santander Brasil SA ADR |
|
|
14,291,264 |
|
|
1,004,500 |
|
|
BM&FBOVESPA SA |
|
|
5,488,130 |
|
|
2,339,100 |
|
|
BR Malls Participacoes SA |
|
|
23,683,978 |
|
|
1,583,900 |
|
|
Brasil Brokers Participacoes SA |
|
|
5,334,117 |
|
|
680,165 |
|
|
Brasil Telecom SA ADR |
|
|
12,120,540 |
|
|
727,800 |
|
|
BRF Brasil Foods SA |
|
|
14,665,170 |
|
|
390,180 |
|
|
Centrais Eletricas Brasileiras SA ADR |
|
|
5,228,412 |
|
|
886,270 |
|
|
Centrais Eletricas Brasileiras SA Sponsored ADR |
|
|
8,233,448 |
|
|
1,228,763 |
|
|
CETIP SA |
|
|
17,870,693 |
|
|
6,200 |
|
|
Cia de Bebidas das Americas ADR |
|
|
170,376 |
|
|
1,040,302 |
|
|
Cia de Saneamento Basico do Estado de Sao Paulo |
|
|
28,758,093 |
|
|
36,282 |
|
|
Cia de Saneamento Basico do Estado de Sao Paulo ADR |
|
|
2,003,492 |
|
|
254,800 |
|
|
Cia Paranaense de Energia Sponsored ADR |
|
|
5,134,220 |
|
|
1,329,800 |
|
|
Cielo SA |
|
|
35,407,897 |
|
|
608,060 |
|
|
Companhia de Bebidas das Americas |
|
|
16,678,063 |
|
|
716,200 |
|
|
Companhia de Bebidas das Americas ADR |
|
|
24,622,956 |
|
|
1,076,800 |
|
|
Companhia de Saneamento de Minas Gerais-Copasa MG |
|
|
19,215,493 |
|
|
18,300 |
|
|
Companhia Energetica de Minas Gerais Sponsored ADR |
|
|
321,165 |
|
|
605,300 |
|
|
Cosan SA Industria e Comercio |
|
|
9,004,103 |
|
|
1,470,000 |
|
|
Cyrela Brazil Realty SA |
|
|
12,217,823 |
|
|
1,280,592 |
|
|
Electrobras (Centro) |
|
|
11,734,128 |
|
|
693,300 |
|
|
Fleury SA |
|
|
7,897,796 |
|
|
838,400 |
|
|
Gafisa SA ADR |
|
|
5,047,168 |
|
|
3,055,100 |
|
|
Gerdau SA |
|
|
19,580,617 |
|
|
2,663,300 |
|
|
Gerdau SA Sponsored ADR |
|
|
20,454,144 |
|
|
15,500 |
|
|
HRT Participacoes em Petroleo SA * |
|
|
5,699,947 |
|
|
7,257,650 |
|
|
Itau Unibanco Holding SA ADR |
|
|
129,186,170 |
|
|
1,980,300 |
|
|
Light SA |
|
|
30,016,326 |
|
|
1,013,800 |
|
|
LPS Brasil Consultoria de Imoveis SA |
|
|
15,142,388 |
|
|
1,180,300 |
|
|
Multiplus SA |
|
|
20,690,414 |
|
|
1,058,200 |
|
|
PDG Realty SA Empreendimentos e Participacoes |
|
|
3,932,372 |
|
|
6,650,790 |
|
|
Petroleo Brasileiro SA (Petrobras) ADR |
|
|
179,504,822 |
|
|
4,077,000 |
|
|
Redecard SA |
|
|
68,763,514 |
|
|
1,332,860 |
|
|
Telefonica Brasil SA ADR |
|
|
35,947,234 |
|
|
321,103 |
|
|
Tim Participacoes SA ADR |
|
|
7,645,462 |
|
|
911,100 |
|
|
Ultrapar Participacoes SA |
|
|
16,031,853 |
|
|
105,100 |
|
|
Ultrapar Participacoes SA Sponsored ADR |
|
|
1,867,627 |
|
|
22,700 |
|
|
Usinas Siderurgicas de Minas Gerais SA Sponsored ADR |
|
|
135,519 |
|
|
1,723,800 |
|
|
Vale SA |
|
|
39,702,641 |
|
|
6,998,200 |
|
|
Vale SA Sponsored ADR |
|
|
162,708,150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
1,238,584,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chile 0.2% |
|
|
|
|
|
826,614 |
|
|
Empresa National de Telecomunicaciones SA |
|
|
16,751,898 |
|
|
52,949,871 |
|
|
Madeco SA * |
|
|
2,341,234 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Chile |
|
|
19,093,132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China 12.7% |
|
|
|
|
|
61,800 |
|
|
Baidu Inc Sponsored ADR * |
|
|
8,095,182 |
|
|
133,249,640 |
|
|
Bank of China Ltd Class H |
|
|
43,445,600 |
|
|
30,572,480 |
|
|
Bank of Communications Co Ltd Class H |
|
|
19,961,839 |
|
|
4,786,000 |
|
|
Belle International Holdings Ltd |
|
|
9,208,402 |
|
|
|
|
|
|
|
|
|
|
|
9,315,400 |
|
|
Changsha Zoomlion Heavy Industry Science and Technology Development Co Ltd Class H |
|
|
9,990,166 |
|
|
26,906,000 |
|
|
China CITIC Bank Corp Class H |
|
|
14,493,806 |
|
|
12,361,700 |
|
|
China Coal Energy Co Class H |
|
|
14,766,420 |
|
|
17,669,700 |
|
|
China Communication Services Corp Ltd Class H |
|
|
8,531,128 |
|
|
34,459,150 |
|
|
China Communications Construction Co Ltd Class H |
|
|
26,571,459 |
|
|
25,124,099 |
|
|
China Construction Bank Class H |
|
|
17,867,205 |
|
|
4,038,000 |
|
|
China Everbright Ltd |
|
|
6,069,149 |
|
|
44,600 |
|
|
China Life Insurance Co Ltd ADR |
|
|
1,795,596 |
|
|
9,329,000 |
|
|
China Life Insurance Co Ltd Class H |
|
|
25,088,238 |
|
|
6,646,000 |
|
|
China Mengniu Dairy Co Ltd |
|
|
23,945,658 |
|
|
10,177,000 |
|
|
China Minsheng Banking Corp Ltd |
|
|
8,351,659 |
|
|
30,297,237 |
|
|
China Mobile Ltd |
|
|
299,166,850 |
|
|
546,800 |
|
|
China Mobile Ltd Sponsored ADR |
|
|
27,159,556 |
|
|
8,466,000 |
|
|
China National Building Material Co Ltd Class H |
|
|
10,305,198 |
|
|
947,080 |
|
|
China Ocean Resources Co Ltd |
|
|
4,272,165 |
|
|
5,929,400 |
|
|
China Pacific Insurance Group Co Ltd |
|
|
17,063,424 |
|
|
40,100 |
|
|
China Petroleum & Chemical Corp ADR |
|
|
4,264,635 |
|
|
119,449,351 |
|
|
China Petroleum & Chemical Corp Class H |
|
|
126,477,424 |
|
|
24,211,000 |
|
|
China Railway Group Ltd Class H |
|
|
7,755,666 |
|
|
9,388,500 |
|
|
China Shenhua Energy Co Ltd Class H |
|
|
41,440,896 |
|
|
7,878,000 |
|
|
China Southern Airlines Co Ltd Class H * |
|
|
4,197,165 |
|
|
41,500 |
|
|
China Telecom Corp Ltd ADR |
|
|
2,568,020 |
|
|
128,558,000 |
|
|
China Telecom Corp Ltd Class H |
|
|
78,518,237 |
|
|
4,268,400 |
|
|
China Ting Group Holding Ltd |
|
|
232,058 |
|
|
24,077,900 |
|
|
China Unicom Hong Kong Ltd |
|
|
52,274,518 |
|
|
1,458,500 |
|
|
China Unicom Hong Kong Ltd ADR |
|
|
31,459,845 |
|
|
9,826,400 |
|
|
Citic Pacific Ltd |
|
|
18,667,570 |
|
|
5,283,000 |
|
|
CNOOC Ltd |
|
|
10,248,111 |
|
|
820 |
|
|
CNOOC Ltd ADR |
|
|
158,522 |
|
|
3,602,000 |
|
|
Dah Chong Hong Holdings Ltd |
|
|
4,991,691 |
|
|
13,834,000 |
|
|
Dongfeng Motor Group Co Ltd Class H |
|
|
20,777,709 |
|
|
6,988,000 |
|
|
Galaxy Entertainment Group Ltd * |
|
|
13,948,979 |
|
|
35,140,000 |
|
|
GOME Electrical Appliances Holdings Ltd |
|
|
9,026,073 |
|
|
4,188,525 |
|
|
Great Wall Motor Co Ltd Class H |
|
|
6,032,397 |
|
|
17,237,500 |
|
|
Haitian International Holdings Ltd |
|
|
14,946,958 |
|
|
2,289,000 |
|
|
Hengan International Group Co Ltd |
|
|
21,565,220 |
|
|
97,400 |
|
|
Home Inns & Hotels Management Inc ADR * |
|
|
3,025,244 |
|
|
12,902,440 |
|
|
Hopson Development Holdings Ltd |
|
|
7,756,828 |
|
|
92,276,000 |
|
|
Industrial and Commercial Bank of China Ltd Class H |
|
|
53,802,559 |
|
|
3,769,500 |
|
|
Intime Department Store Group Co Ltd |
|
|
4,426,158 |
|
|
11,654,000 |
|
|
Kingdee International Software Group Co Ltd |
|
|
3,964,402 |
|
|
6,210,000 |
|
|
Kunlun Energy Company Ltd |
|
|
8,405,133 |
|
|
4,656,160 |
|
|
Lianhua Supermarket Holdings Co Ltd |
|
|
5,751,118 |
|
|
7,536,700 |
|
|
Minth Group Ltd |
|
|
7,024,999 |
|
|
285,400 |
|
|
New Oriental Education & Technology Group Inc Sponsored ADR * |
|
|
7,203,496 |
|
|
6,356,172 |
|
|
Peace Mark Holdings Ltd * (a)(b) |
|
|
|
|
|
63,100 |
|
|
PetroChina Co Ltd ADR |
|
|
8,250,325 |
|
|
41,484,301 |
|
|
PetroChina Co Ltd Class H |
|
|
53,869,913 |
|
|
15,908,000 |
|
|
PICC Property & Casualty Co Ltd Class H |
|
|
21,558,651 |
|
|
3,299,000 |
|
|
Ping An Insurance (Group) Co of China Ltd Class H |
|
|
22,983,821 |
|
|
13,568,000 |
|
|
Sun Art Retail Group Ltd * |
|
|
18,547,663 |
|
|
348,700 |
|
|
Suntech Power Holdings Co Ltd ADR * |
|
|
864,776 |
|
|
5,044,000 |
|
|
Tingyi (Cayman Islands) Holding Corp |
|
|
16,410,074 |
|
|
3,143,600 |
|
|
Weichai Power Co Ltd Class H |
|
|
14,756,116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total China |
|
|
1,324,301,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Czech Republic 1.5% |
|
|
|
|
|
2,557,442 |
|
|
CEZ AS |
|
|
100,969,986 |
|
|
176,400 |
|
|
Komercni Banka AS |
|
|
29,160,442 |
|
|
|
|
|
|
|
|
|
|
|
196,730 |
|
|
Pegas Nonwovens SA |
|
|
4,693,580 |
|
|
10,667 |
|
|
Philip Morris CR AS |
|
|
6,930,136 |
|
|
599,330 |
|
|
Telefonica 02 Czech Republic AS |
|
|
12,541,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Czech Republic |
|
|
154,295,845 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt 1.4% |
|
|
|
|
|
1,403,439 |
|
|
Alexandria Mineral Oils Co |
|
|
15,091,928 |
|
|
9,183,853 |
|
|
Arab Cotton Ginning |
|
|
3,985,172 |
|
|
4,313,370 |
|
|
Commercial International Bank |
|
|
17,236,673 |
|
|
59,608 |
|
|
EFG-Hermes Holding GDR * |
|
|
214,760 |
|
|
1,697,999 |
|
|
EFG-Hermes Holding SAE * |
|
|
3,115,246 |
|
|
448,823 |
|
|
Egyptian Co for Mobile Services |
|
|
7,298,953 |
|
|
1,751,207 |
|
|
ElSwedy Electric Co |
|
|
6,386,498 |
|
|
526,146 |
|
|
Orascom Construction Industries |
|
|
19,370,357 |
|
|
34,261 |
|
|
Orascom Construction Industries GDR |
|
|
1,234,767 |
|
|
14,449,944 |
|
|
Orascom Telecom Holding SAE * |
|
|
7,163,255 |
|
|
4,705,236 |
|
|
Orascom Telecom Holding SAE GDR (Registered Shares) * |
|
|
12,277,641 |
|
|
6,195,288 |
|
|
Sidi Kerir Petrochemicals Co |
|
|
12,873,555 |
|
|
9,875,104 |
|
|
South Valley Cement |
|
|
5,719,755 |
|
|
11,433,399 |
|
|
Talaat Moustafa Group * |
|
|
7,129,225 |
|
|
9,866,090 |
|
|
Telecom Egypt |
|
|
23,080,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Egypt |
|
|
142,177,845 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 0.0% |
|
|
|
|
|
1,185,000 |
|
|
Chow Sang Sang Holdings International Ltd |
|
|
3,287,784 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hungary 1.0% |
|
|
|
|
|
55,072 |
|
|
Egis Gyogyszergyar Nyrt |
|
|
4,514,260 |
|
|
6,697,748 |
|
|
Magyar Telekom Nyrt |
|
|
15,333,235 |
|
|
119,203 |
|
|
MOL Hungarian Oil and Gas Nyrt * |
|
|
9,922,244 |
|
|
4,637,155 |
|
|
OTP Bank Nyrt |
|
|
68,878,058 |
|
|
37,195 |
|
|
Richter Gedeon Nyrt |
|
|
5,607,212 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hungary |
|
|
104,255,009 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 5.1% |
|
|
|
|
|
996,097 |
|
|
Aban Offshore Ltd |
|
|
6,767,815 |
|
|
11,840,176 |
|
|
Alok Industries Ltd |
|
|
4,347,961 |
|
|
105,319 |
|
|
Asian Paints Ltd |
|
|
5,858,007 |
|
|
1,408,103 |
|
|
Aurobindo Pharma Ltd |
|
|
2,526,095 |
|
|
156,860 |
|
|
Bayer Cropscience Ltd |
|
|
2,330,641 |
|
|
1,718,215 |
|
|
Bharti Airtel Ltd |
|
|
12,666,369 |
|
|
1,587,014 |
|
|
Canara Bank Ltd |
|
|
13,287,114 |
|
|
1,823,810 |
|
|
Coal India Ltd |
|
|
11,619,177 |
|
|
832,320 |
|
|
Coromandel International Ltd |
|
|
4,615,416 |
|
|
4,197,855 |
|
|
Dish TV India Ltd * |
|
|
5,249,620 |
|
|
1,048,356 |
|
|
GAIL India Ltd |
|
|
8,068,285 |
|
|
1,218,069 |
|
|
Gitanjali Gems Ltd |
|
|
7,973,527 |
|
|
90,829 |
|
|
Glaxo SmithKline Consumer Healthcare Ltd |
|
|
4,374,292 |
|
|
490,883 |
|
|
Grasim Industries Ltd (a) |
|
|
23,009,567 |
|
|
1,018,207 |
|
|
HDFC Bank Ltd |
|
|
8,843,943 |
|
|
392,500 |
|
|
HDFC Bank Ltd ADR |
|
|
10,856,550 |
|
|
278,224 |
|
|
Hero Honda Motors Ltd |
|
|
10,883,887 |
|
|
8,736,910 |
|
|
Hexaware Technologies Ltd |
|
|
14,442,926 |
|
|
947,250 |
|
|
HSIL Ltd |
|
|
2,743,645 |
|
|
5,827,143 |
|
|
Idea Cellular Ltd * |
|
|
10,754,062 |
|
|
2,604,877 |
|
|
Indraprastha Gas Ltd |
|
|
20,200,696 |
|
|
1,665,626 |
|
|
IndusInd Bank Ltd (a) |
|
|
8,061,341 |
|
|
302,308 |
|
|
Infosys Technologies Ltd |
|
|
15,490,011 |
|
|
733,490 |
|
|
Infosys Technologies Ltd Sponsored ADR |
|
|
37,862,754 |
|
|
|
|
|
|
|
|
|
|
|
1,369,784 |
|
|
Ipca Laboratories Ltd |
|
|
6,783,875 |
|
|
426,834 |
|
|
Jubilant Foodworks Ltd * |
|
|
6,416,645 |
|
|
1,227,170 |
|
|
Kiri Industries Ltd (c) |
|
|
1,895,901 |
|
|
276,979 |
|
|
Kotak Mahindra Bank Ltd |
|
|
2,524,618 |
|
|
717,709 |
|
|
Mahindra & Mahindra Ltd |
|
|
10,230,392 |
|
|
1,135,425 |
|
|
Mphasis Ltd |
|
|
7,117,657 |
|
|
104,083 |
|
|
Nestle India Ltd |
|
|
8,459,099 |
|
|
2,576,042 |
|
|
NTPC Ltd |
|
|
8,182,634 |
|
|
4,738,139 |
|
|
Oil & Natural Gas Corp Ltd |
|
|
24,637,745 |
|
|
5,116,997 |
|
|
Petronet LNG Ltd |
|
|
16,222,290 |
|
|
4,174,275 |
|
|
Power Grid Corp of India Ltd |
|
|
8,025,013 |
|
|
1,305,020 |
|
|
Rallis India Ltd |
|
|
3,822,699 |
|
|
1,316,394 |
|
|
Reliance Industries Ltd |
|
|
20,179,333 |
|
|
46,756 |
|
|
Reliance Industries Ltd Sponsored GDR, 144A |
|
|
1,408,441 |
|
|
5,644,438 |
|
|
Satyam Computer Services Ltd * |
|
|
7,333,130 |
|
|
7,898,140 |
|
|
Sesa Goa Ltd |
|
|
28,607,142 |
|
|
9,442,568 |
|
|
Shree Renuka Sugars Ltd |
|
|
5,592,077 |
|
|
5,433,778 |
|
|
Sterlite Industries India Ltd |
|
|
10,711,277 |
|
|
612,700 |
|
|
Sterlite Industries India Ltd ADR |
|
|
4,938,362 |
|
|
807,650 |
|
|
Sun TV Network Ltd |
|
|
4,115,397 |
|
|
1,736,803 |
|
|
Tata Consultancy Services Ltd |
|
|
37,871,453 |
|
|
3,865,735 |
|
|
Tata Motors Ltd |
|
|
13,251,859 |
|
|
270,800 |
|
|
Tata Motors Ltd Sponsored ADR |
|
|
4,657,760 |
|
|
4,088,793 |
|
|
Tata Power Co Ltd |
|
|
7,349,179 |
|
|
2,365,200 |
|
|
Tata Steel Ltd |
|
|
17,725,608 |
|
|
710,993 |
|
|
Torrent Pharmaceuticals Ltd |
|
|
7,584,071 |
|
|
2,827,962 |
|
|
Welspun Corp Ltd |
|
|
3,849,303 |
|
|
428,574 |
|
|
Whirlpool of India Ltd * |
|
|
1,555,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total India |
|
|
533,882,326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 6.3% |
|
|
|
|
|
15,102,500 |
|
|
ACE Hardware Indonesia Tbk PT |
|
|
6,402,751 |
|
|
25,416,000 |
|
|
AKR Corporindo Tbk PT |
|
|
8,184,642 |
|
|
27,013,500 |
|
|
Astra International Tbk PT |
|
|
216,978,473 |
|
|
178,985,775 |
|
|
Bakrie Telecom Tbk PT * |
|
|
5,610,651 |
|
|
15,598,500 |
|
|
Bank Central Asia Tbk PT |
|
|
13,904,943 |
|
|
36,788,668 |
|
|
Bank Danamon Indonesia Tbk PT |
|
|
18,193,886 |
|
|
90,617,202 |
|
|
Bank Mandiri Tbk PT |
|
|
66,001,886 |
|
|
21,896,500 |
|
|
Bank Negara Indonesia (Persero) Tbk PT |
|
|
9,423,653 |
|
|
75,642,500 |
|
|
Bank Rakyat Tbk PT |
|
|
56,017,452 |
|
|
60,980,000 |
|
|
Gajah Tunggal Tbk PT |
|
|
19,438,006 |
|
|
72,212,500 |
|
|
Global Mediacom Tbk PT |
|
|
7,917,792 |
|
|
7,236,000 |
|
|
Harum Energy Tbk PT |
|
|
5,521,399 |
|
|
24,703,550 |
|
|
Indofood Sukses Makmur Tbk PT |
|
|
13,195,995 |
|
|
1,564,500 |
|
|
Indomobil Sukses Internasional Tbk PT * |
|
|
2,298,063 |
|
|
55,192,000 |
|
|
Kalbe Farma Tbk PT |
|
|
21,839,136 |
|
|
10,530,000 |
|
|
Matahari Putra Prima Tbk PT |
|
|
1,107,071 |
|
|
61,017,000 |
|
|
Media Nusantara Citra Tbk PT |
|
|
7,695,614 |
|
|
61,051,500 |
|
|
Perusahaan Gas Negara PT |
|
|
21,205,064 |
|
|
7,111,000 |
|
|
Straits Asia Resources Ltd |
|
|
10,939,216 |
|
|
6,572,500 |
|
|
Tambang Batubara Bukit Asam Tbk PT |
|
|
12,654,282 |
|
|
64,257,000 |
|
|
Telekomunikasi Indonesia Tbk PT |
|
|
52,657,963 |
|
|
470,300 |
|
|
Telekomunikasi Indonesia Tbk PT Sponsored ADR |
|
|
15,402,325 |
|
|
22,602,112 |
|
|
United Tractors Tbk PT |
|
|
59,611,005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
652,201,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kazakhstan 0.2% |
|
|
|
|
|
972,711 |
|
|
KazMunaiGas Exploration Production GDR |
|
|
15,669,332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Macau 0.1% |
|
|
|
|
|
3,330,000 |
|
|
Wynn Macau Ltd * |
|
|
9,760,544 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 0.5% |
|
|
|
|
|
8,327,930 |
|
|
AMMB Holdings Berhad |
|
|
15,840,181 |
|
|
1,952,000 |
|
|
Genting Berhad |
|
|
6,879,413 |
|
|
3,349,913 |
|
|
Hong Leong Bank Berhad |
|
|
11,132,693 |
|
|
11,727,819 |
|
|
Lion Industries Corp Berhad |
|
|
5,046,962 |
|
|
2,037,027 |
|
|
Shangri-La Hotels Berhad |
|
|
1,344,449 |
|
|
3,844,400 |
|
|
UMW Holdings Berhad |
|
|
8,173,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Malaysia |
|
|
48,417,674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexico 1.5% |
|
|
|
|
|
43,381,400 |
|
|
America Movil SAB de CV Class L |
|
|
51,634,866 |
|
|
3,122,600 |
|
|
America Movil SAB de CV Class L ADR |
|
|
74,380,332 |
|
|
234,000 |
|
|
First Cash Financial Services Inc * |
|
|
8,494,200 |
|
|
1,801,000 |
|
|
Grupo Financiero Banorte SAB de CV Class O |
|
|
6,095,458 |
|
|
262,400 |
|
|
Grupo Televisa SA Sponsored ADR |
|
|
5,447,424 |
|
|
2,900,800 |
|
|
Grupo Televisa SA-Series CPO |
|
|
12,083,343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Mexico |
|
|
158,135,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Morocco 0.1% |
|
|
|
|
|
749,424 |
|
|
Maroc Telecom |
|
|
12,718,173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nigeria 0.1% |
|
|
|
|
|
1,732,376 |
|
|
Nestle Nigeria Plc |
|
|
4,117,336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 1.2% |
|
|
|
|
|
4,235,830 |
|
|
BDO Unibank Inc |
|
|
5,443,517 |
|
|
98,766,400 |
|
|
Lopez Holding Corp |
|
|
10,502,926 |
|
|
7,179,552 |
|
|
Metropolitan Bank & Trust Co |
|
|
11,102,535 |
|
|
848,220 |
|
|
Philippine Long Distance Telephone Co |
|
|
47,127,570 |
|
|
443,300 |
|
|
Philippine Long Distance Telephone Co Sponsored ADR |
|
|
24,470,160 |
|
|
51,350,600 |
|
|
Puregold Price Club Inc * |
|
|
18,011,558 |
|
|
10,608,100 |
|
|
Universal Robina Corp |
|
|
12,267,457 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Philippines |
|
|
128,925,723 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland 1.5% |
|
|
|
|
|
524,825 |
|
|
Asseco Poland SA |
|
|
7,790,941 |
|
|
1,065,854 |
|
|
Grupa Lotos SA * |
|
|
8,022,305 |
|
|
2,246,638 |
|
|
KGHM Polska Miedz SA |
|
|
89,285,344 |
|
|
2,783,621 |
|
|
PGE SA |
|
|
17,825,214 |
|
|
794,260 |
|
|
Polski Koncern Naftowy Orlen SA * |
|
|
9,570,895 |
|
|
5,316,338 |
|
|
Synthos SA |
|
|
6,789,119 |
|
|
9,716,593 |
|
|
Tauron Polska Energia SA |
|
|
15,772,772 |
|
|
712,388 |
|
|
Telekomunikacja Polska SA |
|
|
3,936,840 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Poland |
|
|
158,993,430 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 11.5% |
|
|
|
|
|
138,966 |
|
|
Bashneft OAO Class S |
|
|
6,611,925 |
|
|
2,694,062 |
|
|
Gazprom Neft Class S |
|
|
12,588,624 |
|
|
394,348 |
|
|
Gazprom Neft JSC Sponsored ADR |
|
|
9,034,193 |
|
|
30,676,111 |
|
|
Gazprom OAO Sponsored ADR |
|
|
354,718,179 |
|
|
4,383,257 |
|
|
Lukoil OAO ADR |
|
|
246,811,852 |
|
|
1,407,798 |
|
|
Magnit OJSC Sponsored GDR |
|
|
31,305,870 |
|
|
892,861 |
|
|
Magnitogorsk Iron & Steel Works Sponsored GDR (Registered Shares) |
|
|
5,590,414 |
|
|
9,196 |
|
|
Mail.ru Group Ltd GDR *, 144A |
|
|
283,237 |
|
|
700,752 |
|
|
Mail.ru Group Ltd GDR (Registered Shares) * |
|
|
21,692,763 |
|
|
|
|
|
|
|
|
|
|
|
1,136,270 |
|
|
Mechel Sponsored ADR |
|
|
12,373,980 |
|
|
1,406,980 |
|
|
MMC Norilsk Nickel JSC ADR |
|
|
24,843,357 |
|
|
1,625,260 |
|
|
Mobile Telesystems Sponsored ADR |
|
|
28,084,493 |
|
|
353,986 |
|
|
NovaTek OAO Sponsored GDR (Registered Shares) |
|
|
54,233,097 |
|
|
2,039,222 |
|
|
OAO Tatneft Sponsored GDR (Registered Shares) |
|
|
66,036,206 |
|
|
18,610,649 |
|
|
Rosneft OJSC GDR (Registered Shares) |
|
|
136,202,947 |
|
|
2,745,787 |
|
|
Rostelecom * |
|
|
14,453,817 |
|
|
135,000 |
|
|
RUSIA Petroleum Class S * (a) |
|
|
1,350 |
|
|
2,782,198 |
|
|
Sberbank Sponsored ADR * (a) |
|
|
33,847,152 |
|
|
523,492 |
|
|
Sistema JSFC Sponsored GDR (Registered Shares) |
|
|
10,497,208 |
|
|
9,852,907 |
|
|
Surgutneftegas Sponsored ADR |
|
|
94,707,255 |
|
|
643,121 |
|
|
Tatneft |
|
|
3,466,211 |
|
|
508,707 |
|
|
TNK-BP Holding Class S |
|
|
1,401,451 |
|
|
586,554 |
|
|
Uralkali Sponsored GDR (Registered Shares) |
|
|
23,831,024 |
|
|
107,800 |
|
|
Yandex NV * |
|
|
2,369,444 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
1,194,986,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Africa 3.3% |
|
|
|
|
|
1,463,950 |
|
|
Absa Group Ltd |
|
|
25,978,483 |
|
|
198,735 |
|
|
AngloGold Ashanti Ltd |
|
|
9,415,342 |
|
|
2,825,762 |
|
|
Blue Label Telecoms Ltd |
|
|
2,030,684 |
|
|
885,888 |
|
|
Exxaro Resources Ltd |
|
|
19,771,337 |
|
|
13,014,594 |
|
|
FirstRand Ltd |
|
|
32,338,601 |
|
|
8,694 |
|
|
Gold Fields Ltd |
|
|
146,499 |
|
|
256,800 |
|
|
Gold Fields Ltd Sponsored ADR |
|
|
4,350,192 |
|
|
3,559,591 |
|
|
Growthpoint Properties Ltd |
|
|
8,081,792 |
|
|
502,263 |
|
|
Impala Platinum Holdings Ltd |
|
|
10,681,735 |
|
|
1,241,476 |
|
|
Investec Ltd |
|
|
7,288,163 |
|
|
267,284 |
|
|
Kumba Iron Ore Ltd |
|
|
16,836,807 |
|
|
1,351,057 |
|
|
MTN Group Ltd |
|
|
24,338,186 |
|
|
614,756 |
|
|
Nedbank Group Ltd |
|
|
10,907,228 |
|
|
1,016,289 |
|
|
Remgro Ltd |
|
|
15,334,843 |
|
|
2,788,254 |
|
|
Sanlam Ltd |
|
|
10,337,879 |
|
|
724,545 |
|
|
Sasol Ltd |
|
|
34,759,116 |
|
|
65,900 |
|
|
Sasol Ltd Sponsored ADR |
|
|
3,157,269 |
|
|
1,047,345 |
|
|
Shoprite Holdings Ltd |
|
|
17,678,958 |
|
|
645,516 |
|
|
Standard Bank Group Ltd |
|
|
7,872,527 |
|
|
1,530,084 |
|
|
Steinhoff International Holdings Ltd * |
|
|
4,482,375 |
|
|
5,345,735 |
|
|
Telkom South Africa Ltd |
|
|
19,157,137 |
|
|
371,704 |
|
|
Tiger Brands Ltd |
|
|
11,258,295 |
|
|
2,122,279 |
|
|
Vodacom Group Ltd |
|
|
23,998,570 |
|
|
992,236 |
|
|
Wilson Bayly Holmes-Ovcon Ltd |
|
|
12,909,002 |
|
|
2,290,709 |
|
|
Woolworths Holdings Ltd |
|
|
11,453,596 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Africa |
|
|
344,564,616 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 12.6% |
|
|
|
|
|
329,245 |
|
|
BS Financial Group Inc * |
|
|
3,428,430 |
|
|
471,263 |
|
|
Celltrion Inc |
|
|
15,628,386 |
|
|
310,470 |
|
|
Cheil Worldwide Inc |
|
|
5,424,822 |
|
|
33,596 |
|
|
CJ CheilJedang Corp |
|
|
8,612,468 |
|
|
63,917 |
|
|
Daum Communications Corp |
|
|
8,397,222 |
|
|
1,019,672 |
|
|
DGB Financial Group Inc * |
|
|
12,010,183 |
|
|
46,398 |
|
|
Dong-A Pharmaceutical Co Ltd |
|
|
3,913,188 |
|
|
295,563 |
|
|
Dongbu Insurance Co Ltd |
|
|
13,621,258 |
|
|
312,250 |
|
|
Dongkuk Steel Mill Co Ltd |
|
|
6,378,722 |
|
|
23,676 |
|
|
E-Mart Co Ltd * |
|
|
6,143,154 |
|
|
289,126 |
|
|
Edu Ark Co Ltd * (a) |
|
|
|
|
|
427,229 |
|
|
Finetex EnE Inc * |
|
|
681,319 |
|
|
676,820 |
|
|
Foosung Co Ltd * |
|
|
5,036,700 |
|
|
|
|
|
|
|
|
|
|
|
71,169 |
|
|
GS Home Shopping Inc |
|
|
6,809,660 |
|
|
1,033,609 |
|
|
Hana Financial Group Inc |
|
|
37,392,649 |
|
|
697,615 |
|
|
Hanwha Corp |
|
|
22,826,723 |
|
|
373,710 |
|
|
Hynix Semiconductor Inc |
|
|
7,870,125 |
|
|
211,806 |
|
|
Hyosung Corp |
|
|
11,924,238 |
|
|
131,426 |
|
|
Hyundai Heavy Industries Co Ltd |
|
|
32,789,804 |
|
|
380,364 |
|
|
Hyundai Hysco |
|
|
14,385,285 |
|
|
445,880 |
|
|
Hyundai Marine & Fire Insurance Co Ltd |
|
|
13,378,617 |
|
|
110,782 |
|
|
Hyundai Mobis |
|
|
30,721,083 |
|
|
205,320 |
|
|
Hyundai Motor Co |
|
|
39,938,046 |
|
|
209,965 |
|
|
Hyundai Steel Co |
|
|
18,639,043 |
|
|
3,457,522 |
|
|
In the F Co Ltd * (c) |
|
|
1,887,120 |
|
|
2,325,464 |
|
|
Industrial Bank of Korea |
|
|
30,914,805 |
|
|
677,465 |
|
|
Kangwon Land Inc |
|
|
16,698,563 |
|
|
17,733 |
|
|
KCC Corp |
|
|
3,725,003 |
|
|
136,124 |
|
|
Kia Motors Corp |
|
|
8,659,798 |
|
|
1,112,955 |
|
|
KleanNara Co Ltd * |
|
|
3,653,603 |
|
|
241,320 |
|
|
Kolon Corp |
|
|
4,568,681 |
|
|
171,210 |
|
|
Kolon Industries Inc |
|
|
9,247,764 |
|
|
4,396,328 |
|
|
Korea Exchange Bank |
|
|
32,128,570 |
|
|
246,831 |
|
|
Korea Investment Holdings Co Ltd |
|
|
8,294,212 |
|
|
24,737 |
|
|
Korea Zinc Co Ltd |
|
|
7,624,803 |
|
|
911,126 |
|
|
KT Corp |
|
|
29,179,181 |
|
|
944,900 |
|
|
KT Corp Sponsored ADR |
|
|
15,165,645 |
|
|
941,985 |
|
|
KT&G Corp |
|
|
63,750,461 |
|
|
186,513 |
|
|
LG International Corp |
|
|
8,536,995 |
|
|
3,389,382 |
|
|
LG Uplus Corp |
|
|
20,263,719 |
|
|
18,710 |
|
|
Lotte Shopping Co Ltd |
|
|
5,898,816 |
|
|
62,307 |
|
|
NCSoft Corp |
|
|
16,954,291 |
|
|
61,322 |
|
|
NHN Corp * |
|
|
13,604,539 |
|
|
11,557 |
|
|
ORION Corp |
|
|
6,245,369 |
|
|
300,539 |
|
|
POSCO |
|
|
101,289,697 |
|
|
74,900 |
|
|
POSCO ADR |
|
|
6,415,185 |
|
|
489,930 |
|
|
Pumyang Construction Co Ltd * |
|
|
367,649 |
|
|
1,870,110 |
|
|
RNL BIO Co Ltd * |
|
|
10,859,388 |
|
|
295,999 |
|
|
Samsung Electronics Co Ltd |
|
|
269,394,526 |
|
|
154,007 |
|
|
Samsung Fire & Marine Insurance Co Ltd |
|
|
30,381,595 |
|
|
87,031 |
|
|
Samsung Life Insurance Co Ltd |
|
|
6,482,333 |
|
|
88,113 |
|
|
Seah Besteel Corp |
|
|
4,511,893 |
|
|
1,223,587 |
|
|
Shinhan Financial Group Co Ltd |
|
|
45,619,028 |
|
|
36,935 |
|
|
Shinsegae Co Ltd |
|
|
7,945,159 |
|
|
643,724 |
|
|
Simm Tech Co Ltd |
|
|
7,047,047 |
|
|
197,794 |
|
|
SK C&C Co Ltd |
|
|
24,308,378 |
|
|
156,024 |
|
|
SK Chemicals Co Ltd |
|
|
9,254,038 |
|
|
444,682 |
|
|
SK Telecom Co Ltd |
|
|
59,586,527 |
|
|
2,289,700 |
|
|
SK Telecom Co Ltd ADR |
|
|
33,864,663 |
|
|
60,415 |
|
|
SK Holdings Co Ltd |
|
|
7,869,443 |
|
|
162,250 |
|
|
SM Entertainment Co * |
|
|
6,483,430 |
|
|
1,691,940 |
|
|
Tong Yang Securities Inc |
|
|
6,387,265 |
|
|
3,849,940 |
|
|
Woori Finance Holdings Co Ltd |
|
|
34,492,606 |
|
|
499,262 |
|
|
Youngone Corp |
|
|
12,975,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
1,318,488,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sri Lanka 0.1% |
|
|
|
|
|
20,990,000 |
|
|
Anilana Hotel & Properties (a)(d) |
|
|
1,842,925 |
|
|
5,731,554 |
|
|
Hatton National Bank Plc |
|
|
7,743,956 |
|
|
268,616 |
|
|
Hatton National Bank Plc (Non Voting) |
|
|
200,469 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sri Lanka |
|
|
9,787,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 6.2% |
|
|
|
|
|
3,989,600 |
|
|
Advantech Co Ltd |
|
|
11,143,747 |
|
|
5,315,070 |
|
|
Asustek Computer Inc |
|
|
37,137,016 |
|
|
5,189,229 |
|
|
Catcher Technology Co Ltd |
|
|
25,357,234 |
|
|
30,681,329 |
|
|
Chunghwa Telecom Co Ltd |
|
|
101,705,063 |
|
|
228,500 |
|
|
Chunghwa Telecom Co Ltd ADR |
|
|
7,638,755 |
|
|
57,471,311 |
|
|
Compal Electronics Inc |
|
|
52,423,565 |
|
|
6,540,000 |
|
|
E Ink Holdings Inc |
|
|
12,126,383 |
|
|
16,972,994 |
|
|
Far Eastone Telecommunications Co Ltd |
|
|
32,335,496 |
|
|
5,455,732 |
|
|
Gintech Energy Corp |
|
|
5,182,896 |
|
|
829,000 |
|
|
Global Unichip Corp |
|
|
2,706,926 |
|
|
330,000 |
|
|
Grand Pacific Petrochemical Corp |
|
|
138,091 |
|
|
7,801,312 |
|
|
Hon Hai Precision Industry Co Ltd |
|
|
21,215,495 |
|
|
257,188 |
|
|
HTC Corp |
|
|
4,234,194 |
|
|
13,284,349 |
|
|
Lite-On Technology Corp |
|
|
14,558,147 |
|
|
37,422,000 |
|
|
Macronix International Co Ltd |
|
|
15,507,872 |
|
|
2,355,000 |
|
|
MediaTek Inc |
|
|
22,474,320 |
|
|
9,928,000 |
|
|
Neo Solar Power Corp |
|
|
6,011,230 |
|
|
3,605,658 |
|
|
Novatek Microelectronics Corp Ltd |
|
|
9,081,429 |
|
|
7,700,749 |
|
|
Powertech Technology Inc |
|
|
17,552,231 |
|
|
27,746,290 |
|
|
Quanta Computer Inc |
|
|
55,845,908 |
|
|
3,130,660 |
|
|
Radiant Opto-Electronics Corp |
|
|
9,513,257 |
|
|
1,385,000 |
|
|
Senao International Co Ltd |
|
|
4,550,285 |
|
|
16,058,923 |
|
|
Taishin Financial Holding Co Ltd |
|
|
5,987,459 |
|
|
7,575,676 |
|
|
Taiwan Mobile Co Ltd |
|
|
24,378,498 |
|
|
28,446,044 |
|
|
Taiwan Semiconductor Manufacturing Co Ltd |
|
|
71,314,518 |
|
|
28,700 |
|
|
TPK Holding Co Ltd * |
|
|
393,123 |
|
|
60,140,000 |
|
|
United Microelectronics Corp |
|
|
26,685,793 |
|
|
1,119,400 |
|
|
United Microelectronics Corp Sponsored ADR |
|
|
2,563,426 |
|
|
28,283,212 |
|
|
Wistron Corp |
|
|
35,612,354 |
|
|
9,221,570 |
|
|
Yungtay Engineering Co Ltd |
|
|
13,992,412 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Taiwan |
|
|
649,367,123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 3.9% |
|
|
|
|
|
11,764,090 |
|
|
Advanced Info Service Pcl (Foreign Registered) (a) |
|
|
53,677,940 |
|
|
7,865,105 |
|
|
Airports of Thailand Pcl (Foreign Registered) (a) |
|
|
11,114,488 |
|
|
35,542,571 |
|
|
Asian Property Development Pcl (Foreign Registered) (a) |
|
|
5,666,768 |
|
|
62,000 |
|
|
Bangkok Bank Pcl (Foreign Registered) (a) |
|
|
321,996 |
|
|
2,202,890 |
|
|
Bangkok Bank Pcl NVDR |
|
|
10,499,364 |
|
|
10,881,886 |
|
|
Bangkok Dusit Medical Service Pcl (Foreign Registered) (a) |
|
|
26,555,604 |
|
|
352,700 |
|
|
Banpu Pcl (Foreign Registered) (a) |
|
|
6,321,248 |
|
|
8,008,300 |
|
|
BEC World Pcl (Foreign Registered) (a) |
|
|
10,245,232 |
|
|
10,022,600 |
|
|
Charoen Pokphand Foods Pcl (Foreign Registered) (a) |
|
|
10,834,652 |
|
|
5,363,000 |
|
|
CP ALL Pcl (Foreign Registered) (a) |
|
|
8,778,983 |
|
|
5,378,850 |
|
|
Electricity Generating Pcl (Foreign Registered) (a) |
|
|
15,380,903 |
|
|
34,388,100 |
|
|
Esso Thailand Pcl (Foreign Registered) (a) |
|
|
10,008,836 |
|
|
10,303,800 |
|
|
Glow Energy Pcl (Foreign Registered) (a) |
|
|
17,391,773 |
|
|
81,144,700 |
|
|
Hemaraj Land and Development Pcl (Foreign Registered) (a) |
|
|
5,948,242 |
|
|
36,543,071 |
|
|
Home Product Center Pcl (Foreign Registered) (a) |
|
|
12,178,394 |
|
|
3,766,120 |
|
|
Kasikornbank Pcl (Foreign Registered) (a) |
|
|
14,654,980 |
|
|
2,305,200 |
|
|
Kasikornbank Pcl NVDR |
|
|
8,894,132 |
|
|
10,423,000 |
|
|
Land & Houses Pcl NVDR |
|
|
2,046,897 |
|
|
6,101,570 |
|
|
PTT Pcl (Foreign Registered) (a) |
|
|
61,420,920 |
|
|
13,489,950 |
|
|
Robinson Department Store Pcl (Foreign Registered) (a) |
|
|
16,048,959 |
|
|
12,577,500 |
|
|
Saha Pathana Inter-Holding Pcl (Foreign Registered) (a) |
|
|
9,342,832 |
|
|
2,400,828 |
|
|
Siam Cement Pcl (Foreign Registered) (a) |
|
|
28,101,251 |
|
|
3,288,480 |
|
|
Siam Commercial Bank Pcl (Foreign Registered) (a) |
|
|
11,752,498 |
|
|
507,800 |
|
|
Siam Makro Pcl (Foreign Registered) (a) |
|
|
3,765,118 |
|
|
3,108,050 |
|
|
Star Block Co Ltd (Foreign Registered) * (a)(b)(c) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,575,402 |
|
|
Thai Tap Water Supply Pcl (Foreign Registered) (a) |
|
|
5,892,553 |
|
|
7,508,900 |
|
|
Thanachart Capital Pcl (Foreign Registered) (a) |
|
|
6,175,241 |
|
|
4,113,400 |
|
|
Tisco Financial Group Pcl (Foreign Registered) (a) |
|
|
5,230,797 |
|
|
2,322,900 |
|
|
Total Access Communication Pcl (Foreign Registered) (a) |
|
|
6,028,104 |
|
|
2,991,710 |
|
|
Total Access Communication Pcl NVDR |
|
|
7,836,960 |
|
|
35,383,800 |
|
|
TPI Polene Pcl (Foreign Registered) (a) |
|
|
17,739,179 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Thailand |
|
|
409,854,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turkey 2.9% |
|
|
|
|
|
1,467,164 |
|
|
Akbank TAS |
|
|
5,191,938 |
|
|
4,002,484 |
|
|
Akenerji Elektrik Uretim AS * |
|
|
4,596,478 |
|
|
1,818,232 |
|
|
Aksa Akrilik Kimya Sanayii |
|
|
4,375,394 |
|
|
2,511,551 |
|
|
Aygaz AS |
|
|
12,453,280 |
|
|
7,680,438 |
|
|
Dogus Otomotiv Servis ve Ticaret AS * |
|
|
13,818,367 |
|
|
5,875,122 |
|
|
Eregli Demir ve Celik Fabrikalari TAS |
|
|
10,992,185 |
|
|
1,447,052 |
|
|
Ford Otomotiv Sanayi AS |
|
|
11,607,945 |
|
|
3,323,616 |
|
|
Haci Omer Sabanci Holding AS |
|
|
10,489,187 |
|
|
1,881,526 |
|
|
Ipek Dogal Enerji Kaynaklari Ve Uretim AS * |
|
|
2,632,638 |
|
|
4,027,195 |
|
|
Izmir Demir Celik Sanayii AS * |
|
|
7,907,304 |
|
|
12,498,000 |
|
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class D * |
|
|
5,355,636 |
|
|
5,166,367 |
|
|
Koc Holding AS |
|
|
17,889,913 |
|
|
4,205,336 |
|
|
Koza Anadolu Metal Madencilik Isletmeleri AS * |
|
|
7,062,966 |
|
|
42,150 |
|
|
Medya Holding AS (a)(b) |
|
|
|
|
|
1,162,838 |
|
|
Tupras-Turkiye Petrol Rafineriler AS |
|
|
26,621,919 |
|
|
6,040,518 |
|
|
Turk Hava Yollari Anonim Ortakligi * |
|
|
7,952,278 |
|
|
8,878,382 |
|
|
Turk Telekomunikasyon AS |
|
|
36,540,265 |
|
|
232,817 |
|
|
Turk Traktor ve Ziraat Makineleri AS |
|
|
3,989,617 |
|
|
5,768,575 |
|
|
Turkcell Iletisim Hizmet AS * |
|
|
28,838,197 |
|
|
80,300 |
|
|
Turkcell Iletisim Hizmetleri AS ADR * |
|
|
1,011,780 |
|
|
9,656,274 |
|
|
Turkiye Garanti Bankasi |
|
|
33,079,414 |
|
|
3,243,082 |
|
|
Turkiye IS Bankasi Class C |
|
|
6,716,761 |
|
|
10,832,428 |
|
|
Turkiye Sise ve Cam Fabrikalari AS |
|
|
18,322,592 |
|
|
4,731,241 |
|
|
Turkiye Vakiflar Bankasi TAO Class D |
|
|
7,024,564 |
|
|
3,318,559 |
|
|
Turkiye Halk Bankasi AS |
|
|
20,074,993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Turkey |
|
|
304,545,611 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $9,630,316,420) |
|
|
8,940,411,276 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 10.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 8.3% |
|
|
|
|
|
1,839,100 |
|
|
AES Tiete SA 11.00% |
|
|
25,069,160 |
|
|
4,593,571 |
|
|
Banco Bradesco SA 0.62% |
|
|
75,266,131 |
|
|
1,930,900 |
|
|
Banco do Estado do Rio Grande do Sul SA Class B 0.59% |
|
|
20,597,263 |
|
|
1,348,900 |
|
|
Bradespar SA 0.03% |
|
|
24,727,533 |
|
|
1,884,600 |
|
|
Brasil Telecom SA 2.70% |
|
|
11,255,388 |
|
|
1,739,300 |
|
|
Centrais Eletricas Brasileiras SA Class B 6.98% |
|
|
22,641,149 |
|
|
585,180 |
|
|
Cia Energetica de Minas Gerais 5.76% |
|
|
10,038,037 |
|
|
183,600 |
|
|
Companhia Paranaense de Energia Class B 0.85% |
|
|
3,704,794 |
|
|
1,486,500 |
|
|
Eletropaulo Metropolitana SA 10.99% |
|
|
26,921,157 |
|
|
912,900 |
|
|
Gerdau SA 3.47% |
|
|
6,815,135 |
|
|
7,123,341 |
|
|
Itausa-Investimentos Itau SA 0.51% |
|
|
41,557,911 |
|
|
1,134,400 |
|
|
Klabin SA 2.65% |
|
|
4,529,194 |
|
|
2,721,500 |
|
|
Metalurgica Gerdau SA 4.35% |
|
|
25,764,968 |
|
|
1,615,404 |
|
|
Petroleo Brasileiro SA (Petrobras) 0.56% |
|
|
19,697,325 |
|
|
7,674,860 |
|
|
Petroleo Brasileiro SA Sponsored ADR 0.60% |
|
|
192,408,740 |
|
|
1,004,700 |
|
|
Randon Participacoes SA 1.08% |
|
|
5,505,890 |
|
|
3,085,000 |
|
|
Tele Norte Leste Participacoes ADR 5.35% |
|
|
29,184,100 |
|
|
5,950,100 |
|
|
Usinas Siderrurgicas de Minas Gerais SA Class A 3.15% |
|
|
34,088,001 |
|
|
|
|
|
|
|
|
|
|
|
530,200 |
|
|
Vale Fertilizantes SA 0.44% |
|
|
7,253,656 |
|
|
592,008 |
|
|
Vale SA Class A 0.98% |
|
|
12,777,434 |
|
|
12,421,110 |
|
|
Vale SA Sponsored ADR 2.10% |
|
|
271,649,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
871,452,642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 1.6% |
|
|
|
|
|
2,409,658 |
|
|
Sberbank 1.80% |
|
|
5,318,392 |
|
|
132,951,696 |
|
|
Surgutneftegaz Class S 7.78% |
|
|
72,732,289 |
|
|
12,100 |
|
|
Surgutneftegaz Sponsored ADR 7.51% |
|
|
65,945 |
|
|
2,622,835 |
|
|
TNK BP Holding 9.77% |
|
|
6,319,199 |
|
|
48,063 |
|
|
Transneft 0.70% |
|
|
79,259,203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
163,695,028 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 1.0% |
|
|
|
|
|
272,070 |
|
|
Hyundai Motor Co 2.29% |
|
|
16,961,339 |
|
|
162,679 |
|
|
Samsung Electronics Co Ltd (Non Voting) 0.86% |
|
|
90,711,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
107,673,226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $1,224,441,741) |
|
|
1,142,820,896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China 0.1% |
|
|
|
|
|
199,464 |
|
|
Martin Currie China A Share Fund Ltd Class B * (a)(d) |
|
|
7,248,933 |
|
|
25,045 |
|
|
Martin Currie China A Share Fund Ltd Class S * (a)(d) |
|
|
1,589,993 |
|
|
245,374 |
|
|
Martin Currie China A Share Fund Ltd Class S * (a)(d) |
|
|
2,208,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total China |
|
|
11,047,658 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 0.1% |
|
|
|
|
|
11,806 |
|
|
Fire Capital Mauritius Private Fund * (a)(d) |
|
|
11,162,634 |
|
|
1,371,900 |
|
|
TDA India Technology Fund II LP * (a)(d) |
|
|
905,255 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total India |
|
|
12,067,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland 0.0% |
|
|
|
|
|
1,749,150 |
|
|
Templeton EE FD * (a)(d) |
|
|
235,581 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 0.1% |
|
|
|
|
|
9,500,000 |
|
|
NCH Eagle Fund LP * (a)(d) |
|
|
8,880,315 |
|
|
2,769 |
|
|
Steep Rock Russia Fund LP * (a)(d) |
|
|
735,170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
9,615,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ukraine 0.0% |
|
|
|
|
|
16,667 |
|
|
Societe Generale Thalmann Ukraine Fund * (a)(e) |
|
|
4,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 0.8% |
|
|
|
|
|
2,005,771 |
|
|
Vanguard Emerging Markets ETF (f) |
|
|
81,835,457 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $110,003,265) |
|
|
114,806,070 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland 0.2% |
|
|
|
|
PLN 100,677,888 |
|
|
TRI Media Secured Term Note, 5.93% , due 02/07/13(a)(d) |
|
|
25,417,698 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 0.1% |
|
|
|
|
|
7,994,487 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00% , due 04/15/12(g) |
|
|
8,021,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $37,592,749) |
|
|
33,439,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
8,064 |
|
|
GMO Special Purpose Holding Fund (h) |
|
|
3,145 |
|
|
6,473,460 |
|
|
GMO U.S. Treasury Fund |
|
|
161,901,238 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $161,901,238) |
|
|
161,904,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.5% |
|
|
|
|
USD |
|
|
31,779 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
31,779 |
|
USD |
|
|
1,700,000 |
|
|
Bank of Montreal Time Deposit, 0.03%, due 12/01/11 |
|
|
1,700,000 |
|
USD |
|
|
12,500,000 |
|
|
Barclays Plc Time Deposit, 0.12%, due 12/01/11 |
|
|
12,500,000 |
|
EUR |
|
|
17 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11 |
|
|
23 |
|
GBP |
|
|
225 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11 |
|
|
353 |
|
ZAR |
|
|
719,200 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 4.85%, due 12/01/11 |
|
|
88,640 |
|
HKD |
|
|
429,468 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
55,281 |
|
USD |
|
|
12,500,000 |
|
|
Deutsche Bank Time Deposit, 0.06%, due 12/01/11 |
|
|
12,500,000 |
|
USD |
|
|
12,500,000 |
|
|
HSBC Bank USA (Grand Cayman) Time Deposit, 0.05%, due 12/01/11 |
|
|
12,500,000 |
|
USD |
|
|
12,500,000 |
|
|
Royal Bank of Canada (Grand Cayman) Time Deposit, 0.03%, due 12/01/11 |
|
|
12,500,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
51,876,076 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $51,876,076) |
|
|
51,876,076 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.1% |
|
|
|
|
|
|
|
|
|
|
(Cost $11,216,131,489) |
|
|
10,445,258,371 |
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.1%) |
|
|
(9,939,029 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
10,435,319,342 |
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
Notional |
|
Expiration |
|
|
|
|
|
|
|
Appreciation/ |
Amount |
|
Date |
|
Counterparty |
|
Fund Pays |
|
Fund (Pays)/Receives |
|
(Depreciation) |
15,025,840 USD
|
|
12/27/2011
|
|
Morgan Stanley Capital
Services Inc.
|
|
Daily Fed Funds
Rate minus 8.00%
|
|
Total
Return on TPK Holding Co
Ltd
|
|
$ |
(2,986,216 |
) |
2,972,590 USD
|
|
1/19/2012
|
|
Morgan Stanley Capital
Services Inc.
|
|
Monthly Fed Funds Rate minus
15.00% |
|
Total
Return on Suntech Power
Holdings Co Ltd
|
|
|
338,996 |
|
9,859,800 USD
|
|
1/30/2012
|
|
Goldman Sachs International
|
|
Daily
Fed Funds Rate minus 16.25%
|
|
Total
Return on JBS SA
|
|
|
172,943 |
|
18,598,751 USD
|
|
2/9/2012
|
|
Morgan Stanley Capital
Services Inc.
|
|
Daily
Fed Funds Rate minus 2.50%
|
|
Total
Return on Asustek
Computer Inc.
|
|
|
(21,389 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(2,495,666 |
) |
|
|
|
|
|
|
|
|
Premiums to
(Pay) Receive
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had
sufficient cash and/or securities to cover any commitments or collateral requirements of the
relevant broker or exchange.
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933.
These securities may be resold in transactions exempt from registration, normally to qualified
institutional investors.
ADR American Depositary Receipt
CPO Ordinary Participation Certificate (Certificado de Participacion Ordinares), representing a
bundle of shares of the multiple series of one issuer that trade together as a unit.
ETF Exchange-Traded Fund
Foreign Registered Shares issued to foreign investors in markets that have foreign ownership
limits.
GDR Global Depository Receipt
NVDR Non-Voting Depository Receipt
* Non-income producing security.
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction
of the Trustees of GMO Trust. |
|
(b) |
|
Bankrupt issuer. |
(c) |
|
Affiliated company. |
|
(d) |
|
Private placement securities are restricted as to resale. |
|
(e) |
|
The security is currently in full liquidation. |
|
(f) |
|
Represents an investment to obtain exposure to equitize cash. The Vanguard Emerging Markets
ETF is a separate investment portfolio of Vanguard, Inc., a registered investment company. The
Vanguard Emerging Markets ETF prospectus states that the fund invests substantially all (normally
about 95%) of its assets in the common stocks included in the MSCI Emerging Market Index, while
employing a form of sampling to reduce risk. |
|
(g) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument
or financial statistic. |
|
(h) |
|
Underlying investment represents interests in defaulted claims. See Other matters for
additional information. |
Currency Abbreviations:
EUR Euro
GPB British Pound
HKD Hong Kong Dollar
PLN Polish Zloty
USD United States Dollar
ZAR South African Rand
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$11,418,700,634 |
|
$ |
555,903,331 |
|
|
$ |
(1,529,345,594 |
) |
|
$ |
(973,442,263 |
) |
Additional information on each restricted security is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value as a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage |
|
|
Value as of |
|
|
|
Acquisition |
|
|
Acquisition |
|
|
of Funds |
|
|
November 30, |
|
Issuer Description |
|
Date |
|
|
Cost |
|
|
Net Assets |
|
|
2011 |
|
Anilana Hotel & Properties |
|
|
2/10/11 |
|
|
$ |
1,890,310 |
|
|
|
0.02 |
% |
|
$ |
1,842,925 |
|
Fire Capital Mauritius Private Fund ** |
|
|
9/06/06-10/26/09 |
|
|
|
12,180,554 |
|
|
|
0.11 |
% |
|
|
11,162,634 |
|
Martin Currie China A Share Fund Ltd Class B |
|
|
1/20/06 |
|
|
|
2,159,084 |
|
|
|
0.07 |
% |
|
|
7,248,933 |
|
Martin Currie China A Share Fund Ltd Class S |
|
|
10/14/08 |
|
|
|
|
|
|
|
0.02 |
% |
|
|
1,589,993 |
|
Martin Currie China A Share Fund Ltd Class S |
|
|
4/23/10 |
|
|
|
2,453,738 |
|
|
|
0.02 |
% |
|
|
2,208,732 |
|
NCH Eagle Fund LP |
|
|
1/08/03 |
|
|
|
9,500,000 |
|
|
|
0.09 |
% |
|
|
8,880,315 |
|
Societe Generale Thalmann Ukraine Fund |
|
|
7/15/97 |
|
|
|
199,943 |
|
|
|
0.00 |
% |
|
|
4,000 |
|
Steep Rock Russia Fund LP |
|
|
12/22/06-5/13/09 |
|
|
|
2,250,000 |
|
|
|
0.01 |
% |
|
|
735,170 |
|
TDA India Technology Fund II LP |
|
|
2/23/00-3/23/04 |
|
|
|
787,800 |
|
|
|
0.01 |
% |
|
|
905,255 |
|
TRI Media Secured Term Note |
|
|
8/7/09 |
|
|
|
29,505,475 |
|
|
|
0.24 |
% |
|
|
25,417,698 |
|
Templeton EE FD |
|
|
12/05/97-6/24/02 |
|
|
|
471,720 |
|
|
|
0.00 |
% |
|
|
235,581 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
60,231,236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
** GMO
Emerging Markets Fund has committed an additional $7,724,246 to this
investment. |
|
|
|
|
|
|
|
|
|
|
Investments
in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Special Purpose Holding Fund |
|
$ |
4,032 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,145 |
|
GMO U.S. Treasury Fund |
|
|
110,007,196 |
|
|
|
976,581,843 |
|
|
|
924,714,708 |
|
|
|
34,549 |
|
|
|
4,587 |
|
|
|
161,901,238 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
110,011,228 |
|
|
$ |
976,581,843 |
|
|
$ |
924,714,708 |
|
|
$ |
34,549 |
|
|
$ |
4,587 |
|
|
$ |
161,904,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments in Other Affiliated Issuers
An affiliated company is a company in which the Fund has or had owndership of at least 5% of the voting securities. A summary of the Funds transactions with companies
that are or were affiliates during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliate |
|
Value, beginning of period |
|
|
Purchases |
|
|
Sales Proceeds |
|
|
Dividend Income |
|
|
Value, end of period |
|
In the F Co Ltd |
|
$ |
2,759,050 |
|
|
$ |
|
|
|
$ |
21,203 |
|
|
$ |
|
|
|
$ |
1,887,120 |
|
Kiri Industries Ltd |
|
|
7,389,591 |
|
|
|
833,078 |
|
|
|
486,923 |
|
|
|
1,834,005 |
|
|
|
1,895,901 |
|
Medquist Holdings, Inc* |
|
|
24,003,561 |
|
|
|
|
|
|
|
26,805,264 |
|
|
|
|
|
|
|
|
|
Pumyang Constduction Co Ltd* |
|
|
2,075,101 |
|
|
|
|
|
|
|
267,571 |
|
|
|
|
|
|
|
367,649 |
|
Star Block
Co Ltd (Foreign Registered) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
36,227,303 |
|
|
$ |
833,078 |
|
|
$ |
27,580,961 |
|
|
$ |
1,834,005 |
|
|
$ |
4,150,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
No longer an affiliate as of November 30, 2011. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
4.8% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For
the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC
derivatives contracts based on the creditworthiness of its counterparties. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
65.2% |
Swap Agreements |
|
(0.0)^ |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the fair value of equity securities that underlie
futures (to the extent the market for such futures closes prior to the close of the NYSE) and
other derivatives) due to market events that have occurred since the local market close but
prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following:
Certain of the Funds securities in Thailand and India were valued at the local price as
adjusted by applying a premium or discount when the holdings exceed foreign ownership
limitations. The Fund valued various third-party investment funds based on valuations provided
by fund sponsors and adjusted the values for liquidity considerations as well as the timing of
the receipt of information. The Fund valued certain equity securities based on the last traded
exchange price adjusted for the movement in a securities index. The Fund valued certain debt
securities by using an estimated specified spread above the Warsaw Interbank Offered Rate
(WIBOR) and adjusted the values for liquidity considerations.
The Fund values certain securities using a price from a comparable
security related to the same issuer that trades on a different
exchange.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
$ |
1,238,584,706 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,238,584,706 |
|
Chile |
|
|
19,093,132 |
|
|
|
|
|
|
|
|
|
|
|
19,093,132 |
|
China |
|
|
113,392,860 |
|
|
|
1,210,908,810 |
|
|
|
0 |
* |
|
|
1,324,301,670 |
|
Czech Republic |
|
|
|
|
|
|
154,295,845 |
|
|
|
|
|
|
|
154,295,845 |
|
Egypt |
|
|
|
|
|
|
142,177,845 |
|
|
|
|
|
|
|
142,177,845 |
|
Hong Kong |
|
|
|
|
|
|
3,287,784 |
|
|
|
|
|
|
|
3,287,784 |
|
Hungary |
|
|
|
|
|
|
104,255,009 |
|
|
|
|
|
|
|
104,255,009 |
|
India |
|
|
58,315,426 |
|
|
|
444,495,992 |
|
|
|
31,070,908 |
|
|
|
533,882,326 |
|
Indonesia |
|
|
15,402,325 |
|
|
|
636,798,943 |
|
|
|
|
|
|
|
652,201,268 |
|
Kazakhstan |
|
|
|
|
|
|
15,669,332 |
|
|
|
|
|
|
|
15,669,332 |
|
Macau |
|
|
|
|
|
|
9,760,544 |
|
|
|
|
|
|
|
9,760,544 |
|
Malaysia |
|
|
|
|
|
|
48,417,674 |
|
|
|
|
|
|
|
48,417,674 |
|
Mexico |
|
|
158,135,623 |
|
|
|
|
|
|
|
|
|
|
|
158,135,623 |
|
Morocco |
|
|
|
|
|
|
12,718,173 |
|
|
|
|
|
|
|
12,718,173 |
|
Nigeria |
|
|
|
|
|
|
4,117,336 |
|
|
|
|
|
|
|
4,117,336 |
|
Philippines |
|
|
42,481,718 |
|
|
|
86,444,005 |
|
|
|
|
|
|
|
128,925,723 |
|
Poland |
|
|
|
|
|
|
158,993,430 |
|
|
|
|
|
|
|
158,993,430 |
|
Russia |
|
|
73,336,569 |
|
|
|
1,087,800,978 |
|
|
|
33,848,502 |
|
|
|
1,194,986,049 |
|
South Africa |
|
|
16,922,803 |
|
|
|
327,641,813 |
|
|
|
|
|
|
|
344,564,616 |
|
South Korea |
|
|
55,445,493 |
|
|
|
1,263,042,770 |
|
|
|
0 |
* |
|
|
1,318,488,263 |
|
Sri Lanka |
|
|
200,469 |
|
|
|
7,743,956 |
|
|
|
1,842,925 |
|
|
|
9,787,350 |
|
Taiwan |
|
|
10,202,181 |
|
|
|
639,164,942 |
|
|
|
|
|
|
|
649,367,123 |
|
Thailand |
|
|
|
|
|
|
29,277,353 |
|
|
|
380,577,491 |
|
|
|
409,854,844 |
|
Turkey |
|
|
1,011,780 |
|
|
|
303,533,831 |
|
|
|
0 |
* |
|
|
304,545,611 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON
STOCKS |
|
|
1,802,525,085 |
|
|
|
6,690,546,365 |
|
|
|
447,339,826 |
|
|
|
8,940,411,276 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
|
871,452,642 |
|
|
|
|
|
|
|
|
|
|
|
871,452,642 |
|
Russia |
|
|
78,116,626 |
|
|
|
85,578,402 |
|
|
|
|
|
|
|
163,695,028 |
|
South Korea |
|
|
|
|
|
|
107,673,226 |
|
|
|
|
|
|
|
107,673,226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
949,569,268 |
|
|
|
193,251,628 |
|
|
|
|
|
|
|
1,142,820,896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China |
|
|
|
|
|
|
|
|
|
|
11,047,658 |
|
|
|
11,047,658 |
|
India |
|
|
|
|
|
|
|
|
|
|
12,067,889 |
|
|
|
12,067,889 |
|
Poland |
|
|
|
|
|
|
|
|
|
|
235,581 |
|
|
|
235,581 |
|
Russia |
|
|
|
|
|
|
|
|
|
|
9,615,485 |
|
|
|
9,615,485 |
|
Ukraine |
|
|
|
|
|
|
|
|
|
|
4,000 |
|
|
|
4,000 |
|
United States |
|
|
81,835,457 |
|
|
|
|
|
|
|
|
|
|
|
81,835,457 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS |
|
|
81,835,457 |
|
|
|
|
|
|
|
32,970,613 |
|
|
|
114,806,070 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland |
|
|
|
|
|
|
|
|
|
|
25,417,698 |
|
|
|
25,417,698 |
|
United States |
|
|
|
|
|
|
8,021,972 |
|
|
|
|
|
|
|
8,021,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
8,021,972 |
|
|
|
25,417,698 |
|
|
|
33,439,670 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
161,901,238 |
|
|
|
3,145 |
|
|
|
|
|
|
|
161,904,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Mutual Funds |
|
|
161,901,238 |
|
|
|
3,145 |
|
|
|
|
|
|
|
161,904,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
51,876,076 |
|
|
|
|
|
|
|
|
|
|
|
51,876,076 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
3,047,707,124 |
|
|
|
6,891,823,110 |
|
|
|
505,728,137 |
|
|
|
10,445,258,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives ** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
511,939 |
|
|
|
|
|
|
|
511,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives ** |
|
|
|
|
|
|
511,939 |
|
|
|
|
|
|
|
511,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,047,707,124 |
|
|
$ |
6,892,335,049 |
|
|
$ |
505,728,137 |
|
|
$ |
10,445,770,310 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
(3,007,605 |
) |
|
|
|
|
|
|
(3,007,605 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
*
Represents the investment in securities that were determined to have a fair value of zero at
November 30, 2011.
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds investments (both direct and indirect) in securities using Level 3 inputs were 4.9% of
total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
Transfers |
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
into Level |
|
|
Transfers out |
|
|
Balances as of |
|
|
|
Still Held as of |
|
|
|
2011 |
|
|
Purchase |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
3 * |
|
|
of Level 3 * |
|
|
November 30, 2011 |
|
|
|
November 30, 2011 |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt |
|
$ |
138,391,206 |
|
|
$ |
49,010,099 |
|
|
$ |
(38,941,819 |
) |
|
$ |
|
|
|
$ |
(10,480,910 |
) |
|
$ |
(9,527,899 |
) |
|
$ |
|
|
|
$ |
(128,450,677 |
)** |
|
$ |
|
|
|
|
$ |
|
|
India |
|
|
25,524,840 |
|
|
|
31,551,437 |
|
|
|
(19,866,520 |
) |
|
|
|
|
|
|
(706,936 |
) |
|
|
(5,431,913 |
) |
|
|
|
|
|
|
|
|
|
|
31,070,908 |
|
|
|
|
(4,137,405 |
) |
Russia |
|
|
151,244,856 |
|
|
|
130,720,230 |
|
|
|
(191,848,241 |
) |
|
|
|
|
|
|
22,573,351 |
|
|
|
(40,008,262 |
) |
|
|
|
|
|
|
(38,833,432 |
)** |
|
|
33,848,502 |
|
|
|
|
(3,073,986 |
) |
Sri Lanka |
|
|
1,894,404 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(51,479 |
) |
|
|
|
|
|
|
|
|
|
|
1,842,925 |
|
|
|
|
(51,479 |
) |
Thailand |
|
|
408,898,018 |
|
|
|
278,979,528 |
|
|
|
(342,303,776 |
) |
|
|
|
|
|
|
67,568,580 |
|
|
|
(32,564,859 |
) |
|
|
|
|
|
|
|
|
|
|
380,577,491 |
|
|
|
|
41,080,885 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
725,953,324 |
|
|
|
490,261,294 |
|
|
|
(592,960,356 |
) |
|
|
|
|
|
|
78,954,085 |
|
|
|
(87,584,412 |
) |
|
|
|
|
|
|
(167,284,109 |
) |
|
|
447,339,826 |
|
|
|
|
33,818,015 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia |
|
|
134,030,568 |
|
|
|
20,033,123 |
|
|
|
(11,320,881 |
) |
|
|
|
|
|
|
769,278 |
|
|
|
8,479,405 |
|
|
|
|
|
|
|
(151,991,493 |
)** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China |
|
|
12,771,635 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,723,977 |
) |
|
|
|
|
|
|
|
|
|
|
11,047,658 |
|
|
|
|
(1,723,977 |
) |
India |
|
|
11,624,316 |
|
|
|
|
|
|
|
(274,014 |
) |
|
|
|
|
|
|
(75,154 |
) |
|
|
792,741 |
|
|
|
|
|
|
|
|
|
|
|
12,067,889 |
|
|
|
|
1,241,632 |
|
Poland |
|
|
252,509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(16,928 |
) |
|
|
|
|
|
|
|
|
|
|
235,581 |
|
|
|
|
(16,928 |
) |
Russia |
|
|
10,315,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(699,824 |
) |
|
|
|
|
|
|
|
|
|
|
9,615,485 |
|
|
|
|
(699,824 |
) |
Ukraine |
|
|
4,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,967,769 |
|
|
|
|
|
|
|
(274,014 |
) |
|
|
|
|
|
|
(75,154 |
) |
|
|
(1,647,988 |
) |
|
|
|
|
|
|
|
|
|
|
32,970,613 |
|
|
|
|
(1,199,097 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland |
|
|
27,902,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,484,739 |
) |
|
|
|
|
|
|
|
|
|
|
25,417,698 |
|
|
|
|
(2,484,739 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
922,854,098 |
|
|
$ |
510,294,417 |
|
|
$ |
(604,555,251 |
) |
|
$ |
|
|
|
$ |
79,648,209 |
|
|
$ |
(83,237,734 |
) |
|
$ |
|
|
|
$ |
(319,275,602 |
) |
|
$ |
505,728,137 |
|
|
|
$ |
30,134,179 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at
the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
|
** |
|
Financial assets transferred between Level 2 and Level 3 were due to a change in observable
and/or unobservable inputs. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
In addition, Indian regulators alleged in 2002 that the Fund violated some conditions under
which it was granted permission to operate in India and have restricted the Funds locally held
assets pending resolution of the dispute. Although these locally held assets remain the property
of the Fund, a portion of the assets are not permitted to be withdrawn from the Funds local
custodial account located in India. The amount of restricted assets is small relative to the
size of the Fund, representing approximately 0.6% of the Funds total net assets as of November
30, 2011. The effect of this claim on the value of the restricted assets, and all matters
relating to the Funds response to these allegations are subject to the supervision and control
of the Trusts Board of Trustees. The Funds costs in respect of this matter are being borne by
the Fund.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in the
Fund are summarized below. The risks of investing in the Fund depend on the types of investments
in its portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Equity Securities The market value of equity investments may decline due to
factors affecting the issuing companies, their industries, or the economy and equity markets
generally. If the Fund purchases equity investments at a discount from their value as determined
by the Manager, the Fund runs the risk that the market prices of these investments will not
increase to that value for a variety of reasons, one of which may be the Managers
overestimation of value of those investments. Because the Fund normally does not take temporary
defensive positions, declines in stock market prices generally are likely to reduce the net
asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more than
those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less
regulated than U.S. markets, and the cost of trading in those markets often is higher than in
U.S markets. Foreign portfolio transactions generally involve higher commission rates, transfer
taxes and custodial costs than similar transactions in the U.S. In addition, the Fund may be
subject to foreign taxes on capital gains or other income payable on foreign securities, on
transactions in those securities and on the repatriation of proceeds generated from those
securities. Also, many foreign markets require a license for the Fund to invest directly in
those markets, and the Fund is subject to the risk that it could not invest if its license were
terminated or suspended. In some foreign markets, prevailing custody and trade settlement
practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to
credit and other risks with respect to participating brokers, custodians, clearing banks or
other clearing agents, escrow agents and issuers. Further, adverse changes in investment
regulations, capital requirements or exchange controls could adversely affect the value of the
Funds investments. These and other risks (e.g., nationalization, expropriation or other
confiscation of assets of foreign issuers) tend to be greater for investments in companies tied
economically to emerging markets, the economies of which tend to be more volatile than the
economies of developed markets.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of the
Funds foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or legal
restrictions may limit or prevent the Fund from selling particular securities or unwinding
derivative positions at desirable prices. The more less-liquid securities the Fund
holds, the more likely it is to honor a redemption request in-kind. In addition, the Fund may
buy securities that are less liquid than those in its benchmark.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well as
other changes in foreign and domestic economic and political conditions could adversely affect
the value of the Funds investments.
Smaller Company Risk Smaller companies may have limited product lines, markets or financial
resources, may lack the competitive strength of larger companies, or may lack managers with
experience or depend on a few key employees. The securities of small- and midcap companies often
are less widely held and trade less frequently and in lesser quantities, and their market prices
often fluctuate more, than the securities of companies with larger market capitalizations. The
Fund may buy securities that have smaller market capitalizations than those in its benchmark.
Management and Operational Risk The Fund relies on GMOs ability to achieve its investment
objective by effectively implementing its investment approach. The Fund runs the risk that GMOs
proprietary investment techniques will fail to produce the desired results. The Funds portfolio
managers may use quantitative analyses and/or models and any imperfections or limitations in
such analyses and/or models could affect the ability of the portfolio managers to implement
strategies. By necessity, these analyses and models make simplifying assumptions that limit
their efficacy. Models that appear to explain prior market data can fail to predict future
market events. Further, the data used in models may be inaccurate and/or it may not include the
most recent information about a company or a security. The Fund is also subject to the risk that
deficiencies in the Managers or another service providers internal systems or controls will
cause losses for the Fund or impair Fund operations.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Focused Investment Risk Focusing investments in a limited number of countries and
geographic regions creates additional risk.
Derivatives Risk The use of derivatives involves the risk that their value may not move as
expected relative to the value of the relevant underlying assets, rates or indices. Derivatives
also present other Fund risks, including market risk, liquidity risk, currency risk and
counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an investment in
underlying funds, including the risk that the underlying funds (including ETFs) in which it
invests will not perform as expected.
Leveraging Risk The Funds use of reverse repurchase agreements and other derivatives and
securities lending may cause its portfolio to be leveraged. Leverage increases the Funds
portfolio losses when the value of its investments decline.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the
Fund is subject to the risk that these shareholders will disrupt the Funds operations by
purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund
holds a large proportion of stocks of companies in a particular sector and the Manager believes
that stocks of companies in another sector will outperform those stocks, the Fund might use a
short futures contract on an appropriate index (to synthetically sell a portion of the Funds
portfolio) in combination with a long futures contract on another index (to synthetically buy
exposure to that index). In adjusting its investment exposure, the Fund also may use currency
derivatives in an attempt to adjust its currency exposure, seeking currency exposure that is
different (in some cases, significantly different) from the currency exposure represented by its
portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by
making certain types of derivatives transactions no longer available to the Fund) and/or
increase the costs of such derivatives transactions (for example, by increasing margin or
capital requirements), and the Fund may be unable to execute its investment strategy as a
result. It is unclear how the regulatory changes will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. The Fund had no forward currency
contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market. The Fund
had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used total return swap
agreements as a substitute for direct investment in securities and/or
to achieve returns comparable to holding and lending a direct equity
position. Swap
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants as a result of corporate actions. The Fund held no rights or warrants at the
end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on swap agreements |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
511,939 |
|
|
$ |
|
|
|
$ |
511,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
511,939 |
|
|
$ |
|
|
|
$ |
511,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on swap agreements |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
$ |
|
|
|
$ |
(3,007,605 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly
greater risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (rights and/or warrants), or notional
amounts (swap agreements) outstanding at each month-end, was as follows for the period ended
November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
Rights and/or |
|
Swap |
|
|
Warrants |
|
Agreements |
Average amount outstanding |
|
$ |
179,656 |
|
|
$ |
38,550,960 |
|
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Flexible Equities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 93.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 93.4% |
|
|
|
|
|
66,700 |
|
|
ABC-Mart Inc |
|
|
2,479,916 |
|
|
1,400 |
|
|
Accordia Golf Co Ltd |
|
|
1,086,842 |
|
|
4,482 |
|
|
Advance Residence Investment Corp (REIT) |
|
|
8,362,329 |
|
|
567,000 |
|
|
Aeon Co Ltd |
|
|
7,747,798 |
|
|
197,000 |
|
|
Aichi Machine Industry Co Ltd |
|
|
575,869 |
|
|
50,600 |
|
|
Aisan Industry Co Ltd |
|
|
418,398 |
|
|
109,400 |
|
|
Aisin Seiki Co Ltd |
|
|
3,305,700 |
|
|
59,800 |
|
|
Alfresa Holdings Corp |
|
|
2,205,733 |
|
|
11,400 |
|
|
Alpen Co Ltd |
|
|
194,572 |
|
|
557,700 |
|
|
Alps Electric Co Ltd |
|
|
3,904,513 |
|
|
215,900 |
|
|
AOC Holdings Inc |
|
|
1,304,997 |
|
|
11,700 |
|
|
AOKI Holdings Inc |
|
|
174,610 |
|
|
41,000 |
|
|
Aoyama Trading Co Ltd |
|
|
667,922 |
|
|
45,500 |
|
|
Arc Land Sakamoto Co Ltd |
|
|
778,046 |
|
|
52,000 |
|
|
Arcs Co Ltd |
|
|
989,380 |
|
|
93,000 |
|
|
Arnest One Corp |
|
|
949,534 |
|
|
27,700 |
|
|
AsatsuDK Inc |
|
|
689,729 |
|
|
290,000 |
|
|
Astellas Pharma Inc |
|
|
11,178,462 |
|
|
37,400 |
|
|
Axell Corp |
|
|
784,108 |
|
|
119,000 |
|
|
Bando Chemical Industries Ltd |
|
|
473,228 |
|
|
187,800 |
|
|
Belluna Co Ltd |
|
|
1,411,391 |
|
|
326,500 |
|
|
Best Denki Co Ltd * |
|
|
875,942 |
|
|
3,013 |
|
|
BIC Camera Inc |
|
|
1,651,858 |
|
|
145,900 |
|
|
Brother Industries Ltd |
|
|
1,972,902 |
|
|
615,000 |
|
|
Calsonic Kansei Corp |
|
|
3,550,171 |
|
|
107,600 |
|
|
Canon Inc |
|
|
4,827,174 |
|
|
84,600 |
|
|
Cawachi Ltd |
|
|
1,650,852 |
|
|
184,000 |
|
|
Central Glass Co Ltd |
|
|
900,652 |
|
|
334,420 |
|
|
Century Tokyo Leasing Corp |
|
|
6,635,934 |
|
|
2,090,000 |
|
|
Chiba Bank Ltd |
|
|
13,632,407 |
|
|
20,600 |
|
|
Chiyoda Integre Co Ltd |
|
|
266,636 |
|
|
107,800 |
|
|
Chubu Electric Power Co Inc |
|
|
2,052,202 |
|
|
142,000 |
|
|
Chuetsu Pulp & Paper Co Ltd |
|
|
230,381 |
|
|
85,000 |
|
|
Chugoku Marine Paints Ltd |
|
|
574,226 |
|
|
55,300 |
|
|
Circle K Sunkus Co Ltd |
|
|
901,841 |
|
|
13,700 |
|
|
CocaCola Central Japan Co Ltd |
|
|
178,287 |
|
|
83,900 |
|
|
Cocokara fine Inc |
|
|
2,247,780 |
|
|
144,400 |
|
|
COMSYS Holdings Corp |
|
|
1,474,473 |
|
|
2,521,000 |
|
|
Cosmo Oil Co Ltd |
|
|
6,971,682 |
|
|
12,224 |
|
|
Dai-ichi Life Insurance Co Ltd (The) |
|
|
13,636,580 |
|
|
775,750 |
|
|
Daiei Inc * |
|
|
2,819,384 |
|
|
62,000 |
|
|
Daifuku Co Ltd |
|
|
328,395 |
|
|
68,000 |
|
|
Daihatsu Diesel Manufacturing Co Ltd |
|
|
325,936 |
|
|
117,000 |
|
|
Daihatsu Motor Co Ltd |
|
|
2,049,909 |
|
|
81,000 |
|
|
Daiichi Jitsugyo Co Ltd |
|
|
322,959 |
|
|
78,500 |
|
|
Daiichikosho Co Ltd |
|
|
1,456,513 |
|
|
8,400 |
|
|
Daikoku Denki Co Ltd |
|
|
74,593 |
|
|
74,000 |
|
|
Dainichiseika Color & Chemicals Manufacturing Co Ltd |
|
|
331,528 |
|
|
190,000 |
|
|
Daio Paper Corp |
|
|
1,337,320 |
|
|
414,100 |
|
|
Daito Trust Construction Co Ltd |
|
|
36,933,200 |
|
|
93,000 |
|
|
Daiwa Industries Ltd |
|
|
495,643 |
|
|
853,000 |
|
|
Daiwabo Holdings Co Ltd |
|
|
2,003,542 |
|
|
602 |
|
|
Daiwa Office Investment Corp (REIT) |
|
|
1,259,733 |
|
|
195,200 |
|
|
DCM Holdings Co Ltd |
|
|
1,489,465 |
|
|
74,912 |
|
|
Dena Co Ltd |
|
|
2,325,632 |
|
|
|
|
|
|
|
|
|
|
|
1,284,000 |
|
|
DIC Corp |
|
|
2,168,338 |
|
|
740 |
|
|
Digital Garage Inc * |
|
|
2,417,364 |
|
|
21,800 |
|
|
Doshisha Co Ltd |
|
|
575,004 |
|
|
14,900 |
|
|
DTS Corp |
|
|
176,791 |
|
|
462,000 |
|
|
Edion Corp |
|
|
3,618,192 |
|
|
104,200 |
|
|
Electric Power Development Co Ltd |
|
|
2,629,363 |
|
|
148,100 |
|
|
Elpida Memory Inc * |
|
|
737,990 |
|
|
18,500 |
|
|
Fanuc Ltd |
|
|
3,039,522 |
|
|
10,300 |
|
|
Fast Retailing Co Ltd |
|
|
1,671,449 |
|
|
233 |
|
|
Fields Corp |
|
|
349,891 |
|
|
89,800 |
|
|
Foster Electric Co Ltd |
|
|
1,338,625 |
|
|
1,192 |
|
|
Fuji Media Holdings Inc |
|
|
1,638,293 |
|
|
347,000 |
|
|
Fujikura Ltd |
|
|
1,071,832 |
|
|
2,000 |
|
|
Fujitsu General Ltd |
|
|
11,041 |
|
|
624,000 |
|
|
Fuji Electric Co Ltd |
|
|
1,845,743 |
|
|
190,000 |
|
|
Fuji Heavy Industries Ltd |
|
|
1,098,159 |
|
|
32,300 |
|
|
Fuji Soft Inc |
|
|
544,437 |
|
|
349,000 |
|
|
Furukawa-Sky Aluminum Corp |
|
|
790,410 |
|
|
354,000 |
|
|
Futaba Industrial Co Ltd |
|
|
2,170,410 |
|
|
85,700 |
|
|
Fuyo General Lease Co Ltd |
|
|
2,941,474 |
|
|
972 |
|
|
Geo Corp |
|
|
1,045,647 |
|
|
139 |
|
|
Global One Real Estate Investment Co Ltd (REIT) |
|
|
882,392 |
|
|
207,000 |
|
|
Godo Steel Ltd |
|
|
518,131 |
|
|
10,500 |
|
|
Gulliver International Co Ltd |
|
|
444,655 |
|
|
190,000 |
|
|
Gunze Ltd |
|
|
547,032 |
|
|
84,000 |
|
|
H2O Retailing Corp |
|
|
630,582 |
|
|
20,200 |
|
|
Hajime Construction Co Ltd |
|
|
449,218 |
|
|
19,900 |
|
|
Hakuto Co Ltd |
|
|
180,780 |
|
|
214 |
|
|
Hankyu Reit Inc (REIT) |
|
|
931,573 |
|
|
1,156,000 |
|
|
Hanwa Co Ltd |
|
|
5,011,394 |
|
|
1,775,500 |
|
|
Haseko Corp * |
|
|
1,150,461 |
|
|
18,100 |
|
|
Heiwa Corp |
|
|
325,217 |
|
|
117,600 |
|
|
Heiwado Co Ltd |
|
|
1,522,300 |
|
|
22,100 |
|
|
Hikari Tsushin Inc |
|
|
561,886 |
|
|
470,000 |
|
|
Hino Motors Ltd |
|
|
2,890,574 |
|
|
67,100 |
|
|
Hisamitsu Pharmaceutical Co Inc |
|
|
2,677,128 |
|
|
80,300 |
|
|
Hitachi Chemical Co Ltd |
|
|
1,550,239 |
|
|
48,300 |
|
|
Hitachi Koki Co Ltd |
|
|
356,398 |
|
|
608,000 |
|
|
Hitachi Ltd |
|
|
3,373,737 |
|
|
12,600 |
|
|
Hogy Medical Co Ltd |
|
|
517,104 |
|
|
70,300 |
|
|
Hokkaido Electric Power Co Inc |
|
|
948,317 |
|
|
226,000 |
|
|
Hokuetsu Kishu Paper Co Ltd |
|
|
1,434,794 |
|
|
147,300 |
|
|
Honda Motor Co Ltd |
|
|
4,674,472 |
|
|
86,200 |
|
|
Hosiden Corp |
|
|
606,959 |
|
|
209,700 |
|
|
Hoya Corp |
|
|
4,466,491 |
|
|
71,400 |
|
|
Idemitsu Kosan Co Ltd |
|
|
7,635,404 |
|
|
1,257,000 |
|
|
IHI Corporation |
|
|
2,952,160 |
|
|
26,400 |
|
|
Inaba Denki Sangyo Co Ltd |
|
|
759,673 |
|
|
312,600 |
|
|
Inabata & Co Ltd |
|
|
1,828,108 |
|
|
1,028 |
|
|
INPEX Corp |
|
|
6,939,903 |
|
|
152,000 |
|
|
Isetan Mitsukoshi Holdings Ltd |
|
|
1,487,905 |
|
|
188,500 |
|
|
IT Holdings Corp |
|
|
2,127,103 |
|
|
160,800 |
|
|
Itochu Enex Co Ltd |
|
|
907,830 |
|
|
41,300 |
|
|
Itochu Techno-Solutions Corp |
|
|
1,784,022 |
|
|
5,500 |
|
|
Itochu-Shokuhin Co Ltd |
|
|
189,760 |
|
|
2,069,400 |
|
|
Itochu Corp |
|
|
21,030,051 |
|
|
20,100 |
|
|
Itoki Corp |
|
|
44,142 |
|
|
48,600 |
|
|
Ito En Ltd |
|
|
846,288 |
|
|
567,000 |
|
|
Iwatani Corp |
|
|
2,000,767 |
|
|
206,675 |
|
|
Izumiya Co Ltd |
|
|
1,032,583 |
|
|
|
|
|
|
|
|
|
|
|
174,400 |
|
|
Izumi Co Ltd |
|
|
2,612,418 |
|
|
7,900 |
|
|
Japan Drilling Co Ltd |
|
|
258,007 |
|
|
1,485 |
|
|
Japan Prime Realty Investment Corp (REIT) |
|
|
3,615,414 |
|
|
51,000 |
|
|
Japan Pulp & Paper Co Ltd |
|
|
182,484 |
|
|
347 |
|
|
Japan Excellent Inc (REIT) |
|
|
1,395,162 |
|
|
4,913 |
|
|
Japan Retail Fund Investment Corp (REIT) |
|
|
7,513,543 |
|
|
770,000 |
|
|
JFE Shoji Holdings Inc |
|
|
3,239,107 |
|
|
131,800 |
|
|
JFE Holdings Inc |
|
|
2,426,045 |
|
|
166,489 |
|
|
Joshin Denki Co Ltd |
|
|
1,864,266 |
|
|
22,600 |
|
|
JSP Corp |
|
|
315,594 |
|
|
162,400 |
|
|
JSR Corp |
|
|
3,166,347 |
|
|
343,800 |
|
|
JVC Kenwood Holdings Inc * |
|
|
1,447,409 |
|
|
2,537,000 |
|
|
JX Holdings Inc |
|
|
16,134,359 |
|
|
206,000 |
|
|
JOil Mills Inc |
|
|
575,004 |
|
|
162,840 |
|
|
Ks Holdings Corp |
|
|
6,418,625 |
|
|
32,700 |
|
|
Kaga Electronics Co Ltd |
|
|
336,819 |
|
|
2,773,000 |
|
|
Kajima Corp |
|
|
8,350,536 |
|
|
35,000 |
|
|
Kaken Pharmaceutical Co Ltd |
|
|
424,363 |
|
|
89,000 |
|
|
Kandenko Co Ltd |
|
|
380,235 |
|
|
199,000 |
|
|
Kaneka Corp. |
|
|
1,070,624 |
|
|
2,432,000 |
|
|
Kanematsu Corp * |
|
|
2,351,416 |
|
|
253,200 |
|
|
Kansai Electric Power Co Inc (The) |
|
|
3,792,828 |
|
|
183,900 |
|
|
Kanto Auto Works Ltd |
|
|
1,516,159 |
|
|
111,600 |
|
|
Kao Corp |
|
|
2,953,440 |
|
|
90,000 |
|
|
Kasumi Co Ltd |
|
|
577,669 |
|
|
80,900 |
|
|
Kato Sangyo Co Ltd |
|
|
1,674,136 |
|
|
2,564,000 |
|
|
Kawasaki Kisen Kaisha Ltd |
|
|
4,458,100 |
|
|
2,254 |
|
|
KDDI Corp |
|
|
14,934,549 |
|
|
95,700 |
|
|
Keiyo Co Ltd |
|
|
577,090 |
|
|
1,181 |
|
|
Kenedix Realty Investment Corp (REIT) |
|
|
3,375,132 |
|
|
15,700 |
|
|
Keyence Corp |
|
|
4,017,207 |
|
|
1,910,000 |
|
|
Kobe Steel Ltd |
|
|
3,049,946 |
|
|
192,300 |
|
|
Kohnan Shoji Co Ltd |
|
|
3,091,893 |
|
|
172,700 |
|
|
Kojima Co Ltd |
|
|
1,152,245 |
|
|
140,000 |
|
|
Krosaki Harima Corp |
|
|
472,178 |
|
|
670,000 |
|
|
Kurabo Industries Ltd |
|
|
1,302,835 |
|
|
39,100 |
|
|
Kuroda Electric Co Ltd |
|
|
419,010 |
|
|
426,000 |
|
|
KYB Co Ltd |
|
|
2,040,977 |
|
|
136,000 |
|
|
Kyodo Printing Co Ltd |
|
|
336,581 |
|
|
72,100 |
|
|
Kyoei Steel Ltd |
|
|
1,450,446 |
|
|
66,000 |
|
|
Kyoritsu Maintenance Co Ltd |
|
|
1,106,648 |
|
|
199,400 |
|
|
Kyowa Exeo Corp |
|
|
1,937,366 |
|
|
119,000 |
|
|
Kyudenko Corp |
|
|
718,197 |
|
|
110,800 |
|
|
Lawson Inc |
|
|
6,561,874 |
|
|
384 |
|
|
M3 Inc |
|
|
1,904,607 |
|
|
417,000 |
|
|
Maeda Corp |
|
|
1,530,763 |
|
|
53,000 |
|
|
Maeda Road Construction Co Ltd |
|
|
525,338 |
|
|
15,900 |
|
|
Mars Engineering Corp |
|
|
269,606 |
|
|
2,822,000 |
|
|
Marubeni Corp |
|
|
17,433,545 |
|
|
400,300 |
|
|
Marudai Food Co Ltd |
|
|
1,401,342 |
|
|
152,074 |
|
|
Maruetsu Inc (The) |
|
|
548,272 |
|
|
1,295,000 |
|
|
Maruha Nichiro Holdings Inc |
|
|
2,284,073 |
|
|
38,000 |
|
|
Maruzen Showa Unyu Co Ltd |
|
|
118,667 |
|
|
46,600 |
|
|
Matsumotokiyoshi Holdings Co Ltd |
|
|
915,592 |
|
|
2,184,000 |
|
|
Mazda Motor Corp * |
|
|
3,983,038 |
|
|
367,900 |
|
|
Medipal Holdings Corp |
|
|
3,615,880 |
|
|
82,600 |
|
|
Megane TOP Co Ltd |
|
|
1,004,764 |
|
|
1,327 |
|
|
MID REIT Inc (REIT) |
|
|
3,259,985 |
|
|
85,900 |
|
|
Mikuni CocaCola Bottling Co Ltd |
|
|
763,602 |
|
|
16,800 |
|
|
Ministop Co Ltd |
|
|
313,030 |
|
|
|
|
|
|
|
|
|
|
|
242,500 |
|
|
Mirait Holdings Corp |
|
|
1,892,808 |
|
|
110,000 |
|
|
Mitsuba Corp |
|
|
734,192 |
|
|
400,000 |
|
|
Mitsubishi Materials Corp |
|
|
1,125,725 |
|
|
45,400 |
|
|
Mitsubishi Shokuhin Co Ltd |
|
|
1,144,959 |
|
|
125,000 |
|
|
Mitsubishi Steel Manufacturing Co Ltd |
|
|
338,519 |
|
|
1,816,000 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
10,549,936 |
|
|
418,100 |
|
|
Mitsubishi Corp |
|
|
8,643,560 |
|
|
243,000 |
|
|
Mitsubishi Gas Chemical Co Inc |
|
|
1,447,097 |
|
|
1,267,392 |
|
|
Mitsubishi Paper Mills Ltd * |
|
|
1,182,006 |
|
|
9,927,000 |
|
|
Mitsubishi UFJ Financial Group Inc |
|
|
43,480,434 |
|
|
152,260 |
|
|
Mitsubishi UFJ Lease & Finance Co Ltd |
|
|
5,829,141 |
|
|
2,324,000 |
|
|
Mitsui Chemicals Inc |
|
|
7,556,414 |
|
|
1,455,000 |
|
|
Mitsui Engineer & Shipbuilding Co Ltd |
|
|
2,234,303 |
|
|
343,000 |
|
|
Mitsui Matsushima Co Ltd |
|
|
625,931 |
|
|
188,200 |
|
|
Mitsui & Co Ltd |
|
|
2,969,398 |
|
|
73,000 |
|
|
Mitsui Home Co Ltd |
|
|
364,907 |
|
|
770,000 |
|
|
Mitsui Mining & Smelting Co Ltd |
|
|
1,995,193 |
|
|
1,776,000 |
|
|
Mitsui OSK Lines Ltd |
|
|
5,645,654 |
|
|
32,592,600 |
|
|
Mizuho Financial Group Inc |
|
|
42,905,863 |
|
|
517 |
|
|
Mori Hills REIT Investment Corp (REIT) |
|
|
1,667,349 |
|
|
417,000 |
|
|
Morinaga Milk Industry Co Ltd |
|
|
1,591,593 |
|
|
57,250 |
|
|
Moshi Moshi Hotline Inc |
|
|
530,851 |
|
|
3,400 |
|
|
Nafco Co Ltd |
|
|
57,681 |
|
|
400,000 |
|
|
Nakayama Steel Works Ltd * |
|
|
332,138 |
|
|
134,300 |
|
|
Namco Bandai Holdings Inc |
|
|
1,936,318 |
|
|
104,600 |
|
|
Namura Shipbuilding Co Ltd |
|
|
405,805 |
|
|
24,000 |
|
|
NEC Capital Solutions Ltd |
|
|
354,987 |
|
|
2,028,000 |
|
|
NEC Corp * |
|
|
4,363,053 |
|
|
26,000 |
|
|
NEC Mobiling Ltd |
|
|
858,205 |
|
|
22,800 |
|
|
NEC Fielding Ltd |
|
|
280,783 |
|
|
25,100 |
|
|
NEC Networks & System Integration Corp |
|
|
384,678 |
|
|
663 |
|
|
Net One Systems Co Ltd |
|
|
1,710,331 |
|
|
65,000 |
|
|
Nichias Corp |
|
|
354,459 |
|
|
26,600 |
|
|
Nichiha Corp |
|
|
287,853 |
|
|
278,200 |
|
|
Nichirei Corp |
|
|
1,297,356 |
|
|
89,300 |
|
|
Nihon Unisys Ltd |
|
|
563,021 |
|
|
213,000 |
|
|
Nihon Yamamura Glass Co Ltd |
|
|
508,687 |
|
|
47,100 |
|
|
Nintendo Co Ltd |
|
|
7,170,380 |
|
|
221,000 |
|
|
Nippon Carbide Industries Co Inc |
|
|
296,865 |
|
|
302,000 |
|
|
Nippon Coke & Engineering Co Ltd |
|
|
404,931 |
|
|
210,000 |
|
|
Nippon Corp |
|
|
1,827,935 |
|
|
238,000 |
|
|
Nippon Formula Feed Manufacturing Co Ltd * |
|
|
329,926 |
|
|
288,000 |
|
|
Nippon Road Co Ltd (The) |
|
|
744,132 |
|
|
18,000 |
|
|
Nippon Seiki Co Ltd |
|
|
178,844 |
|
|
138,000 |
|
|
Nippon Shokubai Co Ltd |
|
|
1,511,491 |
|
|
238,000 |
|
|
Nippon Soda Co Ltd |
|
|
1,009,762 |
|
|
150,000 |
|
|
Nippon Steel Trading Co Ltd |
|
|
365,059 |
|
|
90,000 |
|
|
Nippon Densetsu Kogyo Co Ltd |
|
|
822,966 |
|
|
396,000 |
|
|
Nippon Express Co Ltd |
|
|
1,500,770 |
|
|
42,000 |
|
|
Nippon Flour Mills Co Ltd |
|
|
186,706 |
|
|
1,168,000 |
|
|
Nippon Light Metal Co Ltd |
|
|
1,552,749 |
|
|
331,800 |
|
|
Nippon Paper Group Inc |
|
|
7,112,224 |
|
|
558,000 |
|
|
Nippon Sheet Glass Co Ltd |
|
|
1,073,155 |
|
|
431,800 |
|
|
Nippon Suisan Kaisha Ltd |
|
|
1,457,276 |
|
|
514,100 |
|
|
Nippon Telegraph & Telephone Corp |
|
|
25,354,626 |
|
|
3,715,000 |
|
|
Nippon Yusen Kabushiki Kaisha |
|
|
8,275,694 |
|
|
56,500 |
|
|
Nishimatsuya Chain Co Ltd |
|
|
428,895 |
|
|
2,085,984 |
|
|
Nishimatsu Construction Co Ltd |
|
|
3,386,811 |
|
|
190,000 |
|
|
Nissan Shatai Co Ltd |
|
|
1,860,832 |
|
|
260,000 |
|
|
Nissan Chemical Industries Ltd |
|
|
2,460,613 |
|
|
|
|
|
|
|
|
|
|
|
570,700 |
|
|
Nissan Motor Co Ltd |
|
|
5,240,916 |
|
|
138,300 |
|
|
Nissen Holdings Co Ltd |
|
|
783,676 |
|
|
798,000 |
|
|
Nisshin Steel Co Ltd |
|
|
1,144,325 |
|
|
55,000 |
|
|
Nisshin Oillio Group Ltd (The) |
|
|
222,741 |
|
|
166,000 |
|
|
Nissin Corp |
|
|
391,300 |
|
|
28,100 |
|
|
Nitori Holdings Co Ltd |
|
|
2,626,647 |
|
|
104,000 |
|
|
Nittetsu Mining Co Ltd |
|
|
417,442 |
|
|
54,100 |
|
|
Nitto Denko Corp |
|
|
2,248,767 |
|
|
541 |
|
|
Nomura Real Estate Office Fund (REIT) |
|
|
2,773,513 |
|
|
96,300 |
|
|
Nomura Research Institute Ltd |
|
|
2,124,979 |
|
|
70,000 |
|
|
NS United Kaiun Kaisha Ltd |
|
|
97,063 |
|
|
144,000 |
|
|
NTN Corp |
|
|
572,182 |
|
|
7,328 |
|
|
NTT Docomo Inc |
|
|
12,952,576 |
|
|
570,000 |
|
|
Obayashi Corp |
|
|
2,396,067 |
|
|
4,520 |
|
|
Obic Co Ltd |
|
|
828,044 |
|
|
320,000 |
|
|
OJI Paper Co Ltd |
|
|
1,595,121 |
|
|
3,000 |
|
|
Okamura Corp |
|
|
20,707 |
|
|
790,000 |
|
|
Oki Electric Industry Co Ltd * |
|
|
648,553 |
|
|
145 |
|
|
Okinawa Cellular Telephone Co |
|
|
297,649 |
|
|
31,900 |
|
|
Okinawa Electric Power Co |
|
|
1,358,506 |
|
|
63,000 |
|
|
Okuwa Co Ltd |
|
|
1,051,836 |
|
|
10,000 |
|
|
Onoken Co Ltd |
|
|
81,881 |
|
|
45,200 |
|
|
Ono Pharmaceutical Co Ltd |
|
|
2,354,878 |
|
|
68,200 |
|
|
ORIX Corp |
|
|
5,754,368 |
|
|
897,132 |
|
|
Osaka Gas Co Ltd |
|
|
3,422,597 |
|
|
279,000 |
|
|
Pacific Metals Co Ltd |
|
|
1,426,254 |
|
|
26,600 |
|
|
Paltac Corp |
|
|
504,113 |
|
|
27,800 |
|
|
Parco Co Ltd |
|
|
208,986 |
|
|
314 |
|
|
Pasona Group Inc |
|
|
327,500 |
|
|
2,109,000 |
|
|
Penta Ocean Construction Co Ltd |
|
|
6,656,553 |
|
|
3,766 |
|
|
PGM Holdings KK |
|
|
2,637,840 |
|
|
63,620 |
|
|
Point Inc |
|
|
2,645,196 |
|
|
302 |
|
|
Premier Investment Corp (REIT) |
|
|
972,432 |
|
|
220,000 |
|
|
Press Kogyo Co Ltd |
|
|
1,033,096 |
|
|
666,000 |
|
|
Prima Meat Packers Ltd |
|
|
1,019,387 |
|
|
100,900 |
|
|
Raito Kogyo Co Ltd |
|
|
488,653 |
|
|
434,000 |
|
|
Rengo Co Ltd |
|
|
3,088,281 |
|
|
589,000 |
|
|
Ricoh Company Ltd |
|
|
5,307,900 |
|
|
88,600 |
|
|
Right On Co Ltd |
|
|
661,389 |
|
|
46,000 |
|
|
Riken Corp |
|
|
176,393 |
|
|
28,700 |
|
|
Riso Kagaku Corp |
|
|
478,384 |
|
|
513,200 |
|
|
Round One Corp |
|
|
3,066,541 |
|
|
93,000 |
|
|
Ryobi Ltd |
|
|
360,483 |
|
|
49,200 |
|
|
Ryohin Keikaku Co Ltd |
|
|
2,238,551 |
|
|
14,500 |
|
|
S Foods Inc |
|
|
113,910 |
|
|
23,000 |
|
|
Saint Marc Holdings Co Ltd |
|
|
891,237 |
|
|
155,000 |
|
|
San-Ai Oil Co Ltd |
|
|
644,640 |
|
|
235,000 |
|
|
Sanden Corp |
|
|
715,360 |
|
|
32,000 |
|
|
Sanki Engineering |
|
|
157,681 |
|
|
194,000 |
|
|
SankyoTateyama Holdings Inc * |
|
|
260,506 |
|
|
100,300 |
|
|
Sankyo Co Ltd |
|
|
5,013,592 |
|
|
189,418 |
|
|
Sankyu Inc |
|
|
717,573 |
|
|
50,300 |
|
|
Sanshin Electronics Co Ltd |
|
|
416,529 |
|
|
159 |
|
|
Sanwa Holdings Corp |
|
|
492 |
|
|
3,200 |
|
|
SanA Co Ltd |
|
|
123,810 |
|
|
180,000 |
|
|
Sasebo Heavy Industries Co Ltd |
|
|
267,454 |
|
|
5,500 |
|
|
Secom Co Ltd |
|
|
248,056 |
|
|
74,000 |
|
|
Seika Corp |
|
|
203,554 |
|
|
374,000 |
|
|
Seikitokyu Kogyo Co Ltd * |
|
|
218,762 |
|
|
85,000 |
|
|
Seiko Holdings Corp |
|
|
169,828 |
|
|
|
|
|
|
|
|
|
|
|
127,000 |
|
|
Seino Holdings Co Ltd |
|
|
922,690 |
|
|
23,800 |
|
|
Seiren Co Ltd |
|
|
143,652 |
|
|
278 |
|
|
Sekisui House SI Investment Co (REIT) |
|
|
1,027,879 |
|
|
393,516 |
|
|
Senko Co Ltd |
|
|
1,477,705 |
|
|
34,700 |
|
|
Senshukai Co Ltd |
|
|
235,794 |
|
|
50,400 |
|
|
Shimachu Co Ltd |
|
|
1,116,411 |
|
|
25,700 |
|
|
Shimamura Co Ltd |
|
|
2,442,734 |
|
|
538,000 |
|
|
Shimizu Corp |
|
|
2,218,162 |
|
|
32,700 |
|
|
Shinko Plantech Co Ltd |
|
|
292,145 |
|
|
40,000 |
|
|
Shinko Shoji Co Ltd |
|
|
312,217 |
|
|
86,000 |
|
|
ShinMaywa Industries Ltd |
|
|
305,346 |
|
|
6,759,000 |
|
|
Shinsei Bank Ltd |
|
|
6,849,364 |
|
|
166,000 |
|
|
Shinsho Corp |
|
|
391,322 |
|
|
53,888 |
|
|
Ship Healthcare Holdings Inc |
|
|
1,281,824 |
|
|
883,000 |
|
|
Shizuoka Bank Ltd (The) |
|
|
9,153,943 |
|
|
104,500 |
|
|
Shizuoka Gas Co Ltd |
|
|
700,642 |
|
|
54,300 |
|
|
Showa Corp * |
|
|
299,732 |
|
|
1,690,000 |
|
|
Showa Denko KK |
|
|
3,449,520 |
|
|
68,000 |
|
|
Showa Sangyo Co Ltd |
|
|
209,221 |
|
|
676,000 |
|
|
Showa Shell Sekiyu KK |
|
|
4,525,662 |
|
|
74,000 |
|
|
Sinanen Co Ltd |
|
|
336,152 |
|
|
2,104 |
|
|
SKY Perfect JSAT Holdings Inc |
|
|
1,075,333 |
|
|
101,900 |
|
|
Sodick Co Ltd |
|
|
552,499 |
|
|
4,706,200 |
|
|
Sojitz Corp |
|
|
7,384,873 |
|
|
123,600 |
|
|
Stanley Electric Co Ltd |
|
|
1,823,469 |
|
|
407,000 |
|
|
Sumikin Bussan Corp |
|
|
979,747 |
|
|
25,120 |
|
|
Sumisho Computer Systems Corp |
|
|
409,254 |
|
|
1,938,000 |
|
|
Sumitomo Light Metal Industries Ltd * |
|
|
1,826,361 |
|
|
58,000 |
|
|
Sumitomo Seika Chemicals Co Ltd |
|
|
259,651 |
|
|
1,562,600 |
|
|
Sumitomo Corp |
|
|
20,857,667 |
|
|
71,400 |
|
|
Sumitomo Forestry Co Ltd |
|
|
610,840 |
|
|
90,000 |
|
|
Sumitomo Metal Mining Co Ltd |
|
|
1,214,402 |
|
|
1,403,500 |
|
|
Sumitomo Mitsui Financial Group Inc |
|
|
39,037,903 |
|
|
505,000 |
|
|
Sumitomo Osaka Cement Co Ltd |
|
|
1,467,745 |
|
|
69,500 |
|
|
Suzuken Co Ltd |
|
|
1,792,936 |
|
|
278,000 |
|
|
SWCC Showa Holdings Co Ltd * |
|
|
257,300 |
|
|
82,000 |
|
|
T RAD Co Ltd |
|
|
273,982 |
|
|
51,200 |
|
|
Tachi-S Co Ltd |
|
|
874,977 |
|
|
3,118,000 |
|
|
Taiheiyo Cement Co Ltd |
|
|
6,057,078 |
|
|
497,400 |
|
|
Taihei Kogyo Co Ltd |
|
|
2,710,180 |
|
|
2,397,836 |
|
|
Taisei Corp |
|
|
6,214,546 |
|
|
283,000 |
|
|
Takashimaya Co Ltd |
|
|
2,016,620 |
|
|
557,900 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
22,915,171 |
|
|
47,000 |
|
|
Takiron Co Ltd |
|
|
158,178 |
|
|
402,000 |
|
|
Takuma Co Ltd * |
|
|
1,737,792 |
|
|
56,800 |
|
|
Teikoku Piston Ring Co Ltd |
|
|
605,581 |
|
|
253,000 |
|
|
Tekken Corp |
|
|
287,679 |
|
|
648,098 |
|
|
TOA Corp |
|
|
1,157,772 |
|
|
222,000 |
|
|
Tohoku Electric Power Co Inc |
|
|
2,312,354 |
|
|
201,200 |
|
|
Toho Holdings Co Ltd |
|
|
2,572,552 |
|
|
110,000 |
|
|
Tohto Suisan Co Ltd |
|
|
188,380 |
|
|
61,300 |
|
|
Tokai Rika Co Ltd |
|
|
951,099 |
|
|
38,940 |
|
|
Token Corp |
|
|
1,452,007 |
|
|
693,900 |
|
|
Tokio Marine Holdings Inc |
|
|
16,866,067 |
|
|
459,000 |
|
|
Tokuyama Corp |
|
|
1,566,583 |
|
|
644,000 |
|
|
Tokyo Gas Co Ltd |
|
|
2,762,461 |
|
|
69,400 |
|
|
Tokyo Steel Manufacturing Co |
|
|
591,143 |
|
|
520 |
|
|
Tokyu REIT Inc (REIT) |
|
|
2,372,430 |
|
|
103,810 |
|
|
Tokyu Construction Co Ltd |
|
|
258,002 |
|
|
252,000 |
|
|
TonenGeneral Sekiyu KK |
|
|
2,874,000 |
|
|
|
|
|
|
|
|
|
|
|
38,100 |
|
|
Toppan Forms Co Ltd |
|
|
280,690 |
|
|
281,000 |
|
|
Toppan Printing Co Ltd |
|
|
2,071,781 |
|
|
224,000 |
|
|
Topy Industries Ltd |
|
|
573,607 |
|
|
89,000 |
|
|
Toshiba TEC Corp |
|
|
336,039 |
|
|
1,337,000 |
|
|
Tosoh Corp |
|
|
3,912,659 |
|
|
33,000 |
|
|
Touei Housing Corp |
|
|
337,140 |
|
|
100,000 |
|
|
Toyo Ink SC Holdings Co Ltd |
|
|
372,015 |
|
|
199,000 |
|
|
Toyo Kanetsu KK |
|
|
382,069 |
|
|
951,000 |
|
|
Toyo Tire & Rubber Co Ltd |
|
|
2,227,748 |
|
|
75,800 |
|
|
Toyota Auto Body Co Ltd |
|
|
1,125,874 |
|
|
210,900 |
|
|
Toyota Motor Corp |
|
|
6,945,048 |
|
|
669,800 |
|
|
Toyota Tsusho Corp |
|
|
11,270,420 |
|
|
1,170,000 |
|
|
Toyo Construction Co Ltd |
|
|
1,162,183 |
|
|
115,000 |
|
|
Toyo Engineering Corp |
|
|
421,670 |
|
|
69,000 |
|
|
Toyo Suisan Kaisha Ltd |
|
|
1,697,804 |
|
|
19,700 |
|
|
Transcosmos Inc |
|
|
228,597 |
|
|
61,900 |
|
|
Tsumura & Co |
|
|
1,717,111 |
|
|
17,800 |
|
|
Tsuruha Holdings Inc |
|
|
927,209 |
|
|
543 |
|
|
TGaia Corp |
|
|
1,053,424 |
|
|
259,000 |
|
|
Uchida Yoko Co Ltd |
|
|
717,521 |
|
|
67,000 |
|
|
Uniden Corp |
|
|
256,112 |
|
|
45,900 |
|
|
Unipres Corp |
|
|
1,273,018 |
|
|
5,270 |
|
|
United Urban Investment Corp (REIT) |
|
|
5,625,469 |
|
|
1,235,000 |
|
|
Unitika Ltd * |
|
|
669,739 |
|
|
311,100 |
|
|
UNY Co Ltd |
|
|
2,857,063 |
|
|
159,230 |
|
|
Usen Corp * |
|
|
101,859 |
|
|
26,220 |
|
|
USS Co Ltd |
|
|
2,279,859 |
|
|
131,800 |
|
|
Valor Co Ltd |
|
|
2,099,743 |
|
|
21,600 |
|
|
Vital KSK Holdings Inc |
|
|
173,433 |
|
|
645,000 |
|
|
Wakachiku Construction Co Ltd * |
|
|
924,053 |
|
|
65,200 |
|
|
Xebio Co Ltd |
|
|
1,509,264 |
|
|
9,585 |
|
|
Yahoo Japan Corp |
|
|
3,037,175 |
|
|
166,660 |
|
|
Yamada Denki Co Ltd |
|
|
12,055,034 |
|
|
67,400 |
|
|
Yamato Holdings Co Ltd |
|
|
1,082,336 |
|
|
81,000 |
|
|
Yamato Kogyo Co Ltd |
|
|
2,243,914 |
|
|
116,800 |
|
|
Yamazen Corp |
|
|
841,280 |
|
|
283,000 |
|
|
Yokohama Rubber Co Ltd |
|
|
1,573,058 |
|
|
43,600 |
|
|
Yokohama Reito Co Ltd |
|
|
335,662 |
|
|
71,500 |
|
|
Yonekyu Corp |
|
|
628,769 |
|
|
37,000 |
|
|
Yorozu Corp |
|
|
790,353 |
|
|
854,000 |
|
|
Yuasa Trading Co Ltd |
|
|
1,171,706 |
|
|
86,000 |
|
|
Yurtec Corp |
|
|
421,840 |
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
1,052,093,863 |
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $1,085,481,383) |
|
|
1,052,093,863 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
SHORT-TERM INVESTMENTS 6.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 6.0% |
|
|
|
|
USD 10,000,000 |
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
10,000,000 |
|
USD 27,529,993 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.03%, due 12/01/11 |
|
|
27,529,993 |
|
JPY 222,107,166 |
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
2,863,682 |
|
USD 7,139,084 |
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
7,139,084 |
|
USD 10,000,000 |
|
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
10,000,000 |
|
USD 10,000,000 |
|
JPMorgan Chase (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
10,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
67,532,759 |
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $67,532,759) |
|
|
67,532,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.4% |
|
|
|
|
|
|
|
|
(Cost $1,153,014,142) |
|
|
1,119,626,622 |
|
|
|
|
|
Other Assets and Liabilities (net) 0.6% |
|
|
6,270,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,125,896,657 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
Counterparty |
|
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/07/11 |
|
Bank of New York Mellon |
|
JPY |
|
|
5,038,305,916 |
|
|
$ |
64,964,175 |
|
|
$ |
58,045 |
|
12/07/11 |
|
Barclays Bank PLC |
|
JPY |
|
|
12,530,211,951 |
|
|
|
161,565,197 |
|
|
|
155,794 |
|
12/07/11 |
|
Brown Brothers Harriman & Co. |
|
JPY |
|
|
11,788,471,519 |
|
|
|
152,001,158 |
|
|
|
146,572 |
|
12/07/11 |
|
Deutsche Bank AG |
|
JPY |
|
|
7,570,598,233 |
|
|
|
97,615,683 |
|
|
|
94,129 |
|
12/07/11 |
|
Morgan Stanley Capital Services Inc. |
|
JPY |
|
|
11,331,250,000 |
|
|
|
146,105,720 |
|
|
|
129,604 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
622,251,933 |
|
|
$ |
584,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/07/11 |
|
Bank of New York Mellon |
|
JPY |
|
|
5,038,305,916 |
|
|
$ |
64,964,175 |
|
|
$ |
(316,637 |
) |
12/07/11 |
|
Barclays Bank PLC |
|
JPY |
|
|
12,530,211,951 |
|
|
|
161,565,197 |
|
|
|
(788,504 |
) |
12/07/11 |
|
Brown Brothers Harriman & Co. |
|
JPY |
|
|
11,788,471,519 |
|
|
|
152,001,158 |
|
|
|
(744,739 |
) |
12/07/11 |
|
Deutsche Bank AG |
|
JPY |
|
|
7,570,598,233 |
|
|
|
97,615,683 |
|
|
|
(478,274 |
) |
12/07/11 |
|
Morgan Stanley Capital Services Inc. |
|
JPY |
|
|
11,331,250,000 |
|
|
|
146,105,720 |
|
|
|
(713,988 |
) |
1/10/12 |
|
Bank of New York Mellon |
|
JPY |
|
|
16,369,555,916 |
|
|
|
211,276,630 |
|
|
|
(214,510 |
) |
1/10/12 |
|
Barclays Bank PLC |
|
JPY |
|
|
12,530,211,951 |
|
|
|
161,723,444 |
|
|
|
(180,862 |
) |
1/10/12 |
|
Brown Brothers Harriman & Co. |
|
JPY |
|
|
11,788,471,519 |
|
|
|
152,150,037 |
|
|
|
(158,398 |
) |
1/10/12 |
|
Deutsche Bank AG |
|
JPY |
|
|
7,570,598,233 |
|
|
|
97,711,293 |
|
|
|
(109,274 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,245,113,337 |
|
|
$ |
(3,705,186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
|
|
|
|
|
|
Expiration |
|
|
|
|
|
|
Appreciation |
|
Number of Contracts |
|
Type |
|
|
Date |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
468 |
|
TOPIX |
|
December 2011 |
|
$ |
44,956,118 |
|
|
$ |
1,458,746 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or
agreements, the Fund had sufficient cash and/or
securities to cover any commitments or collateral
requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
|
|
|
REIT |
|
Real Estate Investment Trust |
* |
|
Non-income producing security. |
Currency Abbreviations:
|
|
|
JPY |
|
Japanese Yen |
USD |
|
United States Dollar |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes
and gross and net unrealized appreciation (depreciation) in value of investments were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
|
Gross |
|
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
|
Unrealized |
|
|
|
Appreciation |
|
Aggregate Cost |
|
|
Appreciation |
|
|
|
(Depreciation) |
|
|
|
(Depreciation) |
|
$1,168,451,770 |
|
|
$45,191,664 |
|
|
|
$(94,016,812) |
|
|
|
$(48,825,148) |
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
|
Equity Securities |
|
93.4% |
|
|
Futures Contracts |
|
0.1% |
|
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of
the NYSE) and other derivatives) due to market events that have occurred since the local market
close but prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in |
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Identical Assets |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan |
|
$ |
|
|
|
$ |
1,052,093,863 |
|
|
$ |
|
|
|
$ |
1,052,093,863 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
|
|
|
|
1,052,093,863 |
|
|
|
|
|
|
|
1,052,093,863 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
67,532,759 |
|
|
|
|
|
|
|
|
|
|
|
67,532,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
67,532,759 |
|
|
|
1,052,093,863 |
|
|
|
|
|
|
|
1,119,626,622 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
|
|
|
|
|
584,144 |
|
|
|
|
|
|
|
584,144 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
1,458,746 |
|
|
|
|
|
|
|
1,458,746 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
67,532,759 |
|
|
$ |
1,054,136,753 |
|
|
$ |
|
|
|
$ |
1,121,669,512 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
Quoted Prices in |
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for |
|
|
|
|
|
|
|
|
|
|
|
|
Identical |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Liabilities |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the [Investment Company Act of 1940 (the 1940 Act)
and therefore a decline in the market value of a particular security held by the Fund may affect
the Funds performance more than if the Fund were diversified. Selected risks of investing
in the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. Declines in stock market prices generally are likely to reduce the net
asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another creates additional risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of
the Funds foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Leveraging Risk The Funds use of reverse repurchase agreements and other derivatives
and securities lending may cause its portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Short Sales Risk The Fund runs the risk that the Funds loss on a short sale of
securities that the Fund does not own is unlimited.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes and adjust exposure to foreign currencies. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
maintain the diversity and liquidity of the portfolio. Futures contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments
purchased. Gains and losses from the expiration or closing of written option contracts are
separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves
counterparty credit, legal, and documentation risk that is generally not reflected in the
models used to price the swap agreement. Such risks include the possibility that the
counterparty defaults on its obligations to perform or disagrees as to the meaning of
contractual terms, that the Fund has amounts on deposit in excess of amounts owed by the Fund,
or that any collateral the other party posts is insufficient or not timely received by the Fund.
Credit risk is particularly acute in economic environments in which financial services firms are
exposed to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions. During the period ended November 30, 2011, the Fund used
swap agreements to manage against anticipated currency exchange rates and to adjust exposure to
foreign currencies. The Fund had no swap agreements outstanding at the end of the
period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency contracts |
|
$ |
|
|
|
$ |
584,144 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
584,144 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,458,746 |
|
|
|
|
|
|
|
1,458,746 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
$ |
584,144 |
|
|
$ |
|
|
|
$ |
1,458,746 |
|
|
$ |
|
|
|
$ |
2,042,890 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(3,705,186 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures
contracts), or notional amounts (swap agreements), outstanding at each month-end, was as follows
for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
Currency |
|
Futures |
|
Swap |
|
|
Contracts |
|
Contracts |
|
Agreements |
Average amount outstanding |
|
$ |
929,190,447 |
|
|
$ |
29,787,405 |
|
|
$ |
46,103,998 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Foreign Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 93.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 2.6% |
|
|
|
|
|
1,913,063 |
|
|
Asciano Group |
|
|
3,111,030 |
|
|
53,715 |
|
|
Australia and New Zealand Banking Group Ltd |
|
|
1,141,244 |
|
|
34,000 |
|
|
Commonwealth Bank of Australia |
|
|
1,702,522 |
|
|
202,016 |
|
|
Crown Ltd |
|
|
1,745,821 |
|
|
1,542,683 |
|
|
Dexus Property Group (REIT) |
|
|
1,395,572 |
|
|
1,009,457 |
|
|
Incitec Pivot Ltd |
|
|
3,491,060 |
|
|
145,735 |
|
|
James Hardie Industries SE * |
|
|
1,046,988 |
|
|
100,207 |
|
|
Macquarie Group Ltd |
|
|
2,509,975 |
|
|
508,638 |
|
|
Myer Holdings Ltd |
|
|
1,279,056 |
|
|
202,427 |
|
|
Santos Ltd |
|
|
2,830,691 |
|
|
1,237,720 |
|
|
Telstra Corp Ltd |
|
|
4,066,746 |
|
|
296,123 |
|
|
Westpac Banking Corp |
|
|
6,469,400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
30,790,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.1% |
|
|
|
|
|
21,523 |
|
|
Telekom Austria AG |
|
|
249,345 |
|
|
44,547 |
|
|
Wienerberger AG |
|
|
472,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
722,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.7% |
|
|
|
|
|
162,214 |
|
|
Belgacom SA |
|
|
5,151,403 |
|
|
81,407 |
|
|
Umicore SA |
|
|
3,504,846 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
8,656,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 1.2% |
|
|
|
|
|
144,200 |
|
|
Cia Hering |
|
|
3,054,088 |
|
|
175,000 |
|
|
EDP-Energias Do Brasil SA |
|
|
3,735,449 |
|
|
348,200 |
|
|
OGX Petroleo e Gas Participacoes SA * |
|
|
2,688,015 |
|
|
213,100 |
|
|
Sonae Sierra Brasil SA |
|
|
2,762,222 |
|
|
237,600 |
|
|
T4F Entretenimento SA * |
|
|
1,773,772 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
14,013,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denmark 0.5% |
|
|
|
|
|
289,300 |
|
|
H Lundbeck A/S |
|
|
5,606,863 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 3.1% |
|
|
|
|
|
87,529 |
|
|
Amer Sports Oyj Class A |
|
|
1,085,588 |
|
|
127,688 |
|
|
Elisa Oyj |
|
|
2,776,617 |
|
|
111,582 |
|
|
Fortum Oyj |
|
|
2,566,974 |
|
|
230,058 |
|
|
Neste Oil Oyj |
|
|
2,877,633 |
|
|
133,203 |
|
|
Nokian Renkaat Oyj |
|
|
4,412,251 |
|
|
1,362,392 |
|
|
Nokia Oyj |
|
|
7,874,074 |
|
|
142,471 |
|
|
Orion Oyj Class B |
|
|
2,898,190 |
|
|
203,979 |
|
|
Sampo Oyj Class A |
|
|
5,328,573 |
|
|
477,558 |
|
|
UPMKymmene Oyj |
|
|
5,590,656 |
|
|
53,629 |
|
|
Wartsila Oyj |
|
|
1,762,515 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Finland |
|
|
37,173,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 8.4% |
|
|
|
|
|
100,918 |
|
|
Accor SA |
|
|
2,823,762 |
|
|
336,603 |
|
|
AXA |
|
|
4,873,889 |
|
|
81,872 |
|
|
BNP Paribas |
|
|
3,259,165 |
|
|
109,610 |
|
|
Carrefour SA |
|
|
2,918,413 |
|
|
26,544 |
|
|
Christian Dior SA |
|
|
3,437,666 |
|
|
|
|
|
|
|
|
|
|
|
78,074 |
|
|
Compagnie de Saint-Gobain |
|
|
3,310,564 |
|
|
88,005 |
|
|
Compagnie Generale des Etablissements Michelin-Class B |
|
|
5,610,165 |
|
|
118,452 |
|
|
European Aeronautic Defense and Space Co NV |
|
|
3,553,776 |
|
|
15,019 |
|
|
LOreal SA |
|
|
1,625,580 |
|
|
101,400 |
|
|
Legrand SA |
|
|
3,282,228 |
|
|
53,135 |
|
|
Pernod-Ricard SA |
|
|
5,012,668 |
|
|
74,958 |
|
|
Publicis Groupe SA |
|
|
3,580,617 |
|
|
33,731 |
|
|
Renault SA |
|
|
1,263,916 |
|
|
251,534 |
|
|
Sanofi |
|
|
17,593,798 |
|
|
32,531 |
|
|
Societe BIC SA |
|
|
2,888,145 |
|
|
81,181 |
|
|
Sodexo |
|
|
5,904,239 |
|
|
418,668 |
|
|
Total SA |
|
|
21,600,157 |
|
|
33,791 |
|
|
Vallourec SA |
|
|
2,319,828 |
|
|
285,322 |
|
|
Vivendi SA |
|
|
6,581,252 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
101,439,828 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 6.5% |
|
|
|
|
|
88,222 |
|
|
Allianz SE (Registered) |
|
|
9,168,391 |
|
|
32,983 |
|
|
Axel Springer AG |
|
|
1,482,886 |
|
|
140,365 |
|
|
Bayer AG |
|
|
9,236,178 |
|
|
78,617 |
|
|
Beiersdorf AG |
|
|
4,503,772 |
|
|
67,829 |
|
|
Continental AG * |
|
|
4,815,799 |
|
|
201,074 |
|
|
Daimler AG (Registered) |
|
|
9,147,515 |
|
|
721,105 |
|
|
Deutsche Telekom AG (Registered) |
|
|
9,363,287 |
|
|
398,696 |
|
|
E.ON AG |
|
|
9,869,196 |
|
|
64,956 |
|
|
HeidelbergCement AG |
|
|
2,740,548 |
|
|
73,323 |
|
|
RWE AG |
|
|
3,039,553 |
|
|
173,393 |
|
|
SAP AG |
|
|
10,382,661 |
|
|
40,843 |
|
|
Siemens AG (Registered) |
|
|
4,133,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
77,883,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 1.6% |
|
|
|
|
|
2,033,853 |
|
|
CITIC Securities Co Ltd * |
|
|
3,324,851 |
|
|
626,000 |
|
|
Hutchison Whampoa Ltd |
|
|
5,498,005 |
|
|
845,000 |
|
|
Power Assets Holdings Ltd |
|
|
6,331,351 |
|
|
280,000 |
|
|
Swire Pacific Ltd |
|
|
3,418,110 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
18,572,317 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 0.1% |
|
|
|
|
|
764,411 |
|
|
Housing Development & Infrastructure Ltd * |
|
|
909,503 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 0.3% |
|
|
|
|
|
240,782 |
|
|
C&C Group Plc |
|
|
986,453 |
|
|
30,607 |
|
|
DCC Plc |
|
|
741,020 |
|
|
61,992 |
|
|
Kerry Group Plc Class A |
|
|
2,315,205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
4,042,678 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 4.8% |
|
|
|
|
|
221,378 |
|
|
Assicurazioni Generali SPA |
|
|
3,676,343 |
|
|
341,686 |
|
|
Autogrill SPA |
|
|
3,563,703 |
|
|
441,625 |
|
|
Enel SPA |
|
|
1,881,720 |
|
|
1,289,697 |
|
|
ENI SPA |
|
|
27,313,567 |
|
|
387,705 |
|
|
Fiat Industrial SPA * |
|
|
3,475,656 |
|
|
3,580,501 |
|
|
Intesa San Paolo |
|
|
5,947,106 |
|
|
1,023,726 |
|
|
Intesa Sanpaolo SPA-Di RISP |
|
|
1,319,607 |
|
|
222,863 |
|
|
Italcementi SPA-Di RISP |
|
|
611,009 |
|
|
180,045 |
|
|
Lottomatica SPA * |
|
|
2,778,089 |
|
|
988,001 |
|
|
Mediaset SPA |
|
|
2,920,659 |
|
|
85,477 |
|
|
Prysmian SPA |
|
|
1,168,396 |
|
|
|
|
|
|
|
|
|
|
|
1,201,957 |
|
|
Saras SPA * |
|
|
1,893,648 |
|
|
217,011 |
|
|
Unione di Banche Italiane ScpA |
|
|
885,018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
57,434,521 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 25.7% |
|
|
|
|
|
804,800 |
|
|
Aeon Co Ltd |
|
|
10,997,228 |
|
|
248,400 |
|
|
Aisin Seiki Co Ltd |
|
|
7,505,813 |
|
|
347,600 |
|
|
Alps Electric Co Ltd |
|
|
2,433,582 |
|
|
664,000 |
|
|
Asahi Glass Co Ltd |
|
|
5,684,085 |
|
|
1,194,000 |
|
|
Asahi Kasei Corp |
|
|
7,242,764 |
|
|
177,400 |
|
|
Astellas Pharma Inc |
|
|
6,838,135 |
|
|
286,200 |
|
|
Canon Inc |
|
|
12,839,566 |
|
|
713,000 |
|
|
Chiba Bank Ltd |
|
|
4,650,673 |
|
|
244,700 |
|
|
Chugai Pharmaceutical Co Ltd |
|
|
3,738,331 |
|
|
272,700 |
|
|
Daikin Industries Ltd |
|
|
8,030,714 |
|
|
84,700 |
|
|
Daito Trust Construction Co Ltd |
|
|
7,554,316 |
|
|
1,326,000 |
|
|
Ebara Corp |
|
|
4,847,712 |
|
|
3,078,000 |
|
|
Hitachi Ltd |
|
|
17,079,546 |
|
|
588,600 |
|
|
Honda Motor Co Ltd |
|
|
18,678,846 |
|
|
250,800 |
|
|
Hoya Corp |
|
|
5,341,897 |
|
|
751,800 |
|
|
Itochu Corp |
|
|
7,640,085 |
|
|
3,923 |
|
|
Japan Retail Fund Investment Corp (REIT) |
|
|
5,999,517 |
|
|
1,346 |
|
|
Japan Tobacco Inc |
|
|
6,459,140 |
|
|
320,400 |
|
|
JSR Corp |
|
|
6,246,906 |
|
|
256,400 |
|
|
JS Group Corp |
|
|
4,862,701 |
|
|
1,928,600 |
|
|
JX Holdings Inc |
|
|
12,265,166 |
|
|
166,800 |
|
|
Lawson Inc |
|
|
9,878,345 |
|
|
99,600 |
|
|
Miraca Holdings Inc |
|
|
3,824,712 |
|
|
1,652,500 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
9,600,093 |
|
|
1,221,000 |
|
|
Mitsubishi Electric Corp |
|
|
11,558,538 |
|
|
593,900 |
|
|
Mitsui & Co Ltd |
|
|
9,370,487 |
|
|
1,633,200 |
|
|
Nissan Motor Co Ltd |
|
|
14,998,185 |
|
|
1,049,000 |
|
|
NSK Ltd |
|
|
6,942,771 |
|
|
9,326 |
|
|
NTT Docomo Inc |
|
|
16,484,132 |
|
|
706,000 |
|
|
Sekisui Chemical Co Ltd |
|
|
5,305,225 |
|
|
68,800 |
|
|
Shimamura Co Ltd |
|
|
6,539,303 |
|
|
4,499,000 |
|
|
Shinsei Bank Ltd |
|
|
4,559,149 |
|
|
395,600 |
|
|
Sumitomo Rubber Industries |
|
|
4,745,044 |
|
|
358,300 |
|
|
Sumitomo Electric Industries Ltd |
|
|
3,890,783 |
|
|
467,300 |
|
|
Sumitomo Mitsui Financial Group Inc |
|
|
12,997,800 |
|
|
1,838,000 |
|
|
Sumitomo Mitsui Trust Holdings Inc |
|
|
5,631,946 |
|
|
273,500 |
|
|
Sumitomo Realty & Development Co Ltd |
|
|
5,424,979 |
|
|
1,410,000 |
|
|
Teijin Ltd |
|
|
4,314,483 |
|
|
258,900 |
|
|
Tokio Marine Holdings Inc |
|
|
6,292,873 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
309,295,571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 0.2% |
|
|
|
|
|
1,357,000 |
|
|
Petronas Chemicals Group Bhd |
|
|
2,614,737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexico 0.2% |
|
|
|
|
|
55,500 |
|
|
Grupo Aeroportuario del Sureste SAB de CV ADR |
|
|
3,128,535 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 0.6% |
|
|
|
|
|
116,940 |
|
|
Arcadis NV |
|
|
2,099,372 |
|
|
98,397 |
|
|
Imtech NV |
|
|
2,530,000 |
|
|
173,664 |
|
|
Koninklijke KPN NV |
|
|
2,125,482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
6,754,854 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.0% |
|
|
|
|
|
52,286 |
|
|
Sky Network Television Ltd |
|
|
225,695 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 0.9% |
|
|
|
|
|
506,992 |
|
|
ProSafe ASA |
|
|
3,823,206 |
|
|
268,330 |
|
|
Statoil ASA |
|
|
6,938,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
10,762,177 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 0.3% |
|
|
|
|
|
10,723,400 |
|
|
Alliance Global Group Inc |
|
|
2,560,019 |
|
|
657,030 |
|
|
Cebu Air Inc |
|
|
1,068,945 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Philippines |
|
|
3,628,964 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 1.8% |
|
|
|
|
|
132,063 |
|
|
Lukoil OAO ADR |
|
|
7,436,186 |
|
|
51,908 |
|
|
Magnit OJSC Sponsored GDR |
|
|
1,154,303 |
|
|
240,520 |
|
|
Phosagro OAO GDR |
|
|
2,453,304 |
|
|
889,900 |
|
|
VimpelCom Ltd Sponsored ADR |
|
|
10,607,608 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Russia |
|
|
21,651,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 1.0% |
|
|
|
|
|
487,554 |
|
|
DBS Group Holdings Ltd |
|
|
4,848,461 |
|
|
2,308,000 |
|
|
Global Logistic Properties Ltd * |
|
|
3,355,863 |
|
|
551,100 |
|
|
Keppel Corp Ltd |
|
|
4,093,769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
12,298,093 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 2.0% |
|
|
|
|
|
69,694 |
|
|
Doosan Heavy Industries and Construction Co |
|
|
4,145,679 |
|
|
10,822 |
|
|
Hyundai Mobis |
|
|
3,001,061 |
|
|
83,960 |
|
|
Kangwon Land Inc |
|
|
2,069,496 |
|
|
4,732 |
|
|
LG Chem Ltd |
|
|
1,416,245 |
|
|
30,134 |
|
|
LG Corp |
|
|
1,696,072 |
|
|
181,970 |
|
|
LG Display Co Ltd |
|
|
4,339,015 |
|
|
38,786 |
|
|
LG Electronics Inc |
|
|
2,597,662 |
|
|
56,490 |
|
|
Shinhan Financial Group Co Ltd |
|
|
2,106,118 |
|
|
16,986 |
|
|
SK Holdings Co Ltd |
|
|
2,212,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
23,583,884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 1.0% |
|
|
|
|
|
299,171 |
|
|
Banco Santander SA |
|
|
2,245,646 |
|
|
217,988 |
|
|
Enagas |
|
|
4,090,321 |
|
|
297,130 |
|
|
Telefonica SA |
|
|
5,579,612 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
11,915,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 1.6% |
|
|
|
|
|
444,038 |
|
|
Ericsson LM B Shares |
|
|
4,737,092 |
|
|
135,575 |
|
|
Getinge AB Class B |
|
|
3,494,735 |
|
|
513,941 |
|
|
Svenska Cellulosa AB Class B |
|
|
7,647,451 |
|
|
438,101 |
|
|
TeliaSonera AB |
|
|
2,988,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
18,867,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 4.3% |
|
|
|
|
|
50,218 |
|
|
Adecco SA * |
|
|
2,184,111 |
|
|
417,564 |
|
|
Novartis AG (Registered) |
|
|
22,550,230 |
|
|
40,492 |
|
|
Roche Holding AG (Non Voting) |
|
|
6,441,236 |
|
|
39,800 |
|
|
Sulzer AG |
|
|
4,442,966 |
|
|
11,394 |
|
|
Swisscom AG (Registered) |
|
|
4,302,884 |
|
|
|
|
|
|
|
|
|
|
|
9,011 |
|
|
Syngenta AG (Registered) * |
|
|
2,651,696 |
|
|
43,304 |
|
|
Zurich Financial Services AG * |
|
|
9,537,202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
52,110,325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 0.3% |
|
|
|
|
|
570,416 |
|
|
Asustek Computer Inc |
|
|
3,985,563 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 0.6% |
|
|
|
|
|
952,900 |
|
|
Bangkok Bank Pcl NVDR |
|
|
4,541,690 |
|
|
13,666,800 |
|
|
Land & Houses Pcl NVDR |
|
|
2,683,923 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Thailand |
|
|
7,225,613 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 23.1% |
|
|
|
|
|
221,089 |
|
|
AMEC Plc |
|
|
3,025,585 |
|
|
466,159 |
|
|
BG Group Plc |
|
|
9,998,563 |
|
|
3,409,003 |
|
|
BP Plc |
|
|
24,689,230 |
|
|
502,494 |
|
|
British American Tobacco Plc |
|
|
23,319,269 |
|
|
1,314,289 |
|
|
BT Group Plc |
|
|
3,932,904 |
|
|
620,183 |
|
|
Centrica Plc |
|
|
2,948,021 |
|
|
47,509 |
|
|
Charter International Plc |
|
|
697,349 |
|
|
474,879 |
|
|
Diageo Plc |
|
|
10,170,970 |
|
|
251,269 |
|
|
GlaxoSmithKline Plc |
|
|
5,568,631 |
|
|
2,428,608 |
|
|
HSBC Holdings Plc |
|
|
18,944,239 |
|
|
249,694 |
|
|
Imperial Tobacco Group Plc |
|
|
8,983,242 |
|
|
549,484 |
|
|
Inchcape Plc |
|
|
2,822,276 |
|
|
385,946 |
|
|
International Power Plc |
|
|
2,039,557 |
|
|
169,010 |
|
|
John Wood Group Plc |
|
|
1,736,787 |
|
|
30,820 |
|
|
Johnson Matthey Plc |
|
|
929,081 |
|
|
177,109 |
|
|
Land Securities Group Plc (REIT) |
|
|
1,915,283 |
|
|
819,972 |
|
|
National Express Group Plc |
|
|
2,709,728 |
|
|
279,170 |
|
|
National Grid Plc |
|
|
2,743,489 |
|
|
823,017 |
|
|
Premier Oil Plc * |
|
|
4,727,550 |
|
|
496,272 |
|
|
Prudential Plc |
|
|
4,884,619 |
|
|
174,628 |
|
|
Reckitt Benckiser Group Plc |
|
|
8,859,355 |
|
|
292,703 |
|
|
Rio Tinto Plc |
|
|
15,409,541 |
|
|
276,990 |
|
|
Rolls-Royce Holdings Plc * |
|
|
3,183,860 |
|
|
708,588 |
|
|
Royal Dutch Shell Plc A Shares (London) |
|
|
24,782,572 |
|
|
612,778 |
|
|
Royal Dutch Shell Plc B Shares (London) |
|
|
22,081,190 |
|
|
1,508,782 |
|
|
Tesco Plc |
|
|
9,632,997 |
|
|
188,829 |
|
|
Travis Perkins Plc |
|
|
2,479,057 |
|
|
144,487 |
|
|
Ultra Electronics Holdings Plc |
|
|
3,284,866 |
|
|
240,668 |
|
|
Unilever Plc |
|
|
8,084,507 |
|
|
8,983,184 |
|
|
Vodafone Group Plc |
|
|
24,318,455 |
|
|
1,639,965 |
|
|
WM Morrison Supermarkets Plc |
|
|
8,314,364 |
|
|
688,159 |
|
|
Xstrata Plc |
|
|
11,047,458 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
278,264,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $1,163,498,516) |
|
|
1,123,557,255 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 0.5% |
|
|
|
|
|
214,100 |
|
|
Telefonica Brasil SA 0.72% |
|
|
5,777,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 0.1% |
|
|
|
|
|
30,672 |
|
|
Porsche Automobil Holding SE 1.12% |
|
|
1,879,540 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 0.4% |
|
|
|
|
|
38,888 |
|
|
Hyundai Motor Co 2.29% |
|
|
2,424,349 |
|
|
|
|
|
|
|
|
|
|
|
10,785 |
|
|
LG Chem Ltd 3.40% |
|
|
1,167,341 |
|
|
33,070 |
|
|
LG Electronics Inc 1.04% |
|
|
717,464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
4,309,154 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $10,694,429) |
|
|
11,966,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 0.0% |
|
|
|
|
|
7,448 |
|
|
LG Electronics Inc Rights, Expires 12/21/11* |
|
|
141,438 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 0.0% |
|
|
|
|
|
20,989,248 |
|
|
Rolls-Royce Holdings Plc Rights, Expires 2/09/12* |
|
|
32,930 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $177,079) |
|
|
174,368 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 4.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 4.9% |
|
|
|
|
USD |
15,000,000 |
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
15,000,000 |
|
AUD |
124 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11 |
|
|
127 |
|
GBP |
144,194 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.10%, due 12/01/11 |
|
|
226,226 |
|
NOK |
120 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
21 |
|
SEK |
146 |
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11 |
|
|
21 |
|
EUR |
5,186,899 |
|
Citibank (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
6,969,636 |
|
JPY |
69,997,496 |
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
902,498 |
|
USD |
7,116,033 |
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
7,116,033 |
|
USD |
13,370,406 |
|
HSBC Bank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
13,370,406 |
|
EUR |
11,142,889 |
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
14,972,699 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
58,557,667 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $58,557,667) |
|
|
58,557,667 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.4%
(Cost $1,232,927,691) |
|
|
1,194,255,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.6% |
|
|
7,120,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,201,375,776 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
13,853,500 |
|
|
$ |
18,615,017 |
|
|
$ |
707,072 |
|
|
12/06/11 |
|
|
HSBC Bank USA |
|
EUR |
|
|
13,853,500 |
|
|
|
18,615,016 |
|
|
|
721,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
37,230,033 |
|
|
$ |
1,428,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Fund sells foreign currency; buys USD. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to
cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
ADR American Depositary Receipt
GDR Global Depository Receipt
NVDR Non-Voting Depository Receipt
REIT Real Estate Investment Trust
* Non-income producing security.
Currency Abbreviations:
AUD Australian Dollar
EUR Euro
GBP British Pound
JPY Japanese Yen
NOK Norwegian Krone
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax
purposes and gross and net unrealized appreciation (depreciation) in value of
investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
|
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
|
|
$1,275,599,746 |
|
$ |
66,712,881 |
|
|
$ |
(148,056,956 |
) |
|
$ |
(81,344,075 |
) |
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
91.3% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
30,790,105 |
|
|
$ |
|
|
|
$ |
30,790,105 |
|
Austria |
|
|
|
|
|
|
722,166 |
|
|
|
|
|
|
|
722,166 |
|
Belgium |
|
|
|
|
|
|
8,656,249 |
|
|
|
|
|
|
|
8,656,249 |
|
Brazil |
|
|
14,013,546 |
|
|
|
|
|
|
|
|
|
|
|
14,013,546 |
|
Denmark |
|
|
|
|
|
|
5,606,863 |
|
|
|
|
|
|
|
5,606,863 |
|
Finland |
|
|
|
|
|
|
37,173,071 |
|
|
|
|
|
|
|
37,173,071 |
|
France |
|
|
|
|
|
|
101,439,828 |
|
|
|
|
|
|
|
101,439,828 |
|
Germany |
|
|
|
|
|
|
77,883,064 |
|
|
|
|
|
|
|
77,883,064 |
|
Hong Kong |
|
|
3,324,851 |
|
|
|
15,247,466 |
|
|
|
|
|
|
|
18,572,317 |
|
India |
|
|
|
|
|
|
909,503 |
|
|
|
|
|
|
|
909,503 |
|
Ireland |
|
|
|
|
|
|
4,042,678 |
|
|
|
|
|
|
|
4,042,678 |
|
Italy |
|
|
|
|
|
|
57,434,521 |
|
|
|
|
|
|
|
57,434,521 |
|
Japan |
|
|
|
|
|
|
309,295,571 |
|
|
|
|
|
|
|
309,295,571 |
|
Malaysia |
|
|
|
|
|
|
2,614,737 |
|
|
|
|
|
|
|
2,614,737 |
|
Mexico |
|
|
3,128,535 |
|
|
|
|
|
|
|
|
|
|
|
3,128,535 |
|
Netherlands |
|
|
|
|
|
|
6,754,854 |
|
|
|
|
|
|
|
6,754,854 |
|
New Zealand |
|
|
|
|
|
|
225,695 |
|
|
|
|
|
|
|
225,695 |
|
Norway |
|
|
|
|
|
|
10,762,177 |
|
|
|
|
|
|
|
10,762,177 |
|
Philippines |
|
|
|
|
|
|
3,628,964 |
|
|
|
|
|
|
|
3,628,964 |
|
Russia |
|
|
13,060,912 |
|
|
|
8,590,489 |
|
|
|
|
|
|
|
21,651,401 |
|
Singapore |
|
|
|
|
|
|
12,298,093 |
|
|
|
|
|
|
|
12,298,093 |
|
South Korea |
|
|
|
|
|
|
23,583,884 |
|
|
|
|
|
|
|
23,583,884 |
|
Spain |
|
|
|
|
|
|
11,915,579 |
|
|
|
|
|
|
|
11,915,579 |
|
Sweden |
|
|
|
|
|
|
18,867,758 |
|
|
|
|
|
|
|
18,867,758 |
|
Switzerland |
|
|
|
|
|
|
52,110,325 |
|
|
|
|
|
|
|
52,110,325 |
|
Taiwan |
|
|
|
|
|
|
3,985,563 |
|
|
|
|
|
|
|
3,985,563 |
|
Thailand |
|
|
|
|
|
|
7,225,613 |
|
|
|
|
|
|
|
7,225,613 |
|
United Kingdom |
|
|
|
|
|
|
278,264,595 |
|
|
|
|
|
|
|
278,264,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
33,527,844 |
|
|
|
1,090,029,411 |
|
|
|
|
|
|
|
1,123,557,255 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
|
5,777,687 |
|
|
|
|
|
|
|
|
|
|
|
5,777,687 |
|
Germany |
|
|
|
|
|
|
1,879,540 |
|
|
|
|
|
|
|
1,879,540 |
|
South Korea |
|
|
|
|
|
|
4,309,154 |
|
|
|
|
|
|
|
4,309,154 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
5,777,687 |
|
|
|
6,188,694 |
|
|
|
|
|
|
|
11,966,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea |
|
|
|
|
|
|
141,438 |
|
|
|
|
|
|
|
141,438 |
|
United Kingdom |
|
|
|
|
|
|
32,930 |
|
|
|
|
|
|
|
32,930 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS |
|
|
|
|
|
|
174,368 |
|
|
|
|
|
|
|
174,368 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Short-Term Investments |
|
|
58,557,667 |
|
|
|
|
|
|
|
|
|
|
|
58,557,667 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
97,863,198 |
|
|
|
1,096,392,473 |
|
|
|
|
|
|
|
1,194,255,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
|
|
|
|
|
1,428,094 |
|
|
|
|
|
|
|
1,428,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
1,428,094 |
|
|
|
|
|
|
|
1,428,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
97,863,198 |
|
|
$ |
1,097,820,567 |
|
|
$ |
|
|
|
$ |
1,195,683,765 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see
the Investment and other risks and Derivative financial instruments sections below for a
further discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from Investments |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
Transfers |
|
|
Transfers out |
|
|
Balances as |
|
|
|
Still Held as of |
|
|
|
28, 2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
into Level 3* |
|
|
of Level 3* |
|
|
of
November 30, 2011 |
|
|
|
November
30, 2011 |
|
Common
Stocks |
|
|
|
|
|
Thailand |
|
$ |
3,966,670 |
|
|
$ |
|
|
|
$ |
(3,910,885 |
) |
|
$ |
|
|
|
$ |
(33,316 |
) |
|
$ |
(22,469 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,966,670 |
|
|
$ |
|
|
|
$ |
(3,910,885 |
) |
|
$ |
|
|
|
$ |
(33,316 |
) |
|
$ |
(22,469 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at
the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period.
|
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of value of those investments. Declines in stock market prices
generally are likely to reduce the net asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of
the Funds foreign currency holdings and investments denominated in foreign currencies.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency
contract
fluctuates with changes in forward currency
exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes. Forward currency contracts outstanding at the end of the period are
listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments
purchased. Gains and losses from the expiration or closing of written option contracts are
separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of
available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and
may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or
warrants held by the Fund at the end of the period are listed in the Funds Schedule of
Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
174,368 |
|
|
$ |
|
|
|
$ |
174,368 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
1,428,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,428,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
1,428,094 |
|
|
$ |
|
|
|
$ |
174,368 |
|
|
$ |
|
|
|
$ |
1,602,462 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and rights
and/or warrants) outstanding at each month-end, was as follows for the period ended November 30,
2011:
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
Currency |
|
|
Rights and/or |
|
|
|
Contracts |
|
|
Warrants |
|
Average amount outstanding |
|
$ |
27,874,005 |
|
|
$ |
1,955,774 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Foreign Small Companies Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 95.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 3.6% |
|
|
|
|
|
249,244 |
|
|
Aquarius Platinum Ltd |
|
|
670,684 |
|
|
1,288,353 |
|
|
Asciano Group |
|
|
2,095,124 |
|
|
243,908 |
|
|
Billabong International Ltd |
|
|
954,847 |
|
|
3,407,775 |
|
|
Dexus Property Group (REIT) |
|
|
3,082,807 |
|
|
511,521 |
|
|
Iress Market Technology Ltd |
|
|
4,081,095 |
|
|
347,519 |
|
|
Nufarm Ltd * |
|
|
1,755,271 |
|
|
1,527,883 |
|
|
Pacific Brands Ltd |
|
|
851,959 |
|
|
198,843 |
|
|
PanAust Ltd * |
|
|
692,526 |
|
|
391,677 |
|
|
Primary Health Care Ltd |
|
|
1,328,056 |
|
|
197,476 |
|
|
Seven West Media Ltd |
|
|
696,931 |
|
|
3,348,485 |
|
|
Ten Network Holdings Ltd |
|
|
3,165,289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
19,374,589 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.4% |
|
|
|
|
|
16,047 |
|
|
Flughafen Wien AG |
|
|
617,936 |
|
|
8,600 |
|
|
Lenzing AG |
|
|
782,813 |
|
|
58,311 |
|
|
Wienerberger AG |
|
|
618,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
2,019,661 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 1.6% |
|
|
|
|
|
40,914 |
|
|
CMB Cie Maritime Belge SA |
|
|
877,977 |
|
|
38,030 |
|
|
Compagnie dEntreprises CFE |
|
|
1,986,188 |
|
|
41,011 |
|
|
Mobistar SA |
|
|
2,242,581 |
|
|
50,893 |
|
|
SA DIeteren NV |
|
|
2,405,299 |
|
|
26,961 |
|
|
Umicore SA |
|
|
1,160,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
8,672,807 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 3.4% |
|
|
|
|
|
204,400 |
|
|
Aliansce Shopping Centers SA |
|
|
1,593,740 |
|
|
480,000 |
|
|
Brasil Brokers Participacoes SA |
|
|
1,616,501 |
|
|
129,500 |
|
|
Brasil Insurance Participacoes e Administracao SA |
|
|
1,278,279 |
|
|
220,000 |
|
|
Brazil Pharma SA * |
|
|
2,109,547 |
|
|
423,600 |
|
|
Cia Hering |
|
|
8,971,648 |
|
|
207,000 |
|
|
Iochpe-Maxion SA |
|
|
2,552,659 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
18,122,374 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 4.3% |
|
|
|
|
|
151,340 |
|
|
Alamos Gold Inc |
|
|
2,559,552 |
|
|
657,000 |
|
|
Canaco Resources Inc * |
|
|
908,250 |
|
|
700,000 |
|
|
Chinook Energy Inc * |
|
|
1,029,462 |
|
|
87,100 |
|
|
Corus Entertainment Inc Class B |
|
|
1,617,407 |
|
|
113,200 |
|
|
Flint Energy Services Ltd * |
|
|
1,429,497 |
|
|
625,000 |
|
|
Gran
Colombia Gold Corp
*(a) |
|
|
324,771 |
|
|
128,250 |
|
|
Gran Colombia Gold Corp * |
|
|
66,643 |
|
|
475,100 |
|
|
Guide Exploration Ltd Class A * |
|
|
1,457,976 |
|
|
166,300 |
|
|
Just Energy Group Inc |
|
|
1,671,234 |
|
|
123,700 |
|
|
Karnalyte Resources Inc * |
|
|
1,597,264 |
|
|
172,300 |
|
|
Karnalyte Resources Inc (a) |
|
|
2,224,806 |
|
|
349,500 |
|
|
NuVista Energy Ltd * |
|
|
1,548,841 |
|
|
224,800 |
|
|
Precision Drilling Corp * |
|
|
2,598,551 |
|
|
763,100 |
|
|
RMP Energy Inc * |
|
|
1,645,983 |
|
|
332,550 |
|
|
Western Energy Services Corp * |
|
|
2,523,591 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
23,203,828 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China 0.4% |
|
|
|
|
|
4,605,000 |
|
|
361 Degrees International Ltd |
|
|
1,979,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denmark 0.9% |
|
|
|
|
|
141,931 |
|
|
H Lundbeck A/S |
|
|
2,750,735 |
|
|
1,527,788 |
|
|
Ossur hf * |
|
|
2,113,212 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Denmark |
|
|
4,863,947 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 1.6% |
|
|
|
|
|
45,070 |
|
|
Amer Sports Oyj Class A |
|
|
558,985 |
|
|
113,100 |
|
|
Elisa Oyj |
|
|
2,459,396 |
|
|
72,000 |
|
|
Huhtamaki Oyj |
|
|
837,906 |
|
|
593,200 |
|
|
M-real Oyj B shares * |
|
|
1,135,177 |
|
|
479,518 |
|
|
Oriola-KD Oyj Class B |
|
|
1,366,320 |
|
|
79,700 |
|
|
Orion Oyj Class B |
|
|
1,621,282 |
|
|
147,630 |
|
|
Talvivaara Mining Co Plc * |
|
|
556,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Finland |
|
|
8,535,752 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 5.1% |
|
|
|
|
|
139,127 |
|
|
Boursorama * |
|
|
1,129,652 |
|
|
85,896 |
|
|
Cap Gemini SA |
|
|
3,262,331 |
|
|
64,262 |
|
|
Compagnie Generale des Etablissements Michelin-Class B |
|
|
4,096,590 |
|
|
107,428 |
|
|
Faurecia |
|
|
2,263,795 |
|
|
112,191 |
|
|
Legrand SA |
|
|
3,631,523 |
|
|
50,296 |
|
|
Societe BIC SA |
|
|
4,465,346 |
|
|
62,421 |
|
|
Sodexo |
|
|
4,539,837 |
|
|
25,932 |
|
|
Virbac SA |
|
|
4,170,918 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
27,559,992 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 3.3% |
|
|
|
|
|
48,332 |
|
|
Bauer AG |
|
|
1,312,371 |
|
|
62,218 |
|
|
Cat Oil AG |
|
|
395,517 |
|
|
28,123 |
|
|
Continental AG * |
|
|
1,996,708 |
|
|
45,917 |
|
|
Gerresheimer AG |
|
|
1,931,834 |
|
|
41,970 |
|
|
GSW Immobilien AG * |
|
|
1,342,724 |
|
|
36,818 |
|
|
HeidelbergCement AG |
|
|
1,553,382 |
|
|
78,172 |
|
|
KUKA AG * |
|
|
1,530,170 |
|
|
100,954 |
|
|
NORMA Group * |
|
|
1,888,030 |
|
|
170,000 |
|
|
Prime Office REIT-AG * |
|
|
1,043,840 |
|
|
61,797 |
|
|
Rhoen-Klinikum AG |
|
|
1,170,204 |
|
|
112,974 |
|
|
Tom Tailor Holding AG * |
|
|
2,012,634 |
|
|
38,287 |
|
|
Wincor Nixdorf AG |
|
|
1,838,163 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
18,015,577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 1.3% |
|
|
|
|
|
7,073,900 |
|
|
PCCW Ltd |
|
|
2,621,932 |
|
|
1,425,000 |
|
|
Yue Yuen Industrial Holdings |
|
|
4,106,539 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
6,728,471 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 0.3% |
|
|
|
|
|
302,200 |
|
|
Housing Development & Infrastructure Ltd * |
|
|
359,560 |
|
|
277,400 |
|
|
Orchid Chemicals & Pharmaceuticals Ltd |
|
|
833,719 |
|
|
254,100 |
|
|
Rolta India Ltd |
|
|
296,239 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total India |
|
|
1,489,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 0.2% |
|
|
|
|
|
4,011,000 |
|
|
Borneo Lumbung Energi & Metal Tbk PT * |
|
|
370,752 |
|
|
|
|
|
|
|
|
|
|
|
381,500 |
|
|
Tambang Batubara Bukit Asam Tbk PT |
|
|
734,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Indonesia |
|
|
1,105,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 0.8% |
|
|
|
|
|
329,129 |
|
|
C&C Group Plc |
|
|
1,348,400 |
|
|
83,494 |
|
|
DCC Plc |
|
|
2,021,456 |
|
|
30,100 |
|
|
Kerry Group Plc Class A |
|
|
1,124,140 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
4,493,996 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 3.5% |
|
|
|
|
|
464,323 |
|
|
Autogrill SPA |
|
|
4,842,777 |
|
|
109,100 |
|
|
Buzzi Unicem SPA * |
|
|
1,003,278 |
|
|
427,232 |
|
|
Credito Emiliano SPA |
|
|
1,661,087 |
|
|
335,758 |
|
|
Italcementi SPA-Di RISP |
|
|
920,526 |
|
|
151,165 |
|
|
Lottomatica SPA * |
|
|
2,332,471 |
|
|
790,054 |
|
|
Mediaset SPA |
|
|
2,335,502 |
|
|
488,436 |
|
|
Mediolanum SPA |
|
|
1,784,782 |
|
|
200,000 |
|
|
Piaggio & C SPA |
|
|
590,954 |
|
|
1,339,325 |
|
|
Prelios SPA * |
|
|
155,610 |
|
|
115,821 |
|
|
Prysmian SPA |
|
|
1,583,172 |
|
|
1,202,408 |
|
|
Saras SPA * |
|
|
1,894,359 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
19,104,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 25.7% |
|
|
|
|
|
438,000 |
|
|
Air Water Inc |
|
|
5,722,051 |
|
|
475,900 |
|
|
Alps Electric Co Ltd |
|
|
3,331,823 |
|
|
1,827,000 |
|
|
Aozora Bank Ltd |
|
|
4,894,226 |
|
|
230,300 |
|
|
Avex Group Holding Inc |
|
|
2,613,366 |
|
|
226,900 |
|
|
Century Tokyo Leasing Corp |
|
|
4,502,402 |
|
|
224,600 |
|
|
Circle K Sunkus Co Ltd |
|
|
3,662,810 |
|
|
170,200 |
|
|
Cosmos Pharmaceutical Corp |
|
|
8,292,320 |
|
|
400,500 |
|
|
Fuji Oil Co Ltd |
|
|
5,732,866 |
|
|
155,200 |
|
|
Hitachi Chemical Co Ltd |
|
|
2,996,228 |
|
|
324,700 |
|
|
Hitachi Transport System Ltd |
|
|
5,457,247 |
|
|
151,400 |
|
|
IRISO Electronics Co Ltd |
|
|
2,337,762 |
|
|
256,500 |
|
|
Izumi Co Ltd |
|
|
3,842,232 |
|
|
507,000 |
|
|
Japan Aviation Electronics Industry Ltd |
|
|
3,683,760 |
|
|
120,040 |
|
|
Ks Holdings Corp |
|
|
4,731,587 |
|
|
276,900 |
|
|
Keihin Corp |
|
|
4,358,624 |
|
|
1,224 |
|
|
Kenedix Realty Investment Corp (REIT) |
|
|
3,498,020 |
|
|
121,500 |
|
|
Kintetsu World Express Inc |
|
|
3,621,439 |
|
|
157,000 |
|
|
Kyorin Co Ltd |
|
|
2,647,029 |
|
|
114,420 |
|
|
Mitsubishi UFJ Lease & Finance Co Ltd |
|
|
4,380,469 |
|
|
315,300 |
|
|
Nabtesco Corp |
|
|
6,943,398 |
|
|
643,500 |
|
|
NHK Spring Co Ltd |
|
|
5,873,264 |
|
|
331,300 |
|
|
Nihon Kohden Corp |
|
|
7,662,639 |
|
|
69,000 |
|
|
Nippon Soda Co Ltd |
|
|
292,746 |
|
|
489,000 |
|
|
Nissin Electric Co Ltd |
|
|
2,807,393 |
|
|
760,200 |
|
|
Pioneer Corp * |
|
|
3,730,072 |
|
|
638,000 |
|
|
Rengo Co Ltd |
|
|
4,539,915 |
|
|
170,200 |
|
|
Saizeriya Co Ltd |
|
|
2,790,620 |
|
|
764,000 |
|
|
Sanken Electric Co Ltd |
|
|
2,635,428 |
|
|
2,085,000 |
|
|
Shinsei Bank Ltd |
|
|
2,112,875 |
|
|
217,200 |
|
|
Sumitomo Rubber Industries |
|
|
2,605,216 |
|
|
231,300 |
|
|
Takata Corp |
|
|
5,013,164 |
|
|
741,000 |
|
|
Tsubakimoto Chain Co |
|
|
4,028,440 |
|
|
1,418,000 |
|
|
Ube Industries Ltd |
|
|
4,011,688 |
|
|
|
|
|
|
|
|
|
|
|
173,900 |
|
|
United Arrows Ltd |
|
|
3,114,656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
138,467,775 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexico 0.4% |
|
|
|
|
|
1,221,200 |
|
|
Fibra Uno Administracion SA de CV (REIT) |
|
|
2,238,967 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 2.4% |
|
|
|
|
|
131,030 |
|
|
AerCap Holdings NV * |
|
|
1,409,883 |
|
|
144,481 |
|
|
Arcadis NV |
|
|
2,593,804 |
|
|
76,500 |
|
|
CSM NV |
|
|
1,005,482 |
|
|
99,032 |
|
|
Imtech NV |
|
|
2,546,326 |
|
|
50,723 |
|
|
Koninklijke Ten Cate NV |
|
|
1,471,036 |
|
|
30,762 |
|
|
Nutreco Holding NV |
|
|
2,017,247 |
|
|
90,472 |
|
|
SBM Offshore NV |
|
|
1,948,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
12,992,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.6% |
|
|
|
|
|
1,056,738 |
|
|
Fisher & Paykel Appliances Holdings Ltd * |
|
|
294,827 |
|
|
170,048 |
|
|
Pumpkin Patch Ltd |
|
|
79,506 |
|
|
1,120,349 |
|
|
Sky City Entertainment Group Ltd |
|
|
3,004,710 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total New Zealand |
|
|
3,379,043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 2.2% |
|
|
|
|
|
729,820 |
|
|
BWG Homes ASA |
|
|
1,228,635 |
|
|
88,623 |
|
|
Fred Olsen Energy ASA |
|
|
2,974,693 |
|
|
78,085 |
|
|
Kongsberg Gruppen ASA |
|
|
1,575,596 |
|
|
530,407 |
|
|
ProSafe ASA |
|
|
3,999,778 |
|
|
295,810 |
|
|
SpareBank 1 SR Bank |
|
|
2,129,580 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
11,908,282 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 1.3% |
|
|
|
|
|
12,352,000 |
|
|
Alliance Global Group Inc |
|
|
2,948,818 |
|
|
1,061,100 |
|
|
Cebu Air Inc |
|
|
1,726,341 |
|
|
5,938,800 |
|
|
Puregold Price Club Inc * |
|
|
2,083,073 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Philippines |
|
|
6,758,232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 0.3% |
|
|
|
|
|
99,423 |
|
|
Cherkizovo Group GDR (Registered) * |
|
|
1,488,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 1.1% |
|
|
|
|
|
605,000 |
|
|
ComfortDelgro Corp Ltd |
|
|
672,754 |
|
|
3,725,000 |
|
|
First Ship Lease Trust |
|
|
859,050 |
|
|
2,587,640 |
|
|
Mapletree Logistics Trust (REIT) |
|
|
1,693,134 |
|
|
854,000 |
|
|
MobileOne Ltd |
|
|
1,629,966 |
|
|
985,000 |
|
|
Petra Foods Ltd |
|
|
1,312,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
6,167,293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 5.7% |
|
|
|
|
|
209,083 |
|
|
CrucialTec Co Ltd * |
|
|
3,344,599 |
|
|
20,750 |
|
|
Daelim Industrial Co Ltd |
|
|
1,846,115 |
|
|
290,330 |
|
|
DGB Financial Group Inc * |
|
|
3,419,645 |
|
|
42,990 |
|
|
Golfzon Co Ltd * |
|
|
2,079,603 |
|
|
442,142 |
|
|
Kortek Corp |
|
|
4,164,128 |
|
|
250,000 |
|
|
Magnachip Semiconductor Corp * |
|
|
2,002,500 |
|
|
13,095 |
|
|
Mando Corp |
|
|
2,391,495 |
|
|
27,560 |
|
|
Mirae Asset Securities Co Ltd |
|
|
838,579 |
|
|
10,467 |
|
|
Nong Shim Co Ltd |
|
|
2,168,688 |
|
|
35,140 |
|
|
S1 Corp |
|
|
1,781,593 |
|
|
|
|
|
|
|
|
|
|
|
17,730 |
|
|
Sindoh Co Ltd |
|
|
783,447 |
|
|
5,600 |
|
|
SK Holdings Co Ltd |
|
|
729,436 |
|
|
81,600 |
|
|
Tong Yang Life Insurance Co Ltd |
|
|
1,096,565 |
|
|
79,520 |
|
|
Youngone Holding Co Ltd |
|
|
4,317,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
30,964,364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 1.2% |
|
|
|
|
|
146,205 |
|
|
Banco Espanol de Credito SA |
|
|
704,785 |
|
|
2,662 |
|
|
Construcciones y Auxiliar de Ferrocarriles SA |
|
|
1,425,855 |
|
|
150,968 |
|
|
Enagas |
|
|
2,832,760 |
|
|
33,034 |
|
|
Red Electrica de Espana |
|
|
1,452,157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
6,415,557 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 2.2% |
|
|
|
|
|
103,561 |
|
|
Elekta AB Class B |
|
|
4,409,272 |
|
|
205,781 |
|
|
Getinge AB Class B |
|
|
5,304,444 |
|
|
1,994,403 |
|
|
Trigon Agri A/S * |
|
|
2,399,163 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
12,112,879 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 2.9% |
|
|
|
|
|
7,227 |
|
|
Alpiq Holding AG (Registered) |
|
|
1,229,214 |
|
|
100,479 |
|
|
Aryzta AG |
|
|
4,850,775 |
|
|
10,921 |
|
|
Kaba Holding AG Class B (Registered) |
|
|
3,847,718 |
|
|
29,275 |
|
|
Sulzer AG |
|
|
3,268,036 |
|
|
13,617 |
|
|
Valora Holding AG |
|
|
2,582,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
15,777,964 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 0.2% |
|
|
|
|
|
640,982 |
|
|
Altek Corp |
|
|
523,855 |
|
|
434,500 |
|
|
Coretronic Corp |
|
|
320,627 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Taiwan |
|
|
844,482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 0.4% |
|
|
|
|
|
15,969,100 |
|
|
Quality Houses PCL (Foreign Registered) (b) |
|
|
725,347 |
|
|
10,770,200 |
|
|
SVI PCL (Foreign Registered) (b) |
|
|
1,180,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Thailand |
|
|
1,905,513 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 18.4% |
|
|
|
|
|
401,205 |
|
|
Babcock International Group Plc |
|
|
4,581,378 |
|
|
228,267 |
|
|
Berkeley Group Holdings Plc (Unit Shares) * |
|
|
4,595,993 |
|
|
983,386 |
|
|
Centaur Media Plc |
|
|
599,404 |
|
|
214,443 |
|
|
Charter International Plc |
|
|
3,147,647 |
|
|
516,156 |
|
|
Diploma Plc |
|
|
2,708,553 |
|
|
497,482 |
|
|
Euromoney Institutional Investor Plc |
|
|
5,443,531 |
|
|
1,482,352 |
|
|
F&C Asset Management Plc |
|
|
1,610,849 |
|
|
878,781 |
|
|
Filtrona Plc |
|
|
5,423,953 |
|
|
589,351 |
|
|
Great Portland Estates Plc (REIT) |
|
|
3,271,115 |
|
|
682,417 |
|
|
Inchcape Plc |
|
|
3,505,051 |
|
|
1,320,418 |
|
|
ITE Group Plc |
|
|
4,187,869 |
|
|
503,032 |
|
|
James Fisher & Sons Plc |
|
|
3,912,294 |
|
|
383,282 |
|
|
John Wood Group Plc |
|
|
3,938,697 |
|
|
1,016,645 |
|
|
Jupiter Fund Management Plc |
|
|
3,564,978 |
|
|
3,073,885 |
|
|
KCOM Group Plc |
|
|
3,629,449 |
|
|
119,354 |
|
|
Kier Group Plc |
|
|
2,658,687 |
|
|
1,683,237 |
|
|
Lupus Capital Plc |
|
|
2,613,149 |
|
|
1,122,251 |
|
|
Metric Property Investments Plc (REIT) |
|
|
1,589,723 |
|
|
613,952 |
|
|
N Brown Group |
|
|
2,569,332 |
|
|
811,850 |
|
|
National Express Group Plc |
|
|
2,682,887 |
|
|
|
|
|
|
|
|
|
|
|
537,139 |
|
|
Premier Oil Plc * |
|
|
3,085,418 |
|
|
447,287 |
|
|
PZ Cussons Plc |
|
|
2,524,956 |
|
|
662,329 |
|
|
Restaurant Group Plc |
|
|
3,179,392 |
|
|
1,039,336 |
|
|
RPS Group Plc |
|
|
3,082,487 |
|
|
1,698,286 |
|
|
Senior Plc |
|
|
4,700,172 |
|
|
163,885 |
|
|
Travis Perkins Plc |
|
|
2,151,578 |
|
|
138,786 |
|
|
Ultra Electronics Holdings Plc |
|
|
3,155,256 |
|
|
94,826 |
|
|
Weir Group Plc (The) |
|
|
3,082,264 |
|
|
834,233 |
|
|
WM Morrison Supermarkets Plc |
|
|
4,229,430 |
|
|
890,880 |
|
|
WSP Group Plc |
|
|
2,883,521 |
|
|
70,000 |
|
|
XP Power Ltd |
|
|
1,044,938 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
99,353,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $519,994,487) |
|
|
516,045,103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 0.5% |
|
|
|
|
|
628,000 |
|
|
Marcopolo SA 2.96% |
|
|
2,833,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chile 0.4% |
|
|
|
|
|
1,100,000 |
|
|
Coca-Cola Embonor SA Class B 2.97% |
|
|
1,883,642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 0.2% |
|
|
|
|
|
63,170 |
|
|
Daelim Industrial Co Ltd 0.68% |
|
|
1,228,526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $5,189,216) |
|
|
5,945,956 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 0.0% |
|
|
|
|
|
312,500 |
|
|
Gran Colombia Gold Corp Warrants, Expires 08/24/15* |
|
|
52,086 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $114,573) |
|
|
52,086 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 3.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 3.2% |
|
|
|
|
USD 7,000,000 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
7,000,000 |
|
CAD 19,978 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11 |
|
|
19,587 |
|
NZD 87 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11 |
|
|
68 |
|
JPY 23,796,441 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
306,826 |
|
SGD 41,144 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
32,102 |
|
USD 4,333,293 |
|
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
4,333,293 |
|
AUD 176,136 |
|
|
JPMorgan Chase (New York) Time Deposit, 3.78%, due 12/01/11 |
|
|
181,138 |
|
EUR 3,981,814 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
5,350,363 |
|
GBP 113,996 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
178,848 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
17,402,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $17,402,225) |
|
|
17,402,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.0%
(Cost $542,700,501) |
|
|
539,445,370 |
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(211,376 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
539,233,994 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
Value |
|
(Depreciation) |
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
Deutsche Bank AG |
|
EUR |
|
|
1,913,500 |
|
|
$ |
2,571,179 |
|
|
$ |
48,689 |
|
12/06/11 |
|
HSBC Bank |
|
EUR |
|
|
1,913,500 |
|
|
|
2,571,179 |
|
|
|
48,689 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
5,142,358 |
|
|
$ |
97,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# Fund sells foreign currency; buys USD.
Notes to Schedule of Investments:
Foreign
Registered Shares issued to foreign investors in markets that
have foreign ownership limits.
GDR
Global Depository Receipt
REIT
Real Estate Investment Trust
|
|
|
* |
|
Non-income producing security. |
|
(a) |
|
144A Securities exempt from registration under Rule
144A of the Securities Act of 1933. These securities may be resold in
transactions exempt
from registration, normally to qualified institutional investors. |
|
(b) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
Currency Abbreviations:
AUD
Australian Dollar
CAD Canadian Dollar
EUR Euro
GBP British Pound
JPY Japanese Yen
NZD New Zealand Dollar
SGD
Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax
purposes and gross and net unrealized appreciation (depreciation) in value of
investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$546,447,334 |
|
$ |
62,346,310 |
|
|
$ |
(69,348,274 |
) |
|
$ |
(7,001,964 |
) |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the
most recent quoted price. Unlisted securities for which market quotations are readily available
are generally valued at the most recent quoted price. Non-emerging market debt instruments with
a remaining maturity of sixty days or less may be valued at amortized cost (unless
circumstances dictate otherwise; for example, if the issuers creditworthiness has become
impaired), which approximates market value. Shares of open-end investment companies are
generally valued at their net asset value. Derivatives and other securities for which
quotations are not readily available or whose values the Manager has determined to be
unreliable are valued at fair value as determined in good faith by the Trustees or persons
acting at their direction pursuant to procedures approved by the Trustees. Although the goal of
fair valuation is to determine the amount the owner of the securities might reasonably expect
to receive upon their current sale, because of the uncertainty inherent in fair value pricing,
the value determined for a particular security may be materially different from the value
realized upon its sale. For the period ended November 30, 2011, the Fund did not reduce the
value of any of its OTC derivatives contracts based on the creditworthiness of its
counterparties. As of November 30, 2011, the total value of securities held directly
that were fair valued using methods determined in good faith by or at the direction of the
Trustees of the Trust represented 0.4% of net assets. The Fund classifies such securities
(levels defined below) as Level 3. See Derivative financial instruments below for a further
discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
|
Security Type |
|
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
|
86.5 % |
Quotation or quoted price typically means the bid price for securities held long and the
ask price for securities sold short. If the pricing convention for a security does not involve
a bid or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily
an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about
fair value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1
Valuations based on quoted prices for identical securities in active markets.
Level 2
Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) due to market events that have occurred since the local market
close but prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value technique on Level 3 investments: Certain of the Funds
securities in Thailand were valued at the local price as adjusted by applying a premium or
discount when the holdings exceed foreign ownership limitations.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assests |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
19,374,589 |
|
|
$ |
|
|
|
$ |
19,374,589 |
|
Austria |
|
|
|
|
|
|
2,019,661 |
|
|
|
|
|
|
|
2,019,661 |
|
Belgium |
|
|
|
|
|
|
8,672,807 |
|
|
|
|
|
|
|
8,672,807 |
|
Brazil |
|
|
18,122,374 |
|
|
|
|
|
|
|
|
|
|
|
18,122,374 |
|
Canada |
|
|
23,203,828 |
|
|
|
|
|
|
|
|
|
|
|
23,203,828 |
|
China |
|
|
|
|
|
|
1,979,821 |
|
|
|
|
|
|
|
1,979,821 |
|
Denmark |
|
|
|
|
|
|
4,863,947 |
|
|
|
|
|
|
|
4,863,947 |
|
Finland |
|
|
|
|
|
|
8,535,752 |
|
|
|
|
|
|
|
8,535,752 |
|
France |
|
|
|
|
|
|
27,559,992 |
|
|
|
|
|
|
|
27,559,992 |
|
Germany |
|
|
|
|
|
|
18,015,577 |
|
|
|
|
|
|
|
18,015,577 |
|
Hong Kong |
|
|
|
|
|
|
6,728,471 |
|
|
|
|
|
|
|
6,728,471 |
|
India |
|
|
|
|
|
|
1,489,518 |
|
|
|
|
|
|
|
1,489,518 |
|
Indonesia |
|
|
|
|
|
|
1,105,268 |
|
|
|
|
|
|
|
1,105,268 |
|
Ireland |
|
|
|
|
|
|
4,493,996 |
|
|
|
|
|
|
|
4,493,996 |
|
Italy |
|
|
|
|
|
|
19,104,518 |
|
|
|
|
|
|
|
19,104,518 |
|
Japan |
|
|
|
|
|
|
138,467,775 |
|
|
|
|
|
|
|
138,467,775 |
|
Mexico |
|
|
2,238,967 |
|
|
|
|
|
|
|
|
|
|
|
2,238,967 |
|
Netherlands |
|
|
1,409,883 |
|
|
|
11,582,338 |
|
|
|
|
|
|
|
12,992,221 |
|
New Zealand |
|
|
|
|
|
|
3,379,043 |
|
|
|
|
|
|
|
3,379,043 |
|
Norway |
|
|
|
|
|
|
11,908,282 |
|
|
|
|
|
|
|
11,908,282 |
|
Philippines |
|
|
2,083,073 |
|
|
|
4,675,159 |
|
|
|
|
|
|
|
6,758,232 |
|
Russia |
|
|
|
|
|
|
1,488,461 |
|
|
|
|
|
|
|
1,488,461 |
|
Singapore |
|
|
|
|
|
|
6,167,293 |
|
|
|
|
|
|
|
6,167,293 |
|
South Korea |
|
|
2,002,500 |
|
|
|
28,961,864 |
|
|
|
|
|
|
|
30,964,364 |
|
Spain |
|
|
|
|
|
|
6,415,557 |
|
|
|
|
|
|
|
6,415,557 |
|
Sweden |
|
|
|
|
|
|
12,112,879 |
|
|
|
|
|
|
|
12,112,879 |
|
Switzerland |
|
|
|
|
|
|
15,777,964 |
|
|
|
|
|
|
|
15,777,964 |
|
Taiwan |
|
|
|
|
|
|
844,482 |
|
|
|
|
|
|
|
844,482 |
|
Thailand |
|
|
|
|
|
|
|
|
|
|
1,905,513 |
|
|
|
1,905,513 |
|
United Kingdom |
|
|
|
|
|
|
99,353,951 |
|
|
|
|
|
|
|
99,353,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
49,060,625 |
|
|
|
465,078,965 |
|
|
|
1,905,513 |
|
|
|
516,045,103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
|
2,833,788 |
|
|
|
|
|
|
|
|
|
|
|
2,833,788 |
|
Chile |
|
|
1,883,642 |
|
|
|
|
|
|
|
|
|
|
|
1,883,642 |
|
South Korea |
|
|
|
|
|
|
1,228,526 |
|
|
|
|
|
|
|
1,228,526 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
4,717,430 |
|
|
|
1,228,526 |
|
|
|
|
|
|
|
5,945,956 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada |
|
|
|
|
|
|
52,086 |
|
|
|
|
|
|
|
52,086 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS |
|
|
|
|
|
|
52,086 |
|
|
|
|
|
|
|
52,086 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
17,402,225 |
|
|
|
|
|
|
|
|
|
|
|
17,402,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
71,180,280 |
|
|
|
466,359,577 |
|
|
|
1,905,513 |
|
|
|
539,445,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
|
|
|
|
|
97,378 |
|
|
|
|
|
|
|
97,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
71,180,280 |
|
|
$ |
466,456,955 |
|
|
$ |
1,905,513 |
|
|
$ |
539,542,748 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than
the uncertainties surrounding inputs for a non-derivative security with the same market value.
The aggregate net value of the Funds direct investments in securities using Level 3 inputs was
0.4% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as |
|
|
|
Still Held as of |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
Transfers into |
|
|
Transfers out of |
|
|
of November 30, |
|
|
|
November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
level 3 * |
|
|
2011 |
|
|
|
2011 |
|
Common Stocks
Thailand |
|
$ |
921,051 |
|
|
$ |
2,468,778 |
|
|
$ |
(433,494 |
) |
|
$ |
|
|
|
$ |
(275,209 |
) |
|
$ |
(775,613 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,905,513 |
|
|
|
$ |
(775,613 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
921,051 |
|
|
$ |
2,468,778 |
|
|
$ |
(433,494 |
) |
|
$ |
|
|
|
$ |
(275,209 |
) |
|
$ |
(775,613 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
1,905,513 |
|
|
|
$ |
(775,613 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day
the income and expenses are accrued or incurred. Fluctuations in the value of currency holdings
and other assets and liabilities resulting from changes in exchange rates are recorded as
unrealized foreign currency gains or losses. Realized gains or losses and unrealized
appreciation or depreciation on investment securities and income and expenses are translated on
the respective dates of such transactions. The effects of changes in foreign currency exchange
rates on investments in securities are not separated from the effects of changes in market
prices of those securities, but are included with the net realized and unrealized gain or loss
on investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small
companies often are less widely held and trade less frequently and in lesser quantities,
and their market prices often fluctuate more, than the securities of companies with larger
market capitalizations.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and
equity markets generally. If the Fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of value of those investments. Declines in stock
market prices generally are likely to reduce the net asset value of
the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Shares of small- and mid-cap companies often have lower trading
volumes and a limited number or no market makers. Thus, a large position may limit or
prevent the Fund from selling those shares or unwinding derivative positions on them at
desirable prices. The more less-liquid securities the Fund holds, the more likely it is to
honor a redemption request in-kind.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC
derivatives contract or a borrower of the Funds securities will be unable or unwilling to
make timely settlement payments or otherwise honor its obligations.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs
the risk that GMOs proprietary investment techniques will fail to produce the desired
results. The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of
the portfolio managers to implement strategies. By necessity, these analyses and models
make simplifying assumptions that limit their efficacy. Models that appear to explain
prior market data can fail to predict future market events. Further, the data used in
models may be inaccurate and/or it may not include
the most recent information about a company or a security. The Fund is also subject to the
risk that deficiencies in the Managers or another service providers internal systems or
controls will cause losses for the Fund or impair Fund
operations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value
of its investments decline.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a
frequent basis.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund
below a certain level over a specified period of time and entitle a counterparty to elect to
terminate early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value
of underlying assets, reference rates, or indices, to increase, decrease or adjust elements of
the investment exposures of the Funds portfolio. Derivatives may relate to securities,
interest rates, currencies, currency exchange rates, inflation rates, commodities and related
indices, and include foreign currency contracts, swap contracts, reverse repurchase agreements,
and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures
contracts, swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks
of companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting their investment exposure, the Fund also may use currency derivatives
in an attempt to adjust its currency exposure, seeking currency exposure that is different (in
some cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than,
the risks associated with investing directly in securities and other more traditional assets.
In particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to
a derivatives contract will be unable or unwilling to make timely settlement payments or
otherwise to honor its obligations. OTC derivatives contracts typically can be closed only with
the other party to the contract. If the counterparty defaults, the Fund will have contractual
remedies, but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after
the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral
to be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the
collateral is called for and the day the Fund receives it. When a counterpartys obligations
are not fully secured by collateral, the Fund is exposed to the risk of having limited recourse
if the counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The
pricing models used by the Fund or their pricing agents may not produce valuations that are
consistent with the values realized when OTC derivatives are actually closed out or sold. This
valuation risk is more pronounced when the Fund enters into OTC derivatives with specialized
terms because the value of those derivatives in some cases is determined only by reference to
similar derivatives with more standardized terms. As a result, incorrect valuations may result
in increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic
costs of taking some derivative positions may be prohibitive, and if a counterparty or its
affiliate is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade
with that counterparty. In addition, the Manager may decide not to use derivatives to hedge or
otherwise reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of
derivatives also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation
service and changes in value are recorded by the Fund as unrealized gains or losses. Realized
gains or losses on the contracts are equal to the difference between the value of the contract
at the time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and
the risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
Most forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes. Forward currency contracts outstanding at the end of the period are
listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the
settlement price established at the close of business each day by the board of trade or
exchange on which they are traded (unless otherwise adjusted due to the time at which foreign
markets close). The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded
by the Fund. The payable or receivable is settled on the following business day. Gains or
losses are recognized but not accounted for as realized until the contracts expire or are
closed. Futures contracts involve, to varying degrees, risk of loss in excess of the variation
margin. Under some circumstances, futures exchanges may establish daily limits on the amount
that the price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions),
securities or currencies it owns or in which it may invest. Writing options alters the Funds
exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell
the underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When
the Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the
time it was closed. Realized gains and losses on purchased options are included in realized
gains and losses on investment securities. If a written call option is exercised, the premium
originally received is recorded as an addition to sales proceeds. If a written put option is
exercised, the premium originally received is recorded as a reduction in the cost of
investments purchased. Gains and losses from the expiration or closing of written option
contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty
may post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective
commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest
payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence
of a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers,
a credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on
the measured variance (or square of volatility) of a specified underlying asset. One party
agrees to exchange a fixed rate or strike price payment for the floating rate or realized
price variance on the underlying asset with respect to the notional amount. At inception, the
strike price chosen is generally fixed at a level such that the fair value of the swap is zero.
As a result, no money changes hands at the initiation of the contract. At the expiration date,
the amount payable by one party to the other is the difference between the realized price
variance of the underlying asset and the strike price multiplied by the notional amount. A
receiver of the realized price variance would be entitled to receive a payment when the
realized price variance of the underlying asset is greater than the strike price and would be
obligated to make a payment when that variance is less than the strike price. A payer of the
realized price variance would be obligated to make a payment when the realized price variance
of the underlying asset is greater than the strike price and would be entitled to receive a
payment when that variance is less than the strike price. This type of agreement is essentially
a forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other
party posts is insufficient or not timely received by the Fund. Credit risk is particularly
acute in economic environments in which financial services firms are exposed to systemic risks
of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights
generally give the holder the right to receive, upon exercise, a security of the issuer at a
set price. Funds typically use warrants and rights in a manner similar to their use of
purchased options on securities, as described in options above. Risks associated with the use
of warrants and rights are generally similar to risks associated with the use of purchased
options. However, warrants and rights often do not have standardized terms, and may have longer
maturities and may be less liquid than exchange-traded options. In addition, the terms of
warrants or rights may limit the Funds ability to exercise the warrants or rights at such
times and in such quantities as the Fund would otherwise wish. During the
period ended November 30, 2011, the Fund held rights and/or warrants received as a
result of corporate actions. Rights and/or warrants held by the Fund at the end of the
period are listed in the Funds Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November
30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
52,086 |
|
|
$ |
|
|
|
$ |
52,086 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
97,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
97,378 |
|
|
$ |
|
|
|
$ |
52,086 |
|
|
$ |
|
|
|
$ |
149,464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the
table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of
derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with
correspondingly greater risk) the greater the notional amount. For further information on notional amounts, see the
Schedule of Investments.
|
The volume of derivative activity, based on absolute values (forward currency contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30,
2011: |
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
Currency |
|
|
Rights and /or |
|
|
|
Contracts |
|
|
Warrants |
|
Average amount outstanding |
|
$ |
1,350,135 |
|
|
$ |
199,333 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Global Asset Allocation Fund
(formerly GMO Global Balanced Asset Allocation Fund)
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares / Par Value ($) |
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 98.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 98.9% |
|
|
|
|
|
19,982,387 |
|
|
GMO Alpha Only Fund, Class IV |
|
|
497,361,623 |
|
|
1,463,575 |
|
|
GMO Asset Allocation Bond Fund, Class VI |
|
|
35,886,863 |
|
|
23,737,369 |
|
|
GMO Domestic Bond Fund, Class VI |
|
|
70,262,611 |
|
|
1,652,011 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
15,644,547 |
|
|
30,412,253 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
355,519,234 |
|
|
6,481,654 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
111,095,552 |
|
|
11,694,720 |
|
|
GMO International Core Equity Fund, Class VI |
|
|
308,857,556 |
|
|
6,881,116 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
147,255,885 |
|
|
12,448,686 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
242,749,374 |
|
|
37,507,629 |
|
|
GMO Quality Fund, Class VI |
|
|
819,166,611 |
|
|
356,591 |
|
|
GMO Short-Duration Investment Fund, Class III |
|
|
2,945,445 |
|
|
4,698,916 |
|
|
GMO Special Situations Fund, Class VI |
|
|
124,239,343 |
|
|
22,084,117 |
|
|
GMO Strategic Fixed Income Fund, Class VI |
|
|
375,871,669 |
|
|
1,016,189 |
|
|
GMO World Opportunity Overlay Fund |
|
|
23,982,062 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $2,892,791,213) |
|
|
3,130,838,375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Airlines 0.0% |
|
|
|
|
|
491,736 |
|
|
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24 |
|
|
236,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto Financing 0.1% |
|
|
|
|
|
133,660 |
|
|
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14 |
|
|
134,078 |
|
|
612,695 |
|
|
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13 |
|
|
616,426 |
|
|
309,607 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4A, 5.32%, due 11/10/14 |
|
|
311,309 |
|
|
265,377 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14 |
|
|
266,041 |
|
|
548,833 |
|
|
Ford Credit Auto Owner Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 2.00%, 2.25%, due 03/15/13 |
|
|
551,275 |
|
|
20,400 |
|
|
Franklin Auto Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.95%, 2.20%, due 05/20/16 |
|
|
20,420 |
|
|
258,720 |
|
|
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14 |
|
|
259,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Auto Financing |
|
|
2,159,147 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business Loans 0.1% |
|
|
|
|
|
120,015 |
|
|
ACAS Business Loan Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .14%, 0.60%, due 08/16/19 |
|
|
117,015 |
|
|
74,746 |
|
|
Bayview Commercial Asset Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .36%, 0.62%, due 04/25/34 |
|
|
56,807 |
|
|
53,927 |
|
|
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35 |
|
|
40,445 |
|
|
265,509 |
|
|
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36 |
|
|
167,271 |
|
|
242,471 |
|
|
Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, 1 mo. LIBOR + .24%, 0.50%, due 07/25/37 |
|
|
152,757 |
|
|
954,830 |
|
|
Bayview Commercial Asset Trust, Series 07-6A, Class A2, 144A, 1 mo. LIBOR + 1.30%, 1.56%, due 12/25/37 |
|
|
668,381 |
|
|
72,678 |
|
|
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32 |
|
|
64,320 |
|
|
119,474 |
|
|
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33 |
|
|
97,969 |
|
|
199,686 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30 |
|
|
153,670 |
|
|
|
|
|
|
|
|
|
|
|
159,280 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30 |
|
|
125,656 |
|
|
388,984 |
|
|
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37 |
|
|
311,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Business Loans |
|
|
1,955,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS 0.1% |
|
|
|
|
|
341,936 |
|
|
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44 |
|
|
337,662 |
|
|
1,100,000 |
|
|
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20 |
|
|
995,500 |
|
|
292,800 |
|
|
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45 |
|
|
292,800 |
|
|
383,390 |
|
|
GE Capital Commercial Mortgage Corp., Series 06-C1, Class A2, 5.33%, due 03/10/44 |
|
|
383,390 |
|
|
491,883 |
|
|
GS Mortgage Securities Corp., Series 06-GG6, Class A2, 5.51%, due 04/10/38 |
|
|
496,648 |
|
|
194,890 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A1, 144A, 1 mo. LIBOR + .39%, 1.14%, due 03/06/20 |
|
|
192,941 |
|
|
300,000 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20 |
|
|
297,000 |
|
|
123,417 |
|
|
J.P. Morgan Chase Commercial Mortgage Securities Corp., Series 06-LDP7, Class A2, 5.86%, due 04/15/45 |
|
|
123,491 |
|
|
618,019 |
|
|
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39 |
|
|
630,132 |
|
|
257,619 |
|
|
Morgan Stanley Capital I, Series 06-IQ11, Class A3, 5.69%, due 10/15/42 |
|
|
262,640 |
|
|
516,025 |
|
|
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21 |
|
|
490,223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS |
|
|
4,502,427 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS Collateralized Debt Obligations 0.0% |
|
|
|
|
|
499,812 |
|
|
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52 |
|
|
4,998 |
|
|
297,845 |
|
|
G-Force LLC, Series 05-RR2, Class A2, 144A, 5.16%, due 12/25/39 |
|
|
279,975 |
|
|
133,000 |
|
|
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30 |
|
|
122,692 |
|
|
766,126 |
|
|
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46 |
|
|
559,272 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS Collateralized Debt Obligations |
|
|
966,937 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Collateralized Debt Obligations 0.0% |
|
|
|
|
|
1,000,000 |
|
|
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13 |
|
|
880,900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Cards 0.1% |
|
|
|
|
|
1,300,000 |
|
|
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17 |
|
|
1,302,145 |
|
|
400,000 |
|
|
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + .13%, 0.38%, due 02/15/17 |
|
|
396,876 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Credit Cards |
|
|
1,699,021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Auto Financing 0.1% |
|
|
|
|
|
208,280 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13 |
|
|
207,760 |
|
|
172,187 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-BF, Class A4, FSA, 1 mo. LIBOR + .05%, 0.30%, due 12/06/13 |
|
|
172,183 |
|
|
228,701 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14 |
|
|
228,583 |
|
|
413,132 |
|
|
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + .50%, 0.75%, due 03/08/16 |
|
|
411,562 |
|
|
|
|
|
|
|
|
|
|
|
1,258,896 |
|
|
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14 |
|
|
1,265,027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Auto Financing |
|
|
2,285,115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Business Loans 0.0% |
|
|
|
|
|
223,971 |
|
|
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%, 0.70%, due 10/25/30 |
|
|
162,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured High Yield Collateralized Debt Obligations § 0.0% |
|
|
|
|
|
14,332 |
|
|
GSC Partners CDO Fund Ltd., Series 03-4A, Class A3, 144A, AMBAC, 3 mo. LIBOR + .46%, 0.87%, due 12/16/15 |
|
|
14,117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Other 0.1% |
|
|
|
|
|
1,500,000 |
|
|
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37 |
|
|
1,505,775 |
|
|
598,060 |
|
|
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41 |
|
|
529,914 |
|
|
592,807 |
|
|
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41 |
|
|
527,390 |
|
|
300,497 |
|
|
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14 |
|
|
240,398 |
|
|
100,000 |
|
|
Toll Road
Investment Part II, Series B, 144A, MBIA, Zero Coupon, due 02/15/30 |
|
|
13,533 |
|
|
900,000 |
|
|
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37 |
|
|
56,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Other |
|
|
2,873,341 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Asset-Backed Securities (United States) ♦
0.0% |
|
|
|
|
|
71,166 |
|
|
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34 |
|
|
56,221 |
|
|
85,059 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 03-HE3, Class A, AMBAC, 1 mo. LIBOR + .38%, 0.64%, due 12/25/33 |
|
|
68,472 |
|
|
23,574 |
|
|
Quest Trust, Series 04-X1, Class A, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 03/25/34 |
|
|
17,681 |
|
|
350,433 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + .22%, 0.48%, due 11/25/35 |
|
|
245,303 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Residential Asset-Backed Securities (United States) |
|
|
387,677 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Mortgage-Backed Securities (United States) 0.0% |
|
|
|
|
|
12,867 |
|
|
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%, 0.60%, due 10/25/34 |
|
|
8,222 |
|
|
35,123 |
|
|
Chevy Chase Mortgage Funding Corp., Series 04-1A, Class A2, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 01/25/35 |
|
|
21,952 |
|
|
271,862 |
|
|
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37 |
|
|
160,398 |
|
|
176,410 |
|
|
GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, 1 mo. LIBOR + .23%, 0.49%, due 10/25/34 |
|
|
123,769 |
|
|
8,154 |
|
|
GreenPoint Home Equity Loan Trust, Series 04-1, Class A, AMBAC, 1 mo. LIBOR + .23%, 0.72%, due 07/25/29 |
|
|
5,489 |
|
|
11,538 |
|
|
GreenPoint Home Equity Loan Trust, Series 04-4, Class A, AMBAC, 1 mo. LIBOR + .28%, 0.81%, due 08/15/30 |
|
|
7,127 |
|
|
18,600 |
|
|
Lehman ABS Corp., Series 04-2, Class A, AMBAC, 1 mo. LIBOR + .22%, 0.70%, due 06/25/34 |
|
|
12,276 |
|
|
5,030 |
|
|
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR + .29%, 0.55%, due 12/25/32 |
|
|
1,459 |
|
|
125,526 |
|
|
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35 |
|
|
113,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Residential Mortgage-Backed Securities (United States) |
|
|
454,406 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Time Share 0.0% |
|
|
|
|
|
65,367 |
|
|
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18 |
|
|
64,693 |
|
|
86,705 |
|
|
Sierra Receivables Funding Co., Series 07-1A, Class A2, 144A, FGIC, 1 mo. LIBOR + .15%, 0.40%, due 03/20/19 |
|
|
83,508 |
|
|
|
|
|
|
|
|
|
|
|
252,571 |
|
|
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19 |
|
|
245,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Time Share |
|
|
393,395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Transportation 0.0% |
|
|
|
|
|
96,667 |
|
|
GE Seaco Finance SRL, Series 04-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .30%, 0.55%, due 04/17/19 |
|
|
94,008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Asset-Backed Securities (United States) ♦ 0.3% |
|
|
|
|
|
37,311 |
|
|
Accredited Mortgage Loan Trust, Series 04-4, Class A1B, 1 mo. LIBOR + .39%, 0.65%, due 01/25/35 |
|
|
29,243 |
|
|
84,050 |
|
|
ACE Securities Corp., Series 06-ASL1, Class A, 1 mo. LIBOR + .14%, 0.40%, due 02/25/36 |
|
|
17,440 |
|
|
189,289 |
|
|
ACE Securities Corp., Series 06-ASP2, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 03/25/36 |
|
|
156,636 |
|
|
65,871 |
|
|
ACE Securities Corp., Series 06-ASP4, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36 |
|
|
60,848 |
|
|
700,000 |
|
|
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36 |
|
|
196,000 |
|
|
219,011 |
|
|
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36 |
|
|
204,775 |
|
|
182,810 |
|
|
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36 |
|
|
89,577 |
|
|
63,024 |
|
|
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36 |
|
|
57,352 |
|
|
389,446 |
|
|
ACE Securities Corp., Series 06-OP1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 04/25/36 |
|
|
227,826 |
|
|
114,561 |
|
|
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35 |
|
|
20,048 |
|
|
257,318 |
|
|
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36 |
|
|
41,814 |
|
|
329,312 |
|
|
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36 |
|
|
40,341 |
|
|
139,952 |
|
|
ACE Securities Corp., Series 07-HE1, Class A2A, 1 mo. LIBOR + .09%, 0.35%, due 01/25/37 |
|
|
41,286 |
|
|
123,917 |
|
|
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36 |
|
|
41,512 |
|
|
367,392 |
|
|
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37 |
|
|
18,370 |
|
|
130,475 |
|
|
Argent Securities, Inc., Series 04-W8, Class A5, 1 mo. LIBOR + .52%, 1.30%, due 05/25/34 |
|
|
112,800 |
|
|
1,360,354 |
|
|
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
353,267 |
|
|
256,406 |
|
|
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36 |
|
|
74,999 |
|
|
338,813 |
|
|
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36 |
|
|
98,256 |
|
|
257,557 |
|
|
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
67,770 |
|
|
283,571 |
|
|
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36 |
|
|
164,471 |
|
|
542,634 |
|
|
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37 |
|
|
427,324 |
|
|
222,899 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 05/28/39 |
|
|
72,442 |
|
|
222,899 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39 |
|
|
62,969 |
|
|
299,776 |
|
|
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40 |
|
|
180,165 |
|
|
122,708 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36 |
|
|
74,471 |
|
|
300,000 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36 |
|
|
40,050 |
|
|
70,981 |
|
|
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37 |
|
|
11,222 |
|
|
29,733 |
|
|
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37 |
|
|
28,960 |
|
|
1,300,000 |
|
|
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37 |
|
|
801,190 |
|
|
343,847 |
|
|
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36 |
|
|
261,324 |
|
|
5,978 |
|
|
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33 |
|
|
5,021 |
|
|
2,843 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 04-OPT1, Class A1B, 1 mo. LIBOR + .41%, 0.67%, due 10/25/34 |
|
|
2,644 |
|
|
400,000 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36 |
|
|
120,000 |
|
|
1,000,000 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37 |
|
|
727,500 |
|
|
|
|
|
|
|
|
|
|
|
27,847 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC5, Class 2A1, 1 mo. LIBOR + .08%, 0.34%, due 03/25/37 |
|
|
27,485 |
|
|
17,934 |
|
|
Equity One ABS, Inc., Series 04-1, Class AV2, 1 mo. LIBOR + .30%, 0.56%, due 04/25/34 |
|
|
12,884 |
|
|
395,834 |
|
|
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 04/25/36 |
|
|
235,027 |
|
|
127,998 |
|
|
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36 |
|
|
68,579 |
|
|
48,896 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A2, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36 |
|
|
16,288 |
|
|
570,480 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36 |
|
|
159,734 |
|
|
107,243 |
|
|
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35 |
|
|
92,129 |
|
|
97,931 |
|
|
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35 |
|
|
86,149 |
|
|
281,614 |
|
|
Household Home Equity Loan Trust, Series 06-1, Class A1, 1 mo. LIBOR + .16%, 0.41%, due 01/20/36 |
|
|
247,820 |
|
|
907,622 |
|
|
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36 |
|
|
286,718 |
|
|
62,401 |
|
|
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35 |
|
|
58,657 |
|
|
64,754 |
|
|
Master Asset-Backed Securities Trust, Series 06-AM3, Class A2, 1 mo. LIBOR + .13%, 0.39%, due 10/25/36 |
|
|
62,812 |
|
|
544,444 |
|
|
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36 |
|
|
190,556 |
|
|
400,000 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
120,000 |
|
|
722,248 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36 |
|
|
191,396 |
|
|
494,506 |
|
|
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36 |
|
|
148,352 |
|
|
194,830 |
|
|
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36 |
|
|
23,380 |
|
|
149,966 |
|
|
Merrill Lynch Mortgage Investors, Series 07-HE2, Class A2A, 1 mo. LIBOR + .12%, 0.38%, due 02/25/37 |
|
|
68,234 |
|
|
78,338 |
|
|
Morgan Stanley Capital, Inc., Series 04-SD1, Class A, 1 mo. LIBOR + .40%, 0.66%, due 08/25/34 |
|
|
56,208 |
|
|
1,000,000 |
|
|
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due 02/25/37 |
|
|
210,000 |
|
|
142,172 |
|
|
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37 |
|
|
116,226 |
|
|
290,611 |
|
|
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 |
|
|
71,200 |
|
|
191,162 |
|
|
Peoples Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35 |
|
|
110,071 |
|
|
186,146 |
|
|
RAAC Series Trust, Series 06-SP1, Class A2, 1 mo. LIBOR + .19%, 0.45%, due 09/25/45 |
|
|
154,315 |
|
|
49,900 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS8, Class A2, 1 mo. LIBOR + .29%, 0.55%, due 10/25/33 |
|
|
45,724 |
|
|
150,842 |
|
|
Residential Asset Securities Corp., Series 05-KS12, Class A2, 1 mo. LIBOR + .25%, 0.51%, due 01/25/36 |
|
|
135,758 |
|
|
12,511 |
|
|
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due 04/25/37 |
|
|
12,421 |
|
|
9,319 |
|
|
Saxon Asset Securities Trust, Series 04-1, Class A, 1 mo. LIBOR + .27%, 0.80%, due 03/25/35 |
|
|
5,807 |
|
|
12,237 |
|
|
Securitized Asset Backed Receivables LLC, Series 06-NC1, Class A2, 1 mo. LIBOR + .16%, 0.42%, due 03/25/36 |
|
|
11,258 |
|
|
10,654 |
|
|
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36 |
|
|
10,574 |
|
|
34,104 |
|
|
SG Mortgage Securities Trust, Series 05-OPT1, Class A2, 1 mo. LIBOR + .26%, 0.52%, due 10/25/35 |
|
|
31,591 |
|
|
28,190 |
|
|
Soundview Home Equity Loan Trust, Series 07-NS1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 01/25/37 |
|
|
26,965 |
|
|
500,000 |
|
|
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37 |
|
|
210,000 |
|
|
154,955 |
|
|
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36 |
|
|
111,568 |
|
|
|
|
|
|
|
|
|
|
|
88,092 |
|
|
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35 |
|
|
68,051 |
|
|
488,506 |
|
|
Yale Mortgage Loan Trust, Series 07-1, Class A, 144A, 1 mo. LIBOR + .40%, 0.66%, due 06/25/37 |
|
|
39,080 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Asset-Backed Securities (United States) |
|
|
8,452,930 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (Australian) 0.1% |
|
|
|
|
|
173,127 |
|
|
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38 |
|
|
168,636 |
|
|
272,658 |
|
|
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38 |
|
|
262,001 |
|
|
58,315 |
|
|
Interstar Millennium Trust, Series 03-3G, Class A2, 3 mo. LIBOR + .25%, 0.86%, due 09/27/35 |
|
|
53,524 |
|
|
453,856 |
|
|
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36 |
|
|
417,393 |
|
|
39,075 |
|
|
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36 |
|
|
34,777 |
|
|
56,009 |
|
|
Interstar Millennium Trust, Series 06-2GA, Class A2, 144A, 3 mo. LIBOR + .08%, 0.81%, due 05/27/38 |
|
|
51,221 |
|
|
32,153 |
|
|
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36 |
|
|
31,001 |
|
|
207,434 |
|
|
Medallion Trust, Series 06-1G, Class A1, 3 mo. LIBOR + .05%, 0.39%, due 06/14/37 |
|
|
201,830 |
|
|
209,070 |
|
|
National RMBS Trust, Series 06-3, Class A1, 144A, 3 mo. LIBOR + .07%, 0.48%, due 10/20/37 |
|
|
202,577 |
|
|
256,520 |
|
|
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38 |
|
|
234,741 |
|
|
272,858 |
|
|
Superannuation Members Home Loans Global Fund, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.40%, due 06/12/40 |
|
|
257,082 |
|
|
31,154 |
|
|
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36 |
|
|
30,213 |
|
|
28,721 |
|
|
Superannuation Members Home Loans Global Fund, Series 8, Class A1, 3 mo. LIBOR + .07%, 0.53%, due 01/12/37 |
|
|
28,139 |
|
|
201,524 |
|
|
Westpac Securitization Trust, Series 07-1G, Class A2A, 3 mo. LIBOR + .05%, 0.53%, due 05/21/38 |
|
|
195,505 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (Australian) |
|
|
2,168,640 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (European) 0.1% |
|
|
|
|
|
344,878 |
|
|
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66 |
|
|
282,800 |
|
|
775,726 |
|
|
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39 |
|
|
687,278 |
|
|
115,283 |
|
|
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .08%, 0.33%, due 12/20/54 |
|
|
110,441 |
|
|
60,023 |
|
|
Granite Mortgages Plc, Series 04-3, Class 2A1, 3 mo. LIBOR + .28%, 0.63%, due 09/20/44 |
|
|
57,682 |
|
|
278,436 |
|
|
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43 |
|
|
247,808 |
|
|
82,148 |
|
|
Leek Finance Plc, Series 17A, Class A2B, 144A, 3 mo. LIBOR + .28%, 0.63%, due 12/21/37 |
|
|
73,522 |
|
|
194,038 |
|
|
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34 |
|
|
155,890 |
|
|
306,669 |
|
|
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .22%, 0.68%, due 11/15/38 |
|
|
227,134 |
|
|
215,208 |
|
|
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39 |
|
|
160,825 |
|
|
1,000,000 |
|
|
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33 |
|
|
990,300 |
|
|
100,000 |
|
|
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33 |
|
|
99,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (European) |
|
|
3,093,170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (United States) 0.0% |
|
|
|
|
|
20,616 |
|
|
Chevy Chase Mortgage Funding Corp., Series 04-3A, Class A2, 144A, 1 mo. LIBOR + .30%, 0.56%, due 08/25/35 |
|
|
12,885 |
|
|
71,855 |
|
|
Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/26/34 |
|
|
58,202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (United States) |
|
|
71,087 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Loans 0.0% |
|
|
|
|
|
700,000 |
|
|
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24 |
|
|
682,500 |
|
|
14,891 |
|
|
Goal Capital Funding Trust, Series 07-1, Class A1, 3 mo. LIBOR + .02%, 0.38%, due 06/25/21 |
|
|
14,863 |
|
|
36,862 |
|
|
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23 |
|
|
35,756 |
|
|
400,000 |
|
|
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19 |
|
|
394,816 |
|
|
97,698 |
|
|
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22 |
|
|
97,454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Student Loans |
|
|
1,225,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Share 0.0% |
|
|
|
|
|
95,076 |
|
|
Sierra Receivables Funding Co., Series 08-1A, Class A2, 144A, 1 mo. LIBOR + 4.00%, 4.25%, due 02/20/20 |
|
|
97,705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
34,173,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.0% |
|
|
|
|
|
598,000 |
|
|
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13 |
|
|
616,809 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 0.0% |
|
|
|
|
|
67,600 |
|
|
Agency for International Development Floater (Support of C.A.B.E.I.), 6 mo. U.S. Treasury Bill + .40%, 0.47%, due 10/01/12(a) |
|
|
66,814 |
|
|
471,651 |
|
|
Agency for International Development Floater (Support of Jamaica), 6 mo. U.S. Treasury Bill + 0.75%, 0.82%, due 03/30/19(a) |
|
|
454,591 |
|
|
37,439 |
|
|
Agency for International Development Floater (Support of Peru), Series B, 6 mo. U.S. Treasury Bill +.35%, 0.42%, due 05/01/14(a) |
|
|
36,719 |
|
|
100,001 |
|
|
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a) |
|
|
99,848 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
657,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $35,414,813) |
|
|
35,447,936 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
33,889 |
|
|
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(b) |
|
|
33,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $33,889) |
|
|
33,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.0%
(Cost $2,928,239,915) |
|
|
3,166,320,200 |
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(115,431 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
3,166,204,769 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
AMBAC Insured as to the payment of principal and interest by AMBAC Assurance Corporation.
C.A.B.E.I. Central American Bank for Economic Integration
CDO Collateralized Debt Obligation
CMBS Commercial Mortgage Backed Security
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
FSA Insured as to the payment of principal and interest by Financial Security Assurance.
LIBOR London Interbank Offered Rate
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp.
MTN Medium Term Note
NPGC Insured as to the payment of principal and interest by National Public Guarantee Corp.
RMBS Residential Mortgage Backed Security
XL Insured as to the payment of principal and interest by XL Capital Assurance.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
§ |
|
These securities were categorized as high yield as a result of being rated below investment grade at issuance. |
|
♦ |
|
These securities are primarily backed by subprime mortgages. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of
the Trustees of GMO Trust. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax
purposes and gross and net unrealized appreciation (depreciation) in value of
investments were as follows:
|
|
|
|
|
|
|
Aggregate Cost
|
|
Gross
Unrealized
Appreciation
|
|
Gross
Unrealized
(Depreciation)
|
|
Net Unrealized
Appreciation
(Depreciation) |
|
|
|
|
|
|
|
$3,244,438,964
|
|
$
|
|
$(78,118,764)
|
|
$(78,118,764) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be
read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Alpha Only Fund, Class IV |
|
$ |
444,489,793 |
|
|
$ |
227,499,578 |
|
|
$ |
207,369,629 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
497,361,623 |
|
GMO Asset Allocation Bond Fund, Class VI |
|
|
108,350,120 |
|
|
|
84,828,322 |
|
|
|
154,102,537 |
|
|
|
1,843,725 |
|
|
|
5,937,562 |
|
|
|
|
|
|
|
35,886,863 |
|
GMO Domestic Bond Fund, Class VI |
|
|
112,619,380 |
|
|
|
|
|
|
|
2,985,073 |
|
|
|
1,102,707 |
|
|
|
|
|
|
|
36,025,475 |
|
|
|
70,262,611 |
|
GMO Emerging Country Debt Fund, Class IV |
|
|
15,394,798 |
|
|
|
317,038 |
|
|
|
724,696 |
|
|
|
201,418 |
|
|
|
|
|
|
|
|
|
|
|
15,644,547 |
|
GMO Emerging Markets Fund, Class VI |
|
|
407,920,924 |
|
|
|
80,837,617 |
|
|
|
51,055,857 |
|
|
|
143,487 |
|
|
|
30,272,350 |
|
|
|
|
|
|
|
355,519,234 |
|
GMO Flexible Equities Fund, Class VI |
|
|
40,832,080 |
|
|
|
87,342,567 |
|
|
|
8,628,790 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
111,095,552 |
|
GMO International Core Equity Fund, Class VI |
|
|
547,460,836 |
|
|
|
52,771,405 |
|
|
|
241,152,977 |
|
|
|
4,890,400 |
|
|
|
|
|
|
|
|
|
|
|
308,857,556 |
|
GMO International Growth Equity Fund, Class IV |
|
|
150,549,756 |
|
|
|
28,010,427 |
|
|
|
14,677,806 |
|
|
|
1,057,734 |
|
|
|
|
|
|
|
|
|
|
|
147,255,885 |
|
GMO International Intrinsic Value Fund, Class IV |
|
|
155,598,926 |
|
|
|
116,478,011 |
|
|
|
5,982,606 |
|
|
|
2,939,296 |
|
|
|
|
|
|
|
|
|
|
|
242,749,374 |
|
GMO Quality Fund, Class VI |
|
|
877,962,197 |
|
|
|
171,628,715 |
|
|
|
269,652,239 |
|
|
|
13,240,406 |
|
|
|
|
|
|
|
|
|
|
|
819,166,611 |
|
GMO Short-Duration Investment Fund, Class III |
|
|
3,023,794 |
|
|
|
5,662 |
|
|
|
48,076 |
|
|
|
5,662 |
|
|
|
|
|
|
|
|
|
|
|
2,945,445 |
|
GMO Special Situations Fund, Class VI |
|
|
147,372,218 |
|
|
|
4,195,689 |
|
|
|
21,513,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
124,239,343 |
|
GMO Strategic Fixed Income Fund, Class VI |
|
|
365,706,603 |
|
|
|
13,096,298 |
|
|
|
41,758,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
375,871,669 |
|
GMO World Opportunity Overlay Fund |
|
|
23,422,041 |
|
|
|
|
|
|
|
378,657 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,982,062 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
3,400,703,466 |
|
|
$ |
867,011,329 |
|
|
$ |
1,020,030,800 |
|
|
$ |
25,424,835 |
|
|
$ |
36,209,912 |
|
|
$ |
36,025,475 |
|
|
$ |
3,130,838,375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined at the end of
fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011,
the total value of securities held directly and indirectly that were fair valued using methods
determined in good faith by or at the direction of the Trustees of the Trust represented 0.8% of
net assets. The Fund and the underlying funds classify such securities (levels defined below)
as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
|
|
|
|
|
|
|
|
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
|
|
|
|
|
|
|
|
Equity Securities |
|
41.8% |
|
|
|
|
|
|
|
|
Futures Contracts |
|
0.1% |
|
|
|
|
|
|
|
|
Swap Agreements |
|
0.8% |
|
|
|
|
|
|
|
|
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 1.0% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the
valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. The Fund valued certain other debt
securities by using an estimated specified spread above the LIBOR Rate.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
3,130,838,375 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,130,838,375 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
|
|
|
|
|
4,959,949 |
|
|
|
29,213,206 |
|
|
|
34,173,155 |
|
Corporate Debt |
|
|
|
|
|
|
616,809 |
|
|
|
|
|
|
|
616,809 |
|
U.S. Government Agency |
|
|
|
|
|
|
|
|
|
|
657,972 |
|
|
|
657,972 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
5,576,758 |
|
|
|
29,871,178 |
|
|
|
35,447,936 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
33,889 |
|
|
|
|
|
|
|
|
|
|
|
33,889 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
3,130,872,264 |
|
|
|
5,576,758 |
|
|
|
29,871,178 |
|
|
|
3,166,320,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,130,872,264 |
|
|
$ |
5,576,758 |
|
|
$ |
29,871,178 |
|
|
$ |
3,166,320,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds investments
(both direct and indirect) in securities and derivative financial instruments using Level 3
inputs were 6.5% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) from |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
Unrealized |
|
|
Transfers |
|
|
Transfers |
|
|
Balances as of |
|
|
|
Investments Still Held as |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Realized |
|
|
Appreciation |
|
|
into Level |
|
|
out of |
|
|
November 30, |
|
|
|
of November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Discounts/Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
3* |
|
|
Level 3* |
|
|
2011 |
|
|
|
2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
44,061,730 |
|
|
$ |
|
|
|
$ |
(13,253,275 |
) |
|
$ |
565,156 |
|
|
$ |
1,988,081 |
|
|
$ |
(4,148,486 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
29,213,206 |
|
|
|
$ |
(3,572,405 |
) |
U.S. Government Agency |
|
$ |
971,897 |
|
|
$ |
|
|
|
$ |
(312,290 |
) |
|
$ |
1,758 |
|
|
$ |
6,473 |
|
|
$ |
(9,866 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
657,972 |
|
|
|
$ |
(9,599 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt Obligations |
|
$ |
45,033,627 |
|
|
$ |
|
|
|
$ |
(13,565,565 |
) |
|
$ |
566,914 |
|
|
$ |
1,994,554 |
|
|
$ |
(4,158,352 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
29,871,178 |
|
|
|
$ |
(3,582,004 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments transferred into Level 3 at the value at the beginning of
the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Declines
in stock market prices generally are likely to reduce the net asset value of the Funds
shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses associated with an investment in
the Fund are less predictable and may be higher than fees and expenses associated with an
investment in funds that charge a fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies, or that the
U.S. dollar will decline in value relative to the foreign currency being hedged.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. Below investment grade securities have speculative characteristics, and changes in
economic conditions or other circumstances are more likely to impair the capacity of
issuers to make principal and interest payments than is the case with issuers of investment
grade securities.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations
default and the value of the defaulted obligations exceeds whatever credit support the
securities may have. The obligations of issuers (and obligors of underlying assets) also are
subject to bankruptcy, insolvency, and other laws affecting the rights and remedies of
creditors. Many asset-backed securities in which the Fund has invested are now rated below
investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Global Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value |
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 39.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 2.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
CAD |
1,500,000 |
|
|
Government of Canada, 8.00%, due 06/01/23 |
|
|
2,316,952 |
|
CAD |
2,000,000 |
|
|
Government of Canada, 3.50%, due 06/01/20 |
|
|
2,182,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
4,499,353 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 2.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
3,000,000 |
|
|
Government of France, 4.00%, due 10/25/38 |
|
|
4,047,908 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 1.0% |
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
1,000,000 |
|
|
Republic of Deutschland, 4.75%, due 07/04/34 |
|
|
1,709,992 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
2,400,000 |
|
|
Buoni Poliennali Del Tesoro, 5.00%, due 08/01/34 |
|
|
2,427,367 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 18.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
JPY |
2,200,000,000 |
|
|
Japan Government Twenty Year Bond, 2.20%, due 06/20/26 |
|
|
30,864,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 1.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
2,000,000 |
|
|
Government of Spain, 4.70%, due 07/30/41 |
|
|
2,074,565 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 6.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
GBP |
5,500,000 |
|
|
U.K. Treasury Gilt, 4.25%, due 12/07/27 |
|
|
10,328,857 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 6.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government |
|
|
|
|
USD |
3,242,374 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b) |
|
|
3,253,265 |
|
USD |
10,000,000 |
|
|
U.S. Treasury Principal Strip Bond, due 11/15/21 |
|
|
8,043,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
11,296,705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $60,270,946) |
|
|
67,248,852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 59.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 59.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
638,217 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
6,043,919 |
|
|
7,873,225 |
|
|
GMO Short-Duration Collateral Fund |
|
|
52,042,020 |
|
|
45,838 |
|
|
GMO Special Purpose Holding Fund(c) |
|
|
17,877 |
|
|
319,010 |
|
|
GMO U.S. Treasury Fund |
|
|
7,978,452 |
|
|
1,501,007 |
|
|
GMO World Opportunity Overlay Fund |
|
|
35,423,765 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
101,506,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $111,935,780) |
|
|
101,506,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares/Par |
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
70,064 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(d) |
|
|
70,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 1.0% |
|
|
|
|
|
1,750,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(e) |
|
|
1,748,435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $1,818,374) |
|
|
1,818,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.2%
(Cost $174,025,100) |
|
|
170,573,384 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.2%) |
|
|
(396,742 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
170,176,642 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Barclays Bank PLC |
|
AUD |
|
|
1,200,000 |
|
|
$ |
1,233,506 |
|
|
$ |
(4,417 |
) |
|
12/06/11 |
|
|
Citibank N.A. |
|
AUD |
|
|
300,000 |
|
|
|
308,376 |
|
|
|
(4,512 |
) |
|
12/06/11 |
|
|
Credit Suisse International |
|
AUD |
|
|
1,100,000 |
|
|
|
1,130,713 |
|
|
|
52,735 |
|
|
12/06/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
10,700,000 |
|
|
|
10,998,757 |
|
|
|
573,626 |
|
|
12/06/11 |
|
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
600,000 |
|
|
|
616,753 |
|
|
|
14,058 |
|
|
12/13/11 |
|
|
Barclays Bank PLC |
|
CAD |
|
|
700,000 |
|
|
|
686,105 |
|
|
|
(17,133 |
) |
|
12/13/11 |
|
|
Citibank N.A. |
|
CAD |
|
|
600,000 |
|
|
|
588,090 |
|
|
|
(14,967 |
) |
|
12/13/11 |
|
|
Credit Suisse International |
|
CAD |
|
|
3,800,000 |
|
|
|
3,724,571 |
|
|
|
(17,546 |
) |
|
12/13/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
3,800,000 |
|
|
|
3,724,571 |
|
|
|
22,400 |
|
|
12/13/11 |
|
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
2,700,000 |
|
|
|
2,646,405 |
|
|
|
(41,349 |
) |
|
1/31/12 |
|
|
Deutsche Bank AG |
|
CHF |
|
|
400,000 |
|
|
|
438,568 |
|
|
|
1,452 |
|
|
2/07/12 |
|
|
Citibank N.A. |
|
EUR |
|
|
600,000 |
|
|
|
806,742 |
|
|
|
(4,146 |
) |
|
2/07/12 |
|
|
Credit Suisse International |
|
EUR |
|
|
1,300,000 |
|
|
|
1,747,941 |
|
|
|
12,935 |
|
|
2/07/12 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
16,700,000 |
|
|
|
22,454,322 |
|
|
|
(282,728 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1/10/12 |
|
|
Citibank N.A. |
|
GBP |
|
|
800,000 |
|
|
|
1,254,678 |
|
|
|
(27,148 |
) |
|
1/10/12 |
|
|
Credit Suisse International |
|
GBP |
|
|
3,300,000 |
|
|
|
5,175,546 |
|
|
|
(47,901 |
) |
|
1/10/12 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
800,000 |
|
|
|
1,254,678 |
|
|
|
(27,722 |
) |
|
1/10/12 |
|
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
1,000,000 |
|
|
|
1,568,347 |
|
|
|
(8,488 |
) |
|
2/14/12 |
|
|
Credit Suisse International |
|
JPY |
|
|
160,000,000 |
|
|
|
2,066,182 |
|
|
|
1,746 |
|
|
2/14/12 |
|
|
Deutsche Bank AG |
|
JPY |
|
|
730,000,000 |
|
|
|
9,426,954 |
|
|
|
(73,306 |
) |
|
2/21/12 |
|
|
Deutsche Bank AG |
|
NOK |
|
|
21,400,000 |
|
|
|
3,692,112 |
|
|
|
43,970 |
|
|
2/21/12 |
|
|
Royal Bank of Scotland PLC |
|
NOK |
|
|
3,700,000 |
|
|
|
638,356 |
|
|
|
9,931 |
|
|
1/24/12 |
|
|
Credit Suisse International |
|
NZD |
|
|
1,100,000 |
|
|
|
855,736 |
|
|
|
(7,434 |
) |
|
12/20/11 |
|
|
Barclays Bank PLC |
|
SEK |
|
|
10,500,000 |
|
|
|
1,550,263 |
|
|
|
(31,339 |
) |
|
12/20/11 |
|
|
Citibank N.A. |
|
SEK |
|
|
6,800,000 |
|
|
|
1,003,980 |
|
|
|
(8,016 |
) |
|
12/20/11 |
|
|
Credit Suisse International |
|
SEK |
|
|
14,700,000 |
|
|
|
2,170,368 |
|
|
|
42,849 |
|
|
12/20/11 |
|
|
Deutsche Bank AG |
|
SEK |
|
|
9,200,000 |
|
|
|
1,358,325 |
|
|
|
(78,872 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
83,120,945 |
|
|
$ |
78,678 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
|
Citibank N.A. |
|
AUD |
|
|
1,100,000 |
|
|
$ |
1,130,713 |
|
|
$ |
5,684 |
|
|
12/06/11 |
|
|
Credit Suisse International |
|
AUD |
|
|
2,800,000 |
|
|
|
2,878,180 |
|
|
|
(14,953 |
) |
|
12/06/11 |
|
|
Deutsche Bank AG |
|
AUD |
|
|
1,100,000 |
|
|
|
1,130,713 |
|
|
|
(9,813 |
) |
|
12/06/11 |
|
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
1,500,000 |
|
|
|
1,541,882 |
|
|
|
(74,074 |
) |
|
12/13/11 |
|
|
Citibank N.A. |
|
CAD |
|
|
900,000 |
|
|
|
882,135 |
|
|
|
3,831 |
|
|
12/13/11 |
|
|
Credit Suisse International |
|
CAD |
|
|
1,100,000 |
|
|
|
1,078,165 |
|
|
|
(41,212 |
) |
|
12/13/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
13,500,000 |
|
|
|
13,232,027 |
|
|
|
(210,600 |
) |
|
1/31/12 |
|
|
Barclays Bank PLC |
|
CHF |
|
|
800,000 |
|
|
|
877,135 |
|
|
|
13,029 |
|
|
1/31/12 |
|
|
Credit Suisse International |
|
CHF |
|
|
3,900,000 |
|
|
|
4,276,035 |
|
|
|
113,094 |
|
|
1/31/12 |
|
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
1,600,000 |
|
|
|
1,754,271 |
|
|
|
29,950 |
|
|
2/07/12 |
|
|
Citibank N.A. |
|
EUR |
|
|
1,100,000 |
|
|
|
1,479,027 |
|
|
|
1,958 |
|
|
1/10/12 |
|
|
Citibank N.A. |
|
GBP |
|
|
1,300,000 |
|
|
|
2,038,851 |
|
|
|
(15,271 |
) |
|
1/10/12 |
|
|
Credit Suisse International |
|
GBP |
|
|
2,200,000 |
|
|
|
3,450,364 |
|
|
|
(16,961 |
) |
|
1/10/12 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
400,000 |
|
|
|
627,339 |
|
|
|
4,821 |
|
|
1/10/12 |
|
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
800,000 |
|
|
|
1,254,678 |
|
|
|
5,750 |
|
|
2/14/12 |
|
|
Barclays Bank PLC |
|
JPY |
|
|
50,000,000 |
|
|
|
645,682 |
|
|
|
5,631 |
|
|
2/14/12 |
|
|
Citibank N.A. |
|
JPY |
|
|
60,000,000 |
|
|
|
774,818 |
|
|
|
536 |
|
|
2/14/12 |
|
|
Credit Suisse International |
|
JPY |
|
|
110,000,000 |
|
|
|
1,420,500 |
|
|
|
13,154 |
|
|
2/14/12 |
|
|
Royal Bank of Scotland PLC |
|
JPY |
|
|
100,000,000 |
|
|
|
1,291,364 |
|
|
|
10,279 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1/24/12 |
|
|
Citibank N.A. |
|
NZD |
|
|
400,000 |
|
|
|
311,177 |
|
|
|
(9,137 |
) |
|
1/24/12 |
|
|
Deutsche Bank AG |
|
NZD |
|
|
700,000 |
|
|
|
544,559 |
|
|
|
7,076 |
|
|
1/24/12 |
|
|
Royal Bank of Scotland PLC |
|
NZD |
|
|
800,000 |
|
|
|
622,354 |
|
|
|
(15,786 |
) |
|
12/20/11 |
|
|
Barclays Bank PLC |
|
SEK |
|
|
6,300,000 |
|
|
|
930,158 |
|
|
|
350 |
|
|
12/20/11 |
|
|
Credit Suisse International |
|
SEK |
|
|
26,200,000 |
|
|
|
3,868,274 |
|
|
|
179,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
48,040,401 |
|
|
$ |
(13,044 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
|
|
Australian Government Bond 3 Yr. |
|
December 2011 |
|
$ |
1,222,846 |
|
|
$ |
12,678 |
|
|
67 |
|
|
Euro BOBL |
|
December 2011 |
|
|
11,040,117 |
|
|
|
5,212 |
|
|
96 |
|
|
Euro Bund |
|
December 2011 |
|
|
17,262,132 |
|
|
|
(392,365 |
) |
|
4 |
|
|
Japanese Government Bond 10 Yr. (TSE) |
|
December 2011 |
|
|
7,311,501 |
|
|
|
(40,776 |
) |
|
47 |
|
|
U.S. Treasury Bond 30 Yr. (CBT) |
|
March 2012 |
|
|
6,644,625 |
|
|
|
(171,047 |
) |
|
80 |
|
|
U.S. Treasury Note 10 Yr. (CBT) |
|
March 2012 |
|
|
10,347,500 |
|
|
|
(97,737 |
) |
|
111 |
|
|
U.S. Treasury Note 2 Yr. (CBT) |
|
March 2012 |
|
|
24,475,500 |
|
|
|
5,283 |
|
|
112 |
|
|
U.S. Treasury Note 5 Yr. (CBT) |
|
March 2012 |
|
|
13,735,750 |
|
|
|
(17,836 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
92,039,971 |
|
|
$ |
(696,588 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
46 |
|
|
Australian Government Bond 10 Yr. |
|
December 2011 |
|
$ |
5,519,037 |
|
|
$ |
(123,289 |
) |
|
46 |
|
|
Canadian Government Bond 10 Yr. |
|
March 2012 |
|
|
5,954,135 |
|
|
|
(14,829 |
) |
|
7 |
|
|
Euro SCHATZ |
|
December 2011 |
|
|
1,036,624 |
|
|
|
(4,600 |
) |
|
56 |
|
|
UK Gilt Long Bond |
|
March 2012 |
|
|
9,971,932 |
|
|
|
111,230 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
22,481,728 |
|
|
$ |
(31,488 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
Net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
|
|
|
Amount of Future |
|
|
Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
|
Receive |
|
Annual |
|
|
Credit |
|
|
Reference |
|
Payments by the Fund |
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
Counterparty |
|
(Pay)^ |
|
Premium |
|
|
Spread (1) |
|
|
Entity |
|
Under the Contract (2) |
|
|
(Depreciation) |
|
21,000,000 |
|
USD |
|
|
|
3/20/2014 |
|
|
Deutsche Bank AG |
|
(Pay) |
|
|
1.70 |
% |
|
|
5.01 |
% |
|
Italy Government International Bond |
|
|
N/A |
|
|
|
|
|
|
$ |
1,395,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000,000 |
|
USD |
|
|
|
3/20/2019 |
|
|
Deutsche Bank AG |
|
Receive |
|
|
1.66 |
% |
|
|
4.75 |
% |
|
Italy Government International Bond |
|
|
15,000,000 |
|
|
USD |
|
|
(2,443,553 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,048,154 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a
credit event occurs, as defined under the terms of that particular
swap agreement, the Fund will either (i) pay to the buyer of
protection an amount equal to the notional amount of the swap and take
delivery of the referenced obligation or underlying securities
comprising the referenced index or (ii) pay a net settlement amount in
the form of cash or securities equal to the notional amount of the
swap less the recovery value of the referenced obligation or
underlying securities comprising the referenced index.
(Pay) Fund pays premium and buys credit protection. If a credit
event occurs, as defined under the terms of that particular swap
agreement, the Fund will either (i) receive from the seller of
protection an amount equal to the notional amount of the swap and
deliver the referenced obligation or underlying securities comprising
the referenced index or (ii) receive a net settlement amount in the
form of cash or securities equal to the notional amount of the swap
less the recovery value of the referenced obligation or underlying
securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in
determining the market value of credit default swap agreements on the
reference security, as of November 30, 2011, serve as an indicator of
the current status of the payment/performance risk and reflect the
likelihood or risk of default for the reference entity. The implied
credit spread of a particular referenced entity reflects the cost of
buying/selling protection. Wider (i.e. higher) credit spreads
represent a deterioration of the referenced entitys credit soundness
and a greater likelihood or risk of default or other credit event
occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a
seller of credit protection if a credit event occurs as defined under
the terms of that particular swap agreement. |
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
Receive |
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
|
Variable Rate |
|
(Depreciation) |
|
3,300,000 |
|
|
CHF |
|
|
|
3/21/2022 |
|
|
Barclays Bank PLC |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
$ |
118,134 |
|
3,100,000 |
|
|
CHF |
|
|
|
3/21/2022 |
|
|
Citibank N.A. |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
110,974 |
|
3,100,000 |
|
|
CHF |
|
|
|
3/21/2022 |
|
|
Deutsche Bank AG |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
110,974 |
|
12,000,000 |
|
|
EUR |
|
|
|
8/11/2014 |
|
|
Merrill Lynch Capital Services, Inc. |
|
Receive |
|
|
1.86 |
% |
|
6 Month EUR LIBOR |
|
|
94,280 |
|
33,700,000 |
|
|
SEK |
|
|
|
3/21/2022 |
|
|
Barclays Bank PLC |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(226,416 |
) |
34,600,000 |
|
|
SEK |
|
|
|
3/21/2022 |
|
|
JPMorgan Chase Bank, N.A. |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(232,463 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(24,517 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
38,865 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate. |
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund
had sufficient cash and/or securities to cover any commitments or collateral
requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
BOBL Bundesobligationen
CHF LIBOR London Interbank Offered Rate denominated in Swiss Franc.
EUR LIBOR London Interbank Offered Rate denominated in Euros.
SEK STIBOR Stockholm Interbank Offered Rate denominated in Swedish Krona.
(a) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options,
if any. |
|
(b) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific
instrument or financial statistic. |
|
(c) |
|
Underlying investment represents interests in defaulted claims. See Other matters for
additional information. |
|
(d) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(e) |
|
Rate shown represents yield-to-maturity. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
EUR Euro
GBP British Pound
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in
value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
183,303,068 |
|
$ |
8,986,902 |
|
|
$ |
(21,716,586 |
) |
|
$ |
(12,729,684 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be
read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Emerging Country Debt Fund, Class IV |
|
$ |
7,020,716 |
|
|
$ |
1,008,841 |
|
|
$ |
2,275,000 |
|
|
$ |
93,841 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
6,043,919 |
|
GMO Short-Duration Collateral Fund |
|
|
81,724,080 |
|
|
|
|
|
|
|
|
|
|
|
619,064 |
|
|
|
|
|
|
|
27,266,677 |
|
|
|
52,042,020 |
|
GMO Special Purpose Holding Fund |
|
|
22,919 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,877 |
|
GMO U.S. Treasury Fund |
|
|
4,227,972 |
|
|
|
44,395,088 |
|
|
|
40,650,000 |
|
|
|
4,170 |
|
|
|
918 |
|
|
|
|
|
|
|
7,978,452 |
|
GMO World Opportunity Overlay Fund |
|
|
41,828,178 |
|
|
|
600,000 |
|
|
|
8,500,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35,423,765 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
134,823,865 |
|
|
$ |
46,003,929 |
|
|
$ |
51,425,000 |
|
|
$ |
717,075 |
|
|
$ |
918 |
|
|
$ |
27,266,677 |
|
|
$ |
101,506,033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined at the end of the
fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly
and indirectly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
1.5% of net assets. The underlying funds classify such securities (levels defined below) as
Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of
any of its OTC derivatives contracts based on the creditworthiness of its counterparties.
See Derivative financial instruments below for a further discussion on valuation of
derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 6.3% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
$ |
|
|
|
$ |
55,952,147 |
|
|
$ |
|
|
|
$ |
55,952,147 |
|
U.S. Government |
|
|
|
|
|
|
11,296,705 |
|
|
|
|
|
|
|
11,296,705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
67,248,852 |
|
|
|
|
|
|
|
67,248,852 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
101,488,156 |
|
|
|
17,877 |
|
|
|
|
|
|
|
101,506,033 |
|
Short-Term Investments |
|
|
1,818,499 |
|
|
|
|
|
|
|
|
|
|
|
1,818,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
103,306,655 |
|
|
|
67,266,729 |
|
|
|
|
|
|
|
170,573,384 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
|
|
|
|
|
1,170,465 |
|
|
|
|
|
|
|
1,170,465 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
|
134,403 |
|
|
|
|
|
|
|
|
|
|
|
134,403 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk |
|
|
|
|
|
|
1,395,399 |
|
|
|
|
|
|
|
1,395,399 |
|
Interest rate risk |
|
|
|
|
|
|
434,362 |
|
|
|
|
|
|
|
434,362 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
134,403 |
|
|
|
3,000,226 |
|
|
|
|
|
|
|
3,134,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
103,441,058 |
|
|
$ |
70,266,955 |
|
|
$ |
|
|
|
$ |
173,708,013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
$ |
|
|
|
$ |
(1,104,831 |
) |
|
$ |
|
|
|
$ |
(1,104,831 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
|
(862,479 |
) |
|
|
|
|
|
|
|
|
|
|
(862,479 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk |
|
|
|
|
|
|
(2,443,553 |
) |
|
|
|
|
|
|
(2,443,553 |
) |
Interest rate risk |
|
|
|
|
|
|
(458,879 |
) |
|
|
|
|
|
|
(458,879 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
(862,479 |
) |
|
|
(4,007,263 |
) |
|
|
|
|
|
|
(4,869,742 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(862,479 |
) |
|
$ |
(4,007,263 |
) |
|
$ |
|
|
|
$ |
(4,869,742 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds indirect investments in securities and derivative financial instruments using Level 3
inputs were 28.7% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities.
The Fund had no reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining
defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in the
Fund are summarized below. The risks of investing in the Fund depend on the types of investments
in its portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of rising interest rates and widening
of credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may or
may not move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During
these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change
in relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to
adjust exposure to foreign currencies and otherwise adjust currency exchange risk.
Forward currency contracts outstanding at the end of the period are listed in the Funds
Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest rate exposure and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust exposure to foreign currencies and otherwise manage currency
exchange rate risk. The Fund had no purchased option contracts outstanding at the end
of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written option contracts to adjust exposure to foreign currencies and otherwise
manage currency exchange rate risk. The Fund had no written option contracts outstanding at the
end of the period.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Amount of |
|
|
of |
|
|
|
|
|
|
Amount of |
|
|
of |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding, beginning of period |
|
|
(11,600,00 |
) |
|
|
|
|
|
$ |
(228,729 |
) |
|
|
|
|
|
|
|
|
|
$ |
|
|
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
11,600,000 |
|
|
|
|
|
|
|
228,729 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment
when that variance is less than the strike price. This type of agreement is essentially a
forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure, achieve exposure to a reference entitys credit, and/or
provide a measure of protection against default loss. Swap agreements outstanding at
the end of the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency contracts |
|
$ |
|
|
|
$ |
1,170,465 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,170,465 |
|
Unrealized appreciation on futures contracts* |
|
|
134,403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
134,403 |
|
Unrealized appreciation on swap agreements |
|
|
434,362 |
|
|
|
|
|
|
|
1,395,399 |
|
|
|
|
|
|
|
|
|
|
|
1,829,761 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
568,765 |
|
|
$ |
1,170,465 |
|
|
$ |
1,395,399 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
3,134,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(1,104,831 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(1,104,831 |
) |
Unrealized depreciation on futures contracts* |
|
|
(862,479 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(862,479 |
) |
Unrealized depreciation on swap agreements |
|
|
(458,879 |
) |
|
|
|
|
|
|
(2,443,553 |
) |
|
|
|
|
|
|
|
|
|
|
(2,902,432 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(1,321,358 |
) |
|
$ |
(1,104,831 |
) |
|
$ |
(2,443,553 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(4,869,742 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table above is based
on market values or unrealized appreciation / (depreciation) rather than the notional amounts of
derivatives. Changes to market values of reference asset(s) will tend to
have a greater impact on the Fund (with correspondingly greater risk) the greater the
notional amount. For further information on notional amounts, see the Schedule
of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, and
futures contracts), notional amounts (swap agreements), or principal amounts (options)
outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
162,585,149 |
|
|
$ |
146,586,214 |
|
|
$ |
81,216,535 |
|
|
$ |
5,491,824 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Global Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares/ |
|
|
|
|
|
|
|
|
|
|
Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affilliated Issuers 100.0% |
|
|
|
|
|
|
|
|
|
665,102 |
|
|
GMO Alpha Only Fund, Class IV |
|
|
16,554,387 |
|
|
|
|
|
|
19,177,879 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
224,189,410 |
|
|
|
|
|
|
2,984,061 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
51,146,806 |
|
|
|
|
|
|
10,553,104 |
|
|
GMO International Core Equity Fund, Class VI |
|
|
278,707,487 |
|
|
|
|
|
|
3,633,108 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
77,748,499 |
|
|
|
|
|
|
9,205,992 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
179,516,845 |
|
|
|
|
|
|
26,833,208 |
|
|
GMO Quality Fund, Class VI |
|
|
586,037,257 |
|
|
|
|
|
|
17,113 |
|
|
GMO Short-Duration Investment Fund, Class III |
|
|
141,353 |
|
|
|
|
|
|
6,385,343 |
|
|
GMO U.S. Core Equity Fund, Class VI |
|
|
77,518,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $1,400,783,184) |
|
|
1,491,560,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRIVATE INVESTMENT FUNDS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affilliated Issuers 0.0% |
|
|
|
|
|
|
|
|
|
175 |
|
|
GMO SPV I, LLC (a) |
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PRIVATE INVESTMENT FUNDS (COST $-) |
|
|
16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.0% |
|
|
|
|
|
|
|
|
|
15,708 |
|
|
State Street Eurodollar Time Deposit , 0.01%, due 12/01/11 |
|
|
15,708 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $15,708) |
|
|
15,708 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.0%
(Cost $1,400,798,892) |
|
|
1,491,575,833 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(64,984 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,491,510,849 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
(a) |
|
Underlying investment represents interests in defaulted claims. See Other matters for additional
information. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$1,508,084,485 |
|
$ |
|
|
$(16,508,652) |
|
|
$(16,508,652) |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds
Schedule of Investments.
A summary
of the Funds transactions in the shares of other funds managed
by GMO during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Alpha Only Fund,
Class IV |
|
$ |
14,851,414 |
|
|
$ |
1,071,856 |
|
|
$ |
273,687 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
16,554,387 |
|
GMO Emerging Markets
Fund, Class VI |
|
|
238,829,624 |
|
|
|
45,621,106 |
|
|
|
9,720,252 |
|
|
|
90,279 |
|
|
|
18,478,317 |
|
|
|
224,189,410 |
|
GMO Flexible Equities
Fund, Class VI |
|
|
18,160,575 |
|
|
|
38,584,066 |
|
|
|
811,170 |
|
|
|
|
|
|
|
|
|
|
|
51,146,806 |
|
GMO International Core
Equity Fund, Class VI |
|
|
359,986,618 |
|
|
|
42,300,949 |
|
|
|
77,962,774 |
|
|
|
4,254,964 |
|
|
|
|
|
|
|
278,707,487 |
|
GMO International Growth
Equity Fund, Class IV |
|
|
127,710,937 |
|
|
|
12,000,163 |
|
|
|
46,436,562 |
|
|
|
907,572 |
|
|
|
|
|
|
|
77,748,499 |
|
GMO International
Intrinsic Value Fund,
Class IV |
|
|
131,550,402 |
|
|
|
73,103,442 |
|
|
|
4,257,106 |
|
|
|
2,478,307 |
|
|
|
|
|
|
|
179,516,845 |
|
GMO Quality Fund, Class VI |
|
|
519,733,118 |
|
|
|
101,511,135 |
|
|
|
60,308,582 |
|
|
|
8,536,981 |
|
|
|
|
|
|
|
586,037,257 |
|
GMO Short-Duration
Investment Fund, Class
III |
|
|
142,792 |
|
|
|
270 |
|
|
|
|
|
|
|
270 |
|
|
|
|
|
|
|
141,353 |
|
GMO SPV I, LLC |
|
|
26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16 |
|
GMO U.S. Core Equity
Fund, Class VI |
|
|
74,768,699 |
|
|
|
6,785,775 |
|
|
|
5,197,374 |
|
|
|
1,175,818 |
|
|
|
|
|
|
|
77,518,065 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
1,485,734,205 |
|
|
$ |
320,978,762 |
|
|
$ |
204,967,507 |
|
|
$ |
17,444,191 |
|
|
$ |
18,478,317 |
|
|
$ |
1,491,560,125 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods determined in good
faith by or at the direction of the Trustees of the Trust represented 0.7% of net assets. The
underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described
in the disclosures of the
underlying funds.
|
|
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
|
Equity Securities
|
|
52.6% |
|
|
Futures Contracts
|
|
0.2% |
|
|
Swap Agreements
|
|
0.1% |
|
|
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 0.0% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
1,491,560,109 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,491,560,109 |
|
Private Investment Fund |
|
|
|
|
|
|
16 |
|
|
|
|
|
|
|
16 |
|
Short-Term Investments |
|
|
15,708 |
|
|
|
|
|
|
|
|
|
|
|
15,708 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
1,491,575,817 |
|
|
|
16 |
|
|
|
|
|
|
|
1,491,575,833 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,491,575,817 |
|
|
$ |
16 |
|
|
$ |
|
|
|
$ |
1,491,575,833 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as either Level 1 or Level 2.
For the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds indirect investments in securities and derivative financial instruments using Level 3
inputs were 0.7% and 0.0% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Other matters
GMO SPV I, LLC (SPV), an investment of the Fund, has litigation pending against various
entities related to the 2002 fraud and related default of asset-backed securities issued by NPF
VI, Inc. and NPF XII, Inc. The outcome of the lawsuits against the remaining defendants is not
known and any potential recoveries are not reflected in the net asset value of SPV. For the
period ended November 30, 2011, the Fund received no distributions from SPV in connection with
the defaulted securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will
not increase to that value for a variety of reasons, one of which may be the Managers
overestimation of the value of those investments. An underlying fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund and the
underlying funds normally do not take temporary defensive positions, declines in stock
market prices generally are likely to reduce the net asset value of the Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses associated with an investment in
the Fund are less predictable and may be higher than fees and expenses associated with an
investment in funds that charge a fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies, or that the
U.S. dollar will decline in value relative to the foreign currency being hedged.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Inflation Indexed Plus Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value ($) / |
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 40.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 40.3% |
|
|
|
|
|
|
|
|
|
1,259,616 |
|
|
U.S. Treasury Inflation Indexed Bond, 2.13%, due 02/15/40(a) |
|
|
1,675,782 |
|
|
|
|
|
|
2,166,498 |
|
|
U.S. Treasury Inflation Indexed Bond, 2.38%, due 01/15/25(a) |
|
|
2,734,357 |
|
|
|
|
|
|
5,033,150 |
|
|
U.S. Treasury Inflation Indexed Bond, 0.63%, due 07/15/21(a) (e) |
|
|
5,332,778 |
|
|
|
|
|
|
2,236,120 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a) |
|
|
2,243,631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government |
|
|
11,986,548 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $11,652,765) |
|
|
11,986,548 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 55.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 55.0% |
|
|
|
|
|
|
|
|
|
108,656 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
1,028,976 |
|
|
|
|
|
|
1,338,468 |
|
|
GMO Short-Duration Collateral Fund |
|
|
8,847,273 |
|
|
|
|
|
|
28,918 |
|
|
GMO Special Purpose Holding Fund(b) |
|
|
11,278 |
|
|
|
|
|
|
16,275 |
|
|
GMO U.S. Treasury Fund |
|
|
407,043 |
|
|
|
|
|
|
257,374 |
|
|
GMO World Opportunity Overlay Fund |
|
|
6,074,038 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $15,535,537) |
|
|
16,368,608 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 4.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.5% |
|
|
|
|
|
|
|
|
|
153,776 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00% (c) |
|
|
153,776 |
|
|
|
|
|
|
|
|
|
|
U.S. Government 3.6% |
|
|
|
|
|
|
|
|
|
|
1,050,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (d)(e) |
|
|
1,049,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $1,202,762) |
|
|
1,202,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.4%
(Cost $28,391,064) |
|
|
29,557,993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.6% |
|
|
190,606 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
29,748,599 |
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
Barclays Bank PLC |
|
AUD |
|
|
100,000 |
|
|
$ |
102,792 |
|
|
$ |
(1,150 |
) |
12/06/11 |
|
Citibank N.A. |
|
AUD |
|
|
100,000 |
|
|
|
102,792 |
|
|
|
(1,504 |
) |
12/06/11 |
|
Credit Suisse International |
|
AUD |
|
|
200,000 |
|
|
|
205,584 |
|
|
|
9,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
Deutsche Bank AG |
|
AUD |
|
|
1,600,000 |
|
|
|
1,644,674 |
|
|
|
83,259 |
|
12/06/11 |
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
100,000 |
|
|
|
102,792 |
|
|
|
933 |
|
12/13/11 |
|
Barclays Bank PLC |
|
CAD |
|
|
200,000 |
|
|
|
196,030 |
|
|
|
(4,895 |
) |
12/13/11 |
|
Citibank N.A. |
|
CAD |
|
|
100,000 |
|
|
|
98,015 |
|
|
|
(2,495 |
) |
12/13/11 |
|
Credit Suisse International |
|
CAD |
|
|
600,000 |
|
|
|
588,090 |
|
|
|
(2,867 |
) |
12/13/11 |
|
Deutsche Bank AG |
|
CAD |
|
|
700,000 |
|
|
|
686,105 |
|
|
|
3,582 |
|
12/13/11 |
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
500,000 |
|
|
|
490,075 |
|
|
|
(7,888 |
) |
1/31/12 |
|
Deutsche Bank AG |
|
CHF |
|
|
100,000 |
|
|
|
109,642 |
|
|
|
363 |
|
2/07/12 |
|
Citibank N.A. |
|
EUR |
|
|
100,000 |
|
|
|
134,457 |
|
|
|
(691 |
) |
2/07/12 |
|
Credit Suisse International |
|
EUR |
|
|
200,000 |
|
|
|
268,914 |
|
|
|
1,990 |
|
1/10/12 |
|
Citibank N.A. |
|
GBP |
|
|
200,000 |
|
|
|
313,670 |
|
|
|
(6,503 |
) |
1/10/12 |
|
Credit Suisse International |
|
GBP |
|
|
500,000 |
|
|
|
784,174 |
|
|
|
(10,786 |
) |
1/10/12 |
|
Deutsche Bank AG |
|
GBP |
|
|
100,000 |
|
|
|
156,835 |
|
|
|
(3,465 |
) |
1/10/12 |
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
100,000 |
|
|
|
156,835 |
|
|
|
(2,325 |
) |
2/14/12 |
|
Credit Suisse International |
|
JPY |
|
|
30,000,000 |
|
|
|
387,409 |
|
|
|
327 |
|
2/21/12 |
|
Deutsche Bank AG |
|
NOK |
|
|
3,700,000 |
|
|
|
638,356 |
|
|
|
7,602 |
|
2/21/12 |
|
Royal Bank of Scotland PLC |
|
NOK |
|
|
600,000 |
|
|
|
103,517 |
|
|
|
1,611 |
|
1/24/12 |
|
Credit Suisse International |
|
NZD |
|
|
200,000 |
|
|
|
155,588 |
|
|
|
(1,352 |
) |
12/20/11 |
|
Barclays Bank PLC |
|
SEK |
|
|
1,800,000 |
|
|
|
265,759 |
|
|
|
(5,392 |
) |
12/20/11 |
|
Citibank N.A. |
|
SEK |
|
|
1,300,000 |
|
|
|
191,937 |
|
|
|
(1,217 |
) |
12/20/11 |
|
Credit Suisse International |
|
SEK |
|
|
2,100,000 |
|
|
|
310,053 |
|
|
|
6,238 |
|
12/20/11 |
|
Deutsche Bank AG |
|
SEK |
|
|
1,600,000 |
|
|
|
236,231 |
|
|
|
(13,717 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
8,430,326 |
|
|
$ |
49,246 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
Citibank N.A. |
|
AUD |
|
|
200,000 |
|
|
$ |
205,584 |
|
|
$ |
2,481 |
|
12/06/11 |
|
Credit Suisse International |
|
AUD |
|
|
500,000 |
|
|
|
513,961 |
|
|
|
(2,591 |
) |
12/06/11 |
|
Deutsche Bank AG |
|
AUD |
|
|
200,000 |
|
|
|
205,584 |
|
|
|
(1,784 |
) |
12/06/11 |
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
200,000 |
|
|
|
205,584 |
|
|
|
(10,007 |
) |
12/13/11 |
|
Citibank N.A. |
|
CAD |
|
|
200,000 |
|
|
|
196,030 |
|
|
|
851 |
|
12/13/11 |
|
Credit Suisse International |
|
CAD |
|
|
200,000 |
|
|
|
196,030 |
|
|
|
(7,493 |
) |
12/13/11 |
|
Deutsche Bank AG |
|
CAD |
|
|
2,100,000 |
|
|
|
2,058,315 |
|
|
|
(31,543 |
) |
1/31/12 |
|
Barclays Bank PLC |
|
CHF |
|
|
200,000 |
|
|
|
219,284 |
|
|
|
3,257 |
|
1/31/12 |
|
Credit Suisse International |
|
CHF |
|
|
600,000 |
|
|
|
657,852 |
|
|
|
18,500 |
|
1/31/12 |
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
300,000 |
|
|
|
328,926 |
|
|
|
5,616 |
|
2/07/12 |
|
Citibank N.A. |
|
EUR |
|
|
100,000 |
|
|
|
134,457 |
|
|
|
178 |
|
2/07/12 |
|
Deutsche Bank AG |
|
EUR |
|
|
1,400,000 |
|
|
|
1,882,398 |
|
|
|
23,702 |
|
1/10/12 |
|
Citibank N.A. |
|
GBP |
|
|
200,000 |
|
|
|
313,670 |
|
|
|
(2,349 |
) |
1/10/12 |
|
Credit Suisse International |
|
GBP |
|
|
400,000 |
|
|
|
627,339 |
|
|
|
(3,706 |
) |
1/10/12 |
|
Deutsche Bank AG |
|
GBP |
|
|
100,000 |
|
|
|
156,835 |
|
|
|
1,205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1/10/12 |
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
100,000 |
|
|
|
156,835 |
|
|
|
719 |
|
2/14/12 |
|
Barclays Bank PLC |
|
JPY |
|
|
10,000,000 |
|
|
|
129,136 |
|
|
|
1,126 |
|
2/14/12 |
|
Citibank N.A. |
|
JPY |
|
|
10,000,000 |
|
|
|
129,136 |
|
|
|
89 |
|
2/14/12 |
|
Credit Suisse International |
|
JPY |
|
|
20,000,000 |
|
|
|
258,273 |
|
|
|
2,392 |
|
2/14/12 |
|
Deutsche Bank AG |
|
JPY |
|
|
60,000,000 |
|
|
|
774,818 |
|
|
|
6,025 |
|
2/14/12 |
|
Royal Bank of Scotland PLC |
|
JPY |
|
|
20,000,000 |
|
|
|
258,273 |
|
|
|
2,056 |
|
1/24/12 |
|
Deutsche Bank AG |
|
NZD |
|
|
100,000 |
|
|
|
77,794 |
|
|
|
1,011 |
|
1/24/12 |
|
Royal Bank of Scotland PLC |
|
NZD |
|
|
200,000 |
|
|
|
155,588 |
|
|
|
(3,946 |
) |
12/20/11 |
|
Barclays Bank PLC |
|
SEK |
|
|
1,100,000 |
|
|
|
162,409 |
|
|
|
61 |
|
12/20/11 |
|
Credit Suisse International |
|
SEK |
|
|
5,000,000 |
|
|
|
738,220 |
|
|
|
35,557 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
10,742,331 |
|
|
$ |
41,407 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
13 |
|
Euro Bund |
|
December 2011 |
|
$ |
2,341,844 |
|
|
$ |
(52,758 |
) |
1 |
|
U.S. Treasury Note 10 Yr. (CBT) |
|
March 2012 |
|
|
129,344 |
|
|
|
(1,222 |
) |
3 |
|
U.S. Treasury Note 2 Yr. (CBT) |
|
March 2012 |
|
|
661,500 |
|
|
|
137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,132,688 |
|
|
$ |
(53,843 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
Australian Government Bond 10 Yr. |
|
December 2011 |
|
$ |
1,078,657 |
|
|
$ |
(20,529 |
) |
5 |
|
Canadian Government Bond 10 Yr. |
|
March 2012 |
|
|
649,225 |
|
|
|
(2,837 |
) |
1 |
|
U.S. Treasury Bond 30 Yr. (CBT) |
|
March 2012 |
|
|
141,375 |
|
|
|
3,794 |
|
8 |
|
UK Gilt Long Bond |
|
March 2012 |
|
|
1,428,102 |
|
|
|
15,890 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,297,359 |
|
|
$ |
(3,682 |
) |
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
Receive |
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
|
Variable Rate |
|
|
(Depreciation) |
|
1,400,000 |
|
CHF |
|
3/21/2022 |
|
Barclays Bank PLC |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
$ |
50,117 |
|
6,300,000 |
|
SEK |
|
3/21/2022 |
|
Barclays Bank PLC |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
|
(42,327 |
) |
6,300,000 |
|
SEK |
|
3/21/2022 |
|
JPMorgan Chase Bank, N.A. |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
|
(42,327 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(34,537 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
|
$ |
38,501 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate.
|
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
Fund Pays |
|
|
Fund Receives |
|
(Depreciation) |
|
16,000,000 |
|
USD |
|
1/4/2012 |
|
Barclays Bank PLC |
|
0.19% of notional
amount |
|
|
Barclays TIPS Total Return Index (a) |
|
$ |
187,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had
sufficient cash and/or securities to cover any commitments or collateral requirements of the
relevant broker or exchange.
Notes to Schedule of Investments:
CHF LIBOR London Interbank Offered Rate denominated in Swiss Franc.
SEK STIBOR Stockholm Interbank Offered Rate denominated in Swedish Krona.
TIPS Treasury Inflation Protected Securities
(a) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument or
financial statistic. |
|
(b) |
|
Underlying investment represents interests in defaulted claims. See Other Matters for additional
information. |
|
(c) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(d) |
|
Rate shown represents yield-to-maturity. |
|
(e) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options, if
any. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
EUR Euro
GBP British Pound
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$49,085,840 |
|
$ |
|
|
|
$ |
(19,527,847 |
) |
|
$ |
(19,527,847 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The
Schedule of Investments of the underlying funds should be read in conjunction
with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust
during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Emerging
Country Debt Fund,
Class IV |
|
$ |
4,686,583 |
|
|
$ |
207,642 |
|
|
$ |
4,050,000 |
|
|
$ |
62,642 |
|
|
$ |
|
|
|
$ |
|
|
|
|
1,028,976 |
|
GMO Short-Duration
Collateral Fund |
|
|
68,106,389 |
|
|
|
|
|
|
|
37,500,000 |
|
|
|
458,027 |
|
|
|
|
|
|
|
20,173,802 |
|
|
|
8,847,273 |
|
GMO Special Purpose
Holding Fund |
|
|
14,459 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11,278 |
|
GMO U.S. Treasury
Fund |
|
|
6,501,391 |
|
|
|
39,903,410 |
|
|
|
46,000,000 |
|
|
|
2,613 |
|
|
|
797 |
|
|
|
|
|
|
|
407,043 |
|
GMO World
Opportunity Overlay
Fund |
|
|
31,160,332 |
|
|
|
700,000 |
|
|
|
26,425,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,074,038 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
110,469,154 |
|
|
$ |
40,811,052 |
|
|
$ |
113,975,000 |
|
|
$ |
523,282 |
|
|
$ |
797 |
|
|
$ |
20,173,802 |
|
|
|
16,368,608 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined at the end of the
fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 1.4% of net assets. The Fund and the underlying funds classify such securities
(levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did
not reduce the value of any of its OTC derivatives contracts based on the creditworthiness of
its counterparties. See Derivative financial instruments below for a further
discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 4.8% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government |
|
$ |
|
|
|
$ |
11,986,548 |
|
|
$ |
|
|
|
$ |
11,986,548 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
11,986,548 |
|
|
|
|
|
|
|
11,986,548 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
16,357,330 |
|
|
|
11,278 |
|
|
|
|
|
|
|
16,368,608 |
|
Short-Term Investments |
|
|
1,202,837 |
|
|
|
|
|
|
|
|
|
|
|
1,202,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
17,560,167 |
|
|
|
11,997,826 |
|
|
|
|
|
|
|
29,557,993 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
220,319 |
|
|
|
|
|
|
|
220,319 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
19,821 |
|
|
|
|
|
|
|
|
|
|
|
19,821 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
|
|
|
|
237,758 |
|
|
|
|
|
|
|
237,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
19,821 |
|
|
|
458,077 |
|
|
|
|
|
|
|
477,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
17,579,988 |
|
|
$ |
12,455,903 |
|
|
$ |
|
|
|
$ |
30,035,891 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
(129,666 |
) |
|
|
|
|
|
|
(129,666 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
(77,346 |
) |
|
|
|
|
|
|
|
|
|
|
(77,346 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
|
|
|
|
(84,654 |
) |
|
|
|
|
|
|
(84,654 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
(77,346 |
) |
|
|
(214,320 |
) |
|
|
|
|
|
|
(291,666 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(77,346 |
) |
|
$ |
(214,320 |
) |
|
$ |
|
|
|
$ |
(291,666 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds investments (both direct and indirect) in securities and derivative financial instruments
using Level 3 inputs were 27.9% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation,
real interest rates might rise, leading to a decrease in value of inflation indexed bonds.
There can be no assurance, however, that the value of inflation indexed bonds will be directly
correlated to changes in nominal interest rates, and short term increases in inflation may lead
to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds
are included in the Funds gross income for the period in which they accrue. In addition, any
increase or decrease in the principal amount of an inflation indexed bond will increase or
decrease taxable ordinary income to the Fund, even though principal is not paid until maturity.
Inflation-indexed bonds outstanding at the end of the period are listed in the Funds Schedule
of Investments.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in the
Fund are summarized below. The risks of investing in the Fund depend on the types of investments
in its portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads. In addition, increases in real interest rates may not be accompanied by increases
in nominal interest rates. In such instances, the value of inflation indexed bonds may
experience greater declines than non-inflation indexed (or nominal) fixed income
investments with similar maturities. There can be no assurance that the value of the Funds
inflation indexed bond investments will change in the same proportion as changes in nominal
interest rates, and short-term increases in inflation may lead to a decline in their value.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may or
may not move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically.
Concurrently, systemic risks of the type evidenced by the insolvency of Lehman Brothers and
subsequent market disruptions reduced the ability of financial institutions to make markets in
many fixed income securities. These events reduced liquidity and contributed to substantial
declines in the value of asset-backed and other fixed income securities. There can be no
assurance these conditions will not occur again. Also, government actions and proposals
affecting the terms of underlying home and consumer loans, changes in demand for products (e.g.,
automobiles) financed by those loans, and the inability of borrowers to refinance existing loans
(e.g., sub-prime mortgages) have had, and may continue to have, adverse valuation and liquidity
effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated,
the counterparty may interpret contractual terms (e.g., the definition of default) differently
than the Fund and if that occurs, the Fund may decide not to pursue its claims against the
counterparty in order to avoid incurring the cost and unpredictability of legal proceedings. The
Fund, therefore, may be unable to obtain payments the Manager believes are owed under OTC
derivatives contracts or those payments may be delayed or made only after the Fund has incurred
the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to
adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward
currency contracts outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest rate exposure and enhance the diversity and liquidity of the portfolio.
Futures contracts outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust exposure to currencies and otherwise adjust currency exchange rate risk, as
well as to enhance the diversity and liquidity of the portfolio and to adjust interest rate
exposure. The Fund had no purchased option contracts outstanding at the end of the
period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written option contracts to adjust exposure to currencies and otherwise adjust
currency exchange rate risk, as well as to maintain the diversity and liquidity of the portfolio
and to adjust interest rate exposure. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
Amount of |
|
|
of |
|
|
|
|
|
|
Amount of |
|
|
Number of |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
|
(20,900,000 |
) |
|
|
|
|
|
$ |
(412,106 |
) |
|
|
|
|
|
|
|
|
|
$ |
|
|
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options bought back |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
20,900,000 |
|
|
|
|
|
|
|
412,106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between
the closing bid and ask prices. If the last sale price is not within this range, then they will
be valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a
payment when the realized price variance of the underlying asset is greater than the strike price and
would be entitled to receive a payment when that variance is less than the strike price. This
type of agreement is essentially a forward contract on the future realized price variance of the
underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure and adjust its exposure to certain markets. Swap
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency
contracts |
|
$ |
|
|
|
$ |
220,319 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
220,319 |
|
Unrealized appreciation on futures contracts* |
|
|
19,821 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,821 |
|
Unrealized appreciation on swap agreements |
|
|
237,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
237,758 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
257,579 |
|
|
$ |
220,319 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
477,898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency
contracts |
|
$ |
|
|
|
$ |
(129,666 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(129,666 |
) |
Unrealized depreciation on futures contracts* |
|
|
(77,346 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(77,346 |
) |
Unrealized depreciation on swap agreements |
|
|
(84,654 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(84,654 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(162,000 |
) |
|
$ |
(129,666 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(291,666 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance,
the table above is based on market values or unrealized appreciation / (depreciation) rather
than the notional amounts of derivatives. Changes to market
values of reference asset(s) will tend to have a greater impact on
the Fund (with correspondingly greater risk) the greater the notional amount.
For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures
contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
56,609,095 |
|
|
$ |
45,756,722 |
|
|
$ |
98,765,921 |
|
|
$ |
9,894,753 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO International Bond Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 37.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 4.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
CAD |
|
|
3,000,000 |
|
|
Government of Canada, 3.50%, due 06/01/20 |
|
|
3,273,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 3.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
|
|
2,000,000 |
|
|
Government of France, 4.00%, due 10/25/38 |
|
|
2,698,605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
|
|
250,000 |
|
|
Italy Buoni Poliennali Del Tesoro, 5.00%, due 08/01/34 |
|
|
252,851 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 16.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
JPY |
|
|
848,400,000 |
|
|
Japan Government Twenty Year Bond, 2.20%, due 06/20/26 |
|
|
11,902,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
EUR |
|
|
1,100,000 |
|
|
Government of Spain, 4.70%, due 07/30/41 |
|
|
1,141,010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| United Kingdom 6.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
|
|
|
GBP |
|
|
2,350,000 |
|
|
U.K. Treasury Gilt, 4.25%, due 12/07/27 |
|
|
4,413,239 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Foreign Government Obligations |
|
|
23,681,628 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 5.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 5.2% |
|
|
|
|
USD |
|
|
3,790,223 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(a)(b)(c) |
|
|
3,802,955 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $26,178,138) |
|
|
27,484,583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
MUTUAL FUNDS 64.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 64.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
|
|
279,624 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
2,648,036 |
|
|
|
|
3,980,527 |
|
|
GMO Short-Duration Collateral Fund |
|
|
26,311,285 |
|
|
|
|
37,466 |
|
|
GMO Special Purpose Holding Fund(d) |
|
|
14,612 |
|
|
|
|
56,089 |
|
|
GMO U.S. Treasury Fund |
|
|
1,402,795 |
|
|
|
|
701,891 |
|
|
GMO World Opportunity Overlay Fund |
|
|
16,564,627 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
46,941,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $46,524,518) |
|
|
46,941,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares/ |
|
|
|
|
|
|
Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 2.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.7% |
|
|
|
|
|
|
|
528,078 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(e) |
|
|
528,078 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 1.4% |
|
|
|
|
|
|
|
1,000,000 |
|
|
U.S. Treasury Bill, 0.10%, due 10/18/12 (a)(f) |
|
|
999,106 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $1,527,112) |
|
|
1,527,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 103.8%
(Cost $74,229,768) |
|
|
75,953,122 |
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (3.8%) |
|
|
(2,777,746 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
73,175,376 |
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
Barclays Bank PLC |
|
AUD |
|
|
300,000 |
|
|
$ |
308,377 |
|
|
$ |
(3,451 |
) |
12/06/11 |
|
Citibank N.A. |
|
AUD |
|
|
200,000 |
|
|
|
205,584 |
|
|
|
(3,008 |
) |
12/06/11 |
|
Credit Suisse International |
|
AUD |
|
|
600,000 |
|
|
|
616,753 |
|
|
|
28,765 |
|
12/06/11 |
|
Deutsche Bank AG |
|
AUD |
|
|
5,100,000 |
|
|
|
5,242,398 |
|
|
|
283,631 |
|
12/06/11 |
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
200,000 |
|
|
|
205,584 |
|
|
|
1,865 |
|
12/13/11 |
|
Barclays Bank PLC |
|
CAD |
|
|
300,000 |
|
|
|
294,045 |
|
|
|
(7,343 |
) |
12/13/11 |
|
Citibank N.A. |
|
CAD |
|
|
300,000 |
|
|
|
294,045 |
|
|
|
(7,484 |
) |
12/13/11 |
|
Credit Suisse International |
|
CAD |
|
|
1,600,000 |
|
|
|
1,568,240 |
|
|
|
(5,689 |
) |
12/13/11 |
|
Deutsche Bank AG |
|
CAD |
|
|
1,700,000 |
|
|
|
1,666,255 |
|
|
|
10,228 |
|
12/13/11 |
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
1,400,000 |
|
|
|
1,372,210 |
|
|
|
(17,967 |
) |
1/31/12 |
|
Deutsche Bank AG |
|
CHF |
|
|
200,000 |
|
|
|
219,284 |
|
|
|
726 |
|
2/07/12 |
|
Citibank N.A. |
|
EUR |
|
|
400,000 |
|
|
|
537,828 |
|
|
|
(2,764 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/07/12 |
|
Credit Suisse International |
|
EUR |
|
|
400,000 |
|
|
|
537,828 |
|
|
|
3,980 |
|
2/07/12 |
|
Deutsche Bank AG |
|
EUR |
|
|
14,500,000 |
|
|
|
19,496,268 |
|
|
|
(245,482 |
) |
1/10/12 |
|
Citibank N.A. |
|
GBP |
|
|
300,000 |
|
|
|
470,504 |
|
|
|
(10,323 |
) |
1/10/12 |
|
Credit Suisse International |
|
GBP |
|
|
2,800,000 |
|
|
|
4,391,373 |
|
|
|
8,449 |
|
1/10/12 |
|
Deutsche Bank AG |
|
GBP |
|
|
400,000 |
|
|
|
627,339 |
|
|
|
(13,861 |
) |
1/10/12 |
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
600,000 |
|
|
|
941,008 |
|
|
|
811 |
|
2/14/12 |
|
Credit Suisse International |
|
JPY |
|
|
50,000,000 |
|
|
|
645,682 |
|
|
|
546 |
|
2/14/12 |
|
Deutsche Bank AG |
|
JPY |
|
|
1,350,000,000 |
|
|
|
17,433,409 |
|
|
|
(135,566 |
) |
2/21/12 |
|
Deutsche Bank AG |
|
NOK |
|
|
9,300,000 |
|
|
|
1,604,516 |
|
|
|
19,109 |
|
2/21/12 |
|
Royal Bank of Scotland PLC |
|
NOK |
|
|
1,500,000 |
|
|
|
258,793 |
|
|
|
4,026 |
|
1/24/12 |
|
Credit Suisse International |
|
NZD |
|
|
500,000 |
|
|
|
388,971 |
|
|
|
(3,379 |
) |
12/20/11 |
|
Barclays Bank PLC |
|
SEK |
|
|
4,400,000 |
|
|
|
649,634 |
|
|
|
(12,714 |
) |
12/20/11 |
|
Citibank N.A. |
|
SEK |
|
|
2,800,000 |
|
|
|
413,403 |
|
|
|
(3,498 |
) |
12/20/11 |
|
Credit Suisse International |
|
SEK |
|
|
6,900,000 |
|
|
|
1,018,744 |
|
|
|
20,107 |
|
12/20/11 |
|
Deutsche Bank AG |
|
SEK |
|
|
4,100,000 |
|
|
|
605,341 |
|
|
|
(35,225 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
62,013,416 |
|
|
$ |
(125,511 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/06/11 |
|
Citibank N.A. |
|
AUD |
|
|
500,000 |
|
|
$ |
513,961 |
|
|
$ |
3,548 |
|
12/06/11 |
|
Credit Suisse International |
|
AUD |
|
|
1,200,000 |
|
|
|
1,233,506 |
|
|
|
(5,771 |
) |
12/06/11 |
|
Deutsche Bank AG |
|
AUD |
|
|
500,000 |
|
|
|
513,961 |
|
|
|
(4,461 |
) |
12/06/11 |
|
Royal Bank of Scotland PLC |
|
AUD |
|
|
700,000 |
|
|
|
719,545 |
|
|
|
(34,047 |
) |
12/13/11 |
|
Citibank N.A. |
|
CAD |
|
|
400,000 |
|
|
|
392,060 |
|
|
|
1,703 |
|
12/13/11 |
|
Credit Suisse International |
|
CAD |
|
|
500,000 |
|
|
|
490,075 |
|
|
|
(18,733 |
) |
12/13/11 |
|
Deutsche Bank AG |
|
CAD |
|
|
6,800,000 |
|
|
|
6,665,021 |
|
|
|
(106,272 |
) |
1/31/12 |
|
Barclays Bank PLC |
|
CHF |
|
|
300,000 |
|
|
|
328,926 |
|
|
|
4,886 |
|
1/31/12 |
|
Credit Suisse International |
|
CHF |
|
|
1,700,000 |
|
|
|
1,863,913 |
|
|
|
51,621 |
|
1/31/12 |
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
700,000 |
|
|
|
767,493 |
|
|
|
13,103 |
|
2/07/12 |
|
Citibank N.A. |
|
EUR |
|
|
700,000 |
|
|
|
941,199 |
|
|
|
1,246 |
|
1/10/12 |
|
Citibank N.A. |
|
GBP |
|
|
600,000 |
|
|
|
941,008 |
|
|
|
(7,048 |
) |
1/10/12 |
|
Credit Suisse International |
|
GBP |
|
|
600,000 |
|
|
|
941,008 |
|
|
|
(8,980 |
) |
1/10/12 |
|
Deutsche Bank AG |
|
GBP |
|
|
500,000 |
|
|
|
784,174 |
|
|
|
5,326 |
|
1/10/12 |
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
300,000 |
|
|
|
470,504 |
|
|
|
2,156 |
|
2/14/12 |
|
Barclays Bank PLC |
|
JPY |
|
|
20,000,000 |
|
|
|
258,273 |
|
|
|
2,253 |
|
2/14/12 |
|
Citibank N.A. |
|
JPY |
|
|
40,000,000 |
|
|
|
516,545 |
|
|
|
357 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/14/12 |
|
Credit Suisse International |
|
JPY |
|
|
50,000,000 |
|
|
|
645,682 |
|
|
|
5,979 |
|
2/14/12 |
|
Royal Bank of Scotland PLC |
|
JPY |
|
|
60,000,000 |
|
|
|
774,818 |
|
|
|
6,167 |
|
1/24/12 |
|
Citibank N.A. |
|
NZD |
|
|
200,000 |
|
|
|
155,588 |
|
|
|
(4,568 |
) |
1/24/12 |
|
Deutsche Bank AG |
|
NZD |
|
|
300,000 |
|
|
|
233,383 |
|
|
|
3,032 |
|
1/24/12 |
|
Royal Bank of Scotland PLC |
|
NZD |
|
|
400,000 |
|
|
|
311,177 |
|
|
|
(7,893 |
) |
12/20/11 |
|
Barclays Bank PLC |
|
SEK |
|
|
2,700,000 |
|
|
|
398,639 |
|
|
|
150 |
|
12/20/11 |
|
Credit Suisse International |
|
SEK |
|
|
10,700,000 |
|
|
|
1,579,791 |
|
|
|
72,580 |
|
|
|
|
|
|
|
|
|
|
|
$ |
22,440,250 |
|
|
$ |
(23,666 |
) |
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
Australian Government Bond 3 Yr. |
|
December 2011 |
|
$ |
778,175 |
|
|
$ |
8,059 |
|
46 |
|
Euro BOBL |
|
December 2011 |
|
|
7,579,782 |
|
|
|
5,753 |
|
70 |
|
Euro Bund |
|
December 2011 |
|
|
12,586,971 |
|
|
|
(318,900 |
) |
67 |
|
Euro SCHATZ |
|
December 2011 |
|
|
9,921,971 |
|
|
|
26,621 |
|
10 |
|
Japanese
Government Bond 10 Yr. (TSE) |
|
December 2011 |
|
|
18,278,752 |
|
|
|
(90,790 |
) |
2 |
|
U.S. Treasury Note 10 Yr. (CBT) |
|
March 2012 |
|
|
258,687 |
|
|
|
(2,443 |
) |
6 |
|
U.S. Treasury Note 2 Yr. (CBT) |
|
March 2012 |
|
|
1,323,000 |
|
|
|
225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
50,727,338 |
|
|
$ |
(371,475 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
19 |
|
Australian Government Bond 10 Yr. |
|
December 2011 |
|
$ |
2,279,602 |
|
|
$ |
(49,250 |
) |
24 |
|
Canadian Government Bond 10 Yr. |
|
March 2012 |
|
|
3,106,505 |
|
|
|
(4,200 |
) |
3 |
|
U.S. Treasury Bond 30 Yr. (CBT) |
|
March 2012 |
|
|
424,125 |
|
|
|
11,382 |
|
9 |
|
UK Gilt Long Bond |
|
March 2012 |
|
|
1,602,632 |
|
|
|
17,876 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
7,412,864 |
|
|
$ |
(24,192 |
) |
|
|
|
|
|
|
|
|
|
|
|
Reverse Repurchase Agreements
|
|
|
|
|
|
|
|
|
|
|
Face Value |
|
|
Description |
|
Market Value |
|
USD |
|
|
2,195,000 |
|
|
Barclays Bank PLC, 0.15%, dated 11/28/11, to be repurchased on demand at face
value plus accrued interest with a stated maturity date of 12/28/11. |
|
|
(2,195,027 |
) |
|
|
|
|
|
Average balance outstanding |
|
$ |
(2,194,348 |
) |
Average interest rate |
|
|
0.23 |
% |
Maximum balance outstanding |
|
$ |
(3,704,250 |
) |
Average balance outstanding was calculated based on daily face value balances outstanding
during the period that the Fund has entered into reverse repurchase agreements.
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
|
|
|
Amount of Future |
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
|
|
Receive |
|
|
Annual |
|
|
Credit |
|
|
Reference |
|
|
Payments by
the Fund |
|
|
Appreciation/ |
|
Amount |
|
|
Date |
|
Counterparty |
|
|
(Pay)^ |
|
|
Premium |
|
|
Spread
(1) |
|
|
Entity |
|
|
Under
the Contract (2) |
|
|
(Depreciation) |
|
14,000,000 USD |
|
3/20/2014 |
|
Deutsche Bank AG |
|
(Pay) |
|
|
1.70 |
% |
|
|
5.01 |
% |
|
Republic of Italy |
|
|
N/A |
|
|
$ |
930,266 |
|
10,000,000 USD |
|
3/20/2019 |
|
Deutsche Bank AG |
|
Receive |
|
|
1.66 |
% |
|
|
4.75 |
% |
|
Republic of Italy |
|
|
10,000,000 USD |
|
|
(1,629,036) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(698,770 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a credit event occurs, as
defined under the terms of that particular swap agreement, the Fund will either (i) pay to the
buyer of protection an amount equal to the notional amount of the swap and take delivery of the
referenced obligation or underlying securities comprising the referenced index or (ii) pay a net
settlement amount in the form of cash or securities equal to the notional amount of the swap less
the recovery value of the referenced obligation or underlying securities comprising the referenced
index. |
|
|
|
(Pay) Fund pays premium and buys credit protection. If a credit event occurs, as defined under
the terms of that particular swap agreement, the Fund will either (i) receive from the seller of
protection an amount equal to the notional amount of the swap and deliver the referenced obligation
or underlying securities comprising the referenced index or (ii) receive a net settlement amount in
the form of cash or securities equal to the notional amount of the swap less the recovery value of
the referenced obligation or underlying securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in determining the market value
of credit default swap agreements on the reference security, as of November 30, 2011, serve as an
indicator of the current status of the payment/performance risk and reflect the likelihood or risk
of default for the reference entity. The implied credit spread of a particular referenced entity
reflects the cost of buying/selling protection. Wider (i.e. higher) credit spreads represent a
deterioration of the referenced entitys credit soundness and a greater likelihood or risk of
default or other credit event occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a seller of credit protection
if a credit event occurs as defined under the terms of that particular swap agreement. |
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
|
|
|
|
Notional |
|
|
Expiration |
|
|
|
|
Receive |
|
|
|
|
|
Appreciation/ |
|
|
|
|
|
Amount |
|
|
Date |
|
|
Counterparty |
|
(Pay)# |
|
|
Fixed Rate |
|
|
Variable Rate |
|
|
(Depreciation) |
|
100,000 |
|
CHF |
|
|
3/21/2022 |
|
|
Citibank N.A. |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
$ |
3,580 |
|
2,200,000 |
|
CHF |
|
|
3/21/2022 |
|
|
Deutsche Bank AG |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
78,756 |
|
1,900,000 |
|
CHF |
|
|
3/21/2022 |
|
|
Barclays Bank PLC |
|
Receive |
|
|
1.80 |
% |
|
6 Month CHF LIBOR |
|
|
68,016 |
|
17,000,000 |
|
SEK |
|
|
3/21/2022 |
|
|
Barclays Bank PLC |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(114,216 |
) |
12,000,000 |
|
SEK |
|
|
3/21/2022 |
|
|
JPMorgan Chase Bank, N.A. |
|
(Pay) |
|
|
2.90 |
% |
|
3 Month SEK STIBOR |
|
|
(80,623 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(44,487 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
24,030 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate. |
|
|
|
(Pay) Fund pays fixed rate and receives variable rate. |
As of November 30, 2011, for the above contracts and/ or agreements, the Fund had sufficient cash
and/or securities to cover any commitments or collateral requirements of the relevant broker or
exchange.
Notes to Schedule of Investments:
CHF LIBOR
London Interbank Offered Rate denominated in Swiss Franc.
SEK STIBOR Stockholm Interbank Offered Rate denominated in Swedish Krona.
(a) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options, if
any. |
|
(b) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument
or financial statistic. |
|
(c) |
|
All or a portion of this security has been pledged to cover collateral requirements on reverse
repurchase agreements. |
|
(d) |
|
Underlying investment represents interests in defaulted claims. See Other matters for
additional information. |
|
(e) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(f) |
|
Rate shown represents yield-to-maturity. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
EUR Euro
GBP British Pound
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes
and gross and net unrealized appreciation (depreciation) in value of investments
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$87,404,626 |
|
$ |
|
|
|
$ |
(11,451,504 |
) |
|
$ |
(11,451,504 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Emerging Country Debt Fund,
Class IV |
|
$ |
3,312,292 |
|
|
$ |
259,273 |
|
|
$ |
1,050,000 |
|
|
$ |
44,273 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,648,036 |
|
GMO Short-Duration Collateral Fund |
|
|
41,317,873 |
|
|
|
|
|
|
|
|
|
|
|
312,985 |
|
|
|
|
|
|
|
13,785,424 |
|
|
|
26,311,285 |
|
GMO Special Purpose Holding Fund |
|
|
18,733 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,612 |
|
GMO U.S. Treasury Fund |
|
|
1,600,199 |
|
|
|
23,051,676 |
|
|
|
23,250,000 |
|
|
|
1,302 |
|
|
|
374 |
|
|
|
|
|
|
|
1,402,795 |
|
GMO World Opportunity Overlay Fund |
|
|
22,044,168 |
|
|
|
375,000 |
|
|
|
6,600,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,564,627 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
68,293,265 |
|
|
$ |
23,685,949 |
|
|
$ |
30,900,000 |
|
|
$ |
358,560 |
|
|
$ |
374 |
|
|
$ |
13,785,424 |
|
|
|
46,941,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011
for tax purposes. The actual tax characterization of all distributions paid by the underlying funds will be
determined at the end of the fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 1.7% of net assets. The underlying funds classify such securities (levels
defined below) as Level 3. For the period ended November 30, 2011, the Fund did not
reduce the value of any of its OTC derivatives contracts based on the creditworthiness of its
counterparties. See Derivative financial instruments below for a further discussion
on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 5.9% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1
Valuations based on quoted prices for identical securities in active markets.
Level 2
Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and inputs from pricing vendors) to value credit default swaps.
Level 3
Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective
levels assigned to the Funds investments and derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations |
|
$ |
|
|
|
$ |
23,681,628 |
|
|
$ |
|
|
|
$ |
23,681,628 |
|
U.S. Government |
|
|
|
|
|
|
3,802,955 |
|
|
|
|
|
|
|
3,802,955 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
27,484,583 |
|
|
|
|
|
|
|
27,484,583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
46,926,743 |
|
|
|
14,612 |
|
|
|
|
|
|
|
46,941,355 |
|
Short-Term Investments |
|
|
1,527,184 |
|
|
|
|
|
|
|
|
|
|
|
1,527,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
48,453,927 |
|
|
|
27,499,195 |
|
|
|
|
|
|
|
75,953,122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
556,350 |
|
|
|
|
|
|
|
556,350 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
69,916 |
|
|
|
|
|
|
|
|
|
|
|
69,916 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk |
|
|
|
|
|
|
930,266 |
|
|
|
|
|
|
|
930,266 |
|
Interest Rate risk |
|
|
|
|
|
|
150,352 |
|
|
|
|
|
|
|
150,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
48,523,843 |
|
|
$ |
29,136,163 |
|
|
$ |
|
|
|
$ |
77,660,006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
$ |
|
|
|
$ |
(705,527 |
) |
|
$ |
|
|
|
$ |
(705,527 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate risk |
|
|
(465,583 |
) |
|
|
|
|
|
|
|
|
|
|
(465,583 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk |
|
|
|
|
|
|
(1,629,036 |
) |
|
|
|
|
|
|
(1,629,036 |
) |
Interest Rate risk |
|
|
|
|
|
|
(194,839 |
) |
|
|
|
|
|
|
(194,839 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(465,583 |
) |
|
$ |
(2,529,402 |
) |
|
$ |
|
|
|
$ |
(2,994,985 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as either Level 1 or Level 2. For
the summary of valuation inputs (including Level 3 inputs, if any) of the underlying funds,
please refer to the underlying funds portfolio valuation notes. The aggregate net values of the
Funds investments (both direct and indirect) in securities and derivative financial instruments
using Level 3 inputs were 33.0% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. As of November 30,
2011, the Fund had received $2,195,000 from reverse repurchase agreements relating to securities
with a market value, plus accrued interest, of $2,249,374. Reverse repurchase agreements
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of
inflation rises at a faster rate than nominal interest rates, real interest rates (i.e. nominal
interest rate minus inflation) might decline, leading to an increase in value of inflation
indexed bonds. In contrast, if nominal interest rates increase at a faster rate than inflation,
real interest rates might rise, leading to a decrease in value of inflation indexed bonds.
There can be no assurance, however, that the value of inflation indexed bonds will be directly
correlated to changes in nominal interest rates, and short term increases in inflation may lead
to a decline in their value. Coupon payments received by the Fund from inflation indexed bonds
are included in the Funds gross income for the period in which they accrue. In addition, any
increase or decrease in the principal amount of an inflation indexed bond will increase or
decrease taxable ordinary income to the Fund, even though principal is not paid until maturity.
Inflation-indexed bonds outstanding at the end of the period are listed in the Funds Schedule
of Investments.
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of
the Funds foreign currency holdings and investments denominated
in foreign currencies.
Market Risk Fixed Income Securities Typically, the market value of the Funds fixed
income securities will decline during periods of rising interest rates and widening of
credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market
value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may or may
not move as expected relative to the value of the relevant underlying assets, rates or
indices. Derivatives also present other Fund risks, including market risk, liquidity risk,
currency risk and counterparty risk.
Leveraging Risk The Funds use of reverse repurchase agreements and other derivatives
and securities lending may cause its portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates
additional risk.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a
frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused
credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have
contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to adjust
exposure to foreign currencies and otherwise adjust currency exchange rate risk. Forward
currency contracts outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest-rate exposure and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased currency option
contracts to adjust exposure to currencies and otherwise manage currency exchange rate
risk. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written currency option contracts to adjust exposure to currencies and otherwise
manage currency exchange rate risk. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments
purchased. Gains and losses from the expiration or closing of written option contracts are
separately disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal Amount of |
|
|
Number of Futures |
|
|
|
|
|
|
Principal Amount of |
|
|
Number of Futures |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
|
(8,000,000 |
) |
|
|
|
|
|
$ |
(157,744 |
) |
|
|
|
|
|
|
|
|
|
$ |
|
|
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
8,000,000 |
|
|
|
|
|
|
|
157,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to adjust interest rate exposure, achieve exposure to a reference entitys credit, and/or
provide a measure of protection against default loss. Swap agreements outstanding at
the end of the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency contracts |
|
$ |
|
|
|
$ |
556,350 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
556,350 |
|
Unrealized appreciation on futures contracts* |
|
|
69,916 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,916 |
|
Unrealized appreciation on swap agreements |
|
|
150,352 |
|
|
|
|
|
|
|
930,266 |
|
|
|
|
|
|
|
|
|
|
|
1,080,618 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
220,268 |
|
|
$ |
556,350 |
|
|
$ |
930,266 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,706,884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(705,527 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(705,527 |
) |
Unrealized depreciation on futures contracts* |
|
|
(465,583 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(465,583 |
) |
Unrealized depreciation on swap agreements |
|
|
(194,839 |
) |
|
|
|
|
|
|
(1,629,036 |
) |
|
|
|
|
|
|
|
|
|
|
(1,823,875 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(660,422 |
) |
|
$ |
(705,527 |
) |
|
$ |
(1,629,036 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,994,985 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk)
the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures
contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
113,320,038 |
|
|
$ |
60,842,830 |
|
|
$ |
80,446,094 |
|
|
$ |
3,787,465 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO International Core Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 95.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 5.5% |
|
|
|
|
|
237,770 |
|
|
BHP Billiton Ltd |
|
|
8,908,451 |
|
|
1,255,557 |
|
|
Billabong International Ltd |
|
|
4,915,231 |
|
|
4,355,114 |
|
|
BlueScope Steel Ltd |
|
|
1,776,077 |
|
|
877,367 |
|
|
Boart Longyear Group |
|
|
2,837,976 |
|
|
2,003,355 |
|
|
Charter Hall Office (REIT) |
|
|
7,195,760 |
|
|
305,181 |
|
|
Commonwealth Bank of Australia |
|
|
15,281,689 |
|
|
7,985,316 |
|
|
Dexus Property Group (REIT) |
|
|
7,223,830 |
|
|
7,016,917 |
|
|
Goodman Fielder Ltd |
|
|
3,844,797 |
|
|
12,346,449 |
|
|
Goodman Group (REIT) |
|
|
7,778,033 |
|
|
4,437,857 |
|
|
GPT Group (REIT) |
|
|
14,563,872 |
|
|
351,085 |
|
|
Iluka Resources Ltd |
|
|
5,665,432 |
|
|
9,727,652 |
|
|
Investa Office Fund (REIT) |
|
|
6,065,545 |
|
|
3,719,347 |
|
|
Mirvac Group (REIT) |
|
|
4,970,909 |
|
|
345,819 |
|
|
National Australia Bank Ltd |
|
|
8,659,159 |
|
|
1,508,014 |
|
|
OneSteel Ltd |
|
|
1,352,165 |
|
|
3,612,133 |
|
|
Pacific Brands Ltd |
|
|
2,014,153 |
|
|
1,627,792 |
|
|
Qantas Airways Ltd * |
|
|
2,611,783 |
|
|
1,580,214 |
|
|
QBE Insurance Group Ltd |
|
|
22,634,352 |
|
|
838,876 |
|
|
Resolute Mining Ltd * |
|
|
1,745,726 |
|
|
4,134,828 |
|
|
Stockland (REIT) |
|
|
14,821,552 |
|
|
1,353,486 |
|
|
TABCORP Holdings Ltd |
|
|
4,016,706 |
|
|
10,075,216 |
|
|
Telstra Corp Ltd |
|
|
33,103,887 |
|
|
592,575 |
|
|
Wesfarmers Ltd |
|
|
19,026,587 |
|
|
330,897 |
|
|
Westfield Group (REIT) |
|
|
2,857,916 |
|
|
1,034,807 |
|
|
Westpac Banking Corp |
|
|
22,607,432 |
|
|
75 |
|
|
Woolworths Ltd |
|
|
1,931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
226,480,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.7% |
|
|
|
|
|
49,777 |
|
|
Andritz AG |
|
|
4,395,160 |
|
|
341,440 |
|
|
Immofinanz AG * |
|
|
1,056,469 |
|
|
435,716 |
|
|
OMV AG |
|
|
14,469,410 |
|
|
98,205 |
|
|
Raiffeisen International Bank Holding |
|
|
2,334,528 |
|
|
175,753 |
|
|
Voestalpine AG |
|
|
5,110,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
27,366,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.5% |
|
|
|
|
|
2,872,054 |
|
|
Ageas |
|
|
5,065,041 |
|
|
249,113 |
|
|
Belgacom SA |
|
|
7,911,040 |
|
|
96,436 |
|
|
Colruyt SA |
|
|
3,652,134 |
|
|
36,324 |
|
|
Delhaize Group |
|
|
2,142,232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
18,770,447 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 2.4% |
|
|
|
|
|
271,900 |
|
|
BCE Inc |
|
|
10,663,268 |
|
|
447,300 |
|
|
Canadian Natural Resources Ltd |
|
|
16,800,885 |
|
|
119,700 |
|
|
Canadian National Railway Co |
|
|
9,256,080 |
|
|
1,024,300 |
|
|
EnCana Corp |
|
|
20,637,644 |
|
|
277,200 |
|
|
Manulife Financial Corp |
|
|
2,986,841 |
|
|
180,400 |
|
|
Methanex Corp |
|
|
4,421,785 |
|
|
108,200 |
|
|
Metro Inc Class A |
|
|
5,468,611 |
|
|
55,900 |
|
|
National Bank of Canada |
|
|
3,635,870 |
|
|
148,200 |
|
|
Potash Corp of Saskatchewan Inc |
|
|
6,460,093 |
|
|
485,000 |
|
|
Research In Motion Ltd * |
|
|
8,739,938 |
|
|
278,500 |
|
|
Sherritt International Corp |
|
|
1,518,173 |
|
|
|
|
|
|
|
|
|
|
|
542,300 |
|
|
Sun Life Financial Inc |
|
|
9,815,048 |
|
|
3,172,400 |
|
|
Yellow Media Inc |
|
|
606,518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
101,010,754 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denmark 0.7% |
|
|
|
|
|
11 |
|
|
Carlsberg A/S Class B |
|
|
810 |
|
|
241,491 |
|
|
Novo-Nordisk A/S Class B |
|
|
27,414,128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Denmark |
|
|
27,414,938 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 0.6% |
|
|
|
|
|
226,691 |
|
|
Neste Oil Oyj |
|
|
2,835,518 |
|
|
2,632,817 |
|
|
Nokia Oyj |
|
|
15,216,616 |
|
|
137,300 |
|
|
Sampo Oyj Class A |
|
|
3,586,708 |
|
|
80,474 |
|
|
Tieto Oyj |
|
|
1,242,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Finland |
|
|
22,881,567 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 11.3% |
|
|
|
|
|
553,724 |
|
|
Air FranceKLM * |
|
|
3,226,744 |
|
|
1,299,876 |
|
|
Alcatel-Lucent * |
|
|
2,175,476 |
|
|
129,767 |
|
|
Archos * |
|
|
975,113 |
|
|
113,214 |
|
|
Arkema |
|
|
8,246,981 |
|
|
287,308 |
|
|
BNP Paribas |
|
|
11,437,174 |
|
|
13,233 |
|
|
Casino Guichard-Perrachon SA |
|
|
1,177,633 |
|
|
223,516 |
|
|
Compagnie de Saint-Gobain |
|
|
9,477,727 |
|
|
75,975 |
|
|
Compagnie Generale des Etablissements Michelin-Class B |
|
|
4,843,273 |
|
|
31,981 |
|
|
Essilor International SA |
|
|
2,286,191 |
|
|
275,687 |
|
|
European Aeronautic Defense and Space Co NV |
|
|
8,271,113 |
|
|
719,263 |
|
|
France Telecom SA |
|
|
12,414,871 |
|
|
239,511 |
|
|
Lagardere SCA |
|
|
5,832,976 |
|
|
59,750 |
|
|
LVMH Moet Hennessy Louis Vuitton SA |
|
|
9,407,771 |
|
|
203,080 |
|
|
Peugeot SA |
|
|
3,802,327 |
|
|
37,837 |
|
|
Rallye SA |
|
|
1,148,927 |
|
|
234,945 |
|
|
Renault SA |
|
|
8,803,493 |
|
|
206,597 |
|
|
Safran SA |
|
|
6,130,272 |
|
|
2,229,417 |
|
|
Sanofi |
|
|
155,938,807 |
|
|
170,123 |
|
|
Societe Generale |
|
|
4,156,499 |
|
|
133 |
|
|
STMicroelectronics NV |
|
|
843 |
|
|
2,933,437 |
|
|
Total SA |
|
|
151,343,549 |
|
|
48,893 |
|
|
Unibail-Rodamco SE (REIT) |
|
|
9,114,256 |
|
|
156,829 |
|
|
Valeo SA |
|
|
6,944,384 |
|
|
195,211 |
|
|
Vinci SA |
|
|
8,727,086 |
|
|
956,719 |
|
|
Vivendi SA |
|
|
22,067,730 |
|
|
144,324 |
|
|
Wendel |
|
|
10,398,578 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
468,349,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 6.8% |
|
|
|
|
|
127,147 |
|
|
Aareal Bank AG * |
|
|
2,302,794 |
|
|
135,636 |
|
|
Adidas AG |
|
|
9,565,162 |
|
|
166,985 |
|
|
Aixtron AG |
|
|
2,185,652 |
|
|
172,634 |
|
|
Aurubis AG |
|
|
9,851,059 |
|
|
585,548 |
|
|
BASF AG |
|
|
42,776,279 |
|
|
213,556 |
|
|
Bayerische Motoren Werke AG |
|
|
16,189,052 |
|
|
171,735 |
|
|
Deutsche Lufthansa AG (Registered) |
|
|
2,226,568 |
|
|
3,224,307 |
|
|
E.ON AG |
|
|
79,813,489 |
|
|
83,984 |
|
|
Fresenius SE & Co KGaA |
|
|
8,088,331 |
|
|
92,204 |
|
|
Fresenius Medical Care AG & Co |
|
|
6,321,093 |
|
|
213,700 |
|
|
GEA Group AG |
|
|
6,325,579 |
|
|
1,071,155 |
|
|
Infineon Technologies AG |
|
|
8,904,617 |
|
|
253,534 |
|
|
Kloeckner & Co SE |
|
|
3,339,373 |
|
|
|
|
|
|
|
|
|
|
|
165,624 |
|
|
Lanxess AG |
|
|
9,291,042 |
|
|
195,138 |
|
|
Leoni AG |
|
|
7,261,597 |
|
|
61,370 |
|
|
Linde AG |
|
|
9,457,790 |
|
|
10 |
|
|
MTU Aero Engines Holding AG |
|
|
642 |
|
|
253,360 |
|
|
RWE AG |
|
|
10,502,859 |
|
|
110,628 |
|
|
Salzgitter AG |
|
|
5,743,547 |
|
|
146,856 |
|
|
SAP AG |
|
|
8,793,642 |
|
|
27,539 |
|
|
SGL Carbon SE * |
|
|
1,659,575 |
|
|
79,889 |
|
|
Siemens AG (Registered) |
|
|
8,084,700 |
|
|
210,228 |
|
|
Software AG |
|
|
9,062,196 |
|
|
243,706 |
|
|
Suedzucker AG |
|
|
7,763,833 |
|
|
141,786 |
|
|
ThyssenKrupp AG |
|
|
3,662,324 |
|
|
25,110 |
|
|
Volkswagen AG |
|
|
3,824,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
282,997,188 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greece 0.3% |
|
|
|
|
|
131,488 |
|
|
Hellenic Telecommunications Organization SA |
|
|
556,236 |
|
|
562,648 |
|
|
Marfin Investment Group SA * |
|
|
322,722 |
|
|
882,223 |
|
|
National Bank of Greece SA * |
|
|
2,349,768 |
|
|
815,245 |
|
|
OPAP SA |
|
|
7,314,726 |
|
|
198,835 |
|
|
Public Power Corp SA |
|
|
1,135,916 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Greece |
|
|
11,679,368 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 1.6% |
|
|
|
|
|
2,176,800 |
|
|
AIA Group Ltd |
|
|
6,856,413 |
|
|
2,228,221 |
|
|
CLP Holdings Ltd |
|
|
19,843,451 |
|
|
3,063,200 |
|
|
Esprit Holdings Ltd |
|
|
4,420,973 |
|
|
4,406,000 |
|
|
Melco International Development Ltd |
|
|
3,502,956 |
|
|
5,496,000 |
|
|
Pacific Basin Shipping Ltd |
|
|
2,460,443 |
|
|
2,204,500 |
|
|
Power Assets Holdings Ltd |
|
|
16,517,708 |
|
|
1,482,000 |
|
|
SJM Holdings Ltd |
|
|
2,573,868 |
|
|
526,500 |
|
|
Swire Pacific Ltd |
|
|
6,427,268 |
|
|
1,488,500 |
|
|
Yue Yuen Industrial Holdings |
|
|
4,289,532 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
66,892,612 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 1.0% |
|
|
|
|
|
719,786 |
|
|
C&C Group Plc |
|
|
2,948,873 |
|
|
1,139,802 |
|
|
CRH Plc |
|
|
21,759,582 |
|
|
169,925 |
|
|
DCC Plc |
|
|
4,114,020 |
|
|
259,848 |
|
|
Kerry Group Plc Class A |
|
|
9,704,500 |
|
|
75,714 |
|
|
Paddy Power Plc |
|
|
4,110,901 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
42,637,876 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Israel 0.1% |
|
|
|
|
|
1,714,366 |
|
|
Bezeq Israeli Telecommunication Corp Ltd |
|
|
3,240,179 |
|
|
88,342 |
|
|
Israel Chemicals Ltd |
|
|
951,363 |
|
|
214,666 |
|
|
Partner Communications Co Ltd |
|
|
2,065,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Israel |
|
|
6,257,183 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 5.5% |
|
|
|
|
|
2,937,259 |
|
|
Banco Popolare Scarl |
|
|
3,529,646 |
|
|
578,607 |
|
|
Campari |
|
|
4,137,619 |
|
|
13,831,701 |
|
|
Enel SPA |
|
|
58,935,506 |
|
|
4,068,840 |
|
|
ENI SPA |
|
|
86,171,042 |
|
|
1,086,593 |
|
|
Finmeccanica SPA |
|
|
4,714,141 |
|
|
517,754 |
|
|
FondiariaSai SPA * |
|
|
699,085 |
|
|
1,059,883 |
|
|
Intesa Sanpaolo SPA-Di RISP |
|
|
1,366,214 |
|
|
295,699 |
|
|
Mediobanca SPA |
|
|
1,910,707 |
|
|
|
|
|
|
|
|
|
|
|
745,195 |
|
|
Pirelli & C SPA |
|
|
7,049,909 |
|
|
294,520 |
|
|
Recordati SPA |
|
|
2,262,727 |
|
|
253,453 |
|
|
Saipem SPA |
|
|
11,340,603 |
|
|
1,703,817 |
|
|
Snam Rete Gas SPA |
|
|
7,909,871 |
|
|
9,899,300 |
|
|
Telecom Italia SPA |
|
|
11,207,245 |
|
|
13,861,075 |
|
|
Telecom Italia SPA-Di RISP |
|
|
13,543,801 |
|
|
1,777,635 |
|
|
Terna SPA |
|
|
6,378,694 |
|
|
41,009 |
|
|
Tods SPA |
|
|
3,819,441 |
|
|
2,833,259 |
|
|
UniCredit SPA |
|
|
2,959,026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
227,935,277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 23.0% |
|
|
|
|
|
1,847 |
|
|
Advance Residence Investment Corp (REIT) |
|
|
3,446,056 |
|
|
1,144,300 |
|
|
Aeon Co Ltd |
|
|
15,636,341 |
|
|
837,600 |
|
|
Alps Electric Co Ltd |
|
|
5,864,120 |
|
|
602,000 |
|
|
Anritsu Corp |
|
|
6,798,076 |
|
|
672,600 |
|
|
Astellas Pharma Inc |
|
|
25,926,322 |
|
|
504,200 |
|
|
Bridgestone Corp |
|
|
11,683,344 |
|
|
134,300 |
|
|
Canon Inc |
|
|
6,024,996 |
|
|
99,900 |
|
|
Capcom |
|
|
2,562,531 |
|
|
1,740 |
|
|
CyberAgent Inc |
|
|
5,776,011 |
|
|
645,700 |
|
|
Daiei Inc * |
|
|
2,346,731 |
|
|
812,000 |
|
|
Daiichi Chuo Kisen Kaisha * |
|
|
1,070,476 |
|
|
2,386,000 |
|
|
Daikyo Inc * |
|
|
4,610,736 |
|
|
350,900 |
|
|
Daito Trust Construction Co Ltd |
|
|
31,296,450 |
|
|
1,160,000 |
|
|
Daiwabo Holdings Co Ltd |
|
|
2,724,629 |
|
|
272,200 |
|
|
Dena Co Ltd |
|
|
8,450,410 |
|
|
1,365,000 |
|
|
DIC Corp |
|
|
2,305,126 |
|
|
210,300 |
|
|
Don Quijote Co Ltd |
|
|
7,248,200 |
|
|
241,900 |
|
|
Eisai Co Ltd |
|
|
9,338,917 |
|
|
66,300 |
|
|
Fanuc Ltd |
|
|
10,892,991 |
|
|
60,100 |
|
|
Fast Retailing Co Ltd |
|
|
9,752,825 |
|
|
1,176,000 |
|
|
Fuji Electric Co Ltd |
|
|
3,478,515 |
|
|
1,159,000 |
|
|
Fuji Heavy Industries Ltd |
|
|
6,698,771 |
|
|
193,300 |
|
|
Fuji Oil Co Ltd |
|
|
2,766,949 |
|
|
178,500 |
|
|
Gree Inc |
|
|
5,992,781 |
|
|
589,000 |
|
|
Gunze Ltd |
|
|
1,695,800 |
|
|
686,000 |
|
|
Hanwa Co Ltd |
|
|
2,973,889 |
|
|
1,487,500 |
|
|
Haseko Corp * |
|
|
963,847 |
|
|
95,900 |
|
|
Hikari Tsushin Inc |
|
|
2,438,228 |
|
|
3,459,000 |
|
|
Hitachi Ltd |
|
|
19,193,681 |
|
|
157,600 |
|
|
Honda Motor Co Ltd |
|
|
5,001,336 |
|
|
1,524 |
|
|
INPEX Corp |
|
|
10,288,339 |
|
|
1,475,000 |
|
|
Itochu Corp |
|
|
14,989,526 |
|
|
478,500 |
|
|
JFE Holdings Inc |
|
|
8,807,758 |
|
|
114,000 |
|
|
JGC Corp |
|
|
2,873,156 |
|
|
624,000 |
|
|
Juki Corp |
|
|
1,504,810 |
|
|
5,712,830 |
|
|
JX Holdings Inc |
|
|
36,331,435 |
|
|
292,420 |
|
|
Ks Holdings Corp |
|
|
11,526,248 |
|
|
3,874,000 |
|
|
Kajima Corp |
|
|
11,666,057 |
|
|
157,220 |
|
|
Kakaku.com Inc |
|
|
6,028,402 |
|
|
636,400 |
|
|
Kao Corp |
|
|
16,842,021 |
|
|
3,169,000 |
|
|
Kawasaki Kisen Kaisha Ltd |
|
|
5,510,031 |
|
|
5,489 |
|
|
KDDI Corp |
|
|
36,369,005 |
|
|
436,000 |
|
|
Kinugawa Rubber Industrial Co Ltd |
|
|
3,923,314 |
|
|
216,400 |
|
|
Komatsu Ltd |
|
|
5,538,071 |
|
|
255,400 |
|
|
Konami Corp |
|
|
7,681,787 |
|
|
125,000 |
|
|
Lawson Inc |
|
|
7,402,836 |
|
|
1,412,500 |
|
|
Leopalace21 Corp * |
|
|
3,260,471 |
|
|
|
|
|
|
|
|
|
|
|
2,052,000 |
|
|
Marubeni Corp |
|
|
12,676,696 |
|
|
3,926,000 |
|
|
Mazda Motor Corp * |
|
|
7,159,985 |
|
|
50,904 |
|
|
Meiji Holdings Co Ltd |
|
|
2,211,531 |
|
|
896,000 |
|
|
Mitsubishi Heavy Industries Ltd |
|
|
3,762,224 |
|
|
2,051,500 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
11,918,058 |
|
|
242,900 |
|
|
Mitsubishi Corp |
|
|
5,021,575 |
|
|
491,000 |
|
|
Mitsubishi Electric Corp |
|
|
4,648,028 |
|
|
156,140 |
|
|
Mitsubishi UFJ Lease & Finance Co Ltd |
|
|
5,977,683 |
|
|
614,600 |
|
|
Mitsui & Co Ltd |
|
|
9,697,089 |
|
|
1,924,000 |
|
|
Mitsui OSK Lines Ltd |
|
|
6,116,125 |
|
|
8,160,400 |
|
|
Mizuho Financial Group Inc |
|
|
10,742,592 |
|
|
341,000 |
|
|
Nachi-Fujikoshi Corp |
|
|
1,604,689 |
|
|
2,060 |
|
|
Net One Systems Co Ltd |
|
|
5,314,149 |
|
|
105,900 |
|
|
Nikon Corp |
|
|
2,479,592 |
|
|
32,900 |
|
|
Nintendo Co Ltd |
|
|
5,008,609 |
|
|
747,000 |
|
|
Nippon Chemi-Con Corp |
|
|
2,767,726 |
|
|
3,365,000 |
|
|
Nippon Light Metal Co Ltd |
|
|
4,473,460 |
|
|
127,500 |
|
|
Nippon Paper Group Inc |
|
|
2,732,998 |
|
|
4,215,000 |
|
|
Nippon Steel Corp |
|
|
10,232,109 |
|
|
767,500 |
|
|
Nippon Telegraph & Telephone Corp |
|
|
37,851,927 |
|
|
2,823,000 |
|
|
Nippon Yusen Kabushiki Kaisha |
|
|
6,288,637 |
|
|
1,392,900 |
|
|
Nissan Motor Co Ltd |
|
|
12,791,435 |
|
|
113,450 |
|
|
Nitori Holdings Co Ltd |
|
|
10,604,738 |
|
|
101,300 |
|
|
Nitto Denko Corp |
|
|
4,210,723 |
|
|
584,000 |
|
|
NSK Ltd |
|
|
3,865,184 |
|
|
12,883 |
|
|
NTT Docomo Inc |
|
|
22,771,293 |
|
|
1,876,000 |
|
|
Obayashi Corp |
|
|
7,886,003 |
|
|
681,000 |
|
|
OKUMA Corp |
|
|
5,228,565 |
|
|
100 |
|
|
Omron Corp |
|
|
2,141 |
|
|
125,100 |
|
|
Ono Pharmaceutical Co Ltd |
|
|
6,517,593 |
|
|
134,750 |
|
|
ORIX Corp |
|
|
11,369,517 |
|
|
1,773,000 |
|
|
Osaka Gas Co Ltd |
|
|
6,764,071 |
|
|
1,853,500 |
|
|
Penta Ocean Construction Co Ltd |
|
|
5,850,128 |
|
|
115,630 |
|
|
Point Inc |
|
|
4,807,671 |
|
|
566,100 |
|
|
Promise Co Ltd * |
|
|
5,904,675 |
|
|
5,894,700 |
|
|
Resona Holdings Inc |
|
|
26,402,021 |
|
|
514,000 |
|
|
Ricoh Company Ltd |
|
|
4,632,022 |
|
|
768,400 |
|
|
Round One Corp |
|
|
4,591,446 |
|
|
119,500 |
|
|
Ryohin Keikaku Co Ltd |
|
|
5,437,132 |
|
|
193,700 |
|
|
Sankyo Co Ltd |
|
|
9,682,280 |
|
|
80,600 |
|
|
Secom Co Ltd |
|
|
3,635,148 |
|
|
223,100 |
|
|
Seven & I Holdings Co Ltd |
|
|
6,229,060 |
|
|
4,952,800 |
|
|
Sojitz Corp |
|
|
7,771,833 |
|
|
1,907,000 |
|
|
Sumitomo Corp |
|
|
25,454,736 |
|
|
6,697,000 |
|
|
Taiheiyo Cement Co Ltd |
|
|
13,009,703 |
|
|
3,943,000 |
|
|
Taisei Corp |
|
|
10,219,196 |
|
|
51,300 |
|
|
Taisho Pharmaceutical Holdings Co Ltd * |
|
|
3,432,787 |
|
|
1,454,100 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
59,725,668 |
|
|
393,280 |
|
|
Takefuji Corp * (a) (b) |
|
|
5,071 |
|
|
162,500 |
|
|
Tokyo Steel Manufacturing Co |
|
|
1,384,160 |
|
|
2,066,000 |
|
|
Tokyo Tatemono Co Ltd |
|
|
6,049,631 |
|
|
356,000 |
|
|
TonenGeneral Sekiyu KK |
|
|
4,060,095 |
|
|
1,498,000 |
|
|
Toray Industries Inc |
|
|
11,230,378 |
|
|
282,700 |
|
|
Toyota Motor Corp |
|
|
9,309,460 |
|
|
782,800 |
|
|
Toyota Tsusho Corp |
|
|
13,171,820 |
|
|
970,500 |
|
|
UNY Co Ltd |
|
|
8,912,825 |
|
|
58,670 |
|
|
USS Co Ltd |
|
|
5,101,423 |
|
|
279,020 |
|
|
Yamada Denki Co Ltd |
|
|
20,182,381 |
|
|
208,900 |
|
|
Yamato Holdings Co Ltd |
|
|
3,354,599 |
|
|
|
|
|
|
|
|
|
|
|
672,000 |
|
|
Zeon Corp |
|
|
5,714,036 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
951,460,482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malta 0.0% |
|
|
|
|
|
15,998,662 |
|
|
BGP Holdings Plc * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 1.3% |
|
|
|
|
|
53 |
|
|
ASML Holding NV |
|
|
2,092 |
|
|
208,241 |
|
|
CSM |
|
|
2,737,027 |
|
|
21 |
|
|
Heineken NV |
|
|
983 |
|
|
2,889,569 |
|
|
ING Groep NV * |
|
|
22,536,261 |
|
|
909,990 |
|
|
Koninklijke BAM Groep NV |
|
|
3,152,432 |
|
|
611,950 |
|
|
Unilever NV |
|
|
20,842,923 |
|
|
71,650 |
|
|
Wereldhave NV (REIT) |
|
|
4,986,209 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
54,257,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.6% |
|
|
|
|
|
1,884,358 |
|
|
Chorus Ltd * |
|
|
4,840,909 |
|
|
1,123,857 |
|
|
Fletcher Building Ltd |
|
|
5,318,769 |
|
|
9,421,793 |
|
|
Telecom Corp of New Zealand |
|
|
14,934,723 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total New Zealand |
|
|
25,094,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 0.2% |
|
|
|
|
|
163,421 |
|
|
Acergy SA * |
|
|
3,229,870 |
|
|
108,680 |
|
|
Frontline Ltd |
|
|
325,438 |
|
|
186,323 |
|
|
TGS Nopec Geophysical Co ASA |
|
|
4,145,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
7,701,123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portugal 0.2% |
|
|
|
|
|
1,418,618 |
|
|
EDP Energias de Portugal SA |
|
|
4,546,768 |
|
|
223,116 |
|
|
Jeronimo Martins SGPS SA |
|
|
4,070,716 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Portugal |
|
|
8,617,484 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 1.8% |
|
|
|
|
|
1,487,000 |
|
|
Ezra Holdings Ltd |
|
|
1,051,695 |
|
|
35,619,000 |
|
|
Golden Agri-Resources Ltd |
|
|
20,119,142 |
|
|
2,793,000 |
|
|
Jaya Holdings Ltd * |
|
|
1,056,413 |
|
|
779,200 |
|
|
MobileOne Ltd |
|
|
1,487,201 |
|
|
4,164 |
|
|
Oversea-Chinese Banking Corp Ltd |
|
|
26,525 |
|
|
1,346,000 |
|
|
SembCorp Marine Ltd |
|
|
4,047,580 |
|
|
2,450,000 |
|
|
Singapore Exchange Ltd |
|
|
12,036,469 |
|
|
2,147,000 |
|
|
Singapore Press Holdings Ltd |
|
|
6,627,977 |
|
|
9,983,000 |
|
|
Singapore Telecommunications |
|
|
24,333,322 |
|
|
1,432,000 |
|
|
Suntec Real Estate Investment Trust (REIT) |
|
|
1,285,078 |
|
|
305,000 |
|
|
Venture Corp Ltd |
|
|
1,577,906 |
|
|
2,415,000 |
|
|
Yangzijiang Shipbuilding Holdings Ltd |
|
|
1,739,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
75,388,824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 4.4% |
|
|
|
|
|
2,186,305 |
|
|
Banco Popular Espanol SA |
|
|
9,336,058 |
|
|
3,314,232 |
|
|
Banco Santander SA |
|
|
24,877,385 |
|
|
224,981 |
|
|
Ferrovial SA |
|
|
2,789,934 |
|
|
135,108 |
|
|
Fomento de Construcciones y Contratas SA |
|
|
3,496,860 |
|
|
991,708 |
|
|
Gas Natural SDG SA |
|
|
17,264,439 |
|
|
323,799 |
|
|
Grifols SA * |
|
|
5,235,493 |
|
|
1,958,473 |
|
|
Iberdrola SA |
|
|
13,051,034 |
|
|
167,306 |
|
|
Inditex SA |
|
|
14,226,553 |
|
|
788,351 |
|
|
Jazztel Plc * |
|
|
4,387,236 |
|
|
|
|
|
|
|
|
|
|
|
977,345 |
|
|
Repsol YPF SA |
|
|
29,506,980 |
|
|
3,000,126 |
|
|
Telefonica SA |
|
|
56,337,419 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
180,509,391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 0.6% |
|
|
|
|
|
338,316 |
|
|
Boliden AB |
|
|
4,905,050 |
|
|
2 |
|
|
Ericsson LM B Shares |
|
|
21 |
|
|
382,968 |
|
|
Investor AB B Shares |
|
|
7,142,928 |
|
|
144,597 |
|
|
NCC Class B |
|
|
2,356,187 |
|
|
125 |
|
|
Sandvik AB |
|
|
1,602 |
|
|
804,793 |
|
|
Swedbank AB Class A |
|
|
10,766,464 |
|
|
119,835 |
|
|
Trelleborg AB Class B |
|
|
1,010,986 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
26,183,238 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 3.8% |
|
|
|
|
|
65,434 |
|
|
Compagnie Financiere Richemont SA Class A |
|
|
3,550,823 |
|
|
673,440 |
|
|
Nestle SA (Registered) |
|
|
37,795,330 |
|
|
1,418,659 |
|
|
Novartis AG (Registered) |
|
|
76,613,612 |
|
|
133,702 |
|
|
Roche Holding AG (Non Voting) |
|
|
21,268,550 |
|
|
21,925 |
|
|
Swatch Group AG |
|
|
8,551,422 |
|
|
6,534 |
|
|
Swisscom AG (Registered) |
|
|
2,467,531 |
|
|
25,440 |
|
|
Syngenta AG (Registered) * |
|
|
7,486,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
157,733,579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 22.3% |
|
|
|
|
|
1,902,924 |
|
|
3i Group Plc |
|
|
5,700,727 |
|
|
324,415 |
|
|
Aggreko Plc |
|
|
9,671,028 |
|
|
1,839,498 |
|
|
ARM Holdings Plc |
|
|
17,285,359 |
|
|
135,137 |
|
|
ASOS Plc * |
|
|
2,893,163 |
|
|
2,742,407 |
|
|
AstraZeneca Plc |
|
|
126,309,116 |
|
|
1,010,596 |
|
|
Aviva Plc |
|
|
4,960,355 |
|
|
4,056,818 |
|
|
BAE Systems Plc |
|
|
17,514,483 |
|
|
9,271,194 |
|
|
Barclays Plc |
|
|
26,707,758 |
|
|
260,668 |
|
|
BBA Aviation Plc |
|
|
725,109 |
|
|
1,156,049 |
|
|
BG Group Plc |
|
|
24,795,893 |
|
|
177,936 |
|
|
BHP Billiton Plc |
|
|
5,471,944 |
|
|
5,435,345 |
|
|
BP Plc |
|
|
39,364,729 |
|
|
995,869 |
|
|
British American Tobacco Plc |
|
|
46,215,353 |
|
|
12,176,757 |
|
|
BT Group Plc |
|
|
36,437,964 |
|
|
1,061,846 |
|
|
Burberry Group Plc |
|
|
21,272,560 |
|
|
256,909 |
|
|
Capita Group Plc |
|
|
2,547,803 |
|
|
266 |
|
|
Centrica Plc |
|
|
1,264 |
|
|
312,926 |
|
|
Diageo Plc |
|
|
6,702,257 |
|
|
5,879,076 |
|
|
Dixons Retail Plc * |
|
|
1,044,056 |
|
|
1,172,083 |
|
|
Drax Group Plc |
|
|
10,322,856 |
|
|
65 |
|
|
Eurasian Natural Resources Corp |
|
|
683 |
|
|
1,119,421 |
|
|
FirstGroup Plc |
|
|
5,754,383 |
|
|
1,429,769 |
|
|
Game Group Plc |
|
|
166,918 |
|
|
5,570,875 |
|
|
GlaxoSmithKline Plc |
|
|
123,461,890 |
|
|
4,571,420 |
|
|
Home Retail Group Plc |
|
|
6,461,941 |
|
|
103,359 |
|
|
ICAP Plc |
|
|
578,118 |
|
|
587,863 |
|
|
IMI Plc |
|
|
7,401,881 |
|
|
330,605 |
|
|
Imperial Tobacco Group Plc |
|
|
11,894,177 |
|
|
3,084,613 |
|
|
ITV Plc |
|
|
3,154,648 |
|
|
49 |
|
|
Kazakhmys Plc |
|
|
715 |
|
|
2,500,018 |
|
|
Kesa Electricals Plc |
|
|
3,496,644 |
|
|
340,669 |
|
|
Lancashire Holdings Ltd |
|
|
3,923,059 |
|
|
14,681,268 |
|
|
Lloyds Banking Group Plc * |
|
|
5,745,231 |
|
|
424,491 |
|
|
Next Plc |
|
|
17,942,054 |
|
|
|
|
|
|
|
|
|
|
|
451,387 |
|
|
Pearson Plc |
|
|
8,199,807 |
|
|
82,467 |
|
|
Petrofac Ltd |
|
|
1,885,458 |
|
|
655,960 |
|
|
Prudential Plc |
|
|
6,456,368 |
|
|
70,972 |
|
|
Randgold Resources Ltd |
|
|
7,550,624 |
|
|
157,419 |
|
|
Reckitt Benckiser Group Plc |
|
|
7,986,296 |
|
|
363,104 |
|
|
Rio Tinto Plc |
|
|
19,115,848 |
|
|
268,392 |
|
|
Rolls-Royce Holdings Plc * |
|
|
3,085,031 |
|
|
10,457,116 |
|
|
Royal Bank of Scotland Group Plc * |
|
|
3,480,766 |
|
|
581,634 |
|
|
Royal Dutch Shell Group Class A (Amsterdam) |
|
|
20,315,589 |
|
|
1,084,553 |
|
|
Royal Dutch Shell Plc A Shares (London) |
|
|
37,931,793 |
|
|
1,724,787 |
|
|
Royal Dutch Shell Plc B Shares (London) |
|
|
62,151,952 |
|
|
159,424 |
|
|
SABMiller Plc |
|
|
5,628,877 |
|
|
527,846 |
|
|
Scottish & Southern Energy Plc |
|
|
10,929,978 |
|
|
298,938 |
|
|
Shire Plc |
|
|
10,052,684 |
|
|
635,403 |
|
|
Smith & Nephew Plc |
|
|
5,805,333 |
|
|
239,262 |
|
|
Spectris Plc |
|
|
4,721,814 |
|
|
276,441 |
|
|
Standard Chartered Plc |
|
|
6,018,343 |
|
|
289,576 |
|
|
Travis Perkins Plc |
|
|
3,801,723 |
|
|
897,287 |
|
|
Trinity Mirror Plc * |
|
|
677,932 |
|
|
749,774 |
|
|
Tullett Prebon Plc |
|
|
3,609,305 |
|
|
25,466,497 |
|
|
Vodafone Group Plc |
|
|
68,940,575 |
|
|
449,763 |
|
|
Weir Group Plc (The) |
|
|
14,619,287 |
|
|
338,595 |
|
|
WH Smith Plc |
|
|
2,797,600 |
|
|
2,427,575 |
|
|
William Hill Plc |
|
|
7,730,738 |
|
|
186,704 |
|
|
Wolseley Plc |
|
|
5,597,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
925,017,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $4,172,798,103) |
|
|
3,942,638,463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 1.1% |
|
|
|
|
|
401,654 |
|
|
Porsche Automobil Holding SE 1.12% |
|
|
24,612,838 |
|
|
229,262 |
|
|
ProSiebenSat.1 Media AG 7.61% |
|
|
4,535,376 |
|
|
94,603 |
|
|
Volkswagen AG 1.74% |
|
|
16,347,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
45,495,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $38,757,457) |
|
|
45,495,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.0% |
|
|
|
|
|
3,484,091 |
|
|
BlueScope Steel Ltd, Expires 12/14/11* |
|
|
39,413 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $770,472) |
|
|
39,413 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
2,699,282 |
|
|
GMO U.S. Treasury Fund |
|
|
67,509,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $67,509,049) |
|
|
67,509,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 1.0% |
|
|
|
|
USD |
25,000,000 |
|
|
Barclays Plc Time Deposit, 0.12%, due 12/01/11 |
|
|
25,000,000 |
|
|
|
|
|
|
|
|
|
|
CHF |
9,068 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
9,926 |
|
DKK |
54,827 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11 |
|
|
9,907 |
|
NOK |
57,463 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
9,949 |
|
NZD |
12,744 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11 |
|
|
9,952 |
|
SEK |
68,003 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11 |
|
|
10,049 |
|
USD |
807 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.03%, due 12/01/11 |
|
|
807 |
|
HKD |
2,186,423 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
281,438 |
|
JPY |
115,224,480 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
1,485,617 |
|
SGD |
281,846 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
219,909 |
|
USD |
9,800,000 |
|
|
Deutsche Bank Time Deposit, 0.06%, due 12/01/11 |
|
|
9,800,000 |
|
AUD |
205,387 |
|
|
JPMorgan Chase (New York) Time Deposit, 3.78%, due 12/01/11 |
|
|
211,220 |
|
CAD |
27,843 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.25%, due 12/01/11 |
|
|
27,299 |
|
EUR |
2,174,120 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
2,921,365 |
|
GBP |
480,441 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
753,763 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
40,751,201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $40,751,201) |
|
|
40,751,201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 98.9%
(Cost $4,320,586,282) |
|
|
4,096,433,393 |
|
|
|
|
|
|
Other Assets and Liabilities (net) 1.1% |
|
|
47,145,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
4,143,578,860 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
14,666,613 |
|
|
$ |
16,059,150 |
|
|
$ |
(195,187 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
CHF |
|
|
6,931,983 |
|
|
|
7,590,147 |
|
|
|
(91,571 |
) |
|
12/16/11 |
|
|
Bank of America N.A. |
|
CHF |
|
|
7,734,631 |
|
|
|
8,469,004 |
|
|
|
(117,875 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
CHF |
|
|
6,931,983 |
|
|
|
7,590,147 |
|
|
|
(89,274 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
EUR |
|
|
9,952,393 |
|
|
|
13,374,409 |
|
|
|
(109,542 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
10,579,539 |
|
|
|
16,595,928 |
|
|
|
44,292 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
GBP |
|
|
16,512,165 |
|
|
|
25,902,329 |
|
|
|
36,353 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
GBP |
|
|
3,074,371 |
|
|
|
4,822,709 |
|
|
|
8,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
14,697,355 |
|
|
|
23,055,470 |
|
|
|
(37,014 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
GBP |
|
|
16,573,977 |
|
|
|
25,999,293 |
|
|
|
53,063 |
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
GBP |
|
|
11,797,412 |
|
|
|
18,506,383 |
|
|
|
41,321 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
GBP |
|
|
10,773,188 |
|
|
|
16,899,702 |
|
|
|
(20,667 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
GBP |
|
|
17,876,578 |
|
|
|
28,042,659 |
|
|
|
58,306 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
HKD |
|
|
191,759,640 |
|
|
|
24,684,980 |
|
|
|
10,888 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
HKD |
|
|
184,129,190 |
|
|
|
23,702,722 |
|
|
|
17,404 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
HKD |
|
|
184,129,190 |
|
|
|
23,702,722 |
|
|
|
13,985 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
HKD |
|
|
154,537,940 |
|
|
|
19,893,477 |
|
|
|
14,146 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
HKD |
|
|
60,254,935 |
|
|
|
7,756,543 |
|
|
|
5,690 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
SEK |
|
|
48,779,995 |
|
|
|
7,203,057 |
|
|
|
(74,676 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
SEK |
|
|
88,995,030 |
|
|
|
13,141,376 |
|
|
|
(158,045 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
SEK |
|
|
94,627,767 |
|
|
|
13,973,130 |
|
|
|
(106,669 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SEK |
|
|
40,268,668 |
|
|
|
5,946,239 |
|
|
|
(57,616 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
SGD |
|
|
21,021,261 |
|
|
|
16,401,973 |
|
|
|
(112,620 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
SGD |
|
|
19,020,196 |
|
|
|
14,840,630 |
|
|
|
(115,529 |
) |
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
SGD |
|
|
14,692,589 |
|
|
|
11,463,986 |
|
|
|
(88,698 |
) |
|
12/16/11 |
|
|
Bank of America, N.A. |
|
SGD |
|
|
58,447,243 |
|
|
|
45,603,835 |
|
|
|
(438,281 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SGD |
|
|
14,822,079 |
|
|
|
11,565,022 |
|
|
|
(57,057 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
452,787,022 |
|
|
$ |
(1,566,297 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
AUD |
|
|
10,821,675 |
|
|
$ |
11,109,774 |
|
|
$ |
(600,564 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
AUD |
|
|
13,072,046 |
|
|
|
13,420,055 |
|
|
|
(170,883 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
15,935,808 |
|
|
|
15,618,242 |
|
|
|
(63,813 |
) |
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
CAD |
|
|
34,650,473 |
|
|
|
33,959,965 |
|
|
|
43,394 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
CAD |
|
|
15,803,254 |
|
|
|
15,488,330 |
|
|
|
501 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
CAD |
|
|
12,007,266 |
|
|
|
11,767,988 |
|
|
|
6,532 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
Barclays Bank PLC |
|
CAD |
|
|
12,307,889 |
|
|
|
12,062,620 |
|
|
|
(17,083 |
) |
12/16/11 |
|
Deutsche Bank AG |
|
CAD |
|
|
7,813,987 |
|
|
|
7,658,271 |
|
|
|
(16,230 |
) |
12/16/11 |
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
12,998,677 |
|
|
|
14,232,850 |
|
|
|
555,313 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
DKK |
|
|
37,184,648 |
|
|
|
6,720,353 |
|
|
|
107,410 |
|
12/16/11 |
|
State Street Bank and Trust Company |
|
DKK |
|
|
89,495,296 |
|
|
|
16,174,417 |
|
|
|
266,477 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
EUR |
|
|
24,908,163 |
|
|
|
33,472,550 |
|
|
|
554,192 |
|
12/16/11 |
|
Bank of America, N.A. |
|
EUR |
|
|
17,275,058 |
|
|
|
23,214,889 |
|
|
|
472,809 |
|
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
16,823,205 |
|
|
|
22,607,672 |
|
|
|
400,198 |
|
12/16/11 |
|
Deutsche Bank AG |
|
EUR |
|
|
34,806,000 |
|
|
|
46,773,645 |
|
|
|
927,978 |
|
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
JPY |
|
|
410,698,269 |
|
|
|
5,297,006 |
|
|
|
59,625 |
|
12/16/11 |
|
JPMorgan Chase Bank, N.A. |
|
JPY |
|
|
3,203,470,130 |
|
|
|
41,316,950 |
|
|
|
448,194 |
|
12/16/11 |
|
Bank of America, N.A. |
|
JPY |
|
|
1,811,172,000 |
|
|
|
23,359,701 |
|
|
|
254,200 |
|
12/16/11 |
|
Deutsche Bank, AG |
|
JPY |
|
|
1,074,552,130 |
|
|
|
13,859,101 |
|
|
|
150,522 |
|
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
NZD |
|
|
10,386,611 |
|
|
|
8,102,329 |
|
|
|
88,967 |
|
12/16/11 |
|
Bank of America N.A. |
|
NZD |
|
|
12,464,049 |
|
|
|
9,722,886 |
|
|
|
122,180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
385,939,594 |
|
|
$ |
3,589,919 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
OMXS 30 |
|
December 2011 |
|
$ |
73,101 |
|
|
$ |
2,409 |
|
|
256 |
|
|
FTSE 100 |
|
December 2011 |
|
|
22,155,902 |
|
|
|
1,531,046 |
|
|
707 |
|
|
TOPIX |
|
December 2011 |
|
|
67,914,477 |
|
|
|
475,671 |
|
|
797 |
|
|
FTSE/MIB |
|
December 2011 |
|
|
82,051,145 |
|
|
|
9,856,670 |
|
|
25 |
|
|
MSCI Singapore |
|
December 2011 |
|
|
1,224,617 |
|
|
|
43,327 |
|
|
184 |
|
|
DAX |
|
December 2011 |
|
|
37,797,726 |
|
|
|
5,499,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
211,216,968 |
|
|
$ |
17,408,938 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
461 |
|
|
S&P Toronto 60 |
|
December 2011 |
|
$ |
62,780,431 |
|
|
$ |
(603,702 |
) |
|
427 |
|
|
SPI 200 |
|
December 2011 |
|
|
46,640,756 |
|
|
|
(1,567,811 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
109,421,187 |
|
|
$ |
(2,171,513 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
Fund Pays |
|
|
Fund (Pays)/Receives |
|
|
(Depreciation) |
|
|
589,094 |
|
|
EUR |
|
11/27/12 |
|
Goldman Sachs International |
|
1 Month Euribor
Floating Rate -10.0% |
|
Total Return on Dexia SA |
|
$ |
(24,961 |
) |
|
678,631 |
|
|
EUR |
|
11/27/12 |
|
Bank of America Merrill Lynch |
|
3 Month Euribor
Floating Rate -10.0% |
|
Total Return on Alpha Bank A.E. |
|
|
(1,587 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(26,548 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash
and/or securities to cover any commitments or collateral requirements of the relevant broker or
exchange.
Notes to Schedule of Investments:
REIT Real Estate Investment Trust
|
|
|
* |
|
Non-income producing security. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of
the Trustees of GMO Trust. |
|
(b) |
|
Bankrupt issuers. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NZD New Zealand Dollar
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$4,390,760,242
|
|
$350,645,151
|
|
$(644,972,000)
|
|
$(294,326,849) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be
read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury
Fund |
|
$ |
52,104,000 |
|
|
$ |
109,839,000 |
|
|
$ |
94,442,925 |
|
|
$ |
20,646 |
|
|
$ |
2,873 |
|
|
$ |
67,509,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security valuations
are appropriate; however, actual results may differ from those estimates, and the security
valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately
realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or, (iii)
if there is no such reported sale or official closing price (or in the event the Manager deems the
over-the-counter (OTC) market to be a better indicator of market value), at the most recent
quoted price. Unlisted securities for which market quotations are readily available are generally
valued at the most recent quoted price. Non-emerging market debt instruments with a remaining
maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate
otherwise; for example, if the issuers creditworthiness has become impaired), which approximates
market value. Shares of open-end investment companies are generally valued at their net asset
value. Derivatives and other securities for which quotations are not readily available or whose
values the Manager has determined to be unreliable are valued at fair value as determined in good
faith by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the uncertainty
inherent in fair value pricing, the value determined for a particular security may be materially
different from the value realized upon its sale. As of November 30, 2011, the total value
of securities held directly that were fair valued using methods determined in good faith by or at
the direction of the Trustees of the Trust represented less than 0.1% of net assets. The Fund
classifies such securities (levels defined below) as Level 3. For the period ended November 30,
2011, the Fund did not reduce the value of any of its OTC derivatives contracts based on the
creditworthiness of its counterparties. See Derivative financial instruments below for a further
discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including the
value of equity securities that underlie futures (to the extent the market for such futures closes
prior to close of the NYSE) and other derivatives) will be adjusted, to the extent practicable and
available, based on inputs from an independent pricing service approved by the Trustees. The table
below shows the percentage of the net assets of the Fund that were valued using fair value prices
obtained from an independent pricing service as of November 30, 2011. These securities listed on
foreign exchanges (including the value of equity securities that underlie futures (to the extent
the market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below.
|
|
|
Security Type |
Percentage of Net Assets of the Fund |
|
Equity Securities |
93.3% |
|
Futures Contracts |
0.4% |
|
Swap Agreements |
(0.0%)^ |
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid or
an ask, quotation or quoted price may be a market quotation provided by a market participant or
other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S.
GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service applied
to equity securities (including the value of equity securities that underlie futures (to the extent
the market for such futures closes prior to the close of the NYSE) and other derivatives) due to
market events that have occurred since the local market close but prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value technique on Level 3 investments: The Fund considered certain
bankrupt securities to be near worthless.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
226,480,951 |
|
|
$ |
|
|
|
$ |
226,480,951 |
|
Austria |
|
|
|
|
|
|
27,366,543 |
|
|
|
|
|
|
|
27,366,543 |
|
Belgium |
|
|
|
|
|
|
18,770,447 |
|
|
|
|
|
|
|
18,770,447 |
|
Canada |
|
|
101,010,754 |
|
|
|
|
|
|
|
|
|
|
|
101,010,754 |
|
Denmark |
|
|
|
|
|
|
27,414,938 |
|
|
|
|
|
|
|
27,414,938 |
|
Finland |
|
|
|
|
|
|
22,881,567 |
|
|
|
|
|
|
|
22,881,567 |
|
France |
|
|
|
|
|
|
468,349,794 |
|
|
|
|
|
|
|
468,349,794 |
|
Germany |
|
|
|
|
|
|
282,997,188 |
|
|
|
|
|
|
|
282,997,188 |
|
Greece |
|
|
|
|
|
|
11,679,368 |
|
|
|
|
|
|
|
11,679,368 |
|
Hong Kong |
|
|
|
|
|
|
66,892,612 |
|
|
|
|
|
|
|
66,892,612 |
|
Ireland |
|
|
|
|
|
|
42,637,876 |
|
|
|
|
|
|
|
42,637,876 |
|
Israel |
|
|
|
|
|
|
6,257,183 |
|
|
|
|
|
|
|
6,257,183 |
|
Italy |
|
|
|
|
|
|
227,935,277 |
|
|
|
|
|
|
|
227,935,277 |
|
Japan |
|
|
3,432,787 |
|
|
|
948,022,624 |
|
|
|
5,071 |
|
|
|
951,460,482 |
|
Malta |
|
|
|
|
|
|
0 |
* |
|
|
|
|
|
|
0 |
* |
Netherlands |
|
|
|
|
|
|
54,257,927 |
|
|
|
|
|
|
|
54,257,927 |
|
New Zealand |
|
|
19,775,632 |
|
|
|
5,318,769 |
|
|
|
|
|
|
|
25,094,401 |
|
Norway |
|
|
|
|
|
|
7,701,123 |
|
|
|
|
|
|
|
7,701,123 |
|
Portugal |
|
|
|
|
|
|
8,617,484 |
|
|
|
|
|
|
|
8,617,484 |
|
Singapore |
|
|
|
|
|
|
75,388,824 |
|
|
|
|
|
|
|
75,388,824 |
|
Spain |
|
|
|
|
|
|
180,509,391 |
|
|
|
|
|
|
|
180,509,391 |
|
Sweden |
|
|
|
|
|
|
26,183,238 |
|
|
|
|
|
|
|
26,183,238 |
|
Switzerland |
|
|
|
|
|
|
157,733,579 |
|
|
|
|
|
|
|
157,733,579 |
|
United Kingdom |
|
|
|
|
|
|
925,017,516 |
|
|
|
|
|
|
|
925,017,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
124,219,173 |
|
|
|
3,818,414,219 |
|
|
|
5,071 |
|
|
|
3,942,638,463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany |
|
|
|
|
|
|
45,495,267 |
|
|
|
|
|
|
|
45,495,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
|
|
|
|
45,495,267 |
|
|
|
|
|
|
|
45,495,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
|
|
|
|
|
39,413 |
|
|
|
|
|
|
|
39,413 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS |
|
|
|
|
|
|
39,413 |
|
|
|
|
|
|
|
39,413 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
67,509,049 |
|
|
|
|
|
|
|
|
|
|
|
67,509,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
40,751,201 |
|
|
|
|
|
|
|
|
|
|
|
40,751,201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
232,479,423 |
|
|
|
3,863,948,899 |
|
|
|
5,071 |
|
|
|
4,096,433,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange risk |
|
|
|
|
|
|
4,762,516 |
|
|
|
|
|
|
|
4,762,516 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
17,408,938 |
|
|
|
|
|
|
|
17,408,938 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
22,171,454 |
|
|
|
|
|
|
|
22,171,454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
232,479,423 |
|
|
$ |
3,886,120,353 |
|
|
$ |
5,071 |
|
|
$ |
4,118,604,847 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange risk |
|
$ |
|
|
|
$ |
(2,738,894 |
) |
|
$ |
|
|
|
$ |
(2,738,894 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
(603,702 |
) |
|
|
(1,567,811 |
) |
|
|
|
|
|
|
(2,171,513 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
(26,548 |
) |
|
|
|
|
|
|
(26,548 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
(603,702 |
) |
|
|
(4,333,253 |
) |
|
|
|
|
|
|
(4,936,955 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(603,702 |
) |
|
$ |
(4,333,253 |
) |
|
$ |
|
|
|
$ |
(4,936,955 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Represents the interest in securities that were determined to have a fair value of zero at
November 30, 2011. |
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net value of the Funds direct
investments in securities using Level 3 inputs was less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
Balances as of |
|
|
|
Investments Still |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
Transfer |
|
|
Transfer |
|
|
November 30, |
|
|
|
Held as of November |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
into level 3 * |
|
|
out of level 3 * |
|
|
2011 |
|
|
|
30, 2011 |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan |
|
$ |
4,808 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
263 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,071 |
|
|
|
$ |
263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,808 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
263 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,071 |
|
|
|
$ |
263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of
Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. Selected risks
of investing in the Fund are summarized below. The risks of investing in the Fund depend on the
types of investments in its portfolio and the investment strategies the Manager employs on its
behalf. This section does not describe every potential risk of investing in the Fund. The Fund
could be subject to additional risks because of the types of investments it makes and market
conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting their investment exposure, the Fund also may use currency derivatives
in an attempt to adjust its currency exposure, seeking currency exposure that is different (in
some cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC
derivatives contracts typically can be closed only with the other party to the contract. If the
counterparty defaults, the Fund will have contractual remedies, but may not be able to enforce
them. Because the contract for each OTC derivative is individually negotiated, the counterparty
may interpret contractual terms (e.g., the definition of default) differently than the Fund and
if that occurs, the Fund may decide not to pursue its claims against the counterparty in order
to avoid incurring the cost and unpredictability of legal proceedings. The Fund, therefore, may
be unable to obtain payments the Manager believes are owed under OTC derivatives contracts or
those payments may be delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used
forward currency contracts to manage against anticipated currency exchange rate changes and
adjust exposure to foreign currencies. Forward currency contracts outstanding at the
end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain securities markets and maintain the diversity and liquidity of
the portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated
terms of the swap agreement and prevailing market conditions (credit spreads, currency exchange
rates, interest rates, and other relevant factors) are recorded as realized gains or losses. A
liquidation payment received or made at the termination of the swap agreements is recorded as
realized gain or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
During the period ended November 30, 2011, the Fund used swap agreements to achieve returns
comparable to holding and lending a direct equity position. Swap agreements outstanding at the
end of the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or warrants held
by the Fund at the end of the period are listed in the Funds Schedule of Investments.
The
following is a summary of the fair valuations of derivative
instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
39,413 |
|
|
$ |
|
|
|
$ |
39,413 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
4,762,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,762,516 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,408,938 |
|
|
|
|
|
|
|
17,408,938 |
|
Unrealized appreciation on swap agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
4,762,516 |
|
|
$ |
|
|
|
$ |
17,448,351 |
|
|
$ |
|
|
|
$ |
22,210,867 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(2,738,894 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,738,894 |
) |
Unrealized depreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,171,513 |
) |
|
|
|
|
|
$ |
(2,171,513 |
) |
Unrealized depreciation on swap agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26,548 |
) |
|
|
|
|
|
|
(26,548 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(2,738,894 |
) |
|
$ |
|
|
|
$ |
(2,198,061 |
) |
|
$ |
|
|
|
$ |
(4,936,955 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table above
is based on market values or unrealized appreciation / (depreciation) rather than the
notional amounts of derivatives. Changes to market values of reference asset(s)
will tend to have a greater impact on the Fund (with correspondingly
greater risk) the greater the notional amount. For further information
on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures
contracts and rights and/or warrants), or notional amounts (swap agreements) outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Rights and/or |
|
|
Swap |
|
|
|
Contracts |
|
|
Contracts |
|
|
Warrants |
|
|
Agreements |
|
Average amount outstanding |
|
$948,437,538 |
|
|
$385,081,487 |
|
|
$539,285 |
|
|
$277,482 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO International Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares/Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 100.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 100.1% |
|
|
|
|
|
22,366,402 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
261,463,245 |
|
|
2,441,904 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
41,854,243 |
|
|
13,803,848 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
295,402,351 |
|
|
21,948,029 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
427,986,569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $972,732,788) |
|
|
1,026,706,408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.0% |
|
|
|
|
|
20,858 |
|
|
State Street Eurodollar Time Deposit, 0.01%, due 12/01/11 |
|
|
20,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $20,858) |
|
|
20,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.1%
(Cost $972,753,646) |
|
|
1,026,727,266 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.1%) |
|
|
(527,593 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,026,199,673 |
|
|
|
|
|
|
|
|
|
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value
of investments were as follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$1,115,916,108 |
|
$ |
|
$(89,188,842) |
|
$(89,188,842) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in
conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Emerging
Markets Fund, Class
VI |
|
$ |
331,226,965 |
|
|
$ |
47,472,044 |
|
|
$ |
58,186,266 |
|
|
$ |
106,511 |
|
|
$ |
24,815,381 |
|
|
$ |
261,463,245 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GMO Flexible
Equities Fund,
Class VI |
|
|
22,278,407 |
|
|
|
26,532,449 |
|
|
|
2,776,196 |
|
|
|
|
|
|
|
|
|
|
|
41,854,243 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GMO International
Growth Equity Fund,
Class IV |
|
|
461,803,642 |
|
|
|
32,980,814 |
|
|
|
160,014,706 |
|
|
|
2,914,653 |
|
|
|
|
|
|
|
295,402,351 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GMO International
Intrinsic Value
Fund, Class IV |
|
|
462,273,821 |
|
|
|
118,648,077 |
|
|
|
88,684,636 |
|
|
|
8,067,662 |
|
|
|
|
|
|
|
427,986,569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
1,277,582,835 |
|
|
$ |
225,633,384 |
|
|
$ |
309,661,804 |
|
|
$ |
11,088,826 |
|
|
$ |
24,815,381 |
|
|
$ |
1,026,706,408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods determined in good
faith by or at the direction of the Trustees of the Trust represented 1.2% of net assets. The
underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
|
|
|
Security Type |
Percentage of Net Assets of the Fund |
|
Equity Securities |
84.3% |
|
Futures Contracts |
0.3% |
|
Swap Agreements |
(0.0)% ^ |
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
1,026,706,408 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,026,706,408 |
|
Short-Term Investments |
|
|
20,858 |
|
|
|
|
|
|
|
|
|
|
|
20,858 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
1,026,727,266 |
|
|
|
|
|
|
|
|
|
|
|
1,026,727,266 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,026,727,266 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,026,727,266 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds indirect
investments in securities using Level 3 inputs were 1.2% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Because
the Fund and the underlying funds normally do not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses
associated with an investment in the Fund are less predictable and may be higher than fees
and expenses associated with an investment in funds that charge a fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO International Growth Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 94.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 4.6% |
|
|
|
|
|
846,748 |
|
|
BHP Billiton Ltd |
|
|
31,724,830 |
|
|
1,366,831 |
|
|
BlueScope Steel Ltd |
|
|
557,413 |
|
|
176,810 |
|
|
Coca Cola Amatil Ltd |
|
|
2,157,419 |
|
|
42,780 |
|
|
Cochlear Ltd |
|
|
2,526,245 |
|
|
181,726 |
|
|
CSL Ltd |
|
|
5,925,480 |
|
|
220,319 |
|
|
Iluka Resources Ltd |
|
|
3,555,271 |
|
|
338,700 |
|
|
National Australia Bank Ltd |
|
|
8,480,903 |
|
|
601,383 |
|
|
Qantas Airways Ltd * |
|
|
964,916 |
|
|
26,397 |
|
|
Rio Tinto Ltd |
|
|
1,797,499 |
|
|
2,713,296 |
|
|
Telstra Corp Ltd |
|
|
8,915,009 |
|
|
499,826 |
|
|
Wesfarmers Ltd |
|
|
16,048,573 |
|
|
361,502 |
|
|
Westpac Banking Corp |
|
|
7,897,736 |
|
|
172,933 |
|
|
Woodside Petroleum Ltd |
|
|
6,028,111 |
|
|
908,952 |
|
|
Woolworths Ltd |
|
|
23,399,020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
119,978,425 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.2% |
|
|
|
|
|
36,331 |
|
|
Andritz AG |
|
|
3,207,919 |
|
|
946,419 |
|
|
Immofinanz AG (Entitlement Shares) * |
|
|
|
|
|
40,044 |
|
|
Raiffeisen International Bank Holding |
|
|
951,925 |
|
|
72,261 |
|
|
Voestalpine AG |
|
|
2,101,382 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
6,261,226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.3% |
|
|
|
|
|
46,742 |
|
|
Bekaert NV |
|
|
1,857,448 |
|
|
87,822 |
|
|
Colruyt SA |
|
|
3,325,912 |
|
|
63,760 |
|
|
Mobistar SA |
|
|
3,486,551 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
8,669,911 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 3.8% |
|
|
|
|
|
29,500 |
|
|
Agrium Inc |
|
|
2,070,597 |
|
|
73,500 |
|
|
BCE Inc |
|
|
2,882,494 |
|
|
270,900 |
|
|
Canadian National Railway Co |
|
|
20,947,971 |
|
|
77,400 |
|
|
Cenovus Energy Inc |
|
|
2,588,474 |
|
|
361,900 |
|
|
Enbridge Inc |
|
|
12,823,242 |
|
|
78,300 |
|
|
IGM Financial Inc |
|
|
3,324,842 |
|
|
140,600 |
|
|
Imperial Oil Ltd |
|
|
6,013,012 |
|
|
39,000 |
|
|
Metro Inc Class A |
|
|
1,971,126 |
|
|
296,800 |
|
|
Potash Corp of Saskatchewan Inc |
|
|
12,937,623 |
|
|
136,200 |
|
|
Research In Motion Ltd * |
|
|
2,454,391 |
|
|
172,900 |
|
|
Rogers Communications Inc Class B |
|
|
6,411,175 |
|
|
75,200 |
|
|
Saputo Inc |
|
|
2,800,969 |
|
|
82,800 |
|
|
Shoppers Drug Mart Corp |
|
|
3,446,110 |
|
|
268,900 |
|
|
Suncor Energy Inc |
|
|
8,099,032 |
|
|
222,196 |
|
|
Valeant Pharmaceuticals International Inc * |
|
|
10,282,515 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
99,053,573 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denmark 1.5% |
|
|
|
|
|
295,425 |
|
|
Novo-Nordisk A/S Class B |
|
|
33,536,732 |
|
|
131,820 |
|
|
Novozymes A/S B Shares |
|
|
4,227,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Denmark |
|
|
37,764,481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 0.5% |
|
|
|
|
|
112,595 |
|
|
Kone Oyj Class B |
|
|
6,341,687 |
|
|
|
|
|
|
|
|
|
|
|
97,887 |
|
|
Nokian Renkaat Oyj |
|
|
3,242,435 |
|
|
50,846 |
|
|
Sampo Oyj Class A |
|
|
1,328,257 |
|
|
58,434 |
|
|
Wartsila Oyj |
|
|
1,920,432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Finland |
|
|
12,832,811 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 6.5% |
|
|
|
|
|
113,985 |
|
|
Air FranceKLM * |
|
|
664,231 |
|
|
17,760 |
|
|
Air Liquide SA |
|
|
2,247,176 |
|
|
1,663,315 |
|
|
Alcatel-Lucent * |
|
|
2,783,728 |
|
|
57,460 |
|
|
Arkema |
|
|
4,185,627 |
|
|
67,471 |
|
|
BNP Paribas |
|
|
2,685,890 |
|
|
70,374 |
|
|
Bureau Veritas SA |
|
|
5,214,356 |
|
|
262,849 |
|
|
Carrefour SA |
|
|
6,998,466 |
|
|
203,955 |
|
|
Compagnie de Saint-Gobain |
|
|
8,648,284 |
|
|
68,800 |
|
|
Michelin (CGDE) |
|
|
4,385,880 |
|
|
168,226 |
|
|
Credit Agricole SA |
|
|
1,081,380 |
|
|
122,139 |
|
|
Danone SA |
|
|
8,063,926 |
|
|
50,819 |
|
|
Dassault Systemes SA |
|
|
4,161,005 |
|
|
124,827 |
|
|
Essilor International SA |
|
|
8,923,371 |
|
|
195,383 |
|
|
EADS NV |
|
|
5,861,846 |
|
|
78,337 |
|
|
Eutelsat Communications |
|
|
3,044,053 |
|
|
16,696 |
|
|
ICADE REIT |
|
|
1,334,670 |
|
|
27,889 |
|
|
Iliad SA |
|
|
3,407,515 |
|
|
89,947 |
|
|
LOreal SA |
|
|
9,735,405 |
|
|
79,198 |
|
|
Legrand SA |
|
|
2,563,569 |
|
|
43,629 |
|
|
LVMH Moet Hennessy Louis Vuitton SA |
|
|
6,869,483 |
|
|
18,862 |
|
|
Neopost SA |
|
|
1,336,446 |
|
|
83,954 |
|
|
Renault SA |
|
|
3,145,793 |
|
|
86,312 |
|
|
Safran SA |
|
|
2,561,102 |
|
|
398,648 |
|
|
Sanofi |
|
|
27,883,834 |
|
|
85,368 |
|
|
Schneider Electric SA |
|
|
4,854,360 |
|
|
200,684 |
|
|
SES SA Class A FDR |
|
|
4,945,876 |
|
|
50,479 |
|
|
Societe Generale |
|
|
1,233,319 |
|
|
31,467 |
|
|
Sodexo |
|
|
2,288,574 |
|
|
205,333 |
|
|
STMicroelectronics NV |
|
|
1,301,335 |
|
|
40,664 |
|
|
Technip SA |
|
|
3,874,361 |
|
|
49,001 |
|
|
Total SA |
|
|
2,528,087 |
|
|
20,320 |
|
|
Unibail-Rodamco SE REIT |
|
|
3,787,898 |
|
|
76,225 |
|
|
Valeo SA |
|
|
3,375,241 |
|
|
154,119 |
|
|
Vinci SA |
|
|
6,890,031 |
|
|
37,559 |
|
|
Wendel |
|
|
2,706,135 |
|
|
45,517 |
|
|
Zodiac Aerospace |
|
|
3,740,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
169,312,845 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 8.0% |
|
|
|
|
|
95,489 |
|
|
Adidas AG |
|
|
6,733,963 |
|
|
141,551 |
|
|
Aixtron AG |
|
|
1,852,748 |
|
|
71,570 |
|
|
Aurubis AG |
|
|
4,084,018 |
|
|
482,598 |
|
|
BASF AG |
|
|
35,255,430 |
|
|
146,716 |
|
|
Bayerische Motoren Werke AG |
|
|
11,122,108 |
|
|
54,250 |
|
|
Beiersdorf AG |
|
|
3,107,847 |
|
|
43,522 |
|
|
Bilfinger & Berger SE |
|
|
3,975,980 |
|
|
21,962 |
|
|
Brenntag AG |
|
|
2,108,859 |
|
|
44,754 |
|
|
Continental AG * |
|
|
3,177,495 |
|
|
35,575 |
|
|
Deutsche Boerse AG * |
|
|
2,182,748 |
|
|
153,500 |
|
|
Deutsche Lufthansa AG (Registered) |
|
|
1,990,149 |
|
|
17,145 |
|
|
Fielmann AG |
|
|
1,737,866 |
|
|
50,896 |
|
|
Fraport AG |
|
|
2,898,605 |
|
|
52,636 |
|
|
Fresenius SE & Co KGaA |
|
|
5,069,268 |
|
|
|
|
|
|
|
|
|
|
|
80,839 |
|
|
Fresenius Medical Care AG & Co |
|
|
5,541,959 |
|
|
199,955 |
|
|
GEA Group AG |
|
|
5,918,724 |
|
|
29,594 |
|
|
Hochtief AG |
|
|
1,698,236 |
|
|
943,465 |
|
|
Infineon Technologies AG |
|
|
7,843,117 |
|
|
50,591 |
|
|
K+S AG |
|
|
2,754,844 |
|
|
61,372 |
|
|
Kabel Deutschland Holding AG * |
|
|
3,411,555 |
|
|
137,317 |
|
|
Kloeckner & Co SE |
|
|
1,808,644 |
|
|
75,358 |
|
|
Lanxess AG |
|
|
4,227,373 |
|
|
52,638 |
|
|
Leoni AG |
|
|
1,958,798 |
|
|
49,059 |
|
|
Linde AG |
|
|
7,560,530 |
|
|
39,670 |
|
|
Merck KGaA |
|
|
3,948,748 |
|
|
63,902 |
|
|
Metro AG |
|
|
3,153,322 |
|
|
33,214 |
|
|
MTU Aero Engines Holding AG |
|
|
2,133,472 |
|
|
28,174 |
|
|
Rheinmetall AG |
|
|
1,367,607 |
|
|
629,883 |
|
|
SAP AG |
|
|
37,716,987 |
|
|
39,542 |
|
|
SGL Carbon SE * |
|
|
2,382,908 |
|
|
97,702 |
|
|
Siemens AG (Registered) |
|
|
9,887,361 |
|
|
61,251 |
|
|
Software AG |
|
|
2,640,317 |
|
|
47,305 |
|
|
Stada Arzneimittel AG |
|
|
1,320,784 |
|
|
127,216 |
|
|
Suedzucker AG |
|
|
4,052,768 |
|
|
104,456 |
|
|
ThyssenKrupp AG |
|
|
2,698,092 |
|
|
36,983 |
|
|
Volkswagen AG |
|
|
5,632,716 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
204,955,946 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greece 0.1% |
|
|
|
|
|
8 |
|
|
Alpha Bank A.E. * |
|
|
7 |
|
|
226,711 |
|
|
OPAP SA |
|
|
2,034,148 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Greece |
|
|
2,034,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 3.4% |
|
|
|
|
|
3,493,400 |
|
|
AIA Group Ltd |
|
|
11,003,396 |
|
|
182,000 |
|
|
Cheung Kong Holdings Ltd |
|
|
2,101,006 |
|
|
1,334,000 |
|
|
CLP Holdings Ltd |
|
|
11,879,954 |
|
|
1,272,574 |
|
|
Esprit Holdings Ltd |
|
|
1,836,647 |
|
|
1,910,000 |
|
|
Galaxy Entertainment Group Ltd * |
|
|
3,812,614 |
|
|
412,800 |
|
|
Hang Seng Bank Ltd |
|
|
5,093,106 |
|
|
4,556,374 |
|
|
Hong Kong & China Gas |
|
|
10,550,887 |
|
|
66,800 |
|
|
Hong Kong Aircraft Engineering Co Ltd |
|
|
869,898 |
|
|
174,400 |
|
|
Hong Kong Exchanges & Clearing Ltd |
|
|
2,881,853 |
|
|
641,000 |
|
|
Hutchison Whampoa Ltd |
|
|
5,629,746 |
|
|
84,400 |
|
|
Jardine Matheson Holdings Ltd |
|
|
4,268,704 |
|
|
1,263,000 |
|
|
Power Assets Holdings Ltd |
|
|
9,463,309 |
|
|
2,109,600 |
|
|
Sands China Ltd * |
|
|
6,312,806 |
|
|
2,440,000 |
|
|
SJM Holdings Ltd |
|
|
4,237,677 |
|
|
121,000 |
|
|
Sun Hung Kai Properties Ltd |
|
|
1,496,391 |
|
|
78,000 |
|
|
Swire Pacific Ltd |
|
|
952,188 |
|
|
1,286,000 |
|
|
Wynn Macau Ltd * |
|
|
3,769,387 |
|
|
2,320,000 |
|
|
Xinyi Glass Holdings Ltd |
|
|
1,358,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
87,517,617 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 0.3% |
|
|
|
|
|
375,608 |
|
|
CRH Plc |
|
|
7,170,608 |
|
|
32,135 |
|
|
DCC Plc |
|
|
778,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
7,948,622 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 0.3% |
|
|
|
|
|
61,142 |
|
|
Assicurazioni Generali SPA |
|
|
1,015,363 |
|
|
1,165,452 |
|
|
Enel SPA |
|
|
4,965,875 |
|
|
139,898 |
|
|
Mediobanca SPA |
|
|
903,974 |
|
|
|
|
|
|
|
|
|
|
|
51,775 |
|
|
Saipem SPA |
|
|
2,316,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
9,201,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 20.0% |
|
|
|
|
|
37,700 |
|
|
ABC-Mart Inc |
|
|
1,401,692 |
|
|
288,000 |
|
|
Asahi Glass Co Ltd |
|
|
2,465,386 |
|
|
78,600 |
|
|
Astellas Pharma Inc |
|
|
3,029,749 |
|
|
432,900 |
|
|
Bridgestone Corp |
|
|
10,031,178 |
|
|
686,850 |
|
|
Canon Inc |
|
|
30,813,613 |
|
|
408 |
|
|
Central Japan Railway Co |
|
|
3,269,129 |
|
|
269,200 |
|
|
Chugai Pharmaceutical Co Ltd |
|
|
4,112,622 |
|
|
227,000 |
|
|
Daihatsu Motor Co Ltd |
|
|
3,977,175 |
|
|
146,800 |
|
|
Daiichi Sankyo Co Ltd |
|
|
2,647,032 |
|
|
133,800 |
|
|
Daito Trust Construction Co Ltd |
|
|
11,933,499 |
|
|
107,000 |
|
|
Dena Co Ltd |
|
|
3,321,800 |
|
|
529,000 |
|
|
DIC Corp |
|
|
893,342 |
|
|
162,900 |
|
|
Eisai Co Ltd |
|
|
6,289,002 |
|
|
91,800 |
|
|
Fanuc Ltd |
|
|
15,082,603 |
|
|
50,700 |
|
|
Fast Retailing Co Ltd |
|
|
8,227,425 |
|
|
76,600 |
|
|
Gree Inc |
|
|
2,571,692 |
|
|
24,800 |
|
|
Hirose Electric Co Ltd |
|
|
2,294,821 |
|
|
110,100 |
|
|
Hisamitsu Pharmaceutical Co Inc |
|
|
4,392,724 |
|
|
2,634,000 |
|
|
Hitachi Ltd |
|
|
14,615,830 |
|
|
243,100 |
|
|
Honda Motor Co Ltd |
|
|
7,714,624 |
|
|
390,800 |
|
|
Hoya Corp |
|
|
8,323,818 |
|
|
21,400 |
|
|
Idemitsu Kosan Co Ltd |
|
|
2,288,482 |
|
|
997,000 |
|
|
IHI Corporation |
|
|
2,341,530 |
|
|
2,124 |
|
|
INPEX Corp |
|
|
14,338,866 |
|
|
345,600 |
|
|
Itochu Corp |
|
|
3,512,122 |
|
|
80,100 |
|
|
Ito En Ltd |
|
|
1,394,808 |
|
|
819 |
|
|
Japan Tobacco Inc |
|
|
3,930,190 |
|
|
126,000 |
|
|
JGC Corp |
|
|
3,175,593 |
|
|
69,500 |
|
|
Ks Holdings Corp |
|
|
2,739,465 |
|
|
54,629 |
|
|
Kakaku.com Inc |
|
|
2,094,680 |
|
|
561,500 |
|
|
Kao Corp |
|
|
14,859,828 |
|
|
762,000 |
|
|
Kawasaki Heavy Industries Ltd |
|
|
1,982,993 |
|
|
701,000 |
|
|
Kawasaki Kisen Kaisha Ltd |
|
|
1,218,849 |
|
|
2,425 |
|
|
KDDI Corp |
|
|
16,067,560 |
|
|
39,630 |
|
|
Keyence Corp |
|
|
10,140,249 |
|
|
1,012,000 |
|
|
Kintetsu Corp |
|
|
3,755,222 |
|
|
1,000,000 |
|
|
Kobe Steel Ltd |
|
|
1,596,830 |
|
|
405,500 |
|
|
Komatsu Ltd |
|
|
10,377,484 |
|
|
61,500 |
|
|
Konami Corp |
|
|
1,849,765 |
|
|
129,700 |
|
|
Kuraray Co Ltd |
|
|
1,861,352 |
|
|
103,500 |
|
|
Lawson Inc |
|
|
6,129,548 |
|
|
95,100 |
|
|
Makita Corp |
|
|
3,326,857 |
|
|
959,000 |
|
|
Marubeni Corp |
|
|
5,924,440 |
|
|
799,000 |
|
|
Mazda Motor Corp * |
|
|
1,457,164 |
|
|
149,000 |
|
|
Mitsubishi Estate Co Ltd |
|
|
2,487,299 |
|
|
1,228,000 |
|
|
Mitsubishi Heavy Industries Ltd |
|
|
5,156,263 |
|
|
986,500 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
5,731,009 |
|
|
283,100 |
|
|
Mitsubishi Corp |
|
|
5,852,647 |
|
|
599,000 |
|
|
Mitsubishi Electric Corp |
|
|
5,670,405 |
|
|
579,000 |
|
|
Mitsui Engineer & Shipbuilding Co Ltd |
|
|
889,114 |
|
|
577,000 |
|
|
Mitsui & Co Ltd |
|
|
9,103,840 |
|
|
288,000 |
|
|
Mitsui OSK Lines Ltd |
|
|
915,511 |
|
|
67,900 |
|
|
Murata Manufacturing Co Ltd |
|
|
4,023,691 |
|
|
78,900 |
|
|
Nabtesco Corp |
|
|
1,737,501 |
|
|
126,100 |
|
|
Namco Bandai Holdings Inc |
|
|
1,818,092 |
|
|
|
|
|
|
|
|
|
|
|
36,600 |
|
|
Nidec Corp |
|
|
3,342,714 |
|
|
59,900 |
|
|
Nintendo Co Ltd |
|
|
9,119,018 |
|
|
47,000 |
|
|
Nippon Telegraph & Telephone Corp |
|
|
2,317,968 |
|
|
360,600 |
|
|
Nissan Motor Co Ltd |
|
|
3,311,502 |
|
|
83,150 |
|
|
Nitori Holdings Co Ltd |
|
|
7,772,446 |
|
|
113,300 |
|
|
Nitto Denko Corp |
|
|
4,709,525 |
|
|
135,300 |
|
|
Nomura Research Institute Ltd |
|
|
2,985,562 |
|
|
7,061 |
|
|
NTT Docomo Inc |
|
|
12,480,641 |
|
|
509,000 |
|
|
Odakyu Electric Railway Co Ltd |
|
|
4,817,522 |
|
|
67,000 |
|
|
Olympus Corp |
|
|
905,094 |
|
|
49,900 |
|
|
Ono Pharmaceutical Co Ltd |
|
|
2,599,743 |
|
|
33,300 |
|
|
Oriental Land Co Ltd |
|
|
3,466,966 |
|
|
11,630 |
|
|
ORIX Corp |
|
|
981,280 |
|
|
18,420 |
|
|
Point Inc |
|
|
765,868 |
|
|
4,009 |
|
|
Rakuten Inc |
|
|
4,301,311 |
|
|
708,500 |
|
|
Resona Holdings Inc |
|
|
3,173,331 |
|
|
308,000 |
|
|
Ricoh Company Ltd |
|
|
2,775,608 |
|
|
47,800 |
|
|
Sankyo Co Ltd |
|
|
2,389,329 |
|
|
39,100 |
|
|
Sanrio Co Ltd |
|
|
2,033,881 |
|
|
65,700 |
|
|
Santen Pharmaceutical Co Ltd |
|
|
2,478,366 |
|
|
26,900 |
|
|
Sawai Pharmaceuticals Co Ltd |
|
|
2,851,462 |
|
|
86,500 |
|
|
Secom Co Ltd |
|
|
3,901,244 |
|
|
149,100 |
|
|
Sega Sammy Holdings Inc |
|
|
3,049,113 |
|
|
121,000 |
|
|
Seven & I Holdings Co Ltd |
|
|
3,378,379 |
|
|
645,000 |
|
|
Seven Bank Ltd |
|
|
1,274,906 |
|
|
25,600 |
|
|
Shimamura Co Ltd |
|
|
2,433,229 |
|
|
330,000 |
|
|
Shimizu Corp |
|
|
1,360,583 |
|
|
99,700 |
|
|
Shin-Etsu Chemical Co Ltd |
|
|
5,012,333 |
|
|
171,000 |
|
|
Shionogi & Co Ltd |
|
|
2,011,656 |
|
|
259,400 |
|
|
Shiseido Co Ltd |
|
|
4,820,873 |
|
|
33,200 |
|
|
SMC Corp |
|
|
5,514,354 |
|
|
177,100 |
|
|
SoftBank Corp |
|
|
5,981,452 |
|
|
185,800 |
|
|
Stanley Electric Co Ltd |
|
|
2,741,104 |
|
|
112,000 |
|
|
Sumitomo Metal Mining Co Ltd |
|
|
1,511,255 |
|
|
100,400 |
|
|
Sysmex Corp |
|
|
3,456,122 |
|
|
490,100 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
20,130,355 |
|
|
585,000 |
|
|
Teijin Ltd |
|
|
1,790,052 |
|
|
173,300 |
|
|
Terumo Corp |
|
|
8,441,753 |
|
|
342,000 |
|
|
Tobu Railway Co Ltd |
|
|
1,732,503 |
|
|
1,461,000 |
|
|
Toray Industries Inc |
|
|
10,952,992 |
|
|
628,000 |
|
|
Toshiba Corp |
|
|
2,902,598 |
|
|
84,400 |
|
|
Toyota Tsusho Corp |
|
|
1,420,160 |
|
|
98,000 |
|
|
Toyo Suisan Kaisha Ltd |
|
|
2,411,374 |
|
|
144,700 |
|
|
Trend Micro Inc |
|
|
4,442,049 |
|
|
106,400 |
|
|
Tsumura & Co |
|
|
2,951,545 |
|
|
129,700 |
|
|
Unicharm Corp |
|
|
6,152,193 |
|
|
52,136 |
|
|
West Japan Railway Co |
|
|
2,152,177 |
|
|
20,478 |
|
|
Yahoo Japan Corp |
|
|
6,488,812 |
|
|
106,410 |
|
|
Yamada Denki Co Ltd |
|
|
7,696,965 |
|
|
236,500 |
|
|
Yamato Holdings Co Ltd |
|
|
3,797,811 |
|
|
56,400 |
|
|
Yamato Kogyo Co Ltd |
|
|
1,562,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
518,209,513 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 2.1% |
|
|
|
|
|
206,827 |
|
|
Aegon NV * |
|
|
902,885 |
|
|
73,893 |
|
|
ASML Holding NV |
|
|
2,917,252 |
|
|
313,613 |
|
|
ING Groep NV * |
|
|
2,445,924 |
|
|
860,694 |
|
|
Koninklijke KPN NV |
|
|
10,534,075 |
|
|
162,248 |
|
|
Reed Elsevier NV |
|
|
1,912,535 |
|
|
|
|
|
|
|
|
|
|
|
1,037,675 |
|
|
Unilever NV |
|
|
35,343,051 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
54,055,722 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.1% |
|
|
|
|
|
188,686 |
|
|
Chorus Ltd * |
|
|
484,734 |
|
|
943,433 |
|
|
Telecom Corp of New Zealand Ltd |
|
|
1,495,459 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total New Zealand |
|
|
1,980,193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 0.2% |
|
|
|
|
|
927,653 |
|
|
Golden Ocean Group Ltd |
|
|
676,052 |
|
|
112,512 |
|
|
Telenor ASA |
|
|
1,924,928 |
|
|
94,732 |
|
|
TGS Nopec Geophysical Co ASA |
|
|
2,107,852 |
|
|
30,717 |
|
|
Yara International ASA |
|
|
1,250,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
5,959,209 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 2.2% |
|
|
|
|
|
1,424,000 |
|
|
Ezra Holdings Ltd |
|
|
1,007,137 |
|
|
6,261,000 |
|
|
Golden Agri-Resources Ltd |
|
|
3,536,482 |
|
|
1,271,000 |
|
|
Hyflux Ltd |
|
|
1,192,733 |
|
|
1,254,900 |
|
|
Keppel Corp Ltd |
|
|
9,321,849 |
|
|
998,000 |
|
|
SATS Ltd |
|
|
1,720,449 |
|
|
817,000 |
|
|
Sembcorp Industries Ltd |
|
|
2,748,161 |
|
|
976,000 |
|
|
SembCorp Marine Ltd |
|
|
2,934,947 |
|
|
861,000 |
|
|
Singapore Exchange Ltd |
|
|
4,229,959 |
|
|
2,292,000 |
|
|
Singapore Press Holdings Ltd |
|
|
7,075,605 |
|
|
2,130,000 |
|
|
Singapore Technologies Engineering Ltd |
|
|
4,512,176 |
|
|
3,950,500 |
|
|
Singapore Telecommunications |
|
|
9,629,249 |
|
|
1,644,000 |
|
|
SMRT Corp Ltd |
|
|
2,299,972 |
|
|
1,284,000 |
|
|
StarHub Ltd |
|
|
2,868,307 |
|
|
391,000 |
|
|
Wilmar International Ltd |
|
|
1,586,392 |
|
|
1,834,000 |
|
|
Yangzijiang Shipbuilding Holdings Ltd |
|
|
1,321,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
55,984,442 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 1.3% |
|
|
|
|
|
14,702 |
|
|
Acciona SA |
|
|
1,367,450 |
|
|
60,178 |
|
|
Enagas |
|
|
1,129,179 |
|
|
119,508 |
|
|
Gas Natural SDG SA |
|
|
2,080,490 |
|
|
196,680 |
|
|
Inditex SA |
|
|
16,724,316 |
|
|
104,866 |
|
|
Red Electrica de Espana |
|
|
4,609,853 |
|
|
230,203 |
|
|
Repsol YPF SA |
|
|
6,950,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
32,861,337 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 2.5% |
|
|
|
|
|
197,854 |
|
|
Atlas Copco AB |
|
|
3,776,207 |
|
|
184,727 |
|
|
Atlas Copco AB Class A |
|
|
3,963,682 |
|
|
185,372 |
|
|
Boliden AB |
|
|
2,687,602 |
|
|
37,135 |
|
|
Elekta AB Class B |
|
|
1,581,081 |
|
|
711,858 |
|
|
Ericsson LM B Shares |
|
|
7,594,252 |
|
|
597,840 |
|
|
Hennes & Mauritz AB Class B |
|
|
18,993,401 |
|
|
297,448 |
|
|
Investor AB B Shares |
|
|
5,547,852 |
|
|
67,049 |
|
|
Kinnevik Investment AB |
|
|
1,365,042 |
|
|
110,861 |
|
|
Lundin Petroleum AB * |
|
|
2,857,156 |
|
|
46,295 |
|
|
Millicom International Cellular SA SDR |
|
|
5,030,392 |
|
|
131,192 |
|
|
Scania AB Class B |
|
|
2,008,883 |
|
|
441,458 |
|
|
Swedbank AB Class A |
|
|
5,905,794 |
|
|
97,369 |
|
|
Swedish Match AB |
|
|
3,193,801 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
64,505,145 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 9.8% |
|
|
|
|
|
27,339 |
|
|
Actelion Ltd (Registered) * |
|
|
955,988 |
|
|
19,237 |
|
|
Geberit AG (Registered) * |
|
|
3,691,693 |
|
|
23,290 |
|
|
Kuehne & Nagel International AG (Registered) |
|
|
2,843,512 |
|
|
1,258,866 |
|
|
Nestle SA (Registered) |
|
|
70,651,068 |
|
|
65,998 |
|
|
Nobel Biocare Holding AG * |
|
|
837,843 |
|
|
932,719 |
|
|
Novartis AG (Registered) |
|
|
50,370,788 |
|
|
718,802 |
|
|
Roche Holding AG (Non Voting) |
|
|
114,342,914 |
|
|
2,469 |
|
|
SGS SA (Registered) |
|
|
4,177,815 |
|
|
5,456 |
|
|
Swisscom AG (Registered) |
|
|
2,060,430 |
|
|
14,294 |
|
|
Syngenta AG (Registered) * |
|
|
4,206,342 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
254,138,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 26.8% |
|
|
|
|
|
751,740 |
|
|
Aberdeen Asset Management Plc |
|
|
2,376,807 |
|
|
303,240 |
|
|
Admiral Group Plc |
|
|
4,391,942 |
|
|
417,212 |
|
|
Aggreko Plc |
|
|
12,437,369 |
|
|
177,605 |
|
|
AMEC Plc |
|
|
2,430,510 |
|
|
701,931 |
|
|
ARM Holdings Plc |
|
|
6,595,891 |
|
|
465,084 |
|
|
Ashmore Group Plc |
|
|
2,470,484 |
|
|
138,537 |
|
|
ASOS Plc * |
|
|
2,965,954 |
|
|
349,514 |
|
|
AstraZeneca Plc |
|
|
16,097,831 |
|
|
149,322 |
|
|
Babcock International Group Plc |
|
|
1,705,114 |
|
|
779,398 |
|
|
BAE Systems Plc |
|
|
3,364,892 |
|
|
615,678 |
|
|
Balfour Beatty Plc |
|
|
2,437,412 |
|
|
1,489,822 |
|
|
Barclays Plc |
|
|
4,291,767 |
|
|
1,354,895 |
|
|
BG Group Plc |
|
|
29,060,906 |
|
|
327,259 |
|
|
BHP Billiton Plc |
|
|
10,063,971 |
|
|
631,761 |
|
|
BP Plc |
|
|
4,575,441 |
|
|
1,951,857 |
|
|
British American Tobacco Plc |
|
|
90,579,945 |
|
|
805,040 |
|
|
British Sky Broadcasting Group Plc |
|
|
9,693,601 |
|
|
3,620,033 |
|
|
BT Group Plc |
|
|
10,832,657 |
|
|
234,959 |
|
|
Bunzl Plc |
|
|
3,069,839 |
|
|
600,095 |
|
|
Burberry Group Plc |
|
|
12,022,042 |
|
|
597,195 |
|
|
Capita Group Plc |
|
|
5,922,467 |
|
|
664,750 |
|
|
Centrica Plc |
|
|
3,159,869 |
|
|
222,163 |
|
|
Chemring Group Plc |
|
|
1,373,863 |
|
|
1,349,787 |
|
|
Cobham Plc |
|
|
3,755,127 |
|
|
250,681 |
|
|
Cookson Group Plc |
|
|
1,964,380 |
|
|
303,265 |
|
|
Croda International Plc |
|
|
8,706,521 |
|
|
1,637,027 |
|
|
Diageo Plc |
|
|
35,061,885 |
|
|
298,683 |
|
|
Drax Group Plc |
|
|
2,630,583 |
|
|
642,775 |
|
|
Experian Plc |
|
|
8,547,843 |
|
|
84,129 |
|
|
Fresnillo Plc |
|
|
2,275,053 |
|
|
1,122,782 |
|
|
GKN Plc |
|
|
3,448,973 |
|
|
3,940,530 |
|
|
GlaxoSmithKline Plc |
|
|
87,330,138 |
|
|
1,020,315 |
|
|
HSBC Holdings Plc |
|
|
7,958,918 |
|
|
302,289 |
|
|
ICAP Plc |
|
|
1,690,793 |
|
|
307,393 |
|
|
IMI Plc |
|
|
3,870,436 |
|
|
266,183 |
|
|
Imperial Tobacco Group Plc |
|
|
9,576,467 |
|
|
468,898 |
|
|
Inchcape Plc |
|
|
2,408,368 |
|
|
241,906 |
|
|
Inmarsat Plc |
|
|
1,665,500 |
|
|
149,534 |
|
|
InterContinental Hotels Group Plc |
|
|
2,599,899 |
|
|
392,792 |
|
|
International Power Plc |
|
|
2,075,735 |
|
|
145,771 |
|
|
Intertek Group Plc |
|
|
4,418,121 |
|
|
167,401 |
|
|
Investec Plc |
|
|
953,049 |
|
|
2,584,919 |
|
|
ITV Plc |
|
|
2,643,609 |
|
|
304,759 |
|
|
John Wood Group Plc |
|
|
3,131,776 |
|
|
75,204 |
|
|
Johnson Matthey Plc |
|
|
2,267,054 |
|
|
|
|
|
|
|
|
|
|
|
563,075 |
|
|
Kingfisher Plc |
|
|
2,269,224 |
|
|
90,431 |
|
|
Lancashire Holdings Ltd |
|
|
1,041,381 |
|
|
295,812 |
|
|
Land Securities Group Plc REIT |
|
|
3,198,955 |
|
|
21 |
|
|
Legal & General Group Plc |
|
|
35 |
|
|
658,793 |
|
|
LG Group Holdings Plc |
|
|
4,994,029 |
|
|
21,779,541 |
|
|
Lloyds Banking Group Plc * |
|
|
8,523,003 |
|
|
203,967 |
|
|
London Stock Exchange Group Plc |
|
|
2,772,621 |
|
|
940,839 |
|
|
Man Group Plc |
|
|
2,108,710 |
|
|
1,245,947 |
|
|
Marks & Spencer Group Plc |
|
|
6,482,894 |
|
|
281,219 |
|
|
Micro Focus International Plc |
|
|
1,603,813 |
|
|
300,274 |
|
|
Mondi Plc |
|
|
2,165,735 |
|
|
443,326 |
|
|
National Grid Plc |
|
|
4,356,700 |
|
|
240,118 |
|
|
Next Plc |
|
|
10,149,120 |
|
|
390,913 |
|
|
Pearson Plc |
|
|
7,101,249 |
|
|
319,932 |
|
|
Pennon Group Plc |
|
|
3,614,879 |
|
|
182,348 |
|
|
Petrofac Ltd |
|
|
4,169,056 |
|
|
750,442 |
|
|
Prudential Plc |
|
|
7,386,319 |
|
|
42,791 |
|
|
Randgold Resources Ltd |
|
|
4,552,482 |
|
|
414,160 |
|
|
Reckitt Benckiser Group Plc |
|
|
21,011,467 |
|
|
726,504 |
|
|
Reed Elsevier Plc |
|
|
6,041,877 |
|
|
516,202 |
|
|
Resolution Ltd |
|
|
1,915,999 |
|
|
414,042 |
|
|
Rexam Plc |
|
|
2,245,105 |
|
|
220,397 |
|
|
Rightmove Plc |
|
|
4,412,094 |
|
|
395,589 |
|
|
Rio Tinto Plc |
|
|
20,826,042 |
|
|
217,965 |
|
|
Rolls-Royce Holdings Plc * |
|
|
2,505,398 |
|
|
30 |
|
|
Royal Bank of Scotland Group Plc * |
|
|
10 |
|
|
79,376 |
|
|
Royal Dutch Shell Plc A Shares (London) |
|
|
2,776,143 |
|
|
514,053 |
|
|
Royal Dutch Shell Plc B Shares (London) |
|
|
18,523,677 |
|
|
127,725 |
|
|
SABMiller Plc |
|
|
4,509,661 |
|
|
601,470 |
|
|
Sage Group Plc (The) |
|
|
2,748,839 |
|
|
145,678 |
|
|
Schroders Plc |
|
|
3,081,311 |
|
|
342,379 |
|
|
SSE Plc |
|
|
7,089,558 |
|
|
525,540 |
|
|
Shire Plc |
|
|
17,672,854 |
|
|
283,191 |
|
|
Smiths Group Plc |
|
|
4,231,328 |
|
|
737,283 |
|
|
Smith & Nephew Plc |
|
|
6,736,155 |
|
|
157,992 |
|
|
Spectris Plc |
|
|
3,117,958 |
|
|
312,945 |
|
|
Standard Chartered Plc |
|
|
6,813,065 |
|
|
304,320 |
|
|
Tate & Lyle Plc |
|
|
3,223,098 |
|
|
894,201 |
|
|
Tesco Plc |
|
|
5,709,132 |
|
|
316,559 |
|
|
Tullett Prebon Plc |
|
|
1,523,870 |
|
|
179,440 |
|
|
Unilever Plc |
|
|
6,027,739 |
|
|
264,684 |
|
|
Weir Group Plc (The) |
|
|
8,603,401 |
|
|
734,001 |
|
|
William Hill Plc |
|
|
2,337,464 |
|
|
208,903 |
|
|
Wolseley Plc |
|
|
6,263,237 |
|
|
436,245 |
|
|
Xstrata Plc |
|
|
7,003,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
694,340,810 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $2,480,812,927) |
|
|
2,447,566,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 0.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 0.8% |
|
|
|
|
|
23,744 |
|
|
Bayerische Motoren Werke AG 3.40% |
|
|
1,251,052 |
|
|
34,528 |
|
|
Hugo Boss AG 2.95% |
|
|
3,143,298 |
|
|
103,100 |
|
|
Porsche Automobil Holding SE 1.24% |
|
|
6,317,835 |
|
|
153,801 |
|
|
ProSiebenSat.1 Media AG 7.61% |
|
|
3,042,568 |
|
|
53,806 |
|
|
Volkswagen AG 1.95% |
|
|
9,297,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
23,052,233 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $21,800,510) |
|
|
23,052,233 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.0% |
|
|
|
|
|
1,093,464 |
|
|
BlueScope Steel Ltd, Expires 12/14/11* |
|
|
12,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 0.0% |
|
|
|
|
|
19,162 |
|
|
Kinross Gold Corp, Warrants, Strike 21.30, Expires 09/17/14* |
|
|
37,950 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $177,130) |
|
|
50,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 2.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 2.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
2,596,126 |
|
|
GMO U.S. Treasury Fund |
|
|
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $64,929,120) |
|
|
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 1.4% |
|
|
|
|
USD |
|
|
91,940 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
91,940 |
|
USD |
|
|
25,000,000 |
|
|
Barclays Plc Time Deposit, 0.12%, due 12/01/11 |
|
|
25,000,000 |
|
AUD |
|
|
9,899 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11 |
|
|
10,180 |
|
CAD |
|
|
16,520 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11 |
|
|
16,196 |
|
CHF |
|
|
9,068 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
9,926 |
|
DKK |
|
|
54,824 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11 |
|
|
9,907 |
|
NOK |
|
|
57,437 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
9,944 |
|
NZD |
|
|
12,616 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11 |
|
|
9,851 |
|
HKD |
|
|
1,715,546 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
220,826 |
|
JPY |
|
|
85,722,560 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
1,105,242 |
|
SGD |
|
|
421,923 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
329,203 |
|
USD |
|
|
8,300,000 |
|
|
Deutsche Bank Time Deposit, 0.06%, due 12/01/11 |
|
|
8,300,000 |
|
EUR |
|
|
712,028 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
956,752 |
|
GBP |
|
|
348,711 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
547,093 |
|
SEK |
|
|
1,017,866 |
|
|
JPMorgan Chase (New York) Time Deposit, 1.06%, due 12/01/11 |
|
|
150,415 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
36,767,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $36,767,475) |
|
|
36,767,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.2%
(Cost $2,604,487,162) |
|
|
2,572,365,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.8% |
|
|
19,728,069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
2,592,093,446 |
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
CAD |
|
|
10,357,635 |
|
|
$ |
10,151,230 |
|
|
$ |
4,276 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
DKK |
|
|
69,679,199 |
|
|
|
12,593,069 |
|
|
|
(258,652 |
) |
|
12/16/11 |
|
|
Brown Brothers & Harriman & Co. |
|
EUR |
|
|
15,867,809 |
|
|
|
21,323,773 |
|
|
|
(395,817 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
3,666,048 |
|
|
|
4,926,577 |
|
|
|
(97,742 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
EUR |
|
|
3,666,048 |
|
|
|
4,926,577 |
|
|
|
(93,204 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
5,535,000 |
|
|
|
7,438,146 |
|
|
|
(131,669 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
EUR |
|
|
7,477,617 |
|
|
|
10,048,710 |
|
|
|
(125,826 |
) |
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
EUR |
|
|
11,783,460 |
|
|
|
15,835,068 |
|
|
|
(405,839 |
) |
|
12/16/11 |
|
|
Bank of America, N.A. |
|
GBP |
|
|
6,689,070 |
|
|
|
10,493,021 |
|
|
|
23,429 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
GBP |
|
|
4,542,455 |
|
|
|
7,125,665 |
|
|
|
14,816 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
GBP |
|
|
8,886,908 |
|
|
|
13,940,729 |
|
|
|
(17,049 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
GBP |
|
|
6,913,181 |
|
|
|
10,844,580 |
|
|
|
19,285 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
2,567,058 |
|
|
|
4,026,897 |
|
|
|
10,747 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
GBP |
|
|
7,110,070 |
|
|
|
11,153,436 |
|
|
|
43,169 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
HKD |
|
|
114,596,892 |
|
|
|
14,751,915 |
|
|
|
10,832 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
HKD |
|
|
136,659,856 |
|
|
|
17,592,053 |
|
|
|
7,760 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
HKD |
|
|
86,921,174 |
|
|
|
11,189,255 |
|
|
|
8,208 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
HKD |
|
|
114,596,892 |
|
|
|
14,751,915 |
|
|
|
8,704 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
HKD |
|
|
27,881,121 |
|
|
|
3,589,102 |
|
|
|
2,552 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
JPY |
|
|
1,048,626,376 |
|
|
|
13,524,722 |
|
|
|
(148,602 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
JPY |
|
|
423,543,931 |
|
|
|
5,462,684 |
|
|
|
(61,418 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
JPY |
|
|
1,219,187,662 |
|
|
|
15,724,547 |
|
|
|
(170,783 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
JPY |
|
|
913,030,250 |
|
|
|
11,775,863 |
|
|
|
(127,741 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
JPY |
|
|
607,020,455 |
|
|
|
7,829,083 |
|
|
|
(87,663 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
NOK |
|
|
22,173,139 |
|
|
|
3,836,319 |
|
|
|
(105,362 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
NOK |
|
|
9,316,546 |
|
|
|
1,611,916 |
|
|
|
(44,655 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
SEK |
|
|
85,581,248 |
|
|
|
12,637,283 |
|
|
|
(138,898 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
SEK |
|
|
79,170,463 |
|
|
|
11,690,640 |
|
|
|
(332,250 |
) |
|
12/16/11 |
|
|
Bank of America, N.A. |
|
SGD |
|
|
14,891,566 |
|
|
|
11,619,240 |
|
|
|
(111,668 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SGD |
|
|
14,413,175 |
|
|
|
11,245,972 |
|
|
|
(55,483 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
SGD |
|
|
28,088,454 |
|
|
|
21,916,196 |
|
|
|
(150,482 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
SGD |
|
|
8,493,082 |
|
|
|
6,626,782 |
|
|
|
(54,897 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
SGD |
|
|
20,027,257 |
|
|
|
15,626,395 |
|
|
|
(121,646 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
SGD |
|
|
12,129,880 |
|
|
|
9,464,416 |
|
|
|
(70,888 |
) |
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
SGD |
|
|
14,413,175 |
|
|
|
11,245,972 |
|
|
|
(87,011 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
378,539,748 |
|
|
$ |
(3,241,467 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
AUD |
|
|
5,395,172 |
|
|
$ |
5,538,805 |
|
|
$ |
(295,695 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
CAD |
|
|
31,287,488 |
|
|
|
30,663,997 |
|
|
|
(122,008 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
14,418,569 |
|
|
|
14,131,239 |
|
|
|
(29,949 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
21,864,996 |
|
|
|
21,429,275 |
|
|
|
(87,556 |
) |
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
CAD |
|
|
22,994,946 |
|
|
|
22,536,707 |
|
|
|
51,290 |
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
CHF |
|
|
12,132,955 |
|
|
|
13,284,931 |
|
|
|
184,905 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
CHF |
|
|
13,664,951 |
|
|
|
14,962,384 |
|
|
|
175,984 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
CHF |
|
|
8,039,076 |
|
|
|
8,802,355 |
|
|
|
105,702 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
CHF |
|
|
14,758,791 |
|
|
|
16,160,080 |
|
|
|
211,311 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
CHF |
|
|
7,892,767 |
|
|
|
8,642,154 |
|
|
|
120,480 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
CHF |
|
|
5,885,390 |
|
|
|
6,444,185 |
|
|
|
85,959 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
3,444,919 |
|
|
|
3,772,000 |
|
|
|
45,846 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
CHF |
|
|
12,733,524 |
|
|
|
13,942,522 |
|
|
|
175,250 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
DKK |
|
|
69,679,199 |
|
|
|
12,593,069 |
|
|
|
201,273 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
EUR |
|
|
1,188,903 |
|
|
|
1,597,694 |
|
|
|
35,435 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
3,666,048 |
|
|
|
4,926,577 |
|
|
|
108,872 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
EUR |
|
|
3,666,048 |
|
|
|
4,926,577 |
|
|
|
108,968 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
5,535,000 |
|
|
|
7,438,146 |
|
|
|
165,172 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
JPY |
|
|
655,240,000 |
|
|
|
8,450,998 |
|
|
|
83,340 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
NOK |
|
|
22,173,139 |
|
|
|
3,836,319 |
|
|
|
71,944 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
NOK |
|
|
9,316,546 |
|
|
|
1,611,916 |
|
|
|
30,261 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SEK |
|
|
48,727,046 |
|
|
|
7,195,238 |
|
|
|
69,718 |
|
|
12/16/11 |
|
|
Barclays Bank PLC |
|
SEK |
|
|
46,389,309 |
|
|
|
6,850,038 |
|
|
|
68,782 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
SEK |
|
|
165,313,119 |
|
|
|
24,410,823 |
|
|
|
269,776 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
SEK |
|
|
99,880,716 |
|
|
|
14,748,802 |
|
|
|
112,591 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
SEK |
|
|
66,282,770 |
|
|
|
9,787,590 |
|
|
|
114,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
288,684,421 |
|
|
$ |
2,062,175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
324 |
|
|
DAX |
|
December 2011 |
|
$ |
66,556,866 |
|
|
$ |
8,186,933 |
|
|
595 |
|
|
FTSE 100 |
|
December 2011 |
|
|
51,495,162 |
|
|
|
3,798,210 |
|
|
102 |
|
|
CAC 40 |
|
December 2011 |
|
|
4,333,353 |
|
|
|
176,403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
122,385,381 |
|
|
$ |
12,161,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
77 |
|
|
FTSE/MIB |
|
December 2011 |
|
$ |
7,927,149 |
|
|
$ |
(915,687 |
) |
|
446 |
|
|
SPI 200 |
|
December 2011 |
|
|
48,716,106 |
|
|
|
(1,686,399 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
56,643,255 |
|
|
$ |
(2,602,086 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
FDR Fiduciary Depositary Receipt
REIT Real Estate Investment Trust
SDR Swedish Depository Receipt
* Non-income producing security.
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$2,621,664,582 |
|
$212,791,591 |
|
$(262,090,796) |
|
$(49,299,205) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
52,104,025 |
|
|
$ |
143,991,000 |
|
|
$ |
131,171,000 |
|
|
$ |
20,362 |
|
|
$ |
2,934 |
|
|
$ |
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
91.4% |
Futures Contracts |
|
0.4% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) due to market events that have occurred since the local market
close but prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
119,978,425 |
|
|
$ |
|
|
|
$ |
119,978,425 |
|
Austria |
|
|
|
|
|
|
6,261,226 |
|
|
|
|
|
|
|
6,261,226 |
|
Belgium |
|
|
|
|
|
|
8,669,911 |
|
|
|
|
|
|
|
8,669,911 |
|
Canada |
|
|
99,053,573 |
|
|
|
|
|
|
|
|
|
|
|
99,053,573 |
|
Denmark |
|
|
|
|
|
|
37,764,481 |
|
|
|
|
|
|
|
37,764,481 |
|
Finland |
|
|
|
|
|
|
12,832,811 |
|
|
|
|
|
|
|
12,832,811 |
|
France |
|
|
|
|
|
|
169,312,845 |
|
|
|
|
|
|
|
169,312,845 |
|
Germany |
|
|
|
|
|
|
204,955,946 |
|
|
|
|
|
|
|
204,955,946 |
|
Greece |
|
|
|
|
|
|
2,034,155 |
|
|
|
|
|
|
|
2,034,155 |
|
Hong Kong |
|
|
|
|
|
|
87,517,617 |
|
|
|
|
|
|
|
87,517,617 |
|
Ireland |
|
|
|
|
|
|
7,948,622 |
|
|
|
|
|
|
|
7,948,622 |
|
Italy |
|
|
|
|
|
|
9,201,853 |
|
|
|
|
|
|
|
9,201,853 |
|
Japan |
|
|
|
|
|
|
518,209,513 |
|
|
|
|
|
|
|
518,209,513 |
|
Netherlands |
|
|
|
|
|
|
54,055,722 |
|
|
|
|
|
|
|
54,055,722 |
|
New Zealand |
|
|
1,980,193 |
|
|
|
|
|
|
|
|
|
|
|
1,980,193 |
|
Norway |
|
|
|
|
|
|
5,959,209 |
|
|
|
|
|
|
|
5,959,209 |
|
Singapore |
|
|
|
|
|
|
55,984,442 |
|
|
|
|
|
|
|
55,984,442 |
|
Spain |
|
|
|
|
|
|
32,861,337 |
|
|
|
|
|
|
|
32,861,337 |
|
Sweden |
|
|
|
|
|
|
64,505,145 |
|
|
|
|
|
|
|
64,505,145 |
|
Switzerland |
|
|
|
|
|
|
254,138,393 |
|
|
|
|
|
|
|
254,138,393 |
|
United Kingdom |
|
|
|
|
|
|
694,340,810 |
|
|
|
|
|
|
|
694,340,810 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
101,033,766 |
|
|
|
2,346,532,463 |
|
|
|
|
|
|
|
2,447,566,229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany |
|
|
|
|
|
|
23,052,233 |
|
|
|
|
|
|
|
23,052,233 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
|
|
|
|
23,052,233 |
|
|
|
|
|
|
|
23,052,233 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS AND WARRANTS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
|
|
|
|
|
12,370 |
|
|
|
|
|
|
|
12,370 |
|
Canada |
|
|
|
|
|
|
37,950 |
|
|
|
|
|
|
|
37,950 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total RIGHTS AND WARRANTS |
|
|
|
|
|
|
50,320 |
|
|
|
|
|
|
|
50,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
64,929,120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
36,767,475 |
|
|
|
|
|
|
|
|
|
|
|
36,767,475 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
202,730,361 |
|
|
|
2,369,635,016 |
|
|
|
|
|
|
|
2,572,365,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
|
|
|
|
|
2,751,161 |
|
|
|
|
|
|
|
2,751,161 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
12,161,546 |
|
|
|
|
|
|
|
12,161,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
14,912,707 |
|
|
|
|
|
|
|
14,912,707 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
202,730,361 |
|
|
$ |
2,384,547,723 |
|
|
$ |
|
|
|
$ |
2,587,278,084 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency risk |
|
$ |
|
|
|
$ |
(3,930,453 |
) |
|
$ |
|
|
|
$ |
(3,930,453 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
(2,602,086 |
) |
|
|
|
|
|
|
(2,602,086 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
(6,532,539 |
) |
|
|
|
|
|
|
(6,532,539 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(6,532,539 |
) |
|
$ |
|
|
|
$ |
(6,532,539 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. Selected risks
of investing in the Fund are summarized below. The risks of investing in the Fund depend on the
types of investments in its portfolio and the investment strategies the Manager employs on its
behalf. This section does not describe every potential risk of investing in the Fund. The Fund
could be subject to additional risks because of the types of investments it makes and market
conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. The Fund may purchase equity investments that typically trade at higher
multiples of current earnings than other securities, and the market values of these
investments often are more sensitive to changes in future earnings expectations than those
other securities. Because the Fund normally does not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to
be greater for investments in companies tied economically to emerging countries, the
economies of which tend to be more volatile than the economies of developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another
sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
In adjusting its investment exposure, the Fund also may use currency derivatives in an attempt
to adjust its currency exposure, seeking currency exposure that is different (in some cases,
significantly different) from the currency exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives
transactions (for example, by increasing margin or capital requirements), and the Fund may be
unable to execute its investment strategy as a result. It is unclear how the regulatory changes
will affect counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes and adjust exposure to foreign currencies. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market. During
the period ended November 30, 2011, the Fund used futures
contracts to adjust exposure
to certain securities markets and maintain the diversity and liquidity of the portfolio.
Futures contracts outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses on the Statement of
Operations. A liquidation payment received or made at the termination of the swap agreements is
recorded as realized gain or losses in the Statement of Operations.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss in the Statement of Operations.
Gains or losses are realized upon termination of the swap agreements or reset dates, as
appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services
firms are exposed to systemic risks of the type evidenced by
the insolvency of Lehman Brothers
in 2008 and subsequent market disruptions. The Fund had no swap agreements outstanding
at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or warrants held by the
Fund at the end of the period are listed in the Funds Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
50,320 |
|
|
$ |
|
|
|
$ |
50,320 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
2,751,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,751,161 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,161,546 |
|
|
|
|
|
|
|
12,161,546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
2,751,161 |
|
|
$ |
|
|
|
$ |
12,211,866 |
|
|
$ |
|
|
|
$ |
14,963,027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(3,930,453 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(3,930,453 |
) |
Unrealized depreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,602,086 |
) |
|
|
|
|
|
|
(2,602,086 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(3,930,453 |
) |
|
$ |
|
|
|
$ |
(2,602,086 |
) |
|
$ |
|
|
|
$ |
(6,532,539 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as reported in the Schedule of Investments. |
As provided
by authoritative accounting guidance, the table above is based on market values or unrealized
appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend
to have a greater impact on the Fund (with correspondingly greater risk)
the greater the notional amount. For further information on notional
amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
Currency |
|
Futures |
|
Rights and/or |
|
|
|
Contracts |
|
Contracts |
|
Warrants |
|
Average amount outstanding |
|
$ |
700,896,661 |
|
|
$ |
260,301,637 |
|
|
$ |
131,826 |
|
|
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO International Intrinsic Value Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 94.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 4.6% |
|
|
|
|
|
204,280 |
|
|
BHP Billiton Ltd |
|
|
7,653,692 |
|
|
4,906,332 |
|
|
BlueScope Steel Ltd |
|
|
2,000,871 |
|
|
1,910,199 |
|
|
Charter Hall Office (REIT) |
|
|
6,861,157 |
|
|
412,473 |
|
|
Commonwealth Bank of Australia |
|
|
20,654,249 |
|
|
7,831,544 |
|
|
Dexus Property Group (REIT) |
|
|
7,084,722 |
|
|
7,260,431 |
|
|
Goodman Group (REIT) |
|
|
4,573,936 |
|
|
3,060,505 |
|
|
GPT Group (REIT) |
|
|
10,043,767 |
|
|
8,221,532 |
|
|
Investa Office Fund (REIT) |
|
|
5,126,424 |
|
|
879,555 |
|
|
Macquarie Atlas Roads Group * |
|
|
1,261,474 |
|
|
7,500,352 |
|
|
Mirvac Group (REIT) |
|
|
10,024,223 |
|
|
659,398 |
|
|
National Australia Bank Ltd |
|
|
16,511,043 |
|
|
4,632,663 |
|
|
Pacific Brands Ltd |
|
|
2,583,209 |
|
|
2,848,070 |
|
|
QBE Insurance Group Ltd |
|
|
40,794,612 |
|
|
1,400,092 |
|
|
Resolute Mining Ltd * |
|
|
2,913,634 |
|
|
5,525,670 |
|
|
Stockland (REIT) |
|
|
19,807,113 |
|
|
2,262,015 |
|
|
TABCORP Holdings Ltd |
|
|
6,712,924 |
|
|
1,126,117 |
|
|
Tatts Group Ltd |
|
|
2,709,191 |
|
|
16,850,389 |
|
|
Telstra Corp Ltd |
|
|
55,364,904 |
|
|
684,056 |
|
|
Wesfarmers Ltd |
|
|
21,963,888 |
|
|
2,017,905 |
|
|
Westpac Banking Corp |
|
|
44,085,178 |
|
|
1,509 |
|
|
Woodside Petroleum Ltd |
|
|
52,601 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
288,782,812 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.7% |
|
|
|
|
|
66,623 |
|
|
Andritz AG |
|
|
5,882,612 |
|
|
1,167,625 |
|
|
Immofinanz AG (Entitlement Shares) * |
|
|
|
|
|
671,050 |
|
|
OMV AG |
|
|
22,284,464 |
|
|
206,242 |
|
|
Raiffeisen International Bank Holding |
|
|
4,902,781 |
|
|
337,435 |
|
|
Voestalpine AG |
|
|
9,812,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
42,882,619 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.4% |
|
|
|
|
|
2,767,178 |
|
|
Ageas |
|
|
4,880,086 |
|
|
328,465 |
|
|
Belgacom SA |
|
|
10,431,008 |
|
|
55,449 |
|
|
Colruyt SA |
|
|
2,099,913 |
|
|
103,283 |
|
|
KBC Groep NV |
|
|
1,156,975 |
|
|
65,258 |
|
|
Mobistar SA |
|
|
3,568,465 |
|
|
37,341 |
|
|
Solvay SA |
|
|
3,505,096 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
25,641,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 4.3% |
|
|
|
|
|
188,400 |
|
|
Alimentation Couche Tard Inc |
|
|
5,412,148 |
|
|
197,000 |
|
|
Bank of Montreal |
|
|
11,523,134 |
|
|
535,300 |
|
|
BCE Inc |
|
|
20,993,186 |
|
|
741,200 |
|
|
Canadian Natural Resources Ltd |
|
|
27,839,965 |
|
|
295,000 |
|
|
Canadian Oil Sands Ltd |
|
|
6,203,981 |
|
|
103,500 |
|
|
Canadian Tire Corp Ltd |
|
|
6,555,321 |
|
|
87,900 |
|
|
Canadian Western Bank |
|
|
2,372,555 |
|
|
235,800 |
|
|
Canadian National Railway Co |
|
|
18,233,782 |
|
|
116,400 |
|
|
Canadian Pacific Railway Ltd |
|
|
7,014,014 |
|
|
132,900 |
|
|
Enbridge Inc |
|
|
4,709,060 |
|
|
1,247,400 |
|
|
EnCana Corp |
|
|
25,132,673 |
|
|
473,300 |
|
|
First Quantum Minerals Ltd |
|
|
9,559,273 |
|
|
615,700 |
|
|
Husky Energy Inc |
|
|
15,332,889 |
|
|
162,700 |
|
|
IGM Financial Inc |
|
|
6,908,708 |
|
|
|
|
|
|
|
|
|
|
|
943,400 |
|
|
Manulife Financial Corp |
|
|
10,165,171 |
|
|
177,500 |
|
|
Methanex Corp |
|
|
4,350,703 |
|
|
173,900 |
|
|
Metro Inc Class A |
|
|
8,789,200 |
|
|
115,000 |
|
|
National Bank of Canada |
|
|
7,479,876 |
|
|
662,921 |
|
|
Precision Drilling Corp * |
|
|
7,662,962 |
|
|
899,000 |
|
|
Research In Motion Ltd * |
|
|
16,200,422 |
|
|
269,800 |
|
|
RONA Inc |
|
|
2,454,771 |
|
|
259,000 |
|
|
Shoppers Drug Mart Corp |
|
|
10,779,499 |
|
|
292,700 |
|
|
Suncor Energy Inc |
|
|
8,815,867 |
|
|
1,147,600 |
|
|
Sun Life Financial Inc |
|
|
20,770,328 |
|
|
262,500 |
|
|
Yamana Gold Inc |
|
|
4,426,688 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
269,686,176 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denmark 0.2% |
|
|
|
|
|
10,789 |
|
|
Greentech Energy Systems A/S * |
|
|
40,606 |
|
|
88,804 |
|
|
Novo-Nordisk A/S Class B |
|
|
10,081,056 |
|
|
154,730 |
|
|
Pandora A/S |
|
|
1,611,941 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Denmark |
|
|
11,733,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 0.5% |
|
|
|
|
|
4,314,125 |
|
|
Nokia Oyj |
|
|
24,933,895 |
|
|
186,674 |
|
|
Sampo Oyj Class A |
|
|
4,876,512 |
|
|
37,913 |
|
|
Stockmann Oyj ABP A Shares |
|
|
734,717 |
|
|
82,652 |
|
|
Tieto Oyj |
|
|
1,276,359 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Finland |
|
|
31,821,483 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 13.0% |
|
|
|
|
|
653,722 |
|
|
Air FranceKLM * |
|
|
3,809,468 |
|
|
1,928,994 |
|
|
Alcatel-Lucent * |
|
|
3,228,369 |
|
|
178,036 |
|
|
APERAM |
|
|
2,872,220 |
|
|
101,723 |
|
|
Arkema |
|
|
7,409,929 |
|
|
596,677 |
|
|
BNP Paribas |
|
|
23,752,553 |
|
|
14,541 |
|
|
Bongrain SA |
|
|
874,356 |
|
|
105,595 |
|
|
Bouygues SA |
|
|
3,441,742 |
|
|
15,686 |
|
|
Casino Guichard-Perrachon SA |
|
|
1,395,931 |
|
|
106,196 |
|
|
CNP Assurances |
|
|
1,429,313 |
|
|
235,915 |
|
|
Compagnie de Saint-Gobain |
|
|
10,003,481 |
|
|
107,187 |
|
|
Compagnie Generale des Etablissements Michelin-Class B |
|
|
6,832,984 |
|
|
51,407 |
|
|
Dassault Systemes SA |
|
|
4,209,150 |
|
|
100,870 |
|
|
Essilor International SA |
|
|
7,210,783 |
|
|
280,365 |
|
|
European Aeronautic Defense and Space Co NV |
|
|
8,411,461 |
|
|
50,797 |
|
|
Eutelsat Communications |
|
|
1,973,892 |
|
|
1,531,474 |
|
|
France Telecom SA |
|
|
26,434,076 |
|
|
3,499 |
|
|
Fromageries Bel |
|
|
801,540 |
|
|
217,371 |
|
|
Lagardere SCA |
|
|
5,293,785 |
|
|
57,516 |
|
|
LVMH Moet Hennessy Louis Vuitton SA |
|
|
9,056,022 |
|
|
564,595 |
|
|
PagesJaunes Groupe |
|
|
1,961,977 |
|
|
399,782 |
|
|
Peugeot SA |
|
|
7,485,236 |
|
|
18,372 |
|
|
PPR |
|
|
2,753,132 |
|
|
379,403 |
|
|
Renault SA |
|
|
14,216,397 |
|
|
181,199 |
|
|
Safran SA |
|
|
5,376,647 |
|
|
3,907,574 |
|
|
Sanofi |
|
|
273,319,180 |
|
|
74,116 |
|
|
Schneider Electric SA |
|
|
4,214,527 |
|
|
102,016 |
|
|
SES SA Class A FDR |
|
|
2,514,194 |
|
|
436,874 |
|
|
Societe Generale |
|
|
10,673,845 |
|
|
30,971 |
|
|
Sodexo |
|
|
2,252,500 |
|
|
501,096 |
|
|
Technicolor * |
|
|
833,839 |
|
|
63,033 |
|
|
Technip SA |
|
|
6,005,622 |
|
|
5,476,084 |
|
|
Total SA |
|
|
282,525,238 |
|
|
|
|
|
|
|
|
|
|
|
43,651 |
|
|
Unibail-Rodamco (REIT) |
|
|
8,137,083 |
|
|
100,885 |
|
|
Valeo SA |
|
|
4,467,185 |
|
|
149,289 |
|
|
Vinci SA |
|
|
6,674,101 |
|
|
1,645,512 |
|
|
Vivendi SA |
|
|
37,955,465 |
|
|
69,070 |
|
|
Wendel |
|
|
4,976,510 |
|
|
27,234 |
|
|
Zodiac Aerospace |
|
|
2,238,093 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
807,021,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 6.1% |
|
|
|
|
|
279,923 |
|
|
Aareal Bank AG * |
|
|
5,069,761 |
|
|
114,921 |
|
|
Adidas AG |
|
|
8,104,323 |
|
|
196,356 |
|
|
Aurubis AG |
|
|
11,204,714 |
|
|
609,516 |
|
|
BASF AG |
|
|
44,527,223 |
|
|
155,127 |
|
|
Bayerische Motoren Werke AG |
|
|
11,759,722 |
|
|
29,041 |
|
|
Beiersdorf AG |
|
|
1,663,686 |
|
|
53,718 |
|
|
Bilfinger & Berger SE |
|
|
4,907,442 |
|
|
2,934,670 |
|
|
Commerzbank AG * |
|
|
5,515,788 |
|
|
68,390 |
|
|
Continental AG * |
|
|
4,855,630 |
|
|
498,428 |
|
|
Deutsche Post AG (Registered) |
|
|
7,533,938 |
|
|
5,560,736 |
|
|
E.ON AG |
|
|
137,648,723 |
|
|
63,200 |
|
|
Fraport AG |
|
|
3,599,336 |
|
|
82,055 |
|
|
Fresenius Medical Care AG & Co |
|
|
5,625,323 |
|
|
96,327 |
|
|
Fresenius SE & Co KGaA |
|
|
9,277,061 |
|
|
234,336 |
|
|
GEA Group AG |
|
|
6,936,411 |
|
|
170,103 |
|
|
Gildemeister AG * |
|
|
2,322,352 |
|
|
603,565 |
|
|
Heidelberger Druckmaschinen AG * |
|
|
1,196,625 |
|
|
925,062 |
|
|
Infineon Technologies AG |
|
|
7,690,131 |
|
|
30,663 |
|
|
Lanxess AG |
|
|
1,720,108 |
|
|
179,719 |
|
|
Leoni AG |
|
|
6,687,816 |
|
|
53,453 |
|
|
Linde AG |
|
|
8,237,694 |
|
|
56,724 |
|
|
Merck KGaA |
|
|
5,646,301 |
|
|
61,088 |
|
|
MTU Aero Engines Holding AG |
|
|
3,923,934 |
|
|
11,545 |
|
|
Puma AG Rudolf Dassler Sport |
|
|
3,646,683 |
|
|
638,855 |
|
|
RWE AG |
|
|
26,483,281 |
|
|
99,772 |
|
|
Salzgitter AG |
|
|
5,179,928 |
|
|
226,112 |
|
|
SAP AG |
|
|
13,539,441 |
|
|
97,401 |
|
|
Siemens AG (Registered) |
|
|
9,856,900 |
|
|
189,092 |
|
|
Suedzucker AG |
|
|
6,023,974 |
|
|
112,235 |
|
|
ThyssenKrupp AG |
|
|
2,899,024 |
|
|
41,675 |
|
|
Volkswagen AG |
|
|
6,347,334 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
379,630,607 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greece 0.3% |
|
|
|
|
|
439,940 |
|
|
EFG Eurobank Ergasias * |
|
|
283,486 |
|
|
1,751,518 |
|
|
National Bank of Greece SA * |
|
|
4,665,104 |
|
|
1,048,216 |
|
|
OPAP SA |
|
|
9,405,040 |
|
|
1,911,055 |
|
|
Piraeus Bank SA * |
|
|
749,820 |
|
|
440,336 |
|
|
Public Power Corp SA |
|
|
2,515,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Greece |
|
|
17,619,026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 1.1% |
|
|
|
|
|
2,428,598 |
|
|
CLP Holdings Ltd |
|
|
21,627,911 |
|
|
4,272,690 |
|
|
Esprit Holdings Ltd |
|
|
6,166,574 |
|
|
55,000 |
|
|
Guoco Group |
|
|
517,604 |
|
|
71,500 |
|
|
Hong Kong Aircraft Engineering Co Ltd |
|
|
931,103 |
|
|
540,700 |
|
|
Hong Kong Ferry Co Ltd |
|
|
428,284 |
|
|
6,582,983 |
|
|
Hong Kong & China Gas |
|
|
15,243,768 |
|
|
7,622,000 |
|
|
Pacific Basin Shipping Ltd |
|
|
3,412,208 |
|
|
1,259,969 |
|
|
Power Assets Holdings Ltd |
|
|
9,440,599 |
|
|
|
|
|
|
|
|
|
|
|
1,202,000 |
|
|
SJM Holdings Ltd |
|
|
2,087,577 |
|
|
331,000 |
|
|
Swire Pacific Ltd |
|
|
4,040,695 |
|
|
2,168,400 |
|
|
Yue Yuen Industrial Holdings |
|
|
6,248,855 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
70,145,178 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 0.7% |
|
|
|
|
|
803,758 |
|
|
C&C Group Plc |
|
|
3,292,895 |
|
|
875,728 |
|
|
CRH Plc |
|
|
16,718,233 |
|
|
211,452 |
|
|
DCC Plc |
|
|
5,119,422 |
|
|
547,037 |
|
|
Greencore Group Plc |
|
|
542,387 |
|
|
1,492,286 |
|
|
Irish Life & Permanent Group Holdings Plc * |
|
|
64,509 |
|
|
191,572 |
|
|
Kerry Group Plc Class A |
|
|
7,154,607 |
|
|
212,731 |
|
|
Kingspan Group Plc |
|
|
1,898,759 |
|
|
119,273 |
|
|
Paddy Power Plc |
|
|
6,475,943 |
|
|
336,350 |
|
|
Smurfit Kappa Group Plc * |
|
|
2,037,057 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
43,303,812 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Israel 0.1% |
|
|
|
|
|
1,042,805 |
|
|
Bezeq Israeli Telecommunication Corp Ltd |
|
|
1,970,918 |
|
|
206,569 |
|
|
Discount Investment Corp (Registered) |
|
|
1,480,238 |
|
|
208,096 |
|
|
Mizrahi Tefahot Bank Ltd |
|
|
1,722,597 |
|
|
330,942 |
|
|
Partner Communications Co Ltd |
|
|
3,184,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Israel |
|
|
8,358,269 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 6.0% |
|
|
|
|
|
1,113,746 |
|
|
A2A SPA |
|
|
1,167,046 |
|
|
4,622,432 |
|
|
Banca Monte dei Paschi di Siena SPA |
|
|
1,553,144 |
|
|
2,974,107 |
|
|
Banco Popolare Scarl |
|
|
3,573,926 |
|
|
645,560 |
|
|
Campari |
|
|
4,616,400 |
|
|
633,704 |
|
|
CIR-Compagnie Industriali Riunite SPA |
|
|
1,084,120 |
|
|
25,525,138 |
|
|
Enel SPA |
|
|
108,760,082 |
|
|
6,947,835 |
|
|
ENI SPA |
|
|
147,143,211 |
|
|
61,811 |
|
|
Exor SPA |
|
|
1,314,886 |
|
|
1,792,604 |
|
|
Finmeccanica SPA |
|
|
7,777,142 |
|
|
712,561 |
|
|
FondiariaSai SPA * |
|
|
962,119 |
|
|
201,979 |
|
|
Indesit Company SPA |
|
|
1,076,937 |
|
|
3,349,671 |
|
|
Intesa San Paolo |
|
|
5,563,704 |
|
|
212,430 |
|
|
Italcementi SPA-Di RISP |
|
|
582,406 |
|
|
1,264,372 |
|
|
Mediaset SPA |
|
|
3,737,647 |
|
|
2,518,606 |
|
|
Milano Assicurazioni SPA * |
|
|
849,153 |
|
|
94,800 |
|
|
Natuzzi SPA ADR * |
|
|
223,728 |
|
|
573,594 |
|
|
Parmalat SPA |
|
|
1,165,476 |
|
|
615,861 |
|
|
Pirelli & C SPA |
|
|
5,826,346 |
|
|
443,475 |
|
|
Recordati SPA |
|
|
3,407,112 |
|
|
182,832 |
|
|
Saipem SPA |
|
|
8,180,708 |
|
|
1,166,964 |
|
|
Snam Rete Gas SPA |
|
|
5,417,562 |
|
|
22,963,148 |
|
|
Telecom Italia SPA |
|
|
25,997,154 |
|
|
20,569,668 |
|
|
Telecom Italia SPA-Di RISP |
|
|
20,098,837 |
|
|
1,479,342 |
|
|
Terna SPA |
|
|
5,308,328 |
|
|
32,718 |
|
|
Tods SPA |
|
|
3,047,245 |
|
|
4,970,516 |
|
|
UniCredit SPA |
|
|
5,191,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
373,625,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 23.7% |
|
|
|
|
|
2,529 |
|
|
Advance Residence Investment Corp (REIT) |
|
|
4,718,503 |
|
|
1,583,500 |
|
|
Aeon Co Ltd |
|
|
21,637,810 |
|
|
320,800 |
|
|
Aeon Credit Service Co Ltd |
|
|
4,922,476 |
|
|
1,865,900 |
|
|
Aiful Corp * |
|
|
2,706,938 |
|
|
305,000 |
|
|
Ajinomoto Co Inc |
|
|
3,653,517 |
|
|
|
|
|
|
|
|
|
|
|
146,100 |
|
|
Alfresa Holdings Corp |
|
|
5,388,923 |
|
|
761,329 |
|
|
Alps Electric Co Ltd |
|
|
5,330,139 |
|
|
393,000 |
|
|
Anritsu Corp |
|
|
4,437,946 |
|
|
971,000 |
|
|
Aozora Bank Ltd |
|
|
2,601,146 |
|
|
140,500 |
|
|
Asahi Breweries Ltd |
|
|
3,118,562 |
|
|
705,100 |
|
|
Astellas Pharma Inc |
|
|
27,179,081 |
|
|
586,100 |
|
|
Bridgestone Corp |
|
|
13,581,135 |
|
|
763,000 |
|
|
Calsonic Kansei Corp |
|
|
4,404,521 |
|
|
123,500 |
|
|
Canon Inc |
|
|
5,540,484 |
|
|
113,100 |
|
|
Capcom |
|
|
2,901,124 |
|
|
505 |
|
|
Central Japan Railway Co |
|
|
4,046,348 |
|
|
749,000 |
|
|
Chiba Bank Ltd |
|
|
4,885,489 |
|
|
211,000 |
|
|
Chiyoda Corp |
|
|
2,331,135 |
|
|
142,500 |
|
|
Circle K Sunkus Co Ltd |
|
|
2,323,911 |
|
|
2,767,000 |
|
|
Cosmo Oil Co Ltd |
|
|
7,651,981 |
|
|
185,400 |
|
|
Credit Saison Co Ltd |
|
|
3,394,952 |
|
|
1,000 |
|
|
CyberAgent Inc |
|
|
3,319,547 |
|
|
492,200 |
|
|
Daiei Inc * |
|
|
1,788,851 |
|
|
216,000 |
|
|
Daihatsu Motor Co Ltd |
|
|
3,784,448 |
|
|
3,506,000 |
|
|
Daikyo Inc * |
|
|
6,775,037 |
|
|
481,600 |
|
|
Daito Trust Construction Co Ltd |
|
|
42,953,463 |
|
|
264,500 |
|
|
Dena Co Ltd |
|
|
8,211,365 |
|
|
1,192,000 |
|
|
DIC Corp |
|
|
2,012,974 |
|
|
860 |
|
|
Digital Garage Inc * |
|
|
2,809,369 |
|
|
186,300 |
|
|
Don Quijote Co Ltd |
|
|
6,421,016 |
|
|
603,300 |
|
|
Eisai Co Ltd |
|
|
23,291,313 |
|
|
228,200 |
|
|
Electric Power Development Co Ltd |
|
|
5,758,355 |
|
|
29,600 |
|
|
Fanuc Ltd |
|
|
4,863,236 |
|
|
50,100 |
|
|
Fast Retailing Co Ltd |
|
|
8,130,059 |
|
|
661,000 |
|
|
Fuji Electric Co Ltd |
|
|
1,955,186 |
|
|
523,000 |
|
|
Fuji Heavy Industries Ltd |
|
|
3,022,828 |
|
|
265,300 |
|
|
Fuji Oil Co Ltd |
|
|
3,797,576 |
|
|
850,000 |
|
|
Gunze Ltd |
|
|
2,447,249 |
|
|
61,600 |
|
|
Hamamatsu Photonics KK |
|
|
2,269,339 |
|
|
865,000 |
|
|
Hanwa Co Ltd |
|
|
3,749,875 |
|
|
9,378,500 |
|
|
Haseko Corp * |
|
|
6,076,936 |
|
|
128,800 |
|
|
Hikari Tsushin Inc |
|
|
3,274,700 |
|
|
2,941,694 |
|
|
Hitachi Ltd |
|
|
16,323,196 |
|
|
130,500 |
|
|
Honda Motor Co Ltd |
|
|
4,141,334 |
|
|
251,100 |
|
|
Hosiden Corp |
|
|
1,768,067 |
|
|
2,301 |
|
|
INPEX Corp |
|
|
15,533,772 |
|
|
2,514,800 |
|
|
Itochu Corp |
|
|
25,556,380 |
|
|
5,064 |
|
|
Japan Retail Fund Investment Corp (REIT) |
|
|
7,744,470 |
|
|
857,100 |
|
|
JFE Holdings Inc |
|
|
15,776,654 |
|
|
263,000 |
|
|
JGC Corp |
|
|
6,628,421 |
|
|
60,900 |
|
|
JS Group Corp |
|
|
1,154,986 |
|
|
145,000 |
|
|
JTEKT Corp |
|
|
1,430,105 |
|
|
519,200 |
|
|
JVC Kenwood Holdings Inc * |
|
|
2,185,848 |
|
|
7,384,390 |
|
|
JX Holdings Inc |
|
|
46,961,924 |
|
|
460,100 |
|
|
Ks Holdings Corp |
|
|
18,135,650 |
|
|
4,524,993 |
|
|
Kajima Corp |
|
|
13,626,439 |
|
|
988,700 |
|
|
Kao Corp |
|
|
26,165,471 |
|
|
2,982,000 |
|
|
Kawasaki Kisen Kaisha Ltd |
|
|
5,184,889 |
|
|
9,611 |
|
|
KDDI Corp |
|
|
63,680,544 |
|
|
607,000 |
|
|
Kinugawa Rubber Industrial Co Ltd |
|
|
5,462,045 |
|
|
4,934,000 |
|
|
Kobe Steel Ltd |
|
|
7,878,761 |
|
|
388,300 |
|
|
Komatsu Ltd |
|
|
9,937,305 |
|
|
260,000 |
|
|
Konami Corp |
|
|
7,820,144 |
|
|
113,000 |
|
|
Krosaki Harima Corp |
|
|
381,115 |
|
|
178,000 |
|
|
KYB Co Ltd |
|
|
852,802 |
|
|
|
|
|
|
|
|
|
|
|
291,000 |
|
|
Kyowa Exeo Corp |
|
|
2,827,350 |
|
|
186,400 |
|
|
Lawson Inc |
|
|
11,039,110 |
|
|
1,582,200 |
|
|
Leopalace21 Corp * |
|
|
3,652,189 |
|
|
277,000 |
|
|
Makino Milling Machine Co Ltd |
|
|
1,951,105 |
|
|
95,900 |
|
|
Makita Corp |
|
|
3,354,843 |
|
|
2,169,000 |
|
|
Marubeni Corp |
|
|
13,399,490 |
|
|
3,095,000 |
|
|
Mazda Motor Corp * |
|
|
5,644,461 |
|
|
28,100 |
|
|
Miraca Holdings Inc |
|
|
1,079,060 |
|
|
4,380,000 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
25,445,330 |
|
|
358,200 |
|
|
Mitsubishi Corp |
|
|
7,405,221 |
|
|
536,000 |
|
|
Mitsubishi Electric Corp |
|
|
5,074,018 |
|
|
361,000 |
|
|
Mitsubishi Gas Chemical Co Inc |
|
|
2,149,802 |
|
|
1,727,000 |
|
|
Mitsubishi Heavy Industries Ltd |
|
|
7,251,520 |
|
|
191,080 |
|
|
Mitsubishi UFJ Lease & Finance Co Ltd |
|
|
7,315,330 |
|
|
2,092,000 |
|
|
Mitsui Chemicals Inc |
|
|
6,802,073 |
|
|
1,706,000 |
|
|
Mitsui Engineer & Shipbuilding Co Ltd |
|
|
2,619,739 |
|
|
562,100 |
|
|
Mitsui & Co Ltd |
|
|
8,868,750 |
|
|
3,306,000 |
|
|
Mitsui Mining & Smelting Co Ltd |
|
|
8,566,375 |
|
|
2,937,000 |
|
|
Mitsui OSK Lines Ltd |
|
|
9,336,310 |
|
|
22,092,500 |
|
|
Mizuho Financial Group Inc |
|
|
29,083,221 |
|
|
187,000 |
|
|
Nabtesco Corp |
|
|
4,118,032 |
|
|
112,000 |
|
|
Nachi-Fujikoshi Corp |
|
|
527,053 |
|
|
192,200 |
|
|
Namco Bandai Holdings Inc |
|
|
2,771,112 |
|
|
2,110 |
|
|
Net One Systems Co Ltd |
|
|
5,443,133 |
|
|
76,500 |
|
|
Nichicon Corp |
|
|
817,871 |
|
|
1,113,000 |
|
|
Nichirei Corp |
|
|
5,190,355 |
|
|
126,600 |
|
|
Nikon Corp |
|
|
2,964,272 |
|
|
70,600 |
|
|
Nintendo Co Ltd |
|
|
10,747,958 |
|
|
675,000 |
|
|
Nippon Chemi-Con Corp |
|
|
2,500,958 |
|
|
4,478,000 |
|
|
Nippon Light Metal Co Ltd |
|
|
5,953,092 |
|
|
180,700 |
|
|
Nippon Paper Group Inc |
|
|
3,873,354 |
|
|
7,322,000 |
|
|
Nippon Steel Corp |
|
|
17,774,497 |
|
|
1,419,900 |
|
|
Nippon Telegraph & Telephone Corp |
|
|
70,027,298 |
|
|
3,680,000 |
|
|
Nippon Yusen Kabushiki Kaisha |
|
|
8,197,727 |
|
|
436,000 |
|
|
Nipro Corp |
|
|
3,557,285 |
|
|
1,271,900 |
|
|
Nissan Motor Co Ltd |
|
|
11,680,254 |
|
|
742,000 |
|
|
Nisshinbo Holdings Inc |
|
|
6,280,797 |
|
|
98,750 |
|
|
Nitori Holdings Co Ltd |
|
|
9,230,656 |
|
|
111,600 |
|
|
Nitto Denko Corp |
|
|
4,638,861 |
|
|
19,534 |
|
|
NTT Docomo Inc |
|
|
34,527,240 |
|
|
1,061,247 |
|
|
Obayashi Corp |
|
|
4,461,086 |
|
|
524,000 |
|
|
OJI Paper Co Ltd |
|
|
2,612,011 |
|
|
49,200 |
|
|
Okinawa Electric Power Co |
|
|
2,095,251 |
|
|
533,000 |
|
|
OKUMA Corp |
|
|
4,092,254 |
|
|
61,500 |
|
|
Ono Pharmaceutical Co Ltd |
|
|
3,204,093 |
|
|
117,110 |
|
|
ORIX Corp |
|
|
9,881,144 |
|
|
767 |
|
|
ORIX JREIT Inc (REIT) |
|
|
3,240,694 |
|
|
2,298,000 |
|
|
Osaka Gas Co Ltd |
|
|
8,766,969 |
|
|
650,000 |
|
|
Pacific Metals Co Ltd |
|
|
3,322,813 |
|
|
1,232,500 |
|
|
Penta Ocean Construction Co Ltd |
|
|
3,890,091 |
|
|
146,040 |
|
|
Point Inc |
|
|
6,072,060 |
|
|
660,350 |
|
|
Promise Co Ltd * |
|
|
6,887,744 |
|
|
8,112,700 |
|
|
Resona Holdings Inc |
|
|
36,336,314 |
|
|
540,000 |
|
|
Ricoh Company Ltd |
|
|
4,866,326 |
|
|
846,000 |
|
|
Round One Corp |
|
|
5,055,132 |
|
|
135,000 |
|
|
Ryohin Keikaku Co Ltd |
|
|
6,142,366 |
|
|
104,000 |
|
|
Saizeriya Co Ltd |
|
|
1,705,197 |
|
|
242,600 |
|
|
Sankyo Co Ltd |
|
|
12,126,594 |
|
|
1,183,500 |
|
|
Sapporo Hokuyo Holdings Inc |
|
|
4,120,277 |
|
|
90,100 |
|
|
Secom Co Ltd |
|
|
4,063,608 |
|
|
|
|
|
|
|
|
|
|
|
284,400 |
|
|
Sega Sammy Holdings Inc |
|
|
5,816,015 |
|
|
398,000 |
|
|
Seino Holdings Co Ltd |
|
|
2,891,579 |
|
|
284,700 |
|
|
Seven & I Holdings Co Ltd |
|
|
7,948,962 |
|
|
80,200 |
|
|
Shimamura Co Ltd |
|
|
7,622,850 |
|
|
670,000 |
|
|
Shizuoka Bank Ltd (The) |
|
|
6,945,801 |
|
|
978,600 |
|
|
Showa Shell Sekiyu KK |
|
|
6,551,498 |
|
|
5,375,900 |
|
|
Sojitz Corp |
|
|
8,435,753 |
|
|
205,080 |
|
|
Sumisho Computer Systems Corp |
|
|
3,341,154 |
|
|
3,161,200 |
|
|
Sumitomo Corp |
|
|
42,195,863 |
|
|
383,000 |
|
|
Sumitomo Metal Mining Co Ltd |
|
|
5,167,954 |
|
|
97,700 |
|
|
Sumitomo Mitsui Financial Group Inc |
|
|
2,717,494 |
|
|
468,000 |
|
|
Sumitomo Osaka Cement Co Ltd |
|
|
1,360,207 |
|
|
164,200 |
|
|
Sumitomo Rubber Industries |
|
|
1,969,505 |
|
|
5,850,716 |
|
|
Taiheiyo Cement Co Ltd |
|
|
11,365,698 |
|
|
4,649,000 |
|
|
Taisei Corp |
|
|
12,048,958 |
|
|
482,000 |
|
|
Takashimaya Co Ltd |
|
|
3,434,667 |
|
|
2,131,600 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
87,553,287 |
|
|
419,650 |
|
|
Takefuji Corp (a) (b) |
|
|
5,411 |
|
|
1,087,000 |
|
|
Toho Zinc Co Ltd |
|
|
4,395,086 |
|
|
138,100 |
|
|
Tokai Rika Co Ltd |
|
|
2,142,688 |
|
|
2,585,000 |
|
|
Tokyo Tatemono Co Ltd |
|
|
7,569,359 |
|
|
471 |
|
|
Tokyu REIT Inc (REIT) |
|
|
2,148,874 |
|
|
628,000 |
|
|
TonenGeneral Sekiyu KK |
|
|
7,162,190 |
|
|
2,044,000 |
|
|
Toray Industries Inc |
|
|
15,323,694 |
|
|
2,712,000 |
|
|
Tosoh Corp |
|
|
7,936,524 |
|
|
655,000 |
|
|
Toyo Engineering Corp |
|
|
2,401,686 |
|
|
77,000 |
|
|
Toyo Suisan Kaisha Ltd |
|
|
1,894,651 |
|
|
347,200 |
|
|
Toyota Motor Corp |
|
|
11,433,479 |
|
|
771,300 |
|
|
Toyota Tsusho Corp |
|
|
12,978,315 |
|
|
71,800 |
|
|
Trend Micro Inc |
|
|
2,204,140 |
|
|
1,031,000 |
|
|
Ube Industries Ltd |
|
|
2,916,819 |
|
|
100,100 |
|
|
Unicharm Corp |
|
|
4,748,146 |
|
|
1,155 |
|
|
United Urban Investment Corp (REIT) |
|
|
1,232,906 |
|
|
1,217,200 |
|
|
UNY Co Ltd |
|
|
11,178,455 |
|
|
85,190 |
|
|
USS Co Ltd |
|
|
7,407,367 |
|
|
106,934 |
|
|
West Japan Railway Co |
|
|
4,414,241 |
|
|
19,714 |
|
|
Yahoo Japan Corp |
|
|
6,246,725 |
|
|
507,560 |
|
|
Yamada Denki Co Ltd |
|
|
36,713,387 |
|
|
382,700 |
|
|
Yamato Holdings Co Ltd |
|
|
6,145,548 |
|
|
146,100 |
|
|
Yamato Kogyo Co Ltd |
|
|
4,047,356 |
|
|
410,000 |
|
|
Yokohama Rubber Co Ltd |
|
|
2,278,988 |
|
|
270,000 |
|
|
Zeon Corp |
|
|
2,295,818 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
1,479,017,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malta 0.0% |
|
|
|
|
|
15,984,486 |
|
|
BGP Holdings Plc * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 1.2% |
|
|
|
|
|
176,239 |
|
|
Aalberts Industries NV |
|
|
2,873,984 |
|
|
2,672,637 |
|
|
Aegon NV * |
|
|
11,667,163 |
|
|
141,148 |
|
|
CSM NV |
|
|
1,855,186 |
|
|
4,669,161 |
|
|
ING Groep NV * |
|
|
36,415,614 |
|
|
1,238,093 |
|
|
Koninklijke BAM Groep NV |
|
|
4,289,063 |
|
|
494,083 |
|
|
Unilever NV |
|
|
16,828,391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
73,929,401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.5% |
|
|
|
|
|
2,283,832 |
|
|
Chorus Ltd * |
|
|
5,867,156 |
|
|
1,444,281 |
|
|
Fletcher Building Ltd |
|
|
6,835,209 |
|
|
|
|
|
|
|
|
|
|
|
843,391 |
|
|
Sky City Entertainment Group Ltd |
|
|
2,261,924 |
|
|
11,419,160 |
|
|
Telecom Corp of New Zealand |
|
|
18,100,800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total New Zealand |
|
|
33,065,089 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 0.2% |
|
|
|
|
|
160,122 |
|
|
DnB NOR ASA |
|
|
1,637,475 |
|
|
278,030 |
|
|
Frontline Ltd |
|
|
832,550 |
|
|
1,547,307 |
|
|
Golden Ocean Group Ltd |
|
|
1,127,640 |
|
|
273,467 |
|
|
Telenor ASA |
|
|
4,678,651 |
|
|
210,496 |
|
|
TGS Nopec Geophysical Co ASA |
|
|
4,683,681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
12,959,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portugal 0.1% |
|
|
|
|
|
390,104 |
|
|
Banco Espirito Santo SA |
|
|
600,412 |
|
|
2,339,031 |
|
|
EDP Energias de Portugal SA |
|
|
7,496,754 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Portugal |
|
|
8,097,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 1.8% |
|
|
|
|
|
3,092,000 |
|
|
CapitaCommercial Trust (REIT) |
|
|
2,628,715 |
|
|
4,728,000 |
|
|
Ezra Holdings Ltd |
|
|
3,343,922 |
|
|
36,436,000 |
|
|
Golden Agri-Resources Ltd |
|
|
20,580,619 |
|
|
2,489,000 |
|
|
Ho Bee Investment Ltd |
|
|
2,369,907 |
|
|
4,037,000 |
|
|
Jaya Holdings Ltd * |
|
|
1,526,938 |
|
|
870,500 |
|
|
Keppel Corp Ltd |
|
|
6,466,388 |
|
|
3,863,000 |
|
|
Midas Holdings Ltd |
|
|
1,066,232 |
|
|
487,777 |
|
|
Oversea-Chinese Banking Corp Ltd |
|
|
3,107,212 |
|
|
2,183,100 |
|
|
SembCorp Industries Ltd |
|
|
7,343,341 |
|
|
1,249,000 |
|
|
SembCorp Marine Ltd |
|
|
3,755,890 |
|
|
1,161,000 |
|
|
Singapore Exchange Ltd |
|
|
5,703,812 |
|
|
2,840,000 |
|
|
Singapore Press Holdings Ltd |
|
|
8,767,329 |
|
|
2,202,000 |
|
|
Singapore Technologies Engineering Ltd |
|
|
4,664,701 |
|
|
12,711,000 |
|
|
Singapore Telecommunications |
|
|
30,982,756 |
|
|
188,000 |
|
|
Suntec Real Estate Investment Trust (REIT) |
|
|
168,711 |
|
|
4,499,000 |
|
|
Swiber Holdings Ltd * |
|
|
1,883,448 |
|
|
188,000 |
|
|
United Overseas Bank Ltd |
|
|
2,279,437 |
|
|
440,000 |
|
|
Venture Corp Ltd |
|
|
2,276,323 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
108,915,681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 5.1% |
|
|
|
|
|
36,898 |
|
|
Acciona SA |
|
|
3,431,926 |
|
|
2,005,623 |
|
|
Banco Bilbao Vizcaya Argentaria SA |
|
|
16,894,822 |
|
|
4,037,366 |
|
|
Banco Popular Espanol SA |
|
|
17,240,542 |
|
|
6,258,056 |
|
|
Banco Santander SA |
|
|
46,974,403 |
|
|
439,930 |
|
|
Ferrovial SA |
|
|
5,455,463 |
|
|
221,960 |
|
|
Fomento de Construcciones y Contratas SA |
|
|
5,744,760 |
|
|
1,689,648 |
|
|
Gas Natural SDG SA |
|
|
29,414,732 |
|
|
343,458 |
|
|
Grifols SA * |
|
|
5,553,359 |
|
|
3,726,492 |
|
|
Iberdrola SA |
|
|
24,832,905 |
|
|
141,766 |
|
|
Inditex SA |
|
|
12,054,807 |
|
|
354,812 |
|
|
Jazztel Plc * |
|
|
1,974,557 |
|
|
1,598,536 |
|
|
Mapfre SA |
|
|
5,351,016 |
|
|
181,789 |
|
|
Red Electrica de Espana |
|
|
7,991,347 |
|
|
1,645,741 |
|
|
Repsol YPF SA |
|
|
49,686,495 |
|
|
4,500,751 |
|
|
Telefonica SA |
|
|
84,516,681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
317,117,815 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 0.6% |
|
|
|
|
|
603,451 |
|
|
Ericsson LM B Shares |
|
|
6,437,744 |
|
|
|
|
|
|
|
|
|
|
|
748,219 |
|
|
Investor AB B Shares |
|
|
13,955,407 |
|
|
23,751 |
|
|
Millicom International Cellular SA SDR |
|
|
2,580,772 |
|
|
95,699 |
|
|
NCC Class B |
|
|
1,559,401 |
|
|
526,828 |
|
|
Swedbank AB Class A |
|
|
7,047,868 |
|
|
69,636 |
|
|
Swedish Match AB |
|
|
2,284,130 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
33,865,322 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 2.8% |
|
|
|
|
|
709,441 |
|
|
Nestle SA (Registered) |
|
|
39,815,806 |
|
|
2,058,427 |
|
|
Novartis AG (Registered) |
|
|
111,163,802 |
|
|
129,156 |
|
|
Roche Holding AG (Non Voting) |
|
|
20,545,399 |
|
|
12,550 |
|
|
Syngenta AG (Registered) * |
|
|
3,693,129 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
175,218,136 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 20.2% |
|
|
|
|
|
783,918 |
|
|
Amlin Plc |
|
|
4,140,004 |
|
|
708,673 |
|
|
Ashtead Group Plc |
|
|
2,064,466 |
|
|
4,163,970 |
|
|
AstraZeneca Plc |
|
|
191,783,119 |
|
|
3,022,756 |
|
|
Aviva Plc |
|
|
14,836,732 |
|
|
6,468,593 |
|
|
BAE Systems Plc |
|
|
27,926,829 |
|
|
1,202,092 |
|
|
Balfour Beatty Plc |
|
|
4,758,971 |
|
|
17,334,880 |
|
|
Barclays Plc |
|
|
49,937,017 |
|
|
698,977 |
|
|
Barratt Developments Plc * |
|
|
1,098,855 |
|
|
1,314,778 |
|
|
BG Group Plc |
|
|
28,200,444 |
|
|
85,334 |
|
|
BHP Billiton Plc |
|
|
2,624,218 |
|
|
11,480,969 |
|
|
BP Plc |
|
|
83,149,319 |
|
|
1,121,207 |
|
|
British American Tobacco Plc |
|
|
52,031,921 |
|
|
14,542,913 |
|
|
BT Group Plc |
|
|
43,518,495 |
|
|
175,911 |
|
|
Bunzl Plc |
|
|
2,298,351 |
|
|
427,818 |
|
|
Burberry Group Plc |
|
|
8,570,719 |
|
|
466,765 |
|
|
Cape Plc |
|
|
2,394,800 |
|
|
764,134 |
|
|
Catlin Group Ltd |
|
|
4,974,097 |
|
|
1,963,541 |
|
|
Cobham Plc |
|
|
5,462,599 |
|
|
2,618,948 |
|
|
Debenhams Plc |
|
|
2,624,383 |
|
|
199,563 |
|
|
Diageo Plc |
|
|
4,274,245 |
|
|
10,488,127 |
|
|
Dixons Retail Plc * |
|
|
1,862,571 |
|
|
1,721,792 |
|
|
Drax Group Plc |
|
|
15,164,294 |
|
|
1,496,500 |
|
|
FirstGroup Plc |
|
|
7,692,757 |
|
|
1,352,906 |
|
|
Game Group Plc |
|
|
157,945 |
|
|
7,459,162 |
|
|
GlaxoSmithKline Plc |
|
|
165,310,160 |
|
|
4,558,648 |
|
|
Home Retail Group Plc |
|
|
6,443,887 |
|
|
530,457 |
|
|
HSBC Holdings Plc |
|
|
4,137,804 |
|
|
232,780 |
|
|
IMI Plc |
|
|
2,930,972 |
|
|
280,887 |
|
|
Imperial Tobacco Group Plc |
|
|
10,105,473 |
|
|
1,398,037 |
|
|
Inchcape Plc |
|
|
7,180,640 |
|
|
814,646 |
|
|
Intermediate Capital Group Plc |
|
|
3,085,517 |
|
|
128,212 |
|
|
Jardine Lloyd Thompson Group Plc |
|
|
1,337,956 |
|
|
180,870 |
|
|
JD Wetherspoon Plc |
|
|
1,231,371 |
|
|
2,760,984 |
|
|
Kesa Electricals Plc |
|
|
3,861,644 |
|
|
417,668 |
|
|
Lancashire Holdings Ltd |
|
|
4,809,761 |
|
|
445,256 |
|
|
Land Securities Group Plc (REIT) |
|
|
4,815,065 |
|
|
10,013,360 |
|
|
Legal & General Group Plc |
|
|
16,726,976 |
|
|
24,918,432 |
|
|
Lloyds Banking Group Plc * |
|
|
9,751,348 |
|
|
589,038 |
|
|
Melrose Plc |
|
|
3,176,129 |
|
|
691,532 |
|
|
Micro Focus International Plc |
|
|
3,943,858 |
|
|
591,268 |
|
|
National Express Group Plc |
|
|
1,953,939 |
|
|
322,471 |
|
|
Next Plc |
|
|
13,629,953 |
|
|
717,945 |
|
|
Pearson Plc |
|
|
13,042,048 |
|
|
640,279 |
|
|
Prudential Plc |
|
|
6,302,026 |
|
|
|
|
|
|
|
|
|
|
|
2,198,990 |
|
|
Punch Taverns Plc * |
|
|
416,076 |
|
|
103,497 |
|
|
Reckitt Benckiser Group Plc |
|
|
5,250,685 |
|
|
404,072 |
|
|
Rio Tinto Plc |
|
|
21,272,635 |
|
|
32,944,241 |
|
|
Royal Bank of Scotland Group Plc * |
|
|
10,965,852 |
|
|
2,419,622 |
|
|
Royal Dutch Shell Plc A Shares (London) |
|
|
84,625,279 |
|
|
3,312,251 |
|
|
Royal Dutch Shell Plc B Shares (London) |
|
|
119,355,530 |
|
|
156,173 |
|
|
SABMiller Plc |
|
|
5,514,092 |
|
|
1,274,767 |
|
|
Sage Group Plc (The) |
|
|
5,825,941 |
|
|
657,542 |
|
|
Scottish & Southern Energy Plc |
|
|
13,615,562 |
|
|
484,962 |
|
|
Smith & Nephew Plc |
|
|
4,430,835 |
|
|
41,069 |
|
|
Spirax-Sarco Engineering Plc |
|
|
1,232,860 |
|
|
2,198,990 |
|
|
Spirit Pub Co Plc * |
|
|
1,371,373 |
|
|
394,626 |
|
|
Standard Chartered Plc |
|
|
8,591,326 |
|
|
425,436 |
|
|
Tate & Lyle Plc |
|
|
4,505,855 |
|
|
5,350,242 |
|
|
Taylor Wimpey Plc * |
|
|
3,278,207 |
|
|
1,562,028 |
|
|
TUI Travel Plc |
|
|
4,239,433 |
|
|
548,239 |
|
|
United Utilities Group Plc |
|
|
5,427,373 |
|
|
34,706,712 |
|
|
Vodafone Group Plc |
|
|
93,954,841 |
|
|
190,980 |
|
|
Weir Group Plc (The) |
|
|
6,207,695 |
|
|
2,932,616 |
|
|
William Hill Plc |
|
|
9,339,067 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
1,254,744,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $6,456,538,006) |
|
|
5,867,182,719 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 0.7% |
|
|
|
|
|
48,659 |
|
|
Hugo Boss AG 2.95% |
|
|
4,429,730 |
|
|
502,825 |
|
|
Porsche Automobil Holding SE 1.12% |
|
|
30,812,467 |
|
|
9,049 |
|
|
Villeroy & Boch AG 3.22% |
|
|
75,223 |
|
|
62,985 |
|
|
Volkswagen AG 1.74% |
|
|
10,883,578 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
46,200,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $39,858,221) |
|
|
46,200,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.0% |
|
|
|
|
|
3,925,065 |
|
|
BlueScope Steel Ltd, Expires 12/08/11* |
|
|
44,402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $780,398) |
|
|
44,402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
2,596,141 |
|
|
GMO U.S. Treasury Fund |
|
|
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $64,929,485) |
|
|
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 2.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 2.6% |
|
|
|
|
USD |
|
|
25,000,000 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
25,000,000 |
|
USD |
|
|
25,000,000 |
|
|
Bank of Montreal Time Deposit, 0.03%, due 12/01/11 |
|
|
25,000,000 |
|
USD |
|
|
25,000,000 |
|
|
Barclays Plc Time Deposit, 0.12%, due 12/01/11 |
|
|
25,000,000 |
|
CHF |
|
|
102,273 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
111,945 |
|
DKK |
|
|
48,084 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11 |
|
|
8,689 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NOK |
|
|
58,531 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
10,134 |
|
NZD |
|
|
251,636 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11 |
|
|
196,490 |
|
HKD |
|
|
3,462,083 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
445,642 |
|
JPY |
|
|
128,862,160 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
1,661,451 |
|
SGD |
|
|
565,957 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
441,585 |
|
USD |
|
|
1,141,418 |
|
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
1,141,418 |
|
USD |
|
|
25,000,000 |
|
|
Deutsche Bank Time Deposit, 0.06%, due 12/01/11 |
|
|
25,000,000 |
|
USD |
|
|
25,000,000 |
|
|
HSBC Bank USA (Grand Cayman) Time Deposit, 0.05%, due 12/01/11 |
|
|
25,000,000 |
|
AUD |
|
|
333,488 |
|
|
JPMorgan Chase (New York) Time Deposit, 3.78%, due 12/01/11 |
|
|
342,959 |
|
CAD |
|
|
231,086 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.25%, due 12/01/11 |
|
|
226,566 |
|
EUR |
|
|
3,194,759 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
4,292,798 |
|
GBP |
|
|
717,334 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
1,125,426 |
|
SEK |
|
|
1,558,329 |
|
|
JPMorgan Chase (New York) Time Deposit, 1.06%, due 12/01/11 |
|
|
230,282 |
|
USD |
|
|
25,000,000 |
|
|
Royal Bank of Canada (Grand Cayman) Time Deposit, 0.03%, due 12/01/11 |
|
|
25,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
160,235,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $160,235,385) |
|
|
160,235,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 98.5%
(Cost $6,722,341,495) |
|
|
6,138,592,989 |
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 1.5% |
|
|
92,617,629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
6,231,210,618 |
|
|
|
|
|
|
|
|
|
|
|
|
|
GMO International Intrinsic Value Fund
(A Series of GMO Trust)
Schedule of Investments (Continued)
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
Units of |
|
|
|
|
|
|
Appreciation |
|
Date |
|
Counterparty |
|
Deliver/Receive |
|
Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
Bank of America, N.A. |
|
AUD |
|
|
11,006,486 |
|
|
$ |
11,299,504 |
|
|
$ |
(62,623 |
) |
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
AUD |
|
|
24,627,912 |
|
|
|
25,283,565 |
|
|
|
321,945 |
|
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
EUR |
|
|
8,736,925 |
|
|
|
11,741,017 |
|
|
|
(58,105 |
) |
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
GBP |
|
|
5,929,000 |
|
|
|
9,300,713 |
|
|
|
13,053 |
|
12/16/11 |
|
JPMorgan Chase Bank, N.A. |
|
GBP |
|
|
8,757,164 |
|
|
|
13,737,202 |
|
|
|
(16,800 |
) |
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
GBP |
|
|
13,461,526 |
|
|
|
21,116,848 |
|
|
|
37,552 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
GBP |
|
|
8,757,164 |
|
|
|
13,737,202 |
|
|
|
36,663 |
|
12/16/11 |
|
State Street Bank and Trust Company |
|
GBP |
|
|
6,426,763 |
|
|
|
10,081,545 |
|
|
|
39,021 |
|
12/16/11 |
|
Barclays Bank PLC |
|
HKD |
|
|
186,164,043 |
|
|
|
23,964,666 |
|
|
|
17,596 |
|
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
HKD |
|
|
331,552,057 |
|
|
|
42,680,284 |
|
|
|
18,826 |
|
12/16/11 |
|
Deutsche Bank AG |
|
HKD |
|
|
178,461,542 |
|
|
|
22,973,133 |
|
|
|
25,732 |
|
12/16/11 |
|
JPMorgan Chase Bank, N.A. |
|
HKD |
|
|
281,816,156 |
|
|
|
36,277,844 |
|
|
|
26,613 |
|
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
HKD |
|
|
186,164,043 |
|
|
|
23,964,666 |
|
|
|
14,139 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
HKD |
|
|
107,737,008 |
|
|
|
13,868,851 |
|
|
|
(1,782 |
) |
12/16/11 |
|
State Street Bank and Trust Company |
|
HKD |
|
|
472,931,495 |
|
|
|
60,879,884 |
|
|
|
43,292 |
|
12/16/11 |
|
Bank of America, N.A. |
|
SEK |
|
|
109,985,898 |
|
|
|
16,240,975 |
|
|
|
(236,626 |
) |
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
SEK |
|
|
109,985,898 |
|
|
|
16,240,975 |
|
|
|
(179,487 |
) |
12/16/11 |
|
Deutsche Bank AG |
|
SEK |
|
|
109,985,898 |
|
|
|
16,240,975 |
|
|
|
(195,322 |
) |
12/16/11 |
|
JPMorgan Chase Bank, N.A. |
|
SEK |
|
|
109,985,898 |
|
|
|
16,240,975 |
|
|
|
(123,982 |
) |
12/16/11 |
|
Bank of America, N.A. |
|
SGD |
|
|
27,006,408 |
|
|
|
21,071,922 |
|
|
|
(202,514 |
) |
12/16/11 |
|
Bank of New York Mellon |
|
SGD |
|
|
24,705,974 |
|
|
|
19,276,994 |
|
|
|
(95,105 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
Barclays Bank PLC |
|
SGD |
|
|
25,820,548 |
|
|
|
20,146,648 |
|
|
|
(138,332 |
) |
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
SGD |
|
|
24,203,129 |
|
|
|
18,884,646 |
|
|
|
(156,443 |
) |
12/16/11 |
|
JPMorgan Chase Bank N.A. |
|
SGD |
|
|
49,032,796 |
|
|
|
38,258,153 |
|
|
|
(208,295 |
) |
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
SGD |
|
|
29,351,703 |
|
|
|
22,901,854 |
|
|
|
(178,283 |
) |
12/16/11 |
|
Royal Bank of Scotland PLC |
|
SGD |
|
|
38,527,603 |
|
|
|
30,061,409 |
|
|
|
34,215 |
|
12/16/11 |
|
State Street Bank and Trust Company |
|
SGD |
|
|
26,756,398 |
|
|
|
20,876,851 |
|
|
|
(161,527 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
597,349,301 |
|
|
$ |
(1,386,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
Barclays Bank PLC |
|
CAD |
|
|
23,391,692 |
|
|
$ |
22,925,547 |
|
|
$ |
(32,466 |
) |
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
CAD |
|
|
15,536,777 |
|
|
|
15,227,163 |
|
|
|
492 |
|
12/16/11 |
|
JPMorgan Chase Bank N.A. |
|
CAD |
|
|
21,501,595 |
|
|
|
21,073,115 |
|
|
|
(143,220 |
) |
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
CAD |
|
|
21,746,534 |
|
|
|
21,313,173 |
|
|
|
11,829 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
46,746,090 |
|
|
|
45,814,543 |
|
|
|
(187,190 |
) |
12/16/11 |
|
State Street Bank and Trust Company |
|
CAD |
|
|
28,194,946 |
|
|
|
27,633,083 |
|
|
|
(27,786 |
) |
12/16/11 |
|
Bank of America, N.A. |
|
EUR |
|
|
35,532,164 |
|
|
|
47,749,492 |
|
|
|
677,933 |
|
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
EUR |
|
|
43,729,705 |
|
|
|
58,765,665 |
|
|
|
1,482,116 |
|
12/16/11 |
|
JPMorgan Chase Bank, N.A. |
|
EUR |
|
|
30,145,551 |
|
|
|
40,510,754 |
|
|
|
766,403 |
|
12/16/11 |
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
14,490,513 |
|
|
|
19,472,910 |
|
|
|
344,707 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
EUR |
|
|
8,195,742 |
|
|
|
11,013,754 |
|
|
|
182,351 |
|
12/16/11 |
|
State Street Bank and Trust Company |
|
EUR |
|
|
15,072,775 |
|
|
|
20,255,376 |
|
|
|
372,922 |
|
12/16/11 |
|
Barclays Bank PLC |
|
JPY |
|
|
1,175,265,449 |
|
|
|
15,158,058 |
|
|
|
170,426 |
|
12/16/11 |
|
Brown Brothers Harriman & Co. |
|
JPY |
|
|
2,148,008,999 |
|
|
|
27,704,077 |
|
|
|
311,849 |
|
12/16/11 |
|
Deutsche Bank, AG |
|
JPY |
|
|
627,002,545 |
|
|
|
8,086,803 |
|
|
|
87,830 |
|
12/16/11 |
|
JPMorgan Chase Bank, N.A. |
|
JPY |
|
|
2,036,666,897 |
|
|
|
26,268,035 |
|
|
|
284,948 |
|
12/16/11 |
|
Royal Bank of Scotland PLC |
|
JPY |
|
|
1,136,485,817 |
|
|
|
14,657,895 |
|
|
|
162,057 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
State Street Bank and Trust Company |
|
JPY |
|
|
1,059,992,400 |
|
|
|
13,671,316 |
|
|
|
146,321 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
457,300,759 |
|
|
$ |
4,611,522 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
Contracts |
|
Type |
|
Date |
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
401 |
|
DAX |
|
December 2011 |
|
$ |
82,374,392 |
|
|
$ |
11,629,690 |
|
217 |
|
FTSE 100 |
|
December 2011 |
|
|
18,780,589 |
|
|
|
(35,752 |
) |
2,039 |
|
FTSE/MIB |
|
December 2011 |
|
|
209,915,037 |
|
|
|
20,692,654 |
|
597 |
|
IBEX 35 |
|
December 2011 |
|
|
67,857,838 |
|
|
|
1,439,599 |
|
492 |
|
MSCI Singapore |
|
December 2011 |
|
|
24,100,459 |
|
|
|
852,677 |
|
1,097 |
|
TOPIX |
|
December 2011 |
|
|
105,377,909 |
|
|
|
(658,479 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
508,406,224 |
|
|
$ |
33,920,389 |
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
366 |
|
Amesterdam IDX |
|
December 2011 |
|
$ |
29,644,133 |
|
|
$ |
(738,863 |
) |
2,007 |
|
OMXS 30 |
|
December 2011 |
|
|
29,342,701 |
|
|
|
(1,024,843 |
) |
1,145 |
|
S&P Toronto 60 |
|
December 2011 |
|
|
155,929,702 |
|
|
|
(1,781,565 |
) |
1,374 |
|
SPI 200 |
|
December 2011 |
|
|
150,080,560 |
|
|
|
(3,787,555 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
364,997,096 |
|
|
$ |
(7,332,826 |
) |
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
Expiration |
|
|
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
Fund Pays |
|
Fund (Pays)/Receives |
|
|
(Depreciation) |
|
1,339,625 |
|
EUR |
|
11/27/2012 |
|
Bank of America Merrill Lynch |
|
3 Month Euribor Floating Rate minus 10.0% |
|
Total Return on Alpha Bank A.E. |
|
$ |
(2,487 |
) |
946,168 |
|
EUR |
|
11/27/2012 |
|
Goldman Sachs International |
|
1 Month Euribor Floating Rate minus 10.0% |
|
Total Return on Dexia SA |
|
|
(40,092 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(42,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
|
|
|
Notes to Schedule of Investments:
|
|
ADR American Depositary Receipt
|
|
FDR Fiduciary Depositary Receipt
|
|
|
|
|
REIT Real Estate Investment Trust
|
|
SDR Swedish Depository Receipt
|
|
*
|
|
Non-income producing security.
|
|
(a)
|
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust.
|
|
(b)
|
|
Bankrupt issuer.
|
|
Currency Abbreviations:
|
|
AUD Australian Dollar
|
|
CAD Canadian Dollar
|
|
CHF Swiss Franc
|
|
DKK Danish Krone
|
|
EUR Euro
|
|
GBP British Pound
|
|
HKD Hong Kong Dollar
|
|
JPY Japanese Yen
|
|
NOK Norwegian Krone
|
|
NZD New Zealand Dollar
|
|
SEK Swedish Krona
|
|
SGD Singapore Dollar
|
|
USD United States Dollar
|
As of November 30, 2011, the approximate cost for U.S. federal income tax
purposes and gross and net unrealized appreciation (depreciation) in value of
investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$6,844,819,905 |
|
$ |
333,945,812 |
|
|
$ |
(1,040,172,728 |
) |
|
$ |
(706,226,916 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The
Schedule of Investments of the underlying funds should be read in conjunction
with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set
forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S.
Treasury Fund |
|
$ |
30,133,000 |
|
|
$ |
91,849,000 |
|
|
$ |
57,074,000 |
|
|
$ |
20,926 |
|
|
$ |
2,934 |
|
|
$ |
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as
Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its
OTC derivatives contracts based on the creditworthiness of its counterparties. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
90.2% |
Futures Contracts |
|
0.5% |
Swap Agreements |
|
(0.0)%^ |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three
levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value technique on Level 3 investments: The Fund considered certain
bankrupt securities to be near worthless.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
288,782,812 |
|
|
$ |
|
|
|
$ |
288,782,812 |
|
Austria |
|
|
|
|
|
|
42,882,619 |
|
|
|
|
|
|
|
42,882,619 |
|
Belgium |
|
|
|
|
|
|
25,641,543 |
|
|
|
|
|
|
|
25,641,543 |
|
Canada |
|
|
269,686,176 |
|
|
|
|
|
|
|
|
|
|
|
269,686,176 |
|
Denmark |
|
|
|
|
|
|
11,733,603 |
|
|
|
|
|
|
|
11,733,603 |
|
Finland |
|
|
|
|
|
|
31,821,483 |
|
|
|
|
|
|
|
31,821,483 |
|
France |
|
|
|
|
|
|
807,021,826 |
|
|
|
|
|
|
|
807,021,826 |
|
Germany |
|
|
|
|
|
|
379,630,607 |
|
|
|
|
|
|
|
379,630,607 |
|
Greece |
|
|
|
|
|
|
17,619,026 |
|
|
|
|
|
|
|
17,619,026 |
|
Hong Kong |
|
|
|
|
|
|
70,145,178 |
|
|
|
|
|
|
|
70,145,178 |
|
Ireland |
|
|
64,509 |
|
|
|
43,239,303 |
|
|
|
|
|
|
|
43,303,812 |
|
Israel |
|
|
|
|
|
|
8,358,269 |
|
|
|
|
|
|
|
8,358,269 |
|
Italy |
|
|
223,728 |
|
|
|
373,401,846 |
|
|
|
|
|
|
|
373,625,574 |
|
Japan |
|
|
|
|
|
|
1,479,011,978 |
|
|
|
5,411 |
|
|
|
1,479,017,389 |
|
Malta |
|
|
|
|
|
|
0 |
* |
|
|
|
|
|
|
0 |
|
Netherlands |
|
|
|
|
|
|
73,929,401 |
|
|
|
|
|
|
|
73,929,401 |
|
New Zealand |
|
|
23,967,956 |
|
|
|
9,097,133 |
|
|
|
|
|
|
|
33,065,089 |
|
Norway |
|
|
|
|
|
|
12,959,997 |
|
|
|
|
|
|
|
12,959,997 |
|
Portugal |
|
|
|
|
|
|
8,097,166 |
|
|
|
|
|
|
|
8,097,166 |
|
Singapore |
|
|
|
|
|
|
108,915,681 |
|
|
|
|
|
|
|
108,915,681 |
|
Spain |
|
|
|
|
|
|
317,117,815 |
|
|
|
|
|
|
|
317,117,815 |
|
Sweden |
|
|
|
|
|
|
33,865,322 |
|
|
|
|
|
|
|
33,865,322 |
|
Switzerland |
|
|
|
|
|
|
175,218,136 |
|
|
|
|
|
|
|
175,218,136 |
|
United Kingdom |
|
|
1,371,373 |
|
|
|
1,253,372,822 |
|
|
|
|
|
|
|
1,254,744,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
295,313,742 |
|
|
|
5,571,863,566 |
|
|
|
5,411 |
|
|
|
5,867,182,719 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany |
|
|
|
|
|
|
46,200,998 |
|
|
|
|
|
|
|
46,200,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
|
|
|
|
46,200,998 |
|
|
|
|
|
|
|
46,200,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
|
|
|
|
|
44,402 |
|
|
|
|
|
|
|
44,402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS |
|
|
|
|
|
|
44,402 |
|
|
|
|
|
|
|
44,402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
64,929,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
160,235,385 |
|
|
|
|
|
|
|
|
|
|
|
160,235,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
520,478,612 |
|
|
|
5,618,108,966 |
|
|
|
5,411 |
|
|
|
6,138,592,989 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
|
|
|
|
|
5,630,831 |
|
|
|
|
|
|
|
5,630,831 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
|
|
|
|
|
34,614,620 |
|
|
|
|
|
|
|
34,614,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
40,245,451 |
|
|
|
|
|
|
|
40,245,451 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
520,478,612 |
|
|
$ |
5,658,354,417 |
|
|
$ |
5,411 |
|
|
$ |
6,178,838,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
$ |
|
|
|
$ |
(2,405,888 |
) |
|
$ |
|
|
|
$ |
(2,405,888 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
|
(1,781,565 |
) |
|
|
(6,245,492 |
) |
|
|
|
|
|
|
(8,027,057 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
|
|
|
|
|
(42,579 |
) |
|
|
|
|
|
|
(42,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
(1,781,565 |
) |
|
|
(8,693,959 |
) |
|
|
|
|
|
|
(10,475,524 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(1,781,565 |
) |
|
$ |
(8,693,959 |
) |
|
$ |
|
|
|
$ |
(10,475,524 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Represents the interest in securities that were determined to have a fair value of
zero as of November 30, 2011. |
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net value of the Funds direct
investments in securities using Level 3 inputs was less than 0.1% of total net assets.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as of |
|
|
Investments Still |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Total Realized |
|
|
Appreciation |
|
|
Transfer into |
|
|
Transfer out of |
|
|
November 30, |
|
|
Held as of November |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
level 3 * |
|
|
2011 |
|
|
30, 2011 |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan |
|
$ |
5,130 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
281 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,411 |
|
|
$ |
281 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
5,130 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
281 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
5,411 |
|
|
$ |
281 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at
the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty
to a derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of
the contracts. Most forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes and adjust exposure to foreign currencies. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain securities markets and maintain the diversity and liquidity of
the portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another
asset. Some swap contracts are net settled. When entering into a swap agreement and during the
term of the transaction, the Fund and/or the swap counterparty may post or receive cash or
securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to achieve returns comparable to holding and lending a direct equity position. Swap agreements
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants and rights
often do not have standardized terms, and may have longer maturities and may be less liquid than
exchange-traded options. In addition, the terms of warrants or rights may limit the Funds
ability to exercise the warrants or rights at such times and in such quantities as the Fund
would otherwise wish. During the
period ended November 30, 2011, the Fund held rights and/or warrants received as a result of
corporate actions. Rights and/or warrants held by the Fund at the end of the period are
listed in the Funds Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized by
risk exposure:
Fair Values of Derivative Instruments as
of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
44,402 |
|
|
$ |
|
|
|
$ |
44,402 |
|
Unrealized appreciation on forward currency
contracts |
|
|
|
|
|
|
5,630,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,630,831 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34,614,620 |
|
|
|
|
|
|
|
34,614,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
5,630,831 |
|
|
$ |
|
|
|
$ |
34,659,022 |
|
|
$ |
|
|
|
$ |
40,289,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency
contracts |
|
$ |
|
|
|
$ |
(2,405,888 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(2,405,888 |
) |
Unrealized depreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,027,057 |
) |
|
|
|
|
|
|
(8,027,057 |
) |
Unrealized depreciation on swap agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(42,579 |
) |
|
|
|
|
|
|
(42,579 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(2,405,888 |
) |
|
$ |
|
|
|
$ |
(8,069,636 |
) |
|
$ |
|
|
|
$ |
(10,475,524 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures
contracts and rights and/or warrants), or notional amounts (swap agreements), outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
Rights |
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
and /or |
|
|
Swap |
|
|
|
Contracts |
|
|
Contracts |
|
|
Warrants |
|
|
Agreements |
|
Average amount outstanding |
|
$ |
859,716,115 |
|
|
$ |
751,635,739 |
|
|
$ |
742,900 |
|
|
$ |
757,040 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO
International Opportunities Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares / Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 100.0% |
|
|
|
|
|
1,910,786 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
22,337,083 |
|
|
2,572,161 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
44,086,840 |
|
|
13,340,209 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
285,480,464 |
|
|
20,835,518 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
406,292,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $827,701,471) |
|
|
758,196,989 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposit 0.0% |
|
|
|
|
|
21,698 |
|
|
State Street Eurodollar Time Deposit, 0.01%, due 12/01/11 |
|
|
21,698 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $21,698) |
|
|
21,698 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.0%
(Cost $827,723,169) |
|
|
758,218,687 |
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(61,680 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
758,157,007 |
|
|
|
|
|
|
|
|
|
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation)
in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$976,652,077 |
|
$6,125,403 |
|
$(224,558,793) |
|
$(218,433,390) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in
conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Emerging
Markets Fund, Class
VI |
|
$ |
22,727,461 |
|
|
$ |
5,601,974 |
|
|
$ |
1,017,898 |
|
|
$ |
8,881 |
|
|
|
1,768,580 |
|
|
$ |
22,337,083 |
|
|
GMO Flexible
Equities Fund,
Class VI |
|
|
11,463,067 |
|
|
|
37,684,840 |
|
|
|
1,266,531 |
|
|
|
|
|
|
|
|
|
|
|
44,086,840 |
|
|
GMO International
Growth Equity Fund,
Class IV |
|
|
381,363,744 |
|
|
|
55,719,992 |
|
|
|
108,684,018 |
|
|
|
2,717,364 |
|
|
|
|
|
|
|
285,480,464 |
|
|
GMO International
Intrinsic Value
Fund, Class IV |
|
|
380,486,131 |
|
|
|
130,820,756 |
|
|
|
39,998,115 |
|
|
|
7,505,629 |
|
|
|
|
|
|
|
406,292,602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
796,040,403 |
|
|
$ |
229,827,562 |
|
|
$ |
150,966,562 |
|
|
$ |
10,231,874 |
|
|
$ |
1,768,580 |
|
|
$ |
758,196,989 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods determined in good
faith by or at the direction of the Trustees of the Trust represented 0.1% of net assets. The
underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the underlying funds.
|
|
|
Security Type |
Percentage of Net Assets of the Fund |
|
Equity Securities |
90.1% |
|
Futures Contracts |
0.4% |
|
Swap Agreements |
(0.0)%^ |
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
758,196,989 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
758,196,989 |
|
Short-Term Investments |
|
|
21,698 |
|
|
|
|
|
|
|
|
|
|
|
21,698 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
758,218,687 |
|
|
|
|
|
|
|
|
|
|
|
758,218,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
758,218,687 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
758,218,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net value of the Funds indirect
investments in securities using Level 3 inputs was 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Because
the Fund and the underlying funds normally do not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to
be greater for investments in companies tied economically to emerging countries, the
economies of which tend to be more volatile than the economies of developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses associated with an investment in
the Fund are less predictable and may be higher than fees and expenses associated with an
investment in funds that charge a fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO International Small Companies Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 93.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 3.9% |
|
|
|
|
|
676,664 |
|
|
Australian Infrastructure Fund |
|
|
1,348,147 |
|
|
596,528 |
|
|
BlueScope Steel Ltd |
|
|
243,273 |
|
|
17,047 |
|
|
Campbell Brothers Ltd |
|
|
876,100 |
|
|
223,405 |
|
|
Challenger Ltd |
|
|
997,436 |
|
|
861,238 |
|
|
Charter Hall Office (REIT) |
|
|
3,093,442 |
|
|
636,905 |
|
|
Charter Hall Retail (REIT) |
|
|
2,155,848 |
|
|
1,610,793 |
|
|
Goodman Fielder Ltd |
|
|
882,606 |
|
|
147,206 |
|
|
GrainCorp Ltd |
|
|
1,170,460 |
|
|
1,692,981 |
|
|
Investa Office Fund (REIT) |
|
|
1,055,635 |
|
|
998,258 |
|
|
PaperlinX Ltd * |
|
|
79,335 |
|
|
285,982 |
|
|
Regis Resources Ltd * |
|
|
993,337 |
|
|
521,758 |
|
|
Spark Infrastructure Group |
|
|
691,348 |
|
|
287,397 |
|
|
Tatts Group Ltd |
|
|
691,414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
14,278,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.6% |
|
|
|
|
|
11,804 |
|
|
Andritz AG |
|
|
1,042,258 |
|
|
10,478 |
|
|
Flughafen Wien AG |
|
|
403,485 |
|
|
1,761,602 |
|
|
Immofinanz AG (Entitlement Shares) * |
|
|
|
|
|
18,624 |
|
|
Strabag SE |
|
|
559,503 |
|
|
7,493 |
|
|
Zumtobel AG |
|
|
118,423 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
2,123,669 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.5% |
|
|
|
|
|
12,314 |
|
|
GIMV NV |
|
|
600,979 |
|
|
19,012 |
|
|
Omega Pharma SA |
|
|
885,323 |
|
|
17,833 |
|
|
Tessenderlo Chemie |
|
|
495,352 |
|
|
636 |
|
|
Tessenderlo Chemie NV * |
|
|
86 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
1,981,740 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 0.1% |
|
|
|
|
|
25,100 |
|
|
Equatorial Energia SA |
|
|
159,621 |
|
|
16,500 |
|
|
Fertilizantes Heringer SA * |
|
|
95,075 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
254,696 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 4.0% |
|
|
|
|
|
34,200 |
|
|
AltaGas Ltd |
|
|
1,035,104 |
|
|
41,100 |
|
|
Davis & Henderson Income Corp |
|
|
604,441 |
|
|
24,800 |
|
|
Dorel Industries Inc Class B |
|
|
582,342 |
|
|
52,600 |
|
|
Dundee Corp Class A * |
|
|
1,237,708 |
|
|
6,200 |
|
|
Empire Co Ltd |
|
|
372,018 |
|
|
61,400 |
|
|
Ensign Energy Services Inc |
|
|
978,234 |
|
|
33,600 |
|
|
Mullen Group Ltd |
|
|
644,361 |
|
|
32,400 |
|
|
Pembina Pipeline Corp |
|
|
945,046 |
|
|
209,100 |
|
|
Precision Drilling Corp * |
|
|
2,417,069 |
|
|
18,871 |
|
|
Quebecor Inc Class B |
|
|
599,276 |
|
|
119,900 |
|
|
RONA Inc |
|
|
1,090,908 |
|
|
173,800 |
|
|
Sherritt International Corp |
|
|
947,427 |
|
|
50,950 |
|
|
Torstar Corp Class B |
|
|
444,586 |
|
|
71,325 |
|
|
Transcontinental Inc |
|
|
834,963 |
|
|
15,400 |
|
|
Trilogy Energy Corp |
|
|
563,185 |
|
|
157,600 |
|
|
Trinidad Drilling Ltd |
|
|
1,229,958 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
14,526,626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chile 0.0% |
|
|
|
|
|
3,721,532 |
|
|
Madeco SA * |
|
|
164,551 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
China 0.0% |
|
|
|
|
|
447,600 |
|
|
Jiangsu Future Land Co Ltd Class B |
|
|
171,223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Czech Republic 0.0% |
|
|
|
|
|
4,200 |
|
|
Pegas Nonwovens SA |
|
|
100,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 4.5% |
|
|
|
|
|
40,031 |
|
|
Arkema |
|
|
2,916,025 |
|
|
115,962 |
|
|
Derichebourg SA * |
|
|
380,565 |
|
|
14,281 |
|
|
Eiffage SA |
|
|
356,530 |
|
|
22,534 |
|
|
Groupe Steria SCA |
|
|
405,210 |
|
|
7,588 |
|
|
ICADE (REIT) |
|
|
606,581 |
|
|
24,367 |
|
|
Ingenico SA |
|
|
956,856 |
|
|
8,468 |
|
|
Jacquet Metal Service * |
|
|
95,659 |
|
|
20,921 |
|
|
Lagardere SCA |
|
|
509,503 |
|
|
33,104 |
|
|
Maurel et Prom |
|
|
639,382 |
|
|
15,095 |
|
|
Nexans SA |
|
|
886,988 |
|
|
134,595 |
|
|
PagesJaunes Groupe |
|
|
467,720 |
|
|
49,585 |
|
|
Peugeot SA |
|
|
928,395 |
|
|
61,895 |
|
|
Plastic Omnium SA |
|
|
1,363,696 |
|
|
36,962 |
|
|
Rallye SA |
|
|
1,122,357 |
|
|
9,482 |
|
|
Remy Cointreau SA |
|
|
792,884 |
|
|
37,770 |
|
|
SES SA Class A FDR |
|
|
930,845 |
|
|
5,065 |
|
|
Societe BIC SA |
|
|
449,677 |
|
|
16,778 |
|
|
Teleperformance |
|
|
331,046 |
|
|
12,278 |
|
|
Valeo SA |
|
|
543,670 |
|
|
9,659 |
|
|
Wendel |
|
|
695,933 |
|
|
12,455 |
|
|
Zodiac Aerospace |
|
|
1,023,553 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
16,403,075 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 6.2% |
|
|
|
|
|
62,839 |
|
|
Aareal Bank AG * |
|
|
1,138,094 |
|
|
57,489 |
|
|
Aurubis AG |
|
|
3,280,510 |
|
|
69,878 |
|
|
Balda AG * |
|
|
360,224 |
|
|
26,775 |
|
|
Bechtle AG |
|
|
972,111 |
|
|
8,472 |
|
|
Bertrandt AG |
|
|
493,337 |
|
|
24,276 |
|
|
Bilfinger & Berger SE |
|
|
2,217,749 |
|
|
180,956 |
|
|
Drillisch AG |
|
|
1,634,655 |
|
|
130,672 |
|
|
Freenet AG |
|
|
1,725,866 |
|
|
168,495 |
|
|
Gagfah SA |
|
|
1,008,908 |
|
|
12,769 |
|
|
Gerresheimer AG |
|
|
537,221 |
|
|
34,089 |
|
|
Gerry Weber International AG |
|
|
1,063,249 |
|
|
28,662 |
|
|
Hannover Rueckversicherung AG (Registered) |
|
|
1,496,311 |
|
|
46,791 |
|
|
Leoni AG |
|
|
1,741,216 |
|
|
10,237 |
|
|
Rheinmetall AG |
|
|
496,919 |
|
|
29,997 |
|
|
Rhoen-Klinikum AG |
|
|
568,031 |
|
|
19,801 |
|
|
Salzgitter AG |
|
|
1,028,021 |
|
|
15,726 |
|
|
SGL Carbon SE * |
|
|
947,692 |
|
|
61,141 |
|
|
Suedzucker AG |
|
|
1,947,792 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
22,657,906 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greece 0.6% |
|
|
|
|
|
143,182 |
|
|
Alapis Holding Industrial and Commercial SA * |
|
|
6,222 |
|
|
268,346 |
|
|
Intralot SA |
|
|
296,600 |
|
|
94,916 |
|
|
Jumbo SA |
|
|
486,110 |
|
|
1,136,003 |
|
|
Marfin Investment Group SA * |
|
|
651,585 |
|
|
|
|
|
|
|
|
|
|
|
72,262 |
|
|
Motor Oil (Hellas) Corinth Refineries SA |
|
|
592,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Greece |
|
|
2,032,566 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 1.9% |
|
|
|
|
|
2,920,000 |
|
|
Emperor Watch & Jewellery Ltd |
|
|
427,711 |
|
|
1,402,000 |
|
|
First Pacific Co |
|
|
1,557,544 |
|
|
425,600 |
|
|
HKR International Ltd |
|
|
139,529 |
|
|
698,000 |
|
|
Kowloon Development Co Ltd |
|
|
590,084 |
|
|
256,000 |
|
|
Luk Fook Holdings International Ltd |
|
|
1,075,530 |
|
|
1,722,000 |
|
|
Melco International Development Ltd |
|
|
1,369,063 |
|
|
848,000 |
|
|
Texwinca Holdings Ltd |
|
|
1,023,728 |
|
|
226,000 |
|
|
Yue Yuen Industrial Holdings |
|
|
651,283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
6,834,472 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
India 0.4% |
|
|
|
|
|
29,368 |
|
|
Bata India Ltd |
|
|
354,086 |
|
|
154,409 |
|
|
Geodesic Ltd |
|
|
156,607 |
|
|
111,346 |
|
|
Gitanjali Gems Ltd |
|
|
728,875 |
|
|
275,905 |
|
|
Rain Commodities Ltd |
|
|
158,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total India |
|
|
1,397,650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Indonesia 0.1% |
|
|
|
|
|
55,384,000 |
|
|
Bakrie & Brothers Tbk PT * |
|
|
313,585 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 2.2% |
|
|
|
|
|
1,190,403 |
|
|
Allied Irish Banks Plc * |
|
|
103,970 |
|
|
110,781 |
|
|
DCC Plc |
|
|
2,682,097 |
|
|
752,322 |
|
|
Fyffes Plc |
|
|
384,142 |
|
|
202,464 |
|
|
Glanbia Plc |
|
|
1,264,963 |
|
|
718,499 |
|
|
Irish Life & Permanent Group Holdings Plc * |
|
|
31,059 |
|
|
39,982 |
|
|
Paddy Power Plc |
|
|
2,170,828 |
|
|
177,321 |
|
|
Smurfit Kappa Group Plc * |
|
|
1,073,920 |
|
|
551,272 |
|
|
Total Produce Ltd |
|
|
285,103 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
7,996,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Israel 0.4% |
|
|
|
|
|
233,795 |
|
|
Africa Israel Investments Ltd * |
|
|
793,282 |
|
|
14,802 |
|
|
Mellanox Technologies Ltd * |
|
|
519,949 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Israel |
|
|
1,313,231 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 4.3% |
|
|
|
|
|
88,264 |
|
|
Autostrada Torino-Milano SPA |
|
|
868,129 |
|
|
241,819 |
|
|
Benetton Group SPA |
|
|
1,187,796 |
|
|
49,871 |
|
|
Brembo SPA |
|
|
479,307 |
|
|
243,627 |
|
|
Campari |
|
|
1,742,177 |
|
|
79,796 |
|
|
Cementir SPA |
|
|
160,024 |
|
|
36,568 |
|
|
Danieli & Co SPA |
|
|
821,668 |
|
|
137,802 |
|
|
Danieli & Co SPA-RSP |
|
|
1,594,519 |
|
|
97,360 |
|
|
DeLonghi SPA |
|
|
1,032,492 |
|
|
148,922 |
|
|
Italcementi SPA-Di RISP |
|
|
408,290 |
|
|
9,234 |
|
|
Italmobiliare SPA |
|
|
198,730 |
|
|
14,836 |
|
|
Italmobiliare SPA-RSP |
|
|
208,800 |
|
|
94,855 |
|
|
Lottomatica SPA * |
|
|
1,463,610 |
|
|
317,959 |
|
|
Mediolanum SPA |
|
|
1,161,846 |
|
|
1,575,844 |
|
|
Milano Assicurazioni SPA * |
|
|
531,299 |
|
|
69,509 |
|
|
Pirelli & C SPA |
|
|
657,589 |
|
|
243,911 |
|
|
Recordati SPA |
|
|
1,873,910 |
|
|
48,396 |
|
|
Societa Iniziative Autostradali e Servizi SPA |
|
|
366,797 |
|
|
|
|
|
|
|
|
|
|
|
4,695 |
|
|
Tods SPA |
|
|
437,277 |
|
|
1,286,791 |
|
|
Unipol Gruppo Finanziario SPA * |
|
|
431,489 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
15,625,749 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 30.9% |
|
|
|
|
|
1,081 |
|
|
Advance Residence Investment Corp (REIT) |
|
|
2,016,885 |
|
|
188,000 |
|
|
Aichi Steel Corp |
|
|
985,905 |
|
|
29,500 |
|
|
Alpen Co Ltd |
|
|
503,498 |
|
|
87,600 |
|
|
Alps Electric Co Ltd |
|
|
613,296 |
|
|
155,000 |
|
|
Anritsu Corp |
|
|
1,750,335 |
|
|
112,100 |
|
|
AOC Holdings Inc |
|
|
677,583 |
|
|
120,800 |
|
|
Arnest One Corp |
|
|
1,233,373 |
|
|
454,000 |
|
|
Calsonic Kansei Corp |
|
|
2,620,776 |
|
|
54,700 |
|
|
Capcom |
|
|
1,403,108 |
|
|
110,800 |
|
|
Century Tokyo Leasing Corp |
|
|
2,198,617 |
|
|
19,400 |
|
|
Chiba Kogyo Bank Ltd (The) * |
|
|
103,996 |
|
|
43,000 |
|
|
Daido Metal Co Ltd |
|
|
442,618 |
|
|
158,800 |
|
|
Daiei Inc * |
|
|
577,142 |
|
|
56,700 |
|
|
Daiichikosho Co Ltd |
|
|
1,052,029 |
|
|
107,000 |
|
|
Dainippon Screen Manufacturing Co Ltd |
|
|
816,568 |
|
|
335 |
|
|
Daiwa Office Investment Corp (REIT) |
|
|
701,014 |
|
|
235,900 |
|
|
DCM Holdings Co Ltd |
|
|
1,800,025 |
|
|
700,000 |
|
|
DIC Corp |
|
|
1,182,116 |
|
|
138 |
|
|
Dr Ci:Labo Co Ltd |
|
|
851,622 |
|
|
227,500 |
|
|
Edion Corp |
|
|
1,781,685 |
|
|
84,000 |
|
|
Fujitsu General Ltd |
|
|
463,730 |
|
|
22,100 |
|
|
Fuji Oil Co Ltd |
|
|
316,345 |
|
|
29,500 |
|
|
Fuji Soft Inc |
|
|
497,241 |
|
|
195,100 |
|
|
Futaba Industrial Co Ltd |
|
|
1,196,178 |
|
|
47,000 |
|
|
Fuyo General Lease Co Ltd |
|
|
1,613,177 |
|
|
402,000 |
|
|
Godo Steel Ltd |
|
|
1,006,225 |
|
|
11,060 |
|
|
Gulliver International Co Ltd |
|
|
468,370 |
|
|
400,000 |
|
|
Gunze Ltd |
|
|
1,151,647 |
|
|
468,000 |
|
|
Hanwa Co Ltd |
|
|
2,028,834 |
|
|
34,000 |
|
|
Hitachi Transport System Ltd |
|
|
571,439 |
|
|
150,500 |
|
|
Hokuetsu Kishu Paper Co Ltd |
|
|
955,471 |
|
|
512,000 |
|
|
Ishihara Sangyo Kaisha Ltd * |
|
|
598,127 |
|
|
105,400 |
|
|
IT Holdings Corp |
|
|
1,189,372 |
|
|
59,600 |
|
|
Itochu Enex Co Ltd |
|
|
336,484 |
|
|
399,000 |
|
|
JACCS Co Ltd |
|
|
1,233,063 |
|
|
85 |
|
|
Japan Excellent Inc (REIT) |
|
|
341,754 |
|
|
247,000 |
|
|
JFE Shoji Holdings Inc |
|
|
1,039,038 |
|
|
365,000 |
|
|
Juki Corp |
|
|
880,218 |
|
|
143,000 |
|
|
JOil Mills Inc |
|
|
399,153 |
|
|
110,500 |
|
|
Ks Holdings Corp |
|
|
4,355,552 |
|
|
19,800 |
|
|
Kaga Electronics Co Ltd |
|
|
203,946 |
|
|
176,000 |
|
|
Kaken Pharmaceutical Co Ltd |
|
|
2,133,937 |
|
|
433 |
|
|
Kenedix Realty Investment Corp (REIT) |
|
|
1,237,453 |
|
|
152,000 |
|
|
Kinugawa Rubber Industrial Co Ltd |
|
|
1,367,761 |
|
|
127,900 |
|
|
Kohnan Shoji Co Ltd |
|
|
2,056,439 |
|
|
57,000 |
|
|
Kojima Co Ltd |
|
|
380,301 |
|
|
19,300 |
|
|
Komeri Co Ltd |
|
|
590,161 |
|
|
144,000 |
|
|
Krosaki Harima Corp |
|
|
485,669 |
|
|
229,000 |
|
|
Kurabo Industries Ltd |
|
|
445,297 |
|
|
39,800 |
|
|
Kyoei Steel Ltd |
|
|
800,663 |
|
|
52,000 |
|
|
Kyorin Co Ltd |
|
|
876,723 |
|
|
30,000 |
|
|
Kyudenko Corp |
|
|
181,058 |
|
|
298,500 |
|
|
Leopalace21 Corp * |
|
|
689,027 |
|
|
10,600 |
|
|
Mandom Corp |
|
|
270,652 |
|
|
|
|
|
|
|
|
|
|
|
13,300 |
|
|
Maruwa Co Ltd/Aichi |
|
|
592,714 |
|
|
303,000 |
|
|
Mitsubishi Steel Manufacturing Co Ltd |
|
|
820,570 |
|
|
513,000 |
|
|
Mitsui Mining & Smelting Co Ltd |
|
|
1,329,265 |
|
|
303 |
|
|
Mori Hills REIT Investment Corp (REIT) |
|
|
977,189 |
|
|
293,000 |
|
|
Morinaga Milk Industry Co Ltd |
|
|
1,118,313 |
|
|
283,000 |
|
|
Nachi-Fujikoshi Corp |
|
|
1,331,750 |
|
|
150,000 |
|
|
Nakayama Steel Works Ltd * |
|
|
124,552 |
|
|
736 |
|
|
Net One Systems Co Ltd |
|
|
1,898,647 |
|
|
166,000 |
|
|
Nichias Corp |
|
|
905,233 |
|
|
43,800 |
|
|
Nichii Gakkan Co |
|
|
498,577 |
|
|
297,000 |
|
|
Nichirei Corp |
|
|
1,385,027 |
|
|
93,300 |
|
|
Nihon Kohden Corp |
|
|
2,157,936 |
|
|
865,000 |
|
|
Nippon Coke & Engineering Co Ltd |
|
|
1,159,818 |
|
|
115,000 |
|
|
Nippon Corp |
|
|
1,001,012 |
|
|
97,000 |
|
|
Nippon Shokubai Co Ltd |
|
|
1,062,425 |
|
|
210,000 |
|
|
Nippon Soda Co Ltd |
|
|
890,966 |
|
|
71,000 |
|
|
Nippon Synthetic Chemical Industry Co Ltd |
|
|
416,858 |
|
|
100,000 |
|
|
Nippon Flour Mills Co Ltd |
|
|
444,539 |
|
|
1,119,000 |
|
|
Nippon Light Metal Co Ltd |
|
|
1,487,608 |
|
|
196,900 |
|
|
Nippon Suisan Kaisha Ltd |
|
|
664,515 |
|
|
95,000 |
|
|
Nipro Corp |
|
|
775,096 |
|
|
200,000 |
|
|
Nishimatsu Construction Co Ltd |
|
|
324,721 |
|
|
123,000 |
|
|
Nissan Shatai Co Ltd |
|
|
1,204,644 |
|
|
27,000 |
|
|
Nisshin Oillio Group Ltd (The) |
|
|
109,345 |
|
|
16,200 |
|
|
Noritz Corp |
|
|
296,450 |
|
|
156,000 |
|
|
NS United Kaiun Kaisha Ltd |
|
|
216,311 |
|
|
19,500 |
|
|
Okinawa Electric Power Co |
|
|
830,435 |
|
|
1,111,500 |
|
|
Orient Corp * |
|
|
1,000,150 |
|
|
236 |
|
|
ORIX JREIT Inc (REIT) |
|
|
997,137 |
|
|
26,900 |
|
|
Osaka Steel Co Ltd |
|
|
481,168 |
|
|
27,500 |
|
|
PLENUS Co Ltd |
|
|
433,137 |
|
|
30,500 |
|
|
Pola Orbis Holdings Inc |
|
|
778,327 |
|
|
206 |
|
|
Premier Investment Corp (REIT) |
|
|
663,315 |
|
|
270,000 |
|
|
Press Kogyo Co Ltd |
|
|
1,267,891 |
|
|
72,750 |
|
|
Promise Co Ltd * |
|
|
758,815 |
|
|
294,800 |
|
|
Round One Corp |
|
|
1,761,528 |
|
|
299,000 |
|
|
Ryobi Ltd |
|
|
1,158,973 |
|
|
32,300 |
|
|
Ryohin Keikaku Co Ltd |
|
|
1,469,618 |
|
|
40,700 |
|
|
Sanrio Co Ltd |
|
|
2,117,109 |
|
|
142,000 |
|
|
Seino Holdings Co Ltd |
|
|
1,031,669 |
|
|
73,800 |
|
|
Ship Healthcare Holdings Inc |
|
|
1,755,468 |
|
|
121,000 |
|
|
Showa Corp * |
|
|
667,910 |
|
|
1,983 |
|
|
SKY Perfect JSAT Holdings Inc |
|
|
1,013,491 |
|
|
99,600 |
|
|
Sodick Co Ltd |
|
|
540,029 |
|
|
77,700 |
|
|
Start Today Co Ltd |
|
|
1,505,699 |
|
|
479,000 |
|
|
Taiheiyo Cement Co Ltd |
|
|
930,513 |
|
|
178,000 |
|
|
Taihei Kogyo Co Ltd |
|
|
969,868 |
|
|
22,200 |
|
|
Tamron Co Ltd. |
|
|
596,758 |
|
|
93,000 |
|
|
Tatsuta Electric Wire and Cable Co Ltd |
|
|
414,578 |
|
|
263,000 |
|
|
TOA Corp |
|
|
469,827 |
|
|
298,000 |
|
|
Toho Zinc Co Ltd |
|
|
1,204,909 |
|
|
263,000 |
|
|
Toko Inc * |
|
|
526,904 |
|
|
259 |
|
|
Tokyu REIT Inc (REIT) |
|
|
1,181,653 |
|
|
367,000 |
|
|
Topy Industries Ltd |
|
|
939,793 |
|
|
31 |
|
|
Top REIT Inc (REIT) |
|
|
137,901 |
|
|
181,000 |
|
|
Tosoh Corp |
|
|
529,687 |
|
|
404,000 |
|
|
Toyo Tire & Rubber Co Ltd |
|
|
946,383 |
|
|
506 |
|
|
TGaia Corp |
|
|
981,643 |
|
|
70,000 |
|
|
Uchida Yoko Co Ltd |
|
|
193,925 |
|
|
232,000 |
|
|
Uniden Corp |
|
|
886,834 |
|
|
|
|
|
|
|
|
|
|
|
45,100 |
|
|
Unipres Corp |
|
|
1,250,831 |
|
|
32,700 |
|
|
United Arrows Ltd |
|
|
585,677 |
|
|
14,900 |
|
|
Xebio Co Ltd |
|
|
344,908 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
112,191,238 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 0.1% |
|
|
|
|
|
242,966 |
|
|
Coastal Contracts Berhad |
|
|
147,554 |
|
|
176,900 |
|
|
Esso Malaysia Berhad |
|
|
195,581 |
|
|
679,700 |
|
|
Scomi Group Berhad * |
|
|
61,037 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Malaysia |
|
|
404,172 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 1.7% |
|
|
|
|
|
34,839 |
|
|
Aalberts Industries NV |
|
|
568,130 |
|
|
71,962 |
|
|
Delta Lloyd NV |
|
|
1,266,132 |
|
|
24,011 |
|
|
Koninklijke Ten Cate NV |
|
|
696,352 |
|
|
302,704 |
|
|
Koninklijke BAM Groep NV |
|
|
1,048,642 |
|
|
38,655 |
|
|
Mediq NV |
|
|
597,511 |
|
|
62,016 |
|
|
SBM Offshore NV |
|
|
1,335,603 |
|
|
242,666 |
|
|
SNS REAAL NV * |
|
|
541,771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
6,054,141 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.0% |
|
|
|
|
|
16,008 |
|
|
Warehouse Group Ltd (The) |
|
|
39,969 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 0.6% |
|
|
|
|
|
44,636 |
|
|
Atea ASA |
|
|
438,638 |
|
|
48,439 |
|
|
Cermaq ASA * |
|
|
560,991 |
|
|
55,963 |
|
|
TGS Nopec Geophysical Co ASA |
|
|
1,245,215 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
2,244,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Philippines 0.1% |
|
|
|
|
|
1,722,100 |
|
|
Lopez Holding Corp |
|
|
183,130 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Poland 0.0% |
|
|
|
|
|
129,495 |
|
|
MCI Management SA * |
|
|
148,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 2.0% |
|
|
|
|
|
465,000 |
|
|
Ho Bee Investment Ltd |
|
|
442,751 |
|
|
287,000 |
|
|
Hong Leong Asia Ltd |
|
|
356,834 |
|
|
2,296,000 |
|
|
Jaya Holdings Ltd * |
|
|
868,430 |
|
|
744,000 |
|
|
Mapletree Industrial Trust (REIT) |
|
|
626,074 |
|
|
1,232,159 |
|
|
Mapletree Logistics Trust (REIT) |
|
|
806,221 |
|
|
331,000 |
|
|
MobileOne Ltd |
|
|
631,755 |
|
|
1,473,000 |
|
|
STX OSV Holdings Ltd |
|
|
1,431,789 |
|
|
830,000 |
|
|
Swiber Holdings Ltd * |
|
|
347,469 |
|
|
161,000 |
|
|
Venture Corp Ltd |
|
|
832,927 |
|
|
171,000 |
|
|
Wheelock Properties Ltd |
|
|
214,838 |
|
|
630,000 |
|
|
Wing Tai Holdings Ltd |
|
|
535,063 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
7,094,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Africa 0.1% |
|
|
|
|
|
98,254 |
|
|
Basil Read Holdings Ltd |
|
|
162,737 |
|
|
8,176 |
|
|
Evraz Highveld Steel and Vanadium Ltd * |
|
|
37,828 |
|
|
400,000 |
|
|
Simmer & Jack Mines Ltd * |
|
|
1,477 |
|
|
73,315 |
|
|
Stefanutti Stocks Holdings Ltd |
|
|
97,221 |
|
|
1,681,390 |
|
|
Super Group Ltd * |
|
|
186,529 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Africa |
|
|
485,792 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South Korea 2.7% |
|
|
|
|
|
7,301 |
|
|
AtlasBX Co Ltd |
|
|
158,257 |
|
|
7,061 |
|
|
Daum Communications Corp |
|
|
927,653 |
|
|
1,432 |
|
|
Dongwon Industries Co Ltd |
|
|
208,896 |
|
|
22,285 |
|
|
GemVax & Kael Co Ltd * |
|
|
774,078 |
|
|
22,480 |
|
|
Handsome Co Ltd |
|
|
536,006 |
|
|
5,919 |
|
|
KCC Engineering & Construction Co |
|
|
159,640 |
|
|
8,890 |
|
|
KISCO Corp |
|
|
186,734 |
|
|
4,407 |
|
|
KISWIRE Ltd |
|
|
177,613 |
|
|
11,431 |
|
|
Kolon Corp |
|
|
216,412 |
|
|
23,768 |
|
|
Kolon Industries Inc |
|
|
1,283,809 |
|
|
21,840 |
|
|
LG Fashion Corp |
|
|
914,910 |
|
|
20,220 |
|
|
LG International Corp |
|
|
925,501 |
|
|
1,740 |
|
|
Moorim Paper Co Ltd |
|
|
4,033 |
|
|
384 |
|
|
Namyang Dairy Products Co Ltd |
|
|
263,466 |
|
|
2,305 |
|
|
Nong Shim Holdings Co Ltd |
|
|
101,421 |
|
|
94,860 |
|
|
RNL BIO Co Ltd * |
|
|
550,835 |
|
|
6,793 |
|
|
Seah Besteel Corp |
|
|
347,841 |
|
|
1,341 |
|
|
SeAH Holdings Corp |
|
|
136,225 |
|
|
3,828 |
|
|
SeAH Steel Corp |
|
|
238,478 |
|
|
4,180 |
|
|
Silla Co Ltd |
|
|
42,526 |
|
|
6,533 |
|
|
SK Gas Co Ltd |
|
|
447,012 |
|
|
363 |
|
|
Taekwang Industrial Co Ltd |
|
|
410,918 |
|
|
25,960 |
|
|
Youngone Corp |
|
|
674,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total South Korea |
|
|
9,686,940 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 2.1% |
|
|
|
|
|
16,468 |
|
|
Acciona SA |
|
|
1,531,708 |
|
|
61,531 |
|
|
Cintra Concesiones de Infraestructuras de Transporte SA |
|
|
763,031 |
|
|
33,212 |
|
|
Enagas |
|
|
623,189 |
|
|
84,022 |
|
|
Fomento de Construcciones y Contratas SA |
|
|
2,174,654 |
|
|
61,527 |
|
|
Grifols SA * |
|
|
994,828 |
|
|
104,223 |
|
|
Indra Sistemas SA |
|
|
1,469,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
7,556,791 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 2.2% |
|
|
|
|
|
31,429 |
|
|
Axfood AB |
|
|
1,147,980 |
|
|
63,100 |
|
|
D Carnegie & Co. AB * (a) |
|
|
6,994 |
|
|
30,429 |
|
|
Hoganas AB Class B |
|
|
926,902 |
|
|
110,218 |
|
|
Lundin Petroleum AB * |
|
|
2,840,584 |
|
|
185,616 |
|
|
Meda AB |
|
|
1,810,712 |
|
|
67,643 |
|
|
SAAB AB Class B |
|
|
1,211,318 |
|
|
81,342 |
|
|
Vostok Gas Ltd * (a) |
|
|
2,645 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
7,947,135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 1.4% |
|
|
|
|
|
98,449 |
|
|
OC Oerlikon Corp AG * |
|
|
556,100 |
|
|
12,587 |
|
|
PSP Swiss Property AG (Registered) * |
|
|
1,090,368 |
|
|
24,963 |
|
|
Swiss Life Holding AG (Registered) * |
|
|
2,614,618 |
|
|
8,350 |
|
|
Swiss Prime Site AG (Registered) * |
|
|
635,707 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
4,896,793 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 0.7% |
|
|
|
|
|
54,000 |
|
|
AV Tech Corp |
|
|
160,177 |
|
|
76,000 |
|
|
Chinese Maritime Transport Ltd |
|
|
104,630 |
|
|
541,000 |
|
|
Getac Technology Corp |
|
|
261,797 |
|
|
126,000 |
|
|
L&K Engineering Co Ltd |
|
|
107,365 |
|
|
273,000 |
|
|
Long Bon International Co Ltd |
|
|
93,908 |
|
|
|
|
|
|
|
|
|
|
|
86,000 |
|
|
P-Two Industries Inc |
|
|
50,835 |
|
|
430,000 |
|
|
ProMOS Technologies Inc * |
|
|
4,820 |
|
|
500,000 |
|
|
Radiant Opto-Electronics Corp |
|
|
1,519,369 |
|
|
186,000 |
|
|
Sampo Corp |
|
|
47,087 |
|
|
106,000 |
|
|
ThaiLin Semiconductor Corp |
|
|
33,275 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Taiwan |
|
|
2,383,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thailand 0.0% |
|
|
|
|
|
9,246,500 |
|
|
G J Steel Pcl (Foreign Registered) * (a) |
|
|
42,624 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Turkey 0.1% |
|
|
|
|
|
17,794 |
|
|
Goodyear Lastikleri Turk AS |
|
|
465,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 19.4% |
|
|
|
|
|
152,915 |
|
|
Aberdeen Asset Management Plc |
|
|
483,478 |
|
|
115,568 |
|
|
Amlin Plc |
|
|
610,334 |
|
|
183,290 |
|
|
Ashtead Group Plc |
|
|
533,950 |
|
|
149,128 |
|
|
Atkins WS Plc |
|
|
1,539,532 |
|
|
85,760 |
|
|
Babcock International Group Plc |
|
|
979,297 |
|
|
660,874 |
|
|
Balfour Beatty Plc |
|
|
2,616,339 |
|
|
389,731 |
|
|
Bodycote Plc |
|
|
1,691,585 |
|
|
291,069 |
|
|
Cape Plc |
|
|
1,493,368 |
|
|
120,308 |
|
|
Carillion Plc |
|
|
589,366 |
|
|
393,680 |
|
|
Catlin Group Ltd |
|
|
2,562,643 |
|
|
189,115 |
|
|
Cookson Group Plc |
|
|
1,481,938 |
|
|
127,197 |
|
|
Dairy Crest Group Plc |
|
|
662,478 |
|
|
793,079 |
|
|
Debenhams Plc |
|
|
794,725 |
|
|
461,511 |
|
|
Drax Group Plc |
|
|
4,064,654 |
|
|
476,762 |
|
|
DS Smith Plc |
|
|
1,506,124 |
|
|
332,317 |
|
|
Elementis Plc |
|
|
796,424 |
|
|
979,650 |
|
|
Enterprise Inns Plc * |
|
|
555,725 |
|
|
215,183 |
|
|
Fenner Plc |
|
|
1,329,492 |
|
|
270,174 |
|
|
Filtrona Plc |
|
|
1,667,550 |
|
|
517,674 |
|
|
FirstGroup Plc |
|
|
2,661,103 |
|
|
838,824 |
|
|
Game Group Plc |
|
|
97,928 |
|
|
71,469 |
|
|
GoAhead Group Plc |
|
|
1,371,077 |
|
|
147,077 |
|
|
Greene King Plc |
|
|
1,117,918 |
|
|
143,062 |
|
|
Halfords Group Plc |
|
|
742,109 |
|
|
889,326 |
|
|
Home Retail Group Plc |
|
|
1,257,109 |
|
|
461,414 |
|
|
Howden Joinery Group PLC * |
|
|
815,446 |
|
|
748,040 |
|
|
Inchcape Plc |
|
|
3,842,106 |
|
|
356,564 |
|
|
Intermediate Capital Group Plc |
|
|
1,350,506 |
|
|
79,675 |
|
|
Investec Plc |
|
|
453,606 |
|
|
79,423 |
|
|
John Wood Group Plc |
|
|
816,170 |
|
|
964,761 |
|
|
Johnston Press Plc * |
|
|
69,496 |
|
|
634,715 |
|
|
Kesa Electricals Plc |
|
|
887,743 |
|
|
168,358 |
|
|
Ladbrokes Plc |
|
|
342,338 |
|
|
103,475 |
|
|
Lancashire Holdings Ltd |
|
|
1,191,592 |
|
|
1,078,337 |
|
|
Logica Plc |
|
|
1,368,112 |
|
|
33,950 |
|
|
London Stock Exchange Group Plc |
|
|
461,499 |
|
|
774,188 |
|
|
Marstons Plc |
|
|
1,166,933 |
|
|
188,880 |
|
|
Mcbride Plc * |
|
|
374,185 |
|
|
110,436 |
|
|
Melrose Plc |
|
|
595,478 |
|
|
154,416 |
|
|
Mondi Plc |
|
|
1,113,730 |
|
|
418,401 |
|
|
Morgan Crucible Co Plc |
|
|
1,774,768 |
|
|
486,124 |
|
|
National Express Group Plc |
|
|
1,606,474 |
|
|
24,586 |
|
|
Next Plc |
|
|
1,039,182 |
|
|
8,080,027 |
|
|
Premier Foods Plc * |
|
|
747,307 |
|
|
1,547,924 |
|
|
Punch Taverns Plc * |
|
|
292,886 |
|
|
29,997 |
|
|
Rightmove Plc |
|
|
600,505 |
|
|
|
|
|
|
|
|
|
|
|
78,549 |
|
|
Savills Plc |
|
|
395,292 |
|
|
257,135 |
|
|
Senior Plc |
|
|
711,646 |
|
|
369,742 |
|
|
SIG Plc |
|
|
486,794 |
|
|
70,068 |
|
|
Smith News Plc |
|
|
94,199 |
|
|
76,664 |
|
|
Spectris Plc |
|
|
1,512,957 |
|
|
1,240,352 |
|
|
Spirit Pub Co Plc * |
|
|
773,530 |
|
|
433,117 |
|
|
Tate & Lyle Plc |
|
|
4,587,205 |
|
|
36,964 |
|
|
Telecity Group Plc * |
|
|
355,388 |
|
|
1,225,247 |
|
|
Thomas Cook Group Plc |
|
|
352,902 |
|
|
473,563 |
|
|
Trinity Mirror Plc * |
|
|
357,793 |
|
|
296,766 |
|
|
TUI Travel Plc |
|
|
805,440 |
|
|
292,074 |
|
|
Tullett Prebon Plc |
|
|
1,406,003 |
|
|
20,653 |
|
|
Weir Group Plc (The) |
|
|
671,314 |
|
|
42,158 |
|
|
WH Smith Plc |
|
|
348,325 |
|
|
999,785 |
|
|
William Hill Plc |
|
|
3,183,867 |
|
|
2,546,413 |
|
|
Yell Group Plc * |
|
|
200,964 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
70,359,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $369,836,599) |
|
|
340,359,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 3.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil 0.1% |
|
|
|
|
|
2,700 |
|
|
Centrais Eletricas de Santa Catarina SA 6.39% |
|
|
48,614 |
|
|
11,300 |
|
|
Eletropaulo Metropolitana SA 10.99% |
|
|
204,648 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Brazil |
|
|
253,262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 2.4% |
|
|
|
|
|
11,185 |
|
|
Biotest AG 1.19% |
|
|
555,010 |
|
|
12,493 |
|
|
Draegerwerk AG & Co 1.79% |
|
|
1,145,080 |
|
|
29,860 |
|
|
Hugo Boss AG 2.95% |
|
|
2,718,341 |
|
|
35,166 |
|
|
Jungheinrich AG 2.78% |
|
|
970,827 |
|
|
54,124 |
|
|
Porsche Automobil Holding SE 1.12% |
|
|
3,316,649 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
8,705,907 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russia 0.5% |
|
|
|
|
|
1,105 |
|
|
Transneft 0.70% |
|
|
1,822,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $8,897,131) |
|
|
10,781,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.0% |
|
|
|
|
|
477,222 |
|
|
BlueScope Steel Ltd, Expires 12/14/11* |
|
|
5,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia 0.0% |
|
|
|
|
|
11,833 |
|
|
Coastal Contracts Warrants, Expires 07/18/16* |
|
|
1,861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $25,737) |
|
|
7,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.2% |
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
178,050 |
|
|
GMO U.S. Treasury Fund |
|
|
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $4,453,039) |
|
|
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.7% |
|
|
|
|
AUD |
|
|
9,872 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11 |
|
|
10,152 |
|
CAD |
|
|
10,407 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11 |
|
|
10,204 |
|
CHF |
|
|
8,954 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
9,801 |
|
DKK |
|
|
247,728 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11 |
|
|
44,764 |
|
EUR |
|
|
154,824 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
208,037 |
|
GBP |
|
|
21,044 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
33,016 |
|
HKD |
|
|
77,918 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
10,030 |
|
JPY |
|
|
6,679,686 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
86,123 |
|
NOK |
|
|
56,392 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
9,764 |
|
NZD |
|
|
805 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11 |
|
|
629 |
|
SEK |
|
|
68,344 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11 |
|
|
10,099 |
|
SGD |
|
|
81,568 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
63,643 |
|
USD |
|
|
2,106,223 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
2,106,223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
2,602,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $2,602,485) |
|
|
2,602,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 98.7%
(Cost $385,814,991) |
|
|
358,203,909 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 1.3% |
|
|
4,634,099 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
362,838,008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
JPMorgan Chase Bank N.A. |
|
AUD |
|
|
1,267,478 |
|
|
$ |
1,301,221 |
|
|
$ |
24,643 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
AUD |
|
|
1,267,478 |
|
|
|
1,301,221 |
|
|
|
19,294 |
|
|
12/16/11 |
|
|
Brown Brothers & Harriman & Co. |
|
EUR |
|
|
144,291 |
|
|
|
193,904 |
|
|
|
1,780 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
GBP |
|
|
1,791,725 |
|
|
|
2,810,646 |
|
|
|
5,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
GBP |
|
|
2,350,311 |
|
|
|
3,686,890 |
|
|
|
(22,346 |
) |
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
GBP |
|
|
3,799,689 |
|
|
|
5,960,502 |
|
|
|
10,383 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
GBP |
|
|
1,419,050 |
|
|
|
2,226,038 |
|
|
|
10,626 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
HKD |
|
|
13,892,673 |
|
|
|
1,788,386 |
|
|
|
1,309 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
HKD |
|
|
21,035,165 |
|
|
|
2,707,831 |
|
|
|
1,194 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
HKD |
|
|
12,884,956 |
|
|
|
1,658,664 |
|
|
|
1,217 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
HKD |
|
|
9,225,235 |
|
|
|
1,187,553 |
|
|
|
701 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
HKD |
|
|
22,110,191 |
|
|
|
2,846,217 |
|
|
|
2,024 |
|
|
12/16/11 |
|
|
Bank of America N.A. |
|
NOK |
|
|
4,836,342 |
|
|
|
836,767 |
|
|
|
(21,363 |
) |
|
12/16/11 |
|
|
Bank of America N.A. |
|
SEK |
|
|
21,536,119 |
|
|
|
3,180,113 |
|
|
|
(46,333 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
SEK |
|
|
3,059,439 |
|
|
|
451,769 |
|
|
|
(4,377 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
SEK |
|
|
15,794,643 |
|
|
|
2,332,303 |
|
|
|
(24,180 |
) |
|
12/16/11 |
|
|
Bank of America, N.A. |
|
SGD |
|
|
12,170,331 |
|
|
|
9,495,979 |
|
|
|
(91,262 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
43,966,004 |
|
|
$ |
(130,846 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
CAD |
|
|
2,900,553 |
|
|
$ |
2,842,751 |
|
|
$ |
(10,347 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
CAD |
|
|
4,960,106 |
|
|
|
4,861,262 |
|
|
|
(10,302 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank N.A. |
|
CAD |
|
|
2,844,162 |
|
|
|
2,787,484 |
|
|
|
(18,945 |
) |
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CAD |
|
|
3,285,282 |
|
|
|
3,219,813 |
|
|
|
(6,427 |
) |
|
12/16/11 |
|
|
Bank of America, N.A. |
|
CHF |
|
|
883,340 |
|
|
|
967,210 |
|
|
|
(9,951 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
CHF |
|
|
883,340 |
|
|
|
967,210 |
|
|
|
13,059 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
CHF |
|
|
610,795 |
|
|
|
668,788 |
|
|
|
8,129 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
EUR |
|
|
1,989,078 |
|
|
|
2,673,000 |
|
|
|
46,627 |
|
|
12/16/11 |
|
|
Deutsche Bank AG |
|
EUR |
|
|
1,897,000 |
|
|
|
2,549,262 |
|
|
|
50,577 |
|
|
12/16/11 |
|
|
JPMorgan Chase Bank, N.A. |
|
EUR |
|
|
3,552,916 |
|
|
|
4,774,546 |
|
|
|
90,327 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
EUR |
|
|
963,468 |
|
|
|
1,294,745 |
|
|
|
22,919 |
|
|
12/16/11 |
|
|
Morgan Stanley Capital Services Inc. |
|
GBP |
|
|
1,577,000 |
|
|
|
2,473,811 |
|
|
|
(5,178 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
HKD |
|
|
12,059,000 |
|
|
|
1,552,340 |
|
|
|
(4,578 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
JPY |
|
|
162,579,782 |
|
|
|
2,096,883 |
|
|
|
17,919 |
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
JPY |
|
|
232,289,387 |
|
|
|
2,995,966 |
|
|
|
33,724 |
|
|
12/16/11 |
|
|
State Street Bank and Trust Company |
|
JPY |
|
|
160,681,000 |
|
|
|
2,072,393 |
|
|
|
22,180 |
|
|
12/16/11 |
|
|
Bank of America, N.A. |
|
NOK |
|
|
11,674,685 |
|
|
|
2,019,913 |
|
|
|
47,410 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
40,817,377 |
|
|
$ |
287,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
Expiration |
|
|
|
|
|
|
Appreciation |
|
Contracts |
|
|
Type |
|
Date |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
|
|
IBEX 35 |
|
December 2011 |
|
$ |
1,136,647 |
|
|
$ |
24,114 |
|
|
81 |
|
|
CAC 40 |
|
December 2011 |
|
|
3,441,192 |
|
|
|
140,084 |
|
|
19 |
|
|
MSCI Singapore |
|
December 2011 |
|
|
930,709 |
|
|
|
32,929 |
|
|
80 |
|
|
FTSE/MIB |
|
December 2011 |
|
|
8,236,000 |
|
|
|
966,909 |
|
|
57 |
|
|
FTSE 100 |
|
December 2011 |
|
|
4,933,150 |
|
|
|
(20,586 |
) |
|
70 |
|
|
TOPIX |
|
December 2011 |
|
|
6,724,206 |
|
|
|
(11,168 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
25,401,904 |
|
|
$ |
1,132,282 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67 |
|
|
S&P Toronto 60 |
|
December 2011 |
|
$ |
9,124,271 |
|
|
$ |
791 |
|
|
67 |
|
|
SPI 200 |
|
December 2011 |
|
|
7,318,339 |
|
|
|
(247,138 |
) |
|
312 |
|
|
OMXS 30 |
|
December 2011 |
|
|
4,561,496 |
|
|
|
(160,804 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
21,004,106 |
|
|
$ |
(407,151 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the
relevant broker or exchange.
Notes to Schedule of Investments:
Foreign Registered Shares issued to foreign investors in markets that have foreign ownership
limits.
REIT Real Estate Investment Trust
|
|
|
* |
|
Non-income producing security. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NOK Norwegian Krone
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$ 401,185,468
|
|
$ 24,683,591
|
|
$ (67,665,150)
|
|
$ (42,981,559) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in
conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury
Fund |
|
$ |
8,505,000 |
|
|
$ |
41,409,001 |
|
|
$ |
45,461,236 |
|
|
$ |
2,535 |
|
|
$ |
409 |
|
|
$ |
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale.
As of November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as
Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of
any of its OTC derivatives contracts based on the creditworthiness of its counterparties.
See Derivative financial instruments below for a further discussion on valuation of
derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
|
Equity Securities |
|
92.3% |
|
Futures Contracts |
|
0.2% |
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments including the following: With
respect to certain securities for which no current market or quoted prices were available, the
Fund valued those securities at the most recent available market or quoted price. Certain of the
Funds securities in Thailand were valued at the local price as adjusted by applying a premium
or discount when the holdings exceed foreign ownership limitations.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in |
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Identical Assets |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
14,278,381 |
|
|
$ |
|
|
|
$ |
14,278,381 |
|
Austria |
|
|
|
|
|
|
2,123,669 |
|
|
|
|
|
|
|
2,123,669 |
|
Belgium |
|
|
|
|
|
|
1,981,740 |
|
|
|
|
|
|
|
1,981,740 |
|
Brazil |
|
|
254,696 |
|
|
|
|
|
|
|
|
|
|
|
254,696 |
|
Canada |
|
|
14,526,626 |
|
|
|
|
|
|
|
|
|
|
|
14,526,626 |
|
Chile |
|
|
164,551 |
|
|
|
|
|
|
|
|
|
|
|
164,551 |
|
China |
|
|
|
|
|
|
171,223 |
|
|
|
|
|
|
|
171,223 |
|
Czech Republic |
|
|
|
|
|
|
100,204 |
|
|
|
|
|
|
|
100,204 |
|
France |
|
|
|
|
|
|
16,403,075 |
|
|
|
|
|
|
|
16,403,075 |
|
Germany |
|
|
|
|
|
|
22,657,906 |
|
|
|
|
|
|
|
22,657,906 |
|
Greece |
|
|
|
|
|
|
2,032,566 |
|
|
|
|
|
|
|
2,032,566 |
|
Hong Kong |
|
|
|
|
|
|
6,834,472 |
|
|
|
|
|
|
|
6,834,472 |
|
India |
|
|
|
|
|
|
1,397,650 |
|
|
|
|
|
|
|
1,397,650 |
|
Indonesia |
|
|
|
|
|
|
313,585 |
|
|
|
|
|
|
|
313,585 |
|
Ireland |
|
|
135,029 |
|
|
|
7,861,053 |
|
|
|
|
|
|
|
7,996,082 |
|
Israel |
|
|
|
|
|
|
1,313,231 |
|
|
|
|
|
|
|
1,313,231 |
|
Italy |
|
|
|
|
|
|
15,625,749 |
|
|
|
|
|
|
|
15,625,749 |
|
Japan |
|
|
|
|
|
|
112,191,238 |
|
|
|
|
|
|
|
112,191,238 |
|
Malaysia |
|
|
|
|
|
|
404,172 |
|
|
|
|
|
|
|
404,172 |
|
Netherlands |
|
|
|
|
|
|
6,054,141 |
|
|
|
|
|
|
|
6,054,141 |
|
New Zealand |
|
|
|
|
|
|
39,969 |
|
|
|
|
|
|
|
39,969 |
|
Norway |
|
|
|
|
|
|
2,244,844 |
|
|
|
|
|
|
|
2,244,844 |
|
Philippines |
|
|
|
|
|
|
183,130 |
|
|
|
|
|
|
|
183,130 |
|
Poland |
|
|
|
|
|
|
148,019 |
|
|
|
|
|
|
|
148,019 |
|
Singapore |
|
|
|
|
|
|
7,094,151 |
|
|
|
|
|
|
|
7,094,151 |
|
South Africa |
|
|
|
|
|
|
485,792 |
|
|
|
|
|
|
|
485,792 |
|
South Korea |
|
|
|
|
|
|
9,686,940 |
|
|
|
|
|
|
|
9,686,940 |
|
Spain |
|
|
|
|
|
|
7,556,791 |
|
|
|
|
|
|
|
7,556,791 |
|
Sweden |
|
|
|
|
|
|
7,937,496 |
|
|
|
9,639 |
|
|
|
7,947,135 |
|
Switzerland |
|
|
|
|
|
|
4,896,793 |
|
|
|
|
|
|
|
4,896,793 |
|
Taiwan |
|
|
|
|
|
|
2,383,263 |
|
|
|
|
|
|
|
2,383,263 |
|
Thailand |
|
|
|
|
|
|
|
|
|
|
42,624 |
|
|
|
42,624 |
|
Turkey |
|
|
|
|
|
|
465,399 |
|
|
|
|
|
|
|
465,399 |
|
United Kingdom |
|
|
773,530 |
|
|
|
69,586,397 |
|
|
|
|
|
|
|
70,359,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
15,854,432 |
|
|
|
324,453,039 |
|
|
|
52,263 |
|
|
|
340,359,734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazil |
|
|
253,262 |
|
|
|
|
|
|
|
|
|
|
|
253,262 |
|
Germany |
|
|
|
|
|
|
8,705,907 |
|
|
|
|
|
|
|
8,705,907 |
|
Russia |
|
|
|
|
|
|
1,822,221 |
|
|
|
|
|
|
|
1,822,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
253,262 |
|
|
|
10,528,128 |
|
|
|
|
|
|
|
10,781,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rights/Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
|
|
|
|
|
5,399 |
|
|
|
|
|
|
|
5,399 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malaysia |
|
|
|
|
|
|
1,861 |
|
|
|
|
|
|
|
1,861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS |
|
|
|
|
|
|
7,260 |
|
|
|
|
|
|
|
7,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
4,453,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
2,602,485 |
|
|
|
|
|
|
|
|
|
|
|
2,602,485 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
23,163,219 |
|
|
|
334,988,427 |
|
|
|
52,263 |
|
|
|
358,203,909 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
431,886 |
|
|
|
|
|
|
|
431,886 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
791 |
|
|
|
1,164,036 |
|
|
|
|
|
|
|
1,164,827 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
791 |
|
|
|
1,595,922 |
|
|
|
|
|
|
|
1,596,713 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
23,164,010 |
|
|
$ |
336,584,349 |
|
|
$ |
52,263 |
|
|
$ |
359,800,622 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in |
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for |
|
|
|
|
|
|
|
|
|
|
|
|
Identical |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Liabilities |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
$ |
|
|
|
$ |
(275,589 |
) |
|
$ |
|
|
|
$ |
(275,589 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
(439,696 |
) |
|
|
|
|
|
|
(439,696 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
|
|
|
|
(715,285 |
) |
|
|
|
|
|
|
(715,285 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(715,285 |
) |
|
$ |
|
|
|
$ |
(715,285 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net value of the Funds direct
investments in securities using Level 3 inputs was less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments Still |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
Balances as of |
|
|
Held as of |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Total Realized |
|
|
Appreciation |
|
|
Transfers into |
|
|
Transfers out |
|
|
November 30, |
|
|
November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
of level 3 * |
|
|
2011 |
|
|
2011 |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Egypt |
|
$ |
201,417 |
|
|
$ |
|
|
|
$ |
(109,955 |
) |
|
$ |
|
|
|
$ |
(34,642 |
) |
|
$ |
118,561 |
|
|
$ |
|
|
|
$ |
(175,381) |
** |
|
$ |
|
|
|
$ |
|
|
South Korea |
|
|
85,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,472 |
) |
|
|
|
|
|
|
(83,921) |
** |
|
|
|
|
|
|
|
|
Sweden |
|
|
10,297 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(658 |
) |
|
|
|
|
|
|
|
|
|
|
9,639 |
|
|
|
(658 |
) |
Thailand |
|
|
627,570 |
|
|
|
286,165 |
|
|
|
(197,649 |
) |
|
|
|
|
|
|
(199 |
) |
|
$ |
(43,470 |
) |
|
|
|
|
|
|
(629,793) |
** |
|
$ |
42,624 |
|
|
|
(36,988 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
924,677 |
|
|
$ |
286,165 |
|
|
$ |
(307,604 |
) |
|
$ |
|
|
|
$ |
(34,841 |
) |
|
$ |
72,961 |
|
|
$ |
|
|
|
$ |
(889,095 |
) |
|
$ |
52,263 |
|
|
$ |
(37,646 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3
at the value at the beginning of the period and transferred out of Level 3 at the
value at the end of the period. |
|
** |
|
Financial assets transferred between Level 2 and Level 3 were due to a
change in observable and/or unobservable inputs. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market
Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management
and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Liquidity
Risk Shares of small- and mid-cap companies often have lower trading
volumes and a limited number or no market makers. Thus, a large position may limit or
prevent the Fund from selling those shares or unwinding derivative positions on them at
desirable prices. The more less-liquid securities the Fund holds, the more likely it is to
honor a redemption request in-kind.
Foreign
Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and
custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency
Risk Fluctuations in exchange rates can adversely affect the market value of
the Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives
Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Smaller
Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small
companies often are less widely held and trade less frequently and in lesser quantities,
and their market prices often fluctuate more, than the securities of companies with larger
market capitalizations.
Counterparty
Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging
Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Focused
Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market
Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large
Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may
result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to manage against anticipated currency exchange
rate changes and adjust exposure to foreign currencies. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain securities markets and maintain the diversity and liquidity of
the portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC
options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments
purchased. Gains and losses from the expiration or closing of written option contracts are
separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used total return swap
agreements to achieve returns comparable to holding and lending a direct equity
position. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or warrants held
by the Fund at the end of the period are listed in the Funds Schedule of Investments.
The
following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
7,260 |
|
|
$ |
|
|
|
$ |
7,260 |
|
Unrealized appreciation on forward currency contracts |
|
|
|
|
|
|
431,886 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
431,886 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,164,827 |
|
|
|
|
|
|
|
1,164,827 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
431,886 |
|
|
$ |
|
|
|
$ |
1,172,087 |
|
|
$ |
|
|
|
$ |
1,603,973 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(275,589 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(275,589 |
) |
Unrealized depreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(439,696 |
) |
|
|
|
|
|
|
(439,696 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(275,589 |
) |
|
$ |
|
|
|
$ |
(439,696 |
) |
|
$ |
|
|
|
$ |
(715,285 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table above
is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives. Changes
to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater risk) the
greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts, futures
contracts and rights and/or warrants), notional amounts (swap agreements) outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Rights and /or |
|
|
Swap |
|
|
|
Contracts |
|
|
Contracts |
|
|
Warrants |
|
|
Agreements |
|
Average amount outstanding |
|
$ |
91,095,397 |
|
|
$ |
45,194,288 |
|
|
$ |
58,828 |
|
|
$ |
71,339 |
|
For additional information regarding the Funds Schedule of Investments, please see
the Funds most recent annual or semiannual shareholder report filed on the Securities and
Exchange Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Quality Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 96.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 0.1% |
|
|
|
|
|
281,900 |
|
|
3M Co. |
|
|
22,845,176 |
|
|
9,600 |
|
|
United Technologies Corp. |
|
|
735,360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
23,580,536 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 1.3% |
|
|
|
|
|
2,341,300 |
|
|
Nike, Inc.-Class B |
|
|
225,186,234 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 0.5% |
|
|
|
|
|
985,900 |
|
|
McDonalds Corp. |
|
|
94,173,168 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 8.6% |
|
|
|
|
|
11,061,149 |
|
|
BP Plc |
|
|
80,108,778 |
|
|
5,567,370 |
|
|
Chevron Corp. |
|
|
572,436,983 |
|
|
5,225,300 |
|
|
Exxon Mobil Corp. |
|
|
420,323,132 |
|
|
6,371,784 |
|
|
Royal Dutch Shell Group-Class A |
|
|
222,850,534 |
|
|
4,963,543 |
|
|
Total SA |
|
|
256,081,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
1,551,801,114 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 4.3% |
|
|
|
|
|
2,109,000 |
|
|
Sysco Corp. |
|
|
60,190,860 |
|
|
3,620,500 |
|
|
Walgreen Co. |
|
|
122,083,260 |
|
|
10,124,500 |
|
|
WalMart Stores, Inc. |
|
|
596,333,050 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food & Staples Retailing |
|
|
778,607,170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 18.3% |
|
|
|
|
|
178,500 |
|
|
Altria Group, Inc. |
|
|
5,121,165 |
|
|
1,873,031 |
|
|
Anheuser-Busch InBev NV |
|
|
112,001,132 |
|
|
5,286,577 |
|
|
British American Tobacco Plc |
|
|
245,334,450 |
|
|
11,176,400 |
|
|
Coca-Cola Co. (The) |
|
|
751,389,372 |
|
|
1,067,600 |
|
|
Hansen Natural Corp.* |
|
|
98,432,720 |
|
|
1,046,400 |
|
|
Lorillard, Inc. |
|
|
116,799,168 |
|
|
3,849,732 |
|
|
Nestle SA |
|
|
216,057,490 |
|
|
6,939,200 |
|
|
PepsiCo, Inc. |
|
|
444,108,800 |
|
|
12,209,300 |
|
|
Philip Morris International, Inc. |
|
|
930,837,032 |
|
|
14,400 |
|
|
Reynolds American, Inc. |
|
|
602,784 |
|
|
11,022,061 |
|
|
Unilever NV |
|
|
375,409,341 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
3,296,093,454 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 5.1% |
|
|
|
|
|
44,600 |
|
|
Baxter International, Inc. |
|
|
2,304,036 |
|
|
36,600 |
|
|
Cerner Corp.* |
|
|
2,231,868 |
|
|
4,802,780 |
|
|
Express Scripts, Inc.* |
|
|
219,246,907 |
|
|
301,500 |
|
|
Henry Schein, Inc.* |
|
|
19,398,510 |
|
|
11,300 |
|
|
Intuitive Surgical, Inc.* |
|
|
4,906,573 |
|
|
69,200 |
|
|
Laboratory Corp. of America Holdings* |
|
|
5,931,824 |
|
|
600,500 |
|
|
Lincare Holdings, Inc. |
|
|
14,231,850 |
|
|
5,568,730 |
|
|
Medtronic, Inc. |
|
|
202,868,834 |
|
|
360,300 |
|
|
Quest Diagnostics, Inc. |
|
|
21,135,198 |
|
|
6,486,494 |
|
|
UnitedHealth Group, Inc. |
|
|
316,346,312 |
|
|
34,600 |
|
|
WellPoint, Inc. |
|
|
2,441,030 |
|
|
2,151,275 |
|
|
Zimmer Holdings, Inc.* |
|
|
108,746,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
919,789,893 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 4.1% |
|
|
|
|
|
714,700 |
|
|
Church & Dwight Co., Inc. |
|
|
31,625,475 |
|
|
3,047,300 |
|
|
ColgatePalmolive Co. |
|
|
278,827,950 |
|
|
6,557,300 |
|
|
Procter & Gamble Co. (The) |
|
|
423,404,861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
733,858,286 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 19.6% |
|
|
|
|
|
7,471,005 |
|
|
Abbott Laboratories |
|
|
407,543,323 |
|
|
3,062,160 |
|
|
Amgen, Inc. |
|
|
177,329,686 |
|
|
2,448,798 |
|
|
AstraZeneca Plc |
|
|
112,786,087 |
|
|
53,000 |
|
|
BristolMyers Squibb Co. |
|
|
1,734,160 |
|
|
1,219,800 |
|
|
Eli Lilly & Co. |
|
|
46,169,431 |
|
|
456,700 |
|
|
Gilead Sciences, Inc.* |
|
|
18,199,495 |
|
|
8,847,180 |
|
|
GlaxoSmithKline Plc |
|
|
196,071,467 |
|
|
15,367,500 |
|
|
Johnson & Johnson |
|
|
994,584,600 |
|
|
7,298,900 |
|
|
Merck & Co., Inc. |
|
|
260,935,675 |
|
|
4,083,830 |
|
|
Novartis AG (Registered) |
|
|
220,543,989 |
|
|
34,030,548 |
|
|
Pfizer, Inc. |
|
|
682,993,098 |
|
|
1,229,399 |
|
|
Roche Holding AG |
|
|
195,565,630 |
|
|
2,392,367 |
|
|
Sanofi-Aventis |
|
|
167,336,318 |
|
|
921,200 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
37,837,331 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
3,519,630,290 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 2.3% |
|
|
|
|
|
7,707,800 |
|
|
Lowes Cos., Inc. |
|
|
185,064,278 |
|
|
4,343,600 |
|
|
Target Corp. |
|
|
228,907,720 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
413,971,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 19.8% |
|
|
|
|
|
1,286,660 |
|
|
Google, Inc.-Class A* |
|
|
771,211,137 |
|
|
2,194,270 |
|
|
International Business Machines Corp. |
|
|
412,522,760 |
|
|
473,980 |
|
|
MasterCard, Inc.-Class A |
|
|
177,529,209 |
|
|
39,124,500 |
|
|
Microsoft Corp. |
|
|
1,000,804,710 |
|
|
25,699,500 |
|
|
Oracle Corp. |
|
|
805,679,325 |
|
|
2,578,107 |
|
|
SAP AG |
|
|
154,375,252 |
|
|
2,130,800 |
|
|
Visa, Inc.-Class A |
|
|
206,623,676 |
|
|
84,838 |
|
|
Yahoo! Japan Corp. |
|
|
26,882,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
3,555,628,462 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 11.5% |
|
|
|
|
|
1,562,990 |
|
|
Apple, Inc.* |
|
|
597,374,778 |
|
|
51,704,800 |
|
|
Cisco Systems, Inc. |
|
|
963,777,472 |
|
|
9,631,200 |
|
|
Hewlett-Packard Co. |
|
|
269,192,040 |
|
|
4,350,100 |
|
|
Qualcomm, Inc. |
|
|
238,385,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
2,068,729,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 0.9% |
|
|
|
|
|
96,242 |
|
|
NTT Docomo Inc |
|
|
170,112,010 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $15,128,584,447) |
|
|
17,351,162,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 0.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 0.3% |
|
|
|
|
|
2,596,128 |
|
|
GMO U.S. Treasury Fund |
|
|
64,929,160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $64,918,441) |
|
|
64,929,160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 2.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 1.0% |
|
|
|
|
|
177,352,250 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a) |
|
|
177,352,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 1.7% |
|
|
|
|
|
300,000,000 |
|
|
U.S. Treasury Bill, 0.06%, due 05/31/12 (b) |
|
|
299,916,600 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $477,246,083) |
|
|
477,268,850 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.4%
(Cost $15,670,748,971) |
|
|
17,893,360,395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.6% |
|
|
102,154,413 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
17,995,514,808 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
|
|
|
* |
|
Non-income producing security. |
|
(a) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(b) |
|
Rate shown represents yield-to-maturity. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
| |
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 16,010,037,366 |
|
$ |
1,953,519,707 |
|
|
$ |
(70,196,678 |
) |
|
$ |
1,883,323,029 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjuction with the Funds Schedule of Investments.
A summary of the Funds transcations in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury
Fund |
|
$ |
52,104,000 |
|
|
$ |
41,416,000 |
|
|
$ |
28,613,000 |
|
|
$ |
22,438 |
|
|
$ |
2,934 |
|
|
$ |
64,929,160 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Country Summary* |
|
% of Investments |
|
United States |
|
|
83.9 |
% |
United Kingdom |
|
|
4.9 |
|
Switzerland |
|
|
3.6 |
|
France |
|
|
2.4 |
|
Netherlands |
|
|
2.2 |
|
Japan |
|
|
1.4 |
|
Germany |
|
|
0.9 |
|
Belgium |
|
|
0.7 |
|
|
|
|
|
|
|
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
* |
|
The table above shows country exposure
in the Fund. The table excludes short
term investments. The table excludes
exposure through forward currency
contracts and includes exposure through
other derivative financial instruments, if
any. The table takes into account the
market value of securities and options and
the notional amounts of swap agreements
and other derivative financial
instruments, if any. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities
|
|
15.5% |
|
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the
valuation of the Funds investments. The inputs or methodology used for valuing securities are
not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to securities (including the value of equity securities that underlie futures (to the
extent the market for such futures closes prior to the close of the NYSE) and other derivatives)
due to market events that have occurred since the local market close but prior to the close of
the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium |
|
$ |
|
|
|
$ |
112,001,132 |
|
|
$ |
|
|
|
$ |
112,001,132 |
|
France |
|
|
|
|
|
|
423,418,005 |
|
|
|
|
|
|
|
423,418,005 |
|
Germany |
|
|
|
|
|
|
154,375,252 |
|
|
|
|
|
|
|
154,375,252 |
|
Japan |
|
|
|
|
|
|
234,831,734 |
|
|
|
|
|
|
|
234,831,734 |
|
Netherlands |
|
|
|
|
|
|
375,409,341 |
|
|
|
|
|
|
|
375,409,341 |
|
Switzerland |
|
|
|
|
|
|
632,167,109 |
|
|
|
|
|
|
|
632,167,109 |
|
United Kingdom |
|
|
|
|
|
|
857,151,316 |
|
|
|
|
|
|
|
857,151,316 |
|
United States |
|
|
14,561,808,496 |
|
|
|
|
|
|
|
|
|
|
|
14,561,808,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
14,561,808,496 |
|
|
|
2,789,353,889 |
|
|
|
|
|
|
|
17,351,162,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
64,929,160 |
|
|
|
|
|
|
|
|
|
|
|
64,929,160 |
|
Short-Term Investments |
|
|
477,268,850 |
|
|
|
|
|
|
|
|
|
|
|
477,268,850 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
15,104,006,506 |
|
|
$ |
2,789,353,889 |
|
|
$ |
|
|
|
$ |
17,893,360,395 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Declines in stock market
prices generally are likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Focused Investment Risk Focusing investments in a limited number of countries,
sectors or companies or in industries with high positive correlations to one another
creates additional risk. The Fund invests its assets in the securities of a limited number
of issuers, and a decline in the market value of a particular security held by the Fund may
affect the Funds performance more than if the Fund invested in the securities of a larger
number of issuers.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to
be greater for investments in companies tied economically to emerging countries, the
economies of which tend to be more volatile than the economies of developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund
may decide not to pursue its claims against the counterparty in order to avoid incurring the
cost and unpredictability of legal proceedings. The Fund, therefore, may be unable to obtain
payments the Manager believes are owed under OTC derivatives contracts or those payments may be
delayed or made only after the Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. The Fund had no forward currency
contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
maintain the diversity and liquidity of the portfolio and adjust
exposure to certain securities markets. The Fund had no futures
contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The volume of derivative activity, based on absolute values (futures contracts) outstanding at
each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
Futures |
|
|
Contracts |
Average amount outstanding |
|
$ |
28,589,137 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and
Exchange Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Real Estate Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
REAL ESTATE INVESTMENTS 98.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REAL ESTATE INVESTMENT TRUSTS 98.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified 6.3% |
|
|
|
|
|
2,500 |
|
|
CapLease, Inc. |
|
|
10,375 |
|
|
3,200 |
|
|
Colonial Properties Trust |
|
|
63,488 |
|
|
3,500 |
|
|
Liberty Property Trust |
|
|
104,335 |
|
|
700 |
|
|
PS Business Parks, Inc. |
|
|
36,890 |
|
|
9,446 |
|
|
Vornado Realty Trust |
|
|
703,255 |
|
|
900 |
|
|
Washington Real Estate Investment Trust |
|
|
24,489 |
|
|
1,300 |
|
|
Winthrop Realty Trust |
|
|
12,142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified |
|
|
954,974 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial 4.1% |
|
|
|
|
|
9,200 |
|
|
DCT Industrial Trust, Inc. |
|
|
44,252 |
|
|
2,400 |
|
|
DuPont Fabros Technology, Inc. |
|
|
54,072 |
|
|
1,500 |
|
|
EastGroup Properties, Inc. |
|
|
63,855 |
|
|
2,000 |
|
|
First Industrial Realty Trust, Inc. * |
|
|
19,000 |
|
|
15,760 |
|
|
ProLogis, Inc. |
|
|
438,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Industrial |
|
|
619,622 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Office 15.1% |
|
|
|
|
|
3,170 |
|
|
Alexandria Real Estate Equities, Inc. |
|
|
207,825 |
|
|
7,200 |
|
|
BioMed Realty Trust, Inc. |
|
|
128,232 |
|
|
8,400 |
|
|
Boston Properties, Inc. |
|
|
801,192 |
|
|
4,289 |
|
|
Brandywine Realty Trust |
|
|
37,357 |
|
|
4,225 |
|
|
CommonWealth REIT |
|
|
70,727 |
|
|
1,000 |
|
|
Corporate Office Properties Trust |
|
|
20,850 |
|
|
3,300 |
|
|
Digital Realty Trust, Inc. |
|
|
209,550 |
|
|
4,800 |
|
|
Douglas Emmett, Inc. |
|
|
86,304 |
|
|
8,000 |
|
|
Duke Realty Corp. |
|
|
92,800 |
|
|
2,900 |
|
|
Franklin Street Properties Corp. |
|
|
31,639 |
|
|
1,200 |
|
|
Government Properties Income Trust |
|
|
26,100 |
|
|
2,600 |
|
|
Highwoods Properties, Inc. |
|
|
74,984 |
|
|
2,600 |
|
|
Kilroy Realty Corp. |
|
|
93,834 |
|
|
4,608 |
|
|
Lexington Realty Trust |
|
|
34,929 |
|
|
2,200 |
|
|
Mack-Cali Realty Corp. |
|
|
56,056 |
|
|
3,200 |
|
|
Piedmont Office Realty Trust, Inc.-Class A |
|
|
53,248 |
|
|
4,023 |
|
|
SL Green Realty Corp. |
|
|
264,874 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Office |
|
|
2,290,501 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential 18.5% |
|
|
|
|
|
1,800 |
|
|
American Campus Communities, Inc. |
|
|
70,812 |
|
|
5,886 |
|
|
Apartment Investment & Management Co.-Class A |
|
|
128,197 |
|
|
5,283 |
|
|
AvalonBay Communities, Inc. |
|
|
659,583 |
|
|
4,000 |
|
|
BRE Properties, Inc. |
|
|
194,640 |
|
|
2,700 |
|
|
Camden Property Trust |
|
|
155,871 |
|
|
3,100 |
|
|
Education Realty Trust, Inc. |
|
|
28,892 |
|
|
1,000 |
|
|
Equity Lifestyle Properties, Inc. |
|
|
61,830 |
|
|
15,000 |
|
|
Equity Residential |
|
|
827,850 |
|
|
1,170 |
|
|
Essex Property Trust, Inc. |
|
|
155,435 |
|
|
1,800 |
|
|
Home Properties, Inc. |
|
|
98,946 |
|
|
1,600 |
|
|
Mid-America Apartment Communities, Inc. |
|
|
91,712 |
|
|
2,500 |
|
|
Post Properties, Inc. |
|
|
99,975 |
|
|
1,000 |
|
|
Sun Communities, Inc. |
|
|
35,740 |
|
|
|
|
|
|
|
|
|
|
|
7,881 |
|
|
UDR, Inc. |
|
|
185,203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential |
|
|
2,794,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail 26.9% |
|
|
|
|
|
1,984 |
|
|
Acadia Realty Trust |
|
|
38,847 |
|
|
70 |
|
|
Alexanders, Inc. |
|
|
27,763 |
|
|
7,731 |
|
|
CBL & Associates Properties, Inc. |
|
|
110,476 |
|
|
11,197 |
|
|
DDR Corp. |
|
|
130,893 |
|
|
2,200 |
|
|
Equity One, Inc. |
|
|
36,762 |
|
|
2,300 |
|
|
Federal Realty Investment Trust |
|
|
203,389 |
|
|
5,200 |
|
|
General Growth Properties, Inc. |
|
|
73,216 |
|
|
1,300 |
|
|
Getty Realty Corp. |
|
|
20,800 |
|
|
18,258 |
|
|
Kimco Realty Corp. |
|
|
287,928 |
|
|
7,396 |
|
|
Macerich Co. (The) |
|
|
370,539 |
|
|
3,400 |
|
|
National Retail Properties, Inc. |
|
|
89,964 |
|
|
3,300 |
|
|
Ramco-Gershenson Properties Trust |
|
|
28,017 |
|
|
3,700 |
|
|
Realty Income Corp. |
|
|
125,282 |
|
|
3,800 |
|
|
Regency Centers Corp. |
|
|
141,208 |
|
|
300 |
|
|
Saul Centers, Inc. |
|
|
10,473 |
|
|
16,153 |
|
|
Simon Property Group, Inc. |
|
|
2,008,464 |
|
|
1,400 |
|
|
Tanger Factory Outlet Centers, Inc. |
|
|
39,690 |
|
|
3,000 |
|
|
Taubman Centers, Inc. |
|
|
186,990 |
|
|
1,000 |
|
|
Urstadt Biddle Properties, Inc. |
|
|
16,870 |
|
|
5,900 |
|
|
Weingarten Realty Investors |
|
|
122,071 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retail |
|
|
4,069,642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialized 27.8% |
|
|
|
|
|
6,611 |
|
|
DiamondRock Hospitality Co. |
|
|
58,045 |
|
|
2,600 |
|
|
Entertainment Properties Trust |
|
|
116,220 |
|
|
4,300 |
|
|
Extra Space Storage, Inc. |
|
|
103,630 |
|
|
18,500 |
|
|
HCP, Inc. |
|
|
715,025 |
|
|
8,000 |
|
|
Health Care, Inc. |
|
|
401,360 |
|
|
1,200 |
|
|
Healthcare Realty Trust, Inc. |
|
|
21,144 |
|
|
6,100 |
|
|
Hospitality Properties Trust |
|
|
134,383 |
|
|
22,137 |
|
|
Host Hotels & Resorts, Inc. |
|
|
313,238 |
|
|
3,200 |
|
|
LaSalle Hotel Properties |
|
|
74,912 |
|
|
1,200 |
|
|
LTC Properties, Inc. |
|
|
34,500 |
|
|
6,300 |
|
|
Medical Properties Trust, Inc. |
|
|
60,228 |
|
|
1,400 |
|
|
National Health Investors, Inc. |
|
|
59,234 |
|
|
4,100 |
|
|
Omega Healthcare Investors, Inc. |
|
|
73,513 |
|
|
8,484 |
|
|
Public Storage |
|
|
1,119,040 |
|
|
8,200 |
|
|
Senior Housing Properties Trust |
|
|
179,662 |
|
|
1,400 |
|
|
Sovran Self Storage, Inc. |
|
|
58,296 |
|
|
4,500 |
|
|
Sunstone Hotel Investors, Inc. * |
|
|
34,290 |
|
|
800 |
|
|
Universal Health Realty Income Trust |
|
|
29,528 |
|
|
11,904 |
|
|
Ventas, Inc. |
|
|
628,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Specialized |
|
|
4,214,303 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL REAL ESTATE INVESTMENT TRUSTS (COST $11,498,233) |
|
|
14,943,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL REAL ESTATE INVESTMENTS (COST $11,498,233) |
|
|
14,943,728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 1.2% |
|
|
|
|
|
7,638 |
|
|
GMO U.S. Treasury Fund |
|
|
191,041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $191,041) |
|
|
191,041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.4% |
|
|
|
|
|
57,466 |
|
|
State Street
Institutional Treasury Money Market Fund-Institutional Class, 0.00%(a) |
|
|
57,466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $57,466) |
|
|
57,466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.3%
(Cost $11,746,740) |
|
|
15,192,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.3%) |
|
|
(46,652 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
15,145,583 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
REIT Real Estate Investment Trust
* Non-income producing security.
(a) Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%.
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 12,740,566 |
|
$ |
2,731,021 |
|
|
$ |
(279,352 |
) |
|
$ |
2,451,669 |
|
Investments in affiliated issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury
Fund |
|
$ |
201,043 |
|
|
$ |
361,000 |
|
|
$ |
371,062 |
|
|
$ |
56 |
|
|
$ |
2 |
|
|
$ |
191,041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale.
See Derivative financial instruments below for a further discussion on valuation of
derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
14,943,728 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
14,943,728 |
|
Mutual Funds |
|
|
191,041 |
|
|
|
|
|
|
|
|
|
|
|
191,041 |
|
Short-Term Investments |
|
|
57,466 |
|
|
|
|
|
|
|
|
|
|
|
57,466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
15,192,235 |
|
|
|
|
|
|
|
|
|
|
|
15,192,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
15,192,235 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
15,192,235 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All of the Funds common stocks held at period end are classified as Level 1. Please refer
to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Real Estate Risk Real estate-related investments may decline in value as a result of
factors affecting the real estate industry, such as the supply of real property in
particular markets, changes in zoning laws, delays in completion of construction, changes
in real estate values, changes in property taxes, levels of occupancy, adequacy of rent to
cover operating expenses, and local and regional market conditions. The value of real
estate-related investments also may be affected by changes in interest rates and social and
economic trends. REITs are subject to the risk of fluctuations in income from underlying
real estate assets, their inability to manage effectively the cash flows generated by those
assets, prepayments and defaults by borrowers, and failing to qualify for the special tax
treatment granted to REITs under the Internal Revenue Code of 1986 and/or to maintain
exempt status under the 1940 Act.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Models that have demonstrated an
ability to explain prior market data often fail to accurately predict future market events.
Further, the data used in models may be inaccurate and/or it may not include the
most recent information about a company or a security. The Fund is also subject to the risk
that deficiencies in the Managers or another service providers internal systems or
controls will cause losses for the Fund or impair Fund operations.
Focused Investment Risk Focusing investments in sectors and industries with high
positive correlations to one another creates additional risk. The Funds concentration in
real estate-related investments make the Funds net asset value more susceptible to
economic, market, political and other developments affecting the real estate industry.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of rising interest rates and widening
of credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives
transactions (for example, by increasing margin or capital requirements), and the Fund may be
unable to execute its investment strategy as a result. It is unclear how the regulatory changes
will affect counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the
period.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Short-Duration Collateral Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT
OBLIGATIONS 95.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed
Securities 92.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Airlines
1.0% |
|
|
|
|
|
15,899,466 |
|
|
Aircraft Finance Trust, Series 99-1A, Class A1, 144A, 1 mo. LIBOR + .48%, 0.73%, due 05/15/24 |
|
|
7,631,744 |
|
|
5,543,053 |
|
|
Continental Airlines, Inc., Series 99-1A, 6.55%, due 02/02/19 |
|
|
5,743,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Airlines |
|
|
13,375,456 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto
Financing 5.0% |
|
|
|
|
|
3,408,323 |
|
|
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14 |
|
|
3,418,991 |
|
|
18,763,784 |
|
|
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13 |
|
|
18,878,055 |
|
|
9,863,179 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4A, 5.32%, due 11/10/14 |
|
|
9,917,427 |
|
|
7,695,934 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14 |
|
|
7,715,173 |
|
|
15,866,255 |
|
|
Ford Credit Auto Owner Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 2.00%, 2.25%, due 03/15/13 |
|
|
15,936,860 |
|
|
571,193 |
|
|
Franklin Auto Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.95%, 2.20%, due 05/20/16 |
|
|
571,759 |
|
|
7,761,609 |
|
|
Wachovia Auto Owner Trust, Series 08-A, Class A4B, 1 mo. LIBOR + 1.15%, 1.40%, due 03/20/14 |
|
|
7,787,921 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Auto Financing |
|
|
64,226,186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business
Loans 4.9% |
|
|
|
|
|
4,213,868 |
|
|
ACAS Business Loan Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .14%, 0.60%, due 08/16/19 |
|
|
4,108,522 |
|
|
2,391,864 |
|
|
Bayview Commercial Asset Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .36%, 0.62%, due 04/25/34 |
|
|
1,817,816 |
|
|
1,941,375 |
|
|
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due
01/25/35 |
|
|
1,456,031 |
|
|
8,142,267 |
|
|
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due
01/25/36 |
|
|
5,129,628 |
|
|
7,759,078 |
|
|
Bayview Commercial Asset Trust, Series 07-3, Class A1, 144A, 1 mo. LIBOR + .24%, 0.50%, due
07/25/37 |
|
|
4,888,219 |
|
|
29,790,702 |
|
|
Bayview Commercial Asset Trust, Series 07-6A, Class A2, 144A, 1 mo. LIBOR + 1.30%, 1.56%, due
12/25/37 |
|
|
20,853,492 |
|
|
2,507,397 |
|
|
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32 |
|
|
2,219,046 |
|
|
4,958,169 |
|
|
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33 |
|
|
4,065,699 |
|
|
13,210,392 |
|
|
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%,
1.11%, due 10/25/37 |
|
|
10,563,293 |
|
|
6,275,837 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%,
0.51%, due 02/25/30 |
|
|
4,829,633 |
|
|
3,695,292 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%,
0.51%, due 09/25/30 |
|
|
2,915,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Business Loans |
|
|
62,846,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS
10.2% |
|
|
|
|
|
9,329,969 |
|
|
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%,
0.37%, due 07/15/44 |
|
|
9,213,344 |
|
|
32,300,000 |
|
|
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR +
..13%, 0.38%, due 12/15/20 |
|
|
29,231,500 |
|
|
8,393,598 |
|
|
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45 |
|
|
8,393,598 |
|
|
12,996,913 |
|
|
GE Capital Commercial Mortgage Corp., Series 06-C1, Class A2, 5.33%, due 03/10/44 |
|
|
12,996,913 |
|
|
14,865,787 |
|
|
GS Mortgage Securities Corp., Series 06-GG6, Class A2, 5.51%, due 04/10/38 |
|
|
15,009,799 |
|
|
5,429,083 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A1, 144A, 1 mo. LIBOR + .39%, 1.14%, due
03/06/20 |
|
|
5,374,792 |
|
|
6,300,000 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due
03/06/20 |
|
|
6,237,000 |
|
|
3,781,834 |
|
|
J.P. Morgan Chase Commercial Mortgage Securities Corp., Series 06-LDP7, Class A2, 5.86%, due
04/15/45 |
|
|
3,784,103 |
|
|
|
|
|
|
|
|
|
|
|
18,540,572 |
|
|
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39 |
|
|
18,903,967 |
|
|
7,084,521 |
|
|
Morgan Stanley Capital I, Series 06-IQ11, Class A3, 5.69%, due 10/15/42 |
|
|
7,222,598 |
|
|
15,599,822 |
|
|
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%,
0.34%, due 09/15/21 |
|
|
14,819,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS |
|
|
131,187,445 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS
Collateralized Debt Obligations 2.9% |
|
|
|
|
|
4,398,348 |
|
|
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A,
144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52 |
|
|
43,983 |
|
|
5,456,063 |
|
|
Crest Exeter Street Solar, Series 04-1A, Class A1, 144A, 3 mo. LIBOR + .35%, 0.71%, due
06/28/19 |
|
|
5,019,578 |
|
|
9,828,889 |
|
|
G-Force LLC, Series 05-RR2, Class A2, 144A, 5.16%, due 12/25/39 |
|
|
9,239,156 |
|
|
4,626,495 |
|
|
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%,
0.58%, due 08/26/30 |
|
|
4,267,942 |
|
|
25,952,503 |
|
|
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due
05/25/46 |
|
|
18,945,327 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS Collateralized Debt Obligations |
|
|
37,515,986 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
Collateralized Debt Obligations 2.4% |
|
|
|
|
|
34,200,000 |
|
|
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13 |
|
|
30,126,780 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Cards 9.4% |
|
|
|
|
|
7,700,000 |
|
|
Capital One Multi-Asset Execution Trust, Series 07-A4, Class A4, 1 mo. LIBOR + .03%, 0.28%,
due 03/16/15 |
|
|
7,689,451 |
|
|
39,000,000 |
|
|
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due
09/15/17 |
|
|
39,064,350 |
|
|
46,600,000 |
|
|
Chase Issuance Trust, Series 05-A6, Class A6, 1 mo. LIBOR + .07%, 0.32%, due 07/15/14 |
|
|
46,578,156 |
|
|
16,400,000 |
|
|
Discover Card Master Trust I, Series 05-4, Class A2, 1 mo. LIBOR + .09%, 0.34%, due 06/16/15 |
|
|
16,392,313 |
|
|
10,600,000 |
|
|
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR +
..13%, 0.38%, due 02/15/17 |
|
|
10,517,214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Credit Cards |
|
|
120,241,484 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Auto Financing 5.4% |
|
|
|
|
|
5,962,022 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%,
0.29%, due 10/06/13 |
|
|
5,947,117 |
|
|
5,854,354 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-BF, Class A4, FSA, 1 mo. LIBOR + .05%,
0.30%, due 12/06/13 |
|
|
5,854,236 |
|
|
6,083,450 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%,
1.05%, due 06/06/14 |
|
|
6,080,311 |
|
|
13,116,927 |
|
|
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR +
..50%, 0.75%, due 03/08/16 |
|
|
13,067,083 |
|
|
37,989,036 |
|
|
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%,
due 07/14/14 |
|
|
38,174,043 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Auto Financing |
|
|
69,122,790 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Business Loans 0.1% |
|
|
|
|
|
2,105,328 |
|
|
CNL Commercial Mortgage Loan Trust, Series 03-2A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .44%,
0.70%, due 10/25/30 |
|
|
1,526,363 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
High Yield Collateralized Debt Obligations ♣ 0.9% |
|
|
|
|
|
13,578,846 |
|
|
Augusta Funding Ltd., Series 10A, Class F1, 144A, CapMAC, 3mo. LIBOR +.25%, 0.62%, due
06/30/17(a) |
|
|
11,935,260 |
|
|
223,575 |
|
|
GSC Partners CDO Fund Ltd., Series 03-4A, Class A3, 144A, AMBAC, 3 mo. LIBOR + .46%, 0.87%,
due 12/16/15 |
|
|
220,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured High Yield Collateralized Debt Obligations |
|
|
12,155,481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Other 5.6% |
|
|
|
|
|
45,300,000 |
|
|
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37 |
|
|
45,474,405 |
|
|
9,429,020 |
|
|
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due
09/15/41 |
|
|
8,354,628 |
|
|
8,892,105 |
|
|
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due
12/15/41 |
|
|
7,910,847 |
|
|
9,277,851 |
|
|
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14 |
|
|
7,422,281 |
|
|
2,988,000 |
|
|
Toll Road
Investment Part II, Series 1999B, 144A, MBIA, Zero Coupon, due 02/15/30 |
|
|
404,366 |
|
|
26,300,000 |
|
|
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37 |
|
|
1,646,117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Other |
|
|
71,212,644 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Residential Asset-Backed Securities (United States) ♦
0.9% |
|
|
|
|
|
2,134,976 |
|
|
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%,
due 07/25/34 |
|
|
1,686,631 |
|
|
2,424,167 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 03-HE3, Class A, AMBAC, 1 mo. LIBOR + .38%,
0.64%, due 12/25/33 |
|
|
1,951,454 |
|
|
667,926 |
|
|
Quest Trust, Series 04-X1, Class A, 144A, AMBAC, 1 mo. LIBOR + .33%, 0.59%, due 03/25/34 |
|
|
500,945 |
|
|
10,432,111 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR +
..22%, 0.48%, due 11/25/35 |
|
|
7,302,477 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Residential Asset-Backed Securities (United States) |
|
|
11,441,507 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Residential Mortgage-Backed Securities (United States) 1.0% |
|
|
|
|
|
420,312 |
|
|
Chevy Chase Mortgage Funding Corp., Series 03-4A, Class A1, 144A, AMBAC, 1 mo. LIBOR + .34%,
0.60%, due 10/25/34 |
|
|
268,580 |
|
|
953,326 |
|
|
Chevy Chase Mortgage Funding Corp., Series 04-1A, Class A2, 144A, AMBAC, 1 mo. LIBOR + .33%,
0.59%, due 01/25/35 |
|
|
595,829 |
|
|
9,073,373 |
|
|
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%,
due 06/15/37 |
|
|
5,353,290 |
|
|
4,763,061 |
|
|
GMAC Mortgage Corp. Loan Trust, Series 04-HE3, Class A3, FSA, 1 mo. LIBOR + .23%, 0.49%, due
10/25/34 |
|
|
3,341,763 |
|
|
242,574 |
|
|
GreenPoint Home Equity Loan Trust, Series 04-1, Class A, AMBAC, 1 mo. LIBOR + .23%, 0.72%,
due 07/25/29 |
|
|
163,301 |
|
|
276,900 |
|
|
GreenPoint Home Equity Loan Trust, Series 04-4, Class A, AMBAC, 1 mo. LIBOR + .28%, 0.81%,
due 08/15/30 |
|
|
171,041 |
|
|
563,319 |
|
|
Lehman ABS Corp., Series 04-2, Class A, AMBAC, 1 mo. LIBOR + .22%, 0.70%, due 06/25/34 |
|
|
371,790 |
|
|
132,446 |
|
|
Residential Funding Mortgage Securities II, Series 03-HS1, Class AII, FGIC, 1 mo. LIBOR +
..29%, 0.55%, due 12/25/32 |
|
|
38,409 |
|
|
3,313,882 |
|
|
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35 |
|
|
3,002,046 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Residential Mortgage-Backed Securities (United States) |
|
|
13,306,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Time Share 0.9% |
|
|
|
|
|
1,884,750 |
|
|
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%,
0.40%, due 05/20/18 |
|
|
1,865,326 |
|
|
2,184,958 |
|
|
Sierra Receivables Funding Co., Series 07-1A, Class A2, 144A, FGIC, 1 mo. LIBOR + .15%,
0.40%, due 03/20/19 |
|
|
2,104,388 |
|
|
|
|
|
|
|
|
|
|
7,370,478 |
|
|
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%,
1.25%, due 09/20/19 |
|
|
7,155,193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Time Share |
|
|
11,124,907 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Transportation 0.2% |
|
|
|
|
|
3,117,500 |
|
|
GE Seaco Finance SRL, Series 04-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .30%, 0.55%, due
04/17/19 |
|
|
3,031,769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rate
Reduction Bonds 0.7% |
|
|
|
|
|
8,775,803 |
|
|
PG&E Energy Recovery Funding LLC, Series 05-1, Class A4, 4.37%, due 06/25/14 |
|
|
8,852,591 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential
Asset-Backed Securities (United States) ♦ 20.7% |
|
|
|
|
|
977,554 |
|
|
Accredited Mortgage Loan Trust, Series 04-4, Class A1B, 1 mo. LIBOR + .39%, 0.65%, due
01/25/35 |
|
|
766,158 |
|
|
2,479,463 |
|
|
ACE Securities Corp., Series 06-ASL1, Class A, 1 mo. LIBOR + .14%, 0.40%, due 02/25/36 |
|
|
514,489 |
|
|
5,363,172 |
|
|
ACE Securities Corp., Series 06-ASP2, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 03/25/36 |
|
|
4,438,024 |
|
|
2,387,816 |
|
|
ACE Securities Corp., Series 06-ASP4, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36 |
|
|
2,205,745 |
|
|
20,300,000 |
|
|
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36 |
|
|
5,684,000 |
|
|
5,819,433 |
|
|
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36 |
|
|
5,441,170 |
|
|
5,392,887 |
|
|
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36 |
|
|
2,642,514 |
|
|
1,865,498 |
|
|
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36 |
|
|
1,697,603 |
|
|
10,807,121 |
|
|
ACE Securities Corp., Series 06-OP1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 04/25/36 |
|
|
6,322,166 |
|
|
3,505,575 |
|
|
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35 |
|
|
613,476 |
|
|
7,462,226 |
|
|
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36 |
|
|
1,212,612 |
|
|
8,674,087 |
|
|
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36 |
|
|
1,062,576 |
|
|
5,332,165 |
|
|
ACE Securities Corp., Series 07-HE1, Class A2A, 1 mo. LIBOR + .09%, 0.35%, due 01/25/37 |
|
|
1,572,988 |
|
|
3,159,888 |
|
|
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36 |
|
|
1,058,563 |
|
|
11,922,600 |
|
|
Alliance Bancorp Trust, Series 07-S1, Class A1, 144A, 1 mo. LIBOR + .20%, 0.46%, due 05/25/37 |
|
|
596,130 |
|
|
3,448,275 |
|
|
Argent Securities, Inc., Series 04-W8, Class A5, 1 mo. LIBOR + .52%, 1.30%, due 05/25/34 |
|
|
2,981,141 |
|
|
50,049,962 |
|
|
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
12,997,350 |
|
|
7,692,188 |
|
|
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36 |
|
|
2,249,965 |
|
|
10,277,333 |
|
|
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36 |
|
|
2,980,427 |
|
|
288,926 |
|
|
Argent Securities, Inc., Series 06-W4, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 05/25/36 |
|
|
80,177 |
|
|
8,241,821 |
|
|
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
2,168,629 |
|
|
9,546,891 |
|
|
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due
10/25/36 |
|
|
5,537,197 |
|
|
17,228,615 |
|
|
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%,
due 05/25/37 |
|
|
13,567,534 |
|
|
5,238,129 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%,
due 05/28/39 |
|
|
1,702,392 |
|
|
5,461,028 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%,
due 05/28/39 |
|
|
1,542,740 |
|
|
9,592,824 |
|
|
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%,
due 02/28/40 |
|
|
5,765,287 |
|
|
3,394,916 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%,
0.37%, due 11/25/36 |
|
|
2,060,375 |
|
|
8,500,000 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%,
0.46%, due 11/25/36 |
|
|
1,134,750 |
|
|
2,271,390 |
|
|
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due
02/25/37 |
|
|
359,107 |
|
|
991,099 |
|
|
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due
02/25/37 |
|
|
965,330 |
|
|
38,100,000 |
|
|
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due
02/25/37 |
|
|
23,481,030 |
|
|
8,802,480 |
|
|
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36 |
|
|
6,689,885 |
|
|
158,405 |
|
|
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due
04/25/33 |
|
|
133,060 |
|
|
83,407 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 04-OPT1, Class A1B, 1 mo. LIBOR + .41%, 0.67%,
due 10/25/34 |
|
|
77,569 |
|
|
12,100,000 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due
12/25/36 |
|
|
3,630,000 |
|
|
36,200,000 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%,
due 02/25/37 |
|
|
26,335,500 |
|
|
821,482 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC5, Class 2A1, 1 mo. LIBOR + .08%, 0.34%,
due 03/25/37 |
|
|
810,803 |
|
|
417,854 |
|
|
Equity One ABS, Inc., Series 04-1, Class AV2, 1 mo. LIBOR + .30%, 0.56%, due 04/25/34 |
|
|
300,202 |
|
|
11,400,028 |
|
|
First Franklin Mortgage Loan Asset Backed Certificates, Series 06-FF5, Class 2A3, 1 mo. LIBOR
+ .16%, 0.42%, due 04/25/36 |
|
|
6,768,767 |
|
|
3,647,944 |
|
|
Fremont Home Loan Trust, Series 06-A, Class 1A2, 1 mo. LIBOR + .20%, 0.45%, due 05/25/36 |
|
|
1,954,500 |
|
|
1,271,286 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A2, 1 mo. LIBOR + .10%, 0.36%, due 08/25/36 |
|
|
423,497 |
|
|
|
|
|
|
|
|
|
|
|
18,944,685 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36 |
|
|
5,304,512 |
|
|
12,877,893 |
|
|
GE-WMC Mortgage Securities, Series 06-1, Class A2B, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36 |
|
|
3,219,473 |
|
|
2,681,085 |
|
|
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due
01/20/35 |
|
|
2,303,219 |
|
|
2,325,868 |
|
|
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due
01/20/35 |
|
|
2,046,037 |
|
|
7,947,775 |
|
|
Household Home Equity Loan Trust, Series 06-1, Class A1, 1 mo. LIBOR + .16%, 0.41%, due
01/20/36 |
|
|
6,994,042 |
|
|
26,684,086 |
|
|
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%,
due 12/25/36 |
|
|
8,429,503 |
|
|
1,768,028 |
|
|
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%,
due 10/25/35 |
|
|
1,661,947 |
|
|
1,989,571 |
|
|
Master Asset-Backed Securities Trust, Series 06-AM3, Class A2, 1 mo. LIBOR + .13%, 0.39%, due
10/25/36 |
|
|
1,929,884 |
|
|
16,263,328 |
|
|
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%,
due 03/25/36 |
|
|
5,692,165 |
|
|
11,300,000 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due
06/25/36 |
|
|
3,390,000 |
|
|
21,026,429 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due
08/25/36 |
|
|
5,572,004 |
|
|
14,241,776 |
|
|
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due
10/25/36 |
|
|
4,272,533 |
|
|
5,705,604 |
|
|
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36 |
|
|
684,672 |
|
|
5,173,825 |
|
|
Merrill Lynch Mortgage Investors, Series 07-HE2, Class A2A, 1 mo. LIBOR + .12%, 0.38%, due
02/25/37 |
|
|
2,354,090 |
|
|
2,066,168 |
|
|
Morgan Stanley Capital, Inc., Series 04-SD1, Class A, 1 mo. LIBOR + .40%, 0.66%, due 08/25/34 |
|
|
1,482,476 |
|
|
32,500,000 |
|
|
Morgan Stanley Capital, Inc., Series 07-HE4, Class A2C, 1 mo. LIBOR + .23%, 0.49%, due
02/25/37 |
|
|
6,825,000 |
|
|
13,738,633 |
|
|
Morgan Stanley Home Equity Loans, Series 06-3, Class A3, 1 mo. LIBOR + .16%, 0.42%, due
04/25/36 |
|
|
5,770,226 |
|
|
3,443,715 |
|
|
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due
04/25/37 |
|
|
2,815,237 |
|
|
9,202,676 |
|
|
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%,
0.41%, due 11/25/36 |
|
|
2,254,656 |
|
|
5,734,841 |
|
|
Peoples Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%,
0.52%, due 12/25/35 |
|
|
3,302,121 |
|
|
5,460,722 |
|
|
RAAC Series Trust, Series 06-SP1, Class A2, 1 mo. LIBOR + .19%, 0.45%, due 09/25/45 |
|
|
4,526,938 |
|
|
1,272,455 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS8, Class A2, 1 mo. LIBOR + .29%,
0.55%, due 10/25/33 |
|
|
1,165,951 |
|
|
3,424,257 |
|
|
Residential Asset Securities Corp., Series 05-KS12, Class A2, 1 mo. LIBOR + .25%, 0.51%, due
01/25/36 |
|
|
3,081,831 |
|
|
362,821 |
|
|
Residential Asset Securities Corp., Series 07-KS3, Class AI1, 1 mo. LIBOR + .11%, 0.37%, due
04/25/37 |
|
|
360,209 |
|
|
236,691 |
|
|
Saxon Asset Securities Trust, Series 04-1, Class A, 1 mo. LIBOR + .27%, 0.80%, due 03/25/35 |
|
|
147,488 |
|
|
434,413 |
|
|
Securitized Asset Backed Receivables LLC, Series 06-NC1, Class A2, 1 mo. LIBOR + .16%, 0.42%,
due 03/25/36 |
|
|
399,660 |
|
|
270,613 |
|
|
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%,
0.55%, due 10/25/36 |
|
|
268,583 |
|
|
1,044,869 |
|
|
SG Mortgage Securities Trust, Series 05-OPT1, Class A2, 1 mo. LIBOR + .26%, 0.52%, due
10/25/35 |
|
|
967,862 |
|
|
857,434 |
|
|
Soundview Home Equity Loan Trust, Series 07-NS1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due
01/25/37 |
|
|
820,189 |
|
|
17,100,000 |
|
|
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%,
0.41%, due 06/25/37 |
|
|
7,182,000 |
|
|
5,733,332 |
|
|
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due
01/25/36 |
|
|
4,127,999 |
|
|
2,789,578 |
|
|
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due
11/25/35 |
|
|
2,154,949 |
|
|
|
|
|
|
|
|
|
|
|
13,800,276 |
|
|
Yale Mortgage Loan Trust, Series 07-1, Class A, 144A, 1 mo. LIBOR + .40%, 0.66%, due 06/25/37 |
|
|
1,104,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Asset-Backed Securities (United States) |
|
|
265,136,906 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential
Mortgage-Backed Securities (Australian) 5.4% |
|
|
|
|
|
2,316,860 |
|
|
Crusade Global Trust, Series 04-2, Class A1, 3 mo. LIBOR + .13%, 0.61%, due 11/19/37 |
|
|
2,271,127 |
|
|
5,243,278 |
|
|
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38 |
|
|
5,107,273 |
|
|
8,452,393 |
|
|
Crusade Global Trust, Series 07-1, Class A1, 3 mo. LIBOR + .06%, 0.47%, due 04/19/38 |
|
|
8,122,031 |
|
|
1,391,240 |
|
|
Interstar Millennium Trust, Series 03-3G, Class A2, 3 mo. LIBOR + .25%, 0.86%, due 09/27/35 |
|
|
1,276,936 |
|
|
13,959,309 |
|
|
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36 |
|
|
12,837,818 |
|
|
898,718 |
|
|
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36 |
|
|
799,858 |
|
|
1,512,234 |
|
|
Interstar Millennium Trust, Series 06-2GA, Class A2, 144A, 3 mo. LIBOR + .08%, 0.81%, due
05/27/38 |
|
|
1,382,968 |
|
|
1,157,504 |
|
|
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36 |
|
|
1,116,046 |
|
|
5,762,049 |
|
|
Medallion Trust, Series 06-1G, Class A1, 3 mo. LIBOR + .05%, 0.39%, due 06/14/37 |
|
|
5,606,376 |
|
|
2,352,319 |
|
|
Medallion Trust, Series 07-1G, Class A1, 3 mo. LIBOR + .04%, 0.55%, due 02/27/39 |
|
|
2,279,968 |
|
|
6,468,100 |
|
|
National RMBS Trust, Series 06-3, Class A1, 144A, 3 mo. LIBOR + .07%, 0.48%, due 10/20/37 |
|
|
6,267,235 |
|
|
8,106,032 |
|
|
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38 |
|
|
7,417,830 |
|
|
8,485,871 |
|
|
Superannuation Members Home Loans Global Fund, Series 07-1, Class A1, 3 mo. LIBOR + .06%,
0.40%, due 06/12/40 |
|
|
7,995,244 |
|
|
799,630 |
|
|
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%,
due 03/09/36 |
|
|
775,465 |
|
|
689,296 |
|
|
Superannuation Members Home Loans Global Fund, Series 8, Class A1, 3 mo. LIBOR + .07%, 0.53%,
due 01/12/37 |
|
|
675,331 |
|
|
6,065,879 |
|
|
Westpac Securitization Trust, Series 07-1G, Class A2A, 3 mo. LIBOR + .05%, 0.53%, due 05/21/38 |
|
|
5,884,691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (Australian) |
|
|
69,816,197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential
Mortgage-Backed Securities (European) 7.0% |
|
|
|
|
|
9,173,762 |
|
|
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66 |
|
|
7,522,485 |
|
|
21,720,327 |
|
|
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due
01/13/39 |
|
|
19,243,776 |
|
|
3,458,494 |
|
|
Granite Master Issuer Plc, Series 06-2, Class A4, 1 mo. LIBOR + .08%, 0.33%, due 12/20/54 |
|
|
3,313,237 |
|
|
1,920,720 |
|
|
Granite Mortgages Plc, Series 04-3, Class 2A1, 3 mo. LIBOR + .14%, 0.63%, due 09/20/44 |
|
|
1,845,812 |
|
|
8,875,151 |
|
|
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43 |
|
|
7,898,884 |
|
|
3,162,698 |
|
|
Leek Finance Plc, Series 17A, Class A2B, 144A, 3 mo. LIBOR + .28%, 0.63%, due 12/21/37 |
|
|
2,830,615 |
|
|
6,131,587 |
|
|
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34 |
|
|
4,926,117 |
|
|
10,488,068 |
|
|
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .22%, 0.68%, due 11/15/38 |
|
|
7,767,988 |
|
|
6,097,557 |
|
|
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39 |
|
|
4,556,704 |
|
|
26,600,000 |
|
|
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33 |
|
|
26,341,980 |
|
|
3,200,000 |
|
|
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33 |
|
|
3,183,680 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (European) |
|
|
89,431,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential
Mortgage-Backed Securities (United States) 0.2% |
|
|
|
|
|
498,215 |
|
|
Chevy Chase Mortgage Funding Corp., Series 04-3A, Class A2, 144A, 1 mo. LIBOR + .30%, 0.56%,
due 08/25/35 |
|
|
311,385 |
|
|
2,428,688 |
|
|
Mellon Residential Funding Corp., Series 04-TBC1, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%,
due 02/26/34 |
|
|
1,967,237 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (United States) |
|
|
2,278,622 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student
Loans 7.9% |
|
|
|
|
|
20,300,000 |
|
|
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24 |
|
|
19,792,500 |
|
|
421,906 |
|
|
Goal Capital Funding Trust, Series 07-1, Class A1, 3 mo. LIBOR + .02%, 0.38%, due 06/25/21 |
|
|
421,105 |
|
|
1,050,563 |
|
|
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due
08/25/23 |
|
|
1,019,046 |
|
|
9,600,000 |
|
|
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19 |
|
|
9,475,584 |
|
|
9,914,408 |
|
|
SLM Student Loan Trust, Series 05-1, Class A2, 3 mo. LIBOR + .08%, 0.50%, due 04/27/20 |
|
|
9,761,469 |
|
|
24,600,000 |
|
|
SLM Student Loan Trust, Series 05-3, Class A4, 3 mo. LIBOR + .07%, 0.49%, due 04/27/20 |
|
|
24,307,752 |
|
|
3,224,037 |
|
|
SLM Student Loan Trust, Series 07-A, Class A1, 3 mo. LIBOR + .03%, 0.38%, due 09/15/22 |
|
|
3,215,977 |
|
|
16,916,058 |
|
|
SLM Student Loan Trust, Series 07-2, Class A2, 3 mo. LIBOR, 0.42%, due 07/25/17 |
|
|
16,704,607 |
|
|
5,500,000 |
|
|
SLM Student Loan Trust, Series 07-6, Class A2, 3 mo. LIBOR + .25%, 0.67%, due 01/25/19 |
|
|
5,476,900 |
|
|
|
|
|
|
|
|
|
|
|
10,800,000 |
|
|
SLM Student Loan Trust, Series 08-6, Class A3, 3 mo. LIBOR + .75%, 1.17%, due 01/25/19 |
|
|
10,673,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Student Loans |
|
|
100,848,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time
Share 0.1% |
|
|
|
|
|
1,787,417 |
|
|
Sierra Receivables Funding Co., Series 08-1A, Class A2, 144A, 1 mo. LIBOR + 4.00%, 4.25%, due
02/20/20 |
|
|
1,836,850 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
1,190,642,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S.
Government Agency 2.4% |
|
|
|
|
|
11,250,000 |
|
|
Agency for International Development Floater (Support of Morocco), 6 mo. LIBOR + .15%, 0.88%,
due 10/29/26(a) |
|
|
10,541,726 |
|
|
13,331,250 |
|
|
Agency for International Development Floater (Support of Morocco), 6 mo. LIBOR -0.02%, 0.72%,
due 02/01/25(a) |
|
|
12,456,469 |
|
|
316,708 |
|
|
Agency for International Development Floater (Support of Peru), Series A, 6 mo. U.S. Treasury
Bill + .35%, 0.42%, due 05/01/14(a) |
|
|
310,612 |
|
|
8,460,000 |
|
|
Agency for International Development Floater (Support of Tunisia), 6 mo. LIBOR, 0.73%, due
07/01/23(a) |
|
|
7,977,925 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
31,286,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $1,661,242,751) |
|
|
1,221,928,995 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM
INVESTMENTS 4.7% |
|
|
|
|
|
|
|
|
|
Money
Market Funds 4.7% |
|
|
|
|
|
21,940,350 |
|
|
State Street Institutional Liquid Reserves Fund-Institutional Class, 0.17%(b) |
|
|
21,940,350 |
|
|
38,219,754 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class,
0.00%(c) |
|
|
38,219,754 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS
(COST $60,160,104) |
|
|
60,160,104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.9%
(Cost $1,721,402,855) |
|
|
1,282,089,099 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.1% |
|
|
1,402,763 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET
ASSETS 100.0% |
|
$ |
1,283,491,862 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
Amount of Future |
|
|
Net Unrealized |
Notional |
|
Expiration |
|
|
|
Receive |
|
Annual |
|
Credit |
|
Reference |
|
Payments by the Fund |
|
|
Appreciation/ |
Amount |
|
Date |
|
Counterparty |
|
(Pay)^ |
|
Premium |
|
Spread(1) |
|
Entity |
|
Under the Contract(2) |
|
|
(Depreciation) |
31,000,000 USD |
|
3/20/2013 |
|
Morgan Stanley Capital Services Inc. |
|
Receive |
|
0.25% |
|
2.05% |
|
MS Synthetic 2006-1 |
|
31,000,000 |
USD |
|
$(734,788) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) pay to the buyer of protection an amount equal to the notional amount of
the swap and take delivery of the referenced obligation or underlying securities comprising the referenced index or (ii) pay a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value
of the referenced obligation or underlying securities comprising the
referenced index.
(Pay) Fund pays premium and buys credit protection. If a credit event occurs, as defined under the terms of that particular swap agreement, the Fund will either (i) receive from the seller of protection an amount equal to the notional amount of
the swap and deliver the referenced obligation or underlying securities comprising the referenced index or (ii) receive a net settlement amount in the form of cash or securities equal to the notional amount of the swap less the recovery value of the
referenced obligation or underlying securities comprising the referenced index. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011, serve as an indicator of the current status of the
payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads
represent a deterioration of the referenced entitys credit soundness and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement. |
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange. |
|
|
|
|
|
Notes to Schedule of Investments: |
|
|
|
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors. |
|
|
|
AMBAC Insured as to the payment of principal and interest by AMBAC Assurance Corporation. |
|
|
|
CapMAC Insured as to the payment of principal and interest by Capital Markets Assurance Corporation. |
|
|
|
CDO Collateralized Debt Obligation |
|
|
|
CMBS Commercial Mortgage Backed Security |
|
|
|
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation. |
|
|
|
FSA Insured as to the payment of principal and interest by Financial Security Assurance. |
|
|
|
LIBOR London Interbank Offered Rate |
|
|
|
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp. |
|
|
|
RMBS Residential Mortgage Backed Security |
|
|
|
XL Insured as to the payment of principal and interest by XL Capital Assurance. |
|
|
|
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security. |
|
|
|
♣ |
|
These securities were categorized as high yield as a result of being rated below investment grade at issuance. |
|
♦ |
|
These securities are primarily backed by subprime mortgages. |
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. |
|
(c) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
Currency Abbreviations:
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 1,720,854,510 |
|
$ |
5,023,739 |
|
|
$ |
(443,789,150 |
) |
|
$ |
(438,765,411 |
) |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
3.4% of net assets. The Fund classifies such securities (levels defined below) as Level 3. For
the period ended November 30, 2011, the Fund did not reduce the value of any of its OTC
derivatives contracts based on the creditworthiness of its counterparties. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Typically the Fund values debt instruments based on the most recent quoted price supplied by a
single pricing source chosen by the Manager. Although the Manager normally does not evaluate
pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and
may change a pricing source at any time. The Manager monitors erratic or unusual movements
(including unusual inactivity) in the prices supplied for a security and has discretion to
override a price supplied by a source (e.g., by taking a price supplied by another) when it
believes that the price supplied is not reliable. Although alternative prices may be available
for securities held by the Fund, those alternative sources are not typically part of the
valuation process and do not necessarily provide greater certainty about the prices used by the
Fund. As of November 30, 2011, the total value of securities held for which no alternative
pricing source was available represented 11.0% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. The Fund valued certain other debt
securities by using an estimated specified spread above the LIBOR Rate. The Fund also used third
party valuation services to value credit default swaps using unobservable inputs.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
300,646,872 |
|
|
$ |
889,995,391 |
|
|
$ |
1,190,642,263 |
|
U.S. Government Agency |
|
|
|
|
|
|
|
|
|
|
31,286,732 |
|
|
|
31,286,732 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
300,646,872 |
|
|
|
921,282,123 |
|
|
|
1,221,928,995 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
60,160,104 |
|
|
|
|
|
|
|
|
|
|
|
60,160,104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
60,160,104 |
|
|
|
300,646,872 |
|
|
|
921,282,123 |
|
|
|
1,282,089,099 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
60,160,104 |
|
|
$ |
300,646,872 |
|
|
$ |
921,282,123 |
|
|
$ |
1,282,089,099 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
$ |
|
|
|
$ |
|
|
|
$ |
(734,788 |
) |
|
$ |
(734,788 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
(734,788 |
) |
|
$ |
(734,788 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The aggregate net values of the Funds direct investments in securities and derivative financial
instruments using Level 3 inputs were 71.8% and (0.1)% of total net assets, respectively.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments Still |
|
|
Balances as of |
|
|
|
|
|
|
|
|
Accrued |
|
|
|
|
|
Unrealized |
|
|
Transfer |
|
|
Transfer |
|
Balances as of |
|
|
|
Held as of |
|
|
February 28, |
|
|
|
|
|
|
|
|
Discounts/ |
|
Total Realized |
|
Appreciation |
|
|
into level |
|
|
out of level |
|
November 30, |
|
|
|
November 30, |
|
|
2011 |
|
|
Purchases |
|
Sales |
|
Premiums |
|
Gain/(Loss) |
|
(Depreciation) |
|
|
3 * |
|
|
3 * |
|
2011 |
|
|
|
2011 |
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities
|
|
$ |
1,361,784,127 |
|
|
$ |
|
|
$ |
(417,096,505 |
) |
|
$ |
179,010 |
|
|
$ |
(16,629,554 |
) |
|
$ |
(38,241,687 |
) |
|
$ |
|
|
$ |
|
|
$ |
889,995,391 |
|
|
|
|
$ |
(54,525,187 |
) |
U.S. Government Agency
|
|
|
32,607,449 |
|
|
|
|
|
|
(1,707,407 |
) |
|
|
17,788 |
|
|
|
(205 |
) |
|
|
369,107 |
|
|
|
|
|
|
|
|
|
31,286,732 |
|
|
|
|
|
369,107 |
|
Swap Agreements
|
|
|
(254,652 |
) |
|
|
|
|
|
(58,986 |
) |
|
|
|
|
|
|
58,986 |
|
|
|
(480,136 |
) |
|
|
|
|
|
|
|
|
(734,788 |
) |
|
|
|
|
(480,136 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
1,394,136,924 |
|
|
$ |
|
|
$ |
(418,862,898 |
) |
|
$ |
196,798 |
|
|
$ |
(16,570,773 |
) |
|
$ |
(38,352,716 |
) |
|
$ |
|
|
$ |
|
|
$ |
920,547,335 |
|
|
|
|
$ |
(54,636,216 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of
Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Fixed Income Securities Typically, the market value of the Funds
fixed income securities will decline during periods of widening of credit spreads. |
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind. |
|
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk. |
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
|
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk. |
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions. |
|
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. |
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
The Fund invests in asset-backed securities, which may be backed by many types of assets,
including pools of residential and commercial mortgages, automobile loans, educational loans,
home equity loans, or credit card receivables, which expose the Fund to additional types of
market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made
to corporations, or a combination of these bonds and loans (commonly referred to as
collateralized debt obligations or collateralized loan obligations) and by the fees earned
by service providers. Payment of interest on asset backed securities and repayment of principal
largely depend on the cash flows generated by the assets backing the securities. The market risk
of a particular asset-backed security depends on many factors, including the deal structure
(e.g., determination as to the amount of underlying assets or other support needed to produce
the cash flows necessary to service interest and make principal payments), the quality of the
underlying assets and, if any, the level of credit support and the credit quality of the
credit-support provider. Asset-backed securities involve risk of loss of principal if obligors
of the underlying obligations default and the value of the defaulted obligations exceeds
whatever credit support the securities may have. The obligations of issuers (and obligors of
underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the
rights and remedies of creditors. Many asset-backed securities in which the Fund has invested
are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself.
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
During the period ended November 30, 2011, the Fund used forward currency contracts to
adjust exposure to foreign currencies and otherwise adjust currency exchange rate risk. The Fund
had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying
the option. In the event that the Fund writes call options without an offsetting exposure (e.g.,
call options on an asset that the Fund does not own), it bears an unlimited risk of loss if the
price of the underlying asset increases during the term of the option. OTC options expose the
Fund to the risk the Fund may not be able to enter into a closing transaction because of an
illiquid market. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to achieve exposure to a reference entitys credit. Swap agreements outstanding at the end of
the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as
of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on swap agreements |
|
$ |
|
|
|
$ |
|
|
|
$ |
(734,788 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(734,788 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
(734,788 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(734,788 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the
table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts) or notional amounts (swap agreements) outstanding at each month-end, was as follows
for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
Currency |
|
|
Swap |
|
|
|
Contracts |
|
|
Agreements |
|
Average amount outstanding |
|
$ |
24,074,973 |
|
|
$ |
31,000,000 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Short-Duration Collateral Share Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 100.0% |
|
|
|
|
|
4,907,620 |
|
|
GMO Short-Duration Collateral Fund |
|
|
32,439,373 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $31,097,413) |
|
|
32,439,373 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.2% |
|
|
|
|
|
50,222 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(a) |
|
|
50,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $50,222) |
|
|
50,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.2%
(Cost $31,147,635) |
|
|
32,489,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.2%) |
|
|
(55,595 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
32,434,000 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
(a) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 32,688,228 |
|
$ |
|
|
|
$ |
(198,633 |
) |
|
$ |
(198,633 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be
read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust
during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return |
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Capital* |
|
|
Gains* |
|
|
of period |
|
GMO Short-Duration
Collateral Fund |
|
$ |
34,983,226 |
|
|
$ |
13,818,255 |
|
|
$ |
1,435,000 |
|
|
$ |
308,565 |
|
|
$ |
13,590,787 |
|
|
$ |
|
|
|
$ |
32,439,373 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by GMO Short-Duration Collateral Fund (SDCF) during the period March 1, 2011 through November 30, 2011. The actual tax characterization of distributions paid
by SDCF will be determined at the end of the fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
GMO Short-Duration Collateral Share Fund (the Fund) invests substantially all of its assets
in GMO Short-Duration Collateral Fund (SDCF) (an arrangement often referred to as a
master-feeder structure) and, to a limited extent, in cash and cash equivalents.
Shares of SDCF are generally valued at their net asset value. Investments held by SDCF are
valued as follows. Securities listed on a securities exchange (other than exchange-traded
options) for which market quotations are readily available are valued at (i) the last sale price
or (ii) official closing price as of the close of regular trading on the New York Stock Exchange
(NYSE) or, (iii) if there is no such reported sale or official closing price (or in the event
the Manager deems the over-the-counter (OTC) market to be a better indicator of market value),
at the most recent quoted price. Unlisted securities for which market quotations are readily
available are generally valued at the most recent quoted price. Non-emerging market debt
instruments with a remaining maturity of sixty days or less may be valued at amortized cost
(unless circumstances dictate otherwise; for example, if the issuers creditworthiness has
become impaired), which approximates market value. Derivatives and other securities for which
quotations are not readily available or whose values the Manager has determined to be unreliable
are valued at fair value as determined in good faith by the Trustees or persons acting at their
direction pursuant to procedures approved by the Trustees. In addition, although the goal of
fair valuation is to determine the amount the owner of the securities might reasonably expect to
receive upon their current sale, because of the uncertainty inherent in fair value pricing, the
value determined for a particular security may be materially different from the value realized
upon its sale. As of November 30, 2011, the total value of securities held indirectly that were
fair valued using methods determined in good faith by or at the direction of the Trustees of GMO
trust represented 3.4% of net assets. SDCF classifies such securities (levels defined below) as
Level 3.
Typically SDCF values debt instruments based on the most recent quoted price supplied by a
single pricing source chosen by the Manager. Although the Manager normally does not evaluate
pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and
may change a pricing source at any time. The Manager monitors erratic or unusual movements
(including unusual inactivity) in the prices supplied for a security and has discretion to
override a price supplied by a source (e.g., by taking a price supplied by another) when it
believes that the price supplied is not reliable. Although alternative prices may be available
for other securities held by SDCF, those alternative sources are not typically part of the
valuation process and do not necessarily provide greater certainty about the prices used by
SDCF. As of November 30, 2011, the total value of securities held indirectly for which no
alternative pricing source was available represented 11.0% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
|
|
|
Level 1 |
|
Valuations based on quoted prices for identical securities in active markets. |
|
|
|
Level 2 |
|
Valuations determined using other significant direct or indirect observable inputs. |
|
|
|
Level 3 |
|
Valuations based primarily on inputs that are unobservable and significant. |
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
32,439,373 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
32,439,373 |
|
Short-Term Investments |
|
|
50,222 |
|
|
|
|
|
|
|
|
|
|
|
50,222 |
|
Total Investments |
|
|
32,489,595 |
|
|
|
|
|
|
|
|
|
|
|
32,489,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
32,489,595 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
32,489,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SDCF is classified as Level 1. For the summary of valuation inputs (including Level 3
inputs, if any) of SDCF, please refer to SDCFs portfolio valuation note. The aggregate net
value of the Funds indirect investments (through SDCF) in
securities and derivative financial
instruments using Level 3 inputs were 71.8% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. Because the Fund
invests substantially all of its assets in SDCF, the most significant risks of investing in the
Fund are the risks to which the Fund is exposed through SDCF, which include those outlined in
the following brief summary of selected risks. The selected risks of investing in the Fund are
summarized below. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every
potential risk of investing in the Fund. The Fund could be subject to additional risks because
of the types of investments it makes and market conditions, which may change over time. The Fund
and SDCF are non-diversified investment companies under the Investment Company Act of 1940 (the
1940 Act) and therefore a decline in the market value of a particular security held by the
Fund or SDCF may affect the Funds performance more than if the Fund or SDCF were diversified.
Market Risk Fixed Income Securities Typically, the market value of SDCFs fixed
income securities will decline during periods of widening of credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent SDCF from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests indirectly in asset-backed securities, which may be backed by many types
of assets, including pools of residential and commercial mortgages, automobile loans,
educational loans, home equity loans, or credit card receivables, which expose the Fund to
additional types of market risk. They also may be backed by pools of corporate or sovereign
bonds, bank loans made to corporations, or a combination of these bonds and loans (commonly
referred to as collateralized debt obligations or collateralized loan obligations) and by
the fees earned by service providers. Payment of interest on asset backed securities and
repayment of principal largely depend on the cash flows generated by the assets backing the
securities. The market risk of a particular asset-backed security depends on many factors,
including the deal structure (e.g., determination as to the amount of underlying assets or other
support needed to produce the cash flows necessary to service interest and make principal
payments), the quality of the underlying assets and, if any, the level of credit support and the
credit quality of the credit-support provider. Asset-backed securities involve risk of loss of
principal if obligors of the underlying obligations default and the value of the defaulted
obligations exceeds whatever credit support the securities may have. The obligations of issuers
(and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws
affecting the rights and remedies of creditors. Many asset-backed securities in which the Fund
has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of
related documentation also may affect the rights of security holders in and to the underlying
assets. The insolvency of entities that generate receivables or that utilize the assets may
result in a decline in the value of the underlying assets, as well as costs and delays. The
obligations underlying asset-backed securities, in particular securities backed by pools of
residential and commercial mortgages, also are subject to unscheduled prepayment, and a Fund may
be unable to invest prepayments at as high a yield as is provided by the asset-backed security.
The risk of investing in asset-backed securities has increased because performance of the
various sectors in which the assets underlying asset-backed securities are concentrated (e.g.,
auto loans, student loans, sub-prime mortgages, and credit card receivables) has become more
highly correlated since the deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by SDCF, if any, please refer to SDCFs
Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Short-Duration Investment Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) / |
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 6.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 6.6% |
|
|
|
|
|
|
|
|
Agency for International Development Floater (Support of Botswana), 6 mo. U.S. Treasury Bill + |
|
|
|
|
|
23,333 |
|
|
.40%, 0.47%, due 10/01/12(a) |
|
|
22,898 |
|
|
|
|
|
Agency for International Development Floater (Support of C.A.B.E.I.), 6 mo. U.S. Treasury Bill + |
|
|
|
|
|
152,100 |
|
|
.40%, 0.47%, due 10/01/12(a) |
|
|
150,332 |
|
|
|
|
|
Agency for International Development Floater (Support of Peru), Series B, 6 mo. U.S. Treasury Bill |
|
|
|
|
|
14,976 |
|
|
+.35%, 0.42%, due 05/01/14(a) |
|
|
14,688 |
|
|
175,197 |
|
|
Small Business Administration Pool #502320, Prime - 2.19%, 1.06%, due 08/25/18 |
|
|
176,461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
364,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $365,562) |
|
|
364,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 93.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 93.5% |
|
|
|
|
|
231,576 |
|
|
GMO Short-Duration Collateral Fund |
|
|
1,530,718 |
|
|
9,192 |
|
|
GMO Special Purpose Holding Fund(b) |
|
|
3,585 |
|
|
145,356 |
|
|
GMO U.S. Treasury Fund |
|
|
3,635,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS
(COST $5,703,846) |
|
|
5,169,658 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.5% |
|
|
|
|
|
28,961 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(c) |
|
|
28,961 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $28,961) |
|
|
28,961 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL
INVESTMENTS
100.6%(Cost
$6,098,369) |
|
|
5,562,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.6%) |
|
|
(35,238 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
5,527,760 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
C.A.B.E.I. Central American Bank for Economic Integration
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
|
(b) |
|
Underlying investment represents interests in defaulted claims. See Other Matters for additional information. |
|
(c) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$6,713,866 |
|
$ |
5,570 |
|
|
$ |
(1,156,438 |
) |
|
$ |
(1,150,868 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Short-Duration Collateral
Fund |
|
$ |
2,403,760 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
18,209 |
|
|
$ |
|
|
|
$ |
801,998 |
|
|
$ |
1,530,718 |
|
GMO Special Purpose Holding
Fund |
|
|
4,596 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,585 |
|
GMO U.S. Treasury Fund |
|
|
2,863,916 |
|
|
|
1,195,179 |
|
|
|
425,000 |
|
|
|
1,210 |
|
|
|
169 |
|
|
|
|
|
|
$ |
3,635,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
5,272,272 |
|
|
$ |
1,195,179 |
|
|
$ |
425,000 |
|
|
$ |
19,419 |
|
|
$ |
169 |
|
|
$ |
801,998 |
|
|
$ |
5,169,658 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of
distributions paid by the underlying funds will be determined at the end of the fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly and indirectly that were fair
valued using methods determined in good faith by or at the direction of the Trustees of the
Trust represented 4.3% of net assets. The Fund and the underlying funds classify such securities
(levels defined below) as Level 3.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 6.2% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1
Valuations based on quoted prices for identical securities in active markets.
Level 2
Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3
Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. The Fund valued certain other debt
securities by using an estimated specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations
U.S. Government Agency |
|
$ |
|
|
|
$ |
|
|
|
$ |
364,379 |
|
|
$ |
364,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
|
|
|
|
364,379 |
|
|
|
364,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
5,166,073 |
|
|
|
3,585 |
|
|
|
|
|
|
|
5,169,658 |
|
Short-Term Investments |
|
|
28,961 |
|
|
|
|
|
|
|
|
|
|
|
28,961 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
5,195,034 |
|
|
|
3,585 |
|
|
|
364,379 |
|
|
|
5,562,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
5,195,034 |
|
|
$ |
3,585 |
|
|
$ |
364,379 |
|
|
$ |
5,562,998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as either Level 1 or
Level 2. For the summary of valuation inputs (including Level 3 inputs, if any) of the
underlying funds, please refer to the underlying funds portfolio valuation notes. The aggregate
net values of the Funds investments (both direct and indirect) in securities and derivative
financial instruments using Level 3 inputs were 26.5% and (0.1)% of total net assets,
respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) from |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
Transfers |
|
|
Transfers |
|
|
Balances as of |
|
|
|
Investments Still |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
into level |
|
|
out of level |
|
|
November 30, |
|
|
|
Held as of |
|
|
|
28, 2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
3* |
|
|
3* |
|
|
2011 |
|
|
|
November 30, 2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government
Agency |
|
$ |
731,636 |
|
|
$ |
|
|
|
$ |
(369,405 |
) |
|
$ |
37 |
|
|
$ |
26 |
|
|
$ |
2,085 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
364,379 |
|
|
|
$ |
1,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
731,636 |
|
|
$ |
|
|
|
$ |
(369,405 |
) |
|
$ |
37 |
|
|
$ |
26 |
|
|
$ |
2,085 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
364,379 |
|
|
|
$ |
1,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments transferred into Level 3 at the value at the beginning of
the period and transferred out of Level 3 at the value at the end of the period. |
Other matters
GMO Special Purpose Holding Fund (SPHF), an investment of the Fund, has litigation pending
against various entities related to the 2002 fraud and related default of securities previously
held by SPHF. The outcome of the lawsuits against the remaining defendants is not known and any
potential recoveries are not reflected in the net asset value of SPHF. For the period ended
November 30, 2011, the Fund received no distributions from SPHF in connection with the defaulted
securities or the related litigation.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund and
SDCF are non-diversified investment companies under the Investment Company Act of 1940 (the
1940 Act) and therefore a decline in the market value of a particular security held by the
Fund or SDCF may affect the Funds performance more than if the Fund or SDCF were diversified.
Selected risks of investing in the Fund are summarized below. The risks of investing in the
Fund depend on the types of investments in its portfolio and the investment strategies the
Manager employs on its behalf. This section does not describe every potential risk of investing in the Fund. The Fund could be
subject to additional risks because of the types of investments it makes and market conditions,
which may change over time.
Market Risk Fixed Income Securities Typically, the market value of the Funds fixed
income securities will decline during periods of widening of credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request
in-kind.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Foreign
Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments.
Market
Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large
Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Special Purpose Holding Fund
(A Series of GMO Trust)
Consolidated Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 0.0% (a) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Receivables 0.0% |
|
|
|
|
|
|
|
|
Interest related to the Bankruptcy Estate of NPF VI Inc. Series 02-1 Class A (b) (c) |
|
|
|
|
|
|
|
|
Interest related to the Bankruptcy Estate of NPF XII Inc. Series 00-3 Class A (b) (c) |
|
|
|
|
|
|
|
|
Interest related to the Bankruptcy Estate of NPF XII Inc. Series 02-1 Class A (b) (c) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $0) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 9.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 9.8% |
|
|
|
|
|
10,696 |
|
|
State Street Institutional Liquid Reserves Fund-Institutional Class, 0.17% (d) |
|
|
10,696 |
|
|
10,697 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00% (e) |
|
|
10,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $21,393) |
|
|
21,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 9.8%
(Cost $21,393) |
|
|
21,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 90.2% |
|
|
196,898 |
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
218,291 |
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
For details on the composition of the balance see the basis of presentation and
principles of consolidation footnote. |
|
|
|
Notes to Consolidated Schedule of Investments: |
|
(a) |
|
Owned by GMO SPV I, LLC. GMO SPV I, LLC is a 74.9% subsidiary of
GMO Special Purpose Holding Fund. |
|
(b) |
|
Security in default. |
|
(c) |
|
Security valued at fair value using methods determined in good faith by or
at the direction of the Trustees of GMO Trust. |
|
(d) |
|
Rate disclosed, the 7 day net yield, as of November 30, 2011. |
|
(e) |
|
Rate disclosed, the 7 day net yield, as of
November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes
and gross and net unrealized appreciation (depreciation) in value of investments were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Aggregate |
|
|
Gross Unrealized |
|
|
Gross Unrealized |
|
|
Appreciation |
|
Cost |
|
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
21,393 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
|
Basis of presentation and principles of consolidation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security valuations
are appropriate; however, actual results may differ from those estimates, and the security
valuations reflected in the Schedule of Investments may differ from the value the Fund ultimately
realizes upon sale of the securities.
The accompanying consolidated schedule of investments consists primarily of the Fund and its
majority owned investment in units of GMO SPV I, LLC (SPV) a special purpose vehicle that holds
an interest in liquidating trusts, relating to certain defaulted asset-backed securities (the NPF
securities) issued by NPF VI, Inc. and NPF XII, Inc.
The Fund has litigation pending against various entities related to the default of the NPF
securities. The outcome of the lawsuit is not known and any potential recoveries are not reflected
in the net asset value of the Fund.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which market
quotations are readily available are valued at (i) the last sale price or (ii) official closing
price as of the close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there
is no such reported sale or official closing price (or in the event the Manager deems the
over-the-counter (OTC) market to be a better indicator of market value), at the most recent
quoted price. Unlisted securities for which market quotations are readily available are generally
valued at the most recent quoted price. Non-emerging market debt instruments with a remaining
maturity of sixty days or less may be valued at amortized cost (unless circumstances dictate
otherwise; for example, if the issuers creditworthiness has become impaired), which approximates
market value. Shares of open-end investment companies are generally valued at their net asset
value. Derivatives and other securities for which quotations are not readily available or whose
values the Manager has determined to be unreliable are valued at fair value as determined in good
faith by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the uncertainty
inherent in fair value pricing, the value determined for a particular security may be materially
different from the value realized upon its sale. As of November 30, 2011, the total value
of securities held directly that were fair valued using methods determined in good faith by or at
the direction of the Trustees of the Trust represented 0.0% of net assets. The Fund classifies such
securities (levels defined below) as Level 3.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid or
an ask, quotation or quoted price may be a market quotation provided by a market participant or
other third party pricing source in accordance with the convention for that security.
In accordance with the authoritative guidance on fair value measurements and disclosures under U.S.
GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following:
Consistent with U.S. GAAP, the Fund valued potential litigation recoveries with respect to the
bankruptcy proceedings at zero. The Fund valued interests related to bankruptcy proceedings at
zero.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
$ |
|
|
|
$ |
|
|
|
$ |
0 |
* |
|
$ |
|
|
Short-Term Investments |
|
|
21,393 |
|
|
|
|
|
|
|
|
|
|
|
21,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
$ |
21,393 |
|
|
$ |
|
|
|
$ |
0 |
* |
|
$ |
21,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Represents the interest in securities that are defaulted and
were determined to have a fair value of zero at November 30,
2011 or February 28,2011. |
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many factors
can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in the
Fund are summarized below. The risks of investing in the Fund depend on the types of investments in
its portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every potential
risk of investing in the Fund. The Fund could be subject to additional risks because of the types
of investments it makes and market conditions, which may change over time.
Litigation-Related Risk The ultimate amount of the Funds recovery (through its investment
in SPV) of losses on the defaulted NPF Securities and the total costs the Fund may incur with
respect to its funding of litigation related to the NPF Securities is unknown at this time.
Therefore, the Fund is subject to the risk that SPV may ultimately be unable to recover
certain losses related to the NPF Securities.
Liquidity Risk Low trading volume, lack of a market maker, a large size position or legal
restrictions may limit or prevent the Fund from selling particular securities or unwinding
derivative positions at desirable prices. The more less-liquid securities the Fund holds, the
more likely it is to honor a redemption request in-kind. Liquidity risk is particularly
pronounced for the Fund due to the nature and size of its investment in the NPF Securities
(through the SPV). The Fund may be exposed (through the SPV) to the NPF Securities for an
indefinite period of time and may experience a substantial loss in the event the SPV sells the
NPF Securities.
Market Risk Fixed Income Securities Typically, the value of fixed income securities
will decline during periods of rising interest rates and widening of credit spreads.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income security
or the obligor of an obligation underlying an asset-backed security will be unable or
unwilling to satisfy its obligations to pay principal or interest payments or to otherwise
honor its obligations. The market value of a fixed income security normally will decline as a
result of the issuers failure to meet its payment obligations or the markets expectation of
a default, which may result from the downgrading of the issuers credit rating.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well as
other changes in foreign and domestic economic and political conditions could adversely affect
the value of the Funds investments.
Management and Operational Risk The Fund relies on GMOs ability to achieve its investment
objective by effectively implementing its investment approach. The Fund runs the risk that
GMOs proprietary investment techniques will fail to produce the desired results. The Fund is
also subject to the risk that deficiencies in the Managers or another service providers
internal systems or controls will cause losses for the Fund or impair Fund operations.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative contracts.
Subsequent events
On January 17, 2012, the Fund received $106,035 in
connection with a distribution from the NPF VI and NPF XII bankruptcy estates.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Special Situations Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) / |
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Asset-Backed Securities (United States) ¨
0.6% |
|
|
|
|
|
182,975 |
|
|
Countrywide Asset-Backed Certificates, Series 07-S2, Class A1, MBIA, 1 mo. LIBOR + .14%, 0.40%, due 05/25/37 |
|
|
177,486 |
|
|
1,453,036 |
|
|
Countrywide Asset-Backed Certificates, Series 07-S1, Class A1A, MBIA, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36 |
|
|
1,380,384 |
|
|
3,026,940 |
|
|
Countrywide Asset-Backed Certificates, Series 06-S9, Class A2, MBIA, Variable Rate, 5.51%, due 08/25/36 |
|
|
2,930,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Asset-Backed Securities (United States) |
|
|
4,488,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
4,488,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $4,496,503) |
|
|
4,488,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 92.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 92.9% |
|
|
|
|
|
26,628,197 |
|
|
GMO U.S. Treasury Fund |
|
|
665,971,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $665,801,023) |
|
|
665,971,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 7.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 7.6% |
|
|
|
|
|
54,843,809 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00%(a) |
|
|
54,843,809 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $54,843,809) |
|
|
54,843,809 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 101.1%
(Cost $725,141,335) |
|
|
725,303,254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (1.1%) |
|
|
(8,057,859 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
717,245,395 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Forward Currency Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Settlement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
Date |
|
|
Counterparty |
|
Deliver/Receive |
|
|
Units of Currency |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/02/11 |
|
|
Bank of America N.A. |
|
BRL |
|
|
52,761,600 |
|
|
$ |
29,176,653 |
|
|
$ |
41,085 |
|
|
12/02/11 |
|
|
Barclays Bank PLC |
|
BRL |
|
|
272,624,400 |
|
|
|
150,758,647 |
|
|
|
635,079 |
|
|
12/02/11 |
|
|
Brown Brothers Harriman & Co. |
|
BRL |
|
|
139,050,000 |
|
|
|
76,893,300 |
|
|
|
108,276 |
|
|
12/02/11 |
|
|
Royal Bank of Scotland PLC |
|
BRL |
|
|
27,504,000 |
|
|
|
15,209,445 |
|
|
|
21,417 |
|
|
1/13/12 |
|
|
Bank of America N.A. |
|
KRW |
|
|
179,865,270,000 |
|
|
|
156,968,760 |
|
|
|
4,372,451 |
|
|
12/16/11 |
|
|
Bank of America N.A. |
|
SGD |
|
|
46,187,204 |
|
|
|
36,037,668 |
|
|
|
(346,539 |
) |
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
SGD |
|
|
57,416,745 |
|
|
|
44,799,542 |
|
|
|
(371,369 |
) |
|
12/16/11 |
|
|
Deutsche Bank AG |
|
SGD |
|
|
104,131,800 |
|
|
|
81,249,067 |
|
|
|
(558,959 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
591,093,082 |
|
|
$ |
3,901,441 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales # |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Bank of America N.A. |
|
AUD |
|
|
151,262,267 |
|
|
$ |
155,304,835 |
|
|
$ |
(1,834,441 |
) |
|
12/16/11 |
|
|
Bank of New York Mellon |
|
AUD |
|
|
3,375,022 |
|
|
|
3,465,221 |
|
|
|
(59,926 |
) |
|
12/16/11 |
|
|
Barclays Bank PLC |
|
AUD |
|
|
3,375,000 |
|
|
|
3,465,199 |
|
|
|
(62,304 |
) |
|
12/16/11 |
|
|
JPMorgan Chase Bank N.A. |
|
AUD |
|
|
75,631,133 |
|
|
|
77,652,417 |
|
|
|
(1,478,252 |
) |
|
12/02/11 |
|
|
Bank of America N.A. |
|
BRL |
|
|
52,761,600 |
|
|
|
29,176,653 |
|
|
|
(376,653 |
) |
|
12/02/11 |
|
|
Barclays Bank PLC |
|
BRL |
|
|
272,624,400 |
|
|
|
150,758,647 |
|
|
|
(850,028 |
) |
|
3/02/12 |
|
|
Barclays Bank PLC |
|
BRL |
|
|
272,624,400 |
|
|
|
148,008,578 |
|
|
|
(596,228 |
) |
|
12/02/11 |
|
|
Brown Brothers Harriman & Co. |
|
BRL |
|
|
139,050,000 |
|
|
|
76,893,300 |
|
|
|
(4,893,301 |
) |
|
12/02/11 |
|
|
Royal Bank of Scotland PLC |
|
BRL |
|
|
27,504,000 |
|
|
|
15,209,445 |
|
|
|
(809,445 |
) |
|
12/16/11 |
|
|
Bank of America N.A. |
|
CHF |
|
|
12,782,051 |
|
|
|
13,996,492 |
|
|
|
193,962 |
|
|
12/16/11 |
|
|
Bank of New York Mellon |
|
CHF |
|
|
12,873,543 |
|
|
|
14,096,676 |
|
|
|
164,951 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12/16/11 |
|
|
Brown Brothers Harriman & Co. |
|
|
|
|
|
CHF |
|
|
4,750,520 |
|
|
|
5,201,874 |
|
|
|
62,444 |
|
|
12/16/11 |
|
|
Royal Bank of Scotland PLC |
|
|
|
|
|
CHF |
|
|
48,188,202 |
|
|
|
52,766,631 |
|
|
|
638,150 |
|
|
12/23/11 |
|
|
Bank of America N.A. |
|
|
|
|
|
CLP |
|
|
15,061,440,000 |
|
|
|
29,138,191 |
|
|
|
(338,191 |
) |
|
12/23/11 |
|
|
Brown Brothers Harriman & Co. |
|
|
|
|
|
CLP |
|
|
20,120,160,000 |
|
|
|
38,924,902 |
|
|
|
(524,902 |
) |
|
12/23/11 |
|
|
Royal Bank of Scotland PLC |
|
|
|
|
|
CLP |
|
|
14,798,400,000 |
|
|
|
28,629,308 |
|
|
|
170,692 |
|
|
12/22/11 |
|
|
Bank of America N.A. |
|
|
|
|
|
PHP |
|
|
2,109,792,000 |
|
|
|
48,285,554 |
|
|
|
295,727 |
|
|
12/22/11 |
|
|
Bank of America N.A. |
|
|
|
|
|
RUB |
|
|
1,881,240,000 |
|
|
|
61,077,505 |
|
|
|
(3,477,505 |
) |
|
12/22/11 |
|
|
Brown Brothers Harriman & Co. |
|
|
|
|
|
RUB |
|
|
927,648,000 |
|
|
|
30,117,595 |
|
|
|
(1,317,595 |
) |
|
12/22/11 |
|
|
Royal Bank of Scotland PLC |
|
|
|
|
|
RUB |
|
|
313,728,000 |
|
|
|
10,185,688 |
|
|
|
(585,688 |
) |
|
12/23/11 |
|
|
Barclays Bank PLC |
|
|
|
|
|
ZAR |
|
|
237,271,680 |
|
|
|
29,146,975 |
|
|
|
(346,975 |
) |
|
12/23/11 |
|
|
Brown Brothers Harriman & Co. |
|
|
|
|
|
ZAR |
|
|
475,672,320 |
|
|
|
58,432,634 |
|
|
|
(832,634 |
) |
|
12/23/11 |
|
|
Royal Bank of Scotland PLC |
|
|
|
|
|
ZAR |
|
|
76,443,360 |
|
|
|
9,390,470 |
|
|
|
209,529 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,089,324,790 |
|
|
$ |
(16,648,613 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fund buys foreign currency; sells USD. |
|
# |
|
Fund sells foreign currency; buys USD. |
Swap Agreements
Forward Starting Dividend Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net |
Notional |
|
Starting |
|
Expiration |
|
|
|
|
|
|
|
Unrealized |
Amount |
|
Date |
|
Date |
|
Counterparty |
|
Fund Pays |
|
Fund Receives |
|
Appreciation/(Depreciation) |
686,006
|
|
EUR
|
|
12/19/2014
|
|
12/18/2015
|
|
Barclays Bank PLC
|
|
25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
25,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
$ |
25,860 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,020,000
|
|
EUR
|
|
12/18/2015
|
|
12/16/2016
|
|
Barclays Bank PLC
|
|
25,000 EUR for every 1 dividend
25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
25,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(15,147 |
) |
5,436,000
|
|
EUR
|
|
12/16/2016
|
|
12/15/2017
|
|
BNP Paribas
|
|
60,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
60,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(767,456 |
) |
2,072,500
|
|
EUR
|
|
12/15/2017
|
|
12/21/2018
|
|
Barclays Bank PLC
|
|
25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
25,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(102,042 |
) |
2,065,000
|
|
EUR
|
|
12/15/2017
|
|
12/21/2018
|
|
Barclays Bank PLC
|
|
25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
25,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(93,538 |
) |
2,062,500
|
|
EUR
|
|
12/15/2017
|
|
12/21/2018
|
|
BNP Paribas
|
|
25,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
25,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(90,704 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,007,000
|
|
EUR
|
|
12/15/2017
|
|
12/21/2018
|
|
BNP Paribas
|
|
10,000 EUR for every 1 dividend EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
10,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(242,633 |
) |
2,729,225
|
|
EUR
|
|
12/21/2018
|
|
12/20/2019
|
|
BNP Paribas
|
|
30,000 EUR for every 1 dividend
EURO STOXX 50 Index point
decrease in the actual dividends
from the Fixed Strike
|
|
30,000 EUR for every 1 dividend EURO STOXX 50 Index point
increase in the actual dividends from the Fixed Strike
|
|
|
(672,821 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,958,481 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
Notional |
|
Expiration |
|
|
|
Receive |
|
|
|
|
|
|
|
Appreciation/ |
Amount |
|
Date |
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
|
Variable Rate |
|
(Depreciation) |
3,100,000
|
|
CHF
|
|
9/1/2021
|
|
Barclays Bank PLC
|
|
(Pay)
|
|
|
1.63 |
% |
|
6 Month CHF BBA LIBOR
|
|
|
$ (83,191 |
) |
3,200,000
|
|
CHF
|
|
9/5/2021
|
|
Credit Suisse International
|
|
(Pay)
|
|
|
1.71 |
% |
|
6 Month CHF BBA LIBOR
|
|
|
(113,850 |
) |
840,000,000
|
|
JPY
|
|
10/22/2020
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
0.97 |
% |
|
6 Month JPY BBA LIBOR
|
|
|
(15,805 |
) |
840,000,000
|
|
JPY
|
|
10/26/2020
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
0.97 |
% |
|
6 Month JPY BBA LIBOR
|
|
|
(14,950 |
) |
840,000,000
|
|
JPY
|
|
10/26/2020
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
0.97 |
% |
|
6 Month JPY BBA LIBOR
|
|
|
(17,003 |
) |
840,000,000
|
|
JPY
|
|
10/27/2020
|
|
Citibank N.A.
|
|
(Pay)
|
|
|
0.99 |
% |
|
6 Month JPY BBA LIBOR
|
|
|
(28,417 |
) |
2,130,000,000
|
|
JPY
|
|
11/1/2020
|
|
Morgan Stanley Capital Services Inc.
|
|
(Pay)
|
|
|
1.04 |
% |
|
6 Month JPY BBA LIBOR
|
|
|
(188,195 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$(461,411 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate.
(Pay) Fund pays fixed rate and receives variable rate.
|
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional |
|
|
|
|
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Amount |
|
|
|
|
|
Date |
|
|
Counterparty |
|
|
Fund Pays |
|
|
Fund Receives |
|
|
Appreciation/ (Depreciation) |
|
29,105,044 |
|
USD |
|
|
5/16/2012 |
|
|
Goldman Sachs International |
|
Return on Asia Equity Basket Swap |
|
1 Month Federal Funds Effective Rate -.68% |
|
$ |
(438,306 |
) |
11,804,910 |
|
USD |
|
|
5/16/2012 |
|
|
Goldman Sachs International |
|
Return on Europe Equity Basket Swap |
|
1 Month Federal Funds Effective Rate -.33% |
|
|
62,166 |
|
2,860,440 |
|
USD |
|
|
5/16/2012 |
|
|
Goldman Sachs International |
|
Return on U.S. Equity Basket Swap |
|
1 Month Federal Funds Effective Rate -.80% |
|
|
23,585 |
|
178,419 |
|
USD |
|
|
11/1/2012 |
|
|
Morgan Stanley Capital Services |
|
Return on Evergrande Real Estate Group Common Stock |
|
1 Month Federal Funds Effective Rate - .16% |
|
|
1,818 |
|
545,392 |
|
USD |
|
|
11/1/2012 |
|
|
Morgan Stanley Capital Services |
|
Return on Industrial and Commercial Bank of China Ltd. - Class H |
|
1 Month Federal Funds Effective Rate - .40% |
|
|
26,821 |
|
4,400,000 |
|
EUR |
|
|
12/18/2015 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2015 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2015 Dividend Future |
|
|
(409,828 |
) |
8,880,000 |
|
EUR |
|
|
12/16/2016 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2016 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2016 Dividend Future |
|
|
(1,142,145 |
) |
2,585,250 |
|
EUR |
|
|
12/15/2017 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2017 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2017 Dividend Future |
|
|
(582,292 |
) |
9,125,000 |
|
EUR |
|
|
12/15/2017 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2017 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2017 Dividend Future |
|
|
(1,551,973 |
) |
547,500 |
|
EUR |
|
|
12/21/2018 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2018 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2018 Dividend Future |
|
|
(202,899 |
) |
789,000 |
|
EUR |
|
|
12/21/2018 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2018 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2018 Dividend Future |
|
|
(261,014 |
) |
275,860 |
|
EUR |
|
|
12/21/2018 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2018 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2018 Dividend Future |
|
|
(93,629 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
904,250 |
|
EUR |
|
|
12/21/2018 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2018 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2018 Dividend Future |
|
|
(277,353 |
) |
2,663,701 |
|
EUR |
|
|
12/21/2018 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2018 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2018 Dividend Future |
|
|
(702,219 |
) |
552,500 |
|
EUR |
|
|
12/20/2019 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2019 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2019 Dividend Future |
|
|
(214,992 |
) |
3,037,500 |
|
EUR |
|
|
12/20/2019 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2019 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2019 Dividend Future |
|
|
(917,075 |
) |
2,937,000 |
|
EUR |
|
|
12/20/2019 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2019 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2019 Dividend Future |
|
|
(782,033 |
) |
5,587,500 |
|
EUR |
|
|
12/20/2019 |
|
|
Deutsche Bank AG |
|
Depreciation of EURO STOXX 50 December 2019 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2019 Dividend Future |
|
|
(1,179,096 |
) |
881,250 |
|
EUR |
|
|
12/20/2019 |
|
|
Morgan Stanley Capital Services |
|
Depreciation of EURO STOXX 50 December 2019 Dividend Future |
|
Appreciation of EURO STOXX 50 December 2019 Dividend Future |
|
|
(393,032 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(9,033,496 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
|
|
|
|
BBA |
|
British Banks Association |
|
LIBOR |
|
London Interbank Offered Rate |
|
MBIA |
|
Insured as to the payment of principal and interest by MBIA Insurance Corp. |
|
|
|
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security. |
|
¨
|
|
These securities are primarily backed by subprime mortgages. |
|
(a) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
Currency Abbreviations:
AUD Australian Dollar
BRL Brazilian Real
CHF Swiss Franc
CLP Chilean Peso
EUR Euro
JPY Japanese Yen
KRW South Korean Won
PHP Philippine Peso
RUB Russian Ruble
SGD Singapore Dollar
USD United States Dollar
ZAR South African Rand
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes
and gross and net unrealized appreciation (depreciation) in value of investments
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$725,141,335 |
|
$ |
173,360 |
|
|
$ |
(11,441 |
) |
|
$ |
161,919 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should
be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S.
Treasury Fund |
|
$ |
659,449,307 |
|
|
$ |
40,271,662 |
|
|
$ |
34,000,000 |
|
|
$ |
241,632 |
|
|
$ |
30,030 |
|
|
$ |
665,971,194 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Swap Agreements |
|
(0.1)% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. Inputs may also include: fair value adjustments provided
by an independent pricing service applied to foreign equity securities (including the value of
equity securities
that underlie futures (to the extent the market for such futures closes prior to the close of
the NYSE) and other derivatives) due to market events that have occurred since the local market
close but prior to the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value technique on Level 3 investments: The Fund valued certain debt
securities using quoted prices.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
|
|
|
$ |
4,488,251 |
|
|
$ |
4,488,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
|
|
|
|
4,488,251 |
|
|
|
4,488,251 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
665,971,194 |
|
|
|
|
|
|
|
|
|
|
|
665,971,194 |
|
Short-Term Investments |
|
|
54,843,809 |
|
|
|
|
|
|
|
|
|
|
|
54,843,809 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
720,815,003 |
|
|
|
|
|
|
|
4,488,251 |
|
|
|
725,303,254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
|
|
|
|
|
6,913,763 |
|
|
|
|
|
|
|
6,913,763 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
|
|
|
|
140,250 |
|
|
|
|
|
|
|
140,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
720,815,003 |
|
|
$ |
7,054,013 |
|
|
$ |
4,488,251 |
|
|
$ |
732,357,267 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Currency Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency risk |
|
$ |
|
|
|
$ |
(19,660,935 |
) |
|
$ |
|
|
|
$ |
(19,660,935 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest risk |
|
|
|
|
|
|
(461,411 |
) |
|
|
|
|
|
|
(461,411 |
) |
Equity risk |
|
|
|
|
|
|
(11,132,227 |
) |
|
|
|
|
|
|
(11,132,227 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(31,254,573 |
) |
|
$ |
|
|
|
$ |
(31,254,573 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with
the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net value of the Funds direct
investments in securities using Level 3 inputs was 0.6% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments Still |
|
|
|
Balances as of |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
Transfers |
|
|
Transfers |
|
|
Balances as of |
|
|
Held as of |
|
|
|
February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
into level |
|
|
out of level |
|
|
November 30, |
|
|
November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
3 * |
|
|
3 * |
|
|
2011 |
|
|
2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
6,011,997 |
|
|
$ |
(1,577,127 |
) |
|
$ |
2,154 |
|
|
$ |
59,478 |
|
|
$ |
(8,251 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
4,488,251 |
|
|
$ |
(8,251 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
6,011,997 |
|
|
$ |
(1,577,127 |
) |
|
$ |
2,154 |
|
|
$ |
59,478 |
|
|
$ |
(8,251 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
4,488,251 |
|
|
$ |
(8,251 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments transferred into Level 3 at the value at the beginning of the period and transferred out of |
|
Level 3 |
|
at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. The Fund had no
reverse repurchase agreements outstanding at the end of the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. The Fund had no inflation-indexed bonds outstanding at the end of the period.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Customized Investment Program Risk Because the Fund is intended to complement the
Managers asset allocation strategies, the risks associated with the Funds investments
often will be far greater (and investment returns may be far more volatile) than if the
Fund served as a stand-alone investment vehicle.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Liquidity Risk Low trading volume, lack of a market maker, a large size position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions.
Focused Investment Risk Focusing investments in particular countries, regions,
sectors or companies, or in industries with high positive correlations to one another
creates additional risk.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Market Risk Fixed Income Securities Typically, the value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests will not perform as expected or that the Fund will invest in underlying funds
with higher fees or expenses.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other Risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency
exchange rates. The value of each of the Funds forward currency contracts is marked to market
daily using rates supplied by a quotation service and changes in value are recorded by the Fund
as unrealized gains or losses. Realized gains or losses on the contracts are equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. During the period ended November 30,
2011, the Fund used forward currency contracts to adjust exposure to foreign currencies and
manage against anticipated currency exchange rate changes. Forward currency contracts
outstanding at the end of the period are listed in the Funds Schedule of Investments.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
maintain the diversity and liquidity of the portfolio and to adjust exposure to equity
markets. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written options to adjust exposure of the portfolio to various equity
markets. The Fund had no written option contracts outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Amount of |
|
|
of |
|
|
|
|
|
|
Amount of |
|
|
of |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
Options written |
|
|
|
|
|
|
(351,384 |
) |
|
|
(2,822,342 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options bought back |
|
|
|
|
|
|
351,384 |
|
|
|
2,822,342 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund generally values OTC options using inputs provided by primary pricing
sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment
when that variance is less than the strike price. This type of agreement is essentially a
forward contract on the future realized price variance of the underlying asset.
Forward starting dividend swap agreements involve an exchange by the parties of their respective
commitments to pay or right to receive the changes in a dividend index point. The Fund gains
exposure by either paying or receiving an amount in respect of an increase or decrease in the
change of the relevant dividend index point based on a notional amount. For example, if the Fund
took a long position on a dividend index swap, the Fund would receive payments if the relevant
index point increased in value and would be obligated to pay if that index point decreased in
value.
Future swap agreements involve an exchange by the parties of their respective commitments to pay
or right to receive the changes in an index. The Fund gains exposure by either paying or
receiving an amount in respect of an increase or decrease in the change of the index based on a
notional amount. For example, if the Fund took a long position on a future swap, the Fund would
receive payments if the relevant index increased in value and would be obligated to pay if that
index decreased in value.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that the collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
During the period ended November 30, 2011, the Fund used swap agreements to adjust interest rate
exposure, its exposure to certain securities markets, and its exposure to certain companies and
industries, as well as to hedge some or all of the broad market exposure of the assets in which
the Fund invests and manage the duration of the portfolio. Swap agreements outstanding
at the end of the period are listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized appreciation on forward currency ontracts |
|
$ |
|
|
|
$ |
6,913,763 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
6,913,763 |
|
Unrealized appreciation on swap agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
140,250 |
|
|
|
|
|
|
|
140,250 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
6,913,763 |
|
|
$ |
|
|
|
$ |
140,250 |
|
|
$ |
|
|
|
$ |
7,054,013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on forward currency contracts |
|
$ |
|
|
|
$ |
(19,660,935 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(19,660,935 |
) |
Unrealized depreciation on swap agreements |
|
|
(461,411 |
) |
|
|
|
|
|
|
|
|
|
|
(11,132,227 |
) |
|
|
|
|
|
|
(11,593,638 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(461,411 |
) |
|
$ |
(19,660,935 |
) |
|
$ |
|
|
|
$ |
(11,132,227 |
) |
|
$ |
|
|
|
$ |
(31,254,573 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures contracts), or notional amounts (swap agreements), outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
1,158,205,988 |
|
|
$ |
92,476,097 |
|
|
$ |
223,997,423 |
|
|
$ |
19,464 |
* |
|
|
|
* |
|
During the period ended November 30, 2011, the Fund did not hold written options at any month-end, therefore, the average amount outstanding was calculated using daily
outstanding absolute values. |
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Strategic Fixed Income Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value ($)/ |
|
|
|
|
|
|
Shares/ |
|
|
|
|
|
|
Principal Amount |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
|
|
DEBT OBLIGATIONS 12.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 12.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 12.3% |
|
|
|
|
|
|
|
|
|
79,661,775 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00% , due 04/15/12(a)(b) |
|
|
79,929,359 |
|
|
|
|
|
|
50,000,000 |
|
|
U.S. Treasury Note, 0.38% , due 09/30/12 |
|
|
50,101,550 |
|
|
|
|
|
|
33,000,000 |
|
|
U.S. Treasury Note, 1.38% , due 01/15/13 (b) |
|
|
33,442,134 |
|
|
|
|
|
|
150,000,000 |
|
|
U.S. Treasury Note, 1.75% , due 01/31/14 |
|
|
154,687,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
318,160,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $316,822,869) |
|
|
318,160,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 81.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 81.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
|
|
|
|
9,402,704 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
89,043,603 |
|
|
|
|
|
|
105,394,919 |
|
|
GMO Short-Duration Collateral Fund |
|
|
696,660,416 |
|
|
|
|
|
|
30,779,190 |
|
|
GMO U.S. Treasury Fund |
|
|
769,787,532 |
|
|
|
|
|
|
23,817,449 |
|
|
GMO World Opportunity Overlay Fund |
|
|
562,091,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United States |
|
|
2,117,583,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $2,228,126,239) |
|
|
2,117,583,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPTIONS PURCHASED 0.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options on Interest Rate Swaps 0.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NZD |
|
|
250,000,000 |
|
|
Swaption
Call, Expires 06/01/12, Strike 4.00, Upon potential exercise of the
option, the Fund will enter into a swap with a notional amount of
250,000,000 NZD in which it will pay a 3 month NZD Bank Bill and
will receive 4.00%, maturing on June 6, 2013, (OTC) (CP Morgan Stanley Capital Services Inc.) |
|
|
2,270,711 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NZD |
|
|
500,000,000 |
|
|
Swaption
Call, Expires 05/11/12, Strike 3.63, Upon potential exercise of the
option, the Fund will enter into a swap with a notional amount of
500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and
will receive 3.63%, maturing on May 15, 2013, (OTC) (CP Morgan Stanley Capital Services Inc.) |
|
|
3,295,186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NZD |
|
|
500,000,000 |
|
|
Swaption
Call, Expires 03/27/12, Strike 3.80, Upon potential exercise of the
option, the Fund will enter into a swap with a notional amount of
500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and
will receive 3.80%, maturing on March 28, 2013, (OTC) (CP Morgan Stanley Capital Services Inc.) |
|
|
3,940,949 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NZD |
|
|
500,000,000 |
|
|
Swaption
Call, Expires 03/26/12, Strike 3.80, Upon potential exercise of the
option, the Fund will enter into a swap with a notional amount of
500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and
will receive 3.80%, maturing on March 28, 2013, (OTC) (CP Morgan Stanley Capital Services Inc.) |
|
|
3,942,121 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NZD |
|
|
500,000,000 |
|
|
Swaption Call, Expires 02/15/12, Strike 4.22,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
500,000,000 NZD in which it will pay a 3 month NZD Bank Bill and will receive 4.22%,
maturing on February 16, 2013,
(OTC) (CP Morgan Stanley Capital Services Inc.) |
|
|
5,599,474 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD |
|
|
400,000,000 |
|
|
Swaption Call, Expires 05/20/13, Strike 0.77,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
400,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.77%, maturing
on May 22, 2014,
(OTC) (CP Merrill Lynch Capital Services Inc.) |
|
|
1,028,800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD |
|
|
400,000,000 |
|
|
Swaption Call, Expires 05/21/12, Strike 0.77,
Upon potential excercise of the option, the Fund will enter into a swap with a notional amount of
400,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.77%, maturing
on May 23, 2013,
(OTC) (CP Merrill Lynch Capital Services Inc.) |
|
|
938,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD |
|
|
500,000,000 |
|
|
Swaption Call, Expires 01/22/13, Strike 0.85,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
500,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.85%, maturing
on January 24, 2014,
(OTC) (CP Citibank N.A.) |
|
|
1,586,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
USD |
|
|
500,000,000 |
|
|
Swaption Call, Expires 01/23/12, Strike 0.85,
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of
500,000,000 USD in which it will pay a 3 month USD LIBOR and will receive 0.85%, maturing
on January 25, 2013,
(OTC) (CP Citibank N.A.) |
|
|
1,221,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Options on Interest Rate Swaps |
|
|
23,822,741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL OPTIONS PURCHASED (COST $7,920,291) |
|
|
23,822,741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
|
|
|
|
1,036,332 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(c) |
|
|
1,036,332 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 1.1% |
|
|
|
|
|
|
|
|
|
27,300,000 |
|
|
U.S. Treasury Bill, 0.09%, due 10/18/12(b)(d) |
|
|
27,275,594 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $28,309,960) |
|
|
28,311,926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 95.9% |
|
|
|
|
|
|
|
|
|
|
|
|
(Cost $2,581,179,359) |
|
|
2,487,878,555 |
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 4.1% |
|
|
105,723,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
2,593,601,818 |
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
Contracts |
|
Type |
|
Date |
|
Value |
|
(Depreciation) |
|
Buys
|
|
|
|
|
|
|
|
|
|
|
|
|
|
251 |
|
|
Australian Government Bond 10 Yr.
|
|
December 2011
|
|
$ |
30,082,539 |
|
$ |
853,169 |
|
8,650 |
|
|
Euro Dollar 90 Day
|
|
March 2012
|
|
|
2,149,525,000 |
|
|
1,307,625 |
|
|
|
|
|
|
|
|
$ |
2,179,607,539 |
|
$ |
2,160,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
565 |
|
|
Australian Government Bond 3 Yr.
|
|
December 2011
|
|
$ |
62,742,637 |
|
$ |
(544,160) |
|
8,650 |
|
|
Euro Dollar 90 Day
|
|
March 2013
|
|
|
2,147,795,000 |
|
|
(2,726,962) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,210,537,637 |
|
$ |
(3,271,122) |
|
|
|
|
|
|
|
|
|
|
|
Written Options
A summary of open written option contracts for the Fund at November 30, 2011 is as follows:
Options on Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of Underlying Swap |
|
|
|
|
|
|
|
Description |
|
Notional Amount |
|
|
|
Expiration
Date |
|
Counterparty |
|
Receive (Pay) # |
|
|
Fixed Rate |
|
|
Variable Rate |
|
|
Premiums |
|
|
Market Value |
|
|
Call- OTC 2 Year Interest Rate Swap |
|
500,000,000 |
|
USD |
|
01/23/12 |
|
Citibank N.A. |
|
(Pay) |
|
|
0.85 |
% |
|
3 Month USD LIBOR |
|
$ |
(200,000 |
) |
|
(1,940,500 |
) |
Call- OTC 2 Year Interest Rate Swap |
|
400,000,000 |
|
USD |
|
05/21/12 |
|
Merrill Lynch Capital Services Inc. |
|
(Pay) |
|
|
0.77 |
% |
|
3 Month USD LIBOR |
|
|
(310,000 |
) |
|
(1,331,600 |
) |
Call- OTC 1 Year Interest Rate Swap |
|
250,000,000 |
|
NZD |
|
06/01/12 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
3.25 |
% |
|
3 Month NZD Bank Bill |
|
|
(193,871 |
) |
|
(1,057,466 |
) |
Call- OTC 1 Year Interest Rate Swap |
|
500,000,000 |
|
NZD |
|
02/15/12 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
3.33 |
% |
|
3 Month NZD Bank Bill |
|
|
(281,812 |
) |
|
(2,315,220 |
) |
Call- OTC 1 Year Interest Rate Swap |
|
500,000,000 |
|
NZD |
|
05/11/12 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
3.13 |
% |
|
3 Month NZD Bank Bill |
|
|
(354,780 |
) |
|
(1,765,892 |
) |
Call- OTC 1 Year Interest Rate Swap |
|
500,000,000 |
|
NZD |
|
03/27/12 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
2.80 |
% |
|
3 Month NZD Bank Bill |
|
|
(263,568 |
) |
|
(892,511 |
) |
Call- OTC 1 Year Interest Rate Swap |
|
500,000,000 |
|
NZD |
|
03/26/12 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
2.80 |
% |
|
3 Month NZD Bank Bill |
|
|
(262,360 |
) |
|
(890,169 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(1,866,391 |
) |
$ |
(10,193,358 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
Notional |
|
Expiration |
|
|
|
Receive |
|
|
|
|
|
|
|
|
|
Appreciation/ |
Amount |
|
Date |
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
Variable Rate |
|
(Depreciation) |
100,000,000
|
|
AUD
|
|
8/25/2020
|
|
Barclays Bank
PLC
|
|
Receive
|
|
|
5.27 |
% |
|
6 Month AUD
Bank Bill Rate
|
|
$ |
4,186,177 |
|
200,000,000
|
|
AUD
|
|
8/26/2020
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
5.26 |
% |
|
6 Month AUD
Bank Bill Rate
|
|
|
8,192,129 |
|
200,000,000
|
|
AUD
|
|
8/30/2020
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
5.25 |
% |
|
6 Month AUD
Bank Bill Rate
|
|
|
7,984,899 |
|
300,000,000
|
|
AUD
|
|
9/20/2020
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
5.58 |
% |
|
6 Month AUD
Bank Bill Rate
|
|
|
19,408,732 |
|
200,000,000
|
|
AUD
|
|
9/22/2020
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
5.65 |
% |
|
6 Month AUD
Bank Bill Rate
|
|
|
13,930,294 |
|
200,000,000
|
|
AUD
|
|
4/5/2021
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
6.06 |
% |
|
6 Month AUD
Bank Bill Rate
|
|
|
20,692,066 |
|
100,000,000
|
|
NZD
|
|
7/14/2015
|
|
Barclays Bank PLC
|
|
Receive
|
|
|
4.87 |
% |
|
3 Month NZD
Bank Bill Rate
|
|
|
4,329,204 |
|
100,000,000
|
|
NZD
|
|
7/15/2015
|
|
Barclays Bank
PLC
|
|
Receive
|
|
|
4.86 |
% |
|
3 Month NZD
Bank Bill Rate
|
|
|
4,303,455 |
|
100,000,000
|
|
NZD
|
|
7/15/2015
|
|
Citibank N.A.
|
|
Receive
|
|
|
4.85 |
% |
|
3 Month NZD
Bank Bill Rate
|
|
|
4,283,603 |
|
125,000,000
|
|
NZD
|
|
7/16/2015
|
|
Merrill Lynch
Capital Services Inc.
|
|
Receive
|
|
|
4.86 |
% |
|
3 Month NZD
Bank Bill Rate
|
|
|
5,400,313 |
|
1,215,000,000
|
|
USD
|
|
2/8/2014
|
|
Morgan Stanley
Capital Services
Inc.
|
|
(Pay)
|
|
|
0.71 |
% |
|
3 Month USD
Libor
|
|
|
(332,626 |
) |
505,000,000
|
|
USD
|
|
2/8/2017
|
|
Morgan Stanley
Capital Services
Inc.
|
|
Receive
|
|
|
1.79 |
% |
|
3 Month USD
Libor |
|
|
9,764,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
102,142,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to
(Pay) Receive
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate.
(Pay) Fund pays fixed rate and receives variable rate. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient
cash and/or securities to cover any commitments or collateral requirements of the relevant
broker or exchange.
Notes to Schedule of Investments:
CP Counterparty
LIBOR London Interbank Offered Rate
OTC Over-the-Counter
USD LIBOR London Interbank Offered Rate denominated in United States Dollars.
(a) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument
or financial statistic. |
|
(b) |
|
All or a portion of this security has been pledged to cover margin requirements on futures
contracts, collateral on swap contracts, forward currency contracts, and/or written options, if
any. |
(c) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(d) |
|
Rate shown represents yield-to-maturity. |
Currency Abbreviations:
AUD
Australian Dollar
NZD New Zealand Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$2,602,393,499 |
|
$ |
18,107,411 |
|
|
$ |
(132,622,355 |
) |
|
$ |
(114,514,944 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Emerging Country Debt Fund,
Class IV |
|
$ |
74,177,360 |
|
|
$ |
11,900,000 |
|
|
$ |
|
|
|
$ |
1,026,777 |
|
|
|
|
|
|
$ |
|
|
|
$ |
89,043,603 |
|
GMO Short-Duration Collateral Fund |
|
|
1,093,999,261 |
|
|
|
|
|
|
|
|
|
|
|
8,287,092 |
|
|
|
|
|
|
|
365,005,327 |
|
|
|
696,660,416 |
|
GMO U.S. Treasury Fund |
|
|
639,615,835 |
|
|
|
642,115,000 |
|
|
|
512,250,000 |
|
|
|
289,788 |
|
|
|
39,047 |
|
|
|
|
|
|
|
769,787,532 |
|
GMO World Opportunity Overlay Fund |
|
|
539,186,004 |
|
|
|
1,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
562,091,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
2,346,978,460 |
|
|
$ |
655,015,000 |
|
|
$ |
512,250,000 |
|
|
$ |
9,603,657 |
|
|
$ |
39,047 |
|
|
$ |
365,005,327 |
|
|
$ |
2,117,583,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds
during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax
characterization of distributions paid by the underlying funds will be determined through fiscal
year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the
most recent quoted price. Unlisted securities for which market quotations are readily available
are generally valued at the most recent quoted price. Non-emerging market debt instruments with
a remaining maturity of sixty days or less may be valued at amortized cost (unless
circumstances dictate otherwise; for example, if the issuers creditworthiness has become
impaired), which approximates market value. Shares of open-end investment companies are
generally valued at their net asset value. Derivatives and other securities for which
quotations are not readily available or whose values the Manager has determined to be
unreliable are valued at fair value as determined in good faith by the Trustees or persons
acting at their direction pursuant to procedures approved by the Trustees. Although the goal of
fair valuation is to determine the amount the owner of the securities might reasonably expect
to receive upon their current sale, because of the uncertainty inherent in fair value pricing,
the value determined for a particular security may be materially different from the value
realized upon its sale. As of November 30, 2011, the total value of securities held
directly and indirectly that were fair valued using methods determined in good faith by or at
the direction of the Trustees of the Trust represented 1.4% of net assets. The Fund and the
underlying funds classify such securities (levels defined below) as Level 3. For the period ended November 30, 2011, the Fund did not reduce the value of any of its
OTC derivative contracts based on the creditworthiness of its counterparties. See Derivative financial instruments below for a further discussion on valuation of derivatives.
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part
of the valuation process and do not necessarily provide greater certainty about the prices used
by the Fund and the underlying funds. As of November 30, 2011, the total value of securities
held directly and indirectly for which no alternative pricing source was available represented
4.5% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the
ask price for securities sold short. If the pricing convention for a security does not involve
a bid or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily
an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about
fair value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government |
|
$ |
238,231,184 |
|
|
$ |
79,929,359 |
|
|
$ |
|
|
|
$ |
318,160,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
238,231,184 |
|
|
|
79,929,359 |
|
|
|
|
|
|
|
318,160,543 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
2,117,583,345 |
|
|
|
|
|
|
|
|
|
|
|
2,117,583,345 |
|
Options Purchased |
|
|
|
|
|
|
23,822,741 |
|
|
|
|
|
|
|
23,822,741 |
|
Short-Term Investments |
|
|
28,311,926 |
|
|
|
|
|
|
|
|
|
|
|
28,311,926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
2,384,126,455 |
|
|
|
103,752,100 |
|
|
|
|
|
|
|
2,487,878,555 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
|
2,160,794 |
|
|
|
|
|
|
|
|
|
|
|
2,160,794 |
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
|
|
|
|
|
102,475,312 |
|
|
|
|
|
|
|
102,475,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
2,386,287,249 |
|
|
$ |
206,227,412 |
|
|
$ |
|
|
|
$ |
2,592,514,661 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Written Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
$ |
|
|
|
$ |
(10,193,358 |
) |
|
$ |
|
|
|
$ |
(10,193,358 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
|
(3,271,122 |
) |
|
|
|
|
|
|
|
|
|
|
(3,271,122 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate risk |
|
|
|
|
|
|
(332,626 |
) |
|
|
|
|
|
|
(332,626 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(3,271,122 |
) |
|
$ |
(10,525,984 |
) |
|
$ |
|
|
|
$ |
(13,797,106 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds indirect
investments in securities and derivative financial instruments using Level 3
inputs were 26.2% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and liabilities
are typically translated into U.S. dollars at the close of regular trading on the NYSE, generally
at 4:00 pm. Income and expenses denominated in foreign currencies are typically translated into
U.S. dollars at the close of regular trading on the NYSE on the business day the income and
expenses are accrued or incurred. Fluctuations in the value of currency holdings and other assets
and liabilities resulting from changes in exchange rates are recorded as unrealized foreign
currency gains or losses. Realized gains or losses and unrealized appreciation or depreciation on
investment securities and income and expenses are translated on the respective dates of such
transactions. The effects of changes in foreign currency exchange rates on investments in
securities are not separated from the effects of changes in market prices of those securities, but
are included with the net realized and unrealized gain or loss on investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund acquires
a security for cash and obtains a simultaneous commitment from the seller to repurchase the
security at an agreed upon price and date. The Fund, through its custodian, takes possession of
securities it acquired under the repurchase agreement. The value of the securities acquired is
required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings and/or the value of the securities subject to the repurchase
agreement is insufficient, the Funds recovery of cash from the seller may be delayed and the Fund
may incur a loss equal to the difference between the cash it paid and the value of the securities.
The Fund had no repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same assets
at an agreed upon price and date. The Fund can use the proceeds received from entering into a
reverse repurchase agreement to make additional investments, which generally causes the Funds
portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase agreement files
for bankruptcy or becomes insolvent, the Fund may be unable to recover the securities it sold and
as a result would realize a loss equal to the difference between the value of those securities and
the payment it received for them. The size of this loss will depend upon the difference between
what the buyer paid for the securities the Fund sold to it and the value of those securities (e.g.,
a buyer may pay $95 for a bond with a market value of $100). In the event of a buyers bankruptcy
or insolvency, the Funds use of proceeds from the sale of its securities may be restricted while
the other party or its trustee or receiver determines whether to honor the Funds right to
repurchase the securities. The Fund had no reverse repurchase agreements outstanding at the end of
the period.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation. Two
structures are common. The U.S. Treasury and some other issuers use a structure that reflects
inflation in the principal value of the bond. Most other issuers pay out any inflation related
accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real interest
rates. Real interest rates, in turn, are tied to the relationship between nominal interest rates
(i.e., stated interest rates) and the rate of inflation. Therefore, if the rate of inflation rises
at a faster rate than nominal interest rates, real interest rates (i.e. nominal interest rate minus
inflation) might decline, leading to an increase in value of inflation indexed bonds. In contrast,
if nominal interest rates increase at a faster rate than inflation, real interest rates might rise,
leading to a decrease in value of inflation indexed bonds. There can be no assurance, however,
that the value of inflation indexed bonds will be directly correlated to changes in nominal
interest rates, and short term increases in inflation may lead to a decline in their value. Coupon
payments received by the Fund from inflation indexed bonds are included in the Funds gross income
for the period in which they accrue. In addition, any increase or decrease in the principal amount
of an inflation indexed bond will increase or decrease taxable ordinary income to the Fund, even
though principal is not paid until maturity. Inflation-indexed bonds outstanding at the end of the
period are listed in the Funds Schedule of Investments.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many factors
can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in the
Fund are summarized below. The risks of investing in the Fund depend on the types of investments in
its portfolio and the investment strategies the Manager employs on its behalf. This section
does not describe every potential
risk of investing in the Fund. The Fund could be subject to additional risks because of the types
of investments it makes and market conditions, which may change over time.
Market Risk Fixed Income Securities Typically, the market value of the Funds fixed income
securities will decline during periods of rising interest rates and widening of credit spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe credit
downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income security or
the obligor of an obligation underlying an asset backed security will be unable or unwilling to
satisfy its obligations to pay principal or interest payments or to otherwise honor its
obligations. The market value of a fixed income security normally will decline as a result of the
issuers failure to meet its payment obligations or the markets expectation of a default, which
may result from the downgrading of the issuers credit rating. The Funds investments in below
investment grade securities have speculative characteristics, and changes in economic conditions or
other circumstances are more likely to impair the capacity of issuers to make principal and
interest payments than is the case with issuers of investment grade securities.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives contract
or a borrower of the Funds securities will be unable or unwilling to make timely settlement
payments or otherwise honor its obligations. The risk of counterparty default is particularly acute
in economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions.
Derivatives Risk The use of derivatives involves the risk that their value may not move as
expected relative to the value of the relevant underlying assets, rates or indices. Derivatives
also present other Fund risks, including market risk, liquidity risk, currency risk and
counterparty risk.
Management and Operational Risk The Fund relies on GMOs ability to achieve its investment
objective by effectively implementing its investment approach. The Fund runs the risk that GMOs
proprietary investment techniques will fail to produce the desired results. The Funds portfolio
managers may use quantitative analyses and/or models and any imperfections or limitations in such
analyses and/or models could affect the ability of the portfolio managers to implement strategies.
By necessity, these analyses and models make simplifying assumptions that limit their efficacy.
Models that appear to explain prior market data can fail to predict future market events. Further,
the data used in models may be inaccurate and/or it may not include the most recent information
about a company or a security. The Fund is also subject to the risk that deficiencies in the
Managers or another service providers internal systems or controls will cause losses for the Fund
or impair Fund operations.
Foreign Investment Risk The market prices of many foreign securities fluctuate more than
those of U.S. securities. Many foreign markets are less stable, smaller, less liquid and less
regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S.
markets. Foreign portfolio transactions generally involve higher commission rates, transfer taxes
and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to
foreign taxes on capital gains or other income payable on foreign securities, on transactions in
those securities and on the repatriation of proceeds generated from those securities. Also, many
foreign markets require a license for the Fund to invest directly in those markets, and the Fund is
subject to the risk that it could not invest if its license were terminated or suspended. In some
foreign markets, prevailing custody and trade settlement practices (e.g., the requirement to pay
for securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents and
issuers. Further, adverse changes in investment regulations, capital requirements or exchange
controls could adversely affect the value of the Funds investments. These and other risks (e.g.,
nationalization, expropriation or other confiscation of assets of foreign issuers) tend to be
greater for investments in companies tied economically to emerging countries, the economies of
which tend to be more volatile than the economies of developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of the
Funds foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or legal
restrictions may limit or prevent the Fund from selling particular securities or unwinding
derivative positions at desirable prices. The more less-liquid securities the Fund holds, the more
likely it is to honor a redemption request in-kind.
Leveraging Risk The Funds use of reverse repurchase agreements and other derivatives and
securities lending may cause its portfolio to be leveraged. Leverage increases the Funds portfolio
losses when the value of its investments decline.
Focused Investment Risk Focusing investments in countries, regions, sectors or companies with
high positive correlations to one another creates additional risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an investment in
underlying funds, including the risk that the underlying funds in which it invests will not
perform as expected.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well as
other changes in foreign and domestic economic and political conditions could adversely affect
the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds), the
Fund is subject to the risk that these shareholders will disrupt the Funds operations by
purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the
rights and remedies of creditors. Many asset-backed securities in which the Fund has invested
are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to
securities, interest rates, currencies, currency exchange rates, inflation rates, commodities
and related indices, and include foreign currency contracts, swap contracts, reverse repurchase
agreements, and other exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the
Manager may decide not to use derivatives to hedge or otherwise reduce the Funds risk
exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a leverage component (i.e., a notional value
in excess of the assets needed to establish and/or maintain the derivative position), adverse
changes in the value or level of the underlying asset, rate or index may result in a loss
substantially greater than the amount invested in the derivative itself. In addition, the Fund
is not limited in the extent to which it may use derivatives or in the absolute face value of
its derivative positions, and, as a result, it may be leveraged in relation to its assets (see
Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the
contracts. During the period ended November 30, 2011, the Fund used forward
currency contracts to adjust exposure to foreign currencies and otherwise adjust currency
exchange rate risk. The Fund had no forward currency contracts outstanding at the end of the
period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest-rate exposure and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to
buy an asset; a put option gives the holder the right to sell an asset. By purchasing options
the Fund alters its exposure to the underlying asset by, in the case of a call option, entitling
it to purchase the underlying asset at a set price from the writer of the option and, in the
case of a put option, entitling it to sell the underlying asset at a set price to the writer of
the option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss
associated with purchasing put and call options is limited to the premium paid. During the
period ended November 30, 2011, the Fund used purchased option contracts to adjust interest rate
exposure. Option contracts purchased by the Fund and outstanding at the end of the period are
listed in the Funds Schedule of Investments.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions),
securities or currencies it owns or in which it may invest. Writing options alters the Funds
exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell
the underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written option contracts to adjust interest rate exposure. Written options
outstanding at the end of the period are listed in the Funds Schedule of Investments.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Principal |
|
|
Number of |
|
|
|
|
|
|
Amount of |
|
|
of Futures |
|
|
Premium |
|
|
Amount of |
|
|
Futures |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
s |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning
of period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
(1,000,000,000 |
) |
|
|
(3,000 |
) |
|
$ |
(700,812 |
) |
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,150,000,000 |
) |
|
|
|
|
|
|
(1,384,579 |
) |
Options bought back |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,000 |
|
|
|
219,000 |
|
Options expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
|
|
|
|
|
|
|
|
$ |
|
|
|
|
(3,150,000,000 |
) |
|
|
|
|
|
$ |
(1,866,391 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective
commitments to pay or right to receive interest, (e.g., an exchange of floating rate interest
payments for fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other party
in exchange for a payment to it from the other party based on the return of a reference asset
(e.g., a security, basket of securities, or future contract), both based on notional amounts. To
the extent the return of the reference asset exceeds or falls short of the interest payments, one
party is entitled to receive a payment from or obligated to make a payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for the
right to receive a specified return (or to put a security) if a credit event (e.g., default or
similar event) occurs with respect to a reference entity or entities. A seller of credit default
protection receives periodic payments in return for its obligation to pay the principal amount of a
debt security (or other agreed-upon value) to the other party upon the occurrence of a credit
event. If no credit event occurs, the seller has no payment obligations so long as there is no
early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered by
various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the holders
of an asset-backed security to a maturity extension, or a write-down on the collateral underlying
the security. For credit default swap agreements on corporate or sovereign issuers, a credit event
may be triggered by such occurrences as the issuers bankruptcy, failure to pay interest or
principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price variance
on the underlying asset with respect to the notional amount. At inception, the strike price chosen
is generally fixed at a level such that the fair value of the swap is zero. As a result, no money
changes hands at the initiation of the contract. At the expiration date, the amount payable by one
party to the other is the difference between the realized price variance of the underlying asset
and the strike price multiplied by the notional amount. A receiver of the realized price variance
would be entitled to receive a payment when the realized price variance of the underlying asset is
greater than the strike price and would be obligated to make a payment when that variance is less
than the strike price. A payer of the realized price variance would be obligated to make a payment
when the realized price variance of the underlying asset is greater than the strike price and would
be entitled to receive a payment when that variance is less than the strike price. This type of
agreement is essentially a forward contract on the future realized price variance of the underlying
asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from market
makers and records the change in value, if any, as unrealized gain or loss. Gains or losses are
realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to them
may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit, legal,
and documentation risk that is generally not reflected in the models used to price the swap
agreement. Such risks include the possibility that the counterparty defaults on its obligations to
perform or disagrees as to the meaning of contractual terms, that the Fund has amounts on deposit
in excess of amounts owed by the Fund, or that any collateral the other party posts is insufficient
or not timely received by the Fund. Credit risk is particularly acute in economic environments in
which financial services firms are exposed to systemic risks of the type evidenced by the
insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During the
period ended November 30, 2011, the Fund used swap agreements to adjust interest rate exposure and adjust its exposure to certain markets.
Swap agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price. Funds
typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights are
generally similar to risks associated with the use of purchased options. However, warrants and
rights often do not have standardized terms, and may have longer maturities and may be less liquid
than exchange-traded options. In addition, the terms of warrants or rights may limit the Funds
ability to exercise the warrants or rights at such times and in such quantities as the Fund would
otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value
(purchased options) |
|
$ |
23,822,741 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
23,822,741 |
|
Unrealized appreciation on
futures contracts* |
|
|
2,160,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,160,794 |
|
Unrealized appreciation on
swap agreements |
|
|
102,475,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
102,475,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
128,458,847 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
128,458,847 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on
futures contracts* |
|
|
(3,271,122 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,271,122 |
) |
Written options outstanding |
|
$ |
(10,193,358 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(10,193,358 |
) |
Unrealized depreciation on
swap agreements |
|
|
(332,626 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(332,626 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(13,797,106 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(13,797,106 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table
above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts of derivatives.
Changes to market values of reference asset(s) will tend to have a greater impact on the Fund (with correspondingly greater
risk) the greater the notional amount. For further information on notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (forward currency contracts and futures
contracts), notional amounts (swap agreements), or principal amounts (options) outstanding at each
month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward |
|
|
|
|
|
|
|
|
|
|
|
|
Currency |
|
|
Futures |
|
|
Swap |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Agreements |
|
|
Options |
|
Average amount outstanding |
|
$ |
281,995 |
|
|
$ |
7,527,954,071 |
|
|
$ |
5,180,197,268 |
|
|
$ |
6,138,666,376 |
|
Subsequent events
Effective December 9, 2011, the Fund instituted a premium on cash purchases equal to 0.20% of the amount invested
and a fee on cash redemptions equal to 0.20% of the amount redeemed.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Strategic Opportunities Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
|
|
|
|
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 99.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 99.3% |
|
|
|
|
|
|
|
|
|
811,285 |
|
|
GMO Alpha Only Fund, Class IV |
|
|
|
|
|
|
20,192,889 |
|
|
6,170,977 |
|
|
GMO Domestic Bond Fund, Class VI |
|
|
|
|
|
|
18,266,093 |
|
|
1,270,045 |
|
|
GMO Emerging Country Debt Fund, Class IV |
|
|
|
|
|
|
12,027,328 |
|
|
6,264,385 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
|
|
|
|
73,230,658 |
|
|
5,644,923 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
|
|
|
|
96,753,984 |
|
|
10,231,698 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
|
|
|
|
218,958,336 |
|
|
20,477,771 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
|
|
|
|
399,316,531 |
|
|
32,391,339 |
|
|
GMO Quality Fund, Class VI |
|
|
|
|
|
|
707,426,851 |
|
|
3,669,745 |
|
|
GMO Special Situations Fund, Class VI |
|
|
|
|
|
|
97,028,061 |
|
|
11,909,015 |
|
|
GMO Strategic Fixed Income Fund, Class VI |
|
|
|
|
|
|
202,691,433 |
|
|
2,516,982 |
|
|
GMO U.S. Core Equity Fund, Class VI |
|
|
|
|
|
|
30,556,164 |
|
|
384,516 |
|
|
GMO World Opportunity Overlay Fund |
|
|
|
|
|
|
9,074,584 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $1,738,808,506) |
|
|
|
|
|
|
1,885,522,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auto Financing 0.0% |
|
|
|
|
|
400,979 |
|
|
Capital Auto Receivable Asset Trust, Series 08-1, Class A4B, 1 mo. LIBOR + 1.35%, 1.60%, due 07/15/14 |
|
|
402,234 |
|
|
221,148 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4B, 1 mo. LIBOR + 1.85%, 2.10%, due 11/10/14 |
|
|
221,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Auto Financing |
|
|
623,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business Loans 0.1% |
|
|
|
|
|
796,526 |
|
|
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36 |
|
|
501,811 |
|
|
290,713 |
|
|
GE Business Loan Trust, Series 04-1, Class A, 144A, 1 mo. LIBOR + .29%, 0.54%, due 05/15/32 |
|
|
257,281 |
|
|
541,552 |
|
|
Lehman
Brothers Small Balance Commercial, Series 05-2A, Class 1A,
144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30 |
|
|
427,230 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Business Loans |
|
|
1,186,322 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS 0.1% |
|
|
|
|
|
600,000 |
|
|
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20 |
|
|
543,000 |
|
|
162,667 |
|
|
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45 |
|
|
162,667 |
|
|
600,000 |
|
|
GS Mortgage Securities Corp., Series 07-EOP, Class A2, 144A, 1 mo. LIBOR + .57%, 1.32%, due 03/06/20 |
|
|
594,000 |
|
|
52,893 |
|
|
J.P. Morgan Chase Commercial Mortgage Securities Corp., Series 06-LDP7, Class A2, 5.86%, due 04/15/45 |
|
|
52,924 |
|
|
274,675 |
|
|
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39 |
|
|
280,059 |
|
|
238,165 |
|
|
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21 |
|
|
226,257 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS |
|
|
1,858,907 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Collateralized Debt Obligations 0.1% |
|
|
|
|
|
1,100,000 |
|
|
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13 |
|
|
968,990 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Cards 0.0% |
|
|
|
|
|
700,000 |
|
|
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17 |
|
|
701,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Auto Financing 0.1% |
|
|
|
|
|
457,402 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14 |
|
|
457,166 |
|
|
518,369 |
|
|
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14 |
|
|
520,894 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Auto Financing |
|
|
978,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Other 0.1% |
|
|
|
|
|
900,000 |
|
|
Dominos Pizza Master Issuer LLC, Series 07-1, Class A2, 144A, MBIA, 5.26%, due 04/25/37 |
|
|
903,465 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Asset-Backed Securities (United States) ¨ 0.0% |
|
|
|
|
|
107,825 |
|
|
Residential Asset Mortgage Products, Inc., Series 05-RS9, Class AI3, FGIC, 1 mo. LIBOR + .22%, 0.48%, due 11/25/35 |
|
|
75,478 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Mortgage-Backed Securities (United States) 0.0% |
|
|
|
|
|
407,792 |
|
|
Countrywide Home Equity Loan Trust, Series 07-E, Class A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 06/15/37 |
|
|
240,597 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Time Share 0.0% |
|
|
|
|
|
183,688 |
|
|
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19 |
|
|
178,323 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Asset-Backed Securities (United States) ¨ 0.2% |
|
|
|
|
|
418,142 |
|
|
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36 |
|
|
67,948 |
|
|
289,140 |
|
|
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36 |
|
|
96,862 |
|
|
188,230 |
|
|
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36 |
|
|
54,587 |
|
|
153,844 |
|
|
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36 |
|
|
44,999 |
|
|
169,573 |
|
|
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37 |
|
|
133,539 |
|
|
594,398 |
|
|
Bayview Financial Acquisition Trust, Series 04-B, Class A2, 144A, 1 mo. LIBOR + .65%, 1.56%, due 05/28/39 |
|
|
167,917 |
|
|
1,200,000 |
|
|
Carrington Mortgage Loan Trust, Series 07-FRE1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 02/25/37 |
|
|
739,560 |
|
|
17,933 |
|
|
Chase Funding Mortgage Loan Trust, Series 03-3, Class 2A2, 1 mo. LIBOR + .27%, 0.80%, due 04/25/33 |
|
|
15,064 |
|
|
1,600,000 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37 |
|
|
1,164,000 |
|
|
998,384 |
|
|
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36 |
|
|
315,390 |
|
|
311,111 |
|
|
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36 |
|
|
108,889 |
|
|
268,547 |
|
|
Morgan Stanley Home Equity Loans, Series 07-2, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 04/25/37 |
|
|
219,537 |
|
|
286,599 |
|
|
Residential Asset Securities Corp., Series 05-KS12, Class A2, 1 mo. LIBOR + .25%, 0.51%, due 01/25/36 |
|
|
257,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Asset-Backed Securities (United States) |
|
|
3,386,231 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (Australian) 0.0% |
|
|
|
|
|
117,224 |
|
|
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36 |
|
|
104,329 |
|
|
93,463 |
|
|
Superannuation Members Home Loans Global Fund, Series 7, Class A1, 3 mo. LIBOR + .14%, 0.62%, due 03/09/36 |
|
|
90,639 |
|
|
282,134 |
|
|
Westpac Securitization Trust, Series 07-1G, Class A2A, 3 mo. LIBOR + .05%, 0.53%, due 05/21/38 |
|
|
273,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (Australian) |
|
|
468,674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (European) 0.0% |
|
|
|
|
|
423,123 |
|
|
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39 |
|
|
374,879 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
465,690 |
|
|
Paragon Mortgages Plc, Series 7A, Class A1A, 144A, 3 mo. LIBOR + .42%, 0.88%, due 05/15/34 |
|
|
|
|
|
|
374,135 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (European) |
|
|
|
|
|
|
749,014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Loans 0.0% |
|
|
|
|
|
|
|
|
|
12,287 |
|
|
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23 |
|
|
|
|
|
|
11,918 |
|
|
600,000 |
|
|
Nelnet Student Loan Trust, Series 05-2, Class A4, 3 mo. LIBOR + .08%, 0.44%, due 12/23/19 |
|
|
|
|
|
|
592,224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Student Loans |
|
|
|
|
|
|
604,142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
|
|
|
|
12,923,293 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Debt 0.0% |
|
|
|
|
|
|
|
|
|
147,000 |
|
|
Health Care Property Investors, Inc., Series G, MTN, 5.63%, due 02/28/13 |
|
|
|
|
|
|
151,624 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 0.0% |
|
|
|
|
|
|
|
|
|
150,000 |
|
|
Agency for International Development Floater (Support of Morocco), 6 mo. U.S. Treasury Bill + .45%, 0.52%, due 11/15/14(a) |
|
|
|
|
|
|
146,779 |
|
|
33,334 |
|
|
Agency for International Development Floater (Support of Zimbabwe), 3 mo. U.S. Treasury Bill x 115%, 0.04%, due 01/01/12(a) |
|
|
|
|
|
|
33,283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government Agency |
|
|
|
|
|
|
180,062 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT
OBLIGATIONS (COST $12,821,165) |
|
|
|
|
|
|
13,254,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
25,325 |
|
|
State Street Institutional U.S. Government Money Market Fund-Institutional Class, 0.00%(b) |
|
|
25,325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $25,325) |
|
|
25,325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.0%
(Cost $1,751,654,996) |
|
|
1,898,803,216 |
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(108,184 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,898,695,032 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional investors.
CMBS Commercial Mortgage Backed Security
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
FSA Insured as to the payment of principal and interest by Financial Security Assurance.
LIBOR London Interbank Offered Rate
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp.
MTN Medium Term Note
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security.
¨ |
|
These securities are primarily backed by subprime mortgages. |
|
(a) |
|
Security valued at fair value using methods determined in good faith by or at the direction of the
Trustees of GMO Trust. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes
and gross and net unrealized appreciation (depreciation) in value of investments were
as follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$1,814,980,854 |
|
$93,045,255 |
|
$(9,222,893) |
|
$83,822,362 |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Return of |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income* |
|
|
Gains* |
|
|
Capital* |
|
|
of period |
|
GMO Alpha Only Fund, Class IV |
|
$ |
76,562,509 |
|
|
$ |
53,416,408 |
|
|
$ |
115,917,730 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
$ |
20,192,889 |
|
GMO Asset Allocation Bond Fund,
Class VI |
|
|
19,060,719 |
|
|
|
10,366,213 |
|
|
|
28,721,459 |
|
|
|
198,912 |
|
|
|
1,022,195 |
|
|
|
|
|
|
|
|
|
GMO Domestic Bond Fund, Class VI |
|
|
28,263,076 |
|
|
|
|
|
|
|
|
|
|
|
279,846 |
|
|
|
|
|
|
|
9,142,587 |
|
|
|
18,266,093 |
|
GMO Emerging Country Debt Fund,
Class IV |
|
|
10,590,652 |
|
|
|
1,014,705 |
|
|
|
|
|
|
|
148,048 |
|
|
|
|
|
|
|
|
|
|
|
12,027,328 |
|
GMO Emerging Markets Fund, Class
VI |
|
|
71,011,675 |
|
|
|
20,260,404 |
|
|
|
2,625,458 |
|
|
|
28,999 |
|
|
|
5,307,398 |
|
|
|
|
|
|
|
73,230,658 |
|
GMO Flexible Equities Fund,
Class VI |
|
|
30,813,653 |
|
|
|
75,288,184 |
|
|
|
1,974,158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96,753,984 |
|
GMO International Growth Equity
Fund, Class IV |
|
|
320,270,734 |
|
|
|
49,018,681 |
|
|
|
118,571,985 |
|
|
|
1,984,233 |
|
|
|
|
|
|
|
|
|
|
|
218,958,336 |
|
GMO International Intrinsic
Value Fund, Class IV |
|
|
320,384,848 |
|
|
|
181,714,563 |
|
|
|
57,524,391 |
|
|
|
5,524,987 |
|
|
|
|
|
|
|
|
|
|
|
399,316,531 |
|
GMO Quality Fund, Class VI |
|
|
579,206,834 |
|
|
|
157,901,542 |
|
|
|
59,760,260 |
|
|
|
9,613,238 |
|
|
|
|
|
|
|
|
|
|
|
707,426,851 |
|
GMO Special Situations Fund,
Class VI |
|
|
90,321,776 |
|
|
|
12,775,380 |
|
|
|
1,946,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
97,028,061 |
|
GMO Strategic Fixed Income Fund,
Class VI |
|
|
123,130,167 |
|
|
|
66,087,293 |
|
|
|
3,779,693 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
202,691,433 |
|
GMO U.S. Core Equity Fund, Class
VI |
|
|
52,712,842 |
|
|
|
4,035,646 |
|
|
|
25,208,759 |
|
|
|
816,162 |
|
|
|
|
|
|
|
|
|
|
|
30,556,164 |
|
GMO World Opportunity Overlay
Fund |
|
|
8,720,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,074,584 |
|
Totals |
|
$ |
1,731,050,314 |
|
|
$ |
631,879,019 |
|
|
$ |
416,030,161 |
|
|
$ |
18,594,425 |
|
|
$ |
6,329,593 |
|
|
$ |
9,142,587 |
|
|
$ |
1,885,522,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The table above includes estimated sources of all distributions paid by the underlying funds during the period March 1, 2011 through November 30, 2011 for tax purposes. The actual tax characterization of distributions paid by the underlying funds will be determined at
the end of the fiscal year ending February 29, 2012. |
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods
determined in good faith by or at the direction of the Trustees of the Trust represented 0.4% of
net assets. The Fund and the underlying funds classify such securities (levels defined below)
as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
43.0% |
Futures Contracts |
|
0.1% |
Swap Agreements |
|
0.1% |
Typically the Fund and the underlying funds value debt instruments based on the most recent
quoted price supplied by a single pricing source chosen by the Manager. Although the Manager
normally does not evaluate pricing sources on a day-to-day basis, it does evaluate pricing
sources on an ongoing basis and may change a pricing source at any time. The Manager monitors
erratic or unusual movements (including unusual inactivity) in the prices supplied for a
security and has discretion to override a price supplied by a source (e.g., by taking a price
supplied by another) when it believes that the price supplied is not reliable. Although
alternative prices may be available for securities held by the Fund and the underlying funds,
those alternative sources are not typically part of the valuation process and do not necessarily
provide greater certainty about the prices used by the Fund and the underlying funds. As of
November 30, 2011, the total value of securities held directly and indirectly for which no
alternative pricing source was available represented 0.8% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the
valuation of the Funds investments. The inputs or methodology used for valuing securities are
not necessarily an indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities using quoted prices. The Fund valued certain other debt
securities by using an estimated specified spread above the LIBOR rate.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
1,885,522,912 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,885,522,912 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
|
|
|
|
|
1,984,566 |
|
|
|
10,938,727 |
|
|
|
12,923,293 |
|
Corporate Debt |
|
|
|
|
|
|
151,624 |
|
|
|
|
|
|
|
151,624 |
|
U.S. Government Agency |
|
|
|
|
|
|
|
|
|
|
180,062 |
|
|
|
180,062 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
|
|
|
|
2,136,190 |
|
|
|
11,118,789 |
|
|
|
13,254,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
25,325 |
|
|
|
|
|
|
|
|
|
|
|
25,325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
1,885,548,237 |
|
|
|
2,136,190 |
|
|
|
11,118,789 |
|
|
|
1,898,803,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,885,548,237 |
|
|
$ |
2,136,190 |
|
|
$ |
11,118,789 |
|
|
$ |
1,898,803,216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds investments
(both direct and indirect) in securities and derivative financial instruments using Level 3
inputs were 4.6% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a reconciliation of investments and derivatives, if any, in which significant
unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
Investments Still |
|
|
|
of February 28, |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
Transfers |
|
|
Transfers out |
|
|
Balances as of |
|
|
Held as of November 30, |
|
|
|
2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
into level 3 * |
|
|
of level 3 * |
|
|
November 30, 2011 |
|
|
2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
16,149,456 |
|
|
$ |
|
|
|
$ |
(4,573,771 |
) |
|
$ |
300,204 |
|
|
$ |
722,195 |
|
|
$ |
(1,659,357 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
10,938,727 |
|
|
$ |
(1,320,007 |
) |
U.S. Government Agency |
|
|
262,453 |
|
|
|
|
|
|
|
(83,104 |
) |
|
|
684 |
|
|
|
1,657 |
|
|
|
(1,628 |
) |
|
|
|
|
|
|
|
|
|
|
180,062 |
|
|
|
(1,628 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
16,411,909 |
|
|
$ |
|
|
|
$ |
(4,656,875 |
) |
|
$ |
300,888 |
|
|
$ |
723,852 |
|
|
$ |
(1,660,985 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
11,118,789 |
|
|
$ |
(1,321,635 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those Funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Declines
in stock market prices generally are likely to reduce the net
asset value of the Funds shares. |
|
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries. |
|
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads. |
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind. |
|
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk. |
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses associated with an investment in
the Fund are less predictable and may be higher than fees and expenses associated with an
investment in funds that charge a fixed management fee. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
|
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations. |
|
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments. |
|
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies, or that the
U.S. dollar will decline in value relative to the foreign currency being hedged. |
|
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline. |
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. Below investment grade securities have speculative characteristics, and changes in
economic conditions or other circumstances are more likely to impair the capacity of
issuers to make principal and interest payments than is the case with issuers of investment
grade securities. |
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. |
|
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries. |
|
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited. |
|
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk. |
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis. |
The Fund invests (including through investment in underlying funds) in asset-backed securities,
which may be backed by many types of assets, including pools of residential and commercial
mortgages, automobile loans, educational loans, home equity loans, or credit card receivables,
which expose the Fund to additional types of market risk. They also may be backed by pools of
corporate or sovereign bonds, bank loans made to corporations, or a combination of these bonds
and loans (commonly referred to as collateralized debt obligations or collateralized loan
obligations) and by the fees earned by service providers. Payment of interest on asset backed
securities and repayment of principal largely depend on the cash flows generated by the assets
backing the securities. The market risk of a particular asset-backed security depends on many
factors, including the deal structure (e.g., determination as to the amount of underlying assets
or other support needed to produce the cash flows necessary to service interest and make
principal payments), the quality of the underlying assets and, if any, the level of credit
support and the credit quality of the credit-support provider. Asset-backed securities involve
risk of loss of principal if obligors of the underlying obligations default and the value of the
defaulted obligations exceeds whatever credit support the securities may have. The obligations
of issuers (and obligors of underlying assets) also are subject to bankruptcy, insolvency, and
other laws affecting the rights and remedies of creditors. Many asset-backed securities in which
the Fund has invested are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Taiwan Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 95.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan 95.6% |
|
|
|
|
|
384,220 |
|
|
Asia Cement Corp |
|
|
424,785 |
|
|
597,323 |
|
|
Asustek Computer Inc |
|
|
4,173,566 |
|
|
444,448 |
|
|
Catcher Technology Co Ltd |
|
|
2,171,801 |
|
|
186,755 |
|
|
China Life Insurance Co Ltd. |
|
|
165,345 |
|
|
182,650 |
|
|
China Petrochemical Development Corp |
|
|
161,905 |
|
|
444,938 |
|
|
China Steel Corp |
|
|
433,484 |
|
|
653,065 |
|
|
Chinatrust Financial Holding Co Ltd |
|
|
371,067 |
|
|
3,129,612 |
|
|
Chunghwa Telecom Co Ltd |
|
|
10,374,302 |
|
|
13,400 |
|
|
Chunghwa Telecom Co Ltd ADR |
|
|
447,962 |
|
|
4,291,486 |
|
|
Compal Electronics Inc |
|
|
3,914,562 |
|
|
7,952 |
|
|
Compeq Manufacturing Co Ltd * |
|
|
2,402 |
|
|
13,000 |
|
|
Dynapack International Technology Corp |
|
|
45,327 |
|
|
936,000 |
|
|
E Ink Holdings Inc |
|
|
1,735,519 |
|
|
1,601,767 |
|
|
Far Eastone Telecommunications Co Ltd |
|
|
3,051,549 |
|
|
5,647 |
|
|
First Financial Holding Co Ltd |
|
|
3,301 |
|
|
53,000 |
|
|
Formosa Chemicals & Fibre Co |
|
|
139,376 |
|
|
10,605 |
|
|
Formosa Petrochemical Corp |
|
|
33,446 |
|
|
419,000 |
|
|
Fubon Financial Holding Co Ltd |
|
|
436,734 |
|
|
18,655 |
|
|
Genesis Photonics Inc * |
|
|
25,441 |
|
|
61,531 |
|
|
Gintech Energy Corp |
|
|
58,454 |
|
|
11,000 |
|
|
Global Unichip Corp |
|
|
35,918 |
|
|
904,000 |
|
|
Grand Pacific Petrochemical Corp |
|
|
378,286 |
|
|
262,000 |
|
|
Highwealth Construction Corp |
|
|
394,657 |
|
|
890,936 |
|
|
Hon Hai Precision Industry Co Ltd |
|
|
2,422,881 |
|
|
52,228 |
|
|
HTC Corp |
|
|
859,851 |
|
|
2,000 |
|
|
Largan Precision Co Ltd |
|
|
32,979 |
|
|
1,757,852 |
|
|
Lite-On Technology Corp |
|
|
1,926,407 |
|
|
2,741,000 |
|
|
Macronix International Co Ltd |
|
|
1,135,885 |
|
|
256,000 |
|
|
MediaTek Inc |
|
|
2,443,068 |
|
|
653,180 |
|
|
Mega Financial Holding Co Ltd |
|
|
436,877 |
|
|
189,180 |
|
|
Nan Ya Plastics Corp |
|
|
352,320 |
|
|
305,000 |
|
|
Neo Solar Power Corp |
|
|
184,672 |
|
|
175,995 |
|
|
Novatek Microelectronics Corp Ltd |
|
|
443,272 |
|
|
598,425 |
|
|
Powertech Technology Inc |
|
|
1,363,983 |
|
|
2,021,856 |
|
|
Quanta Computer Inc |
|
|
4,069,459 |
|
|
103,080 |
|
|
Radiant Opto-Electronics Corp |
|
|
313,233 |
|
|
250,000 |
|
|
Senao International Co Ltd |
|
|
821,351 |
|
|
2,618,844 |
|
|
Taishin Financial Holding Co Ltd |
|
|
976,418 |
|
|
366,000 |
|
|
Taiwan Cement Corp |
|
|
407,152 |
|
|
9,350 |
|
|
Taiwan Glass Industrial Corp |
|
|
9,432 |
|
|
796,158 |
|
|
Taiwan Mobile Co Ltd |
|
|
2,562,034 |
|
|
2,628,190 |
|
|
Taiwan Semiconductor Manufacturing Co Ltd |
|
|
6,588,899 |
|
|
106,710 |
|
|
TPK Holding Co Ltd * |
|
|
1,461,676 |
|
|
29,400 |
|
|
TSRC Corp |
|
|
70,837 |
|
|
4,906,000 |
|
|
United Microelectronics Corp |
|
|
2,176,929 |
|
|
58,500 |
|
|
United Microelectronics Corp Sponsored ADR |
|
|
133,965 |
|
|
1,947,060 |
|
|
Wistron Corp |
|
|
2,451,609 |
|
|
2,968,195 |
|
|
Ya Hsin Industrial Co Ltd * (a) (b) |
|
|
0 |
|
|
1,208,152 |
|
|
Yungtay Engineering Co Ltd |
|
|
1,833,198 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Taiwan |
|
|
64,457,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $71,684,342) |
|
|
64,457,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 2.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 2.9% |
|
|
|
|
|
160,895 |
|
|
iShares MSCI Taiwan Index Fund (c) |
|
|
1,987,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $1,971,085) |
|
|
1,987,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 1.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 1.3% |
|
|
|
|
|
35,986 |
|
|
GMO U.S. Treasury Fund |
|
|
900,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $900,001) |
|
|
900,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.4% |
|
|
|
|
USD 130,000 |
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
130,000 |
|
USD 117,274 |
|
Citibank (New York) Time Deposit, 0.03%, due 12/01/11 |
|
|
117,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
247,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $247,274) |
|
|
247,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.2%
(Cost $74,802,702) |
|
|
67,591,904 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.2%) |
|
|
(135,769 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
67,456,135 |
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments: |
|
ADR American Depositary Receipt |
|
MSCI Morgan Stanley Capital International |
|
*
|
|
Non-income producing security. |
|
(a)
|
|
Bankrupt issuer. |
|
(b)
|
|
Security valued at fair value using methods determined in good faith by or at the direction of the Trustees of GMO Trust. |
|
(c)
|
|
Represents an investment to equitize cash. The iShares® MSCI Taiwan Index Fund is a separate investment portfolio of iShares, Inc., and a registered
investment company. The iShares® MSCI Taiwan Index Fund prospectus states that the fund invests in the Taiwanese market and seeks investment results
that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Taiwan Index. iShares® is a registered trademark
of BlackRock. Neither BlackRock nor the iShares® Funds make any representations regarding the advisability of investing in the iShares® MSCI Taiwan
Index Fund. |
Currency Abbreviations
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were
as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$76,374,226 |
|
$ |
3,985,467 |
|
|
$ |
(12,767,789 |
) |
|
$ |
(8,782,322 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the
Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
|
|
|
$ |
11,050,118 |
|
|
$ |
10,150,517 |
|
|
$ |
135 |
|
|
$ |
38 |
|
|
$ |
900,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of
November 30, 2011, the total value of securities held directly that were fair valued using
methods determined in good faith by or at the direction of the Trustees of the Trust represented
less than 0.1% of net assets. The Fund classifies such securities (levels defined below) as Level 3. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
|
Equity Securities |
|
|
94.7% |
|
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
used the following fair value technique on Level 3 investments: The Fund deemed certain bankrupt
securities to be worthless.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in |
|
|
|
|
|
|
|
|
|
|
|
|
Active Markets for |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Identical Assets |
|
|
Observable Inputs |
|
|
Unobservable Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan |
|
$ |
581,927 |
|
|
$ |
63,875,649 |
|
|
$ |
0 |
* |
|
$ |
64,457,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
581,927 |
|
|
|
63,875,649 |
|
|
|
0 |
|
|
|
64,457,576 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
1,987,053 |
|
|
|
|
|
|
|
|
|
|
|
1,987,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS |
|
|
1,987,053 |
|
|
|
|
|
|
|
|
|
|
|
1,987,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
900,001 |
|
|
|
|
|
|
|
|
|
|
|
900,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
900,001 |
|
|
|
|
|
|
|
|
|
|
|
900,001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
247,274 |
|
|
|
|
|
|
|
|
|
|
|
247,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
3,716,255 |
|
|
|
63,875,649 |
|
|
|
0 |
* |
|
|
67,591,904 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
3,716,255 |
|
|
$ |
63,875,649 |
|
|
$ |
0 |
* |
|
$ |
67,591,904 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Represents the interest in securities that were determined to have a fair value of zero as of November 30, 2011. |
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying
funds, please refer to the underlying funds portfolio valuation notes. The aggregate net value of the Funds
direct investments in securities using Level 3 inputs was less than 0.1% of total net assets.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. Because the Fund normally does not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries. Certain characteristics of Taiwans economy and geographic location
also subject the Fund to risks. For example, Taiwan is a small island state with few raw
material resources and limited land area and thus it relies heavily on imports for its
commodity needs. Any fluctuations or shortages in the commodity markets could have a
negative impact on the Taiwanese economy. Also, rising labor costs and increasing
environmental consciousness have led some labor-intensive industries to relocate to
countries with cheaper work forces, and continued labor outsourcing may adversely affect
the Taiwanese economy. Taiwans economy also is intricately linked with economies of other
Asian countries, which, like emerging market economies, often experience over-extensions of
credit, frequent and pronounced currency fluctuations, devaluations and restrictions,
rising unemployment and fluctuations in inflation. Currency devaluations in any one country
can have a significant effect on the entire region. Political and social unrest in Asian
countries could cause further economic and market uncertainty in Taiwan. In particular, the
Taiwanese economy is dependent on the economies of Japan and China, and also the United
States, and a reduction in purchases by any of them of Taiwanese products and services or
negative changes in their economies would likely have an adverse impact on the Taiwanese
economy. Taiwans geographic proximity to the Peoples Republic of China and Taiwans
history of political contention with China have resulted in ongoing tensions with China,
including the continual risk of war with China. These tensions may materially affect the
Taiwanese economy and securities markets. All of these risks could reduce the value of an
investment in Taiwan Fund.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments
tied economically to Taiwan, creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in underlying funds, including the risk that the underlying funds in which it
invests will not perform as expected.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. The Fund had no forward currency
contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market. The Fund
had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of
purchased options on securities, as described in options above. Risks associated with the use of
warrants and rights are generally similar to risks associated with the use of purchased options.
However, warrants and rights often do not have standardized terms, and may have longer
maturities and may be less liquid than exchange-traded options. In addition, the terms of
warrants or rights may limit the Funds ability to exercise the warrants or rights at such times
and in such quantities as the Fund would otherwise wish. The Fund held no rights or warrants at
the end of the period.
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov.
GMO Tax-Managed International Equities Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 95.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 3.7% |
|
|
|
|
|
219,598 |
|
|
BlueScope Steel Ltd |
|
|
89,555 |
|
|
174,362 |
|
|
Charter Hall Office (REIT) |
|
|
626,283 |
|
|
21,896 |
|
|
Commonwealth Bank of Australia |
|
|
1,096,424 |
|
|
484,938 |
|
|
Dexus Property Group (REIT) |
|
|
438,694 |
|
|
657,566 |
|
|
Goodman Group (REIT) |
|
|
414,254 |
|
|
343,612 |
|
|
GPT Group (REIT) |
|
|
1,127,644 |
|
|
42,482 |
|
|
Iluka Resources Ltd |
|
|
685,529 |
|
|
302,836 |
|
|
Mirvac Group (REIT) |
|
|
404,740 |
|
|
36,627 |
|
|
National Australia Bank Ltd |
|
|
917,124 |
|
|
199,935 |
|
|
QBE Insurance Group Ltd |
|
|
2,863,789 |
|
|
229,609 |
|
|
Stockland (REIT) |
|
|
823,048 |
|
|
102,872 |
|
|
TABCORP Holdings Ltd |
|
|
305,291 |
|
|
1,263,133 |
|
|
Telstra Corp Ltd |
|
|
4,150,245 |
|
|
44,779 |
|
|
Wesfarmers Ltd |
|
|
1,437,778 |
|
|
100,610 |
|
|
Westpac Banking Corp |
|
|
2,198,027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Australia |
|
|
17,578,425 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Austria 0.8% |
|
|
|
|
|
8,027 |
|
|
Andritz AG |
|
|
708,760 |
|
|
33,320 |
|
|
Immofinanz AG * |
|
|
103,097 |
|
|
88,088 |
|
|
Immofinanz AG (Entitlement Shares) * |
|
|
|
|
|
55,553 |
|
|
OMV AG |
|
|
1,844,824 |
|
|
15,218 |
|
|
Raiffeisen International Bank Holding |
|
|
361,762 |
|
|
29,277 |
|
|
Voestalpine AG |
|
|
851,388 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Austria |
|
|
3,869,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Belgium 0.5% |
|
|
|
|
|
149,206 |
|
|
Ageas |
|
|
263,134 |
|
|
34,388 |
|
|
Belgacom SA |
|
|
1,092,054 |
|
|
13,857 |
|
|
Colruyt SA |
|
|
524,779 |
|
|
3,768 |
|
|
Delhaize Group |
|
|
222,220 |
|
|
6,642 |
|
|
Mobistar SA |
|
|
363,201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Belgium |
|
|
2,465,388 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada 2.6% |
|
|
|
|
|
9,300 |
|
|
Alimentation Couche Tard Inc |
|
|
267,160 |
|
|
6,900 |
|
|
Bank of Montreal |
|
|
403,602 |
|
|
30,600 |
|
|
BCE Inc |
|
|
1,200,059 |
|
|
60,400 |
|
|
Canadian Natural Resources Ltd |
|
|
2,268,664 |
|
|
4,700 |
|
|
Canadian Tire Corp Ltd |
|
|
297,681 |
|
|
16,800 |
|
|
Canadian National Railway Co |
|
|
1,299,099 |
|
|
73,300 |
|
|
EnCana Corp |
|
|
1,476,852 |
|
|
18,000 |
|
|
First Quantum Minerals Ltd |
|
|
363,547 |
|
|
26,000 |
|
|
Husky Energy Inc |
|
|
647,483 |
|
|
28,300 |
|
|
Manulife Financial Corp |
|
|
304,934 |
|
|
10,100 |
|
|
Metro Inc Class A |
|
|
510,471 |
|
|
53,100 |
|
|
Research In Motion Ltd * |
|
|
956,888 |
|
|
15,700 |
|
|
Shoppers Drug Mart Corp |
|
|
653,429 |
|
|
72,100 |
|
|
Sun Life Financial Inc |
|
|
1,304,933 |
|
|
12,900 |
|
|
Valeant Pharmaceuticals International Inc * |
|
|
596,970 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Canada |
|
|
12,551,772 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denmark 0.3% |
|
|
|
|
|
14,358 |
|
|
Novo-Nordisk A/S Class B |
|
|
1,629,924 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Finland 0.6% |
|
|
|
|
|
10,903 |
|
|
Nokian Renkaat Oyj |
|
|
361,154 |
|
|
317,695 |
|
|
Nokia Oyj |
|
|
1,836,148 |
|
|
17,504 |
|
|
Sampo Oyj Class A |
|
|
457,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Finland |
|
|
2,654,562 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
France 11.6% |
|
|
|
|
|
6,500 |
|
|
Arkema |
|
|
473,487 |
|
|
27,810 |
|
|
BNP Paribas |
|
|
1,107,062 |
|
|
9,634 |
|
|
Compagnie de Saint-Gobain |
|
|
408,510 |
|
|
3,861 |
|
|
Compagnie Generale des Etablissements Michelin-Class B |
|
|
246,132 |
|
|
12,581 |
|
|
Dassault Systemes SA |
|
|
1,030,119 |
|
|
12,316 |
|
|
Essilor International SA |
|
|
880,420 |
|
|
1,613 |
|
|
Esso SAF |
|
|
142,700 |
|
|
35,103 |
|
|
European Aeronautic Defense and Space Co NV |
|
|
1,053,154 |
|
|
7,455 |
|
|
Eutelsat Communications |
|
|
289,690 |
|
|
65,546 |
|
|
France Telecom SA |
|
|
1,131,360 |
|
|
16,002 |
|
|
GDF Suez VVPR Strip * |
|
|
22 |
|
|
3,105 |
|
|
LOreal SA |
|
|
336,069 |
|
|
20,102 |
|
|
Lagardere SCA |
|
|
489,558 |
|
|
9,419 |
|
|
LVMH Moet Hennessy Louis Vuitton SA |
|
|
1,483,043 |
|
|
2,071 |
|
|
Nexans SA |
|
|
121,693 |
|
|
4,045 |
|
|
NYSE Euronext |
|
|
119,037 |
|
|
63,982 |
|
|
PagesJaunes Groupe |
|
|
222,339 |
|
|
28,474 |
|
|
Peugeot SA |
|
|
533,127 |
|
|
2,966 |
|
|
PPR |
|
|
444,469 |
|
|
36,488 |
|
|
Renault SA |
|
|
1,367,221 |
|
|
22,853 |
|
|
Safran SA |
|
|
678,108 |
|
|
277,599 |
|
|
Sanofi |
|
|
19,416,940 |
|
|
12,280 |
|
|
SES SA Class A FDR |
|
|
302,642 |
|
|
7,719 |
|
|
Technip SA |
|
|
735,446 |
|
|
362,046 |
|
|
Total SA |
|
|
18,678,883 |
|
|
5,934 |
|
|
Unibail-Rodamco SE (REIT) |
|
|
1,106,170 |
|
|
8,473 |
|
|
Valeo SA |
|
|
375,184 |
|
|
12,315 |
|
|
Vinci SA |
|
|
550,553 |
|
|
91,428 |
|
|
Vivendi SA |
|
|
2,108,883 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total France |
|
|
55,832,021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 7.1% |
|
|
|
|
|
16,460 |
|
|
Adidas AG |
|
|
1,160,773 |
|
|
16,187 |
|
|
Aurubis AG |
|
|
923,683 |
|
|
57,657 |
|
|
BASF AG |
|
|
4,212,041 |
|
|
21,934 |
|
|
Bayerische Motoren Werke AG |
|
|
1,662,752 |
|
|
9,725 |
|
|
Beiersdorf AG |
|
|
557,121 |
|
|
5,042 |
|
|
Bilfinger & Berger SE |
|
|
460,615 |
|
|
3,285 |
|
|
Continental AG * |
|
|
233,232 |
|
|
11,291 |
|
|
Deutsche Bank AG (Registered) |
|
|
441,174 |
|
|
28,692 |
|
|
Deutsche Post AG (Registered) |
|
|
433,691 |
|
|
408,729 |
|
|
E.ON AG |
|
|
10,117,550 |
|
|
4,905 |
|
|
Fraport AG |
|
|
279,347 |
|
|
9,357 |
|
|
Fresenius SE & Co KGaA |
|
|
901,154 |
|
|
11,954 |
|
|
Fresenius Medical Care AG & Co |
|
|
819,513 |
|
|
24,890 |
|
|
GEA Group AG |
|
|
736,751 |
|
|
116,991 |
|
|
Infineon Technologies AG |
|
|
972,558 |
|
|
6,289 |
|
|
Kabel Deutschland Holding AG * |
|
|
349,594 |
|
|
16,442 |
|
|
Lanxess AG |
|
|
922,350 |
|
|
12,445 |
|
|
Leoni AG |
|
|
463,111 |
|
|
6,978 |
|
|
Linde AG |
|
|
1,075,386 |
|
|
5,421 |
|
|
Merck KGaA |
|
|
539,606 |
|
|
|
|
|
|
|
|
|
|
|
44,549 |
|
|
RWE AG |
|
|
1,846,747 |
|
|
13,513 |
|
|
Salzgitter AG |
|
|
701,563 |
|
|
22,815 |
|
|
SAP AG |
|
|
1,366,148 |
|
|
3,511 |
|
|
SGL Carbon SE * |
|
|
211,582 |
|
|
7,692 |
|
|
Siemens AG (Registered) |
|
|
778,424 |
|
|
20,733 |
|
|
Software AG |
|
|
893,727 |
|
|
29,341 |
|
|
Suedzucker AG |
|
|
934,727 |
|
|
1,625 |
|
|
Volkswagen AG |
|
|
247,497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
34,242,417 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Greece 0.2% |
|
|
|
|
|
80,194 |
|
|
OPAP SA |
|
|
719,535 |
|
|
31,481 |
|
|
Public Power Corp SA |
|
|
179,846 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Greece |
|
|
899,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hong Kong 1.2% |
|
|
|
|
|
186,000 |
|
|
AIA Group Ltd |
|
|
585,857 |
|
|
231,900 |
|
|
CLP Holdings Ltd |
|
|
2,065,189 |
|
|
10 |
|
|
Esprit Holdings Ltd |
|
|
14 |
|
|
265,800 |
|
|
Hong Kong & China Gas |
|
|
615,495 |
|
|
583,000 |
|
|
Pacific Basin Shipping Ltd |
|
|
260,997 |
|
|
196,500 |
|
|
Power Assets Holdings Ltd |
|
|
1,472,320 |
|
|
41,500 |
|
|
Swire Pacific Ltd |
|
|
506,613 |
|
|
163,500 |
|
|
Yue Yuen Industrial Holdings |
|
|
471,171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Hong Kong |
|
|
5,977,656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ireland 1.0% |
|
|
|
|
|
57,269 |
|
|
C&C Group Plc |
|
|
234,624 |
|
|
110,360 |
|
|
CRH Plc |
|
|
2,106,846 |
|
|
17,890 |
|
|
DCC Plc |
|
|
433,131 |
|
|
17,996 |
|
|
Elan Corp Plc * |
|
|
196,004 |
|
|
31,679 |
|
|
Kerry Group Plc Class A |
|
|
1,183,110 |
|
|
10,329 |
|
|
Paddy Power Plc |
|
|
560,814 |
|
|
28,048 |
|
|
Smurfit Kappa Group Plc * |
|
|
169,869 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Ireland |
|
|
4,884,398 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Italy 5.8% |
|
|
|
|
|
47,666 |
|
|
Benetton Group SPA |
|
|
234,132 |
|
|
71,755 |
|
|
Campari |
|
|
513,120 |
|
|
1,680,455 |
|
|
Enel SPA |
|
|
7,160,252 |
|
|
478,076 |
|
|
ENI SPA |
|
|
10,124,829 |
|
|
12,403 |
|
|
Exor SPA |
|
|
263,845 |
|
|
155,594 |
|
|
Finmeccanica SPA |
|
|
675,038 |
|
|
74,327 |
|
|
Mediaset SPA |
|
|
219,720 |
|
|
54,141 |
|
|
Mediobanca SPA |
|
|
349,841 |
|
|
93,823 |
|
|
Pirelli & C SPA |
|
|
887,611 |
|
|
34,942 |
|
|
Recordati SPA |
|
|
268,451 |
|
|
33,277 |
|
|
Saipem SPA |
|
|
1,488,959 |
|
|
217,524 |
|
|
Snam Rete Gas SPA |
|
|
1,009,843 |
|
|
1,471,783 |
|
|
Telecom Italia SPA |
|
|
1,666,242 |
|
|
1,553,914 |
|
|
Telecom Italia SPA-Di RISP |
|
|
1,518,346 |
|
|
266,586 |
|
|
Terna SPA |
|
|
956,592 |
|
|
3,659 |
|
|
Tods SPA |
|
|
340,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Italy |
|
|
27,677,608 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Japan 24.2% |
|
|
|
|
|
189 |
|
|
Advance Residence Investment Corp (REIT) |
|
|
352,628 |
|
|
150,100 |
|
|
Aeon Co Ltd |
|
|
2,051,049 |
|
|
|
|
|
|
|
|
|
|
|
16,700 |
|
|
Aisin Seiki Co Ltd |
|
|
504,618 |
|
|
76,800 |
|
|
Alps Electric Co Ltd |
|
|
537,684 |
|
|
18,600 |
|
|
Asahi Breweries Ltd |
|
|
412,849 |
|
|
60,500 |
|
|
Astellas Pharma Inc |
|
|
2,332,058 |
|
|
72,300 |
|
|
Bridgestone Corp |
|
|
1,675,339 |
|
|
14,700 |
|
|
Canon Inc |
|
|
659,475 |
|
|
12,800 |
|
|
Capcom |
|
|
328,332 |
|
|
27 |
|
|
Central Japan Railway Co |
|
|
216,339 |
|
|
205,000 |
|
|
Cosmo Oil Co Ltd |
|
|
566,916 |
|
|
127 |
|
|
CyberAgent Inc |
|
|
421,582 |
|
|
62,300 |
|
|
Daiei Inc * |
|
|
226,423 |
|
|
184,000 |
|
|
Daikyo Inc * |
|
|
355,564 |
|
|
27,000 |
|
|
Dainippon Screen Manufacturing Co Ltd |
|
|
206,050 |
|
|
39,400 |
|
|
Daito Trust Construction Co Ltd |
|
|
3,514,050 |
|
|
31,900 |
|
|
Dena Co Ltd |
|
|
990,331 |
|
|
20,700 |
|
|
Don Quijote Co Ltd |
|
|
713,446 |
|
|
41,300 |
|
|
Edion Corp |
|
|
323,444 |
|
|
46,900 |
|
|
Eisai Co Ltd |
|
|
1,810,646 |
|
|
22,600 |
|
|
Electric Power Development Co Ltd |
|
|
570,284 |
|
|
7,100 |
|
|
Fanuc Ltd |
|
|
1,166,519 |
|
|
7,600 |
|
|
Fast Retailing Co Ltd |
|
|
1,233,302 |
|
|
178,000 |
|
|
Fuji Electric Co Ltd |
|
|
526,510 |
|
|
85,000 |
|
|
Fuji Heavy Industries Ltd |
|
|
491,282 |
|
|
23,500 |
|
|
Fuji Oil Co Ltd |
|
|
336,385 |
|
|
30,900 |
|
|
Gree Inc |
|
|
1,037,406 |
|
|
66,000 |
|
|
Hanwa Co Ltd |
|
|
286,118 |
|
|
371,000 |
|
|
Hitachi Ltd |
|
|
2,058,646 |
|
|
17,600 |
|
|
Honda Motor Co Ltd |
|
|
558,525 |
|
|
23,600 |
|
|
Hosiden Corp |
|
|
166,174 |
|
|
191 |
|
|
INPEX Corp |
|
|
1,289,418 |
|
|
252,000 |
|
|
Itochu Corp |
|
|
2,560,922 |
|
|
368 |
|
|
Japan Retail Fund Investment Corp (REIT) |
|
|
562,789 |
|
|
91 |
|
|
Japan Tobacco Inc |
|
|
436,688 |
|
|
65,000 |
|
|
JFE Holdings Inc |
|
|
1,196,456 |
|
|
30,000 |
|
|
JGC Corp |
|
|
756,094 |
|
|
14,000 |
|
|
JS Group Corp |
|
|
265,514 |
|
|
544,000 |
|
|
JX Holdings Inc |
|
|
3,459,634 |
|
|
32,460 |
|
|
Ks Holdings Corp |
|
|
1,279,468 |
|
|
486,000 |
|
|
Kajima Corp |
|
|
1,463,527 |
|
|
62,000 |
|
|
Kamigumi Co Ltd |
|
|
508,079 |
|
|
88,900 |
|
|
Kao Corp |
|
|
2,352,696 |
|
|
229,000 |
|
|
Kawasaki Kisen Kaisha Ltd |
|
|
398,169 |
|
|
733 |
|
|
KDDI Corp |
|
|
4,856,710 |
|
|
42,000 |
|
|
Kinugawa Rubber Industrial Co Ltd |
|
|
377,934 |
|
|
319,000 |
|
|
Kobe Steel Ltd |
|
|
509,389 |
|
|
38,000 |
|
|
Komatsu Ltd |
|
|
972,489 |
|
|
21,400 |
|
|
Konami Corp |
|
|
643,658 |
|
|
13,000 |
|
|
Kyudenko Corp |
|
|
78,459 |
|
|
18,800 |
|
|
Lawson Inc |
|
|
1,113,387 |
|
|
131,400 |
|
|
Leopalace21 Corp * |
|
|
303,310 |
|
|
9,900 |
|
|
Makita Corp |
|
|
346,329 |
|
|
231,000 |
|
|
Marubeni Corp |
|
|
1,427,055 |
|
|
267,000 |
|
|
Mazda Motor Corp * |
|
|
486,937 |
|
|
53,700 |
|
|
Medipal Holdings Corp |
|
|
527,787 |
|
|
180,000 |
|
|
Mitsubishi Heavy Industries Ltd |
|
|
755,804 |
|
|
295,000 |
|
|
Mitsubishi Chemical Holdings Corp |
|
|
1,713,784 |
|
|
34,900 |
|
|
Mitsubishi Corp |
|
|
721,503 |
|
|
54,000 |
|
|
Mitsubishi Electric Corp |
|
|
511,188 |
|
|
17,510 |
|
|
Mitsubishi UFJ Lease & Finance Co Ltd |
|
|
670,355 |
|
|
27,400 |
|
|
Mitsui & Co Ltd |
|
|
432,314 |
|
|
|
|
|
|
|
|
|
|
|
329,000 |
|
|
Mitsui Mining & Smelting Co Ltd |
|
|
852,492 |
|
|
198,000 |
|
|
Mitsui OSK Lines Ltd |
|
|
629,414 |
|
|
976,000 |
|
|
Mizuho Financial Group Inc |
|
|
1,284,835 |
|
|
16,100 |
|
|
Nagase & Co |
|
|
175,701 |
|
|
22,700 |
|
|
Namco Bandai Holdings Inc |
|
|
327,285 |
|
|
178 |
|
|
Net One Systems Co Ltd |
|
|
459,184 |
|
|
13,900 |
|
|
Nikon Corp |
|
|
325,461 |
|
|
4,300 |
|
|
Nintendo Co Ltd |
|
|
654,621 |
|
|
19,000 |
|
|
Nippon Corp |
|
|
165,385 |
|
|
23,000 |
|
|
Nippon Paper Group Inc |
|
|
493,011 |
|
|
543,000 |
|
|
Nippon Steel Corp |
|
|
1,318,158 |
|
|
97,800 |
|
|
Nippon Telegraph & Telephone Corp |
|
|
4,823,347 |
|
|
191,000 |
|
|
Nippon Yusen Kabushiki Kaisha |
|
|
425,480 |
|
|
138,800 |
|
|
Nissan Motor Co Ltd |
|
|
1,274,644 |
|
|
24,000 |
|
|
Nisshinbo Holdings Inc |
|
|
203,152 |
|
|
9,550 |
|
|
Nitori Holdings Co Ltd |
|
|
892,686 |
|
|
14,300 |
|
|
Nitto Denko Corp |
|
|
594,406 |
|
|
1,302 |
|
|
NTT Docomo Inc |
|
|
2,301,345 |
|
|
186,000 |
|
|
Obayashi Corp |
|
|
781,874 |
|
|
62,000 |
|
|
OJI Paper Co Ltd |
|
|
309,055 |
|
|
12,000 |
|
|
Ono Pharmaceutical Co Ltd |
|
|
625,189 |
|
|
15,390 |
|
|
ORIX Corp |
|
|
1,298,530 |
|
|
133,000 |
|
|
Osaka Gas Co Ltd |
|
|
507,401 |
|
|
31,000 |
|
|
Pacific Metals Co Ltd |
|
|
158,473 |
|
|
111,500 |
|
|
Penta Ocean Construction Co Ltd |
|
|
351,923 |
|
|
11,100 |
|
|
Point Inc |
|
|
461,516 |
|
|
19,850 |
|
|
Promise Co Ltd * |
|
|
207,044 |
|
|
694,600 |
|
|
Resona Holdings Inc |
|
|
3,111,073 |
|
|
80,100 |
|
|
Round One Corp |
|
|
478,624 |
|
|
14,200 |
|
|
Ryohin Keikaku Co Ltd |
|
|
646,086 |
|
|
7,600 |
|
|
Ryosan Co |
|
|
171,282 |
|
|
22,700 |
|
|
Sankyo Co Ltd |
|
|
1,134,681 |
|
|
11,600 |
|
|
Sanrio Co Ltd |
|
|
603,402 |
|
|
7,700 |
|
|
Secom Co Ltd |
|
|
347,278 |
|
|
30,500 |
|
|
Sega Sammy Holdings Inc |
|
|
623,729 |
|
|
24,500 |
|
|
Seven & I Holdings Co Ltd |
|
|
684,052 |
|
|
4,600 |
|
|
Shimamura Co Ltd |
|
|
437,221 |
|
|
3,700 |
|
|
SMC Corp |
|
|
614,551 |
|
|
223,600 |
|
|
Sojitz Corp |
|
|
350,869 |
|
|
8,600 |
|
|
Start Today Co Ltd |
|
|
166,654 |
|
|
255,700 |
|
|
Sumitomo Corp |
|
|
3,413,097 |
|
|
21,000 |
|
|
Sumitomo Metal Mining Co Ltd |
|
|
283,360 |
|
|
592,000 |
|
|
Taiheiyo Cement Co Ltd |
|
|
1,150,029 |
|
|
443,000 |
|
|
Taisei Corp |
|
|
1,148,137 |
|
|
1,000 |
|
|
Taisho Pharmaceutical Holdings Co Ltd * |
|
|
66,916 |
|
|
156,400 |
|
|
Takeda Pharmaceutical Co Ltd |
|
|
6,423,970 |
|
|
165,000 |
|
|
Tokyo Tatemono Co Ltd |
|
|
483,151 |
|
|
69,000 |
|
|
TonenGeneral Sekiyu KK |
|
|
786,928 |
|
|
232,000 |
|
|
Toray Industries Inc |
|
|
1,739,284 |
|
|
150,000 |
|
|
Tosoh Corp |
|
|
438,967 |
|
|
26,900 |
|
|
Toyota Motor Corp |
|
|
885,831 |
|
|
68,600 |
|
|
Toyota Tsusho Corp |
|
|
1,154,301 |
|
|
4,300 |
|
|
Unicharm Corp |
|
|
203,966 |
|
|
108,500 |
|
|
UNY Co Ltd |
|
|
996,436 |
|
|
7,450 |
|
|
USS Co Ltd |
|
|
647,786 |
|
|
10,158 |
|
|
West Japan Railway Co |
|
|
419,323 |
|
|
2,471 |
|
|
Yahoo Japan Corp |
|
|
782,980 |
|
|
45,380 |
|
|
Yamada Denki Co Ltd |
|
|
3,282,476 |
|
|
28,200 |
|
|
Yamaha Motor Co Ltd * |
|
|
393,524 |
|
|
35,200 |
|
|
Yamato Holdings Co Ltd |
|
|
565,256 |
|
|
|
|
|
|
|
|
|
|
|
46,000 |
|
|
Zeon Corp |
|
|
391,139 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Japan |
|
|
116,535,791 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Malta 0.0% |
|
|
|
|
|
1,718,063 |
|
|
BGP Holdings Plc * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Netherlands 1.3% |
|
|
|
|
|
216,631 |
|
|
Aegon NV * |
|
|
945,684 |
|
|
10,641 |
|
|
CSM NV |
|
|
139,861 |
|
|
4,124 |
|
|
Heineken Holding NV |
|
|
165,484 |
|
|
274,147 |
|
|
ING Groep NV * |
|
|
2,138,121 |
|
|
56,813 |
|
|
Koninklijke BAM Groep NV |
|
|
196,814 |
|
|
6,905 |
|
|
Koninklijke DSM NV |
|
|
336,258 |
|
|
69,055 |
|
|
Unilever NV |
|
|
2,352,003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Netherlands |
|
|
6,274,225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New Zealand 0.5% |
|
|
|
|
|
180,039 |
|
|
Chorus Ltd * |
|
|
462,519 |
|
|
113,103 |
|
|
Fletcher Building Ltd |
|
|
535,272 |
|
|
900,197 |
|
|
Telecom Corp of New Zealand |
|
|
1,426,925 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total New Zealand |
|
|
2,424,716 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norway 0.2% |
|
|
|
|
|
23,130 |
|
|
Acergy SA * |
|
|
457,144 |
|
|
17,754 |
|
|
Statoil ASA |
|
|
459,115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Norway |
|
|
916,259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Portugal 0.2% |
|
|
|
|
|
155,807 |
|
|
EDP Energias de Portugal SA |
|
|
499,372 |
|
|
29,353 |
|
|
Jeronimo Martins SGPS SA |
|
|
535,541 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Portugal |
|
|
1,034,913 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Singapore 1.9% |
|
|
|
|
|
208,000 |
|
|
CapitaCommercial Trust (REIT) |
|
|
176,835 |
|
|
346,000 |
|
|
Ezra Holdings Ltd |
|
|
244,712 |
|
|
3,889,000 |
|
|
Golden Agri-Resources Ltd |
|
|
2,196,674 |
|
|
198,000 |
|
|
Ho Bee Investment Ltd |
|
|
188,526 |
|
|
370,200 |
|
|
Jaya Holdings Ltd * |
|
|
140,023 |
|
|
169,400 |
|
|
Keppel Corp Ltd |
|
|
1,258,364 |
|
|
164,000 |
|
|
SembCorp Marine Ltd |
|
|
493,167 |
|
|
169,000 |
|
|
Singapore Exchange Ltd |
|
|
830,271 |
|
|
250,000 |
|
|
Singapore Press Holdings Ltd |
|
|
771,772 |
|
|
998,670 |
|
|
Singapore Telecommunications |
|
|
2,434,234 |
|
|
32,002 |
|
|
Suntec Real Estate Investment Trust (REIT) |
|
|
28,719 |
|
|
341,067 |
|
|
Swiber Holdings Ltd * |
|
|
142,783 |
|
|
38,000 |
|
|
Venture Corp Ltd |
|
|
196,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Singapore |
|
|
9,102,672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Spain 4.9% |
|
|
|
|
|
72,653 |
|
|
Banco Bilbao Vizcaya Argentaria SA |
|
|
612,009 |
|
|
339,086 |
|
|
Banco Popular Espanol SA |
|
|
1,447,980 |
|
|
309,163 |
|
|
Banco Santander SA |
|
|
2,320,648 |
|
|
66,603 |
|
|
Cintra Concesiones de Infraestructuras de Transporte SA |
|
|
825,928 |
|
|
19,186 |
|
|
Fomento de Construcciones y Contratas SA |
|
|
496,571 |
|
|
152,744 |
|
|
Gas Natural SDG SA |
|
|
2,659,089 |
|
|
36,407 |
|
|
Grifols SA * |
|
|
588,664 |
|
|
230,862 |
|
|
Iberdrola SA |
|
|
1,538,437 |
|
|
22,039 |
|
|
Inditex SA |
|
|
1,874,045 |
|
|
|
|
|
|
|
|
|
|
|
172,906 |
|
|
Mapfre SA |
|
|
578,794 |
|
|
13,989 |
|
|
Red Electrica de Espana |
|
|
614,949 |
|
|
104,342 |
|
|
Repsol YPF SA |
|
|
3,150,185 |
|
|
367,029 |
|
|
Telefonica SA |
|
|
6,892,199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Spain |
|
|
23,599,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sweden 0.6% |
|
|
|
|
|
12,050 |
|
|
Atlas Copco AB |
|
|
229,984 |
|
|
11,946 |
|
|
Atlas Copco AB Class A |
|
|
256,325 |
|
|
11,862 |
|
|
Hennes & Mauritz AB Class B |
|
|
376,856 |
|
|
51,797 |
|
|
Investor AB B Shares |
|
|
966,092 |
|
|
62,088 |
|
|
Swedbank AB Class A |
|
|
830,609 |
|
|
7,209 |
|
|
Swedish Match AB |
|
|
236,463 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sweden |
|
|
2,896,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Switzerland 3.4% |
|
|
|
|
|
65,097 |
|
|
Nestle SA (Registered) |
|
|
3,653,425 |
|
|
159,119 |
|
|
Novartis AG (Registered) |
|
|
8,593,102 |
|
|
13,741 |
|
|
Roche Holding AG (Non Voting) |
|
|
2,185,840 |
|
|
2,503 |
|
|
Swatch Group AG |
|
|
976,246 |
|
|
890 |
|
|
Swisscom AG (Registered) |
|
|
336,104 |
|
|
1,855 |
|
|
Syngenta AG (Registered) * |
|
|
545,877 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Switzerland |
|
|
16,290,594 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United Kingdom 22.6% |
|
|
|
|
|
47,044 |
|
|
3i Group Plc |
|
|
140,933 |
|
|
38,511 |
|
|
Aggreko Plc |
|
|
1,148,039 |
|
|
79,832 |
|
|
Amlin Plc |
|
|
421,606 |
|
|
203,387 |
|
|
ARM Holdings Plc |
|
|
1,911,183 |
|
|
14,809 |
|
|
Associated British Foods Plc |
|
|
258,473 |
|
|
315,130 |
|
|
AstraZeneca Plc |
|
|
14,514,181 |
|
|
149,674 |
|
|
Aviva Plc |
|
|
734,652 |
|
|
611,764 |
|
|
BAE Systems Plc |
|
|
2,641,166 |
|
|
97,895 |
|
|
Balfour Beatty Plc |
|
|
387,557 |
|
|
1,144,856 |
|
|
Barclays Plc |
|
|
3,298,015 |
|
|
142,347 |
|
|
BG Group Plc |
|
|
3,053,176 |
|
|
22,363 |
|
|
BHP Billiton Plc |
|
|
687,714 |
|
|
754,372 |
|
|
BP Plc |
|
|
5,463,434 |
|
|
109,205 |
|
|
British American Tobacco Plc |
|
|
5,067,883 |
|
|
1,200,752 |
|
|
BT Group Plc |
|
|
3,593,154 |
|
|
108,950 |
|
|
Burberry Group Plc |
|
|
2,182,657 |
|
|
39,353 |
|
|
Capita Group Plc |
|
|
390,269 |
|
|
197,295 |
|
|
Cobham Plc |
|
|
548,877 |
|
|
26,105 |
|
|
Cookson Group Plc |
|
|
204,563 |
|
|
13,123 |
|
|
Croda International Plc |
|
|
376,752 |
|
|
33,472 |
|
|
Diageo Plc |
|
|
716,904 |
|
|
147,071 |
|
|
Drax Group Plc |
|
|
1,295,295 |
|
|
20,106 |
|
|
Experian Plc |
|
|
267,377 |
|
|
125,029 |
|
|
FirstGroup Plc |
|
|
642,711 |
|
|
12,561 |
|
|
Fresnillo Plc |
|
|
339,680 |
|
|
609,967 |
|
|
GlaxoSmithKline Plc |
|
|
13,518,106 |
|
|
210,476 |
|
|
Home Retail Group Plc |
|
|
297,519 |
|
|
41,712 |
|
|
IMI Plc |
|
|
525,203 |
|
|
37,280 |
|
|
Imperial Tobacco Group Plc |
|
|
1,341,223 |
|
|
92,859 |
|
|
Inchcape Plc |
|
|
476,945 |
|
|
23,191 |
|
|
Intertek Group Plc |
|
|
702,888 |
|
|
40,702 |
|
|
Land Securities Group Plc (REIT) |
|
|
440,158 |
|
|
879,758 |
|
|
Legal & General Group Plc |
|
|
1,469,606 |
|
|
1,406,216 |
|
|
Lloyds Banking Group Plc * |
|
|
550,296 |
|
|
|
|
|
|
|
|
|
|
|
103,105 |
|
|
Man Group Plc |
|
|
231,090 |
|
|
49,343 |
|
|
Next Plc |
|
|
2,085,591 |
|
|
65,833 |
|
|
Pearson Plc |
|
|
1,195,909 |
|
|
13,060 |
|
|
Petrofac Ltd |
|
|
298,593 |
|
|
62,929 |
|
|
Prudential Plc |
|
|
619,387 |
|
|
213,300 |
|
|
Punch Taverns Plc * |
|
|
40,359 |
|
|
6,983 |
|
|
Randgold Resources Ltd |
|
|
742,913 |
|
|
16,795 |
|
|
Reckitt Benckiser Group Plc |
|
|
852,056 |
|
|
46,335 |
|
|
Rio Tinto Plc |
|
|
2,439,336 |
|
|
142,690 |
|
|
Royal Dutch Shell Group Class A (Amsterdam) |
|
|
4,983,944 |
|
|
40,199 |
|
|
Royal Dutch Shell Plc A Shares (London) |
|
|
1,405,943 |
|
|
222,874 |
|
|
Royal Dutch Shell Plc B Shares (London) |
|
|
8,031,168 |
|
|
17,375 |
|
|
SABMiller Plc |
|
|
613,469 |
|
|
156,433 |
|
|
Sage Group Plc (The) |
|
|
714,930 |
|
|
63,700 |
|
|
Scottish & Southern Energy Plc |
|
|
1,319,020 |
|
|
47,431 |
|
|
Shire Plc |
|
|
1,595,009 |
|
|
47,433 |
|
|
Smith & Nephew Plc |
|
|
433,370 |
|
|
213,300 |
|
|
Spirit Pub Co Plc * |
|
|
133,022 |
|
|
22,723 |
|
|
Standard Chartered Plc |
|
|
494,698 |
|
|
29,297 |
|
|
Travis Perkins Plc |
|
|
384,628 |
|
|
106,249 |
|
|
TUI Travel Plc |
|
|
288,366 |
|
|
2,768,253 |
|
|
Vodafone Group Plc |
|
|
7,493,962 |
|
|
44,654 |
|
|
Weir Group Plc (The) |
|
|
1,451,452 |
|
|
253,927 |
|
|
William Hill Plc |
|
|
808,644 |
|
|
20,250 |
|
|
Wolseley Plc |
|
|
607,127 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total United Kingdom |
|
|
108,872,181 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $429,021,652) |
|
|
458,210,561 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PREFERRED STOCKS 1.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany 1.1% |
|
|
|
|
|
6,211 |
|
|
Hugo Boss AG 2.95% |
|
|
565,426 |
|
|
41,675 |
|
|
Porsche Automobil Holding SE 1.12% |
|
|
2,553,790 |
|
|
24,058 |
|
|
ProSiebenSat.1 Media AG 7.61% |
|
|
475,928 |
|
|
9,574 |
|
|
Volkswagen AG 1.74% |
|
|
1,654,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Germany |
|
|
5,249,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS (COST $4,334,397) |
|
|
5,249,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia 0.0% |
|
|
|
|
|
175,678 |
|
|
BlueScope Steel Ltd, Expires 12/14/11* |
|
|
1,987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $135,535) |
|
|
1,987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 2.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States 2.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers |
|
|
|
|
|
520,833 |
|
|
GMO U.S. Treasury Fund |
|
|
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $13,026,025) |
|
|
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Par Value |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.5% |
|
|
|
|
USD |
|
|
1,691,160 |
|
|
Bank of America (Charlotte) Time Deposit, 0.03%, due 12/01/11 |
|
|
1,691,160 |
|
AUD |
|
|
10,034 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 3.78%, due 12/01/11 |
|
|
10,319 |
|
CAD |
|
|
10,228 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.25%, due 12/01/11 |
|
|
10,028 |
|
CHF |
|
|
9,563 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
10,468 |
|
DKK |
|
|
55,076 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.14%, due 12/01/11 |
|
|
9,952 |
|
HKD |
|
|
77,869 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
10,023 |
|
NOK |
|
|
57,310 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.95%, due 12/01/11 |
|
|
9,922 |
|
NZD |
|
|
12,702 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.75%, due 12/01/11 |
|
|
9,918 |
|
SEK |
|
|
67,859 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 1.06%, due 12/01/11 |
|
|
10,028 |
|
SGD |
|
|
16,884 |
|
|
Brown Brothers Harriman (Grand Cayman) Time Deposit, 0.01%, due 12/01/11 |
|
|
13,174 |
|
JPY |
|
|
15,252,400 |
|
|
Citibank (New York) Time Deposit, 0.01%, due 12/01/11 |
|
|
196,653 |
|
EUR |
|
|
274,343 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
368,635 |
|
GBP |
|
|
77,286 |
|
|
JPMorgan Chase (New York) Time Deposit, 0.10%, due 12/01/11 |
|
|
121,254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Time Deposits |
|
|
2,471,534 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $2,471,534) |
|
|
2,471,534 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL
INVESTMENTS 99.5% (Cost $448,989,143) |
|
|
478,959,603 |
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.5% |
|
|
2,619,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
481,579,490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
|
|
Expiration |
|
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
|
Date |
|
|
Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
96 |
|
MSCI EAFE E-Mini |
|
December 2011 |
|
$ |
6,961,440 |
|
|
$ |
390,035 |
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to cover any commitments or collateral requirements of the relevant broker or exchange.
Notes to Schedule of Investments:
FDR Fiduciary Depositary Receipt
REIT Real Estate Investment Trust
* |
|
Non-income producing security. |
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
DKK Danish Krone
EUR Euro
GBP British Pound
HKD Hong Kong Dollar
JPY Japanese Yen
NOK Norwegian Krone
NZD New Zealand Dollar
SEK Swedish Krona
SGD Singapore Dollar
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
454,244,273 |
|
|
$ |
56,048,688 |
|
|
$ |
(31,333,358 |
) |
|
$ |
24,715,330 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
263,025 |
|
|
$ |
26,467,000 |
|
|
$ |
13,703,964 |
|
|
$ |
167 |
|
|
$ |
|
|
|
$ |
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund that were valued
using fair value prices obtained from an independent pricing service as of November 30, 2011.
These securities listed on foreign exchanges (including the value of equity securities that
underlie futures (to the extent the market for such futures closes prior to the close of the
NYSE) and other derivatives) are classified as being valued using Level 2 inputs in the table
below.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities
|
|
93.2% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1
Valuations based on quoted prices for identical securities in active markets.
Level 2
Valuations determined using other significant direct or indirect observable inputs.
These inputs may include: fair value adjustments provided by an independent pricing service
applied to equity securities (including the value of equity securities that underlie futures (to
the extent the market for such futures closes prior to the close of the NYSE) and other
derivatives) due to market events that have occurred since the local market close but prior to
the close of the NYSE.
Level 3
Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices in |
|
|
|
|
|
|
Significant |
|
|
|
|
|
|
Active Markets for |
|
|
Significant Other |
|
|
Unobservable |
|
|
|
|
|
|
Identical Assets |
|
|
Observable Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
$ |
|
|
|
$ |
17,578,425 |
|
|
$ |
|
|
|
$ |
17,578,425 |
|
Austria |
|
|
|
|
|
|
3,869,831 |
|
|
|
|
|
|
|
3,869,831 |
|
Belgium |
|
|
|
|
|
|
2,465,388 |
|
|
|
|
|
|
|
2,465,388 |
|
Canada |
|
|
12,551,772 |
|
|
|
|
|
|
|
|
|
|
|
12,551,772 |
|
Denmark |
|
|
|
|
|
|
1,629,924 |
|
|
|
|
|
|
|
1,629,924 |
|
Finland |
|
|
|
|
|
|
2,654,562 |
|
|
|
|
|
|
|
2,654,562 |
|
France |
|
|
22 |
|
|
|
55,831,999 |
|
|
|
|
|
|
|
55,832,021 |
|
Germany |
|
|
|
|
|
|
34,242,417 |
|
|
|
|
|
|
|
34,242,417 |
|
Greece |
|
|
|
|
|
|
899,381 |
|
|
|
|
|
|
|
899,381 |
|
Hong Kong |
|
|
|
|
|
|
5,977,656 |
|
|
|
|
|
|
|
5,977,656 |
|
Ireland |
|
|
|
|
|
|
4,884,398 |
|
|
|
|
|
|
|
4,884,398 |
|
Italy |
|
|
|
|
|
|
27,677,608 |
|
|
|
|
|
|
|
27,677,608 |
|
Japan |
|
|
66,916 |
|
|
|
116,468,875 |
|
|
|
|
|
|
|
116,535,791 |
|
Malta |
|
|
|
|
|
|
0 |
* |
|
|
|
|
|
|
0 |
|
Netherlands |
|
|
|
|
|
|
6,274,225 |
|
|
|
|
|
|
|
6,274,225 |
|
New Zealand |
|
|
1,889,444 |
|
|
|
535,272 |
|
|
|
|
|
|
|
2,424,716 |
|
Norway |
|
|
|
|
|
|
916,259 |
|
|
|
|
|
|
|
916,259 |
|
Portugal |
|
|
|
|
|
|
1,034,913 |
|
|
|
|
|
|
|
1,034,913 |
|
Singapore |
|
|
|
|
|
|
9,102,672 |
|
|
|
|
|
|
|
9,102,672 |
|
Spain |
|
|
|
|
|
|
23,599,498 |
|
|
|
|
|
|
|
23,599,498 |
|
Sweden |
|
|
|
|
|
|
2,896,329 |
|
|
|
|
|
|
|
2,896,329 |
|
Switzerland |
|
|
|
|
|
|
16,290,594 |
|
|
|
|
|
|
|
16,290,594 |
|
United Kingdom |
|
|
133,022 |
|
|
|
108,739,159 |
|
|
|
|
|
|
|
108,872,181 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS |
|
|
14,641,176 |
|
|
|
443,569,385 |
|
|
|
|
|
|
|
458,210,561 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Germany |
|
|
|
|
|
|
5,249,496 |
|
|
|
|
|
|
|
5,249,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL PREFERRED STOCKS |
|
|
|
|
|
|
5,249,496 |
|
|
|
|
|
|
|
5,249,496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Australia |
|
|
|
|
|
|
1,987 |
|
|
|
|
|
|
|
1,987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total RIGHTS/WARRANTS |
|
|
|
|
|
|
1,987 |
|
|
|
|
|
|
|
1,987 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
|
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS |
|
|
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
13,026,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Investments |
|
|
2,471,534 |
|
|
|
|
|
|
|
|
|
|
|
2,471,534 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
30,138,735 |
|
|
|
448,820,868 |
|
|
|
|
|
|
|
478,959,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives** |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity risk |
|
|
390,035 |
|
|
|
|
|
|
|
|
|
|
|
390,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Derivatives |
|
|
390,035 |
|
|
|
|
|
|
|
|
|
|
|
390,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
30,528,770 |
|
|
$ |
448,820,868 |
|
|
$ |
|
|
|
$ |
479,349,638 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
Represents the interest in securities that were determined to have a fair value of zero at
November 30, 2011. |
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
** Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. There can be no
assurance that the Funds tax management strategies will be effective, and you may incur tax
liabilities that exceed your economic return. The Fund is a non-diversified investment company
under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in the market
value of a particular security held by the Fund may affect the Funds performance more than if
the Fund were diversified. Selected risks of investing in the Fund are summarized below. The
risks of investing in the Fund depend on the types of investments in its portfolio and the
investment strategies the Manager employs on its behalf. This section does not describe every potential risk of investing in
the Fund. The Fund could be subject to additional risks because of the types of investments it
makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to
the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Currency Risk Fluctuations in exchange rates can adversely affect the market value of
the Funds foreign currency holdings and investments denominated in foreign currencies.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Liquidity Risk Shares of small- and mid-cap companies often have lower trading
volumes and a limited number or no market makers. Thus, a large position may limit or
prevent the Fund from selling those shares or unwinding derivative positions on them at
desirable prices. The more less-liquid securities the Fund holds, the more likely it is to
honor a redemption request in-kind.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives. The
Fund also may use currency derivatives (including forward currency contracts, futures contracts,
swap contracts and options) to gain exposure to a given currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). The Fund also may use currency derivatives in an attempt to reduce
some aspect of the currency exposure in its portfolio. For these purposes, the Fund may use an
instrument denominated in a different currency that the Manager believes is highly correlated
with the relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For example, if the Fund holds a large
proportion of stocks of companies in a particular sector and the Manager believes that stocks of
companies in another sector will outperform those stocks, the Fund might use a short futures
contract on an appropriate index (to synthetically sell a portion of the Funds portfolio) in
combination with a long futures contract on another index (to synthetically buy exposure to
that index). In adjusting its investment exposure, the Fund also may use currency derivatives in
an attempt to adjust its currency exposure, seeking currency exposure that is different (in some
cases, significantly different) from the currency exposure represented by its portfolio
investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposures in excess of its net assets. The Funds foreign currency exposure may differ
significantly from the currency exposure represented by its investments.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts. Most
forward currency contracts are not collateralized. The Fund had no forward currency
contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded (unless otherwise adjusted due to the time at which foreign markets close). The
value of each of the Funds futures contracts is marked to market daily and an appropriate
payable or receivable for the change in value (variation margin) is recorded by the Fund. The
payable or receivable is settled on the following business day. Gains or losses are recognized
but not accounted for as realized until the contracts expire or are closed. Futures contracts
involve, to varying degrees, risk of loss in excess of the variation margin. Under some
circumstances, futures exchanges may establish daily limits on the amount that the price of a
futures contract can vary from the previous days settlement price, thereby effectively
preventing liquidation of unfavorable positions. Futures contracts expose the Fund to the risk
that it may not be able to enter into a closing transaction due to an illiquid market.
During the period ended November 30, 2011, the Fund used futures contracts to
adjust exposure to certain securities markets and maintain the diversity and liquidity of
the portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an
addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments
purchased. Gains and losses from the expiration or closing of written option contracts are
separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers (unless otherwise adjusted due to the time at which foreign markets close) and
records the change in value, if any, as unrealized gain or loss. Gains or losses are realized
upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is
insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to achieve returns comparable to holding and lending a direct equity position. The Fund had no
swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or
warrants held by the Fund at the end of the period are listed in the Funds Schedule of
Investments.
The following is a summary of the fair valuations of derivative instruments categorized by
risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,987 |
|
|
$ |
|
|
|
$ |
1,987 |
|
Unrealized appreciation on futures contracts* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
390,035 |
|
|
|
|
|
|
|
390,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
392,022 |
|
|
$ |
|
|
|
$ |
392,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of futures contracts as
reported in the Schedule of Investments.
As provided by authoritative accounting guidance, the
table above is based on market values or unrealized appreciation / (depreciation) rather than the notional amounts
of derivatives. Changes to market values of reference asset(s) will tend to have a greater impact on the Fund
(with correspondingly greater risk) the greater the notional amount. For further information on notional amounts,
see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts and rights and/or warrants) or notional amounts (swap agreements) outstanding at each month-end, was as follows for
the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures |
|
|
Rights and/or |
|
|
Swap |
|
|
|
Contracts |
|
|
Warrants |
|
|
Agreements |
|
Average amount outstanding |
|
$ |
3,243,091 |
|
|
$ |
56,831 |
|
|
$ |
27,174* |
|
* During the period ended November 30, 2011, the Fund did not hold
swap agreements at any month-end, therefore, the average amount outstanding was calculated using daily outstanding notional amounts.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO Tobacco-Free Core Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 98.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automobiles & Components 0.2% |
|
|
|
|
|
2,500 |
|
|
General Motors Co.* |
|
|
53,224 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banks 0.1% |
|
|
|
|
|
100 |
|
|
CapitalSource, Inc. |
|
|
645 |
|
|
600 |
|
|
CIT Group, Inc.* |
|
|
20,316 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Banks |
|
|
20,961 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 3.3% |
|
|
|
|
|
2,600 |
|
|
3M Co. |
|
|
210,704 |
|
|
200 |
|
|
Alliant Techsystems, Inc. |
|
|
11,768 |
|
|
1,400 |
|
|
Danaher Corp. |
|
|
67,732 |
|
|
1,300 |
|
|
Fastenal Co. |
|
|
54,145 |
|
|
1,400 |
|
|
General Dynamics Corp. |
|
|
92,484 |
|
|
401 |
|
|
GeoEye, Inc.* |
|
|
7,615 |
|
|
100 |
|
|
Harsco Corp. |
|
|
2,064 |
|
|
350 |
|
|
ITT Corp. |
|
|
7,060 |
|
|
320 |
|
|
Joy Global, Inc. |
|
|
29,210 |
|
|
600 |
|
|
L-3 Communications Holdings, Inc. |
|
|
39,780 |
|
|
500 |
|
|
Northrop Grumman Corp. |
|
|
28,535 |
|
|
600 |
|
|
Oshkosh Corp.* |
|
|
12,312 |
|
|
230 |
|
|
Precision Castparts Corp. |
|
|
37,892 |
|
|
1,600 |
|
|
United Technologies Corp. |
|
|
122,560 |
|
|
200 |
|
|
WW Grainger, Inc. |
|
|
37,380 |
|
|
100 |
|
|
Xylem, Inc |
|
|
2,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
763,631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Professional Services 0.4% |
|
|
|
|
|
300 |
|
|
Copart, Inc.* |
|
|
13,479 |
|
|
1,000 |
|
|
Pitney Bowes, Inc. |
|
|
18,630 |
|
|
750 |
|
|
Rollins, Inc. |
|
|
16,650 |
|
|
1,400 |
|
|
RR Donnelley & Sons Co. |
|
|
21,028 |
|
|
400 |
|
|
Stericycle, Inc.* |
|
|
32,408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Commercial & Professional Services |
|
|
102,195 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 1.6% |
|
|
|
|
|
1,400 |
|
|
Coach, Inc. |
|
|
87,626 |
|
|
300 |
|
|
Fossil, Inc.* |
|
|
26,877 |
|
|
3,728 |
|
|
KB Home |
|
|
27,401 |
|
|
1,800 |
|
|
Nike, Inc.-Class B |
|
|
173,124 |
|
|
480 |
|
|
VF Corp. |
|
|
66,571 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Durables & Apparel |
|
|
381,599 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 2.5% |
|
|
|
|
|
1,500 |
|
|
Apollo Group, Inc.-Class A* |
|
|
72,720 |
|
|
300 |
|
|
DeVry, Inc. |
|
|
10,353 |
|
|
2,100 |
|
|
H&R Block, Inc. |
|
|
33,033 |
|
|
100 |
|
|
ITT Educational Services, Inc.* |
|
|
5,496 |
|
|
4,500 |
|
|
McDonalds Corp. |
|
|
429,840 |
|
|
400 |
|
|
Weight Watchers International, Inc. |
|
|
23,508 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Services |
|
|
574,950 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financials 0.4% |
|
|
|
|
|
8,507 |
|
|
Bank of America Corp. |
|
|
46,278 |
|
|
600 |
|
|
Capital One Financial Corp. |
|
|
26,796 |
|
|
|
|
|
|
|
|
|
|
|
2,200 |
|
|
SLM Corp. |
|
|
28,336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified Financials |
|
|
101,410 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 8.1% |
|
|
|
|
|
600 |
|
|
Anadarko Petroleum Corp. |
|
|
48,762 |
|
|
440 |
|
|
Apache Corp. |
|
|
43,754 |
|
|
600 |
|
|
Baker Hughes, Inc. |
|
|
32,766 |
|
|
300 |
|
|
Berry Petroleum Co.-Class A |
|
|
13,164 |
|
|
3,860 |
|
|
Chevron Corp. |
|
|
396,885 |
|
|
4,751 |
|
|
ConocoPhillips |
|
|
338,841 |
|
|
7,500 |
|
|
Exxon Mobil Corp. |
|
|
603,300 |
|
|
1,600 |
|
|
Halliburton Co. |
|
|
58,880 |
|
|
300 |
|
|
Key Energy Services, Inc.* |
|
|
4,530 |
|
|
2,300 |
|
|
Marathon Oil Corp. |
|
|
64,308 |
|
|
700 |
|
|
National Oilwell Varco, Inc. |
|
|
50,190 |
|
|
526 |
|
|
Occidental Petroleum Corp. |
|
|
52,022 |
|
|
300 |
|
|
Range Resources Corp. |
|
|
21,513 |
|
|
970 |
|
|
Schlumberger Ltd. |
|
|
73,070 |
|
|
1,800 |
|
|
Valero Energy Corp. |
|
|
40,086 |
|
|
900 |
|
|
Williams Cos., Inc. |
|
|
29,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
1,871,123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 7.0% |
|
|
|
|
|
800 |
|
|
Costco Wholesale Corp. |
|
|
68,240 |
|
|
3,100 |
|
|
CVS Caremark Corp. |
|
|
120,404 |
|
|
2,700 |
|
|
Kroger Co. (The) |
|
|
62,586 |
|
|
1,200 |
|
|
Safeway, Inc. |
|
|
24,000 |
|
|
1,065 |
|
|
Supervalu, Inc. |
|
|
7,828 |
|
|
2,500 |
|
|
Sysco Corp. |
|
|
71,350 |
|
|
5,800 |
|
|
Walgreen Co. |
|
|
195,576 |
|
|
17,930 |
|
|
WalMart Stores, Inc. |
|
|
1,056,077 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food & Staples Retailing |
|
|
1,606,061 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 6.6% |
|
|
|
|
|
600 |
|
|
Brown-Forman Corp.-Class B |
|
|
47,886 |
|
|
1,100 |
|
|
Campbell Soup Co. |
|
|
35,860 |
|
|
8,400 |
|
|
Coca-Cola Co. (The) |
|
|
564,732 |
|
|
1,200 |
|
|
Dean Foods Co.* |
|
|
12,192 |
|
|
600 |
|
|
Flowers Foods, Inc. |
|
|
11,862 |
|
|
2,400 |
|
|
General Mills, Inc. |
|
|
95,880 |
|
|
700 |
|
|
Hansen Natural Corp.* |
|
|
64,540 |
|
|
1,200 |
|
|
Hershey Co. (The) |
|
|
69,216 |
|
|
900 |
|
|
HJ Heinz Co. |
|
|
47,385 |
|
|
1,200 |
|
|
Hormel Foods Corp. |
|
|
36,132 |
|
|
300 |
|
|
J.M. Smucker Co. (The) |
|
|
22,794 |
|
|
1,400 |
|
|
Kellogg Co. |
|
|
68,824 |
|
|
500 |
|
|
McCormick & Co., Inc. (Non Voting) |
|
|
24,350 |
|
|
6,625 |
|
|
PepsiCo, Inc. |
|
|
424,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
1,525,653 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 8.8% |
|
|
|
|
|
1,700 |
|
|
Aetna, Inc. |
|
|
71,094 |
|
|
1,885 |
|
|
Alere, Inc.* |
|
|
44,090 |
|
|
200 |
|
|
AMERIGROUP Corp.* |
|
|
11,434 |
|
|
1,200 |
|
|
AmerisourceBergen Corp. |
|
|
44,580 |
|
|
2,500 |
|
|
Baxter International, Inc. |
|
|
129,150 |
|
|
900 |
|
|
Becton, Dickinson and Co. |
|
|
66,402 |
|
|
700 |
|
|
Brookdale Senior Living, Inc.* |
|
|
10,885 |
|
|
390 |
|
|
C.R. Bard, Inc. |
|
|
34,004 |
|
|
|
|
|
|
|
|
|
|
|
1,000 |
|
|
Cardinal Health, Inc. |
|
|
42,460 |
|
|
800 |
|
|
CareFusion Corp.* |
|
|
19,824 |
|
|
600 |
|
|
Cerner Corp.* |
|
|
36,588 |
|
|
600 |
|
|
Cigna Corp. |
|
|
26,538 |
|
|
900 |
|
|
Coventry Health Care, Inc.* |
|
|
28,746 |
|
|
1,100 |
|
|
Covidien Plc |
|
|
50,105 |
|
|
500 |
|
|
DENTSPLY International, Inc. |
|
|
18,055 |
|
|
400 |
|
|
Edwards Lifesciences Corp.* |
|
|
26,412 |
|
|
2,200 |
|
|
Express Scripts, Inc.* |
|
|
100,430 |
|
|
200 |
|
|
Gen-Probe, Inc.* |
|
|
12,598 |
|
|
300 |
|
|
Henry Schein, Inc.* |
|
|
19,302 |
|
|
900 |
|
|
Humana, Inc. |
|
|
79,812 |
|
|
300 |
|
|
Idexx Laboratories, Inc.* |
|
|
22,557 |
|
|
130 |
|
|
Intuitive Surgical, Inc.* |
|
|
56,447 |
|
|
400 |
|
|
Laboratory Corp. of America Holdings* |
|
|
34,288 |
|
|
1,406 |
|
|
Lincare Holdings, Inc. |
|
|
33,322 |
|
|
700 |
|
|
McKesson Corp. |
|
|
56,917 |
|
|
200 |
|
|
Mednax, Inc.* |
|
|
13,480 |
|
|
6,000 |
|
|
Medtronic, Inc. |
|
|
218,580 |
|
|
500 |
|
|
Patterson Cos., Inc. |
|
|
15,085 |
|
|
300 |
|
|
Quality Systems, Inc. |
|
|
10,605 |
|
|
600 |
|
|
Quest Diagnostics, Inc. |
|
|
35,196 |
|
|
600 |
|
|
ResMed, Inc.* |
|
|
15,630 |
|
|
1,200 |
|
|
Stryker Corp. |
|
|
58,596 |
|
|
1,200 |
|
|
St Jude Medical, Inc. |
|
|
46,128 |
|
|
584 |
|
|
Triple-S Management Corp.-Class B* |
|
|
11,377 |
|
|
6,676 |
|
|
UnitedHealth Group, Inc. |
|
|
325,589 |
|
|
300 |
|
|
Varian Medical Systems, Inc.* |
|
|
18,669 |
|
|
1,800 |
|
|
WellPoint, Inc. |
|
|
126,990 |
|
|
1,300 |
|
|
Zimmer Holdings, Inc.* |
|
|
65,715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
2,037,680 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 5.1% |
|
|
|
|
|
1,100 |
|
|
Avon Products, Inc. |
|
|
18,700 |
|
|
700 |
|
|
Church & Dwight Co., Inc. |
|
|
30,975 |
|
|
500 |
|
|
Clorox Co. |
|
|
32,480 |
|
|
2,100 |
|
|
ColgatePalmolive Co. |
|
|
192,150 |
|
|
910 |
|
|
Estee Lauder Cos. (The), Inc.-Class A |
|
|
107,362 |
|
|
1,000 |
|
|
Herbalife Ltd. |
|
|
55,300 |
|
|
1,400 |
|
|
KimberlyClark Corp. |
|
|
100,058 |
|
|
10,048 |
|
|
Procter & Gamble Co. (The) |
|
|
648,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
1,185,824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 1.2% |
|
|
|
|
|
500 |
|
|
American International Group, Inc.* |
|
|
11,655 |
|
|
700 |
|
|
Aon Corp. |
|
|
32,179 |
|
|
900 |
|
|
Assurant, Inc. |
|
|
35,316 |
|
|
100 |
|
|
Endurance Specialty Holdings Ltd. |
|
|
3,617 |
|
|
1,500 |
|
|
Hartford Financial Services Group, Inc. (The) |
|
|
26,640 |
|
|
400 |
|
|
Protective Life Corp. |
|
|
8,876 |
|
|
800 |
|
|
Prudential Financial, Inc. |
|
|
40,512 |
|
|
1,800 |
|
|
Travelers Cos. (The), Inc. |
|
|
101,250 |
|
|
300 |
|
|
Validus Holdings Ltd. |
|
|
9,027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance |
|
|
269,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials 0.4% |
|
|
|
|
|
700 |
|
|
Ecolab, Inc. |
|
|
39,914 |
|
|
900 |
|
|
LyondellBasell Industries NV-Class A |
|
|
29,403 |
|
|
|
|
|
|
|
|
|
|
|
300 |
|
|
SigmaAldrich Corp. |
|
|
19,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Materials |
|
|
88,760 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media 0.8% |
|
|
|
|
|
1,800 |
|
|
CBS Corp.-Class B (Non Voting) |
|
|
46,872 |
|
|
700 |
|
|
Charter Communications, Inc.-Class A* |
|
|
37,009 |
|
|
1,400 |
|
|
DISH Network Corp.-Class A |
|
|
34,398 |
|
|
1,000 |
|
|
Gannett Co., Inc. |
|
|
10,860 |
|
|
1,100 |
|
|
McGraw-Hill Cos. (The), Inc. |
|
|
46,970 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Media |
|
|
176,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 17.9% |
|
|
|
|
|
9,000 |
|
|
Abbott Laboratories |
|
|
490,950 |
|
|
1,100 |
|
|
Allergan, Inc. |
|
|
92,092 |
|
|
4,200 |
|
|
Amgen, Inc. |
|
|
243,222 |
|
|
1,120 |
|
|
Biogen Idec, Inc.* |
|
|
128,744 |
|
|
6,600 |
|
|
BristolMyers Squibb Co. |
|
|
215,952 |
|
|
8,600 |
|
|
Eli Lilly & Co. |
|
|
325,510 |
|
|
900 |
|
|
Endo Pharmaceuticals Holdings, Inc.* |
|
|
30,807 |
|
|
1,900 |
|
|
Forest Laboratories, Inc.* |
|
|
56,924 |
|
|
3,300 |
|
|
Gilead Sciences, Inc.* |
|
|
131,505 |
|
|
9,120 |
|
|
Johnson & Johnson |
|
|
590,246 |
|
|
18,776 |
|
|
Merck & Co., Inc. |
|
|
671,242 |
|
|
110 |
|
|
Mettler-Toledo International, Inc.* |
|
|
17,578 |
|
|
51,286 |
|
|
Pfizer, Inc. |
|
|
1,029,310 |
|
|
400 |
|
|
Pharmaceutical Product Development, Inc. |
|
|
13,284 |
|
|
200 |
|
|
Techne Corp. |
|
|
13,498 |
|
|
3,100 |
|
|
Warner Chilcott Plc.-Class A* |
|
|
48,732 |
|
|
300 |
|
|
Waters Corp.* |
|
|
24,000 |
|
|
200 |
|
|
Watson Pharmaceuticals, Inc.* |
|
|
12,924 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
4,136,520 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 3.0% |
|
|
|
|
|
500 |
|
|
Advance Auto Parts, Inc. |
|
|
34,610 |
|
|
400 |
|
|
Aeropostale, Inc.* |
|
|
6,204 |
|
|
700 |
|
|
AutoNation, Inc.* |
|
|
25,277 |
|
|
90 |
|
|
AutoZone, Inc.* |
|
|
29,554 |
|
|
1,900 |
|
|
Best Buy Co., Inc. |
|
|
51,471 |
|
|
700 |
|
|
Dollar Tree, Inc.* |
|
|
57,043 |
|
|
600 |
|
|
Family Dollar Stores, Inc. |
|
|
35,652 |
|
|
1,000 |
|
|
GameStop Corp.-Class A* |
|
|
23,120 |
|
|
600 |
|
|
Genuine Parts Co. |
|
|
35,100 |
|
|
600 |
|
|
J.C. Penney Co., Inc. |
|
|
19,224 |
|
|
1,600 |
|
|
Liberty Media Corp.-Interactive-Class A* |
|
|
26,016 |
|
|
2,600 |
|
|
Lowes Cos., Inc. |
|
|
62,426 |
|
|
70 |
|
|
Priceline.com, Inc.* |
|
|
34,013 |
|
|
700 |
|
|
Ross Stores, Inc. |
|
|
62,363 |
|
|
1,200 |
|
|
Target Corp. |
|
|
63,240 |
|
|
2,000 |
|
|
TJX Cos. (The), Inc. |
|
|
123,400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
688,713 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment 0.4% |
|
|
|
|
|
100 |
|
|
ON Semiconductor Corp.* |
|
|
753 |
|
|
2,700 |
|
|
Texas Instruments, Inc. |
|
|
81,270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Semiconductors & Semiconductor Equipment |
|
|
82,023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 21.7% |
|
|
|
|
|
4,000 |
|
|
Accenture Plc.-Class A |
|
|
231,720 |
|
|
|
|
|
|
|
|
|
|
|
1,200 |
|
|
Adobe Systems, Inc.* |
|
|
32,904 |
|
|
1,100 |
|
|
Amdocs Ltd.* |
|
|
31,064 |
|
|
400 |
|
|
Ansys, Inc.* |
|
|
24,788 |
|
|
100 |
|
|
AOL, Inc.* |
|
|
1,434 |
|
|
1,500 |
|
|
Automatic Data Processing, Inc. |
|
|
76,635 |
|
|
800 |
|
|
BMC Software, Inc.* |
|
|
28,528 |
|
|
500 |
|
|
Citrix Systems, Inc.* |
|
|
35,695 |
|
|
1,200 |
|
|
Cognizant Technology Solutions Corp.-Class A* |
|
|
80,820 |
|
|
500 |
|
|
Computer Sciences Corp. |
|
|
12,215 |
|
|
5,000 |
|
|
eBay, Inc.* |
|
|
147,950 |
|
|
300 |
|
|
Factset Research Systems, Inc. |
|
|
27,969 |
|
|
500 |
|
|
Global Payments, Inc. |
|
|
22,115 |
|
|
1,470 |
|
|
Google, Inc.-Class A* |
|
|
881,103 |
|
|
600 |
|
|
Informatica Corp.* |
|
|
26,973 |
|
|
4,924 |
|
|
International Business Machines Corp. |
|
|
925,712 |
|
|
1,200 |
|
|
Intuit, Inc. |
|
|
63,888 |
|
|
400 |
|
|
Jack Henry & Associates, Inc. |
|
|
13,284 |
|
|
380 |
|
|
MasterCard, Inc.-Class A |
|
|
142,329 |
|
|
300 |
|
|
Micros Systems, Inc.* |
|
|
14,151 |
|
|
45,336 |
|
|
Microsoft Corp. |
|
|
1,159,695 |
|
|
27,300 |
|
|
Oracle Corp. |
|
|
855,855 |
|
|
1,300 |
|
|
Paychex, Inc. |
|
|
37,843 |
|
|
100 |
|
|
Quest Software, Inc.* |
|
|
1,807 |
|
|
2,700 |
|
|
Symantec Corp.* |
|
|
44,145 |
|
|
200 |
|
|
Syntel, Inc. |
|
|
9,568 |
|
|
900 |
|
|
Total System Services, Inc. |
|
|
18,036 |
|
|
600 |
|
|
Visa, Inc.-Class A |
|
|
58,182 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
5,006,408 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 6.7% |
|
|
|
|
|
1,190 |
|
|
Apple, Inc.* |
|
|
454,818 |
|
|
600 |
|
|
Arrow Electronics, Inc.* |
|
|
21,936 |
|
|
6,750 |
|
|
Cisco Systems, Inc. |
|
|
125,820 |
|
|
6,380 |
|
|
Dell, Inc.* |
|
|
100,549 |
|
|
400 |
|
|
Harris Corp. |
|
|
14,240 |
|
|
10,000 |
|
|
Hewlett-Packard Co. |
|
|
279,500 |
|
|
1,200 |
|
|
Ingram Micro, Inc.-Class A* |
|
|
21,612 |
|
|
7,032 |
|
|
Qualcomm, Inc. |
|
|
385,353 |
|
|
2,700 |
|
|
Seagate Technology Plc |
|
|
46,170 |
|
|
1,000 |
|
|
Vishay Intertechnology, Inc.* |
|
|
9,890 |
|
|
2,730 |
|
|
Western Digital Corp.* |
|
|
79,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
1,539,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 2.1% |
|
|
|
|
|
6,600 |
|
|
AT&T, Inc. |
|
|
191,268 |
|
|
600 |
|
|
Level 3 Communications, Inc.* |
|
|
12,366 |
|
|
7,500 |
|
|
Sprint Nextel Corp.* |
|
|
20,250 |
|
|
6,884 |
|
|
Verizon Communications, Inc. |
|
|
259,733 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Telecommunication Services |
|
|
483,617 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transportation 0.3% |
|
|
|
|
|
600 |
|
|
CH Robinson Worldwide, Inc. |
|
|
41,106 |
|
|
400 |
|
|
Expeditors International of Washington, Inc. |
|
|
17,404 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Transportation |
|
|
58,510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $20,312,047) |
|
|
22,753,292 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 1.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,911 |
|
|
SPDR S&P 500 ETF Trust (a) |
|
|
239,085 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $232,265) |
|
|
239,085 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 0.2% |
|
|
|
|
|
1,800 |
|
|
GMO U.S. Treasury Fund |
|
|
45,018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $45,018) |
|
|
45,018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.0% |
|
|
|
|
|
9,002 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (b) |
|
|
9,002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $9,002) |
|
|
9,002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.8%
(Cost $20,598,332) |
|
|
23,046,397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.2% |
|
|
35,236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
23,081,633 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional |
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Amount |
|
Date |
|
|
Counterparty |
|
|
Fund Receives |
|
|
Fund (Pays)/Receives |
|
|
Appreciation/(Depreciation) |
|
43,704 |
USD |
|
|
1/19/2012 |
|
|
Deutsche Bank AG |
|
18% of notional amount |
|
Return on Sears Holding Corp. |
|
$ |
(2,570 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient cash and/or securities to
cover any commitments or collateral requirements of the relevant broker or exchange.
|
|
|
Notes to Schedule of Investments: |
|
ETF Exchange-Traded Fund |
|
SPDR Standard and Poors Depositary Receipt |
|
* |
|
Non-income producing security. |
|
(a) |
|
Represents an investment to equitize cash. The SPDR S&P 500 ETF Trust is a unit investment
trust that issues securities called Trust Units or Units that represent an undivided
ownership interest in a portfolio of all of the common stocks of the Standard & Poors 500
Composite Stock Price Index®. The SPDR S&P 500 ETF Trust prospectus states that the Trust
intends to provide investment results that, before expenses, generally correspond to the
price and yield performance of the S&P 500 Index. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
Currency Abbreviations:
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ 21,392,854 |
|
$ |
2,087,701 |
|
|
$ |
(434,158 |
) |
|
$ |
1,653,543 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
436,973 |
|
|
$ |
679,000 |
|
|
$ |
1,071,036 |
|
|
$ |
66 |
|
|
$ |
4 |
|
|
$ |
45,018 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivative
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
22,753,292 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
22,753,292 |
|
Investment Funds |
|
|
239,085 |
|
|
|
|
|
|
|
|
|
|
|
239,085 |
|
Mutual Funds |
|
|
45,018 |
|
|
|
|
|
|
|
|
|
|
|
45,018 |
|
Short-Term Investments |
|
|
9,002 |
|
|
|
|
|
|
|
|
|
|
|
9,002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
$ |
23,046,397 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
23,046,397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
$ |
|
|
|
$ |
(2,570 |
) |
|
$ |
|
|
|
$ |
(2,570 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(2,570 |
) |
|
$ |
|
|
|
$ |
(2,570 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
* Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value.
All of the Funds common stocks held at period end are classified as Level 1. Please refer to
the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in
the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does
not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in sectors or companies or in
industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures
clearing broker in accordance with the initial margin requirements of the broker or exchange.
Futures contracts are generally valued at the settlement price established at the close of
business each day by the board of trade or exchange on which they are traded. The value of each
of the Funds futures contracts is marked to market daily and an appropriate payable or
receivable for the change in value (variation margin) is recorded by the Fund. The payable or
receivable is settled on the following business day. Gains or losses are recognized but not
accounted for as realized until the contracts expire or are closed. Futures contracts involve,
to varying degrees, risk of loss in excess of the variation margin. Under some circumstances,
futures exchanges may establish daily limits on the amount that the price of a futures contract
can vary from the previous days settlement price, thereby effectively preventing liquidation of
unfavorable positions. Futures contracts expose the Fund to the risk that it may not be able to
enter into a closing transaction due to an illiquid market. The Fund had no futures contracts
outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on
notional amounts. To the extent the return of the reference asset exceeds or falls short of the
interest payments, one party is entitled to receive a payment from or obligated to make a
payment to the other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used total return swap
agreements to achieve returns comparable to holding and lending a direct equity
position. Swap agreements outstanding at the end of the period are listed in the Funds
Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on swap agreements |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( 2,570 |
) |
|
$ |
|
|
|
$ |
( 2,570 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
( 2,570 |
) |
|
$ |
|
|
|
$ |
( 2,570 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The derivative financial instruments outstanding as of period end (as disclosed in the Schedule
of Investments) serve as indicators of the volume of derivative activity for the Fund during the
period.
Subsequent events
In 2011, the Board of Trustees of GMO Trust approved the liquidation of the Fund. The
Fund was liquidated on December 28, 2011.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Core Equity Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 97.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automobiles & Components 0.2% |
|
|
|
|
|
137,900 |
|
|
General Motors Co.* |
|
|
2,935,891 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banks 0.1% |
|
|
|
|
|
32,600 |
|
|
CIT Group, Inc.* |
|
|
1,103,836 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 3.0% |
|
|
|
|
|
143,500 |
|
|
3M Co. |
|
|
11,629,240 |
|
|
4,500 |
|
|
Alliant Techsystems, Inc. |
|
|
264,780 |
|
|
75,700 |
|
|
Danaher Corp. |
|
|
3,662,366 |
|
|
67,700 |
|
|
Fastenal Co. |
|
|
2,819,705 |
|
|
78,200 |
|
|
General Dynamics Corp. |
|
|
5,165,892 |
|
|
21,188 |
|
|
GeoEye, Inc.* |
|
|
402,360 |
|
|
5,400 |
|
|
Harsco Corp. |
|
|
111,456 |
|
|
18,650 |
|
|
ITT Corp. |
|
|
376,170 |
|
|
11,620 |
|
|
Joy Global, Inc. |
|
|
1,060,674 |
|
|
30,000 |
|
|
L-3 Communications Holdings, Inc. |
|
|
1,989,000 |
|
|
25,500 |
|
|
Northrop Grumman Corp. |
|
|
1,455,285 |
|
|
16,500 |
|
|
Oshkosh Corp.* |
|
|
338,580 |
|
|
11,860 |
|
|
Precision Castparts Corp. |
|
|
1,953,935 |
|
|
83,700 |
|
|
United Technologies Corp. |
|
|
6,411,420 |
|
|
11,190 |
|
|
WW Grainger, Inc. |
|
|
2,091,411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
39,732,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Professional Services 0.3% |
|
|
|
|
|
14,400 |
|
|
Copart, Inc.* |
|
|
646,992 |
|
|
40,500 |
|
|
Pitney Bowes, Inc. |
|
|
754,515 |
|
|
30,300 |
|
|
Rollins, Inc. |
|
|
672,660 |
|
|
50,500 |
|
|
RR Donnelley & Sons Co. |
|
|
758,510 |
|
|
17,800 |
|
|
Stericycle, Inc.* |
|
|
1,442,156 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Commercial & Professional Services |
|
|
4,274,833 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 1.6% |
|
|
|
|
|
70,900 |
|
|
Coach, Inc. |
|
|
4,437,631 |
|
|
16,710 |
|
|
Fossil, Inc.* |
|
|
1,497,049 |
|
|
202,024 |
|
|
KB Home |
|
|
1,484,876 |
|
|
100,700 |
|
|
Nike, Inc.-Class B |
|
|
9,685,326 |
|
|
24,360 |
|
|
VF Corp. |
|
|
3,378,489 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Durables & Apparel |
|
|
20,483,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 2.4% |
|
|
|
|
|
79,000 |
|
|
Apollo Group, Inc.-Class A* |
|
|
3,829,920 |
|
|
14,600 |
|
|
DeVry, Inc. |
|
|
503,846 |
|
|
97,500 |
|
|
H&R Block, Inc. |
|
|
1,533,675 |
|
|
2,000 |
|
|
ITT Educational Services, Inc.* |
|
|
109,920 |
|
|
252,500 |
|
|
McDonalds Corp. |
|
|
24,118,800 |
|
|
14,600 |
|
|
Weight Watchers International, Inc. |
|
|
858,042 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Services |
|
|
30,954,203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financials 0.4% |
|
|
|
|
|
421,032 |
|
|
Bank of America Corp. |
|
|
2,290,414 |
|
|
37,500 |
|
|
Capital One Financial Corp. |
|
|
1,674,750 |
|
|
119,800 |
|
|
SLM Corp. |
|
|
1,543,024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified Financials |
|
|
5,508,188 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 7.8% |
|
|
|
|
|
30,900 |
|
|
Anadarko Petroleum Corp. |
|
|
2,511,243 |
|
|
24,110 |
|
|
Apache Corp. |
|
|
2,397,498 |
|
|
34,300 |
|
|
Baker Hughes, Inc. |
|
|
1,873,123 |
|
|
3,600 |
|
|
Berry Petroleum Co.-Class A |
|
|
157,968 |
|
|
221,790 |
|
|
Chevron Corp. |
|
|
22,804,448 |
|
|
264,468 |
|
|
ConocoPhillips |
|
|
18,861,858 |
|
|
423,300 |
|
|
Exxon Mobil Corp. |
|
|
34,050,252 |
|
|
85,700 |
|
|
Halliburton Co. |
|
|
3,153,760 |
|
|
9,700 |
|
|
Key Energy Services, Inc.* |
|
|
146,470 |
|
|
2,100 |
|
|
Lufkin Industries, Inc. |
|
|
147,168 |
|
|
120,500 |
|
|
Marathon Oil Corp. |
|
|
3,369,180 |
|
|
35,400 |
|
|
National Oilwell Varco, Inc. |
|
|
2,538,180 |
|
|
22,298 |
|
|
Occidental Petroleum Corp. |
|
|
2,205,272 |
|
|
16,900 |
|
|
Range Resources Corp. |
|
|
1,211,899 |
|
|
51,400 |
|
|
Schlumberger Ltd. |
|
|
3,871,962 |
|
|
94,400 |
|
|
Valero Energy Corp. |
|
|
2,102,288 |
|
|
47,800 |
|
|
Williams Cos., Inc. |
|
|
1,542,984 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
102,945,553 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 6.7% |
|
|
|
|
|
43,700 |
|
|
Costco Wholesale Corp. |
|
|
3,727,610 |
|
|
170,300 |
|
|
CVS Caremark Corp. |
|
|
6,614,452 |
|
|
149,900 |
|
|
Kroger Co. (The) |
|
|
3,474,682 |
|
|
54,000 |
|
|
Safeway, Inc. |
|
|
1,080,000 |
|
|
16,225 |
|
|
Supervalu, Inc. |
|
|
119,254 |
|
|
126,100 |
|
|
Sysco Corp. |
|
|
3,598,894 |
|
|
324,900 |
|
|
Walgreen Co. |
|
|
10,955,628 |
|
|
995,145 |
|
|
WalMart Stores, Inc. |
|
|
58,614,040 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food & Staples Retailing |
|
|
88,184,560 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 9.6% |
|
|
|
|
|
30,600 |
|
|
Brown-Forman Corp.-Class B |
|
|
2,442,186 |
|
|
56,300 |
|
|
Campbell Soup Co. |
|
|
1,835,380 |
|
|
471,000 |
|
|
Coca-Cola Co. (The) |
|
|
31,665,330 |
|
|
12,900 |
|
|
Dean Foods Co.* |
|
|
131,064 |
|
|
37,050 |
|
|
Flowers Foods, Inc. |
|
|
732,478 |
|
|
132,500 |
|
|
General Mills, Inc. |
|
|
5,293,375 |
|
|
34,100 |
|
|
Hansen Natural Corp.* |
|
|
3,144,020 |
|
|
59,800 |
|
|
Hershey Co. (The) |
|
|
3,449,264 |
|
|
43,800 |
|
|
HJ Heinz Co. |
|
|
2,306,070 |
|
|
57,800 |
|
|
Hormel Foods Corp. |
|
|
1,740,358 |
|
|
17,600 |
|
|
J.M. Smucker Co. (The) |
|
|
1,337,248 |
|
|
66,600 |
|
|
Kellogg Co. |
|
|
3,274,056 |
|
|
41,050 |
|
|
Lorillard, Inc. |
|
|
4,582,001 |
|
|
27,400 |
|
|
McCormick & Co., Inc. (Non Voting) |
|
|
1,334,380 |
|
|
372,375 |
|
|
PepsiCo, Inc. |
|
|
23,832,000 |
|
|
444,837 |
|
|
Philip Morris International, Inc. |
|
|
33,914,373 |
|
|
123,700 |
|
|
Reynolds American, Inc. |
|
|
5,178,082 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
126,191,665 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 8.1% |
|
|
|
|
|
93,700 |
|
|
Aetna, Inc. |
|
|
3,918,534 |
|
|
89,950 |
|
|
Alere, Inc.* |
|
|
2,103,931 |
|
|
7,600 |
|
|
AMERIGROUP Corp.* |
|
|
434,492 |
|
|
65,700 |
|
|
AmerisourceBergen Corp. |
|
|
2,440,755 |
|
|
130,400 |
|
|
Baxter International, Inc. |
|
|
6,736,464 |
|
|
46,400 |
|
|
Becton, Dickinson and Co. |
|
|
3,423,392 |
|
|
|
|
|
|
|
|
|
|
|
7,500 |
|
|
Brookdale Senior Living, Inc.* |
|
|
116,625 |
|
|
59,800 |
|
|
Cardinal Health, Inc. |
|
|
2,539,108 |
|
|
27,500 |
|
|
CareFusion Corp.* |
|
|
681,450 |
|
|
35,880 |
|
|
Cerner Corp.* |
|
|
2,187,962 |
|
|
26,500 |
|
|
Cigna Corp. |
|
|
1,172,095 |
|
|
42,900 |
|
|
Coventry Health Care, Inc.* |
|
|
1,370,226 |
|
|
56,200 |
|
|
Covidien Plc |
|
|
2,559,910 |
|
|
18,570 |
|
|
CR Bard, Inc. |
|
|
1,619,118 |
|
|
23,400 |
|
|
DENTSPLY International, Inc. |
|
|
844,974 |
|
|
16,860 |
|
|
Edwards Lifesciences Corp.* |
|
|
1,113,266 |
|
|
109,850 |
|
|
Express Scripts, Inc.* |
|
|
5,014,653 |
|
|
8,200 |
|
|
Gen-Probe, Inc.* |
|
|
516,518 |
|
|
14,900 |
|
|
Henry Schein, Inc.* |
|
|
958,666 |
|
|
44,400 |
|
|
Humana, Inc. |
|
|
3,937,392 |
|
|
14,700 |
|
|
Idexx Laboratories, Inc.* |
|
|
1,105,293 |
|
|
7,310 |
|
|
Intuitive Surgical, Inc.* |
|
|
3,174,075 |
|
|
19,800 |
|
|
Laboratory Corp. of America Holdings* |
|
|
1,697,256 |
|
|
65,163 |
|
|
Lincare Holdings, Inc. |
|
|
1,544,363 |
|
|
35,800 |
|
|
McKesson Corp. |
|
|
2,910,898 |
|
|
7,700 |
|
|
Mednax, Inc.* |
|
|
518,980 |
|
|
335,600 |
|
|
Medtronic, Inc. |
|
|
12,225,908 |
|
|
18,500 |
|
|
Patterson Cos., Inc. |
|
|
558,145 |
|
|
9,800 |
|
|
Quality Systems, Inc. |
|
|
346,430 |
|
|
31,300 |
|
|
Quest Diagnostics, Inc. |
|
|
1,836,058 |
|
|
23,800 |
|
|
ResMed, Inc.* |
|
|
619,990 |
|
|
64,300 |
|
|
Stryker Corp. |
|
|
3,139,769 |
|
|
61,200 |
|
|
St Jude Medical, Inc. |
|
|
2,352,528 |
|
|
31,642 |
|
|
Triple-S Management Corp.-Class B* |
|
|
616,386 |
|
|
377,674 |
|
|
UnitedHealth Group, Inc. |
|
|
18,419,161 |
|
|
19,200 |
|
|
Varian Medical Systems, Inc.* |
|
|
1,194,816 |
|
|
95,700 |
|
|
WellPoint, Inc. |
|
|
6,751,635 |
|
|
68,525 |
|
|
Zimmer Holdings, Inc.* |
|
|
3,463,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
106,165,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 5.0% |
|
|
|
|
|
58,900 |
|
|
Avon Products, Inc. |
|
|
1,001,300 |
|
|
36,600 |
|
|
Church & Dwight Co., Inc. |
|
|
1,619,550 |
|
|
27,873 |
|
|
Clorox Co. |
|
|
1,810,630 |
|
|
115,600 |
|
|
ColgatePalmolive Co. |
|
|
10,577,400 |
|
|
49,360 |
|
|
Estee Lauder Cos., Inc. (The), -Class A |
|
|
5,823,493 |
|
|
49,600 |
|
|
Herbalife Ltd. |
|
|
2,742,880 |
|
|
73,900 |
|
|
KimberlyClark Corp. |
|
|
5,281,633 |
|
|
568,500 |
|
|
Procter & Gamble Co. (The) |
|
|
36,708,045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
65,564,931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 1.0% |
|
|
|
|
|
45,800 |
|
|
American International Group, Inc.* |
|
|
1,067,598 |
|
|
33,000 |
|
|
Aon Corp. |
|
|
1,517,010 |
|
|
45,400 |
|
|
Assurant, Inc. |
|
|
1,781,496 |
|
|
3,400 |
|
|
Endurance Specialty Holdings Ltd. |
|
|
122,978 |
|
|
56,700 |
|
|
Hartford Financial Services Group, Inc. (The) |
|
|
1,006,992 |
|
|
7,000 |
|
|
Protective Life Corp. |
|
|
155,330 |
|
|
37,200 |
|
|
Prudential Financial, Inc. |
|
|
1,883,808 |
|
|
97,100 |
|
|
Travelers Cos., Inc. (The) |
|
|
5,461,875 |
|
|
20,000 |
|
|
Validus Holdings Ltd. |
|
|
601,800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance |
|
|
13,598,887 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials 0.4% |
|
|
|
|
|
40,100 |
|
|
Ecolab, Inc. |
|
|
2,286,502 |
|
|
48,200 |
|
|
LyondellBasell Industries NV-Class A |
|
|
1,574,694 |
|
|
9,827 |
|
|
Schweitzer-Mauduit International, Inc. |
|
|
699,879 |
|
|
15,100 |
|
|
SigmaAldrich Corp. |
|
|
978,631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Materials |
|
|
5,539,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media 0.7% |
|
|
|
|
|
100,700 |
|
|
CBS Corp.-Class B (Non Voting) |
|
|
2,622,228 |
|
|
32,200 |
|
|
Charter Communications, Inc.-Class A* |
|
|
1,702,414 |
|
|
59,400 |
|
|
DISH Network Corp.-Class A |
|
|
1,459,458 |
|
|
60,900 |
|
|
Gannett Co., Inc. |
|
|
661,374 |
|
|
53,100 |
|
|
McGraw-Hill Cos., Inc. (The) |
|
|
2,267,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Media |
|
|
8,712,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 17.6% |
|
|
|
|
|
505,600 |
|
|
Abbott Laboratories |
|
|
27,580,480 |
|
|
59,000 |
|
|
Allergan, Inc. |
|
|
4,939,480 |
|
|
235,300 |
|
|
Amgen, Inc. |
|
|
13,626,223 |
|
|
60,620 |
|
|
Biogen Idec, Inc.* |
|
|
6,968,269 |
|
|
371,300 |
|
|
BristolMyers Squibb Co. |
|
|
12,148,936 |
|
|
481,600 |
|
|
Eli Lilly & Co. |
|
|
18,228,560 |
|
|
38,500 |
|
|
Endo Pharmaceuticals Holdings, Inc.* |
|
|
1,317,855 |
|
|
108,100 |
|
|
Forest Laboratories, Inc.* |
|
|
3,238,676 |
|
|
177,400 |
|
|
Gilead Sciences, Inc.* |
|
|
7,069,390 |
|
|
516,300 |
|
|
Johnson & Johnson |
|
|
33,414,936 |
|
|
1,042,362 |
|
|
Merck & Co., Inc. |
|
|
37,264,441 |
|
|
6,670 |
|
|
Mettler-Toledo International, Inc.* |
|
|
1,065,866 |
|
|
2,898,336 |
|
|
Pfizer, Inc. |
|
|
58,169,604 |
|
|
17,700 |
|
|
Pharmaceutical Product Development, Inc. |
|
|
587,817 |
|
|
7,300 |
|
|
Techne Corp. |
|
|
492,677 |
|
|
161,200 |
|
|
Warner Chilcott Plc.-Class A* |
|
|
2,534,064 |
|
|
15,100 |
|
|
Waters Corp.* |
|
|
1,208,000 |
|
|
11,700 |
|
|
Watson Pharmaceuticals, Inc.* |
|
|
756,054 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
230,611,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 2.7% |
|
|
|
|
|
28,400 |
|
|
Advance Auto Parts, Inc. |
|
|
1,965,848 |
|
|
9,100 |
|
|
Aeropostale, Inc.* |
|
|
141,141 |
|
|
38,100 |
|
|
AutoNation, Inc.* |
|
|
1,375,791 |
|
|
4,484 |
|
|
AutoZone, Inc.* |
|
|
1,472,456 |
|
|
92,600 |
|
|
Best Buy Co., Inc. |
|
|
2,508,534 |
|
|
36,100 |
|
|
Dollar Tree, Inc.* |
|
|
2,941,789 |
|
|
25,500 |
|
|
Family Dollar Stores, Inc. |
|
|
1,515,210 |
|
|
41,200 |
|
|
GameStop Corp.-Class A* |
|
|
952,544 |
|
|
31,700 |
|
|
Genuine Parts Co. |
|
|
1,854,450 |
|
|
27,600 |
|
|
J.C. Penney Co., Inc. |
|
|
884,304 |
|
|
90,600 |
|
|
Liberty Media Corp.-Interactive-Class A* |
|
|
1,473,156 |
|
|
140,000 |
|
|
Lowes Cos., Inc. |
|
|
3,361,400 |
|
|
3,610 |
|
|
Priceline.com, Inc.* |
|
|
1,754,063 |
|
|
36,400 |
|
|
Ross Stores, Inc. |
|
|
3,242,876 |
|
|
66,100 |
|
|
Target Corp. |
|
|
3,483,470 |
|
|
106,800 |
|
|
TJX Cos., Inc. (The) |
|
|
6,589,560 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
35,516,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment 0.3% |
|
|
|
|
|
146,200 |
|
|
Texas Instruments, Inc. |
|
|
4,400,620 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 21.2% |
|
|
|
|
|
227,700 |
|
|
Accenture Plc.-Class A |
|
|
13,190,661 |
|
|
54,800 |
|
|
Adobe Systems, Inc.* |
|
|
1,502,616 |
|
|
|
|
|
|
|
|
|
|
|
59,100 |
|
|
Amdocs Ltd.* |
|
|
1,668,984 |
|
|
15,000 |
|
|
Ansys, Inc.* |
|
|
929,550 |
|
|
8,900 |
|
|
AOL, Inc.* |
|
|
127,626 |
|
|
83,200 |
|
|
Automatic Data Processing, Inc. |
|
|
4,250,688 |
|
|
39,100 |
|
|
BMC Software, Inc.* |
|
|
1,394,306 |
|
|
28,900 |
|
|
Citrix Systems, Inc.* |
|
|
2,063,171 |
|
|
66,400 |
|
|
Cognizant Technology Solutions Corp.-Class A* |
|
|
4,472,040 |
|
|
27,600 |
|
|
Computer Sciences Corp. |
|
|
674,268 |
|
|
272,500 |
|
|
eBay, Inc.* |
|
|
8,063,275 |
|
|
11,200 |
|
|
Factset Research Systems, Inc. |
|
|
1,044,176 |
|
|
17,200 |
|
|
Global Payments, Inc. |
|
|
760,756 |
|
|
83,240 |
|
|
Google, Inc.-Class A* |
|
|
49,893,224 |
|
|
30,600 |
|
|
Informatica Corp.* |
|
|
1,375,623 |
|
|
277,953 |
|
|
International Business Machines Corp. |
|
|
52,255,164 |
|
|
68,400 |
|
|
Intuit, Inc. |
|
|
3,641,616 |
|
|
20,900 |
|
|
Jack Henry & Associates, Inc. |
|
|
694,089 |
|
|
20,140 |
|
|
MasterCard, Inc.-Class A |
|
|
7,543,437 |
|
|
16,700 |
|
|
Micros Systems, Inc.* |
|
|
787,739 |
|
|
2,559,957 |
|
|
Microsoft Corp. |
|
|
65,483,700 |
|
|
1,537,630 |
|
|
Oracle Corp. |
|
|
48,204,700 |
|
|
75,500 |
|
|
Paychex, Inc. |
|
|
2,197,805 |
|
|
7,100 |
|
|
Quest Software, Inc.* |
|
|
128,297 |
|
|
148,400 |
|
|
Symantec Corp.* |
|
|
2,426,340 |
|
|
2,600 |
|
|
Syntel, Inc. |
|
|
124,384 |
|
|
36,200 |
|
|
Total System Services, Inc. |
|
|
725,448 |
|
|
29,900 |
|
|
Visa, Inc.-Class A |
|
|
2,899,403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
278,523,086 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 6.4% |
|
|
|
|
|
67,000 |
|
|
Apple, Inc.* |
|
|
25,607,400 |
|
|
28,900 |
|
|
Arrow Electronics, Inc.* |
|
|
1,056,584 |
|
|
371,834 |
|
|
Cisco Systems, Inc. |
|
|
6,930,986 |
|
|
344,506 |
|
|
Dell, Inc.* |
|
|
5,429,414 |
|
|
20,100 |
|
|
Harris Corp. |
|
|
715,560 |
|
|
559,900 |
|
|
Hewlett-Packard Co. |
|
|
15,649,205 |
|
|
64,400 |
|
|
Ingram Micro, Inc.-Class A* |
|
|
1,159,844 |
|
|
396,300 |
|
|
Qualcomm, Inc. |
|
|
21,717,240 |
|
|
137,200 |
|
|
Seagate Technology Plc |
|
|
2,346,120 |
|
|
11,600 |
|
|
Vishay Intertechnology, Inc.* |
|
|
114,724 |
|
|
130,455 |
|
|
Western Digital Corp.* |
|
|
3,792,327 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
84,519,404 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 2.1% |
|
|
|
|
|
356,000 |
|
|
AT&T, Inc. |
|
|
10,316,880 |
|
|
31,300 |
|
|
Level 3 Communications, Inc.* |
|
|
645,093 |
|
|
470,600 |
|
|
Sprint Nextel Corp.* |
|
|
1,270,620 |
|
|
386,122 |
|
|
Verizon Communications, Inc. |
|
|
14,568,383 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Telecommunication Services |
|
|
26,800,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transportation 0.3% |
|
|
|
|
|
36,500 |
|
|
CH Robinson Worldwide, Inc. |
|
|
2,500,615 |
|
|
22,900 |
|
|
Expeditors International of Washington, Inc. |
|
|
996,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Transportation |
|
|
3,496,994 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $1,143,549,411) |
|
|
1,285,764,903 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INVESTMENT FUNDS 0.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92,066 |
|
|
SPDR S&P 500 ETF Trust (a) |
|
|
11,518,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENT FUNDS (COST $11,312,476) |
|
|
11,518,377 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 0.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 0.7% |
|
|
|
|
|
392,685 |
|
|
GMO U.S. Treasury Fund |
|
|
9,821,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS
(COST $9,821,035) |
|
|
9,821,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.1% |
|
|
|
|
|
720,025 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (b) |
|
|
720,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $720,025) |
|
|
720,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 99.6%
(Cost $1,165,402,947) |
|
|
1,307,824,340 |
|
|
|
|
|
|
Other Assets and Liabilities (net) 0.4% |
|
|
5,524,844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,313,349,184 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Swap Agreements
Total Return Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional |
|
|
Expiration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Amount |
|
|
Date |
|
|
Counterparty |
|
Fund Receives |
|
Fund (Pays)/Receives |
|
Appreciation/(Depreciation) |
|
2,696,769 |
|
USD |
|
|
|
1/19/2012 |
|
|
Deutsche Bank AG |
|
18% of notional amount |
|
Return on Sears Holding Corp. |
|
$ |
(158,580 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2011, for the above contracts and/or agreements, the Fund had sufficient
cash and/or securities to cover any commitments or collateral requirements of the relevant broker
or exchange.
Notes to Schedule of Investments:
|
|
|
ETF Exchange-Traded Fund |
|
SPDR Standard and Poors Depositary Receipt |
|
* |
|
Non-income producing security. |
|
(a) |
|
Represents an investment to equitize cash. The SPDR S&P 500 ETF Trust is a unit investment
trust that issues securities called Trust Units or Units that represent an undivided ownership
interest in a portfolio of all of the common stocks of the Standard & Poors 500 Composite Stock
Price Index®. The SPDR S&P 500 ETF Trust prospectus states that the Trust intends to provide
investment results that, before expenses, generally correspond to the price and yield performance
of the S&P 500 Index. |
|
(b) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
Currency Abbreviations:
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross
and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
1,223,190,421 |
|
$ |
105,549,017 |
|
|
$ |
(20,915,098 |
) |
|
$ |
84,633,919 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S.
Treasury Fund |
|
$ |
23,221,000 |
|
|
$ |
176,577,000 |
|
|
$ |
189,976,965 |
|
|
$ |
6,453 |
|
|
$ |
|
|
|
$ |
9,821,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. For the
period ended November 30, 2011, the Fund did not reduce the value of any of its OTC derivatives
contracts based on the creditworthiness of its counterparties. See Derivative
financial instruments below for a further discussion on valuation of derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
1,285,764,903 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,285,764,903 |
|
Investment Funds |
|
|
11,518,377 |
|
|
|
|
|
|
|
|
|
|
|
11,518,377 |
|
Mutual Funds |
|
|
9,821,035 |
|
|
|
|
|
|
|
|
|
|
|
9,821,035 |
|
Short-Term Investments |
|
|
720,025 |
|
|
|
|
|
|
|
|
|
|
|
720,025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
1,307,824,340 |
|
|
|
|
|
|
|
|
|
|
|
1,307,824,340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,307,824,340 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,307,824,340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity Risk |
|
$ |
|
|
|
$ |
(158,580 |
) |
|
$ |
|
|
|
$ |
(158,580 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
(158,580 |
) |
|
$ |
|
|
|
$ |
(158,580 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see
the Investment and other risks and Derivative financial instruments sections below for a
further discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
All of the Funds common stocks held at period end are classified as Level 1. Please refer to
the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in
the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does
not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of the value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in sectors or companies or in
industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
maintain the diversity and liquidity of the portfolio. The Fund had no futures
contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When
the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment
when that variance is less than the strike price. This type of agreement is essentially a
forward contract on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used total return swap
agreements to achieve returns comparable to holding and lending a direct equity
position. Swap agreements outstanding at the end of the period are listed in the Funds
Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Value of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized depreciation on swap agreements |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(158,580 |
) |
|
$ |
|
|
|
$ |
(158,580 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(158,580 |
) |
|
$ |
|
|
|
$ |
(158,580 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (future contracts), or notional amounts
(swap agreements) outstanding at each month-end, was as follows for the period ended November 30,
2011:
|
|
|
|
|
|
|
|
|
Futures |
|
Swap |
|
|
Contracts |
|
Agreements |
Average amount outstanding
|
|
$705,275* |
|
$ |
3,675,852 |
|
|
|
|
* |
|
During the period ended November 30, 2011, the Fund did not hold futures contracts at any
month-end, therefore, the average amount outstanding was calculated using daily outstanding
absolute values. |
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares / Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
MUTUAL FUNDS 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 100.0% |
|
|
|
|
|
1,408,287 |
|
|
GMO Quality Fund, Class VI |
|
|
30,756,983 |
|
|
2,375,932 |
|
|
GMO U.S. Core Equity Fund, Class VI |
|
|
28,843,820 |
|
|
57,498 |
|
|
GMO U.S. Small/Mid Cap Growth Fund, Class III |
|
|
698,030 |
|
|
77,922 |
|
|
GMO U.S. Small/Mid Cap Value Fund, Class III |
|
|
614,802 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $47,166,236) |
|
|
60,913,635 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.1% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposit 0.1% |
|
|
|
|
|
31,952 |
|
|
State Street Eurodollar Time Deposit, 0.01%, due 12/1/11 |
|
|
31,952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $31,952) |
|
|
31,952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.1%
(Cost $47,198,188) |
|
|
60,945,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.1%) |
|
|
(36,812 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
60,908,775 |
|
|
|
|
|
|
|
|
|
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as
follows:
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$48,737,206 |
|
$12,208,381 |
|
$ |
|
$12,208,381 |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule
of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Quality Fund,
Class VI |
|
$ |
46,703,245 |
|
|
$ |
5,794,571 |
|
|
$ |
23,651,910 |
|
|
$ |
595,605 |
|
|
$ |
|
|
|
$ |
30,756,983 |
|
GMO U.S. Core Equity
Fund, Class VI |
|
|
46,968,900 |
|
|
|
1,582,595 |
|
|
|
20,408,750 |
|
|
|
582,595 |
|
|
|
|
|
|
|
28,843,820 |
|
GMO U.S. Small/Mid Cap
Growth Fund, Class III |
|
|
1,194,609 |
|
|
|
254,434 |
|
|
|
499,425 |
|
|
|
977 |
|
|
|
253,457 |
|
|
|
698,030 |
|
GMO U.S. Small/Mid Cap
Value Fund, Class III |
|
|
1,055,906 |
|
|
|
6,032 |
|
|
|
429,587 |
|
|
|
6,032 |
|
|
|
|
|
|
|
614,802 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
95,922,660 |
|
|
$ |
7,637,632 |
|
|
$ |
44,989,672 |
|
|
$ |
1,185,209 |
|
|
$ |
253,457 |
|
|
$ |
60,913,635 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
7.8% |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
Significant |
|
|
|
|
|
|
Markets for Identical |
|
|
Other Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Mutual Funds |
|
$ |
60,913,635 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
60,913,635 |
|
Short-Term Investments |
|
|
31,952 |
|
|
|
|
|
|
|
|
|
|
|
31,952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
60,945,587 |
|
|
|
|
|
|
|
|
|
|
|
60,945,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
60,945,587 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
60,945,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. The Fund and some of the underlying funds are
non-diversified investment companies under the Investment Company Act of 1940 (the 1940 Act)
and therefore a decline in the market value of a particular security held by the Fund or an
underlying fund may affect the Funds or the underlying funds performance more than if the Fund
or the underlying fund were diversified. Selected risks of investing in the Fund are summarized
below, including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Because
the Fund and the underlying funds normally do not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses associated with an investment in
the Fund are less predictable and may be higher than fees and expenses associated with an
investment in funds that charge a fixed management fee.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Leveraging Risk The use of derivatives and securities lending may cause the Funds
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Growth Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 97.7% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automobiles & Components 0.3% |
|
|
|
|
|
100 |
|
|
Johnson Controls, Inc. |
|
|
3,148 |
|
|
100 |
|
|
Tesla Motors, Inc.* |
|
|
3,274 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Automobiles & Components |
|
|
6,422 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 4.3% |
|
|
|
|
|
486 |
|
|
3M Co. |
|
|
39,385 |
|
|
200 |
|
|
Emerson Electric Co. |
|
|
10,450 |
|
|
62 |
|
|
Goodrich Corp. |
|
|
7,565 |
|
|
136 |
|
|
TransDigm Group, Inc.* |
|
|
13,113 |
|
|
450 |
|
|
United Technologies Corp. |
|
|
34,470 |
|
|
100 |
|
|
WABCO Holdings, Inc.* |
|
|
4,701 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
109,684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Professional Services 0.1% |
|
|
|
|
|
100 |
|
|
Nielsen Holdings NV* |
|
|
2,905 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 1.5% |
|
|
|
|
|
236 |
|
|
Nike, Inc.-Class B |
|
|
22,698 |
|
|
100 |
|
|
Ralph Lauren Corp. |
|
|
14,186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Durables & Apparel |
|
|
36,884 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 3.5% |
|
|
|
|
|
260 |
|
|
Apollo Group, Inc.-Class A* |
|
|
12,605 |
|
|
300 |
|
|
H&R Block, Inc. |
|
|
4,719 |
|
|
100 |
|
|
Marriott International, Inc.-Class A |
|
|
3,062 |
|
|
10 |
|
|
Marriott Vacations Worldwide Corp.* |
|
|
160 |
|
|
566 |
|
|
McDonalds Corp. |
|
|
54,064 |
|
|
100 |
|
|
Royal Caribbean Cruises Ltd. |
|
|
2,771 |
|
|
100 |
|
|
Starwood Hotels & Resorts Worldwide, Inc. |
|
|
4,768 |
|
|
119 |
|
|
Yum! Brands, Inc. |
|
|
6,669 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Services |
|
|
88,818 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financials 0.2% |
|
|
|
|
|
5 |
|
|
BlackRock, Inc. |
|
|
860 |
|
|
299 |
|
|
TD Ameritrade Holding Corp. |
|
|
4,871 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified Financials |
|
|
5,731 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 6.1% |
|
|
|
|
|
200 |
|
|
Chevron Corp. |
|
|
20,564 |
|
|
1,244 |
|
|
Exxon Mobil Corp. |
|
|
100,067 |
|
|
205 |
|
|
Range Resources Corp. |
|
|
14,701 |
|
|
200 |
|
|
Schlumberger Ltd. |
|
|
15,066 |
|
|
100 |
|
|
Whiting Petroleum Corp.* |
|
|
4,651 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
155,049 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 5.8% |
|
|
|
|
|
219 |
|
|
Costco Wholesale Corp. |
|
|
18,682 |
|
|
462 |
|
|
Kroger Co. (The) |
|
|
10,709 |
|
|
748 |
|
|
Sysco Corp. |
|
|
21,348 |
|
|
678 |
|
|
Walgreen Co. |
|
|
22,862 |
|
|
1,137 |
|
|
WalMart Stores, Inc. |
|
|
66,969 |
|
|
100 |
|
|
Whole Foods Market, Inc. |
|
|
6,810 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food & Staples Retailing |
|
|
147,380 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 16.0% |
|
|
|
|
|
579 |
|
|
Altria Group, Inc. |
|
|
16,611 |
|
|
157 |
|
|
Brown-Forman Corp.-Class B |
|
|
12,530 |
|
|
330 |
|
|
Campbell Soup Co. |
|
|
10,758 |
|
|
100 |
|
|
Coca-Cola Enterprises, Inc. |
|
|
2,612 |
|
|
1,165 |
|
|
Coca-Cola Co. (The) |
|
|
78,323 |
|
|
200 |
|
|
ConAgra Foods, Inc. |
|
|
5,052 |
|
|
549 |
|
|
Flowers Foods, Inc. |
|
|
10,854 |
|
|
576 |
|
|
General Mills, Inc. |
|
|
23,011 |
|
|
219 |
|
|
Hansen Natural Corp.* |
|
|
20,192 |
|
|
304 |
|
|
Hershey Co. (The) |
|
|
17,535 |
|
|
272 |
|
|
HJ Heinz Co. |
|
|
14,321 |
|
|
500 |
|
|
Hormel Foods Corp. |
|
|
15,055 |
|
|
345 |
|
|
Kellogg Co. |
|
|
16,960 |
|
|
361 |
|
|
McCormick & Co., Inc. (Non Voting) |
|
|
17,581 |
|
|
19 |
|
|
Mead Johnson Nutrition Co. |
|
|
1,432 |
|
|
898 |
|
|
PepsiCo, Inc. |
|
|
57,472 |
|
|
913 |
|
|
Philip Morris International, Inc. |
|
|
69,607 |
|
|
400 |
|
|
Reynolds American, Inc. |
|
|
16,744 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
406,650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 3.0% |
|
|
|
|
|
38 |
|
|
Baxter International, Inc. |
|
|
1,963 |
|
|
100 |
|
|
Cardinal Health, Inc. |
|
|
4,246 |
|
|
89 |
|
|
DaVita, Inc.* |
|
|
6,780 |
|
|
254 |
|
|
Express Scripts, Inc.* |
|
|
11,595 |
|
|
200 |
|
|
HCA Holdings, Inc.* |
|
|
4,876 |
|
|
336 |
|
|
Health Management Associates, Inc.-Class A* |
|
|
2,762 |
|
|
55 |
|
|
Lincare Holdings, Inc. |
|
|
1,304 |
|
|
100 |
|
|
Medco Health Solutions, Inc.* |
|
|
5,667 |
|
|
100 |
|
|
Mednax, Inc.* |
|
|
6,740 |
|
|
563 |
|
|
Medtronic, Inc. |
|
|
20,510 |
|
|
100 |
|
|
St Jude Medical, Inc. |
|
|
3,844 |
|
|
100 |
|
|
Thoratec Corp.* |
|
|
3,042 |
|
|
100 |
|
|
Universal Health Services, Inc.-Class B |
|
|
4,022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
77,351 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 7.3% |
|
|
|
|
|
540 |
|
|
Avon Products, Inc. |
|
|
9,180 |
|
|
424 |
|
|
Church & Dwight Co., Inc. |
|
|
18,762 |
|
|
214 |
|
|
Clorox Co. |
|
|
13,901 |
|
|
344 |
|
|
ColgatePalmolive Co. |
|
|
31,476 |
|
|
383 |
|
|
Estee Lauder Cos., Inc. (The), -Class A |
|
|
45,186 |
|
|
232 |
|
|
Herbalife Ltd. |
|
|
12,830 |
|
|
319 |
|
|
KimberlyClark Corp. |
|
|
22,799 |
|
|
475 |
|
|
Procter & Gamble Co. (The) |
|
|
30,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
184,805 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 0.1% |
|
|
|
|
|
100 |
|
|
Marsh & McLennan Cos., Inc. |
|
|
3,019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials 1.4% |
|
|
|
|
|
100 |
|
|
International Flavors & Fragrances, Inc. |
|
|
5,426 |
|
|
200 |
|
|
Monsanto Co. |
|
|
14,690 |
|
|
100 |
|
|
Mosaic Co. (The) |
|
|
5,276 |
|
|
116 |
|
|
Sherwin-Williams Co. (The) |
|
|
10,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Materials |
|
|
35,464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media 4.1% |
|
|
|
|
|
700 |
|
|
Cablevision Systems Corp.-Class A |
|
|
10,500 |
|
|
100 |
|
|
Comcast Corp.-Class A |
|
|
2,267 |
|
|
239 |
|
|
DirectTV Class A* |
|
|
11,286 |
|
|
200 |
|
|
Discovery Communications, Inc.* |
|
|
8,396 |
|
|
600 |
|
|
Liberty Global, Inc.-Class A* |
|
|
23,634 |
|
|
500 |
|
|
Sirius XM Radio, Inc.* |
|
|
900 |
|
|
400 |
|
|
Time Warner Cable, Inc. |
|
|
24,192 |
|
|
500 |
|
|
Viacom, Inc.-Class B |
|
|
22,380 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Media |
|
|
103,555 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 5.5% |
|
|
|
|
|
1,008 |
|
|
Abbott Laboratories |
|
|
54,986 |
|
|
100 |
|
|
Charles River Laboratories International, Inc.* |
|
|
2,835 |
|
|
443 |
|
|
Eli Lilly & Co. |
|
|
16,768 |
|
|
195 |
|
|
Gilead Sciences, Inc.* |
|
|
7,771 |
|
|
99 |
|
|
Illumina, Inc.* |
|
|
2,754 |
|
|
851 |
|
|
Johnson & Johnson |
|
|
55,077 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
140,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 4.9% |
|
|
|
|
|
189 |
|
|
Amazon.com, Inc.* |
|
|
36,343 |
|
|
100 |
|
|
Bed Bath & Beyond, Inc.* |
|
|
6,051 |
|
|
420 |
|
|
Dollar General Corp.* |
|
|
17,039 |
|
|
217 |
|
|
Dollar Tree, Inc.* |
|
|
17,683 |
|
|
89 |
|
|
Family Dollar Stores, Inc. |
|
|
5,288 |
|
|
131 |
|
|
Home Depot, Inc. |
|
|
5,138 |
|
|
116 |
|
|
Netflix, Inc.* |
|
|
7,486 |
|
|
100 |
|
|
OReilly Automotive, Inc.* |
|
|
7,724 |
|
|
26 |
|
|
Priceline.com, Inc.* |
|
|
12,633 |
|
|
300 |
|
|
Urban Outfitters, Inc.* |
|
|
8,094 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
123,479 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment 1.0% |
|
|
|
|
|
100 |
|
|
Broadcom Corp.-Class A* |
|
|
3,034 |
|
|
100 |
|
|
First Solar, Inc.* |
|
|
4,786 |
|
|
72 |
|
|
Marvell Technology Group Ltd* |
|
|
1,017 |
|
|
100 |
|
|
Skyworks Solutions, Inc.* |
|
|
1,631 |
|
|
347 |
|
|
Texas Instruments, Inc. |
|
|
10,445 |
|
|
100 |
|
|
Xilinx, Inc. |
|
|
3,271 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Semiconductors & Semiconductor Equipment |
|
|
24,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 18.3% |
|
|
|
|
|
300 |
|
|
Accenture Plc.-Class A |
|
|
17,379 |
|
|
19 |
|
|
Autodesk, Inc.* |
|
|
647 |
|
|
220 |
|
|
Citrix Systems, Inc.* |
|
|
15,706 |
|
|
200 |
|
|
Cognizant Technology Solutions Corp.-Class A* |
|
|
13,470 |
|
|
426 |
|
|
eBay, Inc.* |
|
|
12,605 |
|
|
20 |
|
|
Equinix, Inc.* |
|
|
2,000 |
|
|
200 |
|
|
Genpact Ltd.* |
|
|
3,114 |
|
|
136 |
|
|
Google, Inc.-Class A* |
|
|
81,517 |
|
|
519 |
|
|
International Business Machines Corp. |
|
|
97,572 |
|
|
41 |
|
|
MasterCard, Inc.-Class A |
|
|
15,357 |
|
|
3,811 |
|
|
Microsoft Corp. |
|
|
97,485 |
|
|
2,685 |
|
|
Oracle Corp. |
|
|
84,175 |
|
|
100 |
|
|
Teradata Corp.* |
|
|
5,423 |
|
|
|
|
|
|
|
|
|
|
|
205 |
|
|
Visa, Inc.-Class A |
|
|
19,879 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
466,329 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 12.0% |
|
|
|
|
|
485 |
|
|
Apple, Inc.* |
|
|
185,367 |
|
|
61 |
|
|
Cisco Systems, Inc. |
|
|
1,137 |
|
|
1,116 |
|
|
EMC Corp.* |
|
|
25,679 |
|
|
60 |
|
|
Hewlett-Packard Co. |
|
|
1,677 |
|
|
31 |
|
|
Itron, Inc.* |
|
|
1,098 |
|
|
300 |
|
|
NetApp, Inc.* |
|
|
11,049 |
|
|
1,450 |
|
|
Qualcomm, Inc. |
|
|
79,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
305,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 1.3% |
|
|
|
|
|
126 |
|
|
American Tower Corp.-Class A* |
|
|
7,434 |
|
|
283 |
|
|
Crown Castle International Corp.* |
|
|
11,977 |
|
|
20 |
|
|
Level 3 Communications, Inc.* |
|
|
412 |
|
|
100 |
|
|
NII Holdings, Inc.* |
|
|
2,301 |
|
|
300 |
|
|
Verizon Communications, Inc. |
|
|
11,319 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Telecommunication Services |
|
|
33,443 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transportation 1.0% |
|
|
|
|
|
400 |
|
|
Delta Air Lines, Inc.* |
|
|
3,248 |
|
|
300 |
|
|
United Continental Holdings, Inc.* |
|
|
5,391 |
|
|
241 |
|
|
United Parcel Service, Inc.-Class B |
|
|
17,292 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Transportation |
|
|
25,931 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $2,157,482) |
|
|
2,482,741 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 3.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 3.2% |
|
|
|
|
|
3,279 |
|
|
GMO U.S. Treasury Fund |
|
|
82,023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $82,023) |
|
|
82,023 |
|
|
|
|
|
|
|
|
|
|
Shares |
|
Description |
|
Value ($) |
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money
Market Funds 0.8% |
|
|
|
|
|
20,221 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a) |
|
|
20,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $20,221) |
|
|
20,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 101.7%
(Cost $2,259,726) |
|
|
2,584,985 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (1.7%) |
|
|
(43,321 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
2,541,664 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
|
|
|
* |
|
Non-income producing security. |
|
(a) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
2,284,024 |
|
$ |
371,965 |
|
|
$ |
(71,004 |
) |
|
$ |
300,961 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S.
Treasury Fund |
|
$ |
100,999 |
|
|
$ |
114,000 |
|
|
$ |
133,000 |
|
|
$ |
32 |
|
|
$ |
4 |
|
|
$ |
82,023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
|
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Significant Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
2,482,741 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,482,741 |
|
Mutual Funds |
|
|
82,023 |
|
|
|
|
|
|
|
|
|
|
|
82,023 |
|
Short-Term Investments |
|
|
20,221 |
|
|
|
|
|
|
|
|
|
|
|
20,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
2,584,985 |
|
|
|
|
|
|
|
|
|
|
|
2,584,985 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
2,584,985 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
2,584,985 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All of the Funds common stocks held at period end are classified as Level 1. Please refer to
the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. The Fund may purchase equity investments that typically trade at higher
multiples of current earnings than other securities, and the market values of these
investments often are more sensitive to changes in future earnings expectations than those
other securities. Because the Fund normally does not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in sectors or companies or in
industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
maintain the diversity and liquidity of the portfolio. The Fund had no futures
contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves
counterparty credit, legal, and documentation risk that is generally not reflected in the models
used to price the swap agreement. Such risks include the possibility that the counterparty
defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that
the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral
the other party posts is insufficient or not timely received by the Fund. Credit risk is
particularly acute in economic environments in which financial services firms are exposed to
systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent
market disruptions. The Fund had no swap agreements outstanding at the end of the
period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
The volume of derivative activity, based on absolute values (futures contracts), outstanding
at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
Futures |
|
|
|
Contracts |
|
Average amount outstanding |
|
$ |
15,020 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Intrinsic Value Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 97.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automobiles & Components 0.1% |
|
|
|
|
|
100 |
|
|
Autoliv, Inc. |
|
|
5,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banks 0.2% |
|
|
|
|
|
200 |
|
|
Prosperity Bancshares, Inc. |
|
|
7,998 |
|
|
100 |
|
|
SVB Financial Group* |
|
|
4,704 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Banks |
|
|
12,702 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 3.5% |
|
|
|
|
|
300 |
|
|
3M Co. |
|
|
24,312 |
|
|
200 |
|
|
AGCO Corp.* |
|
|
9,149 |
|
|
180 |
|
|
Eaton Corp. |
|
|
8,084 |
|
|
100 |
|
|
Exelis, Inc. |
|
|
894 |
|
|
200 |
|
|
Fluor Corp. |
|
|
10,964 |
|
|
200 |
|
|
General Cable Corp.* |
|
|
5,300 |
|
|
1,500 |
|
|
General Electric Co. |
|
|
23,865 |
|
|
1,300 |
|
|
General Dynamics Corp. |
|
|
85,878 |
|
|
50 |
|
|
ITT Corp. |
|
|
1,009 |
|
|
200 |
|
|
KBR, Inc. |
|
|
5,780 |
|
|
300 |
|
|
L-3 Communications Holdings, Inc. |
|
|
19,890 |
|
|
170 |
|
|
Lockheed Martin Corp. |
|
|
13,285 |
|
|
400 |
|
|
Northrop Grumman Corp. |
|
|
22,828 |
|
|
100 |
|
|
Parker Hannifin Corp. |
|
|
8,278 |
|
|
40 |
|
|
Precision Castparts Corp. |
|
|
6,590 |
|
|
500 |
|
|
Raytheon Co. |
|
|
22,785 |
|
|
100 |
|
|
Roper Industries, Inc. |
|
|
8,519 |
|
|
100 |
|
|
Timken Co. (The) |
|
|
4,201 |
|
|
100 |
|
|
United Technologies Corp. |
|
|
7,660 |
|
|
200 |
|
|
WESCO International, Inc.* |
|
|
10,192 |
|
|
100 |
|
|
Xylem, Inc |
|
|
2,390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
301,853 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Professional Services 0.2% |
|
|
|
|
|
200 |
|
|
Pitney Bowes, Inc. |
|
|
3,726 |
|
|
800 |
|
|
RR Donnelley & Sons Co. |
|
|
12,016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Commercial & Professional Services |
|
|
15,742 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 0.4% |
|
|
|
|
|
100 |
|
|
Coach, Inc. |
|
|
6,259 |
|
|
70 |
|
|
Fossil, Inc.* |
|
|
6,271 |
|
|
200 |
|
|
Garmin Ltd |
|
|
7,318 |
|
|
100 |
|
|
Nike, Inc.-Class B |
|
|
9,618 |
|
|
60 |
|
|
VF Corp. |
|
|
8,322 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Durables & Apparel |
|
|
37,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 0.6% |
|
|
|
|
|
400 |
|
|
H&R Block, Inc. |
|
|
6,292 |
|
|
500 |
|
|
McDonalds Corp. |
|
|
47,760 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Services |
|
|
54,052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financials 2.6% |
|
|
|
|
|
3,000 |
|
|
Bank of America Corp. |
|
|
16,320 |
|
|
120 |
|
|
BlackRock, Inc. |
|
|
20,645 |
|
|
400 |
|
|
Capital One Financial Corp. |
|
|
17,864 |
|
|
1,800 |
|
|
Citigroup, Inc. |
|
|
49,464 |
|
|
|
|
|
|
|
|
|
|
|
1,300 |
|
|
Discover Financial Services |
|
|
30,966 |
|
|
170 |
|
|
Goldman Sachs Group (The), Inc. |
|
|
16,296 |
|
|
300 |
|
|
Invesco Ltd. |
|
|
6,075 |
|
|
400 |
|
|
Leucadia National Corp. |
|
|
9,368 |
|
|
200 |
|
|
Moodys Corp. |
|
|
6,942 |
|
|
500 |
|
|
Morgan Stanley |
|
|
7,395 |
|
|
700 |
|
|
NASDAQ OMX Group, Inc. (The)* |
|
|
18,375 |
|
|
800 |
|
|
SLM Corp. |
|
|
10,304 |
|
|
200 |
|
|
Stifel Financial Corp.* |
|
|
6,340 |
|
|
400 |
|
|
TD Ameritrade Holding Corp. |
|
|
6,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified Financials |
|
|
222,870 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 17.1% |
|
|
|
|
|
500 |
|
|
Anadarko Petroleum Corp. |
|
|
40,635 |
|
|
100 |
|
|
Atwood Oceanics, Inc.* |
|
|
4,100 |
|
|
700 |
|
|
Baker Hughes, Inc. |
|
|
38,227 |
|
|
600 |
|
|
Chesapeake Energy Corp. |
|
|
15,204 |
|
|
3,720 |
|
|
Chevron Corp. |
|
|
382,491 |
|
|
4,629 |
|
|
ConocoPhillips |
|
|
330,140 |
|
|
100 |
|
|
Devon Energy Corp. |
|
|
6,546 |
|
|
100 |
|
|
Diamond Offshore Drilling, Inc. |
|
|
6,015 |
|
|
400 |
|
|
El Paso Corp. |
|
|
10,004 |
|
|
100 |
|
|
EQT Corp. |
|
|
6,201 |
|
|
3,600 |
|
|
Exxon Mobil Corp. |
|
|
289,584 |
|
|
100 |
|
|
Helmerich & Payne, Inc. |
|
|
5,696 |
|
|
280 |
|
|
Hess Corp. |
|
|
16,862 |
|
|
2,000 |
|
|
Marathon Oil Corp. |
|
|
55,920 |
|
|
200 |
|
|
Murphy Oil Corp. |
|
|
11,184 |
|
|
200 |
|
|
Nabors Industries Ltd.* |
|
|
3,588 |
|
|
1,200 |
|
|
National Oilwell Varco, Inc. |
|
|
86,040 |
|
|
200 |
|
|
Oceaneering International, Inc. |
|
|
9,512 |
|
|
100 |
|
|
Oil States International, Inc.* |
|
|
7,525 |
|
|
400 |
|
|
Patterson-UTI Energy, Inc. |
|
|
8,408 |
|
|
200 |
|
|
Peabody Energy Corp. |
|
|
7,846 |
|
|
200 |
|
|
Plains Exploration & Production Co.* |
|
|
7,116 |
|
|
200 |
|
|
Rowan Cos, Inc.* |
|
|
6,782 |
|
|
80 |
|
|
Schlumberger Ltd. |
|
|
6,026 |
|
|
100 |
|
|
SM Energy Co. |
|
|
7,949 |
|
|
500 |
|
|
Sunoco, Inc. |
|
|
19,405 |
|
|
100 |
|
|
Tidewater, Inc. |
|
|
5,040 |
|
|
1,500 |
|
|
Valero Energy Corp. |
|
|
33,405 |
|
|
300 |
|
|
Weatherford International Ltd.* |
|
|
4,548 |
|
|
800 |
|
|
Williams Cos., Inc. |
|
|
25,824 |
|
|
200 |
|
|
World Fuel Services Corp. |
|
|
8,574 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
1,466,397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 5.1% |
|
|
|
|
|
1,500 |
|
|
CVS Caremark Corp. |
|
|
58,260 |
|
|
1,500 |
|
|
Kroger Co. (The) |
|
|
34,770 |
|
|
500 |
|
|
Safeway, Inc. |
|
|
10,000 |
|
|
3,000 |
|
|
Walgreen Co. |
|
|
101,160 |
|
|
3,900 |
|
|
WalMart Stores, Inc. |
|
|
229,710 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food & Staples Retailing |
|
|
433,900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 5.4% |
|
|
|
|
|
1,300 |
|
|
Altria Group, Inc. |
|
|
37,297 |
|
|
200 |
|
|
Archer-Daniels-Midland Co. |
|
|
6,024 |
|
|
100 |
|
|
Bunge Ltd. |
|
|
6,250 |
|
|
2,600 |
|
|
Coca-Cola Co. (The) |
|
|
174,798 |
|
|
|
|
|
|
|
|
|
|
|
600 |
|
|
Dean Foods Co.* |
|
|
6,096 |
|
|
200 |
|
|
General Mills, Inc. |
|
|
7,990 |
|
|
200 |
|
|
Hansen Natural Corp.* |
|
|
18,440 |
|
|
207 |
|
|
Kraft Foods, Inc.-Class A |
|
|
7,483 |
|
|
140 |
|
|
Lorillard, Inc. |
|
|
15,627 |
|
|
1,097 |
|
|
PepsiCo, Inc. |
|
|
70,208 |
|
|
1,400 |
|
|
Philip Morris International, Inc. |
|
|
106,736 |
|
|
224 |
|
|
Tyson Foods, Inc.-Class A |
|
|
4,511 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
461,460 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 11.7% |
|
|
|
|
|
1,500 |
|
|
Aetna, Inc. |
|
|
62,730 |
|
|
100 |
|
|
AMERIGROUP Corp.* |
|
|
5,717 |
|
|
600 |
|
|
AmerisourceBergen Corp. |
|
|
22,290 |
|
|
100 |
|
|
Baxter International, Inc. |
|
|
5,166 |
|
|
2,000 |
|
|
Boston Scientific Corp.* |
|
|
11,800 |
|
|
1,400 |
|
|
Cardinal Health, Inc. |
|
|
59,444 |
|
|
600 |
|
|
Cigna Corp. |
|
|
26,538 |
|
|
100 |
|
|
Cooper Cos, Inc. (The) |
|
|
6,126 |
|
|
600 |
|
|
Coventry Health Care, Inc.* |
|
|
19,164 |
|
|
100 |
|
|
Covidien Plc |
|
|
4,555 |
|
|
280 |
|
|
Express Scripts, Inc.* |
|
|
12,782 |
|
|
400 |
|
|
Health Net, Inc.* |
|
|
12,456 |
|
|
1,000 |
|
|
Humana, Inc. |
|
|
88,680 |
|
|
800 |
|
|
McKesson Corp. |
|
|
65,048 |
|
|
2,200 |
|
|
Medtronic, Inc. |
|
|
80,146 |
|
|
100 |
|
|
Omnicare, Inc. |
|
|
3,261 |
|
|
200 |
|
|
Quest Diagnostics, Inc. |
|
|
11,732 |
|
|
200 |
|
|
Stryker Corp. |
|
|
9,766 |
|
|
6,467 |
|
|
UnitedHealth Group, Inc. |
|
|
315,396 |
|
|
1,900 |
|
|
WellPoint, Inc. |
|
|
134,045 |
|
|
800 |
|
|
Zimmer Holdings, Inc.* |
|
|
40,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
997,282 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 1.4% |
|
|
|
|
|
300 |
|
|
ColgatePalmolive Co. |
|
|
27,450 |
|
|
100 |
|
|
Energizer Holdings, Inc.* |
|
|
7,228 |
|
|
100 |
|
|
Herbalife Ltd. |
|
|
5,530 |
|
|
1,200 |
|
|
Procter & Gamble Co. (The) |
|
|
77,484 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
117,692 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 7.8% |
|
|
|
|
|
800 |
|
|
ACE Ltd. |
|
|
55,624 |
|
|
1,000 |
|
|
AFLAC Inc. |
|
|
43,440 |
|
|
100 |
|
|
Allied World Assurance Co Holdings Ltd. |
|
|
5,949 |
|
|
1,400 |
|
|
Allstate Corp. (The) |
|
|
37,506 |
|
|
400 |
|
|
American Financial Group, Inc. |
|
|
14,400 |
|
|
1,500 |
|
|
American International Group, Inc.* |
|
|
34,965 |
|
|
600 |
|
|
Arch Capital Group Ltd.* |
|
|
22,662 |
|
|
200 |
|
|
Aspen Insurance Holdings Ltd. |
|
|
5,304 |
|
|
400 |
|
|
Assurant, Inc. |
|
|
15,696 |
|
|
400 |
|
|
Axis Capital Holdings Ltd. |
|
|
12,772 |
|
|
762 |
|
|
Berkshire Hathaway Inc.-Class B* |
|
|
60,015 |
|
|
300 |
|
|
Brown & Brown, Inc. |
|
|
6,258 |
|
|
700 |
|
|
Chubb Corp. |
|
|
47,208 |
|
|
900 |
|
|
CNO Financial Group, Inc.* |
|
|
5,688 |
|
|
200 |
|
|
Endurance Specialty Holdings Ltd. |
|
|
7,234 |
|
|
100 |
|
|
Everest Re Group Ltd. |
|
|
8,773 |
|
|
800 |
|
|
Hartford Financial Services Group, Inc. (The) |
|
|
14,208 |
|
|
|
|
|
|
|
|
|
|
|
400 |
|
|
HCC Insurance Holdings, Inc. |
|
|
10,752 |
|
|
500 |
|
|
Lincoln National Corp. |
|
|
10,090 |
|
|
100 |
|
|
PartnerRe Ltd. |
|
|
6,572 |
|
|
400 |
|
|
Principal Financial Group, Inc. |
|
|
9,652 |
|
|
1,000 |
|
|
Progressive Corp. (The) |
|
|
18,860 |
|
|
300 |
|
|
Protective Life Corp. |
|
|
6,657 |
|
|
100 |
|
|
Prudential Financial, Inc. |
|
|
5,064 |
|
|
200 |
|
|
Reinsurance Group of America, Inc. |
|
|
10,300 |
|
|
200 |
|
|
RenaissanceRe Holdings Ltd. |
|
|
14,688 |
|
|
200 |
|
|
StanCorp Financial Group, Inc. |
|
|
7,052 |
|
|
450 |
|
|
Torchmark Corp. |
|
|
19,166 |
|
|
100 |
|
|
Transatlantic Holdings, Inc. |
|
|
5,464 |
|
|
1,900 |
|
|
Travelers Cos. (The), Inc. |
|
|
106,875 |
|
|
600 |
|
|
Unum Group |
|
|
13,506 |
|
|
300 |
|
|
W.R. Berkley Corp. |
|
|
10,233 |
|
|
900 |
|
|
XL Group Plc |
|
|
18,558 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance |
|
|
671,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials 0.6% |
|
|
|
|
|
1,200 |
|
|
Alcoa, Inc. |
|
|
12,024 |
|
|
300 |
|
|
Dow Chemical Co. (The) |
|
|
8,313 |
|
|
600 |
|
|
Du Pont (E.I.) de Nemours & Co. |
|
|
28,632 |
|
|
200 |
|
|
MeadWestvaco Corp. |
|
|
5,970 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Materials |
|
|
54,939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media 0.4% |
|
|
|
|
|
1,000 |
|
|
CBS Corp.-Class B (Non Voting) |
|
|
26,040 |
|
|
400 |
|
|
News Corp.-Class A |
|
|
6,976 |
|
|
100 |
|
|
Viacom, Inc.-Class B |
|
|
4,476 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Media |
|
|
37,492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 15.1% |
|
|
|
|
|
2,000 |
|
|
Abbott Laboratories |
|
|
109,100 |
|
|
2,300 |
|
|
Amgen, Inc. |
|
|
133,193 |
|
|
1,100 |
|
|
Biogen Idec, Inc.* |
|
|
126,445 |
|
|
400 |
|
|
BristolMyers Squibb Co. |
|
|
13,088 |
|
|
4,900 |
|
|
Eli Lilly & Co. |
|
|
185,465 |
|
|
500 |
|
|
Endo Pharmaceuticals Holdings, Inc.* |
|
|
17,115 |
|
|
1,500 |
|
|
Forest Laboratories, Inc.* |
|
|
44,940 |
|
|
900 |
|
|
Gilead Sciences, Inc.* |
|
|
35,865 |
|
|
2,500 |
|
|
Johnson & Johnson |
|
|
161,800 |
|
|
1,600 |
|
|
Merck & Co., Inc. |
|
|
57,200 |
|
|
100 |
|
|
Mylan, Inc.* |
|
|
1,953 |
|
|
19,976 |
|
|
Pfizer, Inc. |
|
|
400,918 |
|
|
100 |
|
|
Thermo Fisher Scientific, Inc.* |
|
|
4,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
1,291,807 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate 0.3% |
|
|
|
|
|
800 |
|
|
Annaly Capital Management, Inc. REIT |
|
|
12,856 |
|
|
300 |
|
|
ProLogis, Inc. REIT |
|
|
8,346 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Real Estate |
|
|
21,202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 1.5% |
|
|
|
|
|
100 |
|
|
Abercrombie & Fitch Co.-Class A |
|
|
4,791 |
|
|
100 |
|
|
Advance Auto Parts, Inc. |
|
|
6,922 |
|
|
450 |
|
|
Aeropostale, Inc.* |
|
|
6,980 |
|
|
200 |
|
|
AutoNation, Inc.* |
|
|
7,222 |
|
|
30 |
|
|
AutoZone, Inc.* |
|
|
9,851 |
|
|
|
|
|
|
|
|
|
|
|
200 |
|
|
Best Buy Co., Inc. |
|
|
5,418 |
|
|
200 |
|
|
Dollar Tree, Inc.* |
|
|
16,298 |
|
|
100 |
|
|
Family Dollar Stores, Inc. |
|
|
5,942 |
|
|
400 |
|
|
Foot Locker, Inc. |
|
|
9,436 |
|
|
300 |
|
|
GameStop Corp.-Class A* |
|
|
6,936 |
|
|
100 |
|
|
Genuine Parts Co. |
|
|
5,850 |
|
|
100 |
|
|
Guess?, Inc. |
|
|
2,812 |
|
|
200 |
|
|
J.C. Penney Co., Inc. |
|
|
6,408 |
|
|
500 |
|
|
Lowes Cos., Inc. |
|
|
12,005 |
|
|
100 |
|
|
OReilly Automotive, Inc.* |
|
|
7,724 |
|
|
200 |
|
|
Rent-A-Center, Inc. |
|
|
7,190 |
|
|
100 |
|
|
Target Corp. |
|
|
5,270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
127,055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment 0.5% |
|
|
|
|
|
600 |
|
|
Applied Materials, Inc. |
|
|
6,468 |
|
|
200 |
|
|
KLA-Tencor Corp. |
|
|
9,220 |
|
|
900 |
|
|
LSI Corp.* |
|
|
5,058 |
|
|
600 |
|
|
Texas Instruments, Inc. |
|
|
18,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Semiconductors & Semiconductor Equipment |
|
|
38,806 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 10.6% |
|
|
|
|
|
200 |
|
|
Cognizant Technology Solutions Corp.-Class A* |
|
|
13,470 |
|
|
2,700 |
|
|
eBay, Inc.* |
|
|
79,893 |
|
|
100 |
|
|
Fiserv, Inc.* |
|
|
5,766 |
|
|
350 |
|
|
Google, Inc.-Class A* |
|
|
209,786 |
|
|
330 |
|
|
International Business Machines Corp. |
|
|
62,040 |
|
|
9,100 |
|
|
Microsoft Corp. |
|
|
232,778 |
|
|
8,400 |
|
|
Oracle Corp. |
|
|
263,340 |
|
|
1,700 |
|
|
Symantec Corp.* |
|
|
27,795 |
|
|
100 |
|
|
Visa, Inc.-Class A |
|
|
9,697 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
904,565 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 7.0% |
|
|
|
|
|
620 |
|
|
Apple, Inc.* |
|
|
236,964 |
|
|
200 |
|
|
Arrow Electronics, Inc.* |
|
|
7,312 |
|
|
3,200 |
|
|
Cisco Systems, Inc. |
|
|
59,648 |
|
|
700 |
|
|
Dell, Inc.* |
|
|
11,032 |
|
|
4,100 |
|
|
Hewlett-Packard Co. |
|
|
114,595 |
|
|
700 |
|
|
Ingram Micro, Inc.-Class A* |
|
|
12,607 |
|
|
200 |
|
|
Juniper Networks, Inc.* |
|
|
4,542 |
|
|
400 |
|
|
Lexmark International, Inc. |
|
|
13,384 |
|
|
200 |
|
|
Motorola Solutions, Inc. |
|
|
9,334 |
|
|
1,700 |
|
|
Qualcomm, Inc. |
|
|
93,160 |
|
|
200 |
|
|
Tech Data Corp.* |
|
|
9,846 |
|
|
1,000 |
|
|
Western Digital Corp.* |
|
|
29,070 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
601,494 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 4.4% |
|
|
|
|
|
7,658 |
|
|
AT&T, Inc. |
|
|
221,929 |
|
|
200 |
|
|
Centurylink, Inc. |
|
|
7,504 |
|
|
200 |
|
|
MetroPCS Communications, Inc.* |
|
|
1,676 |
|
|
3,952 |
|
|
Verizon Communications, Inc. |
|
|
149,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Telecommunication Services |
|
|
380,218 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transportation 0.6% |
|
|
|
|
|
300 |
|
|
CSX Corp. |
|
|
6,513 |
|
|
100 |
|
|
Norfolk Southern Corp. |
|
|
7,554 |
|
|
|
|
|
|
|
|
|
|
|
350 |
|
|
Union Pacific Corp. |
|
|
36,193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Transportation |
|
|
50,260 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Utilities 0.3% |
|
|
|
|
|
300 |
|
|
Aqua America, Inc. |
|
|
6,570 |
|
|
500 |
|
|
Exelon Corp. |
|
|
22,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Utilities |
|
|
28,725 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $7,431,353) |
|
|
8,334,820 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 2.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 2.5% |
|
|
|
|
|
8,479 |
|
|
GMO U.S. Treasury Fund |
|
|
212,069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $212,001) |
|
|
212,069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 0.0% |
|
|
|
|
|
160 |
|
|
American International Group, Inc., Warrants, Strike 45.00 * |
|
|
979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 0.0% |
|
|
|
|
|
400 |
|
|
Sanofi Aventis, Rights, Expires 12/31/20 * |
|
|
520 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $3,659) |
|
|
1,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.4% |
|
|
|
|
|
38,962 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a) |
|
|
38,962 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $38,962) |
|
|
38,962 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.3%
(Cost $7,685,975) |
|
|
8,587,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.3%) |
|
|
(29,746 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
8,557,604 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
|
|
|
REIT Real Estate Investment Trust |
|
* |
|
Non-income producing security. |
|
(a) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
7,955,773 |
|
$ |
961,886 |
|
$ |
(330,309 |
) |
|
$ |
631,577 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of
Investments of the underlying funds should be read in conjunction with the Funds Schedule of
Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period
ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S.
Treasury Fund |
|
$ |
205,992 |
|
|
$ |
119,000 |
|
|
$ |
113,000 |
|
|
$ |
69 |
|
|
$ |
8 |
|
|
$ |
212,069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
8,334,820 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
8,334,820 |
|
Mutual Funds |
|
|
212,069 |
|
|
|
|
|
|
|
|
|
|
|
212,069 |
|
Rights/Warrants |
|
|
|
|
|
|
1,499 |
|
|
|
|
|
|
|
1,499 |
|
Short-Term Investments |
|
|
38,962 |
|
|
|
|
|
|
|
|
|
|
|
38,962 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
8,585,851 |
|
|
|
1,499 |
|
|
|
|
|
|
|
8,587,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
8,585,851 |
|
|
$ |
1,499 |
|
|
$ |
|
|
|
$ |
8,587,350 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All of the Funds common stocks held at period end are classified as Level 1. Please refer
to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Focused Investment Risk Focusing investments in sectors or companies or in
industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the
Manager may decide not to use derivatives to hedge or otherwise reduce the Funds risk
exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an
addition to sales proceeds. If a written put option is exercised, the premium originally
received is recorded as a reduction in the cost of investments purchased. Gains and losses from
the expiration or closing of written option contracts are separately disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is
insufficient or not timely received by the Fund. Credit risk is particularly acute in economic
environments in which financial services firms are exposed to systemic risks of the type
evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market disruptions. During
the period ended November 30, 2011, the Fund used total return swap agreements to achieve
returns comparable to holding and lending a direct equity position. The Fund had no swap
agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of corporate actions. Rights and/or
warrants held by the Fund at the end of the period are listed in the Funds Schedule of
Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,499 |
|
|
$ |
|
|
|
$ |
1,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,499 |
|
|
$ |
|
|
|
$ |
1,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The volume of derivative activity, based on absolute values (rights and/or warrants) or notional amounts
(swap agreements) outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
Swap |
|
|
Rights and/or |
|
|
|
Agreements |
|
|
Warrants |
|
Average amount outstanding |
|
$ |
3,420 |
|
|
$ |
1,919 |
|
For additional information regarding the Funds Schedule of Investments,
please see the Funds most recent annual or semiannual shareholder report filed on the
Securities and Exchange Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Small/Mid Cap Growth Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 99.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automobiles & Components 1.2% |
|
|
|
|
|
500 |
|
|
Dorman Products, Inc.* |
|
|
19,340 |
|
|
300 |
|
|
Exide Technologies* |
|
|
828 |
|
|
2,500 |
|
|
Goodyear Tire & Rubber Co. (The)* |
|
|
34,975 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Automobiles & Components |
|
|
55,143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banks 0.1% |
|
|
|
|
|
100 |
|
|
Signature Bank/New York NY* |
|
|
5,843 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 9.4% |
|
|
|
|
|
200 |
|
|
Applied Industrial Technologies, Inc. |
|
|
6,906 |
|
|
100 |
|
|
Armstrong World Industries, Inc. |
|
|
3,969 |
|
|
440 |
|
|
Astronics Corp.* |
|
|
15,691 |
|
|
300 |
|
|
Blount International, Inc.* |
|
|
4,593 |
|
|
200 |
|
|
CAI International, Inc.* |
|
|
3,068 |
|
|
800 |
|
|
Chicago Bridge & Iron Co NV (NY Shares) |
|
|
33,080 |
|
|
600 |
|
|
Colfax Corp.* |
|
|
17,586 |
|
|
400 |
|
|
DXP Enterprises, Inc.* |
|
|
12,100 |
|
|
800 |
|
|
Gardner Denver, Inc. |
|
|
68,576 |
|
|
100 |
|
|
General Cable Corp.* |
|
|
2,650 |
|
|
700 |
|
|
Graco, Inc. |
|
|
30,093 |
|
|
100 |
|
|
KBR, Inc. |
|
|
2,890 |
|
|
100 |
|
|
Kennametal, Inc. |
|
|
3,811 |
|
|
400 |
|
|
Lincoln Electric Holdings, Inc. |
|
|
15,792 |
|
|
800 |
|
|
Manitowoc Co. (The), Inc. |
|
|
8,856 |
|
|
300 |
|
|
Middleby Corp.* |
|
|
27,384 |
|
|
100 |
|
|
MSC Industrial Direct Co., Inc.-Class A |
|
|
6,953 |
|
|
100 |
|
|
Nordson Corp. |
|
|
4,706 |
|
|
1,200 |
|
|
Polypore International, Inc.* |
|
|
58,860 |
|
|
200 |
|
|
Primoris Services Corp. |
|
|
2,844 |
|
|
100 |
|
|
Raven Industries, Inc. |
|
|
6,024 |
|
|
900 |
|
|
Sauer-Danfoss, Inc.* |
|
|
33,831 |
|
|
100 |
|
|
Thomas & Betts Corp.* |
|
|
5,201 |
|
|
200 |
|
|
Titan International, Inc. |
|
|
4,308 |
|
|
100 |
|
|
Titan Machinery, Inc.* |
|
|
2,170 |
|
|
1,000 |
|
|
Trimas Corp.* |
|
|
20,410 |
|
|
300 |
|
|
WABCO Holdings, Inc.* |
|
|
14,103 |
|
|
200 |
|
|
Wabtec Corp. |
|
|
13,650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
430,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Professional Services 3.2% |
|
|
|
|
|
200 |
|
|
Acacia Research Acacia Technologies* |
|
|
6,964 |
|
|
300 |
|
|
Brinks Co. (The) |
|
|
7,386 |
|
|
100 |
|
|
CBIZ, Inc.* |
|
|
602 |
|
|
400 |
|
|
Clean Harbors, Inc.* |
|
|
23,988 |
|
|
100 |
|
|
CompX International, Inc. |
|
|
1,552 |
|
|
1,200 |
|
|
Copart, Inc.* |
|
|
53,916 |
|
|
500 |
|
|
Deluxe Corp. |
|
|
11,430 |
|
|
100 |
|
|
Huron Consulting Group, Inc.* |
|
|
3,472 |
|
|
300 |
|
|
Insperity, Inc. |
|
|
7,437 |
|
|
100 |
|
|
KAR Auction Services, Inc.* |
|
|
1,314 |
|
|
400 |
|
|
Knoll, Inc. |
|
|
6,064 |
|
|
300 |
|
|
Rollins, Inc. |
|
|
6,660 |
|
|
100 |
|
|
Steelcase, Inc.-Class A |
|
|
784 |
|
|
|
|
|
|
|
|
|
|
|
500 |
|
|
Waste Connections, Inc. |
|
|
16,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Commercial & Professional Services |
|
|
147,954 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 7.4% |
|
|
|
|
|
200 |
|
|
CROCS, Inc.* |
|
|
3,102 |
|
|
1,500 |
|
|
Fossil, Inc.* |
|
|
134,385 |
|
|
300 |
|
|
Oxford Industries, Inc. |
|
|
11,379 |
|
|
800 |
|
|
Polaris Industries, Inc. |
|
|
48,080 |
|
|
300 |
|
|
Steven Madden Ltd.* |
|
|
10,698 |
|
|
1,500 |
|
|
Tempur-Pedic International, Inc.* |
|
|
81,915 |
|
|
200 |
|
|
True Religion Apparel, Inc.* |
|
|
7,040 |
|
|
700 |
|
|
Tupperware Brands Corp. |
|
|
40,782 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Durables & Apparel |
|
|
337,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 3.1% |
|
|
|
|
|
100 |
|
|
AFC Enterprises, Inc.* |
|
|
1,570 |
|
|
100 |
|
|
Ameristar Casinos, Inc. |
|
|
1,750 |
|
|
100 |
|
|
BJs Restaurants, Inc.* |
|
|
4,808 |
|
|
400 |
|
|
Brinker International, Inc. |
|
|
9,632 |
|
|
100 |
|
|
DineEquity, Inc.* |
|
|
4,708 |
|
|
700 |
|
|
Dominos Pizza, Inc.* |
|
|
23,058 |
|
|
600 |
|
|
Krispy Kreme Doughnuts, Inc.* |
|
|
4,512 |
|
|
200 |
|
|
Papa Johns International, Inc.* |
|
|
7,580 |
|
|
1,400 |
|
|
Weight Watchers International, Inc. |
|
|
82,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Services |
|
|
139,896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financials 3.7% |
|
|
|
|
|
200 |
|
|
Advance America Cash Advance Centers, Inc. |
|
|
1,704 |
|
|
1,100 |
|
|
BGC Partners, Inc.-Class A |
|
|
6,952 |
|
|
200 |
|
|
Cash America International, Inc. |
|
|
9,942 |
|
|
200 |
|
|
Credit Acceptance Corp.* |
|
|
16,402 |
|
|
1,000 |
|
|
DFC Global Corp.* |
|
|
18,150 |
|
|
600 |
|
|
EZCORP, Inc.-Class A* |
|
|
17,454 |
|
|
400 |
|
|
Financial Engines, Inc.* |
|
|
8,788 |
|
|
900 |
|
|
First Cash Financial Services, Inc.* |
|
|
32,670 |
|
|
104 |
|
|
Kohlberg Capital Corp. |
|
|
656 |
|
|
200 |
|
|
Virtus Investment Partners, Inc.* |
|
|
15,178 |
|
|
700 |
|
|
Waddell and Reed Financial, Inc. |
|
|
19,026 |
|
|
300 |
|
|
World Acceptance Corp.* |
|
|
20,586 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified Financials |
|
|
167,508 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 11.5% |
|
|
|
|
|
200 |
|
|
Apco Oil and Gas International, Inc. |
|
|
15,890 |
|
|
100 |
|
|
Atwood Oceanics, Inc.* |
|
|
4,100 |
|
|
400 |
|
|
Basic Energy Services, Inc.* |
|
|
7,536 |
|
|
900 |
|
|
Cabot Oil & Gas Corp. |
|
|
79,731 |
|
|
500 |
|
|
Callon Petroleum Co.* |
|
|
2,685 |
|
|
100 |
|
|
CARBO Ceramics, Inc. |
|
|
14,232 |
|
|
400 |
|
|
Clayton Williams Energy, Inc.* |
|
|
29,584 |
|
|
1,100 |
|
|
CVR Energy, Inc.* |
|
|
20,020 |
|
|
1,700 |
|
|
Golar LNG Ltd. |
|
|
74,120 |
|
|
300 |
|
|
Gulfport Energy Corp.* |
|
|
9,525 |
|
|
4,300 |
|
|
HollyFrontier Corp. |
|
|
99,975 |
|
|
1,000 |
|
|
ION Geophysical Corp.* |
|
|
5,810 |
|
|
300 |
|
|
Lufkin Industries, Inc. |
|
|
21,024 |
|
|
100 |
|
|
Oil States International, Inc.* |
|
|
7,525 |
|
|
950 |
|
|
RPC, Inc. |
|
|
18,544 |
|
|
2,100 |
|
|
SandRidge Energy, Inc.* |
|
|
15,435 |
|
|
300 |
|
|
SM Energy Co. |
|
|
23,847 |
|
|
|
|
|
|
|
|
|
|
|
1,400 |
|
|
Stone Energy Corp.* |
|
|
39,606 |
|
|
200 |
|
|
Superior Energy Services, Inc.* |
|
|
5,942 |
|
|
700 |
|
|
W&T Offshore, Inc. |
|
|
14,014 |
|
|
900 |
|
|
Western Refining, Inc.* |
|
|
10,701 |
|
|
100 |
|
|
World Fuel Services Corp. |
|
|
4,287 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
524,133 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 0.9% |
|
|
|
|
|
600 |
|
|
PriceSmart, Inc. |
|
|
40,710 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 4.4% |
|
|
|
|
|
200 |
|
|
B&G Foods, Inc. |
|
|
4,438 |
|
|
100 |
|
|
Boston Beer Co., Inc.-Class A* |
|
|
9,991 |
|
|
1,800 |
|
|
Darling International, Inc.* |
|
|
25,866 |
|
|
1,200 |
|
|
Flowers Foods, Inc. |
|
|
23,724 |
|
|
1,500 |
|
|
Hansen Natural Corp.* |
|
|
138,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
202,319 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 9.6% |
|
|
|
|
|
500 |
|
|
Accretive Health, Inc.* |
|
|
11,540 |
|
|
100 |
|
|
Air Methods Corp.* |
|
|
8,072 |
|
|
900 |
|
|
AMERIGROUP Corp.* |
|
|
51,453 |
|
|
100 |
|
|
athenahealth, Inc.* |
|
|
5,940 |
|
|
100 |
|
|
Centene Corp.* |
|
|
3,871 |
|
|
200 |
|
|
Chemed Corp. |
|
|
10,732 |
|
|
500 |
|
|
Cooper Cos, Inc. (The) |
|
|
30,630 |
|
|
400 |
|
|
CorVel Corp.* |
|
|
19,084 |
|
|
300 |
|
|
Ensign Group, Inc. (The) |
|
|
7,113 |
|
|
900 |
|
|
Gen-Probe, Inc.* |
|
|
56,691 |
|
|
100 |
|
|
Haemonetics Corp.* |
|
|
5,923 |
|
|
1,500 |
|
|
Health Management Associates, Inc.-Class A* |
|
|
12,330 |
|
|
300 |
|
|
Healthspring, Inc.* |
|
|
16,386 |
|
|
200 |
|
|
Hill-Rom Holdings, Inc. |
|
|
6,320 |
|
|
300 |
|
|
HMS Holdings Corp.* |
|
|
9,099 |
|
|
200 |
|
|
IPC The Hospitalist Co., Inc.* |
|
|
9,220 |
|
|
500 |
|
|
MAKO Surgical Corp.* |
|
|
14,400 |
|
|
200 |
|
|
Medidata Solutions, Inc.* |
|
|
4,036 |
|
|
300 |
|
|
Mednax, Inc.* |
|
|
20,220 |
|
|
200 |
|
|
National Research Corp. |
|
|
6,726 |
|
|
400 |
|
|
Neogen Corp.* |
|
|
14,092 |
|
|
100 |
|
|
Orthofix International NV* |
|
|
3,427 |
|
|
100 |
|
|
Providence Service Corp. (The)* |
|
|
1,171 |
|
|
900 |
|
|
PSS World Medical, Inc.* |
|
|
21,942 |
|
|
600 |
|
|
Quality Systems, Inc. |
|
|
21,210 |
|
|
200 |
|
|
Sirona Dental Systems, Inc.* |
|
|
8,888 |
|
|
1,400 |
|
|
Sunrise Senior Living, Inc.* |
|
|
7,042 |
|
|
100 |
|
|
SXC Health Solutions Corp* |
|
|
5,882 |
|
|
100 |
|
|
Team Health Holdings, Inc.* |
|
|
2,196 |
|
|
600 |
|
|
WellCare Health Plans, Inc.* |
|
|
35,070 |
|
|
100 |
|
|
West Pharmaceutical Services, Inc. |
|
|
3,853 |
|
|
100 |
|
|
Zoll Medical Corp.* |
|
|
4,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
439,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 2.6% |
|
|
|
|
|
2,100 |
|
|
Herbalife Ltd. |
|
|
116,130 |
|
|
64 |
|
|
USANA Health Sciences, Inc.* |
|
|
2,185 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
118,315 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 1.5% |
|
|
|
|
|
100 |
|
|
AmTrust Financial Services, Inc. |
|
|
2,651 |
|
|
913 |
|
|
Erie Indemnity Co.-Class A |
|
|
67,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance |
|
|
70,021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials 6.5% |
|
|
|
|
|
400 |
|
|
Albemarle Corp. |
|
|
21,812 |
|
|
100 |
|
|
Balchem Corp.-Class B |
|
|
4,150 |
|
|
200 |
|
|
Carpenter Technology Corp. |
|
|
10,828 |
|
|
1,200 |
|
|
Crown Holdings, Inc.* |
|
|
38,772 |
|
|
400 |
|
|
Flotek Industries, Inc.* |
|
|
3,644 |
|
|
1,200 |
|
|
Globe Specialty Metals, Inc. |
|
|
17,916 |
|
|
300 |
|
|
Hawkins, Inc. |
|
|
11,853 |
|
|
300 |
|
|
International Flavors & Fragrances, Inc. |
|
|
16,278 |
|
|
300 |
|
|
Koppers Holdings, Inc. |
|
|
9,909 |
|
|
400 |
|
|
Kraton Performance Polymers, Inc.* |
|
|
8,408 |
|
|
500 |
|
|
LSB Industries, Inc.* |
|
|
15,635 |
|
|
200 |
|
|
NewMarket Corp. |
|
|
39,578 |
|
|
300 |
|
|
Noranda Aluminum Holding Corp. |
|
|
2,466 |
|
|
900 |
|
|
Omnova Solutions, Inc.* |
|
|
3,915 |
|
|
600 |
|
|
PolyOne Corp. |
|
|
6,456 |
|
|
900 |
|
|
Rockwood Holdings, Inc.* |
|
|
40,104 |
|
|
100 |
|
|
Schnitzer Steel Industries, Inc.-Class A |
|
|
4,639 |
|
|
200 |
|
|
Silgan Holdings, Inc. |
|
|
7,788 |
|
|
300 |
|
|
Temple-Inland, Inc. |
|
|
9,549 |
|
|
3,200 |
|
|
US Gold Corp.* |
|
|
13,280 |
|
|
200 |
|
|
W.R. Grace & Co.* |
|
|
8,334 |
|
|
100 |
|
|
Worthington Industries, Inc. |
|
|
1,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Materials |
|
|
297,073 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media 0.1% |
|
|
|
|
|
100 |
|
|
Arbitron, Inc. |
|
|
3,761 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 6.9% |
|
|
|
|
|
2,800 |
|
|
Akorn, Inc.* |
|
|
30,128 |
|
|
1,600 |
|
|
ARIAD Pharmaceuticals, Inc.* |
|
|
19,344 |
|
|
700 |
|
|
Bruker Corp.* |
|
|
8,764 |
|
|
300 |
|
|
Cepheid, Inc.* |
|
|
10,290 |
|
|
900 |
|
|
Charles River Laboratories International, Inc.* |
|
|
25,515 |
|
|
100 |
|
|
Covance, Inc.* |
|
|
4,591 |
|
|
300 |
|
|
Cubist Pharmaceuticals, Inc.* |
|
|
11,571 |
|
|
1,000 |
|
|
Depomed, Inc.* |
|
|
4,870 |
|
|
300 |
|
|
Exelixis, Inc.* |
|
|
1,383 |
|
|
300 |
|
|
Impax Laboratories, Inc.* |
|
|
6,042 |
|
|
1,400 |
|
|
Jazz Pharmaceuticals, Inc.* |
|
|
55,468 |
|
|
100 |
|
|
Medicines Co.* |
|
|
1,891 |
|
|
800 |
|
|
Medicis Pharmaceutical Corp.-Class A |
|
|
26,120 |
|
|
60 |
|
|
Mettler-Toledo International, Inc.* |
|
|
9,588 |
|
|
600 |
|
|
PDL BioPharma, Inc. |
|
|
3,840 |
|
|
300 |
|
|
Pharmaceutical Product Development, Inc. |
|
|
9,963 |
|
|
300 |
|
|
Pharmasset, Inc.* |
|
|
39,297 |
|
|
600 |
|
|
Questcor Pharmaceuticals, Inc.* |
|
|
26,970 |
|
|
100 |
|
|
Regeneron Pharmaceuticals, Inc.* |
|
|
5,942 |
|
|
200 |
|
|
Spectrum Pharmaceuticals, Inc.* |
|
|
2,770 |
|
|
200 |
|
|
Techne Corp. |
|
|
13,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
317,845 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate 0.1% |
|
|
|
|
|
100 |
|
|
Anworth Mortgage Asset Corp. REIT |
|
|
633 |
|
|
100 |
|
|
Getty Realty Corp. REIT |
|
|
1,600 |
|
|
100 |
|
|
Rayonier, Inc. REIT |
|
|
4,064 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Real Estate |
|
|
6,297 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 7.1% |
|
|
|
|
|
100 |
|
|
Aarons, Inc. |
|
|
2,628 |
|
|
500 |
|
|
Abercrombie & Fitch Co.-Class A |
|
|
23,955 |
|
|
200 |
|
|
ANN, Inc.* |
|
|
4,692 |
|
|
100 |
|
|
Cato Corp. (The)-Class A |
|
|
2,559 |
|
|
1,300 |
|
|
Chicos FAS, Inc. |
|
|
13,520 |
|
|
100 |
|
|
Destination Maternity Corp. |
|
|
1,465 |
|
|
200 |
|
|
Express, Inc. |
|
|
4,538 |
|
|
100 |
|
|
Finish Line (The), Inc.-Class A |
|
|
2,108 |
|
|
200 |
|
|
Hibbett Sports, Inc.* |
|
|
9,102 |
|
|
150 |
|
|
Jos. A. Bank Clothiers, Inc.* |
|
|
7,392 |
|
|
2,200 |
|
|
Sally Beauty Holdings, Inc.* |
|
|
44,220 |
|
|
400 |
|
|
Select Comfort Corp.* |
|
|
7,412 |
|
|
1,600 |
|
|
Tractor Supply Co. |
|
|
115,568 |
|
|
1,200 |
|
|
Ulta Salon Cosmetics & Fragrance, Inc.* |
|
|
83,556 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
322,715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment 1.1% |
|
|
|
|
|
500 |
|
|
AXT, Inc.* |
|
|
2,105 |
|
|
300 |
|
|
Cypress Semiconductor Corp.* |
|
|
5,721 |
|
|
300 |
|
|
Entegris, Inc.* |
|
|
2,529 |
|
|
800 |
|
|
GT Advanced Technologies, Inc.* |
|
|
6,176 |
|
|
400 |
|
|
IXYS Corp.* |
|
|
4,616 |
|
|
500 |
|
|
LSI Corp.* |
|
|
2,810 |
|
|
200 |
|
|
Micrel, Inc. |
|
|
2,080 |
|
|
100 |
|
|
NVE Corp.* |
|
|
5,858 |
|
|
900 |
|
|
ON Semiconductor Corp.* |
|
|
6,777 |
|
|
2,100 |
|
|
Silicon Image, Inc.* |
|
|
10,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Semiconductors & Semiconductor Equipment |
|
|
48,983 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 12.0% |
|
|
|
|
|
300 |
|
|
ACI Worldwide, Inc.* |
|
|
9,024 |
|
|
1,300 |
|
|
Alliance Data Systems Corp.* |
|
|
133,133 |
|
|
200 |
|
|
Ancestry.com, Inc.* |
|
|
4,742 |
|
|
100 |
|
|
Ariba, Inc.* |
|
|
3,035 |
|
|
100 |
|
|
Broadridge Financial Solutions, Inc. |
|
|
2,257 |
|
|
100 |
|
|
Compuware Corp.* |
|
|
826 |
|
|
300 |
|
|
DST Systems, Inc. |
|
|
14,259 |
|
|
100 |
|
|
Echo Global Logistics, Inc.* |
|
|
1,572 |
|
|
100 |
|
|
Factset Research Systems, Inc. |
|
|
9,323 |
|
|
1,900 |
|
|
Fortinet, Inc.* |
|
|
45,581 |
|
|
400 |
|
|
Genpact Ltd.* |
|
|
6,228 |
|
|
900 |
|
|
Global Payments, Inc. |
|
|
39,807 |
|
|
200 |
|
|
Heartland Payment Systems, Inc. |
|
|
4,510 |
|
|
900 |
|
|
Informatica Corp.* |
|
|
40,460 |
|
|
300 |
|
|
Liquidity Services, Inc.* |
|
|
10,218 |
|
|
300 |
|
|
LivePerson, Inc.* |
|
|
3,774 |
|
|
500 |
|
|
LoopNet, Inc.* |
|
|
9,025 |
|
|
1,100 |
|
|
Magma Design Automation, Inc.* |
|
|
6,292 |
|
|
500 |
|
|
MAXIMUS, Inc. |
|
|
20,800 |
|
|
300 |
|
|
Micros Systems, Inc.* |
|
|
14,151 |
|
|
900 |
|
|
NIC, Inc. |
|
|
11,700 |
|
|
|
|
|
|
|
|
|
|
|
400 |
|
|
Opnet Technologies, Inc. |
|
|
14,268 |
|
|
700 |
|
|
Rackspace Hosting, Inc.* |
|
|
30,366 |
|
|
100 |
|
|
S1 Corp.* |
|
|
974 |
|
|
100 |
|
|
Solera Holdings, Inc. |
|
|
4,732 |
|
|
500 |
|
|
Syntel, Inc. |
|
|
23,920 |
|
|
300 |
|
|
TeleNav, Inc.* |
|
|
2,466 |
|
|
600 |
|
|
TeleTech Holdings, Inc.* |
|
|
10,566 |
|
|
2,100 |
|
|
TIBCO Software, Inc.* |
|
|
57,540 |
|
|
100 |
|
|
Tyler Technologies, Inc.* |
|
|
3,205 |
|
|
200 |
|
|
Valueclick, Inc.* |
|
|
3,092 |
|
|
200 |
|
|
Virtusa Corp.* |
|
|
3,148 |
|
|
100 |
|
|
VistaPrint NV* |
|
|
3,271 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
548,265 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 4.4% |
|
|
|
|
|
400 |
|
|
Anixter International, Inc.* |
|
|
24,564 |
|
|
300 |
|
|
Arrow Electronics, Inc.* |
|
|
10,968 |
|
|
100 |
|
|
Cognex Corp. |
|
|
3,567 |
|
|
300 |
|
|
DDi Corp. |
|
|
2,703 |
|
|
100 |
|
|
Faro Technologies, Inc.* |
|
|
4,845 |
|
|
200 |
|
|
FEI Co.* |
|
|
8,072 |
|
|
500 |
|
|
Finisar Corp.* |
|
|
9,220 |
|
|
200 |
|
|
InterDigital, Inc. |
|
|
8,792 |
|
|
600 |
|
|
IPG Photonics Corp.* |
|
|
22,998 |
|
|
200 |
|
|
National Instruments Corp. |
|
|
5,260 |
|
|
1,900 |
|
|
NCR Corp.* |
|
|
33,231 |
|
|
100 |
|
|
Newport Corp.* |
|
|
1,303 |
|
|
100 |
|
|
Oplink Communications, Inc.* |
|
|
1,651 |
|
|
2,000 |
|
|
Polycom, Inc.* |
|
|
33,800 |
|
|
100 |
|
|
Rofin-Sinar Technologies, Inc.* |
|
|
2,406 |
|
|
64 |
|
|
Vishay Precision Group, Inc.* |
|
|
912 |
|
|
700 |
|
|
Zebra Technologies Corp.* |
|
|
26,502 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
200,794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 0.6% |
|
|
|
|
|
600 |
|
|
Cogent Communications Group, Inc.* |
|
|
10,206 |
|
|
1,800 |
|
|
MetroPCS Communications, Inc.* |
|
|
15,084 |
|
|
100 |
|
|
Neutral Tandem, Inc.* |
|
|
1,081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Telecommunication Services |
|
|
26,371 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transportation 2.1% |
|
|
|
|
|
700 |
|
|
Avis Budget Group, Inc.* |
|
|
8,260 |
|
|
400 |
|
|
Copa Holdings SA |
|
|
25,824 |
|
|
500 |
|
|
Landstar System, Inc. |
|
|
23,135 |
|
|
800 |
|
|
Old Dominion Freight Line, Inc.* |
|
|
31,048 |
|
|
100 |
|
|
Park-Ohio Holdings Corp.* |
|
|
1,940 |
|
|
300 |
|
|
UTi Worldwide, Inc. |
|
|
4,668 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Transportation |
|
|
94,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $4,284,479) |
|
|
4,545,469 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 1.4% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 1.4% |
|
|
|
|
|
2,561 |
|
|
GMO U.S. Treasury Fund |
|
|
64,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $64,034) |
|
|
64,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.2% |
|
|
|
|
|
7,259 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a) |
|
|
7,259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $7,259) |
|
|
7,259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 101.1%
(Cost $4,355,772) |
|
|
4,616,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (1.1%) |
|
|
(48,625 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
4,568,137 |
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments: |
|
REIT Real Estate Investment Trust
|
|
* |
Non-income producing security. |
|
(a) |
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
4,359,204 |
|
$ |
586,747 |
|
|
$ |
(329,189 |
) |
|
$ |
257,558 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
101,000 |
|
|
$ |
399,000 |
|
|
$ |
435,962 |
|
|
$ |
24 |
|
|
$ |
|
|
|
$ |
64,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale.
See Derivative financial instruments below for a further discussion on valuation of
derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
4,545,469 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
4,545,469 |
|
Mutual Funds |
|
|
64,034 |
|
|
|
|
|
|
|
|
|
|
|
64,034 |
|
Short-Term Investments |
|
|
7,259 |
|
|
|
|
|
|
|
|
|
|
|
7,259 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
4,616,762 |
|
|
|
|
|
|
|
|
|
|
|
4,616,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,616,762 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
4,616,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All of the Funds common stocks held at period end are classified as Level 1. Please refer
to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. The Fund may purchase equity investments that typically trade at higher
multiples of current earnings than other securities, and the market values of these
investments often are more sensitive to changes in future earnings expectations than those
other securities. Because the Fund normally does not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Liquidity Risk Shares of small- and mid-cap companies often have lower trading
volumes and a limited number or no market makers. Thus, a large position may limit or
prevent the Fund from selling those shares or unwinding derivative positions on them at
desirable prices. The more less-liquid securities the Fund holds, the more likely it is to
honor a redemption request in-kind.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Focused Investment Risk Focusing investments in sectors or companies or in
industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. The Fund had no futures contracts outstanding at the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves
counterparty credit, legal, and documentation risk that is generally not reflected in the models
used to price the swap agreement. Such risks include the possibility that the counterparty
defaults on its obligations to perform or disagrees as to the meaning of contractual terms, that
the Fund has amounts on deposit in excess of amounts owed by the Fund, or that any collateral
the other party posts is insufficient or not timely received by the Fund. Credit risk is
particularly acute in economic environments in which financial services firms are exposed to
systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent
market disruptions. The Fund had no swap agreements outstanding at the end of the
period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. The Fund held no rights or warrants at the end of the period.
Subsequent events
The Board of Trustees of GMO Trust has approved the liquidation of the Fund. It
is expected that the Fund will be liquidated on or about January 31, 2012.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Small/Mid Cap Value Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
COMMON STOCKS 97.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Automobiles & Components 0.2% |
|
|
|
|
|
400 |
|
|
Standard Motor Products, Inc. |
|
|
7,812 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Banks 0.4% |
|
|
|
|
|
200 |
|
|
Federal Agricultural Mortgage Corp.-Class C |
|
|
3,398 |
|
|
500 |
|
|
MainSource Financial Group, Inc. |
|
|
4,140 |
|
|
300 |
|
|
Prosperity Bancshares, Inc. |
|
|
11,997 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Banks |
|
|
19,535 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Goods 4.4% |
|
|
|
|
|
900 |
|
|
Aircastle Ltd. |
|
|
10,458 |
|
|
200 |
|
|
Alliant Techsystems, Inc. |
|
|
11,768 |
|
|
400 |
|
|
Applied Industrial Technologies, Inc. |
|
|
13,812 |
|
|
600 |
|
|
Carlisle Cos., Inc. |
|
|
26,760 |
|
|
500 |
|
|
Crane Co. |
|
|
23,995 |
|
|
400 |
|
|
Curtiss-Wright Corp. |
|
|
13,180 |
|
|
200 |
|
|
DXP Enterprises, Inc.* |
|
|
6,050 |
|
|
500 |
|
|
Hubbell, Inc.-Class B |
|
|
32,710 |
|
|
100 |
|
|
Preformed Line Products Co. |
|
|
5,317 |
|
|
400 |
|
|
Primoris Services Corp. |
|
|
5,688 |
|
|
15 |
|
|
Seaboard Corp. |
|
|
30,146 |
|
|
100 |
|
|
Standex International Corp. |
|
|
3,193 |
|
|
500 |
|
|
Teledyne Technologies, Inc.* |
|
|
28,340 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Capital Goods |
|
|
211,417 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Professional Services 5.4% |
|
|
|
|
|
200 |
|
|
Brinks Co. (The) |
|
|
4,924 |
|
|
1,500 |
|
|
Cintas Corp. |
|
|
45,600 |
|
|
700 |
|
|
Deluxe Corp. |
|
|
16,002 |
|
|
700 |
|
|
Equifax, Inc. |
|
|
26,005 |
|
|
400 |
|
|
FTI Consulting, Inc.* |
|
|
17,156 |
|
|
300 |
|
|
G&K Services Inc.-Class A |
|
|
8,970 |
|
|
200 |
|
|
Huron Consulting Group, Inc.* |
|
|
6,944 |
|
|
400 |
|
|
Iron Mountain, Inc. |
|
|
12,148 |
|
|
300 |
|
|
Multi-Color Corp. |
|
|
7,866 |
|
|
1,800 |
|
|
RR Donnelley & Sons Co. |
|
|
27,036 |
|
|
600 |
|
|
Sykes Enterprises, Inc.* |
|
|
9,774 |
|
|
900 |
|
|
Towers Watson & Co.-Class A |
|
|
58,644 |
|
|
100 |
|
|
UniFirst Corp. |
|
|
5,783 |
|
|
400 |
|
|
United Stationers, Inc. |
|
|
13,416 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Commercial & Professional Services |
|
|
260,268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Durables & Apparel 4.8% |
|
|
|
|
|
200 |
|
|
American Greetings Corp.-Class A |
|
|
3,398 |
|
|
100 |
|
|
Blyth, Inc. |
|
|
6,582 |
|
|
700 |
|
|
Carters, Inc.* |
|
|
27,839 |
|
|
170 |
|
|
Deckers Outdoor Corp.* |
|
|
18,521 |
|
|
100 |
|
|
Fossil, Inc.* |
|
|
8,959 |
|
|
200 |
|
|
Helen of Troy Ltd.* |
|
|
5,974 |
|
|
700 |
|
|
Iconix Brand Group, Inc.* |
|
|
12,082 |
|
|
400 |
|
|
Jakks Pacific, Inc. |
|
|
7,636 |
|
|
600 |
|
|
Jarden Corp. |
|
|
18,684 |
|
|
200 |
|
|
Oxford Industries, Inc. |
|
|
7,586 |
|
|
100 |
|
|
Polaris Industries, Inc. |
|
|
6,010 |
|
|
400 |
|
|
PVH Corp. |
|
|
27,156 |
|
|
150 |
|
|
Steven Madden Ltd.* |
|
|
5,349 |
|
|
|
|
|
|
|
|
|
|
|
200 |
|
|
True Religion Apparel, Inc.* |
|
|
7,040 |
|
|
800 |
|
|
Tupperware Brands Corp. |
|
|
46,608 |
|
|
600 |
|
|
Wolverine World Wide, Inc. |
|
|
22,104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Durables & Apparel |
|
|
231,528 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consumer Services 5.0% |
|
|
|
|
|
300 |
|
|
Apollo Group, Inc.-Class A* |
|
|
14,544 |
|
|
200 |
|
|
Bob Evans Farms, Inc. |
|
|
6,696 |
|
|
600 |
|
|
Bridgepoint Education, Inc.* |
|
|
13,200 |
|
|
800 |
|
|
Brinker International, Inc. |
|
|
19,264 |
|
|
600 |
|
|
Career Education Corp.* |
|
|
4,236 |
|
|
600 |
|
|
DeVry, Inc. |
|
|
20,706 |
|
|
600 |
|
|
Dominos Pizza, Inc.* |
|
|
19,764 |
|
|
1,300 |
|
|
Education Management Corp.* |
|
|
28,964 |
|
|
3,200 |
|
|
H&R Block, Inc. |
|
|
50,336 |
|
|
300 |
|
|
ITT Educational Services, Inc.* |
|
|
16,488 |
|
|
200 |
|
|
Matthews International Corp.-Class A |
|
|
6,634 |
|
|
300 |
|
|
Papa Johns International, Inc.* |
|
|
11,370 |
|
|
100 |
|
|
Red Robin Gourmet Burgers, Inc.* |
|
|
2,658 |
|
|
400 |
|
|
Six Flags Entertainment Corp. |
|
|
15,200 |
|
|
100 |
|
|
Steiner Leisure Ltd.* |
|
|
4,700 |
|
|
100 |
|
|
Weight Watchers International, Inc. |
|
|
5,877 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Consumer Services |
|
|
240,637 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diversified Financials 2.4% |
|
|
|
|
|
800 |
|
|
Advance America Cash Advance Centers, Inc. |
|
|
6,816 |
|
|
400 |
|
|
Cash America International, Inc. |
|
|
19,884 |
|
|
100 |
|
|
Credit Acceptance Corp.* |
|
|
8,201 |
|
|
200 |
|
|
Encore Capital Group, Inc.* |
|
|
4,360 |
|
|
700 |
|
|
EZCORP, Inc.-Class A* |
|
|
20,363 |
|
|
300 |
|
|
First Cash Financial Services, Inc.* |
|
|
10,890 |
|
|
1,100 |
|
|
NASDAQ OMX Group, Inc. (The)* |
|
|
28,875 |
|
|
400 |
|
|
Primus Guaranty Ltd.* |
|
|
2,336 |
|
|
200 |
|
|
World Acceptance Corp.* |
|
|
13,724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Diversified Financials |
|
|
115,449 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Energy 3.2% |
|
|
|
|
|
700 |
|
|
Energen Corp. |
|
|
35,504 |
|
|
1,600 |
|
|
HollyFrontier Corp. |
|
|
37,200 |
|
|
200 |
|
|
SEACOR Holdings, Inc. |
|
|
17,354 |
|
|
1,000 |
|
|
Tesoro Corp.* |
|
|
23,890 |
|
|
600 |
|
|
Western Refining, Inc.* |
|
|
7,134 |
|
|
800 |
|
|
World Fuel Services Corp. |
|
|
34,296 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Energy |
|
|
155,378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food & Staples Retailing 1.1% |
|
|
|
|
|
600 |
|
|
Ruddick Corp. |
|
|
23,910 |
|
|
400 |
|
|
Spartan Stores, Inc. |
|
|
7,212 |
|
|
1,500 |
|
|
Supervalu, Inc. |
|
|
11,025 |
|
|
100 |
|
|
Susser Holdings Corp.* |
|
|
2,298 |
|
|
200 |
|
|
Weis Markets, Inc. |
|
|
7,984 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food & Staples Retailing |
|
|
52,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food, Beverage & Tobacco 6.5% |
|
|
|
|
|
300 |
|
|
Cal-Maine Foods, Inc. |
|
|
10,158 |
|
|
100 |
|
|
Coca-Cola Bottling Co. |
|
|
5,600 |
|
|
1,300 |
|
|
Constellation Brands, Inc.-Class A* |
|
|
25,311 |
|
|
500 |
|
|
Corn Products International, Inc. |
|
|
25,995 |
|
|
|
|
|
|
|
|
|
|
|
2,300 |
|
|
Dean Foods Co.* |
|
|
23,368 |
|
|
900 |
|
|
Dole Food Co., Inc.* |
|
|
7,605 |
|
|
1,200 |
|
|
Flowers Foods, Inc. |
|
|
23,724 |
|
|
700 |
|
|
Fresh Del Monte Produce, Inc. |
|
|
17,563 |
|
|
200 |
|
|
Hain Celestial Group (The), Inc.* |
|
|
7,468 |
|
|
400 |
|
|
Hansen Natural Corp.* |
|
|
36,880 |
|
|
100 |
|
|
J&J Snack Foods Corp. |
|
|
5,188 |
|
|
200 |
|
|
Lancaster Colony Corp. |
|
|
14,080 |
|
|
400 |
|
|
National Beverage Corp. |
|
|
6,688 |
|
|
800 |
|
|
Ralcorp Holdings, Inc.* |
|
|
65,056 |
|
|
1,200 |
|
|
Smithfield Foods, Inc.* |
|
|
29,388 |
|
|
200 |
|
|
Universal Corp. |
|
|
9,476 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Food, Beverage & Tobacco |
|
|
313,548 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health Care Equipment & Services 13.8% |
|
|
|
|
|
700 |
|
|
AMERIGROUP Corp.* |
|
|
40,019 |
|
|
200 |
|
|
AmSurg Corp.* |
|
|
5,216 |
|
|
200 |
|
|
Cantel Medical Corp. |
|
|
5,262 |
|
|
600 |
|
|
Centene Corp.* |
|
|
23,226 |
|
|
200 |
|
|
Chemed Corp. |
|
|
10,732 |
|
|
400 |
|
|
Conmed Corp.* |
|
|
10,516 |
|
|
600 |
|
|
Cooper Cos, Inc. (The) |
|
|
36,756 |
|
|
1,900 |
|
|
Coventry Health Care, Inc.* |
|
|
60,686 |
|
|
1,400 |
|
|
DENTSPLY International, Inc. |
|
|
50,554 |
|
|
300 |
|
|
Greatbatch, Inc.* |
|
|
6,636 |
|
|
100 |
|
|
Haemonetics Corp.* |
|
|
5,923 |
|
|
1,100 |
|
|
Health Net, Inc.* |
|
|
34,254 |
|
|
1,000 |
|
|
Healthspring, Inc.* |
|
|
54,620 |
|
|
200 |
|
|
ICU Medical, Inc.* |
|
|
8,802 |
|
|
300 |
|
|
Integra LifeSciences Holdings Corp.* |
|
|
9,639 |
|
|
300 |
|
|
Invacare Corp. |
|
|
6,162 |
|
|
500 |
|
|
LifePoint Hospitals, Inc.* |
|
|
19,615 |
|
|
300 |
|
|
Magellan Health Services, Inc.* |
|
|
15,198 |
|
|
400 |
|
|
Mednax, Inc.* |
|
|
26,960 |
|
|
1,241 |
|
|
Metropolitan Health Networks, Inc.* |
|
|
8,985 |
|
|
450 |
|
|
Molina Healthcare, Inc.* |
|
|
9,832 |
|
|
1,600 |
|
|
Omnicare, Inc. |
|
|
52,176 |
|
|
200 |
|
|
Orthofix International (Non Voting)* |
|
|
6,854 |
|
|
600 |
|
|
Owens & Minor, Inc. |
|
|
18,480 |
|
|
800 |
|
|
Patterson Cos., Inc. |
|
|
24,136 |
|
|
400 |
|
|
PharMerica Corp.* |
|
|
6,260 |
|
|
700 |
|
|
PSS World Medical, Inc.* |
|
|
17,066 |
|
|
500 |
|
|
Teleflex, Inc. |
|
|
30,440 |
|
|
1,000 |
|
|
Universal American Corp. |
|
|
13,130 |
|
|
300 |
|
|
US Physical Therapy, Inc. |
|
|
5,901 |
|
|
500 |
|
|
WellCare Health Plans, Inc.* |
|
|
29,225 |
|
|
200 |
|
|
West Pharmaceutical Services, Inc. |
|
|
7,706 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Health Care Equipment & Services |
|
|
660,967 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Household & Personal Products 4.6% |
|
|
|
|
|
1,500 |
|
|
Church & Dwight Co., Inc. |
|
|
66,375 |
|
|
400 |
|
|
Elizabeth Arden, Inc.* |
|
|
15,120 |
|
|
700 |
|
|
Energizer Holdings, Inc.* |
|
|
50,596 |
|
|
1,100 |
|
|
Herbalife Ltd. |
|
|
60,830 |
|
|
200 |
|
|
Nu Skin Enterprises, Inc.-Class A |
|
|
9,548 |
|
|
500 |
|
|
Revlon, Inc.-Class A* |
|
|
7,715 |
|
|
400 |
|
|
Spectrum Brands Holdings, Inc.* |
|
|
11,208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Household & Personal Products |
|
|
221,392 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 7.4% |
|
|
|
|
|
200 |
|
|
Allied World Assurance Co Holdings Ltd. |
|
|
11,898 |
|
|
1,000 |
|
|
American Financial Group, Inc. |
|
|
36,000 |
|
|
700 |
|
|
AmTrust Financial Services, Inc. |
|
|
18,557 |
|
|
800 |
|
|
Arch Capital Group Ltd.* |
|
|
30,216 |
|
|
3,000 |
|
|
CNO Financial Group, Inc.* |
|
|
18,960 |
|
|
120 |
|
|
Enstar Group Ltd.* |
|
|
12,133 |
|
|
400 |
|
|
FBL Financial Group, Inc.-Class A |
|
|
13,592 |
|
|
900 |
|
|
HCC Insurance Holdings, Inc. |
|
|
24,192 |
|
|
400 |
|
|
Kemper Corp. |
|
|
11,020 |
|
|
400 |
|
|
ProAssurance Corp. |
|
|
31,844 |
|
|
800 |
|
|
Reinsurance Group of America, Inc. |
|
|
41,200 |
|
|
200 |
|
|
RLI Corp. |
|
|
14,174 |
|
|
1,000 |
|
|
Torchmark Corp. |
|
|
42,590 |
|
|
700 |
|
|
Validus Holdings Ltd. |
|
|
21,063 |
|
|
800 |
|
|
W.R. Berkley Corp. |
|
|
27,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insurance |
|
|
354,727 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Materials 3.6% |
|
|
|
|
|
1,100 |
|
|
Ball Corp. |
|
|
38,621 |
|
|
500 |
|
|
Eastman Chemical Co. |
|
|
19,810 |
|
|
200 |
|
|
Innospec, Inc.* |
|
|
5,812 |
|
|
600 |
|
|
International Flavors & Fragrances, Inc. |
|
|
32,556 |
|
|
1,300 |
|
|
RPM International, Inc. |
|
|
30,680 |
|
|
400 |
|
|
Sensient Technologies Corp. |
|
|
15,108 |
|
|
600 |
|
|
Silgan Holdings, Inc. |
|
|
23,364 |
|
|
200 |
|
|
TPC Group, Inc.* |
|
|
4,800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Materials |
|
|
170,751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Media 1.9% |
|
|
|
|
|
700 |
|
|
Charter Communications, Inc.-Class A* |
|
|
37,009 |
|
|
600 |
|
|
John Wiley and Sons, Inc.-Class A |
|
|
28,860 |
|
|
1,000 |
|
|
Sinclair Broadcast Group, Inc. |
|
|
10,340 |
|
|
45 |
|
|
Washington Post Co. (The)-Class B |
|
|
16,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Media |
|
|
92,360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharmaceuticals, Biotechnology & Life Sciences 4.2% |
|
|
|
|
|
300 |
|
|
Bio-Rad Laboratories, Inc.* |
|
|
28,290 |
|
|
600 |
|
|
Charles River Laboratories International, Inc.* |
|
|
17,010 |
|
|
400 |
|
|
Covance, Inc.* |
|
|
18,364 |
|
|
600 |
|
|
Cubist Pharmaceuticals, Inc.* |
|
|
23,142 |
|
|
1,500 |
|
|
Endo Pharmaceuticals Holdings, Inc.* |
|
|
51,345 |
|
|
200 |
|
|
Hi-Tech Pharmacal Co., Inc.* |
|
|
8,304 |
|
|
500 |
|
|
Medicis Pharmaceutical Corp.-Class A |
|
|
16,325 |
|
|
500 |
|
|
PerkinElmer, Inc. |
|
|
9,460 |
|
|
900 |
|
|
Viropharma, Inc.* |
|
|
21,609 |
|
|
100 |
|
|
Watson Pharmaceuticals, Inc.* |
|
|
6,462 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Pharmaceuticals, Biotechnology & Life Sciences |
|
|
200,311 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate 1.8% |
|
|
|
|
|
1,700 |
|
|
American Capital Agency Corp. REIT |
|
|
48,773 |
|
|
1,200 |
|
|
Anworth Mortgage Asset Corp. REIT |
|
|
7,596 |
|
|
900 |
|
|
Capstead Mortgage Corp. REIT |
|
|
11,232 |
|
|
500 |
|
|
Hatteras Financial Corp. REIT |
|
|
13,400 |
|
|
700 |
|
|
Newcastle Investment Corp. REIT |
|
|
3,115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Real Estate |
|
|
84,116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retailing 12.4% |
|
|
|
|
|
700 |
|
|
Aarons, Inc. |
|
|
18,396 |
|
|
900 |
|
|
Abercrombie & Fitch Co.-Class A |
|
|
43,119 |
|
|
400 |
|
|
Asbury Automotive Group, Inc.* |
|
|
7,888 |
|
|
800 |
|
|
Ascena Retail Group, Inc.* |
|
|
22,016 |
|
|
900 |
|
|
AutoNation, Inc.* |
|
|
32,499 |
|
|
400 |
|
|
Big Lots, Inc.* |
|
|
16,044 |
|
|
600 |
|
|
Buckle (The), Inc. |
|
|
23,976 |
|
|
200 |
|
|
Cato Corp. (The)-Class A |
|
|
5,118 |
|
|
1,700 |
|
|
Chicos FAS, Inc. |
|
|
17,680 |
|
|
100 |
|
|
Core-Mark Holding Co., Inc. |
|
|
3,856 |
|
|
700 |
|
|
Dillards, Inc.-Class A |
|
|
32,900 |
|
|
130 |
|
|
DSW, Inc.-Class A |
|
|
5,850 |
|
|
300 |
|
|
Express, Inc. |
|
|
6,807 |
|
|
100 |
|
|
Family Dollar Stores, Inc. |
|
|
5,942 |
|
|
300 |
|
|
Finish Line (The), Inc.-Class A |
|
|
6,324 |
|
|
1,200 |
|
|
Foot Locker, Inc. |
|
|
28,308 |
|
|
1,800 |
|
|
GameStop Corp.-Class A* |
|
|
41,616 |
|
|
300 |
|
|
Genesco, Inc.* |
|
|
17,715 |
|
|
300 |
|
|
Group 1 Automotive, Inc. |
|
|
14,733 |
|
|
100 |
|
|
Hibbett Sports, Inc.* |
|
|
4,551 |
|
|
300 |
|
|
Jos. A. Bank Clothiers, Inc.* |
|
|
14,784 |
|
|
400 |
|
|
Lithia Motors, Inc.-Class A |
|
|
8,884 |
|
|
1,000 |
|
|
LKQ Corp.* |
|
|
30,530 |
|
|
500 |
|
|
Mens Wearhouse (The), Inc. |
|
|
13,915 |
|
|
1,100 |
|
|
Penske Auto Group, Inc. |
|
|
22,319 |
|
|
1,200 |
|
|
PetSmart, Inc. |
|
|
57,900 |
|
|
800 |
|
|
Rent-A-Center, Inc. |
|
|
28,760 |
|
|
300 |
|
|
Select Comfort Corp.* |
|
|
5,559 |
|
|
100 |
|
|
Shoe Carnival, Inc.* |
|
|
2,378 |
|
|
500 |
|
|
Sonic Automotive, Inc. |
|
|
7,385 |
|
|
300 |
|
|
Stage Stores, Inc. |
|
|
3,762 |
|
|
400 |
|
|
Systemax, Inc.* |
|
|
5,880 |
|
|
100 |
|
|
Tiffany & Co. |
|
|
6,704 |
|
|
200 |
|
|
Tractor Supply Co. |
|
|
14,446 |
|
|
500 |
|
|
Williams-Sonoma, Inc. |
|
|
18,885 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Retailing |
|
|
597,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Semiconductors & Semiconductor Equipment 0.3% |
|
|
|
|
|
1,100 |
|
|
GT Advanced Technologies, Inc.* |
|
|
8,492 |
|
|
700 |
|
|
Kulicke & Soffa Industries, Inc.* |
|
|
6,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Semiconductors & Semiconductor Equipment |
|
|
14,862 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Software & Services 8.3% |
|
|
|
|
|
500 |
|
|
Alliance Data Systems Corp.* |
|
|
51,205 |
|
|
800 |
|
|
Amdocs Ltd.* |
|
|
22,592 |
|
|
400 |
|
|
CACI International, Inc.-Class A* |
|
|
22,552 |
|
|
1,100 |
|
|
CIBER, Inc.* |
|
|
4,554 |
|
|
400 |
|
|
DST Systems, Inc. |
|
|
19,012 |
|
|
100 |
|
|
ePlus, Inc.* |
|
|
2,777 |
|
|
400 |
|
|
Fair Isaac Corp. |
|
|
14,548 |
|
|
800 |
|
|
Global Payments, Inc. |
|
|
35,384 |
|
|
300 |
|
|
Heartland Payment Systems, Inc. |
|
|
6,765 |
|
|
800 |
|
|
IAC/InterActiveCorp |
|
|
33,504 |
|
|
500 |
|
|
j2 Global Communications, Inc. |
|
|
13,555 |
|
|
500 |
|
|
Jack Henry & Associates, Inc. |
|
|
16,605 |
|
|
400 |
|
|
Mantech International Corp.-Class A |
|
|
13,520 |
|
|
200 |
|
|
MAXIMUS, Inc. |
|
|
8,320 |
|
|
50 |
|
|
MicroStrategy, Inc.-Class A* |
|
|
6,156 |
|
|
|
|
|
|
|
|
|
|
|
600 |
|
|
NeuStar, Inc.-Class A* |
|
|
20,244 |
|
|
800 |
|
|
Synopsys, Inc.* |
|
|
22,376 |
|
|
300 |
|
|
TeleNav, Inc.* |
|
|
2,466 |
|
|
700 |
|
|
TeleTech Holdings, Inc.* |
|
|
12,327 |
|
|
2,600 |
|
|
Total System Services, Inc. |
|
|
52,104 |
|
|
1,200 |
|
|
United Online, Inc. |
|
|
6,336 |
|
|
400 |
|
|
Valueclick, Inc.* |
|
|
6,184 |
|
|
300 |
|
|
Websense, Inc.* |
|
|
5,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Software & Services |
|
|
398,519 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Technology Hardware & Equipment 4.0% |
|
|
|
|
|
1,400 |
|
|
Arrow Electronics, Inc.* |
|
|
51,184 |
|
|
400 |
|
|
Brightpoint, Inc.* |
|
|
3,996 |
|
|
300 |
|
|
Comtech Telecommunications Corp. |
|
|
9,087 |
|
|
200 |
|
|
Harris Corp. |
|
|
7,120 |
|
|
1,400 |
|
|
Ingram Micro, Inc.-Class A* |
|
|
25,214 |
|
|
400 |
|
|
Insight Enterprises, Inc.* |
|
|
5,856 |
|
|
1,200 |
|
|
NCR Corp.* |
|
|
20,988 |
|
|
400 |
|
|
PC Connection, Inc. |
|
|
4,052 |
|
|
200 |
|
|
Scansource, Inc.* |
|
|
7,022 |
|
|
400 |
|
|
SYNNEX Corp.* |
|
|
11,740 |
|
|
600 |
|
|
Tech Data Corp.* |
|
|
29,538 |
|
|
400 |
|
|
Zebra Technologies Corp.* |
|
|
15,144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Technology Hardware & Equipment |
|
|
190,941 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Telecommunication Services 0.3% |
|
|
|
|
|
1,800 |
|
|
Cincinnati Bell, Inc.* |
|
|
5,292 |
|
|
200 |
|
|
IDT Corp.-Class B |
|
|
2,600 |
|
|
700 |
|
|
Premiere Global Services, Inc.* |
|
|
5,789 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Telecommunication Services |
|
|
13,681 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Utilities 1.3% |
|
|
|
|
|
700 |
|
|
Atmos Energy Corp. |
|
|
23,947 |
|
|
500 |
|
|
PNM Resources, Inc. |
|
|
9,555 |
|
|
400 |
|
|
Portland General Electric Co. |
|
|
10,020 |
|
|
600 |
|
|
UGI Corp. |
|
|
17,976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Utilities |
|
|
61,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL COMMON STOCKS (COST $4,364,629) |
|
|
4,669,555 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MUTUAL FUNDS 3.3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 3.3% |
|
|
|
|
|
6,399 |
|
|
GMO U.S. Treasury Fund |
|
|
160,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $160,048) |
|
|
160,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RIGHTS/WARRANTS 0.2% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance 0.2% |
|
|
|
|
|
1,295 |
|
|
American International Group, Inc., Warrants, Strike 45.00 * |
|
|
7,926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL RIGHTS/WARRANTS (COST $22,015) |
|
|
7,926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.6% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.6% |
|
|
|
|
|
27,309 |
|
|
State Street Institutional Treasury Money Market Fund-Institutional Class, 0.00% (a) |
|
|
27,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $27,309) |
|
|
27,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 101.4%
(Cost $4,574,001) |
|
|
4,864,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (1.4%) |
|
|
(66,885 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
4,797,953 |
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments:
|
|
|
REIT |
Real Estate Investment Trust |
* |
Non-income producing security. |
(a) |
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
4,590,427 |
|
$ |
512,956 |
|
|
$ |
(238,545 |
) |
|
$ |
274,411 |
|
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments
of the underlying funds should be read in conjunction with the Funds Schedule of Investments.
A Summary of the Funds transactions in the shares of other funds of the Trust during the period ended
November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO U.S. Treasury Fund |
|
$ |
185,000 |
|
|
$ |
694,000 |
|
|
$ |
718,952 |
|
|
$ |
44 |
|
|
$ |
|
|
|
$ |
160,048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. See
Derivative financial instruments below for a further discussion on valuation of derivatives.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Common Stocks |
|
$ |
4,669,555 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
4,669,555 |
|
Mutual Funds |
|
|
160,048 |
|
|
|
|
|
|
|
|
|
|
|
160,048 |
|
Rights/Warrants |
|
|
|
|
|
|
7,926 |
|
|
|
|
|
|
|
7,926 |
|
Short-Term Investments |
|
|
27,309 |
|
|
|
|
|
|
|
|
|
|
|
27,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
4,856,912 |
|
|
|
7,926 |
|
|
|
|
|
|
|
4,864,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
4,856,912 |
|
|
$ |
7,926 |
|
|
$ |
|
|
|
$ |
4,864,838 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
All of the Funds common stocks held at period end are classified as Level 1. Please refer
to the Schedule of Investments for a more detailed categorization of common stocks.
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in
the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does
not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If the Fund purchases equity investments at a discount from their value
as determined by the Manager, the Fund runs the risk that the market prices of these
investments will not increase to that value for a variety of reasons, one of which may be
the Managers overestimation of value of those investments. The Fund also may purchase
equity investments that typically trade at higher multiples of current earnings than other
securities, and the market values of these investments often are more sensitive to changes
in future earnings expectations than those other securities. Because the Fund normally does
not take temporary defensive positions, declines in stock market prices generally are
likely to reduce the net asset value of the Funds shares.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Liquidity Risk Shares of small- and mid-cap companies often have lower trading
volumes and a limited number or no market makers. Thus, a large position may limit or
prevent the Fund from selling those shares or unwinding derivative positions on them at
desirable prices. The more less-liquid securities the Fund holds, the more likely it is to
honor a redemption request in-kind.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk and
counterparty risk.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Leveraging Risk The Funds use of derivatives and securities lending may cause its
portfolio to be leveraged. Leverage increases the Funds portfolio losses when the value of
its investments decline.
Focused Investment Risk Focusing investments in sectors or companies or in
industries with high positive correlations to one another creates additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. For example, the Fund may use derivatives instead of investing directly in equity
securities, including using equity derivatives, to maintain equity exposure when it holds cash
by equitizing its cash balances using futures contracts or other types of derivatives.
The Fund also may use derivatives in an attempt to reduce its investment exposures (which may
result in a reduction below zero).
In addition, the Fund may use derivatives in an attempt to adjust elements of its investment
exposures to various securities, sectors and markets without actually having to sell existing
investments or make new direct investments. For example, if the Fund holds a large proportion of
stocks of companies in a particular sector and the Manager believes that stocks of companies in
another sector will outperform those stocks, the Fund might use a short futures contract on an
appropriate index (to synthetically sell a portion of the Funds portfolio) in combination
with a long futures contract on another index (to synthetically buy exposure to that index).
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund does not employ leverage as a principal investment strategy, but the Fund may have net
long exposure in excess of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with more standardized terms. As a result, incorrect valuations may result in
increased cash payments to counterparties, undercollateralization and/or errors in the
calculation of the Funds net asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates, or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to maintain
the diversity and liquidity of the portfolio. The Fund had no futures contracts outstanding at
the end of the period.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. The Fund had no purchased option contracts outstanding at the end of the period.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions), securities
or currencies it owns or in which it may invest. Writing options alters the Funds exposure to
the underlying asset by, in the case of a call option, obligating the Fund to sell the
underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. The Fund had no written option contracts
outstanding at the end of the period.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund values OTC options using inputs provided by primary pricing sources and
industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of available
swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. The Fund had no swap agreements outstanding at the end of the period.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit the
Funds ability to exercise the warrants or rights at such times and in such quantities as the
Fund would otherwise wish. During the period ended November 30, 2011, the Fund held rights
and/or warrants received as a result of a corporate action. Rights and/or warrants held
by the Fund at the end of the period are listed in the Funds Schedule of Investments.
The following is a summary of the fair valuations of derivative instruments categorized by risk exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (rights and/or warrants) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
7,926 |
|
|
$ |
|
|
|
$ |
7,926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
7,926 |
|
|
$ |
|
|
|
$ |
7,926 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts and rights and/or warrants) outstanding at each month-end, was as follows for the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
Futures |
|
Rights and/or |
|
|
Contracts |
|
Warrants |
Average amount outstanding |
|
$ |
20,021 |
|
|
$ |
11,596 |
|
Subsequent events
Effective
January 16, 2012, GMO U.S. Small/Mid Cap Value Fund was renamed GMO U.S.
Small/Mid Cap Fund. As of that date, the Manager will seek to achieve the Funds investment
objective by investing in equities or groups of equities that the Manager believes will provide
higher returns than the Russell 2500 Index.
Effective January 16, 2012, the Funds benchmark is the Russell 2500 Index. The Russell 2500
Index is an independently maintained and widely published index that measures the performance of
the small to mid-cap segment of the U.S. equity universe. The Russell 2500 is a subset of the
Russell 3000 Index. It includes approximately 2500 of the smallest securities based on a
combination of their market cap and current index membership. Russell Investment Group is the
source and owner of the trademarks, service marks and copyrights related to the Russell Indexes.
Russell® is a trademark of Russell Investment Group.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO U.S. Treasury Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares/Par |
|
|
|
|
|
|
Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
SHORT-TERM INVESTMENTS 110.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 110.7% |
|
|
|
|
|
246,695,000 |
|
|
U.S. Treasury Bill, 0.00%, due 12/01/11 (b) |
|
|
246,695,000 |
|
|
53,075,000 |
|
|
U.S. Treasury Bill, 0.00%, due 12/08/11 (b) |
|
|
53,075,000 |
|
|
158,800,000 |
|
|
U.S. Treasury Bill, 0.01%, due 12/15/11 (b) |
|
|
158,799,354 |
|
|
346,850,000 |
|
|
U.S. Treasury Bill, 0.01%, due 12/22/11 (b) |
|
|
346,847,930 |
|
|
769,080,000 |
|
|
U.S. Treasury Bill, 0.02%, due 12/29/11 (b) |
|
|
769,070,496 |
|
|
85,000,000 |
|
|
U.S. Treasury Bill, 0.01%, due 02/09/12 (b) |
|
|
84,998,045 |
|
|
125,000,000 |
|
|
U.S. Treasury Bill, 0.01%, due 02/16/12 (b) |
|
|
124,996,750 |
|
|
134,400,000 |
|
|
U.S. Treasury Bill, 0.02%, due 02/23/12 (b) |
|
|
134,396,237 |
|
|
150,000,000 |
|
|
U.S. Treasury Bill, 0.02%, due 03/01/12 (b) |
|
|
149,993,100 |
|
|
69,000,000 |
|
|
U.S. Treasury Bill, 0.03%, due 04/12/12 (b) |
|
|
68,992,341 |
|
|
66,000,000 |
|
|
U.S. Treasury Note, 0.88%, due 01/31/12 |
|
|
66,092,796 |
|
|
50,000,000 |
|
|
U.S. Treasury Note, 1.38%, due 02/15/12 |
|
|
50,138,650 |
|
|
84,000,000 |
|
|
U.S. Treasury Note, 0.88%, due 02/29/12 |
|
|
84,173,880 |
|
|
100,000,000 |
|
|
U.S. Treasury Note, 1.00%, due 03/31/12 |
|
|
100,316,400 |
|
|
38,000,000 |
|
|
U.S. Treasury Note, 1.38%, due 04/15/12 |
|
|
38,185,554 |
|
|
25,000,000 |
|
|
U.S. Treasury Note, 1.00%, due 04/30/12 |
|
|
25,097,650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government |
|
|
2,501,869,183 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 0.2% |
|
|
|
|
|
4,632,968 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00%(a) |
|
|
4,632,968 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $2,506,509,306) |
|
|
2,506,502,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 110.9%
(Cost $2,506,509,306) |
|
|
2,506,502,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (10.9%) |
|
|
(245,890,599 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
2,260,611,552 |
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Schedule of Investments: |
|
(a) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
|
(b) |
|
Rate shown represents yield-to-maturity. |
As of November 30, 2011, the approximate cost for U.S. federal income tax
purposes and gross and net unrealized appreciation (depreciation) in value of
investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
|
Gross |
|
|
Net Unrealized |
|
|
|
|
|
Unrealized |
|
|
Unrealized |
|
|
Appreciation |
|
Aggregate Cost |
|
|
Appreciation |
|
|
(Depreciation) |
|
|
(Depreciation) |
|
$ |
2,506,509,306 |
|
|
$ |
6,739 |
|
|
$ |
(13,894 |
) |
|
$ |
(7,155 |
) |
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost, which approximates
market value. Shares of open-end investment companies are generally valued at their net asset
value. Derivatives and other securities for which quotations are not readily available or whose
values the Manager has determined to be unreliable are valued at fair value as determined in
good faith by the Trustees or persons acting at their direction pursuant to procedures approved
by the Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
U.S. Treasury Bills having sixty days or less to final maturity were valued using amortized
cost.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Short-Term Investments |
|
$ |
932,014,371 |
|
|
$ |
1,574,487,780 |
|
|
$ |
|
|
|
$ |
2,506,502,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
932,014,371 |
|
|
|
1,574,487,780 |
|
|
|
|
|
|
|
2,506,502,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
932,014,371 |
|
|
$ |
1,574,487,780 |
|
|
$ |
|
|
|
$ |
2,506,502,151 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At November 30, 2011, the Funds investments in U.S. Treasury Bills having sixty days or
less to final maturity were valued using amortized cost, in accordance with rules under the
Investment Company Act of 1940. Amortized cost approximates the current fair value of a
security, as the value is not obtained from a quoted price in an active market. Securities
valued at amortized cost are considered to be valued using Level 2.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011, whose fair value was categorized using Level 3 inputs.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in
the Fund. Selected
risks of investing in the Fund are summarized below. The risks of investing in the Fund depend
on the types of investments in its portfolio and the investment strategies the Manager employs
on its behalf. This section does
not describe every potential risk of investing in the Fund. The Fund could be subject to
additional risks because of the types of investments it makes and market conditions, which may
change over time.
Market Risk Fixed Income Securities Typically, the market value of the Funds
U.S. Treasury and other fixed income securities will decline during periods of rising
interest rates, and yields on the Funds securities may equal or approach zero under some
market conditions. |
|
Credit Risk Securities issued by the U.S. Treasury or U.S. government agencies
generally present minimal credit risk. However, a security backed by the full faith and
credit of the U.S. government is guaranteed only as to the timely payment of interest and
principal when held to maturity. The market prices for such securities are not guaranteed
and will fluctuate. |
|
Focused Investment Risk Focusing investments in a particular type of security (e.g.,
Direct U.S. Treasury Obligations) creates additional risk. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund is also
subject to the risk that deficiencies in the Managers or another service providers
internal systems or controls will cause losses for the Fund or impair Fund operations. |
|
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
Derivative financial instruments
At
November 30, 2011, the Fund held no derivative financial
instruments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO World Opportunities Equity Allocation Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Shares / Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
MUTUAL FUNDS 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Affiliated Issuers 100.0% |
|
|
|
|
|
2,615,976 |
|
|
GMO Emerging Markets Fund, Class VI |
|
|
30,580,758 |
|
|
2,568,052 |
|
|
GMO Flexible Equities Fund, Class VI |
|
|
44,016,406 |
|
|
8,201,643 |
|
|
GMO International Growth Equity Fund, Class IV |
|
|
175,515,155 |
|
|
15,535,839 |
|
|
GMO International Intrinsic Value Fund, Class IV |
|
|
302,948,868 |
|
|
22,576,199 |
|
|
GMO Quality Fund, Class VI |
|
|
493,064,184 |
|
|
8,164,162 |
|
|
GMO U.S. Core Equity Fund, Class VI |
|
|
99,112,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL MUTUAL FUNDS (COST $1,077,652,693) |
|
|
1,145,238,298 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 0.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposits 0.0% |
|
|
|
|
|
24,047 |
|
|
State Street Eurodollar Time Deposit, 0.01%, due 12/01/11 |
|
|
24,047 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $24,047) |
|
|
24,047 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 100.0%
(Cost $1,077,676,740) |
|
|
1,145,262,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (0.0%) |
|
|
(70,921 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
1,145,191,424 |
|
|
|
|
|
|
|
|
|
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and net unrealized appreciation
(depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
$1,193,510,682 |
|
$ |
|
|
|
$ |
(48,248,337 |
) |
|
$ |
(48,248,337 |
) |
Investments in Affiliated Issuers
The Fund makes investments in other GMO Trust funds (underlying funds). The Schedule of Investments of the underlying funds should be read in conjunction with the
Funds Schedule of Investments.
A summary of the Funds transactions in the shares of other funds of the Trust during the period ended November 30, 2011 is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Distributions |
|
|
|
|
|
|
beginning of |
|
|
|
|
|
|
Sales |
|
|
Dividend |
|
|
of Realized |
|
|
Value, end |
|
Affiliate |
|
period |
|
|
Purchases |
|
|
Proceeds |
|
|
Income |
|
|
Gains |
|
|
of period |
|
GMO Emerging
Markets Fund, Class
VI |
|
$ |
36,098,808 |
|
|
$ |
3,411,279 |
|
|
$ |
1,716,225 |
|
|
$ |
12,287 |
|
|
$ |
2,750,906 |
|
|
$ |
30,580,758 |
|
GMO Flexible
Equities Fund,
Class VI |
|
|
13,135,642 |
|
|
|
36,831,894 |
|
|
|
1,990,803 |
|
|
|
|
|
|
|
|
|
|
|
44,016,406 |
|
GMO International
Growth Equity Fund,
Class IV |
|
|
308,748,264 |
|
|
|
6,362,079 |
|
|
|
109,464,934 |
|
|
|
1,947,735 |
|
|
|
|
|
|
|
175,515,155 |
|
GMO International
Intrinsic Value
Fund, Class IV |
|
|
308,871,163 |
|
|
|
79,474,947 |
|
|
|
39,665,571 |
|
|
|
5,358,282 |
|
|
|
|
|
|
|
302,948,868 |
|
GMO Quality Fund,
Class VI |
|
|
438,782,086 |
|
|
|
65,243,784 |
|
|
|
31,461,291 |
|
|
|
7,183,905 |
|
|
|
|
|
|
|
493,064,184 |
|
GMO U.S. Core
Equity Fund,
Class
VI |
|
|
109,432,403 |
|
|
|
3,816,168 |
|
|
|
14,821,574 |
|
|
|
1,627,346 |
|
|
|
|
|
|
|
99,112,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Totals |
|
$ |
1,215,068,366 |
|
|
$ |
195,140,151 |
|
|
$ |
199,120,398 |
|
|
$ |
16,129,555 |
|
|
$ |
2,750,906 |
|
|
$ |
1,145,238,298 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Shares of the underlying funds and other investment funds are generally valued at their net
asset value. Investments held by the underlying funds are valued as follows: Securities listed
on a securities exchange (other than exchange-traded options) for which market quotations are
readily available are valued at (i) the last sale price or (ii) official closing price as of the
close of regular trading on the New York Stock Exchange (NYSE) or, (iii) if there is no such
reported sale or official closing price (or in the event the Manager deems the over-the-counter
(OTC) market to be a better indicator of market value), at the most recent quoted price.
Unlisted securities for which market quotations are readily available are generally valued at
the most recent quoted price. Non-emerging market debt instruments with a remaining maturity of
sixty days or less may be valued at amortized cost (unless circumstances dictate otherwise; for
example, if the issuers creditworthiness has become impaired), which approximates market value.
Derivatives and other securities for which quotations are not readily available or whose values
the Manager has determined to be unreliable are valued at fair value as determined in good faith
by the Trustees or persons acting at their direction pursuant to procedures approved by the
Trustees. Although the goal of fair valuation is to determine the amount the owner of the
securities might reasonably expect to receive upon their current sale, because of the
uncertainty inherent in fair value pricing, the value determined for a particular security may
be materially different from the value realized upon its sale. As of November 30, 2011, the
total value of securities held directly and indirectly that were fair valued using methods determined in good
faith by or at the direction of the Trustees of the Trust represented 0.1% of net assets. The
underlying funds classify such securities (levels defined below) as Level 3.
Additionally, the fair value of equity securities listed on foreign exchanges and securities
markets that are closed prior to the close of the NYSE due to time zone differences (including
the value of equity securities that underlie futures (to the extent the market for such futures
closes prior to the close of the NYSE) and other derivatives) will be adjusted, to the extent
practicable and available, based on inputs from an independent pricing service approved by the
Trustees. The table below shows the percentage of the net assets of the Fund, either directly or
through investments in the underlying funds, that were valued using fair value prices obtained
from an independent pricing service as of November 30, 2011. These securities listed on foreign
exchanges (including the value of equity securities that underlie futures (to the extent the
market for such futures closes prior to the close of the NYSE) and other derivatives) are
classified as being valued using Level 2 inputs in the table below
and as described in the disclosures of the
underlying funds.
|
|
|
Security Type |
|
Percentage of Net Assets of the Fund |
Equity Securities |
|
49.9% |
Futures Contracts |
|
0.2% |
Swap Agreements |
|
(0.0)%^ |
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
Level 3 Valuations based primarily on inputs that are unobservable and significant.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mutual Funds |
|
$ |
1,145,238,298 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,145,238,298 |
|
Short-Term Investments |
|
|
24,047 |
|
|
|
|
|
|
|
|
|
|
|
24,047 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
1,145,262,345 |
|
|
|
|
|
|
|
|
|
|
|
1,145,262,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,145,262,345 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1,145,262,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The underlying funds held at period end are classified above as Level 1. For the summary of
valuation inputs (including Level 3 inputs, if any) of the underlying funds, please refer to the
underlying funds portfolio valuation notes. The aggregate net values of the Funds indirect
investments in securities and derivative financial instruments using Level 3 inputs were 0.1%
and 0.0% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The Fund held no investments or derivative financial instruments directly at either November 30,
2011 or February 28, 2011 whose fair value was categorized using Level 3 inputs.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. References to
investments include those held directly by the Fund and indirectly through the Funds
investments in the underlying funds. Some of the underlying funds are non-diversified investment
companies under the Investment Company Act of 1940 (the 1940 Act) and therefore a decline in
the market value of a particular security held by those funds may affect their performance more
than if they were diversified. Selected risks of investing in the Fund are summarized below,
including those risks to which the Fund is exposed as a result of its investments in the
underlying funds. The risks of investing in the Fund depend on the types of investments in its
portfolio and the investment strategies the Manager employs on its behalf. This section does not
describe every potential risk of investing in the Fund. The Fund could be subject to additional
risks because of the types of investments it makes and market conditions, which may change over
time.
Market Risk Equity Securities The market value of equity investments may decline
due to factors affecting the issuing companies, their industries, or the economy and equity
markets generally. If an underlying fund purchases equity investments at a discount from
their value as determined by the Manager, the Fund runs the risk that the market prices of
these investments will not increase to that value for a variety of reasons, one of which
may be the Managers overestimation of the value of those investments. An underlying fund
also may purchase equity investments that typically trade at higher multiples of current
earnings than other securities, and the market values of these investments often are more
sensitive to changes in future earnings expectations than those other securities. Because
the Fund and the underlying funds normally do not take temporary defensive positions,
declines in stock market prices generally are likely to reduce the net asset value of the
Funds shares.
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. These and
other risks (e.g., nationalization, expropriation or other confiscation of assets of
foreign issuers) tend to be greater for investments in companies tied economically to
emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
Liquidity Risk Low trading volume, lack of a market maker, large size of position or
legal restrictions may limit or prevent the Fund or an underlying fund from selling
particular securities or unwinding derivative positions at desirable prices. The more
less-liquid securities the Fund holds, the more likely it is to honor a redemption request
in-kind.
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk.
Fund of Funds Risk The Fund is indirectly exposed to all of the risks of an
investment in the underlying funds, including the risk that the underlying funds in which
it invests do not perform as expected. Because the Fund bears the fees and expenses of the
underlying funds in which it invests, new investments in underlying funds with higher fees
or expenses than those of the underlying funds in which the Fund is currently invested will
increase the Funds total expenses. The fees and expenses associated with an investment in
the Fund are less predictable and may be higher than fees and expenses associated with an
investment in funds that charge a fixed management fee.
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations.
Smaller Company Risk Smaller companies may have limited product lines, markets or
financial resources, may lack the competitive strength of larger companies, or may lack
managers with experience or depend on a few key employees. The securities of small- and
midcap companies often are less widely held and trade less frequently and in lesser
quantities, and their market prices often fluctuate more, than the securities of companies
with larger market capitalizations.
Commodities Risk To the extent an underlying fund has exposure to global commodity
markets, the value of its shares is affected by factors particular to the commodity markets
and may fluctuate more than the value of shares of a fund with a broader range of
investments.
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of foreign currency holdings and investments denominated in foreign currencies, or that the
U.S. dollar will decline in value relative to the foreign currency being hedged.
Leveraging Risk The use of reverse repurchase agreements and other derivatives and
securities lending may cause the Funds portfolio to be leveraged. Leverage increases the
Funds portfolio losses when the value of its investments decline.
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations.
Real Estate Risk To the extent an underlying fund concentrates its assets in real
estate-related investments, the value of its portfolio is subject to factors affecting the
real estate industry and may fluctuate more than the value of a portfolio that consists of
securities of companies in a broader range of industries.
Short Sales Risk The Fund runs the risk that an underlying funds loss on a short
sale of securities that the underlying fund does not own is unlimited.
Market Risk Fixed Income Securities Typically, the market value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads.
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value.
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating.
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies or in industries with high positive correlations to one another creates
additional risk.
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments.
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors), the Fund is subject to the risk that these
shareholders will disrupt the Funds operations by purchasing or redeeming Fund shares in
large amounts and/or on a frequent basis.
Derivative financial instruments
At November 30, 2011, the Fund held no derivative financial instruments directly. For a
listing of derivative financial instruments held by the underlying funds, if any, please refer
to the underlying funds Schedule of Investments.
For additional information regarding the Funds Schedule of Investments, please see the Funds
most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
GMO World Opportunity Overlay Fund
(A Series of GMO Trust)
Schedule of Investments
(showing percentage of total net assets)
November 30, 2011 (Unaudited)
|
|
|
|
|
|
|
|
|
Par Value ($) |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
DEBT OBLIGATIONS 96.9% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities 25.5% |
|
|
|
|
|
|
|
|
Auto Financing 1.4% |
|
|
|
|
|
6,892,818 |
|
|
Carmax Auto Owner Trust, Series 08-2, Class A4B, 1 mo. LIBOR + 1.65%, 1.90%, due 08/15/13 |
|
|
6,934,796 |
|
|
2,072,152 |
|
|
Daimler Chrysler Auto Trust, Series 08-B, Class A4A, 5.32%, due 11/10/14 |
|
|
2,083,549 |
|
|
2,201,416 |
|
|
Merrill Auto Trust Securitization, Series 08-1, Class A4B, 1 mo. LIBOR + 2.20%, 2.45%, due 04/15/15 |
|
|
2,210,001 |
|
|
575,858 |
|
|
Merrill Auto Trust Securitization, Series 07-1, Class A4, 1 mo. LIBOR + .06%, 0.31%, due 12/15/13 |
|
|
575,685 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Auto Financing |
|
|
11,804,031 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business Loans 1.4% |
|
|
|
|
|
1,213,359 |
|
|
Bayview Commercial Asset Trust, Series 04-3, Class A1, 144A, 1 mo. LIBOR + .37%, 0.63%, due 01/25/35 |
|
|
910,019 |
|
|
1,770,058 |
|
|
Bayview Commercial Asset Trust, Series 05-4A, Class A2, 144A, 1 mo. LIBOR + .39%, 0.65%, due 01/25/36 |
|
|
1,115,137 |
|
|
8,593,472 |
|
|
Bayview Commercial Asset Trust, Series 07-6A, Class A2, 144A, 1 mo. LIBOR + 1.30%, 1.56%, due 12/25/37 |
|
|
6,015,430 |
|
|
1,254,477 |
|
|
GE Business Loan Trust, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .24%, 0.49%, due 11/15/33 |
|
|
1,028,671 |
|
|
1,511,906 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-1A, Class A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 02/25/30 |
|
|
1,163,503 |
|
|
1,019,391 |
|
|
Lehman Brothers Small Balance Commercial, Series 05-2A, Class 1A, 144A, 1 mo. LIBOR + .25%, 0.51%, due 09/25/30 |
|
|
804,197 |
|
|
1,312,822 |
|
|
Lehman Brothers Small Balance Commercial, Series 07-3A, Class 1A2, 144A, 1 mo. LIBOR + .85%, 1.11%, due 10/25/37 |
|
|
1,049,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Business Loans |
|
|
12,086,716 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS 3.5% |
|
|
|
|
|
2,540,096 |
|
|
Citigroup/Deutsche Bank Commercial Mortgage, Series 05-CD1, Class A2FL, 1 mo. LIBOR + .12%, 0.37%, due 07/15/44 |
|
|
2,508,345 |
|
|
11,500,000 |
|
|
Commercial Mortgage Pass-Through Certificates, Series 06-FL12, Class AJ, 144A, 1 mo. LIBOR + .13%, 0.38%, due 12/15/20 |
|
|
10,407,500 |
|
|
1,691,733 |
|
|
GE Capital Commercial Mortgage Corp., Series 05-C4, Class A2, 5.31%, due 11/10/45 |
|
|
1,691,733 |
|
|
2,760,406 |
|
|
GE Capital Commercial Mortgage Corp., Series 06-C1, Class A2, 5.33%, due 03/10/44 |
|
|
2,760,406 |
|
|
3,279,218 |
|
|
GS Mortgage Securities Corp., Series 06-GG6, Class A2, 5.51%, due 04/10/38 |
|
|
3,310,985 |
|
|
3,708,115 |
|
|
Merrill Lynch Mortgage Trust, Series 06-C1, Class A2, 5.62%, due 05/12/39 |
|
|
3,780,794 |
|
|
1,738,928 |
|
|
Morgan Stanley Capital I, Series 06-IQ11, Class A3, 5.69%, due 10/15/42 |
|
|
1,772,820 |
|
|
4,128,197 |
|
|
Wachovia Bank Commercial Mortgage Trust, Series 06-WL7A, Class A1, 144A, 1 mo. LIBOR + .09%, 0.34%, due 09/15/21 |
|
|
3,921,787 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS |
|
|
30,154,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS Collateralized Debt Obligations 0.7% |
|
|
|
|
|
6,777,455 |
|
|
American Capital Strategies Ltd. Commercial Real Estate CDO Trust, Series 07-1A, Class A, 144A, 3 mo. LIBOR + .80%, 1.30%, due 11/23/52 |
|
|
67,774 |
|
|
1,149,499 |
|
|
Guggenheim Structured Real Estate Funding, Series 05-2A, Class A, 144A, 1 mo. LIBOR + .32%, 0.58%, due 08/26/30 |
|
|
1,060,413 |
|
|
6,176,887 |
|
|
Marathon Real Estate CDO, Series 06-1A, Class A1, 144A, 1 mo. LIBOR + .33%, 0.59%, due 05/25/46 |
|
|
4,509,128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total CMBS Collateralized Debt Obligations |
|
|
5,637,315 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Collateralized Debt Obligations 0.5% |
|
|
|
|
|
4,800,000 |
|
|
Morgan Stanley ACES SPC, Series 06-13A, Class A, 144A, 3 mo. LIBOR + .29%, 0.64%, due 06/20/13 |
|
|
4,228,320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Cards 1.5% |
|
|
|
|
|
7,700,000 |
|
|
Charming Shoppes Master Trust, Series 07-1A, Class A1, 144A, 1 mo. LIBOR + 1.25%, 1.50%, due 09/15/17 |
|
|
7,712,705 |
|
|
3,900,000 |
|
|
Discover Card Master Trust I, Series 05-4, Class A2, 1 mo. LIBOR + .09%, 0.34%, due 06/16/15 |
|
|
3,898,172 |
|
|
900,000 |
|
|
World Financial Network Credit Card Master Trust, Series 06-A, Class A, 144A, 1 mo. LIBOR + .13%, 0.38%, due 02/15/17 |
|
|
892,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Credit Cards |
|
|
12,503,848 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Auto Financing 1.6% |
|
|
|
|
|
755,016 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-AX, Class A4, XL, 1 mo. LIBOR + .04%, 0.29%, due 10/06/13 |
|
|
753,128 |
|
|
1,234,986 |
|
|
AmeriCredit Automobile Receivables Trust, Series 07-DF, Class A4B, FSA, 1 mo. LIBOR + .80%, 1.05%, due 06/06/14 |
|
|
1,234,349 |
|
|
3,098,487 |
|
|
AmeriCredit Prime Automobile Receivable Trust, Series 07-2M, Class A4B, MBIA, 1 mo. LIBOR + .50%, 0.75%, due 03/08/16 |
|
|
3,086,713 |
|
|
8,145,797 |
|
|
Triad Auto Receivables Owner Trust, Series 07-B, Class A4B, FSA, 1 mo. LIBOR + 1.20%, 1.45%, due 07/14/14 |
|
|
8,185,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Auto Financing |
|
|
13,259,657 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Other 0.7% |
|
|
|
|
|
2,691,272 |
|
|
Henderson Receivables LLC, Series 06-3A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 09/15/41 |
|
|
2,384,614 |
|
|
2,074,825 |
|
|
Henderson Receivables LLC, Series 06-4A, Class A1, 144A, MBIA, 1 mo. LIBOR + .20%, 0.45%, due 12/15/41 |
|
|
1,845,865 |
|
|
1,727,859 |
|
|
TIB Card Receivables Fund, Series 2005-B,144A, FGIC, 3 mo. LIBOR + .25%, 0.63%, due 01/05/14 |
|
|
1,382,287 |
|
|
9,200,000 |
|
|
Toll Road Investment Part II, Series C, 144A, MBIA, Zero Coupon, due 02/15/37 |
|
|
575,828 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Other |
|
|
6,188,594 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured
Residential Asset-Backed Securities (United States) ♦ 0.7% |
|
|
|
|
|
7,122,517 |
|
|
Ameriquest Mortgage Securities, Inc., Series 04-R6, Class A1, XL, 1 mo. LIBOR + .21%, 0.68%, due 07/25/34 |
|
|
5,626,788 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Residential Mortgage-Backed Securities (United States) 0.1% |
|
|
|
|
|
803,365 |
|
|
SBI Heloc Trust, Series 05-HE1, Class 1A, 144A, FSA, 1 mo. LIBOR + .19%, 0.45%, due 11/25/35 |
|
|
727,769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Time Share 0.3% |
|
|
|
|
|
261,468 |
|
|
Sierra Receivables Funding Co., Series 06-1A, Class A2, 144A, MBIA, 1 mo. LIBOR + .15%, 0.40%, due 05/20/18 |
|
|
258,774 |
|
|
2,273,138 |
|
|
Sierra Receivables Funding Co., Series 07-2A, Class A2, 144A, MBIA, 1 mo. LIBOR + 1.00%, 1.25%, due 09/20/19 |
|
|
2,206,742 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Insured Time Share |
|
|
2,465,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Insured Transportation 0.4% |
|
|
|
|
|
3,578,198 |
|
|
CLI Funding LLC, Series 06-1A, Class A, 144A, AMBAC, 1 mo. LIBOR + .18%, 0.43%, due 08/18/21 |
|
|
3,291,942 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Asset-Backed Securities (United States) ♦ 8.4% |
|
|
|
|
|
9,400,000 |
|
|
ACE Securities Corp., Series 06-ASP5, Class A2C, 1 mo. LIBOR + .18%, 0.44%, due 10/25/36 |
|
|
2,632,000 |
|
|
1,407,928 |
|
|
ACE Securities Corp., Series 06-CW1, Class A2B, 1 mo. LIBOR + .10%, 0.36%, due 07/25/36 |
|
|
1,316,412 |
|
|
10,877,178 |
|
|
ACE Securities Corp., Series 06-HE2, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 05/25/36 |
|
|
5,329,817 |
|
|
403,351 |
|
|
ACE Securities Corp., Series 06-HE3, Class A2B, 1 mo. LIBOR + .09%, 0.35%, due 06/25/36 |
|
|
367,050 |
|
|
733,192 |
|
|
ACE Securities Corp., Series 06-SL1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 09/25/35 |
|
|
128,309 |
|
|
1,817,309 |
|
|
ACE Securities Corp., Series 06-SL3, Class A1, 1 mo. LIBOR + .10%, 0.36%, due 06/25/36 |
|
|
295,313 |
|
|
1,975,874 |
|
|
ACE Securities Corp., Series 06-SL3, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 06/25/36 |
|
|
242,045 |
|
|
1,090,999 |
|
|
ACE Securities Corp., Series 06-SL4, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 09/25/36 |
|
|
223,655 |
|
|
4,243,165 |
|
|
ACE Securities Corp., Series 07-ASL1, Class A2, 1 mo. LIBOR + .17%, 0.43%, due 12/25/36 |
|
|
403,101 |
|
|
1,154,495 |
|
|
ACE Securities Corp., Series 07-WM1, Class A2A, 1 mo. LIBOR + .07%, 0.33%, due 11/25/36 |
|
|
386,756 |
|
|
|
|
|
|
|
|
|
|
|
9,692,520 |
|
|
Argent Securities, Inc., Series 06-M1, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
2,517,026 |
|
|
5,538,375 |
|
|
Argent Securities, Inc., Series 06-M2, Class A2B, 1 mo. LIBOR + .11%, 0.37%, due 09/25/36 |
|
|
1,619,975 |
|
|
1,807,004 |
|
|
Argent Securities, Inc., Series 06-W2, Class A2B, 1 mo. LIBOR + .19%, 0.45%, due 03/25/36 |
|
|
524,031 |
|
|
1,974,603 |
|
|
Argent Securities, Inc., Series 06-W5, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
519,567 |
|
|
2,552,139 |
|
|
Asset Backed Funding Certificates, Series 06-OPT2, Class A3C, 1 mo. LIBOR + .15%, 0.41%, due 10/25/36 |
|
|
1,480,241 |
|
|
4,273,239 |
|
|
Asset Backed Funding Certificates, Series 07-NC1, Class A1, 144A, 1 mo. LIBOR + .22%, 0.48%, due 05/25/37 |
|
|
3,365,176 |
|
|
3,522,365 |
|
|
Bayview Financial Acquisition Trust, Series 05-A, Class A1, 144A, 1 mo. LIBOR + .50%, 1.26%, due 02/28/40 |
|
|
2,116,942 |
|
|
2,413,254 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A1, 1 mo. LIBOR + .11%, 0.37%, due 11/25/36 |
|
|
1,464,604 |
|
|
5,400,000 |
|
|
Bear Stearns Asset Backed Securities, Inc., Series 07-AQ1, Class A2, 1 mo. LIBOR + .20%, 0.46%, due 11/25/36 |
|
|
720,900 |
|
|
798,536 |
|
|
Bear Stearns Mortgage Funding Trust, Series 07-SL2, Class 1A, 1 mo. LIBOR + .16%, 0.58%, due 02/25/37 |
|
|
126,248 |
|
|
1,788,004 |
|
|
Centex Home Equity, Series 06-A, Class AV3, 1 mo. LIBOR + .16%, 0.42%, due 06/25/36 |
|
|
1,358,883 |
|
|
2,600,000 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 06-HE3, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 12/25/36 |
|
|
780,000 |
|
|
6,600,000 |
|
|
Citigroup Mortgage Loan Trust, Inc., Series 06-WFH4, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 |
|
|
4,554,000 |
|
|
8,112,000 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC3, Class 2A2, 1 mo. LIBOR + .14%, 0.40%, due 02/25/37 |
|
|
5,901,480 |
|
|
220,454 |
|
|
Countrywide Asset-Backed Certificates, Series 06-BC5, Class 2A1, 1 mo. LIBOR + .08%, 0.34%, due 03/25/37 |
|
|
217,588 |
|
|
4,183,519 |
|
|
Fremont Home Loan Trust, Series 06-B, Class 2A3, 1 mo. LIBOR + .16%, 0.42%, due 08/25/36 |
|
|
1,171,385 |
|
|
965,191 |
|
|
Household Home Equity Loan Trust, Series 05-2, Class A2, 1 mo. LIBOR + .31%, 0.56%, due 01/20/35 |
|
|
829,160 |
|
|
367,242 |
|
|
Household Home Equity Loan Trust, Series 05-3, Class A2, 1 mo. LIBOR + .29%, 0.54%, due 01/20/35 |
|
|
323,058 |
|
|
6,171,830 |
|
|
J.P. Morgan Mortgage Acquisition Corp., Series 06-WMC4, Class A3, 1 mo. LIBOR + .12%, 0.38%, due 12/25/36 |
|
|
1,949,681 |
|
|
228,804 |
|
|
Master Asset-Backed Securities Trust, Series 05-FRE1, Class A4, 1 mo. LIBOR + .25%, 0.51%, due 10/25/35 |
|
|
215,076 |
|
|
3,422,221 |
|
|
Master Asset-Backed Securities Trust, Series 06-FRE2, Class A4, 1 mo. LIBOR + .15%, 0.41%, due 03/25/36 |
|
|
1,197,777 |
|
|
2,700,000 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 06/25/36 |
|
|
810,000 |
|
|
5,561,305 |
|
|
Master Asset-Backed Securities Trust, Series 06-HE3, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 08/25/36 |
|
|
1,473,746 |
|
|
3,065,938 |
|
|
Master Asset-Backed Securities Trust, Series 06-NC3, Class A4, 1 mo. LIBOR + .16%, 0.42%, due 10/25/36 |
|
|
919,781 |
|
|
1,193,335 |
|
|
Master Second Lien Trust, Series 06-1, Class A, 1 mo. LIBOR + .16%, 0.58%, due 03/25/36 |
|
|
143,200 |
|
|
2,349,442 |
|
|
Merrill Lynch Mortgage Trust, Series 06-SD1, Class A, 1 mo. LIBOR + .28%, 0.54%, due 01/25/47 |
|
|
1,450,780 |
|
|
2,228,016 |
|
|
Morgan Stanley IXIS Real Estate Capital Trust, Series 06-2, Class A3, 1 mo. LIBOR + .15%, 0.41%, due 11/25/36 |
|
|
545,864 |
|
|
8,800,000 |
|
|
Nationstar Home Equity Loan Trust, Series 06-B, Class AV3, 1 mo. LIBOR + .17%, 0.43%, due 09/25/36 |
|
|
6,846,125 |
|
|
9,100,000 |
|
|
Nomura Home Equity Loan, Inc., Series 06-HE3, Class 2A3, 1 mo. LIBOR + .15%, 0.41%, due 07/25/36 |
|
|
3,576,016 |
|
|
1,505,396 |
|
|
Peoples Choice Home Loan Securities Trust, Series 05-4, Class 1A2, 1 mo. LIBOR + .26%, 0.52%, due 12/25/35 |
|
|
866,807 |
|
|
3,074,515 |
|
|
Saxon Asset Securities Trust, Series 06-3, Class A2, 1 mo. LIBOR + .11%, 0.37%, due 10/25/46 |
|
|
2,813,182 |
|
|
9,100,000 |
|
|
Securitized Asset-Backed Receivables LLC Trust, Series 06-HE1, Class A2C, 1 mo. LIBOR + .16%, 0.42%, due 07/25/36 |
|
|
2,912,000 |
|
|
191,773 |
|
|
Security National Mortgage Loan Trust, Series 06-2A, Class A1, 144A, 1 mo. LIBOR + .29%, 0.55%, due 10/25/36 |
|
|
190,335 |
|
|
272,834 |
|
|
SG Mortgage Securities Trust, Series 05-OPT1, Class A2, 1 mo. LIBOR + .26%, 0.52%, due 10/25/35 |
|
|
252,726 |
|
|
|
|
|
|
|
|
|
|
|
1,132,283 |
|
|
Soundview Home Equity Loan Trust, Series 07-NS1, Class A1, 1 mo. LIBOR + .12%, 0.38%, due 01/25/37 |
|
|
1,083,099 |
|
|
3,600,000 |
|
|
Specialty Underwriting & Residential Finance, Series 06-BC3, Class A2C, 1 mo. LIBOR + .15%, 0.41%, due 06/25/37 |
|
|
1,512,000 |
|
|
1,394,594 |
|
|
Structured Asset Investment Loan Trust, Series 06-1, Class A3, 1 mo. LIBOR + .20%, 0.46%, due 01/25/36 |
|
|
1,004,108 |
|
|
450,248 |
|
|
Structured Asset Securities Corp., Series 05-S6, Class A2, 1 mo. LIBOR + .29%, 0.84%, due 11/25/35 |
|
|
347,816 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Asset-Backed Securities (United States) |
|
|
71,024,841 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (Australian) 1.1% |
|
|
|
|
|
1,558,144 |
|
|
Crusade Global Trust, Series 06-1, Class A1, 144A, 3 mo. LIBOR + .06%, 0.47%, due 07/20/38 |
|
|
1,517,727 |
|
|
3,916,128 |
|
|
Interstar Millennium Trust, Series 04-2G, Class A, 3 mo. LIBOR + .20%, 0.74%, due 03/14/36 |
|
|
3,601,506 |
|
|
1,660,673 |
|
|
Interstar Millennium Trust, Series 05-1G, Class A, 3 mo. LIBOR + .12%, 0.74%, due 12/08/36 |
|
|
1,477,999 |
|
|
964,587 |
|
|
Medallion Trust, Series 05-1G, Class A1, 3 mo. LIBOR + .08%, 0.52%, due 05/10/36 |
|
|
930,038 |
|
|
2,308,680 |
|
|
Puma Finance Ltd., Series G5, Class A1, 144A, 3 mo. LIBOR + .07%, 0.55%, due 02/21/38 |
|
|
2,112,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (Australian) |
|
|
9,639,943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential Mortgage-Backed Securities (European) 2.8% |
|
|
|
|
|
6,414,736 |
|
|
Aire Valley Mortgages, Series 06-1A, Class 1A, 144A, 3 mo. LIBOR + .11%, 0.46%, due 09/20/66 |
|
|
5,260,084 |
|
|
4,019,671 |
|
|
Brunel Residential Mortgages, Series 07-1A, Class A4C, 144A, 3 mo. LIBOR + .10%, 0.50%, due 01/13/39 |
|
|
3,561,348 |
|
|
2,439,169 |
|
|
Granite Master Issuer Plc, Series 06-3, Class A3, 1 mo. LIBOR + .04%, 0.29%, due 12/20/54 |
|
|
2,329,406 |
|
|
4,002,519 |
|
|
Kildare Securities Ltd., Series 07-1A, Class A2, 144A, 3 mo. LIBOR + .06%, 0.40%, due 12/10/43 |
|
|
3,562,242 |
|
|
2,760,018 |
|
|
Paragon Mortgages Plc, Series 12A, Class A2C, 144A, 3 mo. LIBOR + .22%, 0.68%, due 11/15/38 |
|
|
2,044,207 |
|
|
2,510,759 |
|
|
Paragon Mortgages Plc, Series 14A, Class A2C, 144A, 3 mo. LIBOR + .10%, 0.45%, due 09/15/39 |
|
|
1,876,290 |
|
|
2,700,000 |
|
|
Permanent Master Issuer Plc, Series 06-1, Class 5A, 3 mo. LIBOR + .11%, 0.51%, due 07/15/33 |
|
|
2,673,810 |
|
|
2,250,000 |
|
|
Permanent Master Issuer Plc, Series 07-1, Class 4A, 3 mo. LIBOR + .08%, 0.48%, due 10/15/33 |
|
|
2,238,525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Residential Mortgage-Backed Securities (European) |
|
|
23,545,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Student Loans 0.4% |
|
|
|
|
|
3,100,000 |
|
|
College Loan Corp. Trust, Series 07-2, Class A1, 3 mo. LIBOR + .25%, 0.67%, due 01/25/24 |
|
|
3,022,500 |
|
|
67,580 |
|
|
National Collegiate Student Loan Trust, Series 06-1, Class A2, 1 mo. LIBOR + .14%, 0.40%, due 08/25/23 |
|
|
65,553 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Student Loans |
|
|
3,088,053 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Asset-Backed Securities |
|
|
215,273,615 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Government Obligations 5.7% |
|
|
|
|
|
GBP 25,000,000 |
|
|
U.K. Treasury Bond, 4.25%, due 12/07/46(a) |
|
|
48,569,241 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government 65.6% |
|
|
|
|
|
270,291,005 |
|
|
U.S. Treasury Inflation Indexed Note, 2.00%, due 04/15/12(b)(c) |
|
|
271,198,912 |
|
|
150,000,000 |
|
|
U.S. Treasury Note, 1.38%, due 01/15/13 |
|
|
152,009,700 |
|
|
65,000,000 |
|
|
U.S. Treasury Strip Coupon, due 05/15/22 |
|
|
50,760,450 |
|
|
105,000,000 |
|
|
U.S. Treasury Strip Coupon, due 08/15/22 |
|
|
81,101,370 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total U.S. Government |
|
|
555,070,432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Government Agency 0.1% |
|
|
|
|
|
800,000 |
|
|
U.S. Department of Transportation, 144A, 6.00%, due 12/07/21 |
|
|
877,624 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS (COST $898,341,982) |
|
|
819,790,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal Amount |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
OPTIONS PURCHASED 1.8% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency Options 0.1% |
|
|
|
|
EUR |
3,000,000 |
|
|
EUR Call/CHF Put Expires 06/16/15, Strike 1.56 (OTC) (CP JPMorgan Chase Bank, N.A.) |
|
|
829,540 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Currency Options |
|
|
829,540 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options on Interest Rate Swaps 1.7% |
|
|
|
|
USD |
64,000,000 |
|
|
Swaption Straddle Expires 04/10/18, Strike TBD
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 64,000,000
USD in which it will pay 3 month USD LIBOR and will receive a rate to be determined, maturing on
April 12, 2023, (OTC) (CP Morgan Stanley Capital Services, Inc.) (d) |
|
|
4,924,672 |
|
USD |
64,000,000 |
|
|
Swaption Straddle Expires 04/23/18, Strike TBD
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 64,000,000
USD in which it will pay 3 month USD LIBOR and will receive a rate to be determined, maturing on
April 25, 2023, (OTC) (CP Morgan Stanley Capital Services, Inc.) (d) |
|
|
4,910,208 |
|
USD |
64,000,000 |
|
|
Swaption Straddle Expires 05/01/18, Strike TBD
Upon potential exercise of the option, the Fund will enter into a swap with a notional amount of 64,000,000
USD in which it will pay 3 month USD LIBOR and will receive a rate to be determined, maturing on
May 3, 2023, (OTC) (CP Morgan Stanley Capital Services, Inc.) (d) |
|
|
4,896,704 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Options on Interest Rate Swaps |
|
|
14,731,584 |
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL OPTIONS PURCHASED (COST $10,543,550) |
|
|
15,561,124 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares |
|
|
Description |
|
Value ($) |
|
|
|
|
|
|
SHORT-TERM INVESTMENTS 9.5% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Money Market Funds 9.5% |
|
|
|
|
|
41,799,410 |
|
|
State Street Institutional Liquid Reserve Fund-Institutional Class, 0.17%(e) |
|
|
41,799,410 |
|
|
38,219,754 |
|
|
State Street Institutional Treasury Plus Money Market Fund-Institutional Class, 0.00% (f) |
|
|
38,219,754 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL SHORT-TERM INVESTMENTS (COST $80,019,164) |
|
|
80,019,164 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL INVESTMENTS 108.2%
(Cost $988,904,696) |
|
|
915,371,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Assets and Liabilities (net) (8.2%) |
|
|
(69,168,444 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL NET ASSETS 100.0% |
|
$ |
846,202,756 |
|
|
|
|
|
|
|
|
|
A summary of outstanding financial instruments at November 30, 2011 is as follows:
Reverse Repurchase Agreements
|
|
|
|
|
|
|
|
|
Face Value |
|
|
Description |
|
Market Value |
|
|
GBP |
30,810,000 |
|
|
Barclays Bank PLC, 0.53%
dated 11/18/11, to be
repurchased on demand at face
value plus accrued interest
with a stated maturity date
of 12/19/11. |
|
$ |
(48,347,034 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average balance outstanding |
|
$ |
(42,189,986 |
) |
Average interest rate |
|
|
0.56 |
% |
Maximum balance outstanding |
|
$ |
(48,647,471 |
) |
Average balance outstanding was calculated based on daily face value balances outstanding
during the period that the Fund has entered into reverse repurchase agreements.
Futures Contracts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Number of |
|
|
|
Expiration |
|
|
|
|
|
Appreciation |
|
Contracts |
|
Type |
|
Date |
|
Contract Value |
|
|
(Depreciation) |
|
Buys |
|
|
|
|
|
|
|
|
|
|
|
|
6,480 |
|
Euro Dollar 90 Day |
|
March 2012 |
|
$ |
1,610,280,000 |
|
|
$ |
979,610 |
|
|
|
|
|
|
|
|
|
|
|
|
Sales |
|
|
|
|
|
|
|
|
|
|
|
|
6,480 |
|
Euro Dollar 90 Day |
|
March 2013 |
|
$ |
1,608,984,000 |
|
|
$ |
(2,053,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
GMO World Opportunity Overlay Fund
(A Series of GMO Trust)
Schedule of Investments (Continued)
November 30, 2011 (Unaudited)
Written Options
A summary of open written option contracts for the Fund at November 30, 2011 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Principal |
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount |
|
|
Expiration Date |
|
|
Description |
|
|
Premiums |
|
|
Market Value |
|
Call |
|
|
3,000,000 |
|
|
6/14/2013 |
|
EUR Call/CHF Put, Strike 1.56% |
|
$ |
(1,097,998 |
) |
|
$ |
(242,168 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements
Credit Default Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Potential |
|
|
Net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Implied |
|
|
|
|
Amount of Future |
|
|
Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
Receive |
|
Annual |
|
|
Credit |
|
|
Reference |
|
Payments by the Fund |
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)^ |
|
Premium |
|
|
Spread (1) |
|
|
Entity |
|
Under the Contract (2) |
|
(Depreciation) |
|
|
|
96,449,886 |
|
USD |
|
12/20/2012 |
|
Morgan Stanley Capital Services Inc. |
|
Receive |
|
|
0.71 |
% |
|
|
0.010 |
% |
|
Reference security within CDX IG index |
|
|
96,449,886 |
|
|
USD |
|
$ |
856,176 |
|
|
|
250,769,703 |
|
USD |
|
12/20/2012 |
|
Morgan Stanley Capital Services Inc. |
|
Receive |
|
|
0.71 |
% |
|
|
0.010 |
% |
|
Reference security within CDX IG Index |
|
|
250,769,703 |
|
|
USD |
|
|
2,226,059 |
|
|
|
100,000,000 |
|
USD |
|
12/20/2012 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
1.20 |
% |
|
|
0.052 |
% |
|
Reference security within CDX IG Index |
|
|
N/A |
|
|
|
|
|
|
|
(1,462,375 |
) |
|
|
50,000,000 |
|
USD |
|
12/20/2012 |
|
Morgan Stanley Capital Services Inc. |
|
(Pay) |
|
|
1.93 |
% |
|
|
0.330 |
% |
|
Reference security within CDX IG index |
|
|
N/A |
|
|
|
|
|
|
|
(1,044,071 |
) |
|
|
7,000,000 |
|
USD |
|
3/20/2013 |
|
Morgan Stanley Capital Services Inc. |
|
Receive |
|
|
0.25 |
% |
|
|
2.053 |
% |
|
MS Synthetic 2006-1 |
|
|
7,000,000 |
|
|
USD |
|
|
(165,920 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
409,869 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
^ |
|
Receive Fund receives premium and sells credit protection. |
|
|
|
(Pay) Fund pays premium and buys credit protection. |
|
(1) |
|
Implied credit spreads, represented in absolute terms, utilized in determining the market value of credit default swap agreements on the reference security, as of November 30, 2011,
serve as an indicator of the current status of the payment/performance risk and reflect the likelihood or risk of default for the reference entity. The implied credit spread of a
particular referenced entity reflects the cost of buying/selling protection. Wider (i.e.higher) credit spreads represent a deterioration of the referenced entitys credit soundness
and a greater likelihood or risk of default or other credit event occurring as defined under the terms of the agreement. |
|
(2) |
|
The maximum potential amount the Fund could be required to pay as a seller of credit protection if a credit event occurs as defined under the terms of that particular swap agreement. |
Interest Rate Swaps
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Unrealized |
|
Notional |
|
|
Expiration |
|
|
|
Receive |
|
|
|
|
|
|
|
Appreciation/ |
|
Amount |
|
Date |
|
Counterparty |
|
(Pay)# |
|
Fixed Rate |
|
|
Variable Rate |
|
(Depreciation) |
|
|
|
1,000,000,000 |
|
CHF |
|
8/5/2012 |
|
Credit Suisse International |
|
Pay |
|
|
0.10 |
% |
|
3 Month CHF LIBOR |
|
$ |
(731,706 |
) |
|
|
1,500,000,000 |
|
CHF |
|
8/5/2012 |
|
Merrill Lynch Capital Services |
|
Pay |
|
|
0.10 |
% |
|
3 Month CHF LIBOR |
|
|
(1,070,636 |
) |
|
|
225,000,000 |
|
CHF |
|
8/5/2012 |
|
Deutsche Bank AG |
|
Pay |
|
|
0.10 |
% |
|
3 Month CHF LIBOR |
|
|
(157,462 |
) |
|
|
250,000,000 |
|
CHF |
|
8/5/2012 |
|
Morgan Stanley Capital Services Inc. |
|
Pay |
|
|
0.10 |
% |
|
3 Month CHF LIBOR |
|
|
(189,657 |
) |
|
|
12,100,000,000 |
|
JPY |
|
12/21/2013 |
|
Bank of America |
|
Receive |
|
|
0.50 |
% |
|
6 Month JPY LIBOR |
|
|
322,409 |
|
|
|
157,000,000 |
|
SEK |
|
12/21/2013 |
|
Bank of America |
|
Pay |
|
|
3.25 |
% |
|
3 Month SEK STIBOR |
|
|
(667,752 |
) |
|
|
153,000,000 |
|
CHF |
|
12/21/2013 |
|
Barclays Bank PLC |
|
Pay |
|
|
1.00 |
% |
|
6 Month CHF LIBOR |
|
|
(3,033,750 |
) |
|
|
307,000,000 |
|
SEK |
|
12/21/2013 |
|
Barclays Bank PLC |
|
Pay |
|
|
3.25 |
% |
|
3 Month SEK STIBOR |
|
|
(1,317,116 |
) |
|
|
35,000,000 |
|
GBP |
|
12/21/2013 |
|
Barclays Bank PLC |
|
Receive |
|
|
2.00 |
% |
|
6 Month GBP LIBOR |
|
|
607,345 |
|
|
|
134,000,000 |
|
CAD |
|
12/21/2013 |
|
Citibank N.A. |
|
Pay |
|
|
2.00 |
% |
|
3 Month CAD BAS |
|
|
(2,269,134 |
) |
|
|
2,200,000,000 |
|
JPY |
|
12/21/2013 |
|
Citibank N.A. |
|
Pay |
|
|
0.50 |
% |
|
6 Month JPY LIBOR |
|
|
(58,620 |
) |
|
|
943,000,000 |
|
SEK |
|
12/21/2013 |
|
Citibank N.A. |
|
Receive |
|
|
3.25 |
% |
|
3 Month SEK STIBOR |
|
|
4,045,736 |
|
|
|
141,000,000 |
|
CHF |
|
12/21/2013 |
|
Credit Suisse International |
|
Receive |
|
|
1.00 |
% |
|
6 Month CHF LIBOR |
|
|
2,795,809 |
|
|
|
281,000,000 |
|
CAD |
|
12/21/2013 |
|
Deutsche Bank AG |
|
Pay |
|
|
2.00 |
% |
|
3 Month CAD BAS |
|
|
(4,758,407 |
) |
|
|
93,000,000 |
|
CHF |
|
12/21/2013 |
|
Deutsche Bank AG |
|
Pay |
|
|
1.00 |
% |
|
6 Month CHF LIBOR |
|
|
(1,844,044 |
) |
|
|
76,000,000 |
|
GBP |
|
12/21/2013 |
|
Deutsche Bank AG |
|
Receive |
|
|
2.00 |
% |
|
6 Month GBP LIBOR |
|
|
1,318,806 |
|
|
|
1,923,000,000 |
|
SEK |
|
12/21/2013 |
|
Deutsche Bank AG |
|
Pay |
|
|
3.25 |
% |
|
3 Month SEK STIBOR |
|
|
(8,250,212 |
) |
|
|
184,000,000 |
|
CAD |
|
12/21/2013 |
|
Goldman Sachs International |
|
Pay |
|
|
2.00 |
% |
|
3 Month CAD BAS |
|
|
(3,115,825 |
) |
|
|
172,000,000 |
|
GBP |
|
12/21/2013 |
|
Goldman Sachs International |
|
Receive |
|
|
2.00 |
% |
|
6 Month GBP LIBOR |
|
|
2,984,667 |
|
|
|
25,300,000,000 |
|
JPY |
|
12/21/2013 |
|
Goldman Sachs International |
|
Receive |
|
|
0.50 |
% |
|
6 Month JPY LIBOR |
|
|
674,127 |
|
|
|
152,000,000 |
|
CAD |
|
12/21/2013 |
|
JPMorgan Chase Bank, N.A. |
|
Pay |
|
|
2.00 |
% |
|
3 Month CAD BAS |
|
|
(2,573,943 |
) |
|
|
109,000,000 |
|
CAD |
|
12/21/2013 |
|
Merrill Lynch Capital Service |
|
Receive |
|
|
2.00 |
% |
|
3 Month CAD BAS |
|
|
1,845,788 |
|
|
|
9,000,000 |
|
CHF |
|
12/21/2013 |
|
Merrill Lynch Capital Services |
|
Receive |
|
|
1.00 |
% |
|
6 Month CHF LIBOR |
|
|
178,456 |
|
|
|
19,500,000 |
|
GBP |
|
12/21/2013 |
|
Merrill Lynch Capital Services |
|
Pay |
|
|
2.00 |
% |
|
6 Month GBP LIBOR |
|
|
(338,378 |
) |
|
|
27,100,000,000 |
|
JPY |
|
12/21/2013 |
|
Merrill Lynch Capital Services |
|
Receive |
|
|
0.50 |
% |
|
6 Month JPY LIBOR |
|
|
722,089 |
|
|
|
907,000,000 |
|
USD |
|
2/10/2014 |
|
Deutsche Bank AG |
|
Pay |
|
|
0.68 |
% |
|
3 Month USD LIBOR |
|
|
306,660 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79,000,000 |
|
AUD |
|
6/20/2014 |
|
Citibank N.A. |
|
Pay |
|
|
3.75 |
% |
|
3 Month AUD BBSW |
|
|
126,006 |
|
|
|
107,000,000 |
|
EUR |
|
6/20/2014 |
|
Deutsche Bank AG |
|
Receive |
|
|
1.50 |
% |
|
6 Month EURIBOR |
|
|
161,806 |
|
|
|
313,000,000 |
|
USD |
|
6/20/2014 |
|
Deutsche Bank AG |
|
Pay |
|
|
1.00 |
% |
|
3 Month USD LIBOR |
|
|
(1,449,777 |
) |
|
|
378,000,000 |
|
USD |
|
2/10/2017 |
|
Deutsche Bank AG |
|
Receive |
|
|
1.72 |
% |
|
3 Month USD LIBOR |
|
|
5,979,275 |
|
|
|
2,500,000,000 |
|
JPY |
|
12/21/2021 |
|
Bank of America |
|
Pay |
|
|
1.50 |
% |
|
6 Month JPY LIBOR |
|
|
(1,268,452 |
) |
|
|
13,000,000 |
|
SEK |
|
12/21/2021 |
|
Bank of America |
|
Receive |
|
|
3.75 |
% |
|
3 Month SEK STIBOR |
|
|
231,483 |
|
|
|
7,000,000 |
|
SEK |
|
12/21/2021 |
|
Barclays Bank PLC |
|
Receive |
|
|
3.75 |
% |
|
3 Month SEK STIBOR |
|
|
124,645 |
|
|
|
6,000,000 |
|
GBP |
|
12/21/2021 |
|
Barclays Bank PLC |
|
Pay |
|
|
3.75 |
% |
|
6 Month GBP LIBOR |
|
|
(1,027,630 |
) |
|
|
29,000,000 |
|
CAD |
|
12/21/2021 |
|
Citibank N.A. |
|
Receive |
|
|
3.50 |
% |
|
3 Month CAD BAS |
|
|
2,876,146 |
|
|
|
32,000,000 |
|
CHF |
|
12/21/2021 |
|
Barclays Bank PLC |
|
Receive |
|
|
2.25 |
% |
|
6 Month CHF LIBOR |
|
|
2,837,505 |
|
|
|
31,000,000 |
|
CHF |
|
12/21/2021 |
|
Credit Suisse International |
|
Pay |
|
|
2.25 |
% |
|
6 Month CHF LIBOR |
|
|
(2,748,833 |
) |
|
|
700,000,000 |
|
JPY |
|
12/21/2021 |
|
Citibank N.A. |
|
Receive |
|
|
1.50 |
% |
|
6 Month JPY LIBOR |
|
|
355,167 |
|
|
|
220,000,000 |
|
SEK |
|
12/21/2021 |
|
Citibank N.A. |
|
Pay |
|
|
3.75 |
% |
|
3 Month SEK STIBOR |
|
|
(3,917,409 |
) |
|
|
63,000,000 |
|
CAD |
|
12/21/2021 |
|
Deutsche Bank AG |
|
Receive |
|
|
3.50 |
% |
|
3 Month CAD BA'S |
|
|
6,248,180 |
|
|
|
18,000,000 |
|
CHF |
|
12/21/2021 |
|
Deutsche Bank AG |
|
Receive |
|
|
2.25 |
% |
|
6 Month CHF LIBOR |
|
|
1,596,096 |
|
|
|
17,000,000 |
|
GBP |
|
12/21/2021 |
|
Deutsche Bank AG |
|
Pay |
|
|
3.75 |
% |
|
6 Month GBP LIBOR |
|
|
(2,911,617 |
) |
|
|
418,000,000 |
|
SEK |
|
12/21/2021 |
|
Deutsche Bank AG |
|
Receive |
|
|
3.75 |
% |
|
3 Month SEK STIBOR |
|
|
7,443,077 |
|
|
|
34,000,000 |
|
CAD |
|
12/21/2021 |
|
Goldman Sachs International |
|
Receive |
|
|
3.50 |
% |
|
3 Month CAD BA'S |
|
|
3,372,033 |
|
|
|
38,000,000 |
|
GBP |
|
12/21/2021 |
|
Goldman Sachs International |
|
Pay |
|
|
3.75 |
% |
|
6 Month GBP LIBOR |
|
|
(6,508,321 |
) |
|
|
5,200,000,000 |
|
JPY |
|
12/21/2021 |
|
Goldman Sachs International |
|
Pay |
|
|
1.50 |
% |
|
6 Month JPY LIBOR |
|
|
(2,638,381 |
) |
|
|
33,500,000 |
|
CAD |
|
12/21/2021 |
|
JPMorgan Chase Bank, N.A. |
|
Receive |
|
|
3.50 |
% |
|
3 Month CAD BAS |
|
|
3,322,445 |
|
|
|
24,000,000 |
|
CAD |
|
12/21/2021 |
|
Merrill Lynch Capital Service |
|
Pay |
|
|
3.50 |
% |
|
6 Month CAD BAS |
|
|
(2,380,259 |
) |
|
|
2,000,000 |
|
CHF |
|
12/21/2021 |
|
Merrill Lynch Capital Services |
|
Pay |
|
|
2.25 |
% |
|
6 Month CHF LIBOR |
|
|
(177,344 |
) |
|
|
11,000,000 |
|
GBP |
|
12/21/2021 |
|
Merrill Lynch Capital Services |
|
Receive |
|
|
3.75 |
% |
|
6 Month GBP LIBOR |
|
|
1,883,988 |
|
|
|
5,600,000,000 |
|
JPY |
|
12/21/2021 |
|
Merrill Lynch Capital Services |
|
Pay |
|
|
1.50 |
% |
|
6 Month JPY LIBOR |
|
|
(2,841,333 |
) |
|
|
65,000,000 |
|
USD |
|
5/15/2022 |
|
JPMorgan Chase Bank N.A. |
|
Pay |
|
|
0.00 |
% |
|
3 Month USD LIBOR |
|
|
(14,786,717 |
) |
|
|
19,000,000 |
|
AUD |
|
6/20/2022 |
|
Citibank N.A. |
|
Receive |
|
|
4.75 |
% |
|
6 Month AUD BBSW |
|
|
(174,038 |
) |
|
|
24,000,000 |
|
EUR |
|
6/20/2022 |
|
Deutsche Bank AG |
|
Pay |
|
|
3.00 |
% |
|
6 Month EURIBOR |
|
|
(391,281 |
) |
|
|
68,000,000 |
|
USD |
|
6/20/2022 |
|
Deutsche Bank AG |
|
Receive |
|
|
2.25 |
% |
|
3 Month USD LIBOR |
|
|
(725,607 |
) |
|
|
105,000,000 |
|
USD |
|
8/15/2022 |
|
JPMorgan Chase Bank N.A. |
|
Pay |
|
|
0.00 |
% |
|
3 Month USD LIBOR |
|
|
(23,768,362 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000,000 |
|
GBP |
|
12/7/2046 |
|
Merrill Lynch Capital Services |
|
Pay |
|
|
4.36 |
% |
|
6 month GBP LIBOR |
|
|
(11,369,019 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(57,101,278 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums to (Pay) Receive |
|
$ |
26,197,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# |
|
Receive Fund receives fixed rate and pays variable rate.
(Pay) Fund pays fixed rate and receives variable rate. |
As of November 30, 2011, for the above contracts and/or agreements, the Fund had
sufficient cash and/or securities to cover any commitments or collateral requirements of the
relevant broker or exchange.
Notes to Schedule of Investments:
144A Securities exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration,
normally to qualified institutional investors.
AMBAC Insured as to the payment of principal and interest by AMBAC Assurance Corporation.
BBSW Bank Bill Swap Reference Rate
CAD BA Canadian Brokers Acceptance Rate
CDO Collateralized Debt Obligation
CHF LIBOR London Interbank Offered Rate denominated in Swiss Franc.
CMBS Commercial Mortgage Backed Security
CP Counterparty
EURIBOR Euro Interbank Offered Rate
FGIC Insured as to the payment of principal and interest by Financial Guaranty Insurance Corporation.
FSA Insured as to the payment of principal and interest by Financial Security Assurance.
GBP LIBOR London Interbank Offered Rate denominated in British Pounds.
JPY LIBOR London Interbank Offered Rate denominated in Japanese Yen
LIBOR London Interbank Offered Rate
MBIA Insured as to the payment of principal and interest by MBIA Insurance Corp.
OTC Over-the-Counter
SEK STIBOR Stockholm Interbank Offered Rate denominated in Swedish Krona.
USD LIBOR London Interbank Offered Rate denominated in United States Dollars.
XL Insured as to the payment of principal and interest by XL Capital Assurance.
The rates shown on variable rate notes are the current interest rates at November 30, 2011, which are subject to change based on the terms of the security. |
|
♦ |
|
These securities are primarily backed by subprime mortgages. |
|
(a) |
|
All or a portion of this security has been pledged to cover collateral requirements on reverse repurchase agreements. |
|
(b) |
|
Indexed security in which price and/or coupon is linked to the prices of a specific instrument or financial statistic. |
|
(c) |
|
All or a portion of this security has been pledged to cover margin requirements on futures contracts, collateral on
swap contracts, forward currency contracts, and/or written options, if any. |
|
(d) |
|
Security valued at fair value using methods determined by or at the direction of the Trustees of GMO Trust. |
|
(e) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. |
|
(f) |
|
Rate disclosed, the 7 day net yield, is as of November 30, 2011. Note: Yield rounds to 0.00%. |
Currency Abbreviations:
AUD Australian Dollar
CAD Canadian Dollar
CHF Swiss Franc
EUR Euro
GBP British Pound
JPY Japanese Yen
SEK Swedish Krona
USD United States Dollar
As of November 30, 2011, the approximate cost for U.S. federal income tax purposes and gross and
net unrealized appreciation (depreciation) in value of investments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross |
|
Gross |
|
Net Unrealized |
|
|
|
|
Unrealized |
|
Unrealized |
|
Appreciation |
|
|
Aggregate Cost |
|
Appreciation |
|
(Depreciation) |
|
(Depreciation) |
|
|
$ 988,904,696 |
|
$ |
42,849,889 |
|
|
$ |
(116,383,385 |
) |
|
$ |
(73,533,496 |
) |
|
|
Basis of presentation
The preparation of the Schedule of Investments in accordance with accounting principles
generally accepted in the United States of America (U.S. GAAP) requires management to make
estimates and assumptions that affect the reported amounts and disclosures in the Schedule of
Investments during the reporting period. Management believes the estimates and security
valuations are appropriate; however, actual results may differ from those estimates, and the
security valuations reflected in the Schedule of Investments may differ from the value the Fund
ultimately realizes upon sale of the securities.
Portfolio valuation
Securities listed on a securities exchange (other than exchange-traded options) for which
market quotations are readily available are valued at (i) the last sale price or (ii) official
closing price as of the close of regular trading on the New York Stock Exchange (NYSE) or,
(iii) if there is no such reported sale or official closing price (or in the event the Manager
deems the over-the-counter (OTC) market to be a better indicator of market value), at the most
recent quoted price. Unlisted securities for which market quotations are readily available are
generally valued at the most recent quoted price. Non-emerging market debt instruments with a
remaining maturity of sixty days or less may be valued at amortized cost (unless circumstances
dictate otherwise; for example, if the issuers creditworthiness has become impaired), which
approximates market value. Shares of open-end investment companies are generally valued at their
net asset value. Derivatives and other securities for which quotations are not readily available
or whose values the Manager has determined to be unreliable are valued at fair value as
determined in good faith by the Trustees or persons acting at their direction pursuant to
procedures approved by the Trustees. Although the goal of fair valuation is to determine the
amount the owner of the securities might reasonably expect to receive upon their current sale,
because of the uncertainty inherent in fair value pricing, the value determined for a particular
security may be materially different from the value realized upon its sale. As of November 30,
2011, the total value of securities held directly that were fair valued using methods determined
in good faith by or at the direction of the Trustees of the Trust represented 1.7% of net
assets. For the period ended November 30, 2011, the Fund did not reduce the value of
any of its OTC derivative contracts based on the creditworthiness of its counterparties.
See Derivative financial instruments below for a further discussion on valuation of
derivatives.
Typically the Fund values debt instruments based on the most recent quoted price supplied by a
single pricing source chosen by the Manager. Although the Manager normally does not evaluate
pricing sources on a day-to-day basis, it does evaluate pricing sources on an ongoing basis and
may change a pricing source at any time. The Manager monitors erratic or unusual movements
(including unusual inactivity) in the prices supplied for a security and has discretion to
override a price supplied by a source (e.g., by taking a price supplied by another) when it
believes that the price supplied is not reliable. Although alternative prices may be available
for securities held by the Fund, those alternative sources are not typically part of the
valuation process and do not necessarily provide greater certainty about the prices used by the
Fund. As of November 30, 2011, the total value of securities held for which no alternative
pricing source was available represented 3.5% of the net assets of the Fund.
Quotation or quoted price typically means the bid price for securities held long and the ask
price for securities sold short. If the pricing convention for a security does not involve a bid
or an ask, quotation or quoted price may be a market quotation provided by a market
participant or other third party pricing source in accordance with the convention for that
security.
In accordance with the authoritative guidance on fair value measurements and disclosures under
U.S. GAAP, the Fund discloses the fair value of its investments in a three-level hierarchy. The
valuation hierarchy is based upon the relative observability of inputs to the valuation of the
Funds investments. The inputs or methodology used for valuing securities are not necessarily an
indication of the risk associated with investing in those securities.
During the current year, the Fund became subject to an amendment to authoritative accounting
guidance that requires new disclosures and clarifies existing disclosure requirements about fair
value measurements. Specifically, the amendment requires purchases, sales, issuances and
settlements be disclosed separately (i.e. gross) within the Level 3 roll-forward. The effective
date of the guidance was for interim and annual periods beginning after December 15, 2010.
The three levels are defined as follows:
Level 1 Valuations based on quoted prices for identical securities in active markets.
Level 2 Valuations determined using other significant direct or indirect observable inputs.
These inputs may include most recent quoted prices, interest rates, prepayment speeds, credit
risk, yield curves and similar data. The Fund also used third party valuation services (which
use industry models and inputs from pricing vendors) to value certain credit default swaps.
Level 3 Valuations based primarily on inputs that are unobservable and significant. The Fund
utilized a number of fair value techniques on Level 3 investments, including the following: The
Fund valued certain debt securities and OTC derivatives using quoted prices. The Fund also used
third party valuation services to value certain credit default swaps using unobservable inputs.
The following is a summary of the respective levels assigned to the Funds investments and
derivatives, if any, as of November 30, 2011:
ASSET VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Assets |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed Securities |
|
$ |
|
|
|
$ |
16,983,645 |
|
|
$ |
198,289,970 |
|
|
$ |
215,273,615 |
|
Foreign Government Obligations |
|
|
|
|
|
|
48,569,241 |
|
|
|
|
|
|
|
48,569,241 |
|
U.S. Government |
|
|
152,009,700 |
|
|
|
403,060,732 |
|
|
|
|
|
|
|
555,070,432 |
|
U.S. Government Agency |
|
|
|
|
|
|
877,624 |
|
|
|
|
|
|
|
877,624 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL DEBT OBLIGATIONS |
|
|
152,009,700 |
|
|
|
469,491,242 |
|
|
|
198,289,970 |
|
|
|
819,790,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Purchased |
|
|
|
|
|
|
829,540 |
|
|
|
14,731,584 |
|
|
|
15,561,124 |
|
Short-Term Investments |
|
|
80,019,164 |
|
|
|
|
|
|
|
|
|
|
|
80,019,164 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments |
|
|
232,028,864 |
|
|
|
470,320,782 |
|
|
|
213,021,554 |
|
|
|
915,371,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives * |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
3,082,235 |
|
|
|
|
|
|
|
3,082,235 |
|
Interest Rate Risk |
|
|
|
|
|
|
52,359,744 |
|
|
|
|
|
|
|
52,359,744 |
|
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
979,610 |
|
|
|
|
|
|
|
|
|
|
|
979,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
233,008,474 |
|
|
$ |
525,762,761 |
|
|
$ |
213,021,554 |
|
|
$ |
971,792,789 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITY VALUATION INPUTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices |
|
|
|
|
|
|
|
|
|
|
|
|
in Active |
|
|
Significant |
|
|
|
|
|
|
|
|
|
Markets for |
|
|
Other |
|
|
Significant |
|
|
|
|
|
|
Identical |
|
|
Observable |
|
|
Unobservable |
|
|
|
|
|
|
Liabilities |
|
|
Inputs |
|
|
Inputs |
|
|
|
|
Description |
|
(Level 1) |
|
|
(Level 2) |
|
|
(Level 3) |
|
|
Total |
|
Derivatives* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Written Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Currency Risk |
|
$ |
|
|
|
$ |
(242,168 |
) |
|
$ |
|
|
|
$ |
(242,168 |
) |
Swap Agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit Risk |
|
|
|
|
|
|
(2,506,446 |
) |
|
|
(165,920 |
) |
|
|
(2,672,366 |
) |
Interest Rate Risk |
|
|
|
|
|
|
(109,461,022 |
) |
|
|
|
|
|
|
(109,461,022 |
) |
Futures Contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate Risk |
|
|
(2,053,550 |
) |
|
|
|
|
|
|
|
|
|
|
(2,053,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(2,053,550 |
) |
|
$ |
(112,209,636 |
) |
|
$ |
(165,920 |
) |
|
$ |
(114,429,106 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
The risks referenced above are not intended to be inclusive of all risks. Please see the
Investment and other risks and Derivative financial instruments sections below for a further
discussion of risks.
|
|
|
* |
|
Because the tables above are based on market values or unrealized appreciation/(depreciation)
rather than the notional amounts of derivatives, the uncertainties surrounding the valuation
inputs for a derivative are likely to be more significant to the Funds net asset value than the
uncertainties surrounding inputs for a non-derivative security with the same market value. |
The aggregate net values of the Funds direct investments in securities and derivative financial
instruments using Level 3 inputs were 25.2% and (0.1)% of total net assets, respectively.
For the period ended November 30, 2011, there were no significant transfers between Level 1 and
Level 2.
The following is a
reconciliation of
investments and
derivatives, if
any, in which significant unobservable inputs (Level 3) were used in determining value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Appreciation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Depreciation) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
from |
|
|
|
Balances as |
|
|
|
|
|
|
|
|
|
|
Accrued |
|
|
Total |
|
|
Unrealized |
|
|
Transfers |
|
|
Transfers |
|
|
Balances as |
|
|
Investments |
|
|
|
of February |
|
|
|
|
|
|
|
|
|
|
Discounts/ |
|
|
Realized |
|
|
Appreciation |
|
|
into |
|
|
out of |
|
|
of November 30, |
|
|
Still Held as of |
|
|
|
28, 2011 |
|
|
Purchases |
|
|
Sales |
|
|
Premiums |
|
|
Gain/(Loss) |
|
|
(Depreciation) |
|
|
level 3 * |
|
|
level 3 * |
|
|
2011 |
|
|
November 30, 2011 |
|
Debt Obligations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset-Backed
Securities |
|
$ |
293,962,357 |
|
|
$ |
|
|
|
$ |
(80,059,746 |
) |
|
$ |
16,448 |
|
|
$ |
(178,828 |
) |
|
$ |
(15,450,261 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
198,289,970 |
|
|
$ |
(15,405,855 |
) |
Purchased Options |
|
|
12,123,200 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,608,384 |
|
|
|
|
|
|
|
|
|
|
|
14,731,584 |
|
|
|
2,608,384 |
|
Swaps |
|
|
(57,502 |
) |
|
|
|
|
|
|
(13,319 |
) |
|
|
|
|
|
|
13,319 |
|
|
|
(108,418 |
) |
|
|
|
|
|
|
|
|
|
|
(165,920 |
) |
|
|
(108,418 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
306,028,055 |
|
|
$ |
|
|
|
$ |
(80,073,065 |
) |
|
$ |
16,448 |
|
|
$ |
(165,509 |
) |
|
$ |
(12,950,295 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
212,855,634 |
|
|
$ |
(12,905,889 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fund accounts for investments and derivatives transferred into Level 3 at the value at
the beginning of the period and transferred out of Level 3 at the value at the end of the period. |
Foreign currency translation
The market values of foreign securities, currency holdings and related assets and
liabilities are typically translated into U.S. dollars at the close of regular trading on the
NYSE, generally at 4:00 pm. Income and expenses denominated in foreign currencies are typically
translated into U.S. dollars at the close of regular trading on the NYSE on the business day the
income and expenses are accrued or incurred. Fluctuations in the value of currency holdings and
other assets and liabilities resulting from changes in exchange rates are recorded as unrealized
foreign currency gains or losses. Realized gains or losses and unrealized appreciation or
depreciation on investment securities and income and expenses are translated on the respective
dates of such transactions. The effects of changes in foreign currency exchange rates on
investments in securities are not separated from the effects of changes in market prices of
those securities, but are included with the net realized and unrealized gain or loss on
investment securities.
Repurchase agreements
The Fund may enter into repurchase agreements. Under a repurchase agreement the Fund
acquires a security for cash and obtains a simultaneous commitment from the seller to repurchase
the security at an agreed upon price and date. The Fund, through its custodian, takes possession
of securities it acquired under the repurchase agreement. The value of the securities acquired
is required by contract to be marked to market daily and additional collateral is required to be
transferred so that the market value is at least equal to the amount owed to the Fund by the
seller. If the seller of a repurchase agreement defaults or enters into insolvency proceedings
and/or the value of the securities subject to the repurchase agreement is insufficient, the
Funds recovery of cash from the seller may be delayed and the Fund may incur a loss equal to
the difference between the cash it paid and the value of the securities. The Fund had no
repurchase agreements outstanding at the end of the period.
Reverse repurchase agreements
The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement
the Fund sells portfolio assets subject to an agreement by the Fund to repurchase the same
assets at an agreed upon price and date. The Fund can use the proceeds received from entering
into a reverse repurchase agreement to make additional investments, which generally causes the
Funds portfolio to behave as if it were leveraged. If the buyer in a reverse repurchase
agreement files for bankruptcy or becomes insolvent, the Fund may be unable to recover the
securities it sold and as a result would realize a loss equal to the difference between the
value of those securities and the payment it received for them. The size of this loss will
depend upon the difference between what the buyer paid for the securities the Fund sold to it
and the value of those securities (e.g., a buyer may pay $95 for a bond with a market value of
$100). In the event of a buyers bankruptcy or insolvency, the Funds use of proceeds from the
sale of its securities may be restricted while the other party or its trustee or receiver
determines whether to honor the Funds right to repurchase the securities. As of November 30,
2011, the Fund had received $48,647,471 from reverse repurchase agreements relating to
securities with a market value, plus accrued interest, of $48,551,832. Reverse repurchase
agreements outstanding at the end of the period are listed in the Funds Schedule of
Investments.
Inflation-indexed bonds
The Fund may invest in inflation indexed bonds. Inflation indexed bonds are fixed income
securities whose principal value is adjusted periodically according to the rate of inflation.
Two structures are common. The U.S. Treasury and some other issuers use a structure that
reflects inflation in the principal value of the bond. Most other issuers pay out any inflation
related accruals as part of a semiannual coupon.
The value of inflation indexed bonds is expected to change in response to changes in real
interest rates. Real interest rates, in turn, are tied to the relationship between nominal
interest rates (i.e., stated interest rates) and the rate of inflation. Therefore, if the rate
of inflation rises at a faster rate than nominal interest rates, real interest rates (i.e.
nominal interest rate minus inflation) might decline, leading to an increase in value of
inflation indexed bonds. In contrast, if nominal interest rates increase at a faster rate than
inflation, real interest rates might rise, leading to a decrease in value of inflation indexed
bonds. There can be no assurance, however, that the value of inflation indexed bonds will be
directly correlated to changes in nominal interest rates, and short term increases in inflation
may lead to a decline in their value. Coupon payments received by the Fund from inflation
indexed bonds are included in the Funds gross income for the period in which they accrue. In
addition, any increase or decrease in the principal amount of an inflation indexed bond will
increase or decrease taxable ordinary income to the Fund, even though principal is not paid
until maturity. Inflation-indexed bonds outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Investment and other risks
The value of the Funds shares changes with the value of the Funds investments. Many
factors can affect this value, and you may lose money by investing in the Fund. The Fund is a
non-diversified investment company under the Investment Company Act of 1940 (the 1940 Act) and
therefore a decline in the market value of a particular security held by the Fund may affect the
Funds performance more than if the Fund were diversified. Selected risks of investing in
the Fund are summarized below. The risks of investing in the Fund depend on the types of
investments in its portfolio and the investment strategies the Manager employs on its behalf.
This section does not describe
every potential risk of investing in the Fund. The Fund could be subject to additional risks
because of the types of investments it makes and market conditions, which may change over time.
Market Risk Fixed Income Securities Typically, the value of fixed income
securities will decline during periods of rising interest rates and widening of credit
spreads. |
|
Market Risk Asset-Backed Securities Asset-backed securities are subject to severe
credit downgrades, illiquidity, defaults and declines in market value. |
|
Credit Risk The Fund runs the risk that the issuer or guarantor of a fixed income
security or the obligor of an obligation underlying an asset-backed security will be unable
or unwilling to satisfy its obligations to pay principal or interest payments or to
otherwise honor its obligations. The market value of a fixed income security normally will
decline as a result of the issuers failure to meet its payment obligations or the markets
expectation of a default, which may result from the downgrading of the issuers credit
rating. The Funds investments in below investment grade securities have speculative
characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case
with issuers of investment grade securities. |
|
Liquidity Risk Low trading volume, lack of a market maker, a large size position or
legal restrictions may limit or prevent the Fund from selling particular securities or
unwinding derivative positions at desirable prices. The more less-liquid securities the
Fund holds, the more likely it is to honor a redemption request in-kind. |
|
Derivatives Risk The use of derivatives involves the risk that their value may not
move as expected relative to the value of the relevant underlying assets, rates or indices.
Derivatives also present other Fund risks, including market risk, liquidity risk, currency
risk and counterparty risk. |
|
Leveraging Risk The Funds use of reverse repurchase agreements and other
derivatives and securities lending may cause its portfolio to be leveraged. Leverage
increases the Funds portfolio losses when the value of its investments decline. |
|
Counterparty Risk The Fund runs the risk that the counterparty to an OTC derivatives
contract or a borrower of the Funds securities will be unable or unwilling to make timely
settlement payments or otherwise honor its obligations. The risk of counterparty default is
particularly acute in economic environments in which financial services firms are exposed
to systemic risks of the type evidenced by the insolvency of Lehman Brothers in 2008 and
subsequent market disruptions. |
|
Focused Investment Risk Focusing investments in countries, regions, sectors or
companies with high positive correlations to one another, such as the Funds investments in
asset-backed securities secured by different types of consumer debt (e.g., credit-card
receivables, automobile loans and home equity loans), creates additional risk. |
|
Foreign Investment Risk The market prices of many foreign securities fluctuate more
than those of U.S. securities. Many foreign markets are less stable, smaller, less liquid
and less regulated than U.S. markets, and the cost of trading in those markets often is
higher than in U.S. markets. Foreign portfolio transactions generally involve higher
commission rates, transfer taxes and custodial costs than similar transactions in the U.S.
In addition, the Fund may be subject to foreign taxes on capital gains or other income
payable on foreign securities, on transactions in those securities and on the repatriation
of proceeds generated from those securities. Also, many foreign markets require a license
for the Fund to invest directly in those markets, and the Fund is subject to the risk that
it could not invest if its license were terminated or suspended. In some foreign markets,
prevailing custody and trade settlement practices (e.g., the requirement to pay for
securities prior to receipt) expose the Fund to credit and other risks with respect to
participating brokers, custodians, clearing banks or other clearing agents, escrow agents
and issuers. Further, adverse changes in investment regulations, capital requirements or
exchange controls could adversely affect the value of the Funds investments. |
|
Management and Operational Risk The Fund relies on GMOs ability to achieve its
investment objective by effectively implementing its investment approach. The Fund runs the
risk that GMOs proprietary investment techniques will fail to produce the desired results.
The Funds portfolio managers may use quantitative analyses and/or models and any
imperfections or limitations in such analyses and/or models could affect the ability of the
portfolio managers to implement strategies. By necessity, these analyses and models make
simplifying assumptions that limit their efficacy. Models that appear to explain prior
market data can fail to predict future market events. Further, the data used in models may
be inaccurate and/or it may not include the most recent information about a company or a
security. The Fund is also subject to the risk that deficiencies in the Managers or
another service providers internal systems or controls will cause losses for the Fund or
impair Fund operations. |
Market Disruption and Geopolitical Risk Geopolitical and other events may disrupt
securities markets and adversely affect global economies and markets. Those events as well
as other changes in foreign and domestic economic and political conditions could adversely
affect the value of the Funds investments. |
|
Large Shareholder Risk To the extent that shares of the Fund are held by large
shareholders (e.g., institutional investors, asset allocation funds, or other GMO Funds),
the Fund is subject to the risk that these shareholders will disrupt the Funds operations
by purchasing or redeeming Fund shares in large amounts and/or on a frequent basis. |
|
Currency Risk Fluctuations in exchange rates can adversely affect the market value
of the Funds foreign currency holdings and investments denominated in foreign currencies. |
The Fund invests in asset-backed securities, which may be backed by many types of assets,
including pools of residential and commercial mortgages, automobile loans, educational loans,
home equity loans, or credit card receivables, which expose the Fund to additional types of
market risk. They also may be backed by pools of corporate or sovereign bonds, bank loans made
to corporations, or a combination of these bonds and loans (commonly referred to as
collateralized debt obligations or collateralized loan obligations) and by the fees earned
by service providers. Payment of interest on asset backed securities and repayment of principal
largely depend on the cash flows generated by the assets backing the securities. The market risk
of a particular asset-backed security depends on many factors, including the deal structure
(e.g., determination as to the amount of underlying assets or other support needed to produce
the cash flows necessary to service interest and make principal payments), the quality of the
underlying assets and, if any, the level of credit support and the credit quality of the
credit-support provider. Asset-backed securities involve risk of loss of principal if obligors
of the underlying obligations default and the value of the defaulted obligations exceeds
whatever credit support the securities may have. The obligations of issuers (and obligors of
underlying assets) also are subject to bankruptcy, insolvency, and other laws affecting the
rights and remedies of creditors. Many asset-backed securities in which the Fund has invested
are now rated below investment grade.
The existence of insurance on an asset-based security does not guarantee that the principal
and/or interest will be paid because the insurer could default on its obligations. In recent
years, a significant number of asset-backed security insurers have defaulted on their
obligations.
With the deterioration of worldwide economic and liquidity conditions that occurred and became
acute in 2008, the markets for asset-backed securities became fractured, and uncertainty about
the creditworthiness of those securities (and underlying assets) caused credit spreads (the
difference between yields on the asset-backed securities and U.S. Government securities) to
widen dramatically. Concurrently, systemic risks of the type evidenced by the insolvency of
Lehman Brothers and subsequent market disruptions reduced the ability of financial institutions
to make markets in many fixed income securities. These events reduced liquidity and contributed
to substantial declines in the value of asset-backed and other fixed income securities. There
can be no assurance these conditions will not occur again. Also, government actions and
proposals affecting the terms of underlying home and consumer loans, changes in demand for
products (e.g., automobiles) financed by those loans, and the inability of borrowers to
refinance existing loans (e.g., sub-prime mortgages) have had, and may continue to have, adverse
valuation and liquidity effects on asset-backed securities.
The market value of an asset-backed security may depend on the servicing of its underlying
assets and is, therefore, subject to risks associated with the negligence or defalcation of its
servicer. In some circumstances, the mishandling of related documentation also may affect the
rights of security holders in and to the underlying assets. The insolvency of entities that
generate receivables or that utilize the assets may result in a decline in the value of the
underlying assets, as well as costs and delays. The obligations underlying asset-backed
securities, in particular securities backed by pools of residential and commercial mortgages,
also are subject to unscheduled prepayment, and a Fund may be unable to invest prepayments at as
high a yield as is provided by the asset-backed security. The risk of investing in asset-backed
securities has increased because performance of the various sectors in which the assets
underlying asset-backed securities are concentrated (e.g., auto loans, student loans, sub-prime
mortgages, and credit card receivables) has become more highly correlated since the
deterioration in worldwide economic and liquidity conditions.
Among other trading agreements, the Fund is party to International Swaps and Derivatives
Association, Inc. Master Agreements (ISDA Agreements) or other similar types of agreements
with selected counterparties that generally govern over-the-counter derivative transactions
entered into by the Fund. The ISDA Agreements typically include representations and warranties
as well as contractual terms related to collateral, events of default, termination events, and
other provisions. Termination events may include the decline in the net assets of the Fund below
a certain level over a specified period of time and entitle a counterparty to elect to terminate
early with respect to some or all the transactions under the ISDA Agreement with that
counterparty. Such an election by one or more of the counterparties could have a material
adverse effect on the Funds operations.
Derivative financial instruments
Derivatives are financial contracts whose value depends on, or is derived from, the value of
underlying assets, reference rates, or indices, to increase, decrease or adjust elements of the
investment exposures of the Funds portfolio. Derivatives may relate to securities, interest
rates, currencies, currency exchange rates, inflation rates, commodities and related indices,
and include foreign currency contracts, swap contracts, reverse repurchase agreements, and other
exchange-traded and OTC contracts.
The Fund may use derivatives as a substitute for direct investment in securities or other
assets. In particular, the Fund may use swaps or other derivatives on an index, a single
security or a basket of securities to gain investment exposures (e.g., by selling protection
under a credit default swap). The Fund also may use currency derivatives (including forward
currency contracts, futures contracts, swap contracts and options) to gain exposure to a given
currency.
The Fund may use derivatives in an attempt to reduce its investment exposures (which may result
in a reduction below zero). For example, the Fund may use credit default swaps to take a short
position with respect to the likelihood of default by an issuer. The Fund also may use currency
derivatives in an attempt to reduce (which may result in a reduction below zero) some aspect of
the currency exposure in its portfolio. For these purposes, the Fund may use an instrument
denominated in a different currency that the Manager believes is highly correlated with the
relevant currency.
The Fund may use derivatives in an attempt to adjust elements of its investment exposures to
various securities, sectors, markets, indices and currencies without actually having to sell
existing investments or make new direct investments. For instance, the Manager may alter the
interest rate exposure of debt instruments by employing interest rate swaps. Such a strategy is
designed to maintain the Funds exposure to the credit of an issuer through the debt instrument
but adjust the Funds interest rate exposure through the swap. With these swaps, the Fund and
its counterparties exchange interest rate exposure, such as fixed versus variable rates and
shorter duration versus longer duration exposure. In adjusting its investment exposures, the
Fund also may use currency derivatives in an attempt to adjust its currency exposure, seeking
currency exposure that is different (in some cases, significantly different) from the currency
exposure represented by its portfolio investments.
The Fund may use derivatives to effect transactions intended as a substitute for securities
lending.
The Fund is not limited in the extent to which it uses derivatives or in the absolute face value
of its derivative positions. As a result, the Fund may be leveraged in terms of aggregate
exposure of its assets, and its net long exposure may exceed 100% of its net assets.
The use of derivatives involves risks that are in addition to, and potentially greater than, the
risks associated with investing directly in securities and other more traditional assets. In
particular, the use of OTC derivatives exposes the Fund to the risk that the counterparty to a
derivatives contract will be unable or unwilling to make timely settlement payments or otherwise
to honor its obligations. OTC derivatives contracts typically can be closed only with the other
party to the contract. If the counterparty defaults, the Fund will have contractual remedies,
but may not be able to enforce them. Because the contract for each OTC derivative is
individually negotiated, the counterparty may interpret contractual terms (e.g., the definition
of default) differently than the Fund and if that occurs, the Fund may decide not to pursue its
claims against the counterparty in order to avoid incurring the cost and unpredictability of
legal proceedings. The Fund, therefore, may be unable to obtain payments the Manager believes
are owed under OTC derivatives contracts or those payments may be delayed or made only after the
Fund has incurred the costs of litigation.
The Fund may invest in derivatives that do not require the counterparty to post collateral
(e.g., foreign currency forwards), that require collateral but that do not provide for the
Funds security interest in it to be perfected, that require a significant upfront deposit by
the Fund unrelated to the derivatives intrinsic value, or that do not require the collateral to
be regularly marked-to-market (e.g., certain OTC derivatives). Even where obligations are
required by contract to be collateralized, there is usually a lag between the day the collateral
is called for and the day the Fund receives it. When a counterpartys obligations are not fully
secured by collateral, the Fund is exposed to the risk of having limited recourse if the
counterparty defaults. The Fund may invest in derivatives with a limited number of
counterparties, and events affecting the creditworthiness of any of those counterparties may
have a pronounced effect on the Fund. Derivatives risk is particularly acute in environments
(like those experienced recently) in which financial services firms are exposed to systemic
risks of the type evidenced by the insolvency of Lehman Brothers and subsequent market
disruptions. During these periods of market disruptions, the Fund may have a greater need for
cash to provide collateral for large swings in its mark-to-market obligations under the
derivatives used by the Fund.
Derivatives also present risks described in Investment and other risks above. Many
derivatives, in particular OTC derivatives, are complex and their valuation often requires
modeling and judgment, which increases the risk of mispricing or improper valuation. The pricing
models used by the Fund or their pricing agents may not produce valuations that are consistent
with the values realized when OTC derivatives are actually closed out or sold. This valuation
risk is more pronounced when the Fund enters into OTC derivatives with specialized terms because
the value of those derivatives in some cases is determined only by reference to similar
derivatives with
more standardized terms. As a result, incorrect valuations may result in increased cash payments
to counterparties, undercollateralization and/or errors in the calculation of the Funds net
asset value.
The Funds use of derivatives may not be effective or have the desired results. Moreover,
suitable derivatives will not be available in all circumstances. For example, the economic costs
of taking some derivative positions may be prohibitive, and if a counterparty or its affiliate
is deemed to be an affiliate of the Fund, the Fund will not be permitted to trade with that
counterparty. In addition, the Manager may decide not to use derivatives to hedge or otherwise
reduce the Funds risk exposures, potentially resulting in losses for the Fund.
Derivatives also involve the risk that changes in their value may not move as expected relative
to the value of the assets, rates or indices they are designed to track. The use of derivatives
also may increase or accelerate the taxes payable by shareholders.
When a Fund uses credit default swaps to obtain synthetic long exposure to a fixed income
security such as a debt instrument or index of debt instruments, the Fund is exposed to the risk
that it will be required to pay the full notional value of the swap contract in the event of a
default.
Swap contracts and other OTC derivatives are highly susceptible to liquidity risk and
counterparty risk, and are subject to documentation risks. Because many derivatives have a
leverage component (i.e., a notional value in excess of the assets needed to establish and/or
maintain the derivative position), adverse changes in the value or level of the underlying
asset, rate or index may result in a loss substantially greater than the amount invested in the
derivative itself. In addition, the Fund is not limited in the extent to which it may use
derivatives or in the absolute face value of its derivative positions, and, as a result, it may
be leveraged in relation to its assets (see Leveraging Risk above).
The U.S. government recently enacted legislation that provides for new regulation of the
derivatives markets, including clearing, margin, reporting and registration requirements.
Because the legislation leaves much to rule making, its ultimate impact remains unclear. New
regulations could, among other things, restrict the Funds ability to engage in derivatives
transactions (for example, by making certain types of derivatives transactions no longer
available to the Fund) and/or increase the costs of such derivatives transactions (for example,
by increasing margin or capital requirements), and the Fund may be unable to execute its
investment strategy as a result. It is unclear how the regulatory changes will affect
counterparty risk.
Forward currency contracts
The Fund may enter into forward currency contracts, including forward cross currency
contracts. A forward currency contract is an agreement between two parties to buy and sell a
currency at a set price on a future date (or to pay or receive the amount of the change in
relative values of the two currencies). The market value of a forward currency contract
fluctuates with changes in forward currency exchange rates. The value of each of the Funds
forward currency contracts is marked to market daily using rates supplied by a quotation service
and changes in value are recorded by the Fund as unrealized gains or losses. Realized gains or
losses on the contracts are equal to the difference between the value of the contract at the
time it was opened and the value at the time it was closed.
These contracts involve market risk in excess of the unrealized gain or loss. Forward currency
contracts expose the Fund to the market risk of unfavorable movements in currency values and the
risk that the counterparty will be unable or unwilling to meet the terms of the contracts.
The Fund had no forward currency contracts outstanding at the end of the period.
Futures contracts
The Fund may purchase and sell futures contracts. A futures contract is a contract that
obligates the holder to buy or sell an asset at a predetermined delivery price at a specified
time in the future. Some futures contracts are net (cash) settled. Upon entering into a futures
contract, the Fund is required to deposit cash, U.S. government and agency obligations or other
liquid assets with the futures clearing broker in accordance with the initial margin
requirements of the broker or exchange. Futures contracts are generally valued at the settlement
price established at the close of business each day by the board of trade or exchange on which
they are traded. The value of each of the Funds futures contracts is marked to market daily and
an appropriate payable or receivable for the change in value (variation margin) is recorded by
the Fund. The payable or receivable is settled on the following business day. Gains or losses
are recognized but not accounted for as realized until the contracts expire or are closed.
Futures contracts involve, to varying degrees, risk of loss in excess of the variation margin.
Under some circumstances, futures exchanges may establish daily limits on the amount that the
price of a futures contract can vary from the previous days settlement price, thereby
effectively preventing liquidation of unfavorable positions. Futures contracts expose the Fund
to the risk that it may not be able to enter into a closing transaction due to an illiquid
market. During the period ended November 30, 2011, the Fund used futures contracts to
adjust interest-rate exposure and maintain the diversity and liquidity of the
portfolio. Futures contracts outstanding at the end of the period are listed in the
Funds Schedule of Investments.
Options
The Fund may purchase call and put options. A call option gives the holder the right to buy
an asset; a put option gives the holder the right to sell an asset. By purchasing options the
Fund alters its exposure to the underlying asset by, in the case of a call option, entitling it
to purchase the underlying asset at a set price from the writer of the option and, in the case
of a put option, entitling it to sell the underlying asset at a set price to the writer of the
option. The Fund pays a premium for a purchased option. That premium is disclosed in the
Schedule of Investments and is subsequently reflected in the marked-to-market value of the
option. The potential loss associated with purchasing put and call options is limited to the
premium paid. During the period ended November 30, 2011, the Fund used purchased option
contracts to adjust exposure to currencies and otherwise adjust currency exchange rate risk, as
well as to enhance the diversity and liquidity of the portfolio and to adjust interest rate
exposure. Option contracts purchased by the Fund and outstanding at the end of the
period are listed in the Funds Schedule of Investments.
The Fund may write (i.e., sell) call and put options on futures, swaps (swaptions),
securities or currencies it owns or in which it may invest. Writing options alters the Funds
exposure to the underlying asset by, in the case of a call option, obligating the Fund to sell
the underlying asset at a set price to the option-holder and, in the case of a put option,
obligating the Fund to purchase the underlying asset at a set price from the option-holder. In
some cases (e.g., index options), settlement will be in cash, based on a formula price. When the
Fund writes a call or put option, an amount equal to the premium received is recorded as a
liability and is subsequently included in the marked-to-market value of the option. As a writer
of an option, the Fund has no control over whether it will be required to sell (call) or
purchase (put) the underlying asset and as a result bears the risk of an unfavorable change in
the price of the asset underlying the option. In the event that the Fund writes call options
without an offsetting exposure (e.g., call options on an asset that the Fund does not own), it
bears an unlimited risk of loss if the price of the underlying asset increases during the term
of the option. OTC options expose the Fund to the risk the Fund may not be able to enter into a
closing transaction because of an illiquid market. During the period ended November 30, 2011,
the Fund used written option contracts to adjust exposure to currencies and otherwise adjust
currency exchange rate risk, as well as to enhance the diversity and liquidity of the portfolio
and to adjust interest rate exposure. Written options outstanding at the end of the
period are listed in the Funds Schedule of Investments.
When an option contract is closed, the Fund records a realized gain or loss equal to the
difference between the value of the contract at the time it was opened and the value at the time
it was closed. Realized gains and losses on purchased options are included in realized gains and
losses on investment securities. If a written call option is exercised, the premium originally
received is recorded as an addition to sales proceeds. If a written put option is exercised, the
premium originally received is recorded as a reduction in the cost of investments purchased.
Gains and losses from the expiration or closing of written option contracts are separately
disclosed.
For the period ended November 30, 2011, investment activity in options contracts written by the
Fund was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Puts |
|
|
Calls |
|
|
|
Principal |
|
|
Number |
|
|
|
|
|
|
Principal |
|
|
Number of |
|
|
|
|
|
|
Amount of |
|
|
of Futures |
|
|
|
|
|
|
Amount of |
|
|
Futures |
|
|
|
|
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
|
Contracts |
|
|
Contracts |
|
|
Premiums |
|
Outstanding,
beginning of period |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
(503,000,000 |
) |
|
|
|
|
|
$ |
(1,797,998 |
) |
Options written |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options bought back |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000,000 |
|
|
|
|
|
|
|
700,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding, end of
period |
|
$ |
|
|
|
|
|
|
|
$ |
|
|
|
|
(3,000,000 |
) |
|
|
|
|
|
$ |
(1,097,998 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exchange-traded options are valued at the last sale price, provided that price is between the
closing bid and ask prices. If the last sale price is not within this range, then they will be
valued at the closing bid price for long positions and the closing ask price for short
positions. The Fund generally values OTC options using inputs provided by primary pricing
sources and industry models.
Swap agreements
The Fund may enter into various types of swap agreements, including, without limitation,
swaps on securities and securities indices, interest rate swaps, total return swaps, credit
default swaps, variance swaps, commodity swaps, inflation swaps and other types of
available swaps. A swap agreement is an agreement to exchange the return generated by one asset for the
return generated by another asset. Some swap contracts are net settled. When entering into a
swap agreement and during the term of the transaction, the Fund and/or the swap counterparty may
post or receive cash or securities as collateral.
Initial upfront payments received or made upon entering into a swap agreement are included in
the fair market value of the swap. The Fund does not amortize upfront payments. Net periodic
payments made or received to compensate for differences between the stated terms of the swap
agreement and prevailing market conditions (credit spreads, currency exchange rates, interest
rates, and other relevant factors) are recorded as realized gains or losses. A liquidation
payment received or made at the termination of the swap agreements is recorded as realized gain
or losses.
Interest rate swap agreements involve an exchange by the parties of their respective commitments
to pay or right to receive interest, (e.g., an exchange of floating rate interest payments for
fixed rate interest payments with respect to the notional amount of principal).
Total return swap agreements involve a commitment by one party to pay interest to the other
party in exchange for a payment to it from the other party based on the return of a reference
asset (e.g., a security, basket of securities, or future contract), both based on notional
amounts. To the extent the return of the reference asset exceeds or falls short of the interest
payments, one party is entitled to receive a payment from or obligated to make a payment to the
other party.
In a credit default swap agreement, one party makes payments to another party in exchange for
the right to receive a specified return (or to put a security) if a credit event (e.g., default
or similar event) occurs with respect to a reference entity or entities. A seller of credit
default protection receives periodic payments in return for its obligation to pay the principal
amount of a debt security (or other agreed-upon value) to the other party upon the occurrence of
a credit event. If no credit event occurs, the seller has no payment obligations so long as
there is no early termination.
For credit default swap agreements on asset-backed securities, a credit event may be triggered
by various occurrences, which may include an issuers failure to pay interest or principal on a
reference security, a breach of a material representation or covenant, an agreement by the
holders of an asset-backed security to a maturity extension, or a write-down on the collateral
underlying the security. For credit default swap agreements on corporate or sovereign issuers, a
credit event may be triggered by such occurrences as the issuers bankruptcy, failure to pay
interest or principal, repudiation/moratorium and/or restructuring.
Variance swap agreements involve an agreement by two parties to exchange cash flows based on the
measured variance (or square of volatility) of a specified underlying asset. One party agrees to
exchange a fixed rate or strike price payment for the floating rate or realized price
variance on the underlying asset with respect to the notional amount. At inception, the strike
price chosen is generally fixed at a level such that the fair value of the swap is zero. As a
result, no money changes hands at the initiation of the contract. At the expiration date, the
amount payable by one party to the other is the difference between the realized price variance
of the underlying asset and the strike price multiplied by the notional amount. A receiver of
the realized price variance would be entitled to receive a payment when the realized price
variance of the underlying asset is greater than the strike price and would be obligated to make
a payment when that variance is less than the strike price. A payer of the realized price
variance would be obligated to make a payment when the realized price variance of the underlying
asset is greater than the strike price and would be entitled to receive a payment when that
variance is less than the strike price. This type of agreement is essentially a forward contract
on the future realized price variance of the underlying asset.
The Fund prices its swap agreements daily using models that may incorporate quotations from
market makers and records the change in value, if any, as unrealized gain or loss. Gains or
losses are realized upon termination of the swap agreements or reset dates, as appropriate.
Swap agreements generally are not traded on publicly traded exchanges. The values assigned to
them may differ significantly from the values that would be realized upon termination, and the
differences could be material. Entering into swap agreements involves counterparty credit,
legal, and documentation risk that is generally not reflected in the models used to price the
swap agreement. Such risks include the possibility that the counterparty defaults on its
obligations to perform or disagrees as to the meaning of contractual terms, that the Fund has
amounts on deposit in excess of amounts owed by the Fund, or that any collateral the other party
posts is insufficient or not timely received by the Fund. Credit risk is particularly acute in
economic environments in which financial services firms are exposed to systemic risks of the
type evidenced by the insolvency of Lehman Brothers in 2008 and subsequent market
disruptions. During the period ended November 30, 2011, the Fund used swap agreements
to hedge against default risk, to adjust interest rate exposure, and to achieve exposure to a
reference entitys credit. Swap agreements outstanding at the end of the period are
listed in the Funds Schedule of Investments.
Rights and warrants
The Fund may purchase or otherwise receive warrants or rights. Warrants and rights generally
give the holder the right to receive, upon exercise, a security of the issuer at a set price.
Funds typically use warrants and rights in a manner similar to their use of purchased options on
securities, as described in options above. Risks associated with the use of warrants and rights
are generally similar to risks associated with the use of purchased options. However, warrants
and rights often do not have standardized terms, and may have longer maturities and may be less
liquid than exchange-traded options. In addition, the terms of warrants or rights may limit
the Funds ability to exercise the warrants or rights at such times and in such quantities as
the Fund would otherwise wish. The Fund held no rights or warrants at the end of the
period.
The following is a summary of the fair valuations of derivative instruments categorized by risk
exposure:
Fair Values of Derivative Instruments as of November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate |
|
|
Foreign currency |
|
|
Credit |
|
|
Equity |
|
|
Other |
|
|
|
|
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
contracts |
|
|
Total |
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments, at value (purchased options,
rights and/or warrants) |
|
$ |
14,731,584 |
|
|
$ |
829,540 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
15,561,124 |
|
Unrealized appreciation on futures contracts* |
|
|
979,610 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
979,610 |
|
Unrealized appreciation on swap agreements |
|
|
52,359,744 |
|
|
|
|
|
|
|
3,082,235 |
|
|
|
|
|
|
|
|
|
|
|
55,441,979 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
68,070,938 |
|
|
$ |
829,540 |
|
|
$ |
3,082,235 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
71,982,713 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Written options outstanding |
|
$ |
|
|
|
$ |
(242,168 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
(242,168 |
) |
Unrealized depreciation on futures contracts* |
|
|
(2,053,550 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,053,550 |
) |
Unrealized depreciation on swap agreements |
|
|
(109,461,022 |
) |
|
|
|
|
|
|
(2,672,366 |
) |
|
|
|
|
|
|
|
|
|
|
(112,133,388 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(111,514,572 |
) |
|
$ |
(242,168 |
) |
|
$ |
(2,672,366 |
) |
|
$ |
|
|
|
$ |
|
|
|
$ |
(114,429,106 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
|
The Fair Values of Derivative Instruments table includes cumulative appreciation/depreciation of
futures contracts as reported in the Schedule of Investments. |
As provided by authoritative accounting guidance, the table above is based on market values or unrealized appreciation /
(depreciation) rather than the notional amounts of derivatives. Changes to market values of reference asset(s) will tend to have
a greater impact on the Fund (with correspondingly greater risk) the greater the notional amount. For further information on
notional amounts, see the Schedule of Investments.
The volume of derivative activity, based on absolute values (futures contracts), notional amounts
(swap agreements), or principal amounts (options) outstanding at each month-end, was as follows for
the period ended November 30, 2011:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Futures |
|
Swap |
|
|
|
|
Contracts |
|
Agreements |
|
Options |
Average amount outstanding |
|
$ |
5,195,714,653 |
|
|
$ |
9,134,167,501 |
|
|
$ |
300,485,432 |
|
For additional information regarding the Funds Schedule of Investments, please see the
Funds most recent annual or semiannual shareholder report filed on the Securities and Exchange
Commissions website, www.sec.gov, or visit GMOs website at www.gmo.com.
Item 2. Controls and Procedures.
|
(a) |
|
The registrants Principal Executive Officer and Principal Financial Officer have
concluded as of a date within 90 days of the filing of this report, based on their
evaluation of the registrants disclosure controls and procedures (as defined in Rule
30a-3(c) under the Investment Company Act of 1940) that the design and operation of such
procedures are effective to provide reasonable assurance that information required to be
disclosed by the registrant on Form N-Q is recorded, processed, summarized, and reported
within the time periods specified in the Commissions rules and forms. |
|
|
(b) |
|
There were no changes in the registrants internal control over financial
reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that
occurred during the registrants last fiscal quarter that has materially affected, or
are reasonably likely to materially affect, the registrants internal control over
financial reporting. |
Item 3. Exhibits.
|
|
Certifications by the Principal Executive Officer and Principal Financial Officer of the
registrant as required by Rule 30a-2(a) under the Investment Company Act of 1940 are attached
hereto as EX- 99.CERT. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act
of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
(Registrant) GMO Trust |
|
|
|
By (Signature and Title): |
|
/s/ J.B. Kittredge |
|
|
J.B. Kittredge, Chief Executive Officer |
|
|
|
Date: January 26, 2012 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act
of 1940, this report has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.
|
|
|
|
By (Signature and Title): |
|
/s/ J.B. Kittredge |
|
|
J.B. Kittredge, Principal Executive Officer |
|
|
|
Date:
January 26, 2012 |
|
|
|
By (Signature and Title): |
|
/s/ Sheppard N. Burnett |
|
|
Sheppard N. Burnett, Principal Financial Officer |
|
|
|
Date:
January 26, 2012 |